Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABCB11	"ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP"	ENSG00000073734	"ATP binding cassette subfamily B member 11"	O95342	2	168922938-169031322	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 47.4"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 1: 38.7;Alveolar cells type 2: 58.1;Club cells: 35.2;granulocytes: 22.1;Hepatocytes: 17.9"	"Cancer enriched"	"Detected in single"	87	"liver cancer: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.0;NB-4: 1.7;PC-3: 1.0;THP-1: 2.6;TIME: 1.8;U-2197: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019035	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA019035: AB_1844429"	"unprognostic (7.78e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-1)"	"unprognostic (5.26e-6)"	"unprognostic (7.12e-2)"	"unprognostic (1.82e-1)"		"unprognostic (1.94e-1)"	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.4	0.0	0.0	0.0	0.0	1.7	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.8	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	38.7	58.1	0.0	0.0	0.0	0.0	0.3	0.0	16.0	35.2	0.0	0.0	0.0	0.0	0.1	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.1	17.9	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7
ABCF2	"ABC28, EST133090, HUSSY-18, M-ABC1"	ENSG00000285292	"ATP binding cassette subfamily F member 2"	Q9UG63	7	151207837-151227166	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 41.5"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA020091, HPA021815, HPA030388"	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558"																		7.9	4.3	4.4	6.5	6.4	2.4	6.1	4.2	10.8	5.5	5.4	5.4	4.0	3.6	5.7	3.3	6.1	5.8	4.3	4.5	4.1		6.2	5.2	5.8	6.1	5.0	8.3	4.0	6.0	10.8	2.7	4.1	5.7	4.1	5.2	4.4	2.9	5.8	20.3	5.6	3.1	6.0	3.1	5.9	3.3	7.2	5.6	5.2	4.9	5.5	6.8	4.8	3.3	8.5	11.3	8.7	9.8	10.0	24.2	13.4	12.7	11.8	9.0	18.8	10.4	12.2	5.0	18.2	10.0	8.7	11.4	9.3	10.3	19.5	13.8	16.7	18.9	10.0	14.3	14.3	18.4	7.8	4.2	12.1	9.5	5.6	18.9	24.3	4.7	11.5	9.9	20.7	17.8	8.5	15.0	9.6	26.5	8.9	15.5	9.7	26.4	0.9	8.2	16.5	9.5	8.7	10.1	20.3	4.0	10.3	3.5	9.7	20.2	10.9	8.0	8.1	5.9	10.3	14.1	8.4	2.4	12.9	20.6	12.4	13.1	22.8	16.0	19.5	7.7	8.7	9.8	2.3	10.3	7.1	24.2	8.5	14.4	12.6	11.3	8.4	12.7	12.0	0.7	10.0	5.5	6.8	12.7	13.4											0.0	0.3	9.0	17.6	24.2	17.5	0.0	7.6	0.0	0.0	0.0	7.9	0.0	0.0	0.0	37.1	11.3	15.3	0.0	0.0	0.0	1.0	10.7	10.3	11.4	0.0	9.5	6.4	10.4	10.5	41.5	9.8	4.6	18.6	0.0	8.0	12.9	0.0	20.1	13.8	0.0	11.9	12.9	17.6	22.3	8.4	22.0	0.0	14.9	12.2	13.9
AC008403.1		ENSG00000268465			19	48465837-48472431	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.7;intestine: 3.6;testis: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.9;LHCN-M2: 3.6;NB-4: 3.8;U-698: 5.0"									HPA060662			Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA060662: AB_2732652"																		0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.5	0.1	3.6			0.0	2.7	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.2		0.3	0.0	0.0	0.1	0.0		0.3	0.0		0.1	0.0	0.3	0.1	1.6	0.0	0.2	0.1	0.5	4.7			0.1		0.0	0.0	0.0	1.0	0.5	0.7	0.4	0.0	1.0	0.0	0.0	0.0	0.0	2.9	2.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.6	2.3	1.3	0.0	2.2	0.0	0.0	1.2	0.0	0.0	0.0	1.9	0.3	0.0	3.6	0.0	0.0	3.8	1.9	1.7	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.2	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.9	1.9	0.0	0.0	0.9	0.9	5.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.3	0.2	1.0	0.3	0.4	0.3	0.0	0.6	0.1	0.0	0.0	0.4	0.5	1.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC008878.3		ENSG00000268861			19	7382834-7472477	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 7.7;bone marrow: 7.1;lymphoid tissue: 8.6"	"Cell type enhanced"	"Detected in single"	40	"Club cells: 1.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 18.3;HL-60: 8.3;MOLT-4: 11.7;REH: 9.6;THP-1: 13.8;U-698: 10.9;U-937: 8.6"									"HPA042689, HPA071867"	Supported		Uncertain	Cytosol		NA	NA			Cytosol		"HPA042689: AB_10794385, HPA071867: AB_2686466"	"unprognostic (1.46e-1)"							"unprognostic (2.47e-2)"			"unprognostic (2.97e-1)"		"unprognostic (1.20e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.45e-4)"			0.0	1.2		4.3		7.1	0.0		0.0	0.0	0.5			0.0	0.9	0.1	1.5	0.0	2.1	0.0			0.2	0.0	1.0	8.6			0.0	0.0	0.0		0.0		0.0	0.7		0.0	0.0	0.0	0.6	0.0	2.3		4.9	0.0	0.0			0.7		4.8	2.4		7.4	1.4	7.7	3.3	0.1	4.2	1.4	0.0	0.2	0.5	0.0	1.3	0.3	0.0	0.0	1.1	0.0	0.3	0.0	0.0	18.3	0.0	4.5	0.0	0.0	2.5	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.4	8.3	7.3	2.8	0.1	0.1	2.2	0.0	1.0	4.7	0.0	0.0	3.7	0.0	11.7	3.0	0.0	0.9	0.0	9.6	0.1	3.7	0.2	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	13.8	0.0	0.1	0.3	0.2	0.0	0.1	0.0	10.9	0.3	8.6	0.0	0.9	1.7	7.7	2.7	1.9	1.5	7.4	3.6	1.8	1.1	6.7	4.2	1.4	4.3	0.1	3.3	1.4	1.7	1.4											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC104662.2		ENSG00000281028			4	25160663-25277306	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	14	"Ciliated cells: 1.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004099	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA004099: AB_1855353"					"unprognostic (3.59e-2)"													1.7	2.3	6.7	5.5	11.1	6.7	3.7	9.7	9.3	2.0	4.1	4.3	5.0	7.8	1.7	2.5	5.4	3.5	1.6	1.5	7.3		2.8	10.1	4.0	4.4	10.0	2.4	1.5	1.8	2.9	14.9	2.8	7.1	1.1	5.4	2.1	4.5	2.5	1.8	0.0	6.0	2.6	11.3	2.5	3.6	9.2	10.6	6.1	5.3	1.6	5.3	3.1	4.8	2.1	2.0	7.5	1.9	1.4	4.3	0.9	5.3	3.7	4.4	2.4	3.2	6.1	4.1	8.9	9.1	11.4	12.2	4.0	7.5	13.5	2.1	11.4	10.7	2.9	9.3	3.8	6.9	5.8	2.6	6.3	9.1	3.8	0.6	12.4	3.6	3.1	0.7	4.5	4.6	2.2	3.9	6.0	4.2	15.7	3.5	6.1	10.8	0.9	3.6	6.7	2.4	6.3	12.0	5.9	2.7	9.8	5.0	1.0	3.6	1.3	2.6	4.4	2.9	1.7	7.4	6.3	1.8	2.9	5.2	10.6	12.0	19.1	5.4	6.5	4.6	7.5	1.9	6.2	2.4	1.8	1.6	2.1	2.4	2.3	1.4	1.9	1.8	2.1	3.2	1.4	1.3	2.0	4.3	0.9											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACIN1	"ACINUS, fSAP152, KIAA0670"	ENSG00000100813	"Apoptotic chromatin condensation inducer 1"	Q9UKV3	14	23058564-23095614	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000657	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000657: AB_1078091"	"unprognostic (2.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (4.88e-5)"	"unprognostic (1.49e-3)"	"unprognostic (9.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.33e-2)"	32.4	44.4	34.6	46.6	36.2	57.6	32.5	45.7	41.8	36.6	30.1	39.1	35.2	28.5	52.9	32.2	39.3	34.6	33.3	29.7	33.1	28.3	34.9	35.5	28.8	41.1	34.4	27.7	43.9	34.5	51.1	48.3	37.0	33.7	35.4	34.6	31.5	33.0	38.3	43.8	38.1	35.1	40.1	35.0	52.9	34.0	34.5	40.6	44.2	38.5	27.1	45.9	30.5	47.8	6.9	6.8	13.4	4.9	9.7	5.5	2.7	23.7	24.5	38.7	31.3	24.2	19.5	38.9	26.5	18.7	32.1	26.2	32.4	27.9	44.1	15.7	21.9	21.1	26.2	53.4	30.3	33.0	31.0	23.7	38.8	25.9	44.6	13.9	42.0	34.5	22.8	18.7	32.8	27.7	26.3	28.0	32.9	35.7	17.7	24.1	29.7	47.6	41.5	43.5	26.4	23.4	43.2	30.1	23.5	26.6	42.0	25.8	19.0	35.2	23.0	20.9	29.4	18.9	34.0	28.6	22.0	22.0	20.8	24.4	18.8	21.1	45.7	19.5	31.9	23.8	4.1	4.9	5.6	5.5	4.5	4.4	4.4	3.7	4.2	4.1	6.9	5.1	4.6	13.4	9.7	3.7	6.8	3.8	2.7	34.6	36.2	45.7	41.8	33.1	28.3	34.4	27.7	33.7	40.6	65.5	108.5	33.5	28.5	33.2	38.0	57.7	30.6	109.7	78.5	33.2	25.5	48.1	14.9	45.8	27.6	44.3	40.8	46.7	42.7	55.4	35.5	30.5	120.8	24.7	40.9	14.3	55.9	32.5	26.9	5.0	42.6	35.7	25.3	52.3	37.3	25.9	52.1	42.1	36.0	14.1	42.2	6.5	39.6	35.1	34.6	40.7	57.9	36.3	40.7	34.1
ACP5	"HPAP, TRAP"	ENSG00000102575	"Acid phosphatase 5, tartrate resistant"	P13686	19	11574660-11579008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 117.9;lung: 151.9"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 439.8;Ito cells: 434.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 51.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.6;BJ hTERT+: 9.8;K-562: 10.3;RPMI-8226: 13.9;SK-MEL-30: 41.4;U-138 MG: 38.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002584, HPA057655, HPA059463"	Enhanced		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		3700000	Cytosol		"CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.93e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	117.9	2.8	0.9	21.1	1.1	1.4	7.7	0.7	1.0	11.9	10.2	1.2	2.1	7.7	7.7	6.5	12.1	3.5	9.1	6.8	0.9	0.4	28.0	16.3	151.9	30.8	1.0	1.0	13.2	8.7	0.2	1.6	9.2	1.2	6.4	8.7	19.1	8.6	2.8	3.0	10.4	15.6	3.3	1.9	20.7	15.0	3.5	0.7	9.2	2.2	8.2	18.4	11.4	10.1	51.4	13.9	16.8	9.4	2.6	16.0	8.1	3.3	0.4	0.0	0.0	0.2	0.0	14.6	0.4	9.8	0.0	0.0	0.0	0.1	0.5	0.6	2.9	2.4	0.1	0.0	1.5	0.0	3.7	0.3	0.1	0.0	1.8	0.6	0.0	0.2	0.0	1.1	0.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.7	0.3	0.5	0.3	0.1	0.3	0.1	0.7	13.9	0.0	0.1	0.2	0.3	0.0	0.0	41.4	0.4	0.0	0.1	0.3	38.9	0.4	0.7	0.1	0.2	1.8	0.2	8.0	0.0	1.2	0.0	9.4	16.8	4.1	9.1	2.1	51.4	6.4	4.7	1.7	23.5	8.3	4.7	2.6	2.6	8.7	13.9	16.0	8.1	0.9	1.1	0.7	1.0	0.9	0.4	1.0	1.0	1.2	0.7	8.9	8.5	68.7	8.2	9.2	6.0	1.1	22.9	2.7	2.3	7.0	17.7	29.7	8.3	1.6	0.1	2.9	5.9	0.0	9.9	23.7	12.1	16.2	65.4	6.4	439.8	1.6	2.9	434.6	101.6	0.0	1.7	100.7	13.5	131.7	4.5	43.7	4.7	21.0	11.3	91.3	31.7	0.0	3.2	0.0	0.1	9.7	21.9	25.4	8.3	4.3
ACSF2	"ACSMW, FLJ20920"	ENSG00000167107	"Acyl-CoA synthetase family member 2"	Q96CM8	17	50426158-50474845	"Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 60.0"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 70.1;Proximal tubular cells: 99.5;Syncytiotrophoblasts: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 37.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024693	Enhanced		Uncertain	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Nucleoplasm, Microtubules, Cytosol"		"HPA024693: AB_2671654"	"unprognostic (1.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.49e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.45e-2)"	"prognostic favorable (2.41e-4)"	13.2	37.6	4.8	7.7	4.4	1.1	16.3	2.0	4.0	8.4	19.1	4.0	30.3	9.2	3.5	15.4	6.7	4.3	7.2	12.9	5.6	2.0	60.0	15.0	9.0	3.7	3.7	2.8	9.4	3.4	2.6	1.7	14.1	3.9	12.4	7.4	7.6	10.1	33.3	28.4	9.7	22.4	4.5	3.5	4.5	8.0	4.5	3.6	3.5	30.6	6.6	5.9	13.0	7.6	7.8	13.8	11.9	6.2	1.2	4.3	2.1	9.6	3.1	2.6	6.2	27.5	5.0	15.3	2.3	3.4	5.0	9.9	12.3	18.5	6.0	5.1	2.8	4.6	5.8	1.8	11.4	6.0	7.5	4.4	10.3	1.5	21.8	4.6	1.3	9.6	22.2	17.5	6.4	0.8	18.0	6.8	7.9	1.2	3.4	5.4	11.6	3.1	4.1	0.4	18.2	4.6	7.8	1.9	15.2	1.6	37.7	8.5	4.6	4.5	6.9	4.7	5.5	6.0	8.8	5.1	9.2	2.9	1.3	0.7	6.1	1.2	3.1	3.8	6.5	0.5	0.0	2.5	11.9	1.8	6.2	1.6	7.8	1.3	1.8	13.8	1.9	0.6	0.8	0.4	1.2	5.4	5.2	4.3	2.1	4.8	4.4	2.0	4.0	5.6	2.0	3.7	2.8	3.9	3.6	26.8	22.4	2.4	22.9	5.4	0.0	17.3	10.2	12.0	17.0	3.5	0.0	70.1	10.0	10.9	0.2	5.2	47.0	0.0	3.9	9.5	5.9	3.5	21.9	34.1	19.9	0.0	9.8	4.3	8.8	1.3	24.7	11.5	3.3	15.4	19.9	6.6	4.5	35.1	13.4	99.5	0.2	0.0	3.9	0.0	2.7	6.0	67.7	5.7	18.3	10.6
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.0;liver: 190.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 359.4;Hepatocytes: 1018.8;Late spermatids: 335.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 80.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 80.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 151.2;ASC TERT1: 36.7;HSkMC: 80.3;RPTEC TERT1: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011964"	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Nucleoplasm	"Mitochondria, Cytosol"	"HPA011316: AB_1844536, HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	105.0	6.7	4.2	14.1	13.5	46.0	54.4	3.2	9.6	7.2	12.2	16.4	5.5	4.9	5.7	12.7	8.8	6.4	5.7	24.3	6.4	4.1	32.8	190.9	20.7	18.9	24.0	3.8	4.2	7.3	5.9	8.7	4.4	11.6	14.2	2.6	9.1	17.9	4.8	89.1	20.4	4.5	6.4	18.2	16.9	6.5	6.4	15.9	2.1	8.3	10.1	5.8	7.6	11.0	0.5	2.2	80.2	8.9	0.7	0.7	2.9	6.1	1.9	1.2	3.1	151.2	36.7	1.0	3.4	1.7	2.0	1.4	0.4	1.7	2.5	0.3	4.0	4.9	3.8	5.4	2.2	1.7	12.4	1.9	1.8	1.7	5.0	24.3	4.9	4.6	80.3	18.6	1.7	8.7	3.6	2.6	0.4	0.8	7.8	9.8	3.2	0.3	6.8	0.2	4.1	2.7	0.9	1.0	3.2	47.8	17.5	4.6	4.3	3.1	9.4	10.5	0.5	3.4	5.0	2.8	1.8	2.1	4.3	1.0	3.0	1.5	1.1	5.8	6.9	2.8	2.3	8.9	2.8	0.5	5.2	0.5	0.5	0.4	0.2	2.2	0.5	0.4	0.3	80.2	0.7	3.6	0.4	0.7	2.9	4.2	13.5	3.2	9.6	6.4	4.1	24.0	3.8	11.6	15.9	23.8	107.2	14.5	16.5	18.7	5.8	89.7	28.1	13.4	21.6	29.6	17.7	8.6	79.6	3.9	359.4	5.6	2.6	0.0	11.0	1.9	9.1	56.1	23.1	1018.8	39.4	3.2	0.0	19.0	136.2	335.5	17.8	64.1	30.4	24.4	4.2	3.3	9.0	0.9	15.6	75.0	10.3	12.9	12.0	8.1	16.7	35.9	2.9	10.0	1.7	21.4
ACVR1	"ACVR1A, ACVRLK2, ALK2, SKR1"	ENSG00000115170	"Activin A receptor type 1"	Q04771	2	157736444-157875862	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007505, HPA046514"	Approved		Uncertain	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA007505: AB_1844752, HPA046514: AB_2732526"	"unprognostic (6.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (5.17e-4)"	18.9	9.2	18.0	10.0	12.7	1.6	38.7	15.3	12.2	25.2	14.4	7.4	8.4	8.9	24.8	26.8	11.0	16.6	20.5	18.8	18.7	8.6	21.7	18.9	22.5	15.1	10.4	7.9	18.5	12.3	11.3	17.0	14.2	12.3	16.8	10.5	14.3	18.1	13.6	15.6	12.8	11.5	29.2	12.3	9.2	11.8	8.8	10.9	7.5	34.0	14.6	6.9	16.1	32.5	1.4	2.4	3.8	2.6	1.9	10.0	1.6	2.1	4.3	5.0	6.5	25.4	26.5	7.0	15.4	25.6	12.4	13.2	3.4	4.8	0.0	7.1	16.6	12.0	6.0	3.6	8.3	13.3	14.7	3.1	8.7	2.5	4.9	20.1	0.6	10.4	33.2	15.8	25.3	32.3	16.2	13.4	2.4	3.2	2.4	15.5	3.8	0.1	0.2	7.5	3.0	7.8	1.4	6.7	1.8	16.0	8.1	4.4	5.5	5.9	3.4	21.1	8.2	1.8	2.3	19.3	18.8	6.2	9.2	5.8	1.6	1.2	0.1	19.3	0.5	20.2	3.8	2.6	0.2	1.1	1.7	1.2	1.4	7.8	2.5	1.8	0.8	3.1	1.5	0.8	1.9	2.3	2.4	10.0	1.6	18.0	12.7	15.3	12.2	18.7	8.6	10.4	7.9	12.3	10.9	8.9	7.0	0.8	6.8	8.8	7.5	9.2	12.7	6.7	9.1	7.0	0.0	7.0	5.0	8.4	0.5	13.5	3.1	0.0	15.5	4.4	11.6	8.9	4.7	12.1	6.5	3.2	4.1	17.2	11.6	1.1	18.7	7.7	3.3	3.6	5.2	6.1	14.7	3.5	14.9	15.3	1.5	12.9	15.5	0.5	2.5	6.6	8.8	1.0	3.5	7.6
ACVR2B	ActR-IIB	ENSG00000114739	"Activin A receptor type 2B"	Q13705	3	38453851-38493142	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 16.4;NTERA-2: 20.3;SuSa: 12.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007398, CAB025115, HPA040384"	Approved		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			Cytosol	"Nucleoplasm, Nuclear bodies"	"CAB025115: , HPA007398: AB_2667822, HPA040384: AB_2732484"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.75e-1)"	2.8	7.4	5.5	4.6	7.9	1.1	5.5	13.2	7.5	5.2	3.4	7.2	4.5	2.8	4.7	5.1	2.5	5.6	3.3	3.9	5.9	5.4	5.3	5.4	6.9	2.2	5.9	5.4	8.3	6.1	11.3	5.1	16.0	6.5	3.9	3.6	5.0	4.6	4.2	15.9	2.4	2.8	4.6	4.7	3.1	4.0	9.1	9.1	12.8	4.8	1.7	2.2	4.2	10.3	0.3	0.3	0.5	0.2	0.5	1.6	0.3	0.8	1.4	16.4	1.4	0.6	0.4	8.8	0.3	0.5	0.3	0.7	2.3	1.1	0.1	1.2	0.3	0.5	1.0	6.3	1.0	0.9	2.4	4.1	4.2	2.5	3.5	0.8	2.9	1.6	0.7	0.9	0.5	1.8	1.0	1.1	6.2	6.9	1.4	0.3	1.3	5.1	1.9	20.3	0.8	0.7	1.7	5.5	1.0	1.0	1.9	3.8	6.7	0.4	2.5	2.2	12.2	1.3	3.9	0.9	0.5	2.7	0.4	1.4	3.9	5.4	0.9	0.6	2.5	1.1	0.5	0.1	0.1	0.4	0.2	0.6	0.2	1.0	0.5	0.0	0.3	1.6	1.5	0.3	0.5	0.2	0.3	0.7	0.3	5.5	7.9	13.2	7.0	5.9	5.4	5.9	5.4	6.5	9.1	6.0	6.7	0.5	3.6	3.5	20.7	11.6	5.1	6.7	4.5	0.0	21.6	6.7	0.0	3.2	9.1	6.1	2.9	0.0	3.3	5.8	3.1	3.2	1.1	7.5	2.2	20.6	6.9	4.9	2.1	12.6	10.9	3.2	6.8	0.0	3.2	9.6	3.8	2.5	7.4	2.8	25.5	0.0	5.6	8.1	19.0	3.4	5.1	2.5	4.7	3.3
ADCK2	MGC20727	ENSG00000133597	"AarF domain containing kinase 2"	Q7Z695	7	140673153-140696261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA036036	Approved		Uncertain	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA036036: AB_10672078"	"unprognostic (2.76e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.10e-3)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-3)"	"prognostic favorable (9.75e-5)"	"unprognostic (1.89e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.13e-1)"	12.3	10.6	15.3	11.3	16.6	8.8	13.4	15.4	27.0	12.3	15.1	26.3	13.2	8.8	10.3	11.4	18.0	20.0	10.3	10.2	16.6	18.2	12.3	12.5	12.8	15.6	19.5	13.1	14.5	22.8	21.4	12.7	19.9	18.2	14.4	13.2	10.7	16.8	14.0	12.5	25.8	13.0	10.9	24.0	13.6	13.0	7.6	13.3	20.6	25.1	9.9	16.2	13.4	18.9	8.2	12.0	3.2	5.0	5.1	7.3	2.2	16.0	11.6	2.7	12.7	10.0	11.4	16.5	8.3	10.2	8.7	5.8	10.5	11.4	21.6	12.6	5.8	20.4	13.3	13.9	9.5	2.6	15.9	14.2	4.5	4.5	5.1	13.9	3.0	11.3	9.5	29.1	5.0	6.9	9.0	7.5	15.4	7.9	10.6	3.1	20.0	22.5	7.5	4.0	12.8	12.6	17.8	0.1	10.4	4.7	16.1	10.8	7.6	11.4	16.7	11.4	5.5	14.8	6.1	7.9	10.9	3.8	18.1	16.0	7.4	11.2	15.8	16.1	12.1	12.9	0.0	3.7	3.2	5.4	5.0	4.9	8.2	4.8	5.3	5.7	4.2	7.3	4.7	0.1	5.1	3.0	12.0	6.0	2.2	15.3	16.6	15.4	27.0	16.6	18.2	19.5	13.1	18.2	13.3	8.9	5.1	8.2	18.5	11.0	11.4	5.8	5.1	2.7	1.2	8.7	0.0	25.4	5.0	5.3	16.9	9.0	8.5	0.0	6.4	18.4	7.1	15.5	11.5	8.6	27.9	11.1	16.1	6.7	7.9	12.5	3.1	11.8	3.3	7.2	13.8	11.6	5.9	14.4	12.7	4.8	4.8	0.0	6.9	5.9	3.1	12.2	28.3	7.7	11.3	16.1
ADGRE2	"CD312, EMR2"	ENSG00000127507	"Adhesion G protein-coupled receptor E2"	Q9UHX3	19	14732393-14778541	"CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Cell adhesion, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.7;lymphoid tissue: 38.9"	"Cell type enhanced"	"Detected in many"	15	"granulocytes: 44.2;Kupffer cells: 60.1;Macrophages: 39.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 19.6;eosinophil: 24.2;intermediate monocyte: 15.7;neutrophil: 19.1;non-classical monocyte: 28.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 24.2;monocytes: 28.7"	"Cell line enhanced"	"Detected in some"		"HEL: 10.3;HMC-1: 16.6;NB-4: 10.1;RPMI-8226: 7.3;U-937: 13.2"									HPA055200			Uncertain	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA055200: "	"unprognostic (2.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.35e-6)"	"unprognostic (1.46e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.01e-1)"	6.3	3.1	1.7	22.9	1.9	7.2	4.4	1.0	1.3	14.9	8.1	2.5	0.9	2.4	12.0	1.0	1.9	2.3	3.3	7.3	2.0	1.8	3.4	4.3	15.6	37.4	2.2	0.0	5.3	3.5	0.7	1.6	10.9	2.4	3.8	2.5	3.2	2.4	3.9	3.5	3.0	3.0	2.0	3.1	38.9	2.0	2.2	1.4	2.8	3.4	5.2	2.8	7.5	2.1	0.1	3.1	24.2	28.7	1.2	0.0	1.8	0.2	1.0	0.1	0.2	0.1	0.3	1.1	0.8	1.1	0.0	0.0	0.2	0.2	0.2	0.1	0.7	2.1	1.7	0.3	0.1	0.0	0.2	0.2	10.3	3.3	0.2	0.5	3.8	16.6	0.8	1.5	3.7	0.6	0.1	0.1	0.9	2.4	0.4	1.2	0.5	1.3	10.1	0.4	0.7	0.2	0.1	1.4	7.3	0.0	0.3	0.1	0.2	2.1	1.8	0.4	0.2	0.3	4.8	0.3	0.3	0.3	0.2	0.1	0.2	0.1	0.2	1.0	13.2	0.6	19.6	4.4	24.2	0.0	15.7	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	19.1	1.2	28.7	0.6	0.0	1.8	1.7	1.9	1.0	1.3	2.0	1.8	2.2	0.0	2.4	1.4	3.0	10.6	5.4	4.4	0.0	0.7	0.6	0.0	4.0	4.5	0.0	0.0	0.1	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.3	0.3	1.7	44.2	0.4	13.5	0.0	1.2	1.3	60.1	2.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.2	0.3	0.0	0.3	0.7	0.0	3.0
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 345.2"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 802.6"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		5300000	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	3.6	0.0	0.1	11.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.2	345.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.1	4.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.1	0.1	0.5	1.2	0.7	2.8	0.5	0.4	0.9	0.1	0.3	0.3	0.2	0.3	0.5	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.2	0.5	0.3	0.0	0.2	0.3	0.0	0.2	0.4	0.3	0.1	0.6	0.8	22.4	0.1	1.8	0.5	0.3	0.0	0.2	0.2	0.2	0.1	0.2	0.4	1.0	0.1	0.3	0.3	0.6	0.4	0.0	0.2	0.2	1.8	0.5	0.2	0.4	0.2	0.3	2.0	0.3	0.0	0.3	0.5	0.0	0.4	0.5	0.2	0.5	0.1	0.6	0.4	0.7	0.1	0.7	0.1	2.8	0.4	0.5	0.9	0.5	0.8	0.4	0.5	0.5	0.1	1.2	0.8	0.8	1.0	0.4	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	15.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	21.9	0.0	0.0	23.3	0.5	0.0	0.0	0.0	0.0	802.6	0.0	0.0	0.0	13.5	20.9	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0
ADORA2B		ENSG00000170425	"Adenosine A2b receptor"	P29275	17	15944917-15975746	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 65.4;Suprabasal keratinocytes: 56.2;Urothelial cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.8;myeloid DC: 8.4"	"Group enriched"	"Detected in many"	86	"dendritic cells: 8.4;granulocytes: 12.8;monocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 50.2;HMC-1: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073747			Uncertain	Cytosol		NA	NA			Cytosol		"HPA073747: "	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.68e-1)"	"unprognostic (7.88e-3)"	"unprognostic (2.64e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-9)"	"unprognostic (2.07e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.84e-1)"	1.5	1.5	7.6	4.5	9.1	1.6	1.8	7.3	8.7	2.9	15.3	2.4	0.0	0.8	1.7	1.5	11.1	2.2	3.8	1.2	6.6	3.0	0.6	0.7	4.1	1.0	1.9	5.4	0.6	2.8	0.4	1.9	9.0	5.2	1.7	12.8	10.5	1.9	0.7	0.7	10.4	1.6	2.8	3.9	0.7	2.6	0.7	2.6	0.1	0.6	4.4	4.5	6.8	5.6	0.0	8.4	12.8	4.5	0.0	0.0	1.5	10.0	5.5	0.1	0.2	1.8	3.5	0.2	1.9	8.7	5.7	7.1	2.6	10.5	1.3	2.4	1.7	50.2	15.8	2.4	14.5	7.6	2.8	5.5	9.7	1.8	3.8	7.1	0.0	50.7	2.0	6.2	8.1	18.9	9.8	2.8	1.5	0.4	0.0	5.6	2.6	0.6	1.9	0.6	21.6	7.8	0.0	0.1	0.0	5.8	2.7	0.2	0.3	4.3	1.0	2.6	4.3	0.0	1.5	2.4	2.0	5.4	5.6	9.0	0.8	0.0	0.0	8.1	0.0	2.8	12.8	4.0	2.6	0.0	4.5	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.4	0.0	2.3	0.1	0.0	1.5	7.6	9.1	7.3	8.7	6.6	3.0	1.9	5.4	5.2	2.6	3.0	3.4	0.0	12.7	65.4	0.0	1.2	2.5	8.1	7.9	0.0	0.0	10.1	0.0	6.2	0.3	0.6	4.9	0.0	0.8	2.8	6.1	11.9	0.0	0.0	4.6	0.0	2.4	0.0	2.7	0.0	0.0	5.1	6.8	0.0	1.4	7.4	0.8	4.8	0.0	0.0	0.5	0.0	1.9	0.5	1.2	56.2	5.1	0.0	3.7	26.7
ADRB2	"ADRB2R, ADRBR, B2AR, BAR"	ENSG00000169252	"Adrenoceptor beta 2"	P07550	5	148825245-148828687	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 34.6"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 104.2;Basal keratinocytes: 344.2;granulocytes: 116.5;Suprabasal keratinocytes: 214.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 24.5;hTERT-HME1: 25.4;PC-3: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003431, HPA075322"	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA003431: AB_1845333, HPA075322: "	"unprognostic (2.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.35e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.15e-9)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.65e-2)"	11.7	0.2	0.7	0.9	0.4	4.6	13.8	0.0	0.3	6.1	0.9			0.3	0.9	0.2	6.4	1.4	1.1	2.8	0.7	0.3	0.2	6.0	8.5	1.1	0.9		0.0	0.0	0.5	0.0	4.0		3.8	0.7		3.3	0.1	4.4	15.9	1.3	1.2	1.0	3.7	2.9	0.0			0.5		2.0	2.3	5.4	4.8	6.1	14.0	10.8	7.3	34.6	9.6	7.6	0.0	0.0	0.0	0.3	0.0	0.0	1.5	4.4	2.0	2.3	0.0	3.3	0.0	2.1	0.4	7.4	6.8	0.0	9.2	2.3	0.0	0.2	0.0	1.6	0.0	0.2	0.0	3.8	0.0	24.5	0.6	25.4	1.7	0.9	0.0	0.0	2.9	5.3	0.0	0.0	4.2	0.1	0.0	10.5	2.2	1.4	4.3	1.1	1.9	0.0	0.0	1.8	0.2	0.6	0.9	0.0	2.3	4.1	0.0	1.8	2.5	1.1	0.7	0.0	0.1	0.0	5.0	0.8	3.5	4.7	14.0	34.6	7.8	25.7	4.8	8.2	20.9	5.3	3.0	1.4	12.9	7.6	7.3	10.8	6.1	0.4	9.6											104.2	33.5	11.1	31.2	344.2	0.2	12.4	0.0	8.1	33.0	0.0	0.0	0.3	0.0	1.4	0.2	17.5	0.0	0.0	0.2	0.2	6.1	16.2	116.5	11.9	14.7	0.0	2.9	6.7	12.7	0.4	0.0	16.5	28.7	1.0	1.4	3.5	5.3	0.0	0.0	0.0	4.8	0.0	3.6	0.0	0.0	214.5	0.5	35.5	0.8	48.5
AIF1	"AIF-1, Em:AF129756.17, IBA1, IRT-1"	ENSG00000204472	"Allograft inflammatory factor 1"	P55008	6	31615184-31617021	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 119.2;lymphoid tissue: 99.3"	"Group enriched"	"Detected in many"	19	"Hofbauer cells: 1482.8;Kupffer cells: 1886.5;Macrophages: 1383.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"classical monocyte: 67.4;intermediate monocyte: 104.8;myeloid DC: 35.9;neutrophil: 51.7;non-classical monocyte: 119.2"	"Group enriched"	"Detected in many"	33	"dendritic cells: 35.9;granulocytes: 51.7;monocytes: 119.2"	"Cell line enhanced"	"Detected in some"		"HEL: 25.8;HMC-1: 37.2;JURKAT: 15.1;NB-4: 59.1;THP-1: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049234, HPA062949"	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA049234: AB_2680685, HPA062949: AB_2732694"	"unprognostic (3.20e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.98e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.89e-2)"	13.5	9.5	13.0	27.7	23.8	39.8	7.8	1.8	10.0	5.2	8.0	17.0	0.1	6.1	3.2	8.3	3.6	5.6	9.8	5.8	10.2	10.2	15.4	12.6	19.9	40.5	16.9	3.1	4.9	3.4	2.0	4.9	17.0	12.8	6.1	9.7	4.6	5.7	4.3	3.5	2.9	10.8	11.1	28.5	99.3	4.8	2.6	16.2	71.7	3.6	1.7	9.8	11.2	3.5	0.7	35.9	51.7	119.2	0.3	2.1	59.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	0.0	1.7	37.2	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.1	0.0	0.0	0.0	0.2	59.1	0.1	0.0	0.0	9.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.3	0.0	0.5	67.4	3.2	0.2	104.8	0.2	0.7	0.3	0.3	35.9	0.1	2.1	1.7	51.7	0.3	119.2	3.3	0.1	59.6	13.0	23.8	1.8	10.0	10.2	10.2	16.9	3.1	12.8	16.2	23.8	84.5	70.4	0.6	28.8	0.0	5.5	25.5	18.7	35.2	40.1	0.0	9.9	0.0	0.0	1.1	13.5	0.4	0.0	0.4	10.9	24.2	0.3	64.9	8.9	1482.8	0.0	1.2	43.0	1886.5	1.5	6.9	1383.0	37.1	40.5	0.0	0.0	0.1	5.8	0.7	3.1	0.0	51.8	17.6	0.3	1.5	24.7	19.0	27.4	0.4	0.0
AIPL1	LCA4	ENSG00000129221	"Aryl hydrocarbon receptor interacting protein like 1"	Q9NZN9	17	6393693-6435199	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"retina: 123.7"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 388.8;Rod photoreceptor cells: 1307.2"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.1;OE19: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026578	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA026578: AB_2671905"		"unprognostic (2.42e-2)"		"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.68e-3)"		"unprognostic (3.24e-1)"		"unprognostic (1.13e-3)"				"unprognostic (3.76e-1)"	"unprognostic (5.35e-2)"			0.1	0.1	1.4	0.4	0.3	2.9	0.1	0.5	0.8	0.2	0.1	0.1	0.1	0.0	0.1	0.3	1.1	0.0	0.3	0.1	0.6	0.5	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.1	0.0	0.8	0.1	0.1	0.1	0.0	123.7	2.3	0.1	0.1	2.4	0.1	0.1	0.1	1.0	0.2	3.3	0.1	0.2	0.4	0.1	0.2	0.1	0.1	1.0	1.1	2.2	0.7	1.1	0.6	0.0	0.1	1.5	0.5	0.1	0.1	0.0	0.4	0.0	0.3	0.1	0.5	0.1	0.1	0.3	0.1	0.0	0.1	4.1	0.1	0.2	0.2	0.2	0.3	0.4	1.7	0.4	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.4	0.2	0.1	0.8	7.6	1.3	0.1	0.0	0.0	0.1	1.0	0.2	0.2	0.9	0.3	0.0	0.3	0.2	0.0	0.0	0.3	0.2	0.4	0.3	0.3	0.1	0.1	0.6	0.5	0.2	0.9	0.7	0.6	0.6	0.3	0.3	0.6	0.3	0.1	0.3	1.0	0.3	0.4	2.2	1.1	0.5	1.1	0.4	0.0	1.4	0.3	0.5	0.5	0.6	0.5	0.5	0.1	0.1	0.1	3.0	0.6	0.0	1.0	0.7	109.4	0.6	0.0	0.0	2.3	0.0	388.8	0.1	0.0	0.0	7.5	0.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	62.0	0.0	2.5	0.0	1.0	0.0	0.3	1.7	0.0	0.0	135.1	0.1	0.0	0.4	0.0	1307.2	0.0	0.1	0.2	0.0	0.4	0.2	0.0	0.0	2.0
AL121900.2		ENSG00000284776			20	18567453-18744216	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 8.9;Ciliated cells: 5.3"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 22.9"									HPA040981	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA040981: AB_10673268"																		4.0	5.7	4.0	4.4	5.8	5.8	6.0	4.5	14.1	3.6	6.2	2.0	6.0	5.2	7.4	5.9	4.5	5.4	5.4	7.8	4.4		15.4	6.3	4.7	6.9	4.5	5.4	7.7	16.1	8.3	5.3	4.4	7.6	4.6	6.4	3.1	8.8	8.2	12.2	1.1	5.5	5.9	4.3	5.8	0.9	6.8	5.4	3.6	5.1	9.9	6.8	5.7	6.4	4.9	6.9	2.9	4.8	3.9	5.9	1.7	3.7	1.8	7.9	3.9	2.6	9.1	0.5	2.4	6.5	6.2	0.7	0.9	5.6	0.5	1.9	7.8	3.5	3.5	4.9	15.1	22.9	0.9	0.3	5.1	2.0	2.0	3.1	10.0	6.0	0.0	14.4	4.5	7.4	3.6	8.0	1.5	0.9	7.9	5.3	2.8	1.7	0.8	2.1	3.2	0.0	0.3	4.1	5.5	4.9	4.7	7.8	2.0	0.2	6.4	3.1	6.6	5.0	6.5	0.0	8.5	0.4	7.1	5.3	1.7	8.5	1.5	5.1	1.6	5.6	2.9	3.2	2.7	4.8	4.8	5.9	4.9	5.4	3.6	6.9	2.9	1.7	3.4	1.9	3.9	2.8	1.2	4.5	1.7											8.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL139300.1		ENSG00000256500			14	103562962-103685924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"skeletal muscle: 37.2"	"Cell type enhanced"	"Detected in some"	28	"Ciliated cells: 1.4;granulocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA044617, HPA052450"	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044617: AB_2679024, HPA052450: AB_2681838"					"unprognostic (1.56e-1)"													10.2	7.5	16.6	7.8	20.3	2.8	15.5	21.9	25.1	5.9	4.8	3.2	5.1	2.0	5.5	4.6	5.8	3.9	4.2	20.0	17.2	17.2	5.3	5.6	4.2	7.7	17.3	6.2	5.0	15.8	9.9	5.8	4.2	5.2	5.0	2.9	2.7	7.7	6.3	37.2	2.0	4.2	8.5	22.6	2.9	2.8	18.5	4.0	2.2	7.8	9.2	5.4	6.6	6.9	4.2	4.9	4.2	5.1	2.3	4.4	1.3	6.3	12.0	13.2	1.2	7.3	9.0	5.8	18.5	14.3	20.9	13.2	7.3	9.7	16.2	12.1	13.4	14.1	6.3	8.8	10.6	13.3	5.4	1.0	6.2	6.3	6.8	9.7	8.5	3.7	7.0	2.9	10.0	11.4	11.8	11.9	10.7	8.3	4.2	15.0	12.1	13.3	3.1	9.1	14.3	15.1	5.9	10.4	8.7	10.7	7.4	17.3	10.6	11.0	4.6	10.3	5.5	10.2	4.9	8.4	9.2	7.3	14.7	8.7	5.4	6.3	18.5	15.5	3.5	8.3	0.7	3.2	4.2	2.8	4.3	2.9	1.9	3.4	4.1	1.9	4.2	4.4	1.9	2.8	2.3	5.1	4.9	4.2	1.3	16.6	20.3	21.9	25.1	17.2	17.2	17.3	6.2	5.2	4.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392664-38398661	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 113.9"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 55.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA		210000	Mitochondria	"Nucleoplasm, Vesicles, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	7.4	4.9	2.1	16.8	2.1	0.6	5.4	1.1	5.4	5.8	25.4	1.7	6.1	7.0	27.3	10.7	21.6	16.7	30.8	11.6	3.1	2.0	18.0	55.2	3.5	5.9	2.4	2.0	12.2	14.6	1.4	1.4	1.6	3.0	22.7	11.5	5.2	5.9	18.2	19.4	3.0	11.2	113.9	2.7	2.8	15.8	7.8	1.7	1.6	6.3	7.0	2.0	54.5	8.3	5.9	9.4	1.2	10.5	7.5	10.2	5.1	21.5	20.1	6.2	9.9	8.8	10.5	5.0	10.3	5.2	8.7	9.0	13.4	4.2	13.6	6.2	14.5	13.2	3.0	20.4	21.9	8.7	15.2	8.8	6.7	14.8	39.8	6.4	10.7	7.6	12.5	4.8	7.1	6.2	17.9	8.3	3.3	19.4	13.4	13.2	8.2	0.0	4.3	18.4	55.5	9.0	4.4	37.6	10.4	7.8	9.7	13.6	6.3	7.9	5.2	6.0	6.8	4.9	8.4	5.6	10.1	16.7	8.4	12.9	2.0	3.9	5.4	5.2	11.0	6.8	0.2	4.2	0.2	7.3	9.1	10.2	5.9	7.0	6.6	9.4	3.1	5.8	6.8	1.2	7.5	10.5	1.3	4.8	5.1	2.1	2.1	1.1	5.4	3.1	2.0	2.4	2.0	3.0	1.7	8.9	1.7	3.6	3.8	0.9	1.3	5.6	117.2	0.0	3.4	15.7	2.0	1.3	14.9	60.1	0.5	3.8	7.0	0.0	5.9	40.0	6.2	2.9	9.2	113.4	6.5	0.0	15.0	9.8	3.8	1.3	6.1	4.0	0.0	7.2	16.9	1.3	14.2	3.5	6.3	118.8	0.3	0.0	9.5	0.3	0.6	0.9	1.5	2.9	68.9	2.6
ALKBH5	"FLJ20308, OFOXD1"	ENSG00000091542	"AlkB homolog 5, RNA demethylase"	Q6P6C2	17	18183078-18209954	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 130.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007196	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA007196: AB_1850461"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.94e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.68e-3)"	"prognostic unfavorable (5.69e-4)"	18.0	19.5	17.1	14.6	21.9	19.1	26.2	23.4	25.3	18.2	21.8	20.1	18.8	15.1	22.1	12.1	17.3	30.5	18.7	45.8	16.5	18.9	16.0	24.2	14.7	16.9	19.0	16.9	20.9	25.0	22.7	20.2	14.8	15.4	19.4	8.9	19.9	23.7	21.1	130.4	12.7	16.9	20.4	15.3	18.8	16.2	29.7	17.6	26.8	23.5	19.5	13.7	26.8	44.8	11.5	8.9	17.6	10.6	7.6	17.0	5.7	33.1	32.0	13.0	23.4	19.1	13.3	11.3	16.0	19.8	26.3	24.5	36.1	8.8	21.0	23.7	17.6	13.9	21.9	19.6	16.9	13.6	23.9	26.7	15.4	18.2	20.1	17.8	11.1	20.7	12.7	11.5	19.7	11.7	16.7	15.2	16.4	16.7	9.6	14.6	24.6	23.9	12.4	11.0	13.9	16.4	21.7	25.7	36.8	7.7	11.4	13.4	17.7	20.0	13.9	18.2	42.7	14.0	9.6	15.4	25.4	17.7	37.2	31.3	11.2	8.5	12.7	46.1	18.2	16.6	4.3	7.2	17.6	15.1	7.4	14.0	7.9	13.6	17.0	8.9	11.5	10.9	11.0	4.6	7.6	10.6	6.6	7.9	5.7	17.1	21.9	23.4	25.3	16.5	18.9	19.0	16.9	15.4	17.6	32.8	25.7	39.8	24.5	57.5	79.0	78.7	25.5	28.1	18.2	26.2	37.3	28.1	71.3	24.0	48.1	37.6	35.4	46.7	27.3	36.7	47.3	36.0	41.4	52.9	29.7	112.8	58.5	27.6	39.9	29.1	38.0	25.6	47.2	17.2	41.8	72.5	28.5	42.4	48.8	81.8	52.8	19.4	44.3	106.7	98.2	48.9	26.3	48.4	31.6	21.6
AMBP	"EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI"	ENSG00000106927	"Alpha-1-microglobulin/bikunin precursor"	P02760	9	114060127-114078472	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	75	"liver: 592.2"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 9824.4"	"Cancer enriched"	"Detected in many"	115	"liver cancer: 2620.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	154	"Hep G2: 168.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001497, CAB069436, HPA075585"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"	"Secreted to blood"	NA	NA		71000000000	Vesicles	"Golgi apparatus, Cytosol"	"CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: "	"unprognostic (6.92e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.95e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (9.79e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.84e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.45e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.8	0.1	0.0	0.0	1.7	592.2	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.1	168.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.0	0.8	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	42.0	0.6	1.3	0.0	0.0	2035.7	0.0	1.2	1.8	0.0	0.0	3.3	105.1	19.2	0.0	0.4	256.9	25.3	0.3	0.1	0.4	0.0	9824.4	0.7	0.0	2.4	175.6	182.3	40.5	0.6	0.0	0.0	6.4	0.9	0.0	22.8	1.1	0.0	9.9	0.0	0.0	0.0	0.2	0.1	0.4	1.1	3.8	1.0	0.3
ANKRD23	"DARP, FLJ32449, MARP3"	ENSG00000163126	"Ankyrin repeat domain 23"	Q86SG2	2	96824526-96857934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 184.5"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"Karpas-707: 29.7"					"Not detected"	"Not detected"			HPA036201	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Actin filaments"	"HPA036201: AB_10673347"	"unprognostic (2.48e-1)"	"unprognostic (7.83e-4)"	"unprognostic (4.93e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.27e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.81e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-6)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.70e-4)"	0.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.1	2.6	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.1	0.1	0.1	0.7	0.0	0.1	2.2	0.1	184.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	12.2	0.9	0.1	0.1	0.4	0.2	0.5	0.0	0.9	1.2	0.4	0.3	0.5	0.3	0.6	0.0	0.2	0.8	0.2	0.0	0.2	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.2	0.2	0.2	0.1	0.8	0.7	0.4	0.4	0.1	0.1	0.6	1.4	0.2	0.3	0.4	0.0	0.1	0.1	1.1	0.6	29.7	0.2	0.7	0.3	0.6	0.3	0.1	0.2	1.0	0.0	3.7	0.1	0.7	1.1	0.1	0.2	0.5	0.0	0.1	0.8	0.0	0.2	0.3	0.5	0.5	0.0	1.3	0.5	0.2	0.3	0.8	0.3	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.9	0.0	0.2	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.4	0.0	0.6	0.7	2.1	2.5	0.0	10.7	2.3	0.0	2.0	0.3	0.0	0.3	3.0	0.6	0.4	0.0	0.9	0.1	0.9	0.4	1.1	1.0	0.2	1.6	0.0	2.5	0.8	1.5	1.4	0.0	0.0	0.0	1.1	1.8	0.1	0.0	2.8	0.0	3.6	0.0	1.9	1.0	0.4	1.1	0.2	0.0	0.6	0.1
ANKRD24	KIAA1981	ENSG00000089847	"Ankyrin repeat domain 24"	Q8TF21	19	4183354-4224814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 17.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	9	"B-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.6;U-266/70: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041534, HPA048498"	Uncertain		Uncertain	Microtubules,Cytosol		NA	NA			"Microtubules, Cytosol"		"HPA041534: AB_2677537, HPA048498: AB_2680420"	"unprognostic (3.70e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.23e-9)"	"unprognostic (7.03e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (9.13e-5)"	"unprognostic (1.53e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.73e-4)"	1.4	2.1	6.0	0.8	8.5	1.1	1.2	1.4	22.1	1.0	1.1	0.8	0.1	1.9	1.0	2.1	0.5	1.4	1.3	0.6	5.1	4.4	1.8	5.5	1.1	1.0	4.1	9.4	1.4	3.3	2.4	3.8	1.9	2.3	4.3	0.9	1.0	1.7	1.7	2.5	1.1	1.5	0.7	2.3	1.5	1.6	7.3	1.8	0.1	1.9	0.1	0.6	0.6	0.1	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	3.2	0.3	3.4	0.2	0.1	0.0	0.0	0.1	0.1	0.1	2.0	0.4	0.2	0.2	0.1	0.5	0.0	2.4	0.3	0.1	0.1	0.1	1.8	0.1	0.3	1.8	0.1	0.3	0.8	0.5	0.1	2.0	0.1	5.6	0.0	0.7	0.0	0.1	2.5	0.7	0.7	0.4	0.0	0.4	0.0	0.2	0.9	0.2	0.1	0.1	0.3	0.6	0.7	0.4	0.0	0.1	1.2	0.9	0.0	18.9	1.6	0.1	0.8	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	8.5	1.4	22.1	5.1	4.4	4.1	9.4	2.3	1.8	0.0	3.4	0.0	0.2	0.0	0.8	0.8	2.5	0.0	2.3	0.0	3.9	0.2	0.0	0.1	0.5	0.0	0.3	0.0	0.0	17.7	0.0	0.2	0.0	1.0	0.3	0.0	3.5	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.7	1.1	0.0	0.9	0.0	0.2	0.0
ANO6	"DKFZp313M0720, TMEM16F"	ENSG00000177119	"Anoctamin 6"	Q4KMQ2	12	45215987-45440404	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Lipid transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038958	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		1500000	"Plasma membrane, Cytosol"		"HPA038958: AB_10672835"	"prognostic unfavorable (7.56e-5)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.82e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.28e-1)"	40.7	15.3	6.4	17.3	7.0	3.8	42.8	2.5	7.3	22.2	29.7	6.1	34.8	16.5	33.2	16.0	21.2	18.5	20.2	20.7	6.7	5.4	21.6	25.4	25.6	11.7	7.6	4.2	27.4	12.7	20.1	7.1	23.3	8.8	21.6	6.9	14.2	16.8	39.3	40.3	10.0	41.3	42.8	14.6	12.5	13.5	10.4	5.8	21.6	11.2	14.7	9.6	37.6	38.1	2.1	7.1	4.4	9.3	3.1	4.0	5.0	13.6	15.7	8.8	12.0	40.6	21.1	33.7	19.2	24.2	13.3	12.3	23.6	20.7	7.1	18.0	30.0	11.8	18.1	8.0	10.6	15.5	10.4	5.7	8.2	6.4	19.9	12.9	12.7	6.6	17.6	10.6	11.1	16.4	31.7	17.4	14.9	6.2	11.5	14.1	3.6	13.5	4.1	9.8	0.0	5.9	7.8	11.5	7.8	12.2	21.7	4.0	13.7	20.1	12.5	9.2	23.9	14.7	20.1	23.8	14.2	9.1	14.3	9.7	6.1	7.0	8.6	12.8	40.8	11.3	4.4	7.7	1.9	3.3	9.3	3.4	2.1	3.2	2.8	7.1	1.7	2.9	2.0	0.9	3.1	8.6	3.6	4.0	5.0	6.4	7.0	2.5	7.3	6.7	5.4	7.6	4.2	8.8	5.8	56.6	10.2	3.7	20.1	27.1	0.4	20.3	30.6	6.7	13.6	17.4	0.0	29.4	3.3	35.0	1.0	34.4	4.9	0.0	32.0	21.1	32.3	17.2	12.7	81.6	17.8	0.0	8.1	54.0	49.8	1.3	47.5	21.3	16.9	8.2	11.4	9.8	55.0	10.2	38.2	18.0	0.2	38.8	31.6	2.4	4.2	19.3	20.6	6.4	10.7	25.1
AP000646.1		ENSG00000285509			11	121024125-121113108	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"pancreas: 2.0;parathyroid gland: 2.5"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 4.0"									"HPA038593, HPA038594"	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA038593: AB_10669647, HPA038594: AB_2676103"																		0.0	0.0		0.2		0.0	0.0		0.8	0.6	0.1			0.0	0.5	0.0	0.2	0.0	0.5	0.6			0.8	0.2	0.5	0.0			0.8	2.0	2.5		0.4		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.2		0.0	0.0	1.7			0.0		0.0	0.5		0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.3	0.8	1.7	0.4	0.3	0.4	0.2	1.9	2.4	2.3	0.3	1.1	1.2	0.6	0.7	0.8	1.0	0.0	0.8	0.5	2.5	0.1	0.4	4.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.0	1.1	1.0	0.0	1.0	0.6	1.6	0.0	0.0	0.2	0.1	0.3	0.0	1.4	0.2	2.5	0.7	0.2	0.7	2.2	3.0	0.8	0.1	0.0	2.5	1.4	0.2	0.0	2.0	0.2	0.5	0.9	0.2	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOBEC3F	"ARP8, BK150C2.4.MRNA, KA6"	ENSG00000128394	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3F"	Q8IUX4	22	39040604-39053910	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cholangiocytes: 10.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.7"									HPA073637			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA073637: "	"unprognostic (1.38e-3)"	"unprognostic (1.28e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.06e-3)"	"unprognostic (9.36e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (8.28e-4)"	6.9	9.0	1.9	7.9	2.3	2.5	3.1	0.7	2.0	9.6	5.4	3.9	14.5	3.1	8.2	5.6	5.6	8.1	3.1	6.7	2.4	1.7	5.9	4.5	5.4	13.1	1.8	1.2	14.1	5.5	3.9	4.9	1.7	2.6	6.4	2.4	6.6	6.4	16.3	3.2	1.6	5.0	3.9	3.6	14.3	4.3	11.9	1.9	7.3	4.2	2.5	15.9	5.4	4.5	23.2	4.3	5.9	9.1	9.3	6.9	4.7	4.4	3.5	1.4	5.5	4.1	6.1	2.0	3.4	6.3	8.1	12.9	3.0	8.0	10.6	3.6	7.1	6.7	5.6	1.3	5.3	3.2	10.0	4.4	14.3	0.0	1.5	8.1	1.5	6.0	8.0	2.3	4.1	1.4	4.4	7.4	2.8	1.0	17.7	4.0	3.2	3.2	1.9	0.6	0.0	0.5	5.3	0.5	2.3	6.7	5.9	0.7	1.1	4.1	1.1	2.2	3.3	4.2	1.2	1.9	1.7	4.7	0.2	1.5	3.1	1.6	0.5	4.9	1.4	2.6	1.4	3.3	5.9	6.1	6.6	6.9	16.4	4.0	6.2	4.3	23.2	2.5	3.9	1.5	9.3	9.1	3.7	5.4	4.7	1.9	2.3	0.7	2.0	2.4	1.7	1.8	1.2	2.6	1.9	0.0	0.3	5.2	4.0	0.8	0.0	4.4	10.2	2.7	0.0	0.0	0.0	1.4	1.7	7.1	2.1	1.5	0.5	0.0	3.5	1.2	2.2	3.4	2.3	0.9	5.0	0.0	1.2	4.3	2.1	3.3	4.6	1.9	5.0	6.4	2.1	2.0	4.6	2.8	6.0	2.8	0.3	0.0	1.9	0.3	0.2	0.6	1.4	5.3	1.5	6.2
APOBEC3G	"bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019"	ENSG00000239713	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3G"	Q9HC16	22	39077005-39087743	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 64.4"	"Cell type enhanced"	"Detected in many"	10	"B-cells: 66.5;monocytes: 92.8;T-cells: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 14.8;Daudi: 20.0;HDLM-2: 16.7;Karpas-707: 23.0"									"HPA001812, HPA073637"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA001812: AB_1078175, HPA073637: "	"prognostic favorable (4.78e-4)"	"prognostic favorable (4.70e-4)"	"unprognostic (8.18e-3)"	"prognostic favorable (6.03e-5)"	"unprognostic (2.37e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.13e-3)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (8.66e-13)"	"unprognostic (3.41e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.91e-2)"	"prognostic favorable (6.30e-4)"	6.0	6.1	1.9	8.0	2.2	4.8	3.8	1.4	1.8	6.4	4.2	2.8	8.0	1.7	6.1	4.3	3.7	8.8	7.2	4.6	2.4	1.7	4.1	4.1	5.1	16.0	2.5	1.3	12.4	0.9	2.0	3.4	3.4	2.5	5.0	3.3	4.8	3.8	28.0	3.3	1.2	5.6	3.6	3.1	18.9	3.5	15.6	1.4	6.5	3.8	2.6	15.2	7.4	6.0	16.1	8.6	5.9	17.5	35.5	64.4	39.1	1.9	0.0	0.0	0.0	2.5	4.9	0.1	0.4	8.2	9.6	14.8	0.7	11.9	20.0	0.2	3.4	6.1	0.0	0.1	0.6	2.8	16.7	0.0	10.3	0.0	0.1	11.1	3.4	4.9	7.4	0.2	5.2	1.1	0.0	1.3	0.6	0.9	23.0	1.4	0.0	3.8	3.4	0.3	0.0	0.7	7.7	0.0	12.7	0.0	8.8	0.0	0.0	0.2	0.0	1.1	0.9	0.0	6.5	0.0	1.5	0.1	0.0	0.0	0.0	1.9	0.2	1.7	3.1	2.5	4.0	6.8	4.5	64.4	15.1	37.7	16.1	20.2	49.8	8.6	11.6	6.9	30.3	5.9	35.5	17.5	5.5	15.8	39.1	1.9	2.2	1.4	1.8	2.4	1.7	2.5	1.3	2.5	1.4	3.0	12.8	66.5	12.9	1.5	0.2	2.2	2.5	8.1	12.5	0.0	2.0	2.9	5.0	8.7	39.3	8.7	0.0	23.3	2.1	1.2	7.7	7.9	11.6	0.8	27.1	0.0	5.8	10.4	18.7	11.7	17.5	15.2	6.8	92.8	1.7	7.8	2.3	1.5	8.5	1.0	1.0	19.4	8.0	0.7	1.1	1.1	0.8	124.6	1.1	18.5
ARGLU1	FLJ10154	ENSG00000134884	"Arginine and glutamate rich 1"	Q9NWB6	13	106541673-106568164	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 91.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034962, HPA056792"	Supported		Enhanced	Nucleoplasm,Mitochondria,Cytosol		No	No			Nucleoplasm	"Mitochondria, Cytosol"	"HPA034962: AB_10611676, HPA056792: AB_2683236"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.21e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.91e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (7.34e-5)"	43.5	31.8	59.1	46.5	63.6	67.5	46.1	82.1	72.8	37.9	41.7	44.9	33.5	35.2	62.2	50.9	38.1	50.2	55.0	40.4	55.7	20.6	30.5	24.4	65.3	75.7	62.5	44.5	65.2	34.1	24.0	61.1	48.3	44.0	38.9	48.6	35.5	46.8	48.2	34.1	53.0	54.3	43.3	51.8	50.4	42.8	25.9	67.2	40.2	45.5	22.0	61.0	44.0	44.9	23.7	23.2	34.7	18.0	16.5	18.6	10.9	26.6	14.8	67.4	15.1	10.7	18.6	15.0	29.7	9.0	10.0	15.2	30.2	38.8	32.4	10.2	11.6	11.7	30.2	14.2	12.2	18.8	42.1	15.1	37.2	91.5	15.5	9.5	60.0	24.8	16.6	16.1	9.1	12.3	25.0	12.7	22.5	13.4	25.2	12.8	9.4	23.7	31.9	17.8	19.6	5.6	40.9	16.9	15.4	11.2	31.1	17.6	25.3	14.0	22.5	6.7	27.9	17.7	31.1	23.0	13.4	13.4	14.9	16.6	28.3	23.3	38.8	27.7	38.5	15.3	34.7	18.0	16.7	18.6	14.6	17.2	20.7	13.8	11.6	14.4	23.7	15.8	13.8	30.3	16.5	13.4	23.2	15.5	10.9	59.1	63.6	82.1	72.8	55.7	20.6	62.5	44.5	44.0	67.2	131.0	200.7	147.3	175.2	232.4	221.8	78.3	101.9	224.9	215.0	108.2	127.6	118.5	84.6	100.9	28.5	282.9	157.6	93.5	97.9	120.4	173.1	219.9	158.9	69.6	87.5	287.6	180.1	188.4	85.6	18.1	236.2	133.0	121.4	162.3	134.2	304.1	112.4	133.3	204.7	39.4	283.1	213.4	189.5	194.6	112.8	229.2	154.9	147.4	126.3	268.6
ARSA		ENSG00000100299	"Arylsulfatase A"	P15289	22	50622754-50628173	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 87.0;Late spermatids: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005554, CAB025183"	Enhanced		Uncertain	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		4500000	"Golgi apparatus"	Cytosol	"CAB025183: , HPA005554: AB_1078220"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"prognostic favorable (2.96e-5)"	"unprognostic (4.66e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.73e-3)"	19.0	15.2	14.0	15.2	15.7	16.6	15.2	11.9	17.9	12.0	20.3	21.4	26.4	30.2	13.3	21.4	15.6	18.5	23.3	18.8	13.4	8.8	17.5	24.1	15.7	16.8	19.1	10.3	9.3	45.4	13.1	20.4	18.5	17.3	15.8	8.8	14.0	36.8	21.9	6.3	11.1	23.4	8.7	13.2	25.6	23.6	27.2	17.9	10.6	18.7	7.5	16.5	14.8	13.3	5.6	15.7	30.1	19.8	3.9	8.9	7.7	4.1	5.8	2.8	5.4	20.9	11.4	7.0	6.7	8.2	2.9	5.0	1.6	6.4	2.8	4.1	11.0	5.4	6.4	0.6	6.2	0.4	1.2	4.4	1.6	6.5	5.8	14.5	2.4	17.1	13.5	12.1	4.8	3.1	9.9	6.6	5.8	1.7	39.3	5.9	4.7	2.2	2.8	0.8	4.3	5.8	2.0	0.2	12.9	4.9	6.4	1.3	4.3	9.5	8.5	4.8	2.6	3.8	3.0	11.6	2.1	8.0	7.5	1.9	9.3	0.8	2.1	6.1	2.2	6.9	4.3	13.7	17.1	8.9	16.0	7.9	5.6	6.5	7.3	11.2	5.6	3.9	5.3	30.1	3.9	19.8	15.7	8.5	7.7	14.0	15.7	11.9	17.9	13.4	8.8	19.1	10.3	17.3	17.9	6.0	11.7	17.5	11.1	4.1	4.9	6.5	30.6	13.4	4.5	12.2	3.9	10.2	1.7	28.6	51.1	7.9	87.0	23.3	18.7	18.1	13.0	12.6	5.8	27.6	33.4	6.4	35.3	9.2	28.5	100.4	10.0	17.4	16.9	37.9	23.2	9.3	25.7	35.9	5.6	20.6	6.2	0.0	4.7	43.1	3.1	4.8	11.1	10.5	19.0	14.9
ARSF		ENSG00000062096	"Arylsulfatase F"	P54793	X	3041471-3112726	"Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.3;kidney: 11.5;skin 1: 8.3"	"Cell type enhanced"	"Detected in some"	31	"Distal tubular cells: 1.7;Proximal tubular cells: 4.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"					"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;U-266/70: 1.1"									HPA000549			Uncertain	Cytosol	"Secreted in other tissues"	NA	NA			Cytosol		"HPA000549: AB_1845055"	"unprognostic (2.19e-2)"	"unprognostic (8.88e-2)"		"unprognostic (2.87e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.70e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.48e-1)"	0.0	4.6	2.7	0.0	5.3	0.0	0.1	0.0	1.9	0.4	0.0			0.0	0.0	2.5	3.1	0.0	0.0	0.0	1.3	0.5	11.5	1.7	0.0	0.0	1.5		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	8.3	0.0	0.0	0.2	0.0	0.0	0.0			0.0		0.5	0.6	1.5	0.3	0.2	1.9	0.3	0.8	0.3	0.0	0.2	0.4	0.5	0.7	0.0	0.2	2.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.2	0.3	0.0	0.0	0.3	0.4	0.0	0.4	0.2	0.3	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.3	0.0	0.1	0.5	0.1	0.1	1.1	0.1	0.1	0.8	0.4	0.3	1.9	0.3	0.4	0.2	0.3	0.3	0.1	0.3	0.2	0.0	0.3	0.3	0.3	1.2	0.8	0.1	0.2	0.1	0.0											0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
ASPN	"FLJ20129, PLAP-1, SLRR1C"	ENSG00000106819	Asporin	Q9BXN1	9	92456205-92482506	"Disease related genes, Plasma proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 62.1"	"Cell type enhanced"	"Detected in some"	11	"Basal keratinocytes: 59.6;Fibroblasts: 60.7;Ito cells: 22.7;Sertoli cells: 38.8;Smooth muscle cells: 29.5;Suprabasal keratinocytes: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.7;BJ hTERT+: 5.0;HHSteC: 21.0;HSkMC: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007894, HPA008435, HPA024230"	Approved		Uncertain	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		33000	Nucleoplasm	Cytosol	"HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.13e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (1.64e-7)"	"unprognostic (1.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.48e-2)"	13.4	2.2	0.5	5.2	1.7	0.0	4.8	0.4	0.7	40.2	14.6	0.6	8.1	2.8	62.1	26.7	15.3	9.9	26.4	31.6	0.6	0.6	3.5	21.9	10.3	0.7	0.9	1.4	7.8	4.7	0.8	1.9	3.7	1.0	12.2	3.6	1.6	2.0	3.6	10.8	3.7	19.7	37.1	0.8	0.8	8.8	6.7	0.4	1.5	7.1	27.7	2.2	24.2	3.8	0.4	0.2	1.9	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.3	14.7	0.0	2.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	4.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.2	0.1	0.7	0.2	0.0	0.0	0.5	1.7	0.4	0.7	0.6	0.6	0.9	1.4	1.0	0.4	0.0	1.4	0.0	0.0	59.6	0.5	3.6	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	0.3	5.8	0.0	0.0	0.0	0.0	60.7	0.0	1.1	0.4	0.2	0.0	0.0	22.7	0.0	0.2	5.5	0.5	13.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.6	38.8	29.5	0.0	0.0	23.6	0.0	0.0	0.0	0.0
ATP6V0A1	"a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1"	ENSG00000033627	"ATPase H+ transporting V0 subunit a1"	Q93050	17	42458844-42522611	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.2;parathyroid gland: 65.6"	"Cell type enhanced"	"Detected in all"	8	"Cone photoreceptor cells: 276.9;Rod photoreceptor cells: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022144	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Vesicles,Cytosol"		NA	NA		21000	"Golgi apparatus, Vesicles"	"Nuclear speckles, Cytosol"	"HPA022144: AB_1845189"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (3.07e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (6.90e-4)"	9.4	15.6	19.3	9.3	46.1	9.9	9.1	55.8	66.2	8.0	11.6	25.8	5.1	17.9	11.4	11.1	9.6	9.7	12.2	9.9	23.8	32.8	20.3	11.3	12.7	6.6	23.6	24.8	11.4	9.3	65.6	23.6	11.2	43.3	9.9	11.3	19.7	8.2	10.7	28.9	14.7	12.4	11.7	23.7	11.1	8.8	9.8	13.1	5.2	16.3	6.7	7.8	6.7	6.9	6.3	9.1	14.2	10.5	0.1	2.8	4.2	6.6	13.8	8.5	15.2	14.2	12.4	4.9	4.7	8.8	10.1	13.3	8.8	15.0	1.2	8.7	9.7	13.9	14.5	13.0	8.0	11.8	10.3	13.6	10.7	10.4	6.9	8.8	4.6	19.6	9.1	11.6	16.2	6.9	12.6	7.1	5.0	38.9	42.3	15.0	5.7	1.8	4.1	5.4	8.8	0.1	0.1	8.8	18.6	11.7	5.3	23.4	12.4	7.3	6.7	14.0	11.5	16.3	7.0	4.2	8.6	0.3	12.6	5.6	17.2	23.4	2.5	11.5	0.1	10.0	12.1	10.5	8.0	0.8	3.4	1.2	3.5	0.6	0.1	9.1	6.3	1.0	0.8	14.2	0.1	2.4	4.7	2.8	4.2	19.3	46.1	55.8	65.9	23.8	32.8	23.6	24.8	43.3	13.1	17.9	46.6	27.3	45.1	17.5	158.7	19.5	30.6	6.7	14.8	14.0	276.9	26.4	10.0	14.7	2.4	19.2	44.6	46.7	15.8	13.4	33.9	38.7	23.1	33.6	46.0	90.6	81.5	19.6	33.1	3.1	16.1	25.8	38.8	3.6	23.1	51.9	17.6	38.6	22.3	28.4	349.7	6.5	48.9	38.7	18.5	17.7	83.5	4.4	19.5	10.7
ATP6V0A4	"a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2"	ENSG00000105929	"ATPase H+ transporting V0 subunit a4"	Q9HBG4	7	138706294-138799560	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 40.6;salivary gland: 55.4"	"Cell type enhanced"	"Detected in some"	18	"Collecting duct cells: 15.7;Cytotrophoblasts: 11.7;Distal tubular cells: 26.6;Melanocytes: 6.8"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 35.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA018029, HPA064555"	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA018029: AB_1845190, HPA064555: AB_2685284"	"unprognostic (1.99e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.32e-6)"	"unprognostic (4.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-2)"	0.1	0.0	0.5	0.0	0.3	0.0	2.2	0.1	0.4	1.7	0.0	0.3	3.1	0.0	0.3	0.5	2.7	0.0	0.0	0.0	0.4	0.3	40.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.2	1.0	0.2	0.5	0.0	0.3	55.4	1.2	0.0	6.5	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	1.8	7.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.4	1.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	3.1	1.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	3.0	0.1	0.0	0.0	0.0	35.9	1.2	2.0	0.1	0.0	0.1	0.4	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.1	0.4	0.4	0.3	0.3	0.0	0.2	0.1	0.0	0.6	0.0	0.8	0.0	0.0	0.3	0.0	1.4	1.2	15.7	2.0	11.7	26.6	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.3	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	4.2	0.0	0.0	1.1
ATP8B4	"ATPIM, KIAA1939"	ENSG00000104043	"ATPase phospholipid transporting 8B4 (putative)"	Q8TF62	15	49858238-50182817	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 23.4;granulocytes: 19.6;Hofbauer cells: 12.9;Kupffer cells: 29.9;Late spermatids: 19.9;Macrophages: 17.3;T-cells: 8.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 6.9;NK-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 19.1;NB-4: 7.3;THP-1: 12.3;U-937: 38.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040254	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA040254: AB_10673028"	"unprognostic (6.45e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.08e-1)"	2.3	1.2	1.6	1.5	2.1	28.1	1.0	0.6	0.9	26.0	1.5	1.7	1.6	0.4	18.2	3.5	0.6	9.5	3.1	0.8	2.5	0.9	1.0	1.2	3.2	0.7	2.7	0.1	3.9	0.4	0.2	1.1	2.9	2.1	0.7	1.2	0.8	0.9	0.6	0.4	0.5	1.1	2.7	3.1	2.3	0.6	0.9	4.6	0.8	0.5	0.8	2.1	1.3	1.5	0.0	2.2	6.9	1.7	10.6	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	5.2	0.0	3.0	0.6	0.0	0.0	5.3	19.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.4	38.5	0.0	6.9	1.7	2.4	0.5	0.8	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.8	10.6	0.3	0.0	0.0	0.8	1.6	2.1	0.6	0.9	2.5	0.9	2.7	0.1	2.1	4.6	0.0	3.4	1.3	0.1	1.3	0.2	1.2	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	23.4	0.5	0.4	0.0	0.0	1.6	3.3	0.5	19.6	2.8	12.9	0.0	0.0	1.8	29.9	19.9	1.7	17.3	1.7	1.0	0.3	0.5	0.0	0.0	0.7	0.8	0.0	0.0	4.3	0.4	0.6	0.3	2.4	8.6	0.0	0.1
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 32.3;testis: 41.1"	"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 70.0;Extravillous trophoblasts: 59.5;granulocytes: 55.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"CAB001454, HPA002636"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		Yes	Yes			"Nucleoplasm, Centrosome, Cytosol"		"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	3.7	2.3	1.5	12.7	1.3	8.3	3.0	1.3	1.8	1.4	6.7	1.3	0.8	7.3	1.8	1.2	7.7	1.1	3.7	4.1	1.1	1.1	2.4	5.1	2.9	12.3	1.6	0.9	8.3	1.4	0.3	0.7	6.1	1.5	1.0	8.3	1.5	2.7	0.5	6.9	2.1	7.2	2.7	1.3	7.4	4.3	41.1	1.1	32.3	1.2	5.9	13.3	2.4	2.4	3.9	5.2	6.0	8.7	2.0	6.6	2.6	33.0	24.4	16.3	11.5	0.9	2.1	20.7	27.1	12.7	65.7	27.7	68.2	23.2	10.8	18.7	11.1	34.1	26.7	29.0	18.2	70.0	9.8	11.1	19.3	25.0	42.5	0.5	25.8	27.2	1.0	1.9	22.7	20.4	5.2	15.3	17.7	21.9	8.6	27.9	33.7	15.4	20.0	14.9	27.1	25.1	11.7	31.5	12.0	10.5	8.7	14.1	7.6	37.9	43.6	18.2	15.6	25.8	16.1	8.8	28.6	28.3	15.8	38.2	12.1	14.0	18.8	15.4	15.0	23.6	0.2	5.3	6.0	1.9	8.7	2.9	3.9	3.3	1.9	5.2	1.4	1.5	1.5	3.7	2.0	4.8	1.2	6.6	2.6	1.5	1.3	1.3	1.8	1.1	1.1	1.6	0.9	1.5	1.1	0.0	3.2	4.5	1.1	1.0	1.0	3.4	2.5	1.4	2.3	3.5	2.0	9.8	1.7	3.9	16.9	1.6	5.3	70.0	4.2	59.5	3.8	0.7	55.2	2.4	14.8	1.6	5.8	3.1	2.4	9.5	1.4	5.5	0.0	18.0	5.7	3.5	3.6	3.5	0.4	1.9	2.5	6.5	2.1	16.2	31.6	1.0	6.9	4.9	9.8	1.4
AXIN2	"DKFZp781B0869, MGC126582"	ENSG00000168646	"Axin 2"	Q9Y2T1	17	65528563-65561647	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Extravillous trophoblasts: 87.1"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 33.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 11.8;CACO-2: 22.1;Hep G2: 32.9;OE19: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012283, CAB017783"	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	Cytosol	"CAB012283: AB_2290204, CAB017783: "	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.48e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.84e-3)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.25e-1)"	7.4	10.1	9.0	7.0	8.9	0.9	5.2	8.2	13.1	16.5	12.2	8.7	10.5	7.2	29.0	7.7	6.5	18.6	6.9	7.3	7.9	5.7	3.5	2.5	15.2	3.4	5.3	10.3	14.7	3.9	3.2	5.8	18.2	10.6	14.8	15.2	7.8	4.6	9.8	12.4	14.9	7.5	18.0	4.8	6.9	14.6	6.8	9.0	27.6	11.3	3.6	3.8	11.8	8.7	4.1	0.0	4.4	0.0	1.9	5.1	0.8	0.0	5.9	11.8	0.2	4.3	1.8	5.2	0.1	0.5	0.4	0.7	22.1	2.1	0.4	0.7	3.4	0.4	0.1	2.4	0.0	0.8	1.0	1.3	0.0	1.0	32.9	0.4	0.0	0.0	1.0	0.9	0.9	0.2	0.7	1.0	2.2	0.0	0.5	0.6	0.1	5.7	0.0	2.3	36.5	0.2	4.1	0.6	0.0	1.1	0.1	3.7	2.4	0.2	0.1	2.0	9.1	0.4	0.1	2.6	2.3	4.3	3.3	0.7	0.0	1.2	1.5	1.1	0.2	1.1	4.4	0.0	0.0	0.3	0.0	0.8	1.0	2.3	0.4	0.0	4.1	5.1	0.8	0.0	1.9	0.0	0.0	0.0	0.8	9.0	8.9	8.2	13.1	7.9	5.7	5.3	10.3	10.6	9.0	0.0	7.0	0.0	1.2	10.0	3.8	8.1	2.5	1.4	10.3	0.0	3.9	14.3	0.0	1.0	27.8	3.8	2.8	0.0	0.7	87.1	17.5	4.1	0.0	1.9	3.3	1.6	5.2	1.3	0.0	11.2	6.1	0.3	16.9	1.8	18.7	3.5	0.7	3.5	10.3	0.6	1.9	12.9	5.9	5.4	12.6	4.8	11.9	0.0	16.8	1.1
B4GALNT4	"FLJ25045, NGalNAc-T1"	ENSG00000182272	"Beta-1,4-N-acetyl-galactosaminyltransferase 4"	Q76KP1	11	369796-382116	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.1;ovary: 18.6"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 17.5;Cardiomyocytes: 11.2;Horizontal cells: 31.8;Muller glia cells: 40.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.2;NTERA-2: 18.0;SCLC-21H: 22.4;SH-SY5Y: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043276, HPA053126"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	No			"Nucleoplasm, Cytosol"	Vesicles	"HPA043276: , HPA053126: AB_2682049"	"unprognostic (6.11e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.92e-3)"	"unprognostic (5.36e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.99e-3)"	"unprognostic (1.52e-10)"	"unprognostic (9.01e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-4)"	"unprognostic (1.25e-1)"	1.6	2.5	20.6	2.8	16.7	1.2	3.5	26.5	35.1	5.9	2.0	8.6	0.8	2.4	8.6	2.4	1.8	8.7	2.1	1.4	17.6	16.8	1.2	1.1	1.3	1.6	11.5	14.9	18.6	1.8	6.3	6.1	1.1	13.0	3.8	1.6	2.3	4.0	3.7	1.1	3.8	2.9	3.1	8.3	1.5	1.5	1.8	11.0	0.0	1.1	0.0	1.7	1.3	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.6	20.2	11.5	0.0	0.0	4.7	3.6	0.9	1.6	0.5	2.0	0.0	0.0	2.7	0.4	3.2	0.7	2.7	4.8	0.5	0.0	6.8	0.0	6.4	6.2	0.2	0.0	4.9	0.4	2.9	0.1	2.2	7.3	0.2	1.0	6.1	0.0	0.0	5.9	0.2	0.0	18.0	0.3	7.9	0.0	0.0	2.6	0.2	0.0	22.4	27.3	1.3	1.0	0.2	2.2	7.9	0.0	4.9	1.1	6.4	1.9	0.2	0.0	0.9	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.6	16.7	26.5	21.2	17.6	16.8	11.5	14.9	13.0	11.0	0.0	0.0	0.0	1.3	0.7	17.5	11.2	0.0	0.0	0.0	1.8	3.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.2	31.8	1.7	0.0	0.0	0.0	2.8	0.0	3.3	0.0	0.0	40.9	0.3	0.0	1.1	0.0	8.1	0.0	0.2	0.0	0.2	0.3	0.2	0.0	0.0	0.4
B4GALT3	beta4Gal-T3	ENSG00000158850	"Beta-1,4-galactosyltransferase 3"	O60512	1	161171310-161177968	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 95.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 74.9"	"Low region specificity"	"Detected in all"							HPA010793	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA		74000	"Golgi apparatus"	Cytosol	"HPA010793: AB_1078256"	"unprognostic (5.67e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (5.87e-5)"	"unprognostic (3.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (7.12e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	20.7	18.7	16.5	17.2	22.1	17.3	33.4	20.1	23.2	15.0	19.0	12.4	22.2	18.4	13.6	21.0	20.4	17.2	17.5	17.2	13.4	14.7	22.5	21.7	20.8	21.6	16.4	13.4	25.4	37.5	15.8	29.1	41.0	16.6	18.5	19.3	14.8	33.0	27.8	19.5	20.2	15.1	11.7	14.1	26.6	21.5	28.4	16.4	14.8	28.2	10.7	21.4	20.6	22.9	16.7	22.6	7.1	12.6	15.1	25.5	11.9	9.9	6.6	9.8	12.9	14.6	7.5	15.7	5.7	10.2	11.8	10.9	13.0	20.4	9.2	16.3	6.4	11.3	10.2	10.3	6.3	7.0	9.6	12.6	5.3	4.4	10.4	10.5	10.3	14.8	10.4	9.4	10.9	11.9	14.2	13.4	12.1	17.0	20.8	9.6	10.3	6.7	9.9	12.3	20.1	14.1	8.2	5.5	22.7	10.1	6.2	14.0	16.6	5.7	15.1	11.9	13.9	15.1	18.9	5.6	5.9	10.7	6.7	16.6	74.9	40.4	12.3	8.8	8.9	9.4	5.1	8.9	7.1	17.6	10.1	15.7	16.7	16.7	16.8	10.8	13.5	16.4	15.4	5.9	15.1	12.6	22.6	25.5	11.9	16.5	22.1	20.1	23.2	13.4	14.7	16.4	13.4	16.6	16.4	17.9	18.3	36.5	26.3	34.2	12.6	9.5	7.6	10.7	6.8	24.4	2.0	38.4	5.0	25.4	7.0	20.2	14.7	0.0	19.9	75.2	19.5	33.5	9.2	11.6	25.2	25.4	27.6	26.4	16.8	4.0	8.9	13.8	21.9	6.4	22.4	7.4	28.1	14.4	6.7	17.3	6.3	25.8	34.6	9.8	42.9	36.6	95.5	34.6	21.7	45.5
BARX2		ENSG00000043039	"BARX homeobox 2"	Q9UMQ3	11	129375940-129452279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 99.1;Suprabasal keratinocytes: 72.1;Urothelial cells: 102.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB033311, HPA064966, HPA068414"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984"	"unprognostic (4.25e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.06e-4)"	0.1	0.0	0.3	1.6	0.5	0.0	6.0	0.6	0.9	8.7	4.4	1.4	0.3	7.1	0.6	1.8	49.8	6.8	5.0	0.1	0.5	0.4	1.9	0.1	0.5	0.1	0.7	0.2	1.0	6.9	0.0	0.6	1.5	4.1	1.5	1.9	0.0	78.3	0.7	1.0	11.2	7.9	0.0	1.6	0.0	2.6	1.2	0.2	0.4	0.5	40.7	36.4	0.2	22.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.4	7.8	0.0	1.9	0.0	60.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.7	0.0	1.5	0.0	2.3	0.0	0.0	0.0	7.7	0.3	0.0	0.0	14.7	0.0	0.1	0.1	0.0	0.0	7.4	0.0	0.1	1.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.6	0.9	0.5	0.4	0.7	0.2	4.1	0.2	0.0	1.4	0.0	99.1	38.2	0.4	0.4	2.5	6.7	6.8	0.0	0.0	10.6	6.6	18.2	6.5	0.3	27.5	0.0	0.6	6.4	2.3	15.2	0.0	0.0	1.6	0.0	1.7	0.0	0.0	1.3	0.0	0.8	10.1	0.0	12.2	0.8	5.0	22.1	0.4	1.4	0.2	0.0	0.7	0.0	1.1	72.1	3.5	0.0	15.8	102.1
BATF3	"JDP1, JUNDM1, SNFT"	ENSG00000123685	"Basic leucine zipper ATF-like transcription factor 3"	Q9NR55	1	212686418-212699985	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.8"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 36.2;Macrophages: 24.9;monocytes: 98.2;Smooth muscle cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 18.0;myeloid DC: 16.5;non-classical monocyte: 26.8"	"Group enriched"	"Detected in many"	36	"dendritic cells: 16.5;monocytes: 26.8"	"Cell line enriched"	"Detected in some"	12	"HDLM-2: 93.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA075858			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA075858: "	"unprognostic (3.87e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.85e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.43e-10)"	"unprognostic (9.88e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.08e-2)"	10.4	1.3	6.7	6.3	9.4	5.4	3.5	0.4	5.2	2.0	2.4	3.3	0.2	1.4	1.8	0.4	1.8	2.6	3.8	4.1	5.5	2.1	2.6	2.3	7.2	8.7	9.5	2.8	3.1	3.2	1.2	1.3	4.6	4.3	2.3	1.6	0.5	2.2	1.2	1.5	1.1	4.3	3.7	4.7	9.5	3.2	1.1	7.1	5.0	2.1	2.6	4.9	3.0	6.0	0.2	16.5	0.6	26.8	0.3	0.4	2.4	0.3	0.9	0.1	0.0	0.0	0.6	0.7	0.5	1.1	1.1	1.2	0.0	0.3	0.0	0.2	0.0	1.8	0.0	1.1	0.2	0.8	93.1	2.2	0.0	0.3	0.0	0.2	4.2	0.6	0.1	0.0	2.2	0.3	0.1	0.0	7.7	0.1	1.1	0.2	0.0	3.2	1.7	0.4	0.0	1.5	0.6	0.4	0.0	1.0	0.0	0.2	0.1	0.3	0.0	0.0	0.4	0.0	3.0	0.0	0.5	2.1	0.1	2.4	0.1	0.2	0.5	1.5	3.8	1.1	0.0	4.1	0.0	0.0	18.0	0.0	0.2	0.0	0.0	16.5	0.0	0.0	0.0	0.6	0.3	26.8	0.0	0.4	2.4	6.7	9.4	0.4	5.2	5.5	2.1	9.5	2.8	4.3	7.1	3.0	1.1	0.5	2.2	5.0	0.1	0.3	0.0	4.0	2.3	0.0	0.0	0.8	0.0	0.7	0.3	5.8	0.0	0.0	0.3	36.2	8.5	6.6	4.7	0.2	4.6	0.0	0.0	6.2	10.5	0.8	0.9	24.9	1.7	98.2	0.0	0.2	1.3	0.0	0.0	0.5	0.4	0.0	25.8	1.1	4.3	2.5	3.8	1.0	0.0	0.9
BCL2L14	"BCL-G, BCLG"	ENSG00000121380	"BCL2 like 14"	Q9BZR8	12	12049844-12211084	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 40.1;testis: 29.8"	"Group enriched"	"Detected in many"	11	"Early spermatids: 317.4;Late spermatids: 661.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.0"	"Lineage enhanced"	"Detected in single"		"T-cells: 3.0"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 5.1;NTERA-2: 3.9;OE19: 5.0;RT4: 4.7;SuSa: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040665, HPA059846"	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA040665: AB_10964282, HPA059846: "	"unprognostic (3.65e-4)"	"unprognostic (4.95e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.70e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.59e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.79e-6)"	"unprognostic (3.83e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.73e-8)"	0.1	0.1	0.1	5.3	0.2	0.0	0.3	0.1	0.1	0.3	17.6	0.1	0.1	11.5	0.1	0.4	0.4	0.2	7.7	0.1	0.1	0.1	0.3	0.3	1.3	1.6	0.1	0.1	0.4	11.2	0.0	0.1	0.1	0.1	1.6	13.3	0.1	0.8	0.1	0.1	0.1	40.1	0.1	0.1	0.9	7.8	29.8	0.1	4.1	0.1	0.3	1.2	2.5	0.2	0.9	0.0	0.1	0.2	0.0	3.0	0.3	0.2	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.9	5.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	5.0	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.1	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.7	0.9	1.4	0.7	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	3.0	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	2.9	0.0	2.6	0.3	0.3	0.4	2.5	2.7	4.5	1.8	0.0	0.1	0.0	0.3	317.4	0.3	31.5	0.0	6.6	0.0	0.4	3.1	0.0	0.0	0.2	0.0	6.4	0.0	0.0	661.8	5.2	0.0	0.0	6.4	42.7	0.0	3.3	17.5	3.5	0.0	0.7	6.5	0.0	5.2	2.7	0.4	0.1	0.0	26.4	7.8
BEX2	DJ79P11.1	ENSG00000133134	"Brain expressed X-linked 2"	Q9BXY8	X	103309346-103311046	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 79.2;epididymis: 67.1"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 354.8;Muller glia cells: 185.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 18.0;NK-cells: 21.3;T-cells: 26.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 18.6;hTCEpi: 31.0;NTERA-2: 29.9;SCLC-21H: 44.0;SH-SY5Y: 20.0"									"HPA045384, HPA078630"	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA045384: AB_2679305, HPA078630: "	"unprognostic (7.56e-2)"	"unprognostic (7.08e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (8.54e-7)"	"unprognostic (3.21e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.27e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (7.36e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.22e-3)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.05e-13)"	"unprognostic (4.14e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-3)"	1.7	39.6	49.1	4.1	62.6	6.8	10.9	44.9	79.2	5.8	4.7	11.5	3.0	2.7	14.7	67.1	3.0	8.9	4.8	7.3	53.4	57.6	26.4	1.4	6.6	7.3	32.5	40.3	29.0	13.5	29.6	40.1	5.0	29.6	12.4	4.1	11.5	11.1	12.8	2.5	4.2	4.2	5.7	18.7	7.9	6.5	13.2	13.6	3.1	52.8	1.3	9.2	3.7	2.2	18.0	3.5	4.0	0.1	21.3	26.8	7.1	0.0	0.8	3.8	0.0	0.0	0.0	14.8	0.1	2.0	2.6	3.7	2.6	1.2	0.0	10.4	0.0	18.6	0.6	0.0	3.0	2.2	0.0	8.0	0.4	0.4	0.1	15.2	0.0	8.2	0.9	31.0	1.2	9.5	5.8	0.1	10.7	5.3	0.2	0.3	1.3	6.2	0.0	29.9	0.0	2.6	0.0	0.0	0.0	1.2	1.1	44.0	20.0	2.0	0.4	6.6	3.7	3.6	0.0	0.0	0.0	3.0	0.1	0.6	10.1	6.4	0.0	5.0	0.0	0.4	4.0	0.1	0.3	8.5	0.1	11.8	18.0	16.8	9.8	0.5	15.0	26.8	19.2	0.5	21.3	0.0	3.5	11.3	7.1	49.1	62.6	44.9	60.5	53.4	57.6	32.5	40.3	29.6	13.6	14.9	49.0	36.6	86.3	28.0	178.0	20.2	56.0	13.4	63.7	108.2	41.2	66.0	354.8	40.3	13.3	11.7	2.0	0.0	36.9	9.9	3.3	54.5	12.7	0.8	6.1	114.4	96.4	1.8	0.0	48.7	14.7	4.7	25.3	1.8	25.1	185.5	28.0	7.0	20.8	145.1	106.4	6.5	4.5	14.0	6.0	23.3	53.3	21.7	17.2	43.8
BFSP2	"CP47, CP49, LIFL-L, phakinin"	ENSG00000170819	"Beaded filament structural protein 2"	Q13515	3	133399995-133475222	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"blood: 12.7"	"Group enriched"	"Detected in some"	4	"B-cells: 10.7;Melanocytes: 5.0"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	7	"T-reg: 12.7"	"Lineage enriched"	"Detected in single"	48	"T-cells: 12.7"	"Group enriched"	"Detected in some"	7	"Daudi: 5.7;U-698: 6.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA038464, HPA062959"	Enhanced		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA038464: AB_10672746, HPA062959: AB_2684912"	"unprognostic (1.58e-3)"	"unprognostic (7.47e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.04e-5)"	"unprognostic (8.13e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.68e-5)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.21e-2)"	0.0	0.0	0.1	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	12.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.8	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	1.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.9	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"Bloom syndrome RecQ like helicase"	P54132	15	90717327-90816165	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 36.7"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	1.8	0.4	3.1	11.4	1.5	5.5	0.6	4.7	2.6	0.7	1.9	0.9	0.5	1.4	1.2	1.1	2.9	0.4	1.3	1.0	2.3	2.4	0.9	0.5	2.0	7.7	2.8	0.2	0.9	0.4	0.0	1.2	3.6	0.5	0.7	2.5	0.7	7.8	0.0	1.7	0.6	2.8	0.5	1.9	6.7	1.4	4.9	0.5	36.7	0.6	3.1	9.3	1.4	0.7	7.4	1.2	4.3	1.6	4.6	5.0	1.6	5.5	7.8	8.8	5.1	0.0	0.4	5.5	4.1	1.2	4.7	5.1	6.9	3.9	14.2	2.6	1.1	5.9	9.2	13.5	3.7	6.1	8.6	10.0	14.9	8.5	2.2	0.0	14.3	7.4	0.0	0.0	4.7	2.4	0.6	3.3	7.7	12.8	4.4	4.9	3.4	10.7	7.8	9.3	12.1	1.7	10.9	16.5	5.5	1.1	9.9	6.5	6.1	3.3	4.5	2.6	8.6	3.1	11.7	1.8	3.4	6.3	3.5	8.8	3.3	13.2	14.8	1.9	10.1	5.9	2.5	1.0	4.3	3.1	1.2	4.8	7.4	2.8	3.8	1.2	4.3	2.0	2.2	0.8	4.6	1.6	1.2	5.0	1.6	3.1	1.5	4.7	1.7	2.3	2.4	2.8	0.2	0.5	0.5	3.0	12.8	18.6	0.5	0.2	2.9	8.4	0.0	9.4	6.8	0.0	2.0	1.8	1.7	0.9	2.0	0.7	0.0	0.0	0.6	6.5	1.5	0.6	12.7	0.5	4.8	0.0	0.0	2.5	9.7	1.6	0.0	3.8	0.0	1.0	1.2	1.2	0.8	0.0	0.4	0.0	6.5	0.0	0.4	12.0	11.8	0.5	0.8	8.7	2.3	0.3
BNIP3	Nip3	ENSG00000176171	"BCL2 interacting protein 3"	Q12983	10	131966455-131982013	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 122.7"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 391.8;Proximal tubular cells: 579.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 72.0;hTERT-RPE1: 56.2;U-87 MG: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003015, CAB011676"	Supported		Uncertain	Cytosol		NA	NA			Cytosol		"CAB011676: , HPA003015: AB_1078290"	"unprognostic (1.01e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.62e-3)"	"unprognostic (6.57e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.98e-1)"	19.3	12.0	18.3	4.0	18.6	3.0	8.7	13.5	28.3	7.7	4.6	13.0	5.1	4.0	6.0	11.4	8.1	6.0	7.9	43.3	16.9	14.6	27.6	53.4	6.7	4.6	16.5	14.2	19.3	122.7	6.0	7.3	13.0	22.6	18.2	2.9	5.2	19.2	6.6	48.0	9.0	4.5	6.0	13.3	4.9	6.4	6.0	11.1	3.3	10.8	6.2	4.0	9.2	7.3	6.1	3.0	5.1	3.5	2.2	23.4	8.9	72.0	5.8	4.2	11.7	11.2	11.9	21.6	17.6	16.3	13.3	38.0	1.2	1.6	0.1	28.6	10.1	15.5	4.4	8.8	25.0	50.1	3.8	6.7	2.5	3.7	16.7	15.0	3.3	2.0	8.2	6.3	12.9	13.1	56.2	9.2	4.5	6.6	0.2	21.7	5.7	1.6	18.4	3.5	0.5	17.5	4.0	2.1	6.1	14.5	1.2	5.5	12.9	3.6	7.4	10.0	18.6	4.5	4.6	10.5	18.8	6.3	7.0	13.9	12.3	10.5	10.0	68.2	0.1	3.2	2.2	3.5	5.1	9.8	2.3	10.4	5.7	13.9	10.3	3.0	6.1	23.4	15.4	0.9	2.2	3.1	2.3	13.2	8.9	18.3	18.6	13.5	28.3	16.9	14.6	16.5	14.2	22.6	11.1	44.7	40.9	23.1	75.3	26.6	87.6	141.4	101.9	89.7	48.9	80.3	37.3	149.9	255.4	174.2	61.9	44.2	3.5	0.0	75.7	295.7	56.6	118.1	0.0	391.8	65.8	314.6	77.8	54.6	21.8	85.4	65.0	16.1	32.1	39.7	6.7	125.3	189.3	1.9	97.2	579.1	50.2	38.8	23.8	33.5	100.7	11.4	206.9	25.4	4.8	42.9
BTBD16	"C10orf87, Em:AC061711.1, FLJ25359"	ENSG00000138152	"BTB domain containing 16"	Q32M84	10	122271306-122338162	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skin 1: 9.1;testis: 27.6;urinary bladder: 17.9"	"Group enriched"	"Detected in some"	19	"Early spermatids: 100.4;Late spermatids: 53.9"	"Cancer enriched"	"Detected in many"	14	"urothelial cancer: 18.4"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	29	"T-reg: 2.8"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.8"	"Cell line enriched"	"Detected in some"	8	"RT4: 27.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA040529, HPA057638"	Uncertain		Uncertain	Nucleoli,Cytosol		Yes	NA			Nucleoli	Cytosol	"HPA040529: AB_2677022, HPA057638: "	"unprognostic (1.41e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.12e-2)"	"unprognostic (9.44e-3)"	0.3	0.0	0.6	0.3	0.5	0.0	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.6	0.3	0.3	0.2	0.3	0.3	0.9	0.4	0.3	4.4	0.3	0.3	1.2	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.4	0.3	0.3	9.1	0.3	0.3	2.3	0.3	0.0	27.6	0.3	0.3	0.3	0.3	0.3	17.9	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	1.3	27.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.6	0.5	0.3	0.3	0.9	0.4	1.2	0.3	0.3	0.3	0.0	0.0	0.0	0.2	2.5	0.0	0.2	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.9	100.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	53.9	0.6	0.0	0.0	0.0	0.0	0.0	1.3	2.9	0.4	0.8	0.0	0.0	0.2	3.7	0.9	2.8	0.1	0.0	0.0	0.8
BTBD19		ENSG00000222009	"BTB domain containing 19"	C9JJ37	1	44808482-44815585	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 7.0;HUVEC TERT2: 6.4;TIME: 14.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042633, HPA076404"	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA042633: AB_2678091, HPA076404: AB_2686796"	"unprognostic (4.69e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-4)"	"unprognostic (5.32e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.18e-8)"	"unprognostic (2.20e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.70e-1)"	6.7	8.7	3.5	3.6	1.9	2.7	4.9	0.6	2.8	13.5	2.0	2.4	6.2	1.6	13.9	21.4	2.1	6.4	4.2	3.8	1.3	1.4	4.2	2.2	4.1	1.8	1.4	4.0	8.4	1.5	3.2	11.9	7.9	6.3	5.6	1.8	7.6	1.7	8.3	1.8	1.2	2.2	5.6	1.9	2.3	2.2	3.5	0.6	0.1	6.0	2.0	1.4	2.1	4.3	0.0	0.2	2.3	0.1	0.0	0.2	0.0	0.1	1.1	1.0	1.1	2.3	2.6	0.7	2.1	1.3	1.0	2.0	0.0	0.8	0.1	1.0	3.7	0.5	0.3	0.0	1.1	0.4	0.9	0.2	2.0	0.3	1.1	2.3	0.0	1.6	3.9	0.1	3.7	0.7	7.0	6.4	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.7	0.0	0.0	0.0	0.3	0.1	1.2	1.3	0.0	0.0	14.9	3.8	3.0	1.8	1.6	0.5	0.1	0.0	2.3	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	3.5	1.9	0.6	2.8	1.3	1.4	1.4	4.0	6.3	0.6	3.0	3.4	0.0	1.6	1.8	0.0	1.0	2.5	1.4	4.5	1.8	0.0	0.2	0.0	0.9	0.4	3.5	2.1	0.0	0.5	0.2	3.8	0.9	2.3	2.8	2.7	0.0	0.0	3.7	6.0	0.0	2.8	4.6	3.3	0.0	1.3	1.5	0.8	0.8	1.1	2.7	0.0	0.0	4.6	0.7	0.2	1.9	1.0	0.0	0.7	1.3
BUB1	"BUB1A, BUB1L, hBUB1"	ENSG00000169679	"BUB1 mitotic checkpoint serine/threonine kinase"	O43683	2	110637698-110678114	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 56.5;testis: 30.9"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 68.1"	"Not detected"	"Not detected"							HPA006123			Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA006123: AB_1845498"	"unprognostic (7.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (1.03e-5)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (1.76e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.45e-2)"	"unprognostic (3.64e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	1.1	0.9	0.5	15.8	1.0	8.9	0.6	0.3	1.0	1.2	2.8	0.4	0.0	2.4	0.7	2.3	5.8	0.5	1.0	1.1	0.5	0.5	0.9	0.8	2.1	11.6	0.6	0.2	1.0	0.7	0.0	0.4	2.4	0.5	0.7	4.3	0.4	1.4	0.0	0.5	1.8	3.1	1.4	1.3	7.9	1.8	30.9	0.1	56.5	0.6	5.7	12.1	2.5	2.0	1.8	2.4	3.0	0.2	1.4	6.1	1.1	30.3	8.9	23.4	14.7	1.0	1.7	12.4	15.8	10.4	27.5	20.8	18.7	17.5	20.6	9.8	9.1	25.8	13.3	29.9	11.5	34.2	16.3	14.6	68.1	9.5	14.9	0.2	19.6	19.3	0.4	0.7	21.2	10.5	3.9	16.1	23.1	29.8	43.0	22.5	10.0	32.8	16.4	22.6	10.8	16.9	21.8	20.0	31.4	5.6	9.6	15.7	6.8	11.2	9.6	8.5	14.9	7.5	16.6	6.6	12.5	20.5	9.4	21.9	22.5	21.1	25.3	8.5	15.2	22.0	3.0	0.0	0.7	0.6	0.2	0.9	1.8	2.5	1.0	0.8	1.4	1.6	1.5	0.0	1.4	0.1	2.4	6.1	1.1	0.5	1.0	0.3	1.0	0.5	0.5	0.6	0.2	0.5	0.1	0.0	1.0	7.8	0.2	0.5	0.0	0.8	0.0	1.4	2.3	0.0	0.0	1.3	0.0	0.2	8.3	0.0	0.0	0.0	0.0	8.1	0.3	0.2	0.0	0.2	6.6	0.0	0.0	1.3	1.3	4.7	0.3	1.7	0.0	1.0	0.9	0.0	0.1	0.0	0.4	0.0	0.0	6.5	0.0	68.0	14.1	0.4	0.6	2.5	2.0	0.9
C17orf49	"BAP18, HEPIS, MGC49942"	ENSG00000258315	"Chromosome 17 open reading frame 49"	Q8IXM2	17	7014495-7017525	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"monocytes: 100.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022961, HPA024457"	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA022961: AB_1845592, HPA024457: AB_1845593"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-3)"	"unprognostic (9.09e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.06e-9)"	"unprognostic (5.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.62e-2)"	28.3	21.9	32.7	30.7	29.1	55.4	25.8	24.9	32.1	21.4	20.7	20.9	13.9	18.5	19.1	29.9	29.7	27.2	25.6	25.6	28.4	24.5	23.3	34.3	30.4	45.2	25.9	21.1	19.0	25.1	20.8	20.9	29.7	19.7	20.4	23.2	22.5	22.7	16.8	32.7	30.2	19.2	18.4	23.1	44.6	18.4	21.8	17.9	60.4	31.4	30.7	53.7	25.7	18.8	52.3	78.9	48.8	49.8	82.3	48.3	40.4	18.3	24.5	38.8	30.0	27.7	39.4	13.3	10.0	16.4	20.1	16.5	12.0	15.2	17.7	27.7	23.9	6.5	15.3	9.6	19.4	15.4	61.7	25.6	15.9	7.8	23.1	20.8	10.1	21.3	24.7	26.2	15.0	30.4	14.5	31.4	14.4	5.8	50.6	24.5	21.0	16.6	33.9	12.9	21.1	14.4	10.4	11.4	25.6	22.7	12.3	10.6	30.1	17.6	9.1	17.7	14.6	11.5	13.1	17.1	11.7	14.5	19.7	25.4	18.2	10.3	5.9	18.3	15.1	16.7	48.8	37.6	34.4	47.0	49.8	29.8	52.3	48.3	47.0	57.6	50.6	32.3	35.7	34.3	82.3	37.1	78.9	47.9	40.4	32.7	29.1	24.9	32.1	28.4	24.5	25.9	21.1	19.7	17.9	3.0	10.1	19.8	5.3	9.3	1.0	0.4	0.0	4.0	7.9	1.8	0.0	9.5	14.9	15.3	0.1	9.3	5.6	0.0	20.0	13.6	6.9	2.7	17.4	1.5	9.7	0.0	29.4	8.0	8.7	1.0	3.7	18.0	23.6	100.0	10.0	2.0	18.7	13.6	1.4	3.7	3.9	6.5	15.5	4.6	18.8	10.3	8.7	20.8	16.0	4.6
C19orf38	HIDE1	ENSG00000214212	"Chromosome 19 open reading frame 38"	A8MVS5	19	10836575-10869790	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.7;bone marrow: 54.4"	"Cell type enhanced"	"Detected in many"	18	"Kupffer cells: 101.9;Macrophages: 32.6;monocytes: 24.4;Spermatocytes: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"classical monocyte: 44.3;eosinophil: 26.1;intermediate monocyte: 48.7;myeloid DC: 26.2;neutrophil: 37.3;non-classical monocyte: 58.7"	"Group enriched"	"Detected in many"	19	"dendritic cells: 26.2;granulocytes: 37.3;monocytes: 58.7"	"Cell line enriched"	"Detected in some"	4	"U-937: 32.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA012150, HPA055027"			Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA			Cytosol	"Golgi apparatus, Plasma membrane"	"HPA012150: AB_10603448, HPA055027: "	"unprognostic (6.65e-3)"	"prognostic favorable (2.43e-4)"	"unprognostic (6.44e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.56e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.75e-7)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.11e-2)"	2.7	1.2	2.1	6.9	4.0	54.4	1.8	0.7	3.1	2.0	1.3	4.8	0.0	1.3	0.9	4.0	0.9	2.6	2.1	5.6	2.4	2.1	1.4	2.3	12.8	19.6	4.2	0.6	1.6	1.3	0.3	1.0	1.9	3.8	1.6	1.0	1.5	1.0	0.8	2.3	0.6	1.7	2.3	6.3	22.3	1.2	15.0	3.7	4.1	0.7	0.5	2.0	2.8	3.5	2.1	26.2	37.3	58.7	1.2	0.8	20.7	1.5	0.0	0.1	0.3	1.5	0.8	0.1	0.2	0.0	0.3	0.6	0.1	0.2	3.8	0.3	0.0	0.1	0.1	0.2	0.2	0.2	1.7	0.4	0.2	0.0	0.0	1.1	2.5	0.4	4.1	0.4	0.7	0.2	0.1	0.1	0.4	0.2	8.1	0.1	1.4	0.1	5.9	0.3	0.2	0.3	2.8	0.0	1.9	0.0	0.1	0.2	0.1	0.8	0.0	0.6	0.1	0.1	5.6	0.0	0.0	0.0	0.7	0.0	4.9	2.3	1.1	0.0	32.8	0.0	1.2	44.3	26.1	0.1	48.7	0.2	2.1	0.1	0.1	26.2	1.2	0.8	0.2	37.3	1.2	58.7	0.5	0.3	20.7	2.1	4.0	0.7	3.1	2.4	2.1	4.2	0.6	3.8	3.7	0.0	2.6	12.3	0.3	0.7	0.0	0.6	0.0	2.7	1.2	1.8	2.0	0.8	0.0	0.0	2.7	0.0	0.0	0.0	1.1	0.6	1.1	0.4	2.3	0.9	21.2	0.0	0.0	0.0	101.9	5.3	0.9	32.6	1.7	24.4	0.5	2.3	0.2	3.5	0.7	0.4	1.0	6.5	0.1	27.0	15.8	0.6	0.6	0.8	0.3	0.6
C1orf158	MGC35194	ENSG00000157330	"Chromosome 1 open reading frame 158"	Q8N1D5	1	12746215-12763699	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 23.5;testis: 74.6"	"Group enriched"	"Detected in some"	13	"Ciliated cells: 105.7;Early spermatids: 148.7;Late spermatids: 65.2"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5"	"Region enhanced"	"Detected in many"		"pons and medulla: 9.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028396			Uncertain	Cytosol		NA	NA			Cytosol		"HPA028396: AB_10603451"	"unprognostic (1.11e-2)"			"unprognostic (4.94e-3)"	"unprognostic (4.62e-1)"			"unprognostic (8.00e-2)"		"unprognostic (4.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.45e-1)"		"unprognostic (3.51e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"		0.0	0.0	0.7	0.0	2.4	0.3	0.0	0.0	0.2	0.9	0.0	6.2	0.0	0.0	0.4	4.2	0.1	23.5	0.1	0.0	1.0	1.4	0.0	0.0	2.8	0.1	0.2	0.1	4.8	0.1	0.0	0.4	0.1	9.3	0.0	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.2	0.1	0.1	74.6	0.9	0.0	0.5	0.0	0.1	0.0	0.0	0.9	0.6	2.3	0.6	1.1	0.8	0.1	0.5	1.3	1.1	0.7	0.6	0.0	1.0	0.1	0.3	0.2	0.2	1.3	0.7	1.1	0.3	0.3	0.4	0.4	0.1	0.1	0.2	0.2	0.7	1.1	1.9	0.5	0.0	0.9	1.0	0.1	0.7	0.3	0.1	0.4	0.1	0.5	0.9	1.4	0.3	0.5	0.2	0.7	1.5	0.3	0.5	0.6	0.3	0.9	0.1	0.5	1.9	0.8	0.5	0.6	0.3	1.4	0.7	0.2	0.5	0.5	0.8	0.4	0.8	0.6	0.5	1.2	1.0	1.1	0.5	1.6	0.6	0.5	0.7	0.5	0.6	0.5	0.5	0.5	0.1	0.9	0.8	0.7	2.3	1.1	0.6	0.6	0.4	0.1	0.7	2.4	0.0	0.2	1.0	1.4	0.2	0.1	9.3	0.9	3.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	105.7	7.9	0.0	0.0	0.0	0.0	0.0	148.7	0.0	0.0	0.0	0.0	0.5	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	65.2	1.7	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	6.5	0.0	7.9	1.3	0.0	0.0	0.0	0.0	0.1
C1orf194		ENSG00000179902	"Chromosome 1 open reading frame 194"	Q5T5A4	1	109105951-109113857	"Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 36.5;fallopian tube: 60.2;testis: 77.6"	"Group enriched"	"Detected in some"	10	"Ciliated cells: 776.3;Early spermatids: 1757.0;Late spermatids: 2679.4"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8"	"Region enriched"	"Detected in many"	5	"pons and medulla: 36.5"	"Cell type enriched"	"Detected in some"	5	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in some"		"AF22: 4.5;RPTEC TERT1: 1.1;SCLC-21H: 6.3;U-87 MG: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031144, HPA049684"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA031144: AB_10602109, HPA049684: AB_2680849"	"unprognostic (9.91e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.91e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.98e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.08e-6)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.27e-3)"	0.3	0.4	1.5	0.3	6.8	0.3	0.4	0.3	2.6	1.8	0.3	12.3	0.0	0.4	1.0	11.1	0.4	60.2	0.3	0.3	3.0	1.6	0.3	0.3	7.5	0.4	0.5	1.8	10.3	0.7	0.4	2.7	0.3	36.5	0.4	0.4	0.0	0.3	0.3	0.3	0.3	0.4	0.4	0.7	0.3	0.5	77.6	2.3	0.0	0.5	0.0	0.3	0.5	0.2	0.2	0.0	5.3	0.0	0.0	0.3	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	6.3	0.3	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	6.8	0.3	2.6	3.0	1.6	0.5	1.8	36.5	2.3	0.0	2.6	0.0	0.2	0.0	0.6	2.0	0.0	776.3	56.9	0.0	0.0	0.0	0.0	0.0	1757.0	0.0	0.0	0.0	0.2	0.0	0.2	1.6	3.5	0.0	0.1	0.0	0.0	0.0	0.0	2679.4	19.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	17.7	0.0	0.0	6.5	0.0	176.3	13.0	0.1	0.0	0.0	0.0	0.0
C1orf228	"MGC33556, NCRNA00082, p40"	ENSG00000198520	"Chromosome 1 open reading frame 228"	Q6PIY5	1	44674692-44725591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 14.0;testis: 17.9"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 46.8;Early spermatids: 45.0;granulocytes: 81.7;Late spermatids: 39.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 8.6;MOLT-4: 7.1;NB-4: 10.1;U-937: 13.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034769	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA034769: AB_10670979"	"unprognostic (2.01e-5)"	"unprognostic (4.28e-3)"	"unprognostic (7.27e-2)"	"prognostic favorable (8.64e-4)"	"unprognostic (9.23e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.22e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.25e-10)"	"unprognostic (1.99e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-3)"	0.9	2.2	6.3	0.7	11.2	4.3	1.5	3.2	6.8	1.7	1.0	5.6	3.9	0.7	3.1	6.8	1.3	14.0	1.5	0.6	6.5	2.4	1.4	7.0	2.0	1.5	1.4	7.5	4.5	1.4	3.0	5.4	0.8	7.7	1.8	0.9	3.3	1.6	1.4	0.5	1.7	0.8	0.9	2.4	0.8	1.4	17.9	5.4	0.2	1.3	0.0	1.0	0.8	0.8	1.4	6.2	10.4	2.7	0.5	2.3	1.8	0.2	0.3	2.0	0.1	0.7	2.6	0.5	0.0	0.3	0.5	0.3	0.5	4.3	0.3	0.3	0.9	1.0	0.5	0.0	0.0	0.0	1.1	0.2	1.0	2.6	0.6	0.2	8.6	5.1	2.0	0.3	0.8	0.0	1.5	0.2	0.3	0.1	0.8	0.2	0.1	7.1	10.1	0.1	0.6	0.1	3.7	0.2	2.4	0.9	0.0	1.4	0.9	0.0	1.4	1.1	1.4	0.4	4.5	0.0	0.3	0.3	0.4	0.0	0.3	0.3	0.2	0.3	13.7	0.4	10.4	2.7	7.5	0.3	0.8	0.1	0.7	1.5	1.0	1.3	1.4	2.2	2.3	1.2	0.5	0.1	6.2	0.1	1.8	6.3	11.2	3.2	6.8	6.5	2.4	1.4	7.5	7.7	5.4	6.0	5.0	14.5	0.4	0.7	1.1	0.0	0.0	46.8	9.1	0.0	11.8	0.3	0.0	0.0	45.0	0.0	0.3	0.0	0.0	0.1	0.7	0.4	81.7	3.2	10.7	1.6	9.8	0.0	15.0	39.8	0.3	6.1	0.0	0.0	0.6	6.1	0.0	0.0	0.7	0.0	4.3	6.5	0.3	2.3	14.3	0.6	0.1	1.0	0.6	0.1
C1R		ENSG00000159403	"Complement C1r"	P00736	12	7080209-7092607	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 370.2"	"Group enriched"	"Detected in many"	5	"Fibroblasts: 462.9;Hepatocytes: 1385.8;Leydig cells: 1057.9;Peritubular cells: 364.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 2.0;gdT-cell: 1.6;MAIT T-cell: 2.0;memory CD4 T-cell: 1.4;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.8;naive CD8 T-cell: 2.9;neutrophil: 2.5;NK-cell: 3.2;T-reg: 1.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.5;NK-cells: 3.2;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 181.7;ASC TERT1: 92.7;BJ hTERT+: 80.0;BJ hTERT+ SV40 Large T+ RasG12V: 49.3;HSkMC: 107.4"					"Low region specificity"	"Detected in all"			"HPA001251, HPA001551"	Uncertain		Uncertain	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		14000000000	"Nucleoplasm, Cytosol"		"HPA001251: AB_2666252, HPA001551: AB_10754818"	"unprognostic (1.55e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (1.94e-14)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.59e-2)"	45.8	17.4	2.6	18.1	3.8	0.0	82.0	1.4	2.8	36.7	24.5	2.4	11.2	5.0	27.2	66.8	38.1	33.3	46.7	49.5	1.9	1.8	27.5	370.2	25.3	46.8	3.5	2.0	103.5	11.4	1.4	6.3	10.3	4.6	47.8	15.3	17.7	12.8	13.2	16.0	10.7	14.4	53.2	6.2	35.1	19.8	39.3	1.9	2.3	30.6	20.7	15.1	46.8	83.8	0.4	0.0	2.5	0.4	3.2	3.4	0.8	0.1	1.5	0.1	1.3	181.7	92.7	0.1	20.4	80.0	24.2	49.3	0.2	0.3	0.0	0.6	15.9	1.6	0.3	1.7	0.8	3.4	1.9	0.1	0.0	0.6	0.6	34.9	0.1	0.2	107.4	0.5	11.0	0.8	18.4	0.4	0.1	0.0	2.5	3.1	0.0	0.9	0.1	0.8	0.0	0.1	1.1	0.5	0.1	0.1	0.9	0.0	0.3	14.7	0.4	0.4	0.2	0.0	0.0	0.0	5.8	0.9	26.7	0.1	0.1	0.4	0.0	8.3	0.1	0.8	0.0	0.4	2.0	1.6	0.1	2.0	0.0	1.4	3.4	0.0	0.4	2.8	2.9	2.5	3.2	0.0	0.0	1.4	0.8	2.6	3.8	1.4	2.8	1.9	1.8	3.5	2.0	4.6	1.9	20.8	84.7	28.4	53.6	48.5	0.2	14.6	168.2	6.7	34.2	17.4	2.0	2.9	3.3	164.2	3.5	51.3	0.3	23.3	39.1	4.8	462.9	14.1	9.3	1385.8	10.3	0.0	0.0	128.9	25.4	9.4	1057.9	10.1	50.6	2.8	0.6	15.1	74.1	0.6	364.9	5.0	0.9	168.1	97.8	5.7	4.1	35.0	4.3	13.1	0.7	9.8
C22orf31	"bK747E2.1, HS747E2A"	ENSG00000100249	"Chromosome 22 open reading frame 31"	O95567	22	29058672-29061844	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 3.4;testis: 12.7"	"Group enriched"	"Detected in some"	15	"Early spermatids: 55.4;Late spermatids: 34.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.4"					"Not detected"	"Not detected"			"HPA000604, HPA068522"	Uncertain		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane"	Cytosol	"HPA000604: AB_1079086, HPA068522: "																		0.0	0.4	0.9	0.0	3.4	0.0	0.4	0.4	0.9	0.5	0.3			0.2	0.4	1.6	0.5	0.5	0.0	0.0	1.0	0.2	0.2	0.0	0.2	0.0	0.8		1.1	0.0	0.2	0.4	0.0		0.2	0.3		0.5	0.0	0.1	0.6	0.4	0.1	0.0	0.0	0.6	12.7			0.1		0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.2	0.0	0.8	0.0	0.9	0.8	0.0	0.0	0.4	0.6	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	55.4	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	0.9	0.0	1.7	0.0	0.0	3.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.7	0.6	0.0	0.0	0.0	0.0
C2orf66	UNQ6411	ENSG00000187944	"Chromosome 2 open reading frame 66"	Q6UXQ4	2	196805002-196810276	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 7.0;pituitary gland: 6.4"	"Cell type enriched"	"Detected in some"	12	"Early spermatids: 27.1"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 9.4;RT4: 3.5;TIME: 3.9"									HPA020869	Uncertain		Uncertain	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA020869: AB_1851545"	"unprognostic (1.19e-1)"	"unprognostic (4.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.10e-3)"	"unprognostic (4.54e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.75e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.86e-2)"	7.0	4.0	0.4	0.2	0.7	0.2	1.0	0.1	0.4	0.0	0.2			0.0	0.1	1.2	0.1	1.1	0.4	0.7	0.4	2.8	0.3	0.0	0.2	0.0	0.7		0.3	0.6	0.0	6.4	0.1		0.3	0.4		0.0	0.2	0.0	2.8	0.3	0.1	0.0	0.2	0.0	2.6			0.1		0.2	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.4	1.1	0.5	0.3	0.0	0.5	0.2	0.2	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	1.1	0.2	0.3	0.6	9.4	1.0	0.1	0.0	0.1	0.8	0.7	1.4	0.2	0.2	0.2	0.8	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.2	3.5	0.4	0.2	0.0	0.1	0.1	0.4	0.0	0.0	3.9	0.3	0.3	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
C3orf20	DKFZP434N1817	ENSG00000131379	"Chromosome 3 open reading frame 20"	Q8ND61	3	14675099-14773034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"testis: 30.9"	"Group enriched"	"Detected in some"	27	"Early spermatids: 16.4;Late spermatids: 27.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"Daudi: 5.7;HEL: 12.2;U-698: 9.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA039584	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039584: AB_10795152"	"unprognostic (1.23e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.76e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-4)"	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	30.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.0	0.0	5.7	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	12.2	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	2.0	0.0	0.5	0.8	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
C7orf31		ENSG00000153790	"Chromosome 7 open reading frame 31"	Q8N865	7	25134697-25180356	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 60.9"	"Group enriched"	"Detected in many"	17	"Early spermatids: 399.0;Late spermatids: 665.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 18.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA020346			Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA020346: AB_1845758"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.90e-3)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.12e-3)"	"unprognostic (8.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.15e-2)"	2.4	6.2	1.5	4.8	3.1	1.3	2.3	4.0	1.6	3.3	5.1	2.9	2.0	3.3	3.3	2.9	2.4	2.6	3.7	3.1	1.9	1.5	2.6	1.2	2.8	7.0	2.0	2.2	4.6	1.8	4.3	2.1	1.1	2.3	3.2	3.6	4.1	6.0	2.3	0.9	1.8	3.9	2.4	2.9	3.7	3.4	60.9	2.4	5.9	4.6	0.9	3.3	3.5	5.1	3.0	5.9	2.3	1.3	2.8	2.8	0.9	2.8	2.0	4.5	5.2	1.8	1.0	2.5	1.2	4.9	3.7	5.6	3.9	2.7	7.2	1.9	2.2	14.6	1.1	5.0	1.4	4.0	3.4	4.9	3.4	0.2	5.2	4.3	5.5	8.3	3.1	3.9	3.0	0.7	2.6	0.7	6.2	5.1	4.0	0.9	0.0	5.6	7.0	1.8	6.6	1.8	7.0	5.2	1.1	2.5	3.6	1.3	3.8	1.2	4.9	4.6	6.6	0.8	9.2	1.0	2.3	6.2	0.0	1.8	18.0	5.7	10.3	0.7	5.3	10.6	1.4	1.3	2.3	1.7	0.6	2.3	3.0	1.1	1.5	1.7	2.1	2.8	2.2	0.1	2.8	0.8	5.9	2.8	0.9	1.5	3.1	4.0	1.6	1.9	1.5	2.0	2.2	2.3	2.4	0.0	5.3	2.9	2.3	1.0	0.9	1.0	2.5	5.3	0.0	0.0	0.0	2.8	3.3	1.0	399.0	2.2	2.5	0.0	3.4	2.1	2.5	0.9	0.0	1.0	2.4	0.0	4.1	1.8	5.0	665.4	6.6	2.9	3.3	4.6	2.8	7.7	3.2	6.5	4.9	0.6	0.5	0.0	2.1	31.4	12.4	0.5	1.9	4.3	6.0	0.9
C8orf76	FLJ14825	ENSG00000189376	"Chromosome 8 open reading frame 76"	Q96K31	8	123219957-123241398	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Horizontal cells: 128.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 59.8"									HPA023708	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023708: AB_1845785"	"prognostic unfavorable (9.95e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.71e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (5.95e-11)"	"unprognostic (1.54e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.71e-2)"	11.9	15.4	13.5	11.4	21.8	13.8	14.5	18.5	15.2	12.0	13.5	11.5	27.0	11.8	9.2	16.1	16.4	9.5	11.2	11.1	11.5	11.8	10.1	19.3	10.2	15.9	11.8	10.6	9.8	12.3	8.5	24.0	15.5	10.9	11.5	15.8	12.5	13.9	23.7	16.9	10.0	12.5	10.8	9.4	15.9	10.4	7.4	14.4	18.8	13.9	9.9	18.3	10.3	10.7	12.7	17.2	24.4	18.9	13.4	18.6	11.0	8.5	7.9	7.4	5.2	7.2	6.7	5.0	8.1	7.9	9.5	9.6	7.2	6.3	5.9	8.9	7.7	7.1	6.6	8.4	4.4	10.8	9.3	12.0	6.9	3.6	10.1	13.1	3.6	5.7	4.9	8.6	8.5	7.1	5.7	8.4	9.3	9.8	4.6	7.8	25.0	10.5	8.2	6.0	20.9	13.8	5.6	3.8	6.7	8.1	7.1	9.7	9.1	8.1	59.8	8.5	7.9	7.3	8.8	4.6	5.4	10.4	5.8	6.6	6.1	6.7	6.3	5.8	8.2	5.8	15.9	16.7	24.4	13.3	18.9	13.9	11.2	14.5	16.8	17.2	12.7	13.9	13.7	9.8	13.4	15.3	14.9	18.6	11.0	13.5	21.8	18.5	15.2	11.5	11.8	11.8	10.6	10.9	14.4	11.9	1.3	15.7	15.3	11.9	7.9	4.8	5.1	14.7	5.7	1.8	9.8	23.3	5.0	14.4	2.3	5.8	16.8	0.0	10.4	25.8	12.4	15.5	21.9	9.8	20.4	128.7	23.7	8.0	17.1	3.0	11.8	16.5	13.5	19.0	12.8	10.2	13.7	14.4	7.1	7.9	7.1	19.4	4.5	13.1	19.3	10.0	33.6	13.8	14.0	34.2
CACTIN	"C19orf29, cactin, fSAPc, NY-REN-24"	ENSG00000105298	"Cactin, spliceosome C complex subunit"	Q8WUQ7	19	3610641-3626815	"Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042504, HPA042548"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA042504: AB_10797501, HPA042548: AB_10794760"	"unprognostic (1.18e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.09e-1)"	"prognostic favorable (3.69e-5)"	"unprognostic (5.93e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.22e-3)"	"unprognostic (3.88e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.55e-3)"	16.1	14.4	18.3	19.4	17.8	19.8	16.2	19.2	19.9	11.8	12.4	13.1	12.3	14.5	14.2	9.6	11.9	13.0	13.0	10.3	14.2	10.9	11.9	14.8	11.7	16.5	14.3	9.9	21.4	14.9	8.9	11.1	11.3	13.4	13.4	8.5	10.3	15.5	12.8	28.6	22.0	16.2	12.2	9.8	23.0	15.7	14.4	15.0	13.9	12.6	11.9	12.7	11.3	18.5	2.1	4.3	0.8	2.9	0.9	3.7	1.3	14.5	8.4	7.1	12.1	5.2	5.2	10.8	10.5	4.2	6.3	7.0	8.3	6.6	12.2	9.0	6.5	7.4	13.6	7.4	8.7	3.8	12.3	9.8	7.6	11.5	9.9	7.3	10.2	11.1	5.0	8.5	5.8	4.1	3.8	9.0	10.7	16.8	13.7	3.3	8.8	18.3	8.9	15.2	8.9	9.9	19.4	9.2	11.5	5.8	7.4	9.8	13.7	11.7	8.3	8.4	4.0	6.6	11.8	11.6	8.5	10.7	18.5	18.2	21.0	14.0	13.5	10.5	16.5	11.4	0.0	1.2	0.0	3.7	2.9	1.3	2.0	1.8	1.7	1.0	2.1	2.0	2.5	0.8	0.9	0.4	4.3	1.4	1.3	18.3	17.8	19.2	19.1	14.2	10.9	14.3	9.9	13.4	15.0	0.0	2.4	4.2	3.8	5.4	4.8	2.8	10.2	0.0	1.2	1.8	2.0	3.0	0.0	4.6	2.1	3.0	4.6	0.0	4.2	4.4	3.7	4.6	4.6	4.3	4.4	0.0	1.2	3.1	4.1	3.6	5.5	2.8	1.7	9.0	5.6	5.6	4.8	3.5	5.3	2.8	5.6	0.0	4.5	9.1	9.1	6.9	2.7	3.5	5.2	3.5
CAMK2B	"CAM2, CAMK2, CAMKB"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7"	"Cell type enriched"	"Detected in many"	11	"Bipolar cells: 838.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		680000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	1.4	8.1	20.6	1.4	46.7	1.2	2.0	60.1	81.9	1.2	1.4	4.0	0.7	1.7	1.3	18.8	2.0	1.8	1.2	39.2	36.5	18.0	1.7	3.5	1.2	1.8	10.3	21.3	1.1	3.3	5.6	9.9	1.1	13.4	3.0	1.4	2.7	1.8	2.2	70.7	1.8	1.6	1.2	4.1	1.3	2.4	2.3	4.8	0.0	7.7	2.4	2.0	1.1	0.0	1.3	1.0	3.2	1.2	3.2	1.2	0.8	0.0	0.3	0.2	0.3	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.2	0.8	0.0	1.1	2.4	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	5.3	0.0	0.2	0.1	0.0	2.4	0.1	0.9	0.1	0.0	0.0	42.0	2.2	0.2	0.0	0.0	0.1	1.9	0.2	0.2	0.2	0.4	0.2	0.0	0.5	0.4	0.1	0.2	0.0	0.2	3.2	0.7	1.0	0.8	0.9	1.2	1.1	1.0	0.5	0.5	1.3	1.2	1.1	2.0	3.2	1.2	1.0	0.9	0.8	20.6	46.7	60.1	42.4	36.5	18.0	10.3	21.3	13.4	4.8	0.0	0.0	0.0	27.8	1.0	838.1	74.9	2.5	0.0	0.0	0.0	43.2	0.0	8.3	0.0	0.8	0.6	0.0	0.0	0.0	0.1	0.4	2.6	4.6	4.4	0.2	57.2	39.0	0.0	1.2	2.1	1.7	0.0	1.7	0.0	0.0	14.1	0.1	0.0	0.0	0.8	46.7	0.0	0.9	0.0	1.7	0.4	0.2	0.0	0.0	0.7
CAMTA2	KIAA0909	ENSG00000108509	"Calmodulin binding transcription activator 2"	O94983	17	4967992-4987652	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027835, HPA051147"			Supported	"Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol"		NA	NA			Nucleoplasm	"Vesicles, Actin filaments, Mitochondria, Cytosol"	"HPA027835: , HPA051147: AB_2681362"	"unprognostic (2.82e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.08e-2)"	"prognostic favorable (6.00e-8)"	"unprognostic (3.42e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.19e-1)"	9.8	6.4	27.0	9.2	25.2	6.4	5.4	63.6	44.9	6.2	8.0	6.4	3.8	7.3	6.2	3.1	8.4	6.8	6.1	8.0	33.8	17.4	5.5	4.2	8.8	6.2	11.7	19.1	6.7	11.7	14.8	21.3	5.1	18.5	6.8	8.0	5.5	8.7	9.1	20.1	8.6	9.0	10.5	6.5	8.7	8.0	9.0	8.8	2.7	6.5	2.9	6.5	6.5	4.7	1.3	2.2	5.7	8.1	1.1	2.7	2.1	8.0	14.4	2.7	3.8	18.1	12.6	5.6	7.8	8.7	7.4	6.6	3.6	2.2	9.5	7.6	12.2	6.3	8.2	10.2	12.2	4.2	13.3	13.2	6.0	7.8	4.0	10.4	3.5	25.8	8.7	15.3	7.0	11.0	9.0	12.3	7.4	9.7	8.7	6.9	5.3	6.2	2.2	0.4	9.6	6.0	5.4	3.0	3.7	8.4	8.5	3.7	3.2	4.9	9.0	2.4	4.8	7.9	3.5	16.3	5.9	3.5	6.2	12.7	4.4	4.7	3.4	14.4	7.0	5.7	1.0	2.2	1.8	2.7	3.0	2.1	1.3	1.2	2.5	1.4	0.9	1.8	2.0	5.7	1.1	8.1	2.2	1.1	2.1	27.0	25.2	63.6	44.9	33.8	17.4	11.7	19.1	18.5	8.8	3.0	13.7	8.3	3.5	6.2	12.1	5.9	15.3	5.3	3.4	10.4	9.8	5.2	1.7	6.8	29.0	6.9	16.3	0.0	9.8	6.8	6.8	5.5	12.7	11.9	7.7	33.4	10.9	14.1	9.2	39.5	9.5	8.0	3.3	8.2	13.1	4.3	9.1	12.4	8.9	10.5	9.6	12.9	12.3	5.2	7.6	9.2	10.4	10.2	9.5	3.4
CCDC106	HSU79303	ENSG00000173581	"Coiled-coil domain containing 106"	Q9BWC9	19	55641062-55653161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 11.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 39.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041925, HPA043219"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041925: AB_2677750, HPA043219: AB_2678368"	"unprognostic (5.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.88e-2)"	"unprognostic (8.74e-2)"	"prognostic favorable (2.23e-6)"	"unprognostic (2.28e-1)"	"prognostic favorable (7.54e-11)"	"unprognostic (5.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.26e-1)"	"unprognostic (8.69e-2)"	15.9	18.7	31.6	8.7	43.9	4.4	14.5	27.2	29.8	13.9	10.4	14.3	10.5	7.2	13.2	11.2	13.0	12.5	14.2	18.0	32.3	21.2	23.5	19.2	10.4	14.8	20.3	14.4	20.9	13.8	19.2	17.5	8.8	15.2	14.7	5.2	12.4	18.0	19.6	34.1	9.3	8.3	20.0	15.1	15.6	13.0	15.9	10.8	13.7	18.0	6.5	14.1	16.9	10.0	11.1	9.0	0.0	2.4	0.6	3.4	1.5	3.9	15.5	6.8	11.9	4.9	4.7	0.9	3.4	6.0	11.9	10.0	3.3	6.1	11.5	2.7	6.3	0.3	3.4	11.5	7.4	3.4	0.6	39.5	12.2	10.4	5.9	14.7	0.8	7.0	7.5	0.9	2.8	0.6	8.3	3.7	7.5	8.9	7.4	5.8	1.0	7.3	4.8	3.2	0.4	8.6	11.5	3.5	7.9	12.3	0.3	7.5	14.0	2.7	19.4	6.7	4.2	8.4	7.9	4.1	3.7	3.8	0.3	2.5	4.4	1.5	14.9	9.9	3.9	0.2	0.0	2.4	0.0	0.5	1.6	1.5	7.8	0.5	0.7	3.0	11.1	3.4	2.0	0.0	0.6	0.1	9.0	0.3	1.5	31.6	43.9	27.2	29.4	32.3	21.2	20.3	14.4	15.2	10.8	0.0	2.2	8.3	7.6	2.3	21.3	19.5	12.7	0.0	1.2	19.2	3.9	11.2	34.9	16.1	3.0	11.3	5.5	0.0	6.3	12.7	8.9	4.6	9.2	14.9	14.5	35.0	4.7	5.5	7.8	1.5	13.0	7.1	3.3	18.0	7.0	18.8	9.0	5.8	17.7	41.5	7.1	12.9	7.2	5.9	19.6	3.1	7.3	3.8	4.7	2.0
CCDC153	LOC283152	ENSG00000248712	"Coiled-coil domain containing 153"	Q494R4	11	119189638-119196769	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 15.1;fallopian tube: 15.8;pituitary gland: 20.0"	"Cell type enriched"	"Detected in many"	7	"Ciliated cells: 151.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.1"	"Cell line enhanced"	"Detected in many"		"T-47d: 13.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041497	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA041497: AB_10794378"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.19e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.98e-3)"	1.4	1.1	2.2	0.6	4.8	3.8	0.8	0.5	0.9	1.4	0.6	2.0	0.5	0.5	1.1	5.3	1.5	15.8	3.1	2.0	2.6	3.9	1.5	0.6	5.2	0.5	0.5	0.5	1.7	0.5	3.3	20.0	1.3	9.8	0.5	0.6	0.5	0.7	1.6	0.5	1.4	0.8	0.7	1.2	0.8	1.6	2.8	2.4	0.5	1.1	0.5	0.9	0.7	0.5	0.4	1.6	15.1	2.4	0.3	0.6	0.7	2.2	3.0	1.8	1.8	0.3	0.3	4.4	1.3	1.5	0.6	0.7	4.9	7.7	1.5	6.4	0.3	2.2	1.6	0.4	1.5	0.1	3.0	2.5	7.2	2.2	3.3	1.1	2.3	0.9	0.7	1.0	1.6	0.4	2.4	1.5	1.6	2.1	2.9	0.1	8.9	1.5	2.2	0.9	3.2	5.2	2.0	2.5	1.4	0.5	2.2	2.4	1.2	3.0	1.5	1.7	1.2	13.1	2.7	3.0	3.3	2.6	2.0	2.7	1.2	1.8	1.2	1.5	1.3	4.0	0.4	2.4	3.8	0.3	1.5	0.2	0.4	0.2	0.4	1.6	0.4	0.6	0.5	15.1	0.3	1.5	1.6	0.4	0.7	2.2	4.8	0.5	0.9	2.6	3.9	0.5	0.5	9.8	2.4	0.0	6.7	0.0	1.3	2.5	0.0	0.2	0.0	151.3	20.5	7.0	0.0	3.5	0.0	0.8	2.5	1.5	3.3	0.0	1.8	2.9	1.3	0.9	0.0	1.3	3.1	0.0	1.7	3.1	3.5	4.8	0.3	3.4	3.3	5.4	2.7	0.9	1.0	7.0	2.5	2.9	1.9	6.5	6.2	6.6	3.4	1.9	2.7	0.0	1.8	2.0
CCDC198	"C14orf105, FLJ10650"	ENSG00000100557	"Coiled-coil domain containing 198"	Q9NVL8	14	57469301-57493867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 25.8;kidney: 75.8;pancreas: 21.8"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 54.1;Distal tubular cells: 58.0;Proximal tubular cells: 165.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"A549: 9.3;RPTEC TERT1: 27.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029202			Uncertain	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA029202: AB_10600754"		"unprognostic (1.45e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.67e-2)"		"prognostic unfavorable (5.61e-4)"	"unprognostic (1.21e-1)"		"unprognostic (5.45e-3)"	"unprognostic (1.51e-1)"		"prognostic favorable (1.92e-4)"	"unprognostic (6.07e-2)"	"unprognostic (2.77e-1)"		"unprognostic (1.61e-3)"	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.6	0.1	0.6	0.1	0.0	1.6	0.7	0.4	25.8	0.1	15.3	17.7	0.1	0.1	0.2	75.8	17.7	0.1	0.0	0.1	0.0	6.1	21.8	0.0	0.1	0.1	1.5	0.1	0.0	0.0	0.1	0.8	0.1	0.4	0.1	0.0	0.3	0.1	0.2	1.6	0.0	0.0	0.1	0.0	0.0	0.3	0.1	2.7	1.9	4.5	0.9	3.4	5.0	3.6	0.0	9.3	0.0	0.3	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.9	0.9	0.4	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.3	0.3	0.1	0.2	0.1	0.2	0.1	0.0	0.2	27.7	0.4	0.3	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.7	0.5	0.1	0.1	0.3	0.4	0.3	1.4	0.3	0.2	3.1	0.9	0.6	2.1	0.4	2.6	2.1	4.2	3.0	0.2	2.7	3.5	5.0	4.5	3.4	0.6	1.9	5.0	3.6	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.0	1.5	0.0	3.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	58.0	18.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	165.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC83	"CT148, FLJ42119, MGC34732"	ENSG00000150676	"Coiled-coil domain containing 83"	Q8IWF9	11	85855101-85920021	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 27.7"	"Group enriched"	"Detected in some"	11	"Early spermatids: 142.1;Late spermatids: 149.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"MCF7: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039707, HPA039882"			Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039707: AB_10795259, HPA039882: AB_10795410"	"unprognostic (1.14e-1)"				"unprognostic (4.09e-1)"					"unprognostic (1.49e-2)"		"unprognostic (4.43e-2)"	"unprognostic (7.05e-6)"	"unprognostic (3.52e-1)"			"unprognostic (2.17e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	1.8	0.8	0.3	0.6	0.0	0.1	0.0	0.5	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.2	0.3	0.3	0.3	0.0	0.0	0.0	0.1	0.7	0.3	0.3	0.2	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.3	7.9	0.1	0.4	0.0	1.3	0.0	0.1	0.0	0.1	0.6	0.3	0.1	0.1	0.1	0.5	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.2	0.1	0.4	0.8	0.6	0.3	0.6	0.4	0.4	0.3	0.3	0.3	0.3	0.4	0.3	0.5	1.8	0.3	0.8	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	142.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.4	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	13.1	1.3	0.0	0.0	0.0	0.0	0.0
CD207	"CLEC4K, Langerin"	ENSG00000116031	"CD207 molecule"	Q9UJ71	2	70830214-70835822	"CD markers, Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.5;skin 1: 42.3"	"Cell type enhanced"	"Detected in some"	14	"Basal keratinocytes: 3.5;Macrophages: 1.5;Melanocytes: 5.0;monocytes: 2.8;Suprabasal keratinocytes: 4.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"myeloid DC: 4.0"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 4.0"	"Cell line enriched"	"Detected in some"	4	"AN3-CA: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002222, HPA011216"	Enhanced		Uncertain	Cytosol		No	NA			Cytosol		"CAB002222: AB_563850, HPA011216: AB_1078453"	"unprognostic (1.45e-2)"	"unprognostic (8.28e-3)"	"unprognostic (9.34e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.92e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-2)"	0.5	0.1	0.1	1.8	0.1	0.0	1.4	0.1	0.1	2.4	1.7	0.1	0.1	1.6	1.1	0.4	9.7	0.3	2.9	0.3	0.1	0.1	0.2	0.9	3.7	0.2	0.1	0.1	0.2	0.2	0.0	1.1	0.1	0.1	1.0	1.1	0.4	1.2	0.2	0.1	42.3	2.6	0.1	0.1	1.5	0.4	0.4	0.1	3.3	0.2	11.3	16.5	0.3	1.9	0.0	4.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	14.1	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	1.9	0.0	0.0	0.0	0.3	2.5	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	5.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711851	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.3;lymphoid tissue: 86.3"	"Group enriched"	"Detected in many"	5	"B-cells: 233.4;granulocytes: 88.9;Hofbauer cells: 87.6;Kupffer cells: 195.5;Macrophages: 131.8;T-cells: 297.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 38.9;HMC-1: 43.5;U-266/70: 92.1;U-266/84: 61.5"									"CAB002497, HPA055146"	Enhanced		Supported	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		2600000	"Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"CAB002497: AB_563586, HPA055146: AB_2682716"	"prognostic favorable (3.91e-4)"	"unprognostic (1.72e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (3.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.51e-2)"	5.5	1.4	1.0	44.6	0.9	23.1	2.8	0.6	0.7	3.2	5.0	0.5	1.1	3.2	1.9	2.5	7.3	2.1	4.8	1.8	1.0	1.0	3.6	3.1	15.4	86.3	1.6	0.3	2.3	1.5	0.0	1.3	2.2	0.8	2.8	5.7	2.4	13.9	1.5	1.3	1.2	21.2	1.7	3.8	66.6	5.0	1.3	0.2	50.8	2.9	3.6	58.0	8.6	2.6	34.6	53.6	35.8	74.1	24.9	57.9	81.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	4.6	43.5	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	14.2	0.0	0.0	13.5	6.7	0.0	0.0	0.0	0.8	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.1	61.5	15.8	0.0	11.7	0.0	28.2	52.2	35.8	42.4	74.1	57.9	34.6	48.3	48.8	53.6	27.9	49.7	52.5	13.4	24.9	73.5	9.4	36.4	81.3	1.0	0.9	0.6	0.7	1.0	1.0	1.6	0.3	0.8	0.2	0.0	14.8	233.4	0.5	4.8	0.0	0.8	5.1	4.0	2.3	3.5	0.0	0.7	1.7	0.1	0.0	0.7	0.0	23.3	0.2	0.7	3.1	0.2	88.9	1.8	87.6	0.0	1.2	8.6	195.5	0.4	1.7	131.8	37.1	8.2	0.0	0.0	0.1	0.0	0.4	1.5	0.0	0.0	0.7	0.4	0.1	2.6	0.3	297.5	0.0	0.3
CD79B	"B29, IGB"	ENSG00000007312	"CD79b molecule"	P40259	17	63928740-63932354	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 138.8;lymphoid tissue: 56.6"	"Cell type enriched"	"Detected in many"	8	"B-cells: 486.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 100.6;naive B-cell: 138.8"	"Lineage enriched"	"Detected in many"	6	"B-cells: 138.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 117.7;REH: 38.7;U-698: 161.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009178, CAB009751, HPA044107"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: "	"unprognostic (3.90e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.22e-3)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.75e-1)"	1.7	0.7	0.4	50.6	0.4	11.1	1.2	0.3	0.4	0.6	1.7	0.3	0.3	0.7	0.6	0.5	2.6	0.6	1.4	3.4	0.4	0.2	2.3	1.7	1.3	56.6	0.4	0.3	0.6	1.6	0.0	9.0	0.5	0.3	1.0	1.3	0.8	8.9	0.9	1.2	0.9	22.4	0.5	0.4	56.0	1.8	0.6	0.3	3.7	1.4	1.7	46.6	4.5	0.9	138.8	4.2	0.5	25.0	3.4	9.2	9.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	38.7	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	1.8	0.1	0.0	0.4	0.0	0.0	5.9	5.7	161.1	0.0	0.2	0.0	0.5	1.1	0.0	4.2	16.5	4.8	100.6	5.4	2.8	4.2	138.8	3.7	2.2	0.5	3.4	25.0	0.6	9.2	9.0	0.4	0.4	0.3	0.4	0.4	0.2	0.4	0.3	0.3	0.3	0.0	2.2	486.9	0.3	3.9	0.0	0.8	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	7.1	0.0	23.3	0.0	0.4	4.3	0.3	15.0	0.5	4.7	0.0	1.2	62.0	14.1	1.1	1.1	3.5	20.3	1.0	0.0	0.0	0.0	0.0	1.8	0.8	0.0	0.0	3.3	0.7	0.1	2.8	0.3	34.6	0.0	0.1
CDC73	"C1orf28, FIHP, HRPT1, HRPT2, parafibromin"	ENSG00000134371	"Cell division cycle 73"	Q6P1J9	1	193121997-193253901	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002326, CAB016359, HPA069324"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB016359: AB_628102, HPA002326: , HPA069324: "	"unprognostic (4.41e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.53e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-3)"	"unprognostic (3.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.98e-3)"	23.4	20.0	18.1	16.8	22.9	21.0	20.1	25.6	22.6	20.4	20.1	14.5	16.3	12.0	26.8	15.2	20.6	14.9	16.4	21.4	18.4	15.0	18.8	17.1	17.2	16.6	19.7	15.9	23.3	14.5	27.1	24.8	17.3	19.4	26.9	16.2	13.6	17.3	19.0	44.5	15.0	14.5	25.6	23.9	16.0	15.7	16.3	22.1	20.6	27.1	14.1	15.8	26.8	35.0	6.6	6.7	10.2	7.0	9.0	12.5	5.2	13.4	12.1	16.0	10.3	15.0	14.6	12.3	14.5	14.1	17.6	15.4	8.3	16.0	17.5	10.3	17.8	9.7	13.2	14.5	13.7	21.5	11.1	6.9	12.7	10.9	8.0	14.1	17.2	12.7	11.9	13.3	16.5	15.8	15.6	14.9	10.0	19.2	14.2	23.5	12.4	14.1	8.5	15.4	19.8	4.5	12.6	9.7	16.7	20.6	9.4	4.8	13.2	18.1	22.4	20.7	18.6	19.2	12.5	16.6	17.1	4.0	14.5	14.8	13.3	9.9	14.4	10.3	10.6	29.9	6.6	7.0	10.2	9.3	6.8	12.5	6.6	9.2	9.2	6.7	5.4	8.4	8.7	7.4	9.0	5.7	4.9	9.3	5.2	18.1	22.9	25.6	22.6	18.4	15.0	19.7	15.9	19.4	22.1	32.8	20.1	34.3	31.1	33.1	31.2	36.4	20.4	20.1	19.4	31.4	33.4	21.8	28.2	29.4	11.9	30.1	16.2	23.3	28.5	34.0	29.2	33.5	39.4	14.3	28.0	20.6	10.9	22.1	25.9	6.1	31.1	38.8	27.0	47.7	15.3	33.5	28.2	13.1	33.9	26.4	36.3	25.8	57.1	56.5	32.0	30.6	31.8	29.8	16.1	23.2
CDH9		ENSG00000113100	"Cadherin 9"	Q9ULB4	5	26880600-27121150	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 46.8"	"Cell type enhanced"	"Detected in single"	37	"Proximal tubular cells: 3.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"amygdala: 46.8;basal ganglia: 24.6;cerebral cortex: 23.7;hippocampal formation: 15.9;olfactory region: 15.6"	"Cell type enhanced"	"Detected in some"		"neutrophil: 8.3"	"Group enriched"	"Detected in many"	5	"B-cells: 4.1;granulocytes: 8.3"	"Cell line enhanced"	"Detected in some"		"K-562: 9.4;NTERA-2: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA007167	Approved		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA007167: AB_1078489"					"unprognostic (1.49e-1)"								"unprognostic (2.27e-4)"					0.7	0.5	46.8	1.0	24.6	2.8	0.7	0.5	23.7	0.5	0.8	0.0	0.0	0.6	0.9	1.2	0.7	0.5	0.7	0.5	15.9	3.5	10.5	0.5	0.6	1.6	1.2	15.6	0.6	1.1	1.0	0.5	0.8	1.5	1.0	1.2	0.0	0.5	0.1	0.5	1.9	1.5	0.8	0.6	0.8	0.9	3.7	2.6	0.0	1.9	0.0	1.7	0.5	0.5	4.1	0.9	8.3	1.1	0.1	0.8	1.1	2.5	0.9	0.5	0.8	0.4	0.0	1.6	0.0	0.9	0.3	0.7	0.0	0.9	1.3	0.3	0.3	0.2	0.3	0.1	0.6	0.0	0.1	0.3	0.5	0.7	2.5	0.0	0.0	1.6	0.6	0.7	0.0	0.0	0.0	0.2	0.8	9.4	2.3	0.0	1.5	0.8	0.5	13.9	0.2	0.5	0.3	0.3	0.4	0.5	0.5	3.1	0.3	0.0	0.4	0.5	2.7	0.5	0.9	1.7	0.1	0.8	0.8	0.3	2.8	1.0	4.4	1.0	1.0	0.8	1.3	0.2	0.4	0.2	0.7	0.6	4.1	0.4	0.2	0.1	2.5	0.3	0.5	8.3	0.1	1.1	0.9	0.8	1.1	46.8	24.6	0.5	23.7	15.9	3.5	1.2	15.6	1.5	2.6	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDK13	"CDC2L, CDC2L5, CHED, KIAA1791"	ENSG00000065883	"Cyclin dependent kinase 13"	Q14004	7	39949646-40099580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059241	Uncertain		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Nuclear speckles"	"Golgi apparatus, Cytosol"	"HPA059241: AB_2683956"	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.42e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.53e-2)"	16.9	15.3	16.0	29.0	14.5	26.7	20.4	23.3	18.2	16.6	18.3	16.4	14.2	11.3	20.3	17.7	20.9	18.1	20.2	13.6	14.3	11.3	14.7	17.5	19.6	21.9	16.5	15.1	24.2	15.3	26.3	15.3	14.8	12.0	15.5	15.5	14.9	17.6	14.5	19.4	16.7	16.3	16.4	11.5	17.4	14.5	20.2	15.7	31.2	23.1	14.6	21.5	18.5	23.6	14.0	3.9	7.9	3.4	5.0	5.0	1.4	15.7	9.4	16.4	15.6	14.8	14.5	11.3	12.6	13.7	11.6	14.6	9.8	10.9	28.6	7.4	13.2	20.4	19.2	13.4	11.1	17.1	14.0	9.9	12.7	11.5	8.8	14.2	19.3	13.9	8.5	14.9	13.2	17.7	13.3	13.6	13.3	21.4	19.8	12.0	8.1	15.3	13.7	23.7	11.1	11.0	17.0	10.9	11.5	10.9	16.0	11.7	17.0	16.0	34.7	11.4	22.2	14.2	24.1	16.1	16.0	15.3	10.3	17.1	16.4	13.8	23.6	11.7	17.5	20.4	7.9	2.7	4.4	5.0	2.2	3.4	7.6	4.8	3.7	1.5	14.0	4.9	4.9	7.6	5.0	3.4	3.9	4.3	1.4	16.0	14.5	23.3	18.2	14.3	11.3	16.5	15.1	12.0	15.7	41.7	63.7	28.9	17.1	19.1	42.3	25.6	30.6	34.8	47.8	29.6	66.8	11.5	6.6	19.1	10.7	22.5	15.9	0.0	13.4	7.5	19.4	16.3	16.2	20.7	11.6	35.0	18.0	20.3	23.2	7.0	24.2	18.3	13.5	15.4	17.7	26.6	24.2	10.5	16.6	11.1	68.4	6.5	15.6	31.4	31.5	22.8	10.2	22.5	18.8	21.7
CEP126	KIAA1377	ENSG00000110318	"Centrosomal protein 126"	Q9P2H0	11	101915015-102001058	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 47.3"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 254.3;Horizontal cells: 96.9;Spermatocytes: 115.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 10.0;EFO-21: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038381, HPA038399"			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA038381: AB_10669780, HPA038399: AB_10670157"	"unprognostic (7.61e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.31e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.55e-4)"	"unprognostic (1.52e-2)"	"unprognostic (5.77e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.72e-3)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.30e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.99e-3)"	7.6	11.1	9.0	2.4	20.2	2.4	8.3	16.8	14.8	7.9	4.2	5.0	4.2	2.0	9.1	6.7	5.3	17.5	4.9	4.5	9.6	8.3	3.8	1.4	6.1	3.3	7.5	10.2	11.4	5.0	6.4	47.3	2.6	12.4	6.6	4.8	3.2	3.2	7.6	2.3	8.5	2.7	7.3	9.2	3.1	4.0	19.2	8.9	0.5	7.4	1.5	2.5	3.9	9.7	2.5	4.8	1.4	0.5	3.3	2.0	0.5	0.9	2.2	1.1	1.3	10.0	5.5	0.5	2.1	1.8	1.0	0.9	0.6	3.0	1.3	9.5	1.9	4.4	0.9	1.3	2.4	0.9	3.1	1.5	0.3	3.7	1.2	1.1	0.2	0.3	1.9	4.7	1.3	2.8	5.1	3.0	1.3	0.3	0.4	2.5	1.1	1.1	0.3	0.8	1.1	1.7	0.2	1.1	0.2	2.0	1.2	2.7	4.2	1.3	1.9	0.3	2.0	3.7	0.4	1.7	3.3	1.9	1.0	2.2	2.2	1.2	0.2	3.2	0.3	1.3	0.7	0.5	1.0	2.0	0.1	0.9	1.8	1.2	1.6	0.4	2.5	1.7	1.7	1.4	3.3	0.2	4.8	0.3	0.5	9.0	20.2	16.8	14.8	9.6	8.3	7.5	10.2	12.4	8.9	8.9	7.0	0.5	4.6	0.0	17.6	7.5	5.1	254.3	43.3	17.4	43.2	1.2	3.3	2.0	13.5	3.0	0.0	0.0	0.3	0.7	3.5	2.8	0.0	0.0	0.3	96.9	64.4	3.1	0.0	6.9	49.8	1.4	0.0	0.0	10.3	26.8	1.0	0.0	48.1	4.4	47.8	6.5	1.6	115.1	25.4	0.0	0.1	7.0	1.3	2.0
CEP85	"CCDC21, DKFZP434L0117"	ENSG00000130695	"Centrosomal protein 85"	Q6P2H3	1	26234153-26279038	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.8"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 26.8;Spermatocytes: 43.5;Spermatogonia: 37.7;Syncytiotrophoblasts: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028252	Approved		Approved	"Nucleoli,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Nucleoli, Golgi apparatus"	"Centrosome, Cytosol"	"HPA028252: AB_1846142"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.30e-3)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (3.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.60e-2)"	2.1	2.7	4.8	3.8	11.0	12.4	3.1	7.7	8.8	2.4	3.7	15.5	4.6	3.5	2.6	3.3	5.6	2.7	2.6	19.4	5.5	4.0	3.8	3.7	3.2	5.3	20.4	4.9	2.4	3.3	4.4	4.7	3.6	7.8	3.0	4.5	4.0	3.5	2.5	87.8	8.4	3.3	2.9	10.4	4.3	3.7	26.8	13.5	12.1	5.4	5.5	6.6	3.0	3.8	2.4	3.8	15.6	5.0	2.1	3.4	2.8	13.5	6.7	10.8	11.5	3.0	2.8	21.3	6.9	3.2	9.5	10.2	8.6	12.7	12.9	9.4	2.8	5.2	12.0	12.1	5.7	9.6	9.4	10.5	18.2	13.2	9.1	3.1	16.6	20.2	1.4	5.7	8.0	5.8	4.5	4.2	17.5	24.5	18.0	7.0	4.9	15.9	20.2	10.5	6.7	11.2	16.3	12.6	12.0	4.8	2.1	18.4	8.5	9.7	8.1	8.0	6.2	7.4	11.9	4.9	7.8	13.0	9.1	10.6	14.2	20.7	16.1	4.8	29.3	14.7	3.4	4.6	15.6	3.0	4.4	2.5	2.4	2.0	2.3	3.8	1.3	1.8	3.4	0.5	2.1	5.0	1.3	3.2	2.8	4.8	11.0	7.7	8.8	5.5	4.0	20.4	4.9	7.8	13.5	0.0	2.1	0.0	4.2	6.2	9.6	26.8	2.5	1.4	4.5	5.2	11.8	2.0	6.6	1.7	0.8	1.8	3.9	0.0	1.1	3.6	2.1	2.2	2.3	2.5	4.3	0.0	1.7	1.8	5.2	2.3	1.4	4.0	1.7	4.6	3.1	1.3	2.1	3.4	0.4	0.8	10.1	0.0	1.0	43.5	37.7	5.4	34.9	3.5	4.7	3.2
CERS6	LASS6	ENSG00000172292	"Ceramide synthase 6"	Q6ZMG9	2	168455862-168775137	"Predicted membrane proteins"	"Inflammatory response, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 9.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044683, HPA063527"	Approved		Uncertain	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA044683: AB_10965059, HPA063527: AB_2685030"	"unprognostic (2.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.92e-3)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (3.24e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.80e-2)"	12.3	13.5	17.7	12.2	17.5	9.6	14.2	28.0	23.2	12.3	24.4	6.5	19.8	22.4	17.4	17.0	12.7	9.8	9.7	26.9	14.5	15.9	12.1	11.7	9.4	12.5	11.0	15.9	15.6	7.3	15.8	14.6	8.3	9.2	12.2	27.1	13.4	6.9	17.1	9.4	20.0	28.3	11.0	8.5	6.9	21.0	11.0	8.1	25.1	24.1	7.4	7.5	11.8	30.5	0.8	9.0	0.7	1.7	1.1	1.7	0.5	5.9	5.3	9.5	10.9	23.6	17.6	0.0	6.0	6.1	6.4	8.7	8.4	13.2	0.0	8.7	5.4	9.1	11.3	12.2	13.9	10.8	0.0	8.4	10.9	5.7	6.0	20.7	22.9	5.3	19.5	40.1	13.5	10.6	6.4	3.2	16.3	5.8	0.0	13.3	6.5	20.1	6.4	8.8	12.8	7.8	15.6	18.0	10.3	6.1	17.9	13.2	15.9	5.8	15.0	3.1	8.2	13.3	13.1	1.8	16.5	6.9	4.5	10.3	0.1	0.0	0.0	10.8	12.2	11.0	0.7	1.7	0.0	0.3	1.2	0.6	0.2	0.6	0.3	1.3	0.8	1.7	1.3	0.2	1.1	1.0	9.0	0.0	0.5	17.7	17.5	28.0	23.2	14.5	15.9	11.0	15.9	9.2	8.1	6.0	10.1	10.9	40.4	96.7	20.6	40.6	30.6	25.4	18.2	10.4	0.0	0.5	0.0	12.6	4.2	12.7	42.8	0.0	20.1	0.8	10.8	29.9	10.3	41.4	21.3	35.0	99.7	14.7	43.8	2.7	18.4	31.6	10.1	96.4	94.8	31.2	14.0	35.1	37.4	8.4	2.3	64.7	18.6	3.9	3.0	81.1	0.5	8.6	107.7	39.9
CHAF1A	"CAF-1, CAF1, CAF1B, CAF1P150, MGC71229, P150"	ENSG00000167670	"Chromatin assembly factor 1 subunit A"	Q13111	19	4402662-4445018	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Erythroid cells: 46.7;Spermatocytes: 48.8;Spermatogonia: 120.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 15.2;granulocytes: 4.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015186	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB015186: AB_628065"	"unprognostic (1.91e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (2.49e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.89e-3)"	"unprognostic (5.30e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.54e-2)"	"prognostic favorable (4.15e-6)"	"unprognostic (1.71e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.03e-2)"	5.3	5.3	6.3	14.6	7.3	28.2	5.3	12.6	8.8	4.7	7.2	4.9	8.6	6.9	4.7	5.1	11.5	4.7	5.2	4.0	6.1	3.9	3.0	4.5	4.6	13.3	5.5	5.6	4.6	4.4	3.3	4.3	7.5	5.4	6.5	7.2	4.1	7.8	8.1	12.2	11.3	7.0	6.8	4.8	8.2	5.6	20.4	4.9	27.8	3.3	9.8	11.5	6.7	5.9	1.7	15.2	4.3	2.4	1.0	0.8	0.9	21.4	14.7	24.5	15.4	2.4	3.0	12.6	20.4	8.4	17.3	19.6	17.8	7.7	33.1	8.5	6.5	9.8	16.9	20.9	13.9	20.5	19.0	22.9	20.6	21.9	14.0	1.2	23.8	16.8	1.7	2.9	14.2	6.1	3.2	8.1	18.5	24.8	30.0	10.6	12.4	38.4	13.3	27.3	11.0	12.2	28.6	19.4	18.9	4.5	25.6	17.4	13.5	14.0	9.9	8.1	16.1	8.7	17.8	5.8	14.3	12.5	24.2	24.7	15.1	22.3	31.8	12.0	30.7	16.8	2.9	2.3	4.3	0.5	2.4	0.4	1.7	0.6	0.1	2.0	0.8	0.6	0.4	1.2	1.0	0.4	15.2	0.8	0.9	6.3	7.3	12.6	8.8	6.1	3.9	5.5	5.6	5.4	4.9	0.0	4.6	11.2	5.5	8.7	12.5	5.0	2.5	5.3	2.3	5.2	2.0	15.4	1.7	5.7	5.6	3.3	3.8	46.7	5.9	33.8	3.7	3.9	2.3	3.9	10.3	1.6	1.7	2.5	2.8	5.3	2.8	8.7	1.7	12.6	6.2	5.0	5.1	0.0	3.5	2.1	8.4	32.3	3.4	48.8	120.2	13.0	12.2	5.7	10.0	4.1
CHTF18	"C16orf41, C321D2.4, CHL12, Ctf18"	ENSG00000127586	"Chromosome transmission fidelity factor 18"	Q8WVB6	16	788046-800737	"Predicted intracellular proteins"	"Cell cycle, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 20.9;Extravillous trophoblasts: 16.6;Spermatogonia: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 28.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040976, HPA056209"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040976: AB_2677232, HPA056209: AB_2683066"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.80e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (1.43e-8)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (2.78e-4)"	2.4	3.1	8.3	6.7	5.6	16.8	3.1	11.1	4.7	5.0	5.3	4.1	4.1	6.1	4.1	2.8	5.1	3.2	2.4	1.7	2.7	2.3	2.6	2.0	2.9	4.4	4.4	4.6	5.2	3.1	0.7	2.4	4.1	3.5	3.2	1.7	4.0	4.0	2.6	2.4	8.3	7.2	1.8	2.3	5.9	6.7	11.3	4.3	15.5	3.1	3.8	7.3	2.9	3.6	1.0	1.4	4.6	3.0	2.1	2.4	0.7	8.0	3.9	3.2	2.6	0.3	0.2	28.4	5.1	1.4	2.6	1.8	7.0	6.2	9.1	5.3	0.8	1.3	9.0	0.7	3.9	0.0	5.1	11.6	4.0	4.6	3.6	0.0	2.5	7.9	0.1	0.5	2.5	1.3	0.3	2.2	9.5	6.0	3.0	0.6	15.5	9.7	9.3	4.2	1.8	4.8	17.5	8.2	11.8	0.8	2.3	4.2	5.4	3.7	8.2	2.7	0.4	6.0	6.0	1.4	3.8	14.0	6.9	6.8	7.2	2.4	5.1	1.2	3.6	6.6	4.6	0.6	0.0	2.4	3.0	1.5	0.4	1.1	1.9	1.4	1.0	1.3	0.3	0.3	2.1	1.6	0.8	1.4	0.7	8.3	5.6	11.1	4.7	2.7	2.3	4.4	4.6	3.5	4.3	3.0	3.4	3.7	3.2	4.7	20.9	3.6	0.0	2.7	3.4	1.8	2.0	10.9	1.7	2.4	1.0	1.8	0.9	0.0	3.3	16.6	3.3	1.0	4.6	1.8	5.4	6.4	6.3	2.5	2.1	1.1	1.7	2.9	0.0	0.0	3.3	2.8	1.6	0.0	1.4	0.7	6.7	0.0	3.3	13.3	23.5	1.8	7.2	2.5	3.3	1.4
CKAP4	"CLIMP-63, ERGIC-63, P63"	ENSG00000136026	"Cytoskeleton associated protein 4"	Q07065	12	106237877-106304279	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 34.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 34.6"	"Cell line enhanced"	"Detected in many"		"BJ: 74.6;BJ hTERT+: 94.1;fHDF/TERT166: 112.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000278, HPA000792, HPA001225"	Enhanced		Uncertain	"Nuclear speckles,Cytosol,Cytoplasmic bodies"		NA	NA		11000	"Nuclear speckles, Cytosol"	"Cytoplasmic bodies"	"HPA000278: AB_1078527, HPA000792: AB_1078526, HPA001225: AB_2666241"	"unprognostic (5.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (6.61e-5)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (5.02e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.20e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.66e-2)"	13.0	23.8	7.1	15.3	4.9	39.5	27.2	6.9	8.4	42.3	19.2	6.5	24.8	8.1	23.7	35.2	47.3	17.2	26.6	32.9	5.7	8.0	18.3	42.1	22.2	28.5	6.3	5.4	28.6	55.2	12.7	12.0	30.6	6.8	23.9	20.5	13.2	34.4	28.0	11.1	20.8	10.7	20.4	5.8	16.7	23.0	10.3	4.2	4.0	18.6	30.0	27.8	25.8	21.4	4.2	2.3	34.6	7.5	0.1	1.0	2.4	11.4	14.4	17.5	18.9	34.1	30.4	10.1	74.6	94.1	36.5	42.0	6.1	2.6	0.7	13.6	112.3	12.4	20.8	12.7	11.3	26.3	0.4	7.4	0.0	8.3	11.9	25.4	0.1	0.2	29.1	15.5	30.9	22.4	46.3	42.6	0.8	0.0	1.5	34.6	3.8	0.5	0.4	10.1	6.0	17.5	5.3	12.6	0.9	11.1	10.3	5.7	6.4	13.2	9.0	7.1	16.4	10.1	5.2	36.3	28.8	15.9	11.9	21.0	4.0	0.0	8.1	20.7	1.4	25.1	34.6	7.5	8.7	0.5	2.7	0.7	4.2	0.7	0.4	2.3	1.6	1.0	0.9	12.7	0.1	4.1	0.0	0.2	2.4	7.1	4.9	6.9	8.4	5.7	8.0	6.3	5.4	6.8	4.2	20.8	24.5	3.0	33.7	48.7	12.8	42.1	43.3	5.3	21.6	22.7	9.8	24.4	5.0	32.4	0.9	24.8	13.4	0.0	75.4	79.1	87.2	68.6	19.5	49.1	19.2	44.5	39.7	49.7	37.3	1.1	63.3	14.9	32.1	6.4	162.0	23.7	51.4	5.8	57.7	9.1	18.4	12.9	46.7	2.5	12.2	62.9	22.1	3.2	60.8	36.8
CLCN5	"ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN"	ENSG00000171365	"Chloride voltage-gated channel 5"	P51795	X	49922615-50099235	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 46.1"	"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 6.6;monocytes: 1.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 25.4;RH-30: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000401, HPA003213"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane"	Cytosol	"HPA000401: AB_1078531, HPA003213: AB_2666843"	"unprognostic (3.33e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (3.59e-2)"	"prognostic favorable (2.05e-8)"	"unprognostic (7.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	4.4	4.1	2.5	2.4	2.9	2.1	3.4	9.4	3.4	2.3	3.1	2.6	4.7	5.0	9.8	26.7	3.7	4.6	7.6	2.2	3.1	2.8	46.1	15.8	4.7	3.0	2.6	2.5	10.8	6.7	2.6	8.3	7.3	5.9	2.7	3.7	7.6	4.0	3.5	5.6	6.2	6.4	3.8	4.3	3.0	4.0	5.9	2.3	1.2	3.6	4.0	2.3	2.4	3.1	0.2	6.6	0.5	1.8	0.3	0.4	0.5	1.8	2.8	2.2	3.3	8.4	5.3	4.7	1.5	0.8	1.0	1.2	25.4	1.7	1.8	0.8	1.7	5.6	1.5	6.8	0.8	1.6	0.7	4.6	1.8	1.4	6.6	4.0	2.3	3.4	3.1	1.1	2.6	3.8	0.8	3.6	2.4	2.7	2.7	2.9	1.8	0.8	0.7	3.2	4.2	1.4	1.1	39.3	2.8	3.8	2.9	3.8	2.7	2.2	2.2	3.1	8.7	1.9	1.1	1.8	1.0	2.1	7.8	0.9	2.3	6.9	4.1	1.7	3.8	5.1	0.1	1.8	0.0	0.2	1.5	0.3	0.2	0.4	0.4	3.8	0.2	0.1	0.1	0.5	0.3	0.3	6.6	0.0	0.5	2.5	2.9	9.4	3.4	3.1	2.8	2.6	2.5	5.9	2.3	8.9	5.9	1.5	1.6	6.4	19.5	1.6	5.1	5.3	0.0	12.2	2.0	5.2	10.0	3.7	1.1	3.8	10.9	0.0	2.9	2.2	5.7	3.1	2.3	21.7	8.9	7.9	0.0	0.6	9.5	0.0	4.9	8.9	3.3	5.4	5.7	2.8	5.8	6.2	12.4	32.4	4.3	0.0	3.3	1.0	0.7	8.3	4.2	0.0	6.4	4.6
CLEC4E	"CLECSF9, mincle"	ENSG00000166523	"C-type lectin domain family 4 member E"	Q9ULY5	12	8533305-8540963	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.7;bone marrow: 37.7;lymphoid tissue: 41.2"	"Group enriched"	"Detected in some"	8	"Kupffer cells: 144.8;Macrophages: 65.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"classical monocyte: 22.8;neutrophil: 81.7"	"Group enriched"	"Detected in many"	17	"granulocytes: 81.7;monocytes: 22.8"	"Group enriched"	"Detected in some"	4	"NB-4: 5.8;RPTEC TERT1: 16.3"	"Not detected"	"Not detected"							HPA004935	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA004935: AB_2667299"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.29e-1)"	8.4	3.0	1.1	20.9	2.4	37.7	17.5	1.2	2.2	3.4	1.4	0.0	1.1	0.1	1.2	1.6	1.7	4.2	6.7	5.9	1.3	1.2	6.2	3.5	25.6	41.2	2.8	0.6	1.0	3.3	0.0	1.7	1.7	9.0	1.6	0.5	1.1	1.2	0.6	2.7	0.7	1.9	3.2	5.3	34.2	1.8	3.3	0.8	0.7	12.8	0.9	1.1	2.2	2.2	0.0	2.9	81.7	22.8	0.0	0.0	4.5	0.1	0.6	0.4	0.0	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.1	2.0	0.1	0.2	2.6	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.3	0.3	0.0	0.7	0.1	0.0	1.7	0.1	0.6	0.7	0.1	0.2	0.1	0.0	0.1	0.0	5.8	0.5	0.0	0.1	0.1	0.2	0.1	16.3	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.0	0.5	1.3	0.6	0.1	1.1	0.1	0.2	0.1	0.1	1.6	0.5	0.1	0.0	22.8	0.0	0.0	3.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	81.7	0.0	0.1	0.1	0.0	4.5	1.1	2.4	1.2	2.2	1.3	1.2	2.8	0.6	9.0	0.8	0.0	6.6	1.4	0.0	0.0	0.0	0.3	7.6	1.4	3.4	1.8	0.0	0.0	0.0	4.5	0.3	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.8	5.8	0.0	0.0	11.6	144.8	1.1	0.9	65.6	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	12.9	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0
CMAS		ENSG00000111726	"Cytidine monophosphate N-acetylneuraminic acid synthetase"	Q8NFW8	12	22046174-22065674	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Syncytiotrophoblasts: 445.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039905	Supported		Uncertain	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA039905: AB_10795237"	"unprognostic (5.54e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.03e-1)"	8.1	28.2	28.1	9.6	31.6	17.6	14.9	16.3	39.3	12.1	34.3	14.5	17.1	29.4	12.8	32.0	33.2	10.0	11.0	18.1	28.8	33.4	12.8	31.9	7.9	9.8	33.9	27.3	11.9	18.6	14.6	14.3	20.2	34.3	17.0	33.1	10.2	14.8	12.9	18.2	12.9	32.9	13.3	18.0	8.5	12.9	30.2	14.8	6.4	10.9	11.9	12.4	11.8	17.2	12.2	19.5	19.4	18.9	22.8	19.9	15.0	19.4	15.8	19.4	9.2	15.3	19.1	28.2	13.6	15.0	14.8	15.7	35.3	22.6	17.3	13.4	11.6	27.3	15.9	11.4	18.9	20.0	22.8	14.4	52.1	12.8	17.7	14.3	13.7	27.7	12.8	18.0	18.8	28.1	20.2	19.6	18.8	32.7	8.8	26.2	25.6	15.8	32.0	46.8	21.8	21.9	11.2	20.3	16.4	17.6	21.4	7.8	13.7	10.7	19.0	15.3	40.7	26.1	18.9	14.2	16.7	13.8	14.7	24.9	6.1	7.8	23.0	27.2	10.8	16.8	10.3	17.9	19.4	13.7	18.9	17.8	12.2	18.6	18.1	19.5	12.1	16.8	17.4	1.8	22.8	16.5	12.3	19.9	15.0	28.1	31.6	16.3	39.3	28.8	33.4	33.9	27.3	34.3	14.8	11.9	13.7	19.0	62.8	26.0	35.2	62.1	28.1	46.8	28.4	22.7	3.9	144.0	64.6	44.6	10.3	38.6	126.2	116.8	73.5	117.3	40.1	92.3	22.0	56.7	56.8	33.4	40.0	38.6	32.1	12.9	23.6	27.0	42.2	49.5	94.4	20.7	65.2	133.3	26.2	64.8	17.4	19.4	37.0	79.6	93.5	38.9	445.4	22.3	85.9	97.2
CNTLN	"bA340N12.1, C9orf101, C9orf39, FLJ20276"	ENSG00000044459	Centlein	Q9NXG0	9	17134982-17503923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 58.9;Spermatogonia: 51.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 6.9"	"Lineage enriched"	"Detected in many"	4	"monocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"HEL: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007201, HPA036728, HPA036729"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Centrosome	"Nucleoplasm, Cytosol"	"HPA007201: AB_2667775, HPA036728: AB_10670847, HPA036729: AB_10670240"	"unprognostic (1.97e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.80e-2)"	13.2	5.6	4.3	5.2	5.1	12.5	7.4	15.5	4.5	16.6	8.6	4.2	6.7	2.2	22.6	6.0	6.0	8.0	7.4	4.9	4.2	3.8	5.0	20.0	5.4	4.8	4.9	2.6	15.2	3.6	10.0	13.2	6.1	6.3	9.8	4.0	7.0	3.8	6.3	5.9	3.5	4.4	11.9	8.1	8.6	4.4	8.2	6.8	4.4	5.5	5.8	2.8	11.7	13.5	0.3	1.5	0.8	6.9	1.2	0.2	0.5	5.9	4.1	9.0	5.1	4.5	10.5	0.3	7.0	4.7	5.2	7.2	0.3	2.0	4.3	1.1	4.8	5.7	0.3	10.4	2.9	8.2	0.2	3.7	25.5	8.7	1.5	4.9	3.5	5.6	6.6	1.5	4.4	4.3	4.9	7.4	1.6	0.9	1.0	8.3	0.5	2.8	5.6	7.0	1.0	7.7	4.2	8.3	2.1	3.0	1.5	5.7	5.9	8.5	0.2	2.2	3.7	1.7	8.9	5.4	7.2	2.8	7.8	6.0	3.6	4.3	0.1	3.4	4.4	3.2	0.6	2.7	0.1	0.1	3.3	0.0	0.3	0.2	0.1	1.5	0.3	0.1	0.1	0.8	1.2	6.9	1.5	0.2	0.5	4.3	5.1	15.5	4.5	4.2	3.8	4.9	2.6	6.3	6.8	6.0	14.5	0.8	12.1	7.8	9.1	10.6	5.1	2.7	2.3	8.7	0.0	1.5	5.0	7.5	13.2	20.3	1.3	23.3	10.4	4.0	13.6	3.2	7.0	35.9	15.7	19.1	2.4	19.6	34.5	6.5	42.3	18.3	8.5	26.2	2.6	25.0	4.2	0.0	29.0	6.3	8.4	12.9	15.0	58.9	51.1	4.8	0.8	3.2	3.0	3.5
CNTROB	"LIP8, PP1221"	ENSG00000170037	"Centrobin, centriole duplication and spindle assembly protein"	Q8N137	17	7932101-7949918	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 51.2"	"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023319, HPA023320, HPA023321, HPA023325"	Approved		Supported	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.26e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.48e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.16e-2)"	9.0	7.4	7.5	9.2	10.1	18.4	9.3	11.2	12.7	13.0	10.9	9.8	9.9	6.8	21.3	12.6	11.0	10.4	9.0	7.1	9.5	8.0	9.2	8.7	15.0	8.4	9.3	9.9	11.4	11.0	16.5	9.6	9.9	9.9	9.9	12.5	10.3	9.6	8.6	6.8	16.9	9.1	16.3	7.0	9.9	8.4	51.2	6.4	16.0	10.4	6.2	11.2	9.3	10.0	2.1	7.6	9.4	3.4	3.4	3.5	2.6	22.3	14.7	21.9	12.1	9.3	12.8	7.1	19.5	18.3	27.3	20.9	12.4	8.3	23.0	10.3	17.0	12.2	18.0	17.0	13.6	30.6	22.6	13.3	15.2	24.0	9.8	13.7	14.1	23.6	11.7	10.1	19.2	19.4	13.2	16.8	23.1	11.0	11.3	18.9	7.2	21.4	13.6	4.9	8.1	11.5	22.8	15.1	8.6	12.6	6.9	7.2	12.9	15.8	8.1	6.2	12.2	11.0	9.0	13.7	15.3	13.0	20.6	26.8	17.3	11.6	15.9	13.1	18.1	21.7	9.4	2.5	1.0	2.9	3.4	2.6	2.1	2.2	3.5	1.7	1.5	1.4	2.4	0.4	3.4	1.4	7.6	2.9	2.6	7.5	10.1	11.2	12.7	9.5	8.0	9.3	9.9	9.9	6.4	6.0	15.8	4.5	6.8	7.0	5.8	3.0	5.1	4.0	7.9	12.2	7.9	3.3	1.7	4.4	2.1	5.8	3.6	0.0	6.0	3.6	5.0	5.0	18.4	3.4	5.7	3.2	2.9	5.5	5.9	3.4	4.9	7.2	3.3	0.0	5.6	5.3	5.0	3.5	7.4	2.6	6.5	0.0	3.5	40.6	8.3	7.5	2.1	4.9	7.3	4.1
COL16A1		ENSG00000084636	"Collagen type XVI alpha 1 chain"	Q07092	1	31652247-31704319	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 46.4;Leydig cells: 40.6;Muller glia cells: 43.8;Peritubular cells: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 38.8;ASC TERT1: 30.0;BJ hTERT+: 32.9;fHDF/TERT166: 30.0;HSkMC: 28.4;U-2197: 27.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027237			Uncertain	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		530000	Cytosol	"Plasma membrane"	"HPA027237: AB_10600699"	"unprognostic (2.25e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (4.00e-9)"	"unprognostic (9.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.15e-2)"	18.0	7.3	7.0	12.7	9.0	0.2	10.8	2.8	8.2	63.1	17.3	10.2	12.5	6.1	31.0	15.2	9.3	8.3	15.9	9.1	9.6	6.2	3.4	1.0	7.2	3.1	9.9	10.2	62.6	2.6	1.3	7.3	8.2	8.8	29.3	4.6	12.5	15.3	38.1	4.2	26.9	8.6	45.2	15.7	3.9	10.5	10.0	10.3	1.5	11.8	7.9	5.0	26.1	28.3	0.2	0.0	0.7	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	38.8	30.0	4.1	17.8	32.9	4.3	4.5	0.1	3.1	0.0	0.5	30.0	0.6	13.9	0.0	18.3	1.0	0.0	0.0	0.0	2.0	6.0	12.9	0.0	0.1	28.4	12.6	12.3	6.7	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.4	0.7	2.1	0.3	2.6	0.1	0.3	0.0	0.0	16.0	16.0	27.5	0.3	0.0	0.0	0.0	10.9	0.0	1.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.7	0.1	0.1	0.0	0.0	0.0	7.0	9.0	2.8	7.1	9.6	6.2	9.9	10.2	8.8	10.3	8.9	3.8	0.0	13.1	27.2	2.6	7.0	0.0	8.1	4.5	17.4	2.0	1.4	0.0	4.5	10.5	2.2	4.5	0.0	0.6	3.1	46.4	3.8	6.9	0.0	1.1	0.0	26.6	6.7	0.8	17.8	40.6	1.5	13.5	0.0	14.2	43.8	1.2	2.5	85.9	0.8	1.9	0.0	25.8	8.8	1.8	18.4	1.8	0.0	4.5	10.6
COX10		ENSG00000006695	"COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor"	Q12887	17	14069496-14208677	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Heme biosynthesis"	Transferase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 34.9"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 89.2;Late spermatids: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032005, HPA032006"	Supported		Supported	Nucleoli,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoli, Cytosol"	"HPA032005: AB_10603560, HPA032006: AB_10670554"	"unprognostic (6.17e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.46e-2)"	"prognostic favorable (4.32e-6)"	"prognostic favorable (8.73e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-2)"	5.5	6.9	5.3	5.7	6.5	7.0	5.4	6.5	7.2	4.4	11.8	4.1	2.9	9.7	5.1	3.6	9.4	4.8	3.5	18.9	5.8	3.8	10.0	9.3	5.2	8.4	4.5	2.8	4.9	9.6	7.2	6.4	6.6	5.7	5.2	10.1	5.5	6.7	4.8	34.9	6.0	10.9	7.2	4.0	4.6	7.7	15.5	4.9	5.9	5.2	9.6	7.4	7.2	5.8	11.9	13.6	4.0	14.1	8.8	17.5	9.8	7.3	14.1	5.9	8.4	5.9	5.4	13.3	8.9	6.2	16.3	11.3	12.3	5.4	17.3	7.1	9.0	5.6	14.1	11.9	11.5	13.1	9.3	12.0	10.3	11.3	13.6	10.3	10.6	9.7	7.7	14.5	10.2	13.0	6.5	8.6	12.3	13.9	5.9	7.2	9.1	9.0	7.0	8.9	27.6	7.3	7.6	19.9	12.2	10.2	13.8	4.4	7.4	9.2	12.3	11.0	29.1	6.9	6.0	7.0	7.1	6.0	7.2	11.2	7.2	10.1	7.8	10.7	11.0	8.8	3.0	10.6	4.0	9.9	14.1	10.4	11.9	11.6	10.3	13.6	8.2	12.6	11.9	1.2	8.8	11.9	4.6	17.5	9.8	5.3	6.5	6.5	7.2	5.8	3.8	4.5	2.8	5.7	4.9	0.0	14.3	5.2	7.2	8.7	8.0	89.2	7.6	5.3	4.5	10.4	9.8	16.5	34.9	8.0	33.1	4.9	19.0	0.0	7.5	14.8	5.1	7.4	4.7	8.9	9.4	0.0	12.1	4.9	3.8	61.2	2.0	5.4	5.0	4.6	14.2	2.8	8.6	11.0	6.3	11.4	11.6	0.0	5.1	14.6	15.9	9.2	13.5	5.3	15.1	11.8
CRYGA	"CRY-g-A, CRYG1, CRYG5"	ENSG00000168582	"Crystallin gamma A"	P11844	2	208160740-208163576	"Predicted intracellular proteins"		"Eye lens protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-138 MG: 1.3"	"Not detected"	"Not detected"							HPA043386	Supported		Uncertain	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA043386: "					"unprognostic (1.49e-1)"													0.1	0.0	1.0	0.1	1.8	0.0	0.1	0.1	1.5	0.1	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.0	0.1	0.1	0.9	1.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	0.1	1.5	0.9	1.1	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYGS	CRYG8	ENSG00000213139	"Crystallin gamma S"	P22914	3	186538441-186546702	"Disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 15.1;cervix, uterine: 21.8"	"Cell type enhanced"	"Detected in some"	5	"Rod photoreceptor cells: 3.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035103, HPA063539"	Supported		Uncertain	Cytosol		NA	NA			Cytosol		"HPA035103: AB_10696367, HPA063539: "	"unprognostic (5.52e-4)"	"unprognostic (1.29e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.45e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.72e-9)"	"unprognostic (1.10e-1)"	"unprognostic (9.53e-2)"	"unprognostic (3.67e-1)"	"prognostic favorable (2.73e-4)"	1.6	1.9	3.6	1.8	2.7	4.0	3.4	15.1	3.3	21.8	1.8	3.5	1.6	1.7	2.7	3.8	1.6	1.3	1.6	1.6	4.1	4.1	2.2	1.8	2.6	4.2	4.2	1.6	2.2	1.8	1.9	1.6	1.6	3.0	1.6	3.7	5.8	1.8	2.9	1.6	3.0	1.8	2.3	3.2	3.6	2.4	1.8	1.6	6.0	1.6	3.2	3.3	1.6	1.6	0.3	0.6	0.2	0.2	0.0	2.1	0.1	1.0	2.0	3.7	3.1	3.6	5.6	0.5	0.5	1.2	1.3	2.5	0.4	1.5	3.8	4.1	2.7	1.6	3.2	1.7	2.8	5.5	3.2	4.9	5.0	1.4	1.9	1.4	2.9	3.4	5.9	3.8	1.2	2.1	5.4	4.2	4.2	1.0	2.2	3.0	1.2	2.6	1.5	0.2	1.7	1.6	4.3	0.8	1.8	1.5	2.3	1.7	1.6	2.6	2.5	1.0	3.0	2.0	1.7	4.5	1.4	1.1	1.6	2.7	4.6	2.3	5.3	1.9	1.9	2.7	0.0	0.2	0.0	1.4	0.0	2.1	0.3	1.9	0.8	0.4	0.1	0.2	0.4	0.2	0.0	0.0	0.6	0.2	0.1	3.6	2.7	15.1	3.3	4.1	4.1	4.2	1.6	3.0	1.6	0.0	1.7	0.5	0.2	0.2	1.0	2.2	2.5	0.0	1.2	0.0	2.0	0.1	0.0	0.4	0.1	0.7	0.4	0.0	0.2	0.1	0.5	0.2	1.1	1.1	0.3	1.6	0.0	1.8	0.0	1.0	0.3	1.6	0.0	0.0	0.9	0.5	0.3	0.0	0.7	0.0	3.0	0.0	0.6	1.4	0.7	0.1	0.2	1.3	1.0	0.1
CSNK1A1L	MGC33182	ENSG00000180138	"Casein kinase 1 alpha 1 like"	Q8N752	13	37103259-37105664	"Enzymes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 10.5;testis: 9.0"	"Group enriched"	"Detected in some"	8	"Early spermatids: 23.1;Late spermatids: 19.5;Spermatocytes: 11.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	40	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 10.5"	"Not detected"	"Not detected"											HPA051334			Uncertain	Cytosol		NA	NA			Cytosol		"HPA051334: AB_2681446"	"unprognostic (1.23e-2)"		"unprognostic (1.59e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.40e-2)"		"unprognostic (5.40e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.28e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.38e-1)"		0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.0			0.0		0.0	0.0	0.0	0.1	0.2	10.5	0.2	0.1	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	10.5	0.1	0.2	0.1	0.2	0.2											0.0	0.0	0.0	1.5	1.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.1	0.5	0.0	0.0	0.0	0.1	0.4	0.9	0.0	0.0	0.1	0.0	0.0	1.8	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.4	1.1	2.4	0.2	0.0	0.0	1.0
CTBS	CTB	ENSG00000117151	Chitobiase	Q01459	1	84549606-84574480	"Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	6	"basal ganglia: 7.6"	"CAB017043, HPA023594, HPA048810"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		380000000	Cytosol		"CAB017043: , HPA023594: AB_1847311, HPA048810: "	"unprognostic (7.76e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.04e-2)"	6.4	6.9	4.0	8.8	4.4	9.7	15.3	4.4	3.5	5.3	5.8	3.3	8.1	3.7	6.2	16.4	4.8	5.2	8.0	13.1	4.5	4.4	10.4	22.3	15.6	28.1	5.8	2.3	5.1	15.0	6.5	10.4	6.9	8.1	8.1	5.1	4.7	18.5	12.5	4.3	8.4	7.2	6.7	10.0	12.6	6.1	3.5	4.4	5.5	5.9	4.9	5.1	5.5	5.2	0.8	0.4	3.2	1.6	0.7	0.6	0.2	1.8	0.6	0.4	0.4	5.6	6.7	1.4	1.3	4.5	0.6	1.7	0.2	2.2	2.4	0.5	2.8	0.7	0.8	0.1	1.7	1.9	2.2	0.6	1.5	0.3	0.3	3.4	1.6	0.8	4.9	3.3	1.6	2.5	4.0	1.9	1.0	1.4	4.4	1.3	0.1	1.0	1.8	0.4	0.4	0.6	0.5	0.7	1.6	4.0	0.9	0.3	0.8	0.5	1.8	2.1	1.1	1.0	1.7	2.9	2.3	0.2	3.1	1.4	1.3	0.4	0.7	1.6	2.2	1.6	1.8	0.8	1.5	0.2	0.9	0.4	0.5	0.4	0.3	0.4	0.8	0.3	0.6	3.2	0.7	1.6	0.4	0.4	0.2	4.0	4.4	4.4	3.5	4.5	4.4	5.8	2.3	8.1	4.4	8.9	16.0	29.6	25.9	27.0	5.8	5.1	30.6	26.8	20.5	22.7	39.3	20.5	36.5	15.7	2.6	28.2	17.1	0.0	16.9	19.2	19.6	41.9	43.8	58.7	42.5	3.2	22.2	45.4	70.4	3.0	19.5	43.1	6.8	23.4	21.5	19.9	17.2	21.0	23.0	38.3	40.1	12.9	14.4	7.5	9.8	21.7	21.4	17.5	16.9	25.3
CTC1	"AAF132, C17orf68, FLJ22170"	ENSG00000178971	"CST telomere replication complex component 1"	Q2NKJ3	17	8224821-8248095	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052436			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA052436: "	"unprognostic (6.47e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.66e-2)"	"prognostic favorable (6.49e-5)"	"unprognostic (2.89e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-2)"	9.9	10.0	9.9	15.2	12.2	18.0	12.2	28.5	15.3	10.3	11.3	12.4	8.7	8.9	15.6	12.7	8.2	10.5	10.7	7.0	6.8	7.5	11.8	14.4	13.8	24.1	9.7	7.4	14.5	14.5	12.2	18.5	7.9	9.2	11.2	12.2	11.5	11.0	12.2	5.0	15.5	15.7	13.4	7.4	25.0	9.9	8.8	10.6	32.9	12.5	4.0	23.0	9.1	10.6	6.1	4.6	5.1	2.4	2.7	6.3	2.0	2.5	5.6	5.2	4.9	16.4	3.9	6.5	3.0	3.2	4.3	2.9	4.3	7.6	9.2	3.0	5.1	3.1	8.6	6.1	4.4	2.7	6.7	5.9	4.5	5.4	5.5	2.8	1.4	14.2	3.9	4.9	5.6	7.7	8.5	7.6	13.4	4.3	3.1	3.0	3.3	15.6	6.2	4.3	8.3	1.4	7.4	2.0	5.9	10.9	5.9	4.6	5.3	5.8	7.6	5.0	10.2	4.6	4.3	10.0	1.4	3.2	3.2	3.4	6.5	3.8	6.1	2.6	5.5	3.9	3.6	1.6	2.4	4.7	1.9	4.4	5.0	4.5	4.1	1.5	6.1	6.3	5.8	5.1	2.7	2.4	4.6	3.5	2.0	9.9	12.2	28.5	15.3	6.8	7.5	9.7	7.4	9.2	10.6	0.0	12.0	11.5	2.6	1.6	5.9	3.9	5.1	2.7	3.4	5.2	35.3	5.2	1.7	3.0	2.7	3.1	3.3	0.0	3.3	3.5	2.5	3.2	5.8	8.1	3.3	1.6	6.4	3.7	9.7	4.3	4.0	3.2	0.0	6.4	5.5	2.3	4.5	5.3	2.1	1.5	17.7	0.0	2.8	4.3	4.4	1.8	9.3	7.0	3.2	3.3
CTSF	"CATSF, CLN13"	ENSG00000174080	"Cathepsin F"	Q9UBX1	11	66563463-66568841	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 256.1;Muller glia cells: 186.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"NK-cells: 7.5;T-cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HSkMC: 28.4;SK-MEL-30: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002141, HPA031431"	Approved		Uncertain	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		3600000	Cytosol	"Vesicles, Plasma membrane"	"CAB002141: AB_563471, HPA031431: "	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.12e-2)"	"prognostic favorable (8.92e-7)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.42e-1)"	28.1	29.4	24.7	8.0	29.0	1.8	31.1	38.4	47.1	37.3	23.8	32.6	25.2	5.8	38.1	29.8	12.9	34.3	37.3	34.5	25.3	20.5	29.8	45.4	17.3	8.5	28.0	26.0	68.2	23.1	42.6	15.9	20.2	25.4	32.3	8.1	35.0	35.5	37.8	35.8	19.7	9.4	34.6	22.4	10.4	17.8	37.1	30.1	0.8	18.6	14.2	6.3	22.2	21.5	2.1	1.1	0.5	0.7	7.5	9.7	2.4	0.1	9.3	5.0	13.0	21.5	8.7	3.6	6.6	16.7	6.8	4.8	0.0	8.3	0.0	11.1	14.4	0.3	0.9	8.6	2.8	3.6	2.2	0.0	0.3	3.8	0.0	12.0	0.1	5.1	28.4	9.7	1.5	1.1	20.3	4.3	2.7	2.9	1.5	8.5	1.9	0.1	1.1	0.6	5.0	3.4	0.0	1.9	1.6	6.1	0.2	6.0	6.5	17.5	2.0	52.8	0.5	13.3	0.8	2.8	2.8	2.7	3.2	0.7	8.9	0.1	0.0	6.6	0.1	4.1	0.0	0.7	0.4	6.5	0.7	7.0	2.0	5.6	7.3	0.8	2.1	9.7	5.5	0.5	7.5	0.3	1.1	1.7	2.4	24.7	29.0	38.4	47.1	25.3	20.5	28.0	26.0	25.4	30.1	11.9	14.1	3.4	58.6	35.3	99.1	43.9	35.7	2.7	5.7	34.9	39.3	22.1	13.3	8.5	123.6	24.1	0.0	0.0	6.6	8.1	75.7	48.4	9.2	51.3	13.1	127.1	11.5	49.7	15.8	256.1	134.9	9.9	148.5	2.8	3.1	186.2	8.9	1.9	114.5	30.7	63.2	77.6	43.8	164.4	36.6	22.1	19.8	19.2	3.0	26.5
CWC22	"EIF4GL, fSAPb, KIAA1604, NCM"	ENSG00000163510	"CWC22 spliceosome associated protein homolog"	Q9HCG8	2	179944876-180007113	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036748	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA036748: AB_10669913"	"unprognostic (1.90e-1)"	"unprognostic (7.10e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (7.76e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.44e-3)"	20.4	14.2	15.8	17.3	16.8	18.1	19.2	33.5	24.6	21.1	17.0	10.5	13.5	12.4	21.5	14.3	18.4	17.6	15.5	14.8	17.5	11.9	17.2	20.7	14.7	21.3	14.4	19.6	25.4	14.7	21.8	25.0	17.8	17.0	20.4	15.2	9.1	15.4	14.7	20.2	15.9	17.4	23.6	19.0	20.5	15.4	10.9	16.3	26.5	20.7	17.6	21.7	21.8	23.8	12.4	9.9	26.4	11.9	10.9	16.4	8.2	9.6	6.0	16.8	11.2	12.2	14.5	12.8	12.8	15.1	15.8	15.4	13.5	12.2	19.0	11.5	9.2	13.8	10.6	15.9	11.9	23.9	16.7	14.0	25.4	7.8	18.4	12.0	35.3	14.2	9.5	14.5	19.8	26.9	10.3	11.7	13.2	27.6	11.7	10.3	9.7	18.4	18.4	25.8	11.6	9.7	17.0	20.8	14.2	10.9	12.2	11.5	15.6	10.5	8.4	14.6	18.8	6.3	22.4	10.0	13.5	11.5	8.8	13.2	10.3	10.8	23.2	12.1	14.3	13.5	26.4	9.5	21.5	12.3	11.9	12.4	12.4	13.3	14.5	9.9	11.3	16.4	12.8	15.9	10.9	8.9	6.3	11.3	8.2	15.8	16.8	33.5	24.6	17.5	11.9	14.4	19.6	17.0	16.3	17.9	26.0	19.8	23.6	16.9	14.6	25.2	22.9	52.2	35.2	10.4	23.6	15.7	8.3	21.1	1.2	21.7	10.5	0.0	16.6	14.4	15.9	13.2	26.5	12.4	12.1	12.7	15.0	15.4	19.7	1.5	21.6	21.4	3.3	21.6	15.8	16.3	16.2	16.7	17.3	14.4	16.9	45.3	13.2	25.1	21.5	16.3	20.7	17.5	13.5	15.4
CYTH4	"CYT4, cytohesin-4, PSCD4"	ENSG00000100055	"Cytohesin 4"	Q9UIA0	22	37282027-37315345	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 52.3;lymphoid tissue: 53.9"	"Cell type enhanced"	"Detected in some"	11	"granulocytes: 55.4;Hofbauer cells: 64.0;Kupffer cells: 57.8;Macrophages: 83.4;T-cells: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 12.1;HMC-1: 50.8;THP-1: 33.3;U-266/70: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004065, HPA071573"	Approved		Supported	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		NA	NA			"Plasma membrane"	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA004065: , HPA071573: AB_2686418"	"unprognostic (4.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.28e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (2.41e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.07e-1)"	13.6	6.6	7.0	32.0	9.2	24.2	7.6	1.5	4.2	2.9	5.0	7.0	0.9	4.1	3.9	6.5	3.2	5.5	8.3	9.2	4.7	3.7	5.1	4.5	14.8	27.4	10.3	2.6	2.5	3.1	1.1	3.7	13.5	6.9	4.0	4.8	4.6	10.3	2.1	2.1	3.0	13.2	6.0	9.9	53.9	5.4	2.3	7.5	12.9	3.6	2.9	22.9	12.0	3.2	8.0	27.2	52.3	31.4	11.4	15.1	16.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.1	0.0	0.8	0.0	0.0	0.2	0.0	1.8	0.0	3.5	0.0	0.0	0.0	12.1	50.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.1	4.5	0.0	0.0	0.3	0.4	0.1	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.1	0.0	0.0	0.0	0.0	10.3	1.3	1.6	6.9	4.1	0.1	3.7	15.6	21.6	15.1	26.4	10.6	7.8	8.3	11.9	12.4	8.0	8.0	10.6	52.3	11.4	31.4	27.2	7.5	16.1	7.0	9.2	1.5	4.2	4.7	3.7	10.3	2.6	6.9	7.5	3.0	12.5	18.1	0.7	2.2	0.0	1.6	0.0	0.0	3.4	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.6	2.1	0.3	55.4	0.8	64.0	0.0	0.0	2.5	57.8	0.0	0.6	83.4	6.8	1.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.1	1.9	0.8	48.9	0.0	0.6
DCAF12L1	"KIAA1892L, WDR40B"	ENSG00000198889	"DDB1 and CUL4 associated factor 12 like 1"	Q5VU92	X	126549383-126552851	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 22.6;testis: 30.9"	"Cell type enhanced"	"Detected in some"	21	"Early spermatids: 15.4;Late spermatids: 30.6;Spermatogonia: 12.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"EFO-21: 17.6;U-2 OS: 9.8"									"HPA044737, HPA048981, HPA053138"	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054"				"unprognostic (2.62e-5)"						"unprognostic (2.88e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.74e-1)"		0.2	0.1	0.2	0.0	0.1	0.0	0.7	0.1	0.1	0.5	0.1	0.0	6.2	0.0	0.6	22.6	0.1	4.3	4.3	0.1	0.1	0.4	3.3	0.1	0.1	0.0	0.1	0.0	1.5	0.1	0.0	0.6	0.0	0.3	1.0	0.0	0.5	0.1	3.9	0.1	0.1	0.1	2.5	0.1	1.5	1.6	30.9	0.0	0.3	0.9	0.2	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.8	0.0	0.0	0.0	3.4	12.5	0.0	0.0	0.0	0.0	0.0
DCAF12L2	WDR40C	ENSG00000198354	"DDB1 and CUL4 associated factor 12 like 2"	Q5VW00	X	126163499-126166097	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 15.7;epididymis: 53.6;testis: 15.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HAP1: 5.9;NTERA-2: 4.9;U-2 OS: 8.1"									"HPA044737, HPA048981, HPA053138"	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054"	"unprognostic (1.16e-4)"			"unprognostic (8.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.52e-2)"		"unprognostic (2.72e-1)"		"unprognostic (3.02e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.47e-4)"	"unprognostic (1.56e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.51e-1)"	1.1	1.2	1.1	0.1	1.9	0.1	2.3	0.5	2.1	1.9	0.9	0.0	15.7	0.1	2.4	53.6	0.5	3.0	0.2	0.4	1.0	3.9	0.4	0.1	0.2	0.2	1.0	1.7	1.9	0.2	2.4	1.3	0.1	1.3	2.0	0.2	0.2	0.6	5.6	0.4	0.5	0.5	2.0	0.8	0.2	0.7	15.8	0.1	0.0	0.4	0.0	0.3	2.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.5	2.1	1.0	3.9	1.0	1.7	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DECR1	"DECR, SDR18C1"	ENSG00000104325	"2,4-dienoyl-CoA reductase 1"	Q16698	8	90001405-90052092	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 120.2"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 338.2;Proximal tubular cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"SK-BR-3: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023160, HPA023162, HPA023238"	Enhanced		Supported	Mitochondria,Cytosol		No	No		740000	Mitochondria	Cytosol	"HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587"	"prognostic unfavorable (1.49e-4)"	"unprognostic (5.76e-3)"	"unprognostic (8.37e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.79e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.06e-4)"	26.9	45.7	13.2	18.1	17.6	9.2	15.6	10.3	14.5	13.0	29.0	10.4	11.8	32.4	11.9	13.7	16.2	8.5	12.6	70.0	15.4	9.0	44.8	120.2	12.9	14.0	12.5	12.8	12.7	14.4	22.2	16.8	5.8	13.6	11.0	22.9	9.5	15.7	9.9	37.9	12.5	42.7	11.5	11.9	20.1	12.7	17.0	14.5	20.3	15.0	32.1	15.3	11.6	10.6	23.4	52.3	37.2	42.8	19.8	31.3	27.8	10.5	6.0	17.8	20.1	12.5	20.3	3.8	9.3	16.1	6.1	9.5	2.4	10.5	8.1	7.4	11.1	5.5	8.0	6.6	9.4	10.2	12.2	0.7	19.3	5.4	9.6	15.6	4.2	4.0	16.0	7.3	4.8	8.1	15.1	18.0	12.9	20.1	16.0	29.0	12.1	12.0	6.2	1.1	22.4	18.2	10.2	4.7	14.4	29.8	26.6	0.8	6.7	14.0	132.5	11.1	0.5	17.0	10.9	16.3	10.3	4.9	13.5	5.5	8.1	6.1	9.5	9.8	9.6	13.1	15.0	31.5	10.2	21.4	42.8	22.6	23.4	20.1	21.8	52.3	19.2	21.3	21.0	37.2	19.8	37.2	20.4	31.3	27.8	13.2	17.6	10.3	14.5	15.4	9.0	12.5	12.8	13.6	14.5	71.5	50.7	52.5	52.8	36.7	12.7	229.8	79.0	71.0	51.2	68.0	2.0	44.0	338.2	106.7	118.9	49.7	161.9	0.0	82.2	42.9	47.8	37.6	48.5	196.2	104.2	30.2	100.6	52.2	85.9	33.7	79.1	96.9	81.0	80.2	84.9	41.0	80.5	101.7	48.4	333.3	6.5	71.1	40.1	118.4	23.4	35.9	34.3	71.9	118.0	55.4
DGCR8	"C22orf12, DGCRK6, Gy1, pasha"	ENSG00000128191	"DGCR8, microprocessor complex subunit"	Q8WYQ5	22	20080232-20111877	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 46.8;Rod photoreceptor cells: 59.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 41.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076916, HPA079351"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA076916: , HPA079351: "	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.75e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.34e-1)"	"unprognostic (5.72e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.26e-2)"	7.9	7.8	9.9	10.3	10.1	10.1	9.4	29.8	14.1	9.7	10.3	11.8	13.4	7.6	14.5	8.1	11.7	11.5	10.5	7.8	10.0	6.9	7.9	7.9	8.1	8.9	10.6	9.7	13.9	15.2	11.6	16.8	17.9	10.4	9.5	7.9	11.3	10.5	10.3	19.9	11.3	10.1	12.6	7.4	10.3	10.0	22.4	10.9	11.1	9.8	11.9	9.0	11.5	12.6	1.7	3.3	1.2	6.8	3.2	4.6	2.7	12.1	8.6	11.2	6.6	4.4	7.2	14.3	11.7	7.0	7.9	5.6	9.2	6.2	10.8	6.5	10.9	5.3	11.7	10.2	9.7	6.9	10.6	15.1	11.8	9.1	7.5	11.7	21.7	9.8	5.7	12.2	8.3	6.1	7.3	6.9	6.6	41.6	7.9	9.2	7.8	13.0	6.4	10.9	8.8	6.5	15.6	11.9	3.7	4.8	11.4	12.5	8.0	10.7	6.3	6.8	7.0	6.0	9.3	10.3	11.6	9.7	7.2	11.8	4.4	6.0	10.9	8.6	9.9	11.2	0.0	2.1	1.2	4.5	1.9	3.5	1.7	2.2	4.6	2.9	1.5	2.3	2.6	0.4	3.2	6.8	3.3	2.7	2.7	9.9	10.1	29.8	14.1	10.0	6.9	10.6	9.7	10.4	10.9	6.0	9.3	8.0	4.5	8.5	34.3	2.5	5.1	6.7	6.8	5.2	37.3	11.0	0.0	5.6	46.8	6.7	6.3	0.0	8.7	9.5	5.6	7.7	3.5	11.3	4.6	41.3	7.0	8.6	7.0	31.3	17.0	3.8	5.0	6.4	9.2	15.8	8.6	6.0	9.9	2.8	59.4	6.5	4.7	16.9	13.0	8.2	11.3	6.9	8.2	4.7
DHRSX	"DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6"	ENSG00000169084	"Dehydrogenase/reductase X-linked"	Q8N5I4	X	2219516-2502805	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003035, HPA075955"	Approved		Uncertain	"Mitotic spindle,Cytosol"	"Secreted to blood"	NA	NA			Cytosol	"Mitotic spindle"	"HPA003035: AB_1080631, HPA075955: "	"unprognostic (7.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-2)"	"unprognostic (4.65e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.69e-2)"	7.3	9.5	21.5	3.1	26.7	2.9	55.7	21.5	25.3	32.1	7.3	1.2	1.2	4.6	25.1	6.4	3.2	7.5	6.7	37.8	23.7	3.4	34.6	18.9	5.8	3.2	21.8	16.9	25.0	15.2	5.5	24.2	32.7	28.3	7.7	6.5	1.2	10.8	5.7	6.3	4.9	6.5	5.3	26.5	5.9	8.6	3.4	23.6	1.2	8.1	1.2	2.7	6.1	27.4	12.2	18.3	30.0	21.1	8.7	9.1	10.0	4.5	20.9	14.1	6.5	17.6	11.1	10.6	10.4	17.7	8.0	10.8	15.6	9.9	7.3	13.4	12.3	18.7	2.2	9.7	8.4	5.7	13.4	15.1	7.0	11.0	11.6	20.3	3.8	5.7	13.6	10.4	6.9	6.9	13.6	6.3	8.1	7.7	3.6	12.8	5.2	13.9	5.3	3.4	6.1	5.8	5.4	7.4	2.0	8.6	11.2	13.4	13.4	9.9	11.8	7.7	9.0	5.1	6.0	8.5	8.8	2.1	4.9	6.1	4.2	0.0	18.8	5.8	5.0	3.9	6.5	21.1	17.1	8.4	15.7	8.9	12.2	7.6	7.0	18.3	10.6	7.2	6.0	30.0	8.7	9.5	14.8	9.1	10.0	21.5	26.7	21.5	25.3	23.7	3.4	21.8	16.9	28.3	23.6	17.9	9.4	13.4	20.7	9.4	8.8	20.9	25.5	6.7	5.7	24.4	9.8	36.6	11.6	44.5	0.4	12.8	31.3	0.0	70.9	36.4	20.8	43.3	18.4	46.5	34.3	3.2	18.5	11.6	15.9	1.8	22.5	27.2	11.8	47.7	19.0	8.0	61.5	28.1	23.7	35.4	5.9	19.4	14.4	9.7	17.2	5.6	89.7	13.4	22.6	17.1
DIMT1	"DIMT1L, HSA9761"	ENSG00000086189	"DIM1 dimethyladenosine transferase 1 homolog"	Q9UNQ2	5	62387254-62403939	"Enzymes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042944	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA042944: AB_2678234"	"unprognostic (1.58e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-3)"	"unprognostic (7.16e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.70e-1)"	"prognostic unfavorable (8.90e-12)"	"unprognostic (8.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.15e-2)"	16.7	14.0	18.9	16.7	17.0	10.6	18.9	11.5	23.5	18.6	11.8	12.4	11.8	11.0	16.2	11.9	20.1	14.2	15.3	19.7	19.1	17.0	11.9	16.3	11.7	22.5	18.8	8.5	17.8	28.4	8.9	13.4	16.7	12.3	18.8	9.5	10.0	16.1	18.3	17.9	12.2	11.9	24.6	20.2	22.1	10.2	10.7	9.8	16.3	19.0	19.0	19.2	21.7	13.2	7.9	7.7	5.0	5.6	7.0	13.2	6.1	14.6	8.8	16.1	21.0	11.9	15.8	16.0	18.7	7.1	14.5	15.4	14.2	15.6	30.1	17.2	13.9	15.7	11.4	10.8	11.1	18.4	21.3	18.9	20.6	11.5	11.8	14.3	16.9	15.9	13.7	9.0	14.1	13.8	14.4	12.6	19.8	20.9	13.9	14.8	14.7	24.9	26.1	15.5	6.5	18.5	16.1	16.2	41.5	13.1	13.5	18.0	15.8	16.0	15.0	16.0	12.0	12.1	15.9	13.9	10.0	10.4	14.2	25.6	18.4	19.1	27.1	15.2	30.5	14.8	5.0	3.1	2.3	7.7	5.6	11.7	7.9	10.4	9.3	5.0	6.6	13.2	11.0	0.8	7.0	4.3	7.7	9.3	6.1	18.9	17.0	11.5	14.7	19.1	17.0	18.8	8.5	12.3	9.8	3.0	7.4	18.2	65.3	45.2	5.5	27.9	22.9	13.4	21.6	14.0	9.8	38.5	18.3	24.9	5.1	26.8	3.6	0.0	19.6	38.1	27.3	43.1	12.7	10.9	28.5	0.0	4.6	16.5	16.1	3.6	26.7	17.5	27.0	21.6	11.7	6.0	17.2	2.9	19.1	22.7	4.1	6.5	49.9	12.6	21.1	33.1	29.9	25.4	15.7	57.8
DISP3	"KIAA1337, PTCHD2"	ENSG00000204624	"Dispatched RND transporter family member 3"	Q9P2K9	1	11479166-11537584	"Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4;testis: 7.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;NTERA-2: 3.4;SCLC-21H: 3.2;SH-SY5Y: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054579	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA054579: AB_2682529"	"unprognostic (4.93e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.34e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.88e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.34e-1)"	0.9	1.9	7.3	1.1	10.0	0.9	0.9	4.1	17.4	0.9	1.0	9.0	0.0	1.3	1.1	0.9	0.8	1.0	0.8	0.8	7.3	5.7	0.9	0.8	0.9	1.2	4.0	6.5	0.9	1.6	0.8	4.2	0.8	5.1	1.6	0.9	5.4	0.9	0.8	0.8	0.8	1.3	1.0	2.1	1.1	1.2	7.5	6.8	0.0	0.9	0.0	1.0	0.9	0.1	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	7.9	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	3.4	0.0	0.0	0.8	0.0	2.0	0.0	0.2	3.2	11.0	2.4	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.3	10.0	4.1	12.9	7.3	5.7	4.0	6.5	5.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11963106-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"brain: 94.7;heart muscle: 297.4"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 489.8;Muller glia cells: 1823.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 8.9;memory CD8 T-cell: 5.5;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	90	"T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"BJ: 60.1;BJ hTERT+: 93.0;fHDF/TERT166: 87.0;hTERT-RPE1: 54.3;TIME: 49.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"	No	No		15000000	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	4.8	21.7	44.9	3.5	94.7	1.3	6.8	32.5	60.3	25.8	7.3	12.1	4.1	4.9	7.8	5.6	8.8	4.9	17.9	297.4	49.6	23.5	5.1	2.7	17.8	3.1	19.1	45.8	10.8	5.7	10.9	6.6	7.5	24.7	16.8	4.6	10.7	9.1	22.3	2.7	8.3	7.3	12.0	32.9	9.0	7.0	8.9	25.5	0.0	4.7	2.5	2.6	10.5	7.8	0.0	0.0	0.0	0.0	0.0	8.9	0.6	0.2	1.8	2.6	0.0	2.2	4.4	0.0	60.1	93.0	26.6	30.3	1.3	0.4	0.0	6.6	87.0	14.2	9.2	0.2	25.9	10.2	0.0	0.0	0.0	0.2	0.0	17.0	0.0	0.0	6.7	8.7	9.0	22.3	54.3	28.2	0.0	0.0	0.0	36.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	9.2	0.0	0.0	7.8	0.2	0.0	0.0	7.3	0.0	0.0	49.9	15.8	12.4	1.6	15.5	0.0	0.0	0.0	2.6	0.0	14.8	0.0	0.0	0.0	0.8	0.0	8.9	0.0	0.8	5.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	44.9	94.7	32.5	46.5	49.6	23.5	19.1	45.8	24.7	25.5	3.0	4.8	0.0	55.5	40.5	22.0	489.8	0.0	4.0	20.5	0.0	11.8	0.4	0.0	0.6	98.7	37.6	0.0	0.0	0.2	0.6	30.9	9.6	1.1	0.0	15.3	12.7	1.7	47.3	1.0	66.1	19.0	2.3	60.8	0.0	0.0	1823.0	1.0	0.0	54.1	0.0	52.9	187.5	74.5	0.5	1.3	12.9	0.7	4.9	0.1	2.6
DROSHA	"Etohi2, HSA242976, RN3, RNASE3L, RNASEN"	ENSG00000113360	"Drosha ribonuclease III"	Q9NRR4	5	31400497-31532196	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, RNA-mediated gene silencing"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031150			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031150: AB_2673761"	"unprognostic (8.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (5.40e-2)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (3.11e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.32e-2)"	15.7	16.8	18.4	17.7	32.1	12.2	16.1	33.7	33.7	17.4	16.3	19.1	12.2	15.9	22.3	25.8	16.0	18.2	14.1	15.2	16.6	15.1	15.3	11.7	13.9	17.8	13.6	16.4	26.7	17.8	23.9	38.9	17.0	18.9	17.2	19.2	23.7	17.5	19.2	23.6	16.0	17.5	16.9	19.4	16.8	16.0	12.8	16.4	25.6	21.9	13.4	19.8	18.2	16.2	4.7	6.4	3.3	4.8	4.8	6.4	3.1	12.4	15.7	17.4	23.6	9.3	11.4	25.1	16.5	8.1	15.4	11.5	16.5	16.2	14.0	19.0	12.1	17.9	10.9	21.4	12.5	17.2	13.1	15.1	17.2	51.6	11.9	8.4	19.2	51.4	8.9	8.8	17.2	8.3	11.8	13.1	15.0	21.8	6.6	13.4	12.4	18.5	14.4	16.4	10.1	12.6	16.8	33.3	10.1	8.7	14.2	9.1	12.0	41.9	17.2	10.1	16.2	15.8	11.1	11.4	14.9	17.3	13.3	15.6	12.1	19.8	15.4	10.3	21.7	14.2	1.8	2.4	3.3	5.2	2.6	5.5	4.2	5.4	6.0	5.2	4.7	6.4	4.4	0.8	4.8	4.8	6.4	5.1	3.1	18.4	32.1	33.7	33.7	16.6	15.1	13.6	16.4	18.9	16.4	11.9	14.7	3.0	4.6	3.2	18.2	21.0	7.6	20.1	15.9	5.2	0.0	6.6	3.3	7.2	2.5	6.2	7.3	0.0	7.0	6.4	7.4	5.0	9.2	5.1	6.7	6.4	10.9	9.2	7.8	4.3	10.0	3.2	1.7	9.0	10.1	10.5	7.8	8.6	12.4	4.2	16.8	6.5	4.7	5.8	8.4	3.0	4.1	5.7	10.0	5.1
DSN1	"C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13"	ENSG00000149636	"DSN1 homolog, MIS12 kinetochore complex component"	Q9H410	20	36751791-36773818	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 90.5;Spermatogonia: 91.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002813, HPA030627"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol"		Yes	Yes			Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol"	"HPA002813: AB_1078343, HPA030627: AB_2732460"	"unprognostic (3.60e-2)"	"prognostic favorable (4.49e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (4.16e-5)"	"unprognostic (3.93e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.84e-1)"	6.7	10.4	5.6	15.6	7.4	11.6	8.2	5.4	7.2	5.1	8.6	4.1	9.5	6.3	9.5	12.0	9.1	5.0	8.1	6.2	5.1	4.7	5.8	8.6	6.1	11.0	4.8	3.9	5.3	5.4	3.6	7.6	12.9	5.1	6.5	10.3	10.1	9.7	8.1	4.6	7.3	8.8	5.9	4.1	11.6	7.0	27.2	4.1	21.2	6.3	11.4	13.8	5.8	5.5	10.9	25.4	21.7	5.9	5.6	6.5	3.7	13.0	11.8	13.9	11.1	5.5	7.2	9.2	16.0	13.6	24.6	27.7	20.5	17.0	15.1	10.7	8.7	27.2	17.2	13.0	12.6	23.5	6.6	8.3	29.4	11.3	13.7	1.2	16.8	13.0	2.7	3.6	17.0	5.4	4.0	12.0	16.4	11.4	12.5	16.1	9.3	21.5	13.0	6.5	23.6	20.9	16.9	42.4	10.0	6.2	7.8	14.3	6.5	19.9	20.5	9.7	10.8	20.9	11.3	6.2	22.5	13.7	22.0	17.2	10.5	14.1	17.1	18.9	15.2	16.0	21.7	3.6	7.5	4.4	5.9	4.9	8.8	4.8	5.8	3.9	10.9	5.9	5.5	6.5	5.6	5.0	25.4	6.5	3.7	5.6	7.4	5.4	7.2	5.1	4.7	4.8	3.9	5.1	4.1	6.0	4.1	9.3	10.2	4.4	8.0	4.1	2.5	10.7	10.3	5.2	27.5	42.7	6.6	5.2	6.3	5.8	6.4	0.0	5.6	29.3	7.5	7.5	3.5	4.5	12.6	6.4	2.4	9.8	3.7	5.8	8.1	6.1	1.7	8.2	9.0	4.8	4.7	5.7	7.1	2.9	15.8	0.0	7.2	90.5	91.3	6.4	39.7	6.4	10.5	10.8
DTD1	"bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68"	ENSG00000125821	"D-tyrosyl-tRNA deacylase 1"	Q8TEA8	20	18587893-18766644	"Enzymes, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 137.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA040981	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA		180000	"Nucleoli, Cytosol"		"HPA040981: AB_10673268"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.53e-2)"	14.9	17.7	25.2	13.6	26.5	13.6	19.7	22.4	35.4	13.5	13.7	22.2	10.5	10.6	14.4	17.2	18.8	14.5	11.1	16.7	24.7	29.5	20.1	9.4	13.7	15.5	25.2	30.4	19.1	19.7	20.3	23.7	12.7	27.3	13.6	16.0	17.1	17.6	12.4	22.5	17.6	9.8	15.0	30.9	12.7	16.3	20.6	14.4	4.8	29.5	24.9	17.4	13.4	12.6	20.9	27.5	29.9	20.6	16.4	22.5	12.6	18.7	21.1	20.8	20.4	8.9	16.6	11.6	16.6	15.4	13.2	14.5	13.8	14.7	0.0	11.4	15.4	18.5	10.6	16.6	35.2	13.9	9.1	11.9	20.9	4.8	22.9	28.2	16.2	11.3	13.1	28.3	14.9	55.0	11.3	22.4	3.6	13.0	24.4	19.2	27.5	3.4	29.5	19.3	14.2	46.5	0.0	31.0	15.8	20.1	10.1	28.5	21.5	8.9	24.7	42.8	9.5	14.0	10.1	22.1	17.5	9.5	22.3	22.4	19.6	19.4	10.4	12.0	19.0	14.5	29.9	14.5	10.4	22.2	20.6	22.2	20.9	21.7	22.5	27.5	17.8	16.0	16.7	17.1	16.4	20.5	6.4	16.1	12.6	25.2	26.5	22.4	35.4	24.7	29.5	25.2	30.4	27.3	14.4	32.8	20.0	24.2	32.6	20.9	39.1	17.3	30.6	25.4	17.0	40.1	2.0	25.2	36.5	64.2	24.1	30.8	7.3	0.0	76.4	30.7	25.8	26.4	41.5	10.4	41.2	41.3	22.3	24.5	20.4	17.6	16.7	29.6	40.5	48.7	19.7	48.4	68.4	24.6	18.4	51.2	30.2	0.0	17.5	60.6	137.5	31.1	10.4	30.5	24.3	23.6
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 17.8;Erythroid cells: 23.3;Extravillous trophoblasts: 13.2;Spermatocytes: 35.9;Spermatogonia: 19.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD8 T-cell: 1.5;T-reg: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028016, HPA032023, HPA032031"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	Yes			Nucleoplasm	"Nucleoli, Cytosol"	"HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119"	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	1.3	0.7	0.4	5.4	0.6	10.8	1.3	0.4	0.5	1.2	2.8	0.3	0.1	1.7	1.0	0.6	4.0	0.4	1.5	0.6	0.4	0.4	0.8	1.0	1.6	4.4	0.4	0.1	0.6	0.5	0.6	0.7	5.4	0.2	0.6	4.2	0.2	1.1	0.1	0.4	1.6	3.3	1.4	0.4	4.6	1.1	37.2	0.1	41.2	0.9	5.7	7.5	0.9	1.6	0.7	0.3	0.0	0.4	0.6	5.2	0.7	12.6	10.8	18.5	9.2	1.1	2.3	9.1	15.9	9.9	15.1	22.5	6.7	11.2	9.6	6.0	6.1	9.7	9.9	24.4	13.4	21.8	11.6	11.7	15.3	14.3	8.1	0.0	20.1	9.6	1.0	0.4	24.4	13.0	2.7	6.9	17.0	18.2	19.6	17.4	5.1	26.8	9.2	21.4	9.6	12.5	21.3	32.7	18.5	4.3	8.8	11.6	18.2	15.1	14.5	6.5	19.7	12.4	9.2	3.7	15.1	11.3	15.6	17.9	7.2	11.2	22.2	7.6	13.3	14.6	0.0	0.0	0.0	0.6	0.4	0.0	0.7	0.8	1.5	0.3	0.1	0.0	0.3	0.0	0.6	0.0	0.0	5.2	0.7	0.4	0.6	0.4	0.5	0.4	0.4	0.4	0.1	0.2	0.1	0.0	0.0	7.8	0.4	2.1	0.0	6.1	2.5	0.0	1.2	0.0	0.0	7.5	0.0	0.2	17.8	1.8	0.5	23.3	0.0	13.2	1.2	0.2	0.0	0.0	3.9	0.0	0.0	1.3	0.3	7.9	1.1	1.0	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	35.9	19.1	1.5	1.3	1.9	2.9	0.0
DUSP28	"DUSP26, VHP"	ENSG00000188542	"Dual specificity phosphatase 28"	Q4G0W2	2	240560054-240564014	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047456, CAB069448"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB069448: , HPA047456: AB_10961145"	"unprognostic (1.88e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.71e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-3)"	1.8	2.8	2.7	3.0	3.4	7.9	3.5	6.3	3.7	3.1	2.6	3.3	6.5	2.9	2.6	5.0	3.5	3.1	4.4	16.3	2.8	2.7	3.2	3.4	2.5	6.1	3.5	2.4	2.6	10.2	2.6	5.0	3.2	2.8	4.3	2.8	2.7	3.7	2.4	21.2	4.9	4.2	4.3	2.2	5.9	4.2	8.2	2.3	2.6	4.4	13.4	4.2	2.8	4.5	3.8	3.3	10.7	2.1	2.7	3.3	2.0	1.7	1.6	2.2	2.6	1.4	0.8	2.4	1.9	1.2	1.5	1.1	1.0	4.5	2.7	1.0	1.2	2.3	5.1	1.7	0.7	1.6	3.4	6.4	3.9	3.4	2.5	1.0	2.5	6.7	1.7	1.8	1.0	1.3	2.9	0.7	3.9	2.7	3.3	1.3	1.9	3.1	4.0	1.4	2.6	1.4	3.8	4.8	3.6	1.1	2.9	4.9	2.7	1.8	1.9	2.2	1.4	2.4	4.4	1.7	3.5	2.9	2.2	1.7	13.2	3.8	4.4	2.2	1.9	2.8	10.7	2.1	0.7	2.7	1.4	3.0	2.1	2.8	2.8	1.2	3.8	3.3	3.0	3.6	2.7	1.5	3.3	2.2	2.0	2.7	3.4	6.3	3.6	2.8	2.7	3.5	2.4	2.8	2.3	0.0	5.0	5.1	6.9	3.3	6.3	12.9	12.7	6.7	1.2	12.2	3.9	6.4	13.3	4.1	27.6	3.1	11.8	0.0	5.1	4.0	4.1	8.4	6.9	6.6	10.0	7.9	8.1	2.5	10.3	29.8	2.8	7.0	6.8	8.2	8.1	7.4	3.9	11.8	1.4	11.2	6.6	6.5	5.6	41.1	17.6	4.6	5.8	12.5	10.1	6.8
DUX4		ENSG00000260596	"Double homeobox 4"	Q9UBX2	4	190173774-190185942	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 3.4"	"Group enriched"	"Detected in some"	21	"Early spermatids: 4.1;Late spermatids: 4.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.5;U-2 OS: 3.7;U-266/70: 8.0;U-266/84: 10.4;U-698: 2.4"									HPA058451			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Golgi apparatus, Cytosol"	"HPA058451: AB_2683722"																		0.0	0.4		0.0		0.0	0.0		0.5	0.0	0.0			1.0	0.1	0.0	0.0	0.9	0.0	0.0			0.0	0.0	0.5	0.1			0.1	0.5	0.3		0.0		1.1	0.0		0.5	0.1	0.0	0.3	0.0	0.0		0.0	0.3	3.4			0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	2.5	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	3.7	0.7	0.0	8.0	10.4	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DYNLL2	"Dlc2, DNCL1B, MGC17810, RSPH22"	ENSG00000264364	"Dynein light chain LC8-type 2"	Q96FJ2	17	58083415-58095536	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 366.0;Late spermatids: 723.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039954			Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039954: AB_2676771"	"unprognostic (7.22e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.52e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.72e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.10e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.12e-12)"	"unprognostic (2.87e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.02e-2)"	15.4	28.3	38.6	11.1	55.2	9.9	11.6	41.1	41.1	12.9	14.5	22.6	16.3	16.2	12.0	15.6	11.9	13.5	13.3	43.8	32.2	40.2	28.1	23.1	11.8	9.4	48.3	28.7	14.4	11.8	36.2	15.0	19.7	40.6	20.6	13.7	15.5	19.2	18.8	64.8	12.6	15.6	14.3	32.5	11.2	12.7	19.0	27.2	7.6	22.0	15.1	11.8	9.9	16.4	1.5	0.8	3.5	3.0	1.5	3.1	0.8	20.7	14.1	29.1	13.2	18.1	10.0	46.3	21.0	8.4	10.2	8.0	31.3	10.1	18.6	23.9	13.0	12.2	11.2	13.4	16.6	17.6	18.3	9.7	20.1	8.3	18.3	14.4	21.5	12.5	10.0	11.4	11.8	9.4	10.7	6.7	15.8	20.0	11.3	9.8	31.4	24.3	8.9	20.0	13.7	14.5	22.5	17.1	7.7	8.8	22.7	19.9	15.9	18.8	7.6	16.0	15.7	22.5	10.1	12.2	20.1	25.3	13.3	15.4	21.2	25.7	22.7	10.3	17.3	14.0	3.5	1.1	2.0	2.6	0.6	2.9	1.3	2.1	2.3	0.5	1.5	2.2	3.1	1.7	1.5	3.0	0.8	1.4	0.8	38.6	55.2	41.1	41.1	32.2	40.2	48.3	28.7	40.6	27.2	11.9	49.9	27.4	30.9	43.6	58.8	158.5	38.2	14.7	29.6	57.6	37.3	88.3	26.6	31.4	366.0	29.3	47.1	23.3	27.0	62.0	29.2	30.1	22.0	85.9	36.0	66.7	64.5	22.1	21.7	723.4	27.3	23.1	62.4	27.1	52.5	69.7	32.5	40.3	25.1	66.7	36.2	25.8	38.5	40.0	41.2	40.3	50.2	19.2	44.1	28.3
DYRK3	"hYAK3-2, RED, REDK"	ENSG00000143479	"Dual specificity tyrosine phosphorylation regulated kinase 3"	O43781	1	206635536-206684419	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.1"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA075041			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA075041: AB_2686730"	"unprognostic (6.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.38e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.62e-3)"	7.1	2.7	4.2	4.2	3.5	6.2	7.7	1.3	2.7	5.6	2.7	2.6	3.7	1.2	7.6	5.1	2.7	6.2	12.8	16.3	6.0	3.4	3.4	7.4	5.0	1.6	2.6	2.0	7.6	5.2	2.8	11.2	1.2	4.6	4.5	1.5	4.1	5.5	3.0	2.1	2.0	2.1	7.5	2.7	1.8	3.7	38.2	3.1	5.1	11.9	3.0	1.7	5.4	7.6	0.0	6.1	0.0	0.1	0.0	0.3	0.0	2.5	3.5	0.8	4.9	8.7	7.8	0.1	8.2	18.1	7.5	9.7	0.2	1.3	3.7	1.2	9.6	13.2	0.7	4.2	6.6	8.0	0.0	2.8	5.4	4.4	0.8	13.8	3.7	3.5	5.5	4.3	12.9	35.7	7.7	5.8	5.7	10.4	0.7	11.5	0.9	8.2	2.1	6.9	0.2	6.5	20.4	2.6	0.0	2.4	0.1	5.0	3.7	7.3	0.3	10.0	1.0	0.9	0.9	4.3	15.7	5.9	7.6	6.8	2.9	1.1	4.4	9.3	4.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	4.2	3.5	1.3	2.7	6.0	3.4	2.6	2.0	4.6	3.1	3.0	5.1	0.5	10.3	5.8	0.1	10.3	2.5	13.4	5.7	1.8	9.8	0.0	0.0	3.0	160.9	4.2	0.0	0.0	1.9	0.1	7.3	3.2	0.0	1.1	0.9	0.0	2.4	2.5	1.5	27.7	3.7	1.9	8.5	1.8	0.3	3.0	1.4	0.0	1.8	1.0	7.4	6.5	10.3	17.6	3.4	3.1	0.3	0.0	0.2	3.5
EDNRA		ENSG00000151617	"Endothelin receptor type A"	P25101	4	147480917-147544954	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 62.6;seminal vesicle: 52.3"	"Cell type enhanced"	"Detected in some"	14	"Leydig cells: 40.6;Peritubular cells: 64.0;Sertoli cells: 51.8;Smooth muscle cells: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.3;ASC TERT1: 14.5;HHSteC: 7.4;LHCN-M2: 17.2;SH-SY5Y: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013774, CAB018957"	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"CAB018957: AB_2039838, HPA013774: AB_1847994"	"unprognostic (3.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (1.50e-7)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (6.20e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	7.6	2.6	1.3	1.4	1.8	0.0	7.2	0.6	2.4	62.6	2.6	1.0	21.7	1.5	37.3	14.2	4.7	13.3	7.3	15.1	1.3	1.3	3.1	1.4	12.7	2.0	1.8	1.0	23.5	0.9	1.9	2.2	5.9	2.7	21.5	1.5	10.3	4.1	52.3	4.8	3.2	1.8	19.4	1.6	11.5	4.4	9.1	1.4	2.9	5.0	6.0	2.6	14.7	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	4.2	0.0	7.3	14.5	0.0	2.2	2.9	0.4	0.1	0.2	0.0	0.0	0.0	0.7	0.5	0.0	0.3	0.6	0.2	0.0	1.5	0.0	2.5	0.0	7.4	0.0	0.0	5.6	0.5	0.4	0.0	2.7	0.0	0.0	0.0	1.1	17.2	0.2	0.0	0.1	1.2	0.0	0.9	0.0	0.7	0.1	1.1	0.8	0.0	13.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.9	0.6	0.0	0.0	1.1	0.3	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.8	0.6	2.4	1.3	1.3	1.8	1.0	2.7	1.4	3.0	4.0	0.0	0.6	2.7	0.0	17.1	0.0	0.0	7.9	0.0	0.0	0.2	0.0	0.0	2.0	2.7	0.0	0.0	0.0	0.1	11.8	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.1	40.6	0.3	3.3	0.0	0.0	0.0	0.2	0.0	64.0	0.0	0.0	51.8	84.6	0.6	0.6	2.4	0.1	0.0	0.0	0.2
EDNRB	"ETB, HSCR, HSCR2"	ENSG00000136160	"Endothelin receptor type B"	P24530	13	77895481-77975529	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Deafness, Disease mutation, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 67.5"	"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 97.7;Ito cells: 106.8;Melanocytes: 104.6;Muller glia cells: 142.7;Sertoli cells: 213.4;Smooth muscle cells: 110.2"	"Group enriched"	"Detected in all"	7	"glioma: 41.1;melanoma: 127.7;renal cancer: 28.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"classical monocyte: 2.0;intermediate monocyte: 2.1"	"Lineage enriched"	"Detected in single"	21	"monocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"AF22: 25.2;ASC diff: 19.2;SK-MEL-30: 23.1;U-266/70: 15.1;WM-115: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017842, HPA027546"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"CAB017842: , HPA027546: AB_2672327"	"unprognostic (7.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.59e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (4.17e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.01e-2)"	"prognostic favorable (7.20e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.77e-3)"	25.4	23.2	22.2	10.3	29.8	0.8	23.1	10.3	30.7	8.1	7.2	13.6	2.3	10.9	7.7	3.6	4.9	6.0	8.5	23.7	16.7	16.4	22.3	26.5	28.4	15.6	24.2	8.1	4.9	6.4	7.7	6.3	67.5	33.2	14.9	7.7	51.0	13.4	4.4	6.7	5.1	11.9	7.4	33.4	16.0	5.8	3.1	12.4	0.0	17.6	2.0	2.9	10.9	8.2	0.0	0.0	0.0	2.1	0.0	0.0	0.4	2.0	0.0	25.2	0.0	19.2	0.7	0.3	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.3	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	23.1	3.4	0.0	0.1	0.1	0.2	0.0	0.0	0.1	15.1	8.5	0.0	0.4	0.0	48.1	0.0	2.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22.2	29.8	10.3	11.9	16.7	16.4	24.2	8.1	33.2	12.4	11.9	38.2	0.0	1.0	13.2	3.2	7.3	0.0	2.7	4.5	0.0	5.9	14.3	0.0	0.0	2.4	97.7	0.0	0.0	0.0	10.2	27.8	2.5	5.8	0.5	10.9	0.0	0.0	106.8	21.3	1.8	73.9	9.2	104.6	0.0	0.0	142.7	0.1	0.0	2.5	0.0	3.4	213.4	110.2	0.3	1.4	6.4	4.8	0.0	0.0	1.4
EEF1AKMT4		ENSG00000284753	"EEF1A lysine methyltransferase 4"	O60344	3	184249650-184259585	"Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 29.5"	"Group enriched"	"Detected in some"	4	"Club cells: 5.7;Collecting duct cells: 7.0;Distal tubular cells: 13.3;Ductal cells: 14.2;Exocrine glandular cells: 13.1;Pancreatic endocrine cells: 10.0;Proximal tubular cells: 17.7"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA062215			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA062215: AB_2684714"																		2.1	1.7	0.2	3.3	0.8	1.8	1.9	0.3	0.5	1.3	4.2	0.0	2.5	2.5	0.6	0.5	4.1	0.4	1.4	2.4	0.4		4.2	29.5	2.3	2.5	0.2	0.0	1.7	8.3	1.0	3.1	8.4	0.8	1.6	2.3	0.8	5.7	2.7	5.4	2.4	4.3	1.1	0.1	3.7	1.6	13.0	0.6	4.8	6.9	4.5	3.7	1.3	1.6	4.9	10.1	1.2	12.0	3.4	7.6	5.6	13.1	6.9	1.6	4.4	2.4	1.6	10.1	1.5	2.9	2.3	2.2	12.9	2.0	15.6	10.3	1.7	12.2	4.9	7.4	7.5	1.3	6.1	8.7	4.1	4.4	8.2	2.9	10.8	3.5	2.0	9.1	2.6	4.5	1.0	1.9	5.2	7.4	14.5	1.1	20.6	4.4	13.1	3.3	17.2	13.1	9.2	2.2	12.6	2.7	3.2	8.0	2.7	3.0	23.7	5.8	2.4	19.9	5.0	1.4	2.6	3.5	6.1	7.6	8.7	17.5	15.4	2.1	17.9	2.7	0.0	12.0	1.2	4.3	9.7	4.8	4.9	4.6	4.2	10.1	3.2	3.3	5.2	0.2	3.4	6.2	9.0	7.6	5.6											0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	5.7	7.0	0.0	0.0	13.3	14.2	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.8	0.0	0.0	10.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EEF1AKMT4-ECE2		ENSG00000284917	"EEF1AKMT4-ECE2 readthrough"	O60344	3	184249695-184293031	"Predicted membrane proteins"		"Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 22.6"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"REH: 5.1"									HPA062215			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA062215: AB_2684714"																		1.2	6.6	0.0	2.1	0.1	0.3	0.3	0.0	1.5	0.6	2.9	0.0	1.5	0.9	0.3	0.3	2.8	0.5	0.6	2.1	0.0		2.8	22.6	1.3	1.5	0.0	0.0	0.9	6.0	1.5	2.0	6.1	0.2	1.4	0.6	0.2	4.0	1.6	3.8	0.3	2.9	0.4	0.0	2.4	0.3	9.7	0.0	3.3	4.9	3.1	2.5	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EFS	"CASS3, EFS1, EFS2, HEFS, SIN"	ENSG00000100842	"Embryonal Fyn-associated substrate"	O43281	14	23356402-23365752	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 18.7;Syncytiotrophoblasts: 15.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 28.2;AN3-CA: 15.4;BEWO: 23.7;SH-SY5Y: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001581, HPA001790"	Approved		Uncertain	Nucleoplasm,Cytosol		No	NA			Nucleoplasm	Cytosol	"HPA001581: AB_2666367, HPA001790: "	"unprognostic (9.58e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.09e-5)"	"unprognostic (3.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	12.0	10.2	11.7	4.4	15.7	0.6	13.1	9.4	21.2	17.9	8.5	29.4	8.0	2.8	17.0	9.8	18.3	10.0	6.7	5.5	14.3	8.3	3.2	1.2	5.7	2.8	14.9	8.2	23.7	1.5	25.0	3.2	33.1	15.6	17.9	3.1	8.3	15.6	18.6	3.8	42.3	3.9	13.0	25.7	4.5	4.7	4.4	16.0	0.4	6.8	15.5	10.0	11.8	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	28.2	15.4	7.1	8.2	23.7	2.1	4.3	0.7	0.3	0.0	0.0	0.0	0.0	11.6	0.1	10.8	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	4.6	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	9.0	0.0	0.0	9.0	3.1	27.0	6.0	0.9	0.0	3.6	6.7	0.0	0.0	3.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	15.7	9.4	11.8	14.3	8.3	14.9	8.2	15.6	16.0	0.0	4.1	0.0	7.2	10.3	2.7	0.6	0.0	1.4	4.5	0.0	5.9	8.0	1.7	0.0	0.7	1.4	0.0	0.0	0.0	12.8	13.0	6.3	0.0	0.0	1.3	0.0	0.0	3.1	0.0	0.4	18.7	0.0	6.8	0.0	0.0	8.0	0.0	0.0	13.1	0.1	8.1	6.5	5.1	0.5	0.4	11.7	15.1	0.0	0.0	4.7
ELL	"C19orf17, ELL1, Men, PPP1R68"	ENSG00000105656	"Elongation factor for RNA polymerase II"	P55199	19	18442663-18522127	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 301.9;Late spermatids: 183.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004202, HPA046076"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA004202: , HPA046076: AB_2679526"	"unprognostic (9.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	19.9	7.7	5.1	13.4	9.9	38.4	10.8	17.0	9.7	11.9	13.5	7.7	8.6	10.4	12.6	9.5	9.3	9.1	10.9	9.5	5.8	4.4	9.8	11.6	14.2	10.7	6.2	3.5	12.7	14.6	6.2	10.5	27.0	6.3	10.4	4.4	9.1	10.6	9.0	20.3	13.3	10.9	10.0	5.1	15.9	9.3	31.7	7.7	11.0	7.8	7.2	13.6	18.5	13.2	3.1	8.6	17.2	5.6	2.1	7.9	3.3	8.9	4.4	2.3	4.9	2.5	3.2	17.0	7.1	6.3	5.4	5.2	5.0	7.1	11.3	8.8	4.7	3.7	6.3	3.4	7.8	2.7	9.2	8.0	6.8	4.4	4.3	3.8	7.4	8.7	6.5	6.7	7.0	5.5	4.2	3.8	6.2	9.4	15.6	2.8	7.6	8.7	8.1	7.7	5.4	12.6	7.5	3.7	11.9	3.8	6.3	4.2	4.6	5.2	9.0	7.7	3.1	4.5	9.3	6.3	6.3	4.9	8.6	6.6	25.5	16.0	8.4	8.3	12.6	8.9	0.3	5.6	3.8	4.7	4.1	7.9	3.1	2.9	4.2	4.7	2.3	1.9	2.9	17.2	2.1	2.1	8.6	3.0	3.3	5.1	9.9	17.0	9.7	5.8	4.4	6.2	3.5	6.3	7.7	6.0	6.7	6.0	22.3	24.8	4.1	4.0	10.2	6.7	3.4	3.5	3.9	37.4	10.0	7.0	301.9	11.7	10.5	0.0	7.0	14.6	16.0	13.8	10.5	13.4	16.6	1.6	18.9	8.6	11.5	183.8	6.1	13.8	6.8	11.8	9.0	4.2	8.8	2.9	2.8	5.7	3.5	19.4	28.8	19.0	21.8	26.6	57.4	11.4	6.4	18.6
ELMOD1	DKFZp547C176	ENSG00000110675	"ELMO domain containing 1"	Q8N336	11	107591091-107666779	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 51.1;pituitary gland: 20.8;skin 1: 34.7"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 30.4;Cone photoreceptor cells: 15.7;Horizontal cells: 35.0;Late spermatids: 14.0;Rod photoreceptor cells: 17.8"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 11.9;RH-30: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038435, HPA066479"			Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038435: AB_10795575, HPA066479: "	"unprognostic (2.74e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.13e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.39e-1)"	1.5	4.2	10.7	1.5	41.1	1.3	4.1	12.8	51.1	1.5	1.4	1.7	0.0	1.4	1.6	1.3	1.2	3.6	1.2	4.8	13.8	14.3	4.7	1.3	1.6	1.3	8.7	15.2	1.2	1.2	1.2	20.8	1.2	14.8	2.1	1.3	1.4	1.3	1.2	2.8	34.7	1.3	1.4	6.6	1.2	1.2	2.9	3.9	0.0	1.3	0.0	1.2	1.1	0.1	0.9	0.7	2.4	0.9	1.8	0.5	0.2	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.2	3.5	0.4	2.2	0.3	0.4	0.0	1.8	0.1	0.0	0.1	1.2	0.1	0.0	0.4	0.1	0.0	0.0	0.1	11.9	1.5	0.0	0.1	0.8	0.1	0.0	0.1	0.5	0.0	1.8	0.0	27.1	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.3	1.3	0.0	0.7	0.1	0.0	0.0	3.6	0.0	2.1	1.6	0.9	0.6	0.4	0.6	0.4	0.5	0.5	0.2	0.2	0.9	0.4	0.5	2.4	1.8	0.6	0.7	0.4	0.2	10.7	41.1	12.8	26.9	13.8	14.3	8.7	15.2	14.8	3.9	0.0	3.8	0.0	0.4	0.0	30.4	3.6	0.0	8.1	2.3	0.0	15.7	0.1	0.0	0.0	8.5	0.7	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.8	0.1	35.0	0.0	0.6	0.3	14.0	0.3	1.4	0.0	0.0	0.0	6.5	0.0	0.0	0.4	3.6	17.8	0.0	0.5	0.9	0.4	2.8	0.0	0.0	0.0	0.3
ELOA	"SIII, TCEB3, TCEB3A"	ENSG00000011007	"Elongin A"	Q14241	1	23743155-23762059	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 68.1;monocytes: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005910	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA005910: AB_1080227"	"unprognostic (6.90e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.72e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	25.6	13.7	10.0	14.2	16.1	22.9	16.3	16.0	17.2	13.7	12.2	15.2	15.1	9.8	15.0	9.0	23.6	13.3	15.7	12.9	9.9	9.8	18.1	41.7	20.3	24.1	10.3	12.5	16.0	41.5	19.1	17.1	19.6	12.7	13.6	13.5	13.0	18.6	13.4	26.0	18.3	14.1	14.0	10.9	20.5	24.6	14.4	10.0	19.3	18.4	22.4	21.8	15.6	14.5	20.7	18.8	18.3	20.9	11.0	14.8	13.2	20.3	11.4	16.5	14.1	19.5	12.2	10.4	21.1	19.1	31.5	27.6	13.9	17.9	10.7	26.0	21.4	17.7	19.6	33.8	22.2	35.3	30.6	16.7	24.1	17.8	16.2	17.3	25.2	14.6	12.9	18.0	34.3	26.3	11.7	18.8	17.7	35.6	18.6	25.1	15.4	13.0	10.3	19.1	22.9	17.3	19.6	21.0	20.3	14.8	13.9	31.5	17.7	19.2	19.4	23.4	19.2	14.0	9.3	19.9	24.8	21.9	43.9	24.8	19.3	21.5	23.6	21.7	25.2	24.7	18.3	19.8	15.4	14.8	20.9	14.6	20.7	12.4	13.3	18.8	16.6	10.2	13.4	5.5	11.0	18.4	15.5	14.0	13.2	10.0	16.1	16.0	17.2	9.9	9.8	10.3	12.5	12.7	10.0	26.8	68.1	0.0	0.0	0.0	0.0	0.0	0.0	30.8	33.0	17.4	0.0	23.2	5.0	34.1	0.0	0.0	0.0	0.0	28.4	28.4	0.0	0.0	12.8	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	61.3	0.0	0.0	32.3	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	34.6	0.0	0.0	0.0
EME1	"FLJ31364, MMS4L, SLX2A"	ENSG00000154920	"Essential meiotic structure-specific endonuclease 1"	Q96AY2	17	50373220-50381483	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 15.3;epididymis: 10.6;testis: 21.9"	"Cell type enhanced"	"Detected in some"	13	"Extravillous trophoblasts: 4.0;Spermatocytes: 10.5;Spermatogonia: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	29	"basophil: 15.3"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 15.3"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016127, HPA052188"	Supported		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"		"CAB016127: AB_2278026, HPA052188: "	"unprognostic (3.81e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.94e-5)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.83e-3)"	"unprognostic (0.00e+0)"	"unprognostic (9.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.41e-1)"	1.0	0.9	1.6	2.5	2.0	6.0	0.8	0.8	1.8	1.3	1.9	3.0	0.0	1.1	0.9	10.6	2.6	0.7	1.6	0.7	0.9	0.6	0.7	0.8	1.1	3.3	1.4	0.9	1.3	0.6	0.2	0.5	2.4	1.5	0.7	2.0	1.0	1.6	0.1	1.4	1.5	2.1	0.8	1.9	2.2	1.1	21.9	2.8	5.7	0.5	0.9	3.9	1.0	1.2	0.1	0.5	15.3	0.0	0.0	0.1	0.2	7.4	11.0	14.7	7.7	0.7	1.5	10.6	7.8	3.0	10.9	10.1	17.3	6.1	6.0	10.4	3.1	6.8	5.9	13.6	6.2	15.6	11.7	10.7	14.3	12.7	8.0	0.0	5.8	4.7	0.3	0.4	12.6	5.2	1.4	2.5	17.3	8.6	14.4	6.4	8.2	13.3	7.5	8.5	7.7	7.6	13.8	28.5	8.3	2.4	3.0	5.7	11.4	4.8	2.6	4.5	12.3	9.4	6.7	1.7	14.2	8.5	9.3	10.7	9.0	9.1	5.8	4.5	6.6	8.7	15.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.2	1.6	2.0	0.8	1.8	0.9	0.6	1.4	0.9	1.5	2.8	0.0	1.4	0.0	0.2	0.1	1.5	0.4	0.0	1.4	1.2	0.0	0.0	1.9	0.0	0.2	0.4	0.0	0.0	0.0	0.0	4.0	0.5	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.6	0.7	0.0	1.8	0.4	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.4	10.5	8.0	0.1	0.9	0.0	0.6	0.1
EPB42	"MGC116735, MGC116737, PA"	ENSG00000166947	"Erythrocyte membrane protein band 4.2"	P16452	15	43197227-43221125	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape, Erythrocyte maturation"		"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 54.8;placenta: 16.1"	"Cell type enriched"	"Detected in many"	15	"Erythroid cells: 186.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	92	"HEL: 43.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040261	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA		7500000	"Nucleoplasm, Cytosol"		"HPA040261: AB_10673441"	"unprognostic (8.45e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.47e-3)"	7.5	0.4	0.4	0.4	0.9	54.8	1.3	4.3	1.0	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.4	0.5	0.6	1.9	0.4	0.9	0.5	0.9	5.5	0.3	0.5	0.3	0.8	0.3	0.3	0.3	16.1	0.7	0.5	0.3	0.3	0.3	0.3	1.3	1.1	1.0	0.3	0.3	5.3	0.5	2.4	0.3	0.5	1.2	0.3	0.5	1.6	4.5	0.0	0.3	0.2	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	4.2	0.4	0.9	4.3	1.0	0.4	0.9	0.5	0.3	0.7	0.3	0.0	0.0	0.5	1.2	1.6	3.7	0.3	2.5	0.0	0.0	0.0	5.9	3.3	0.0	0.0	7.7	0.6	1.1	186.9	0.0	1.9	1.7	1.0	4.6	0.5	1.0	6.4	0.0	1.3	0.3	8.0	2.6	0.8	1.7	0.0	0.8	2.8	0.0	1.7	0.7	0.0	7.8	6.5	1.2	12.1	3.8	2.5	5.6	4.4	0.6	1.6
ERCC6L	"FLJ20105, PICH, RAD26L"	ENSG00000186871	"ERCC excision repair 6 like, spindle assembly checkpoint helicase"	Q2NKX8	X	72204657-72239047	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1"	"Cell type enhanced"	"Detected in some"	11	"Cholangiocytes: 2.5;Extravillous trophoblasts: 1.5;Spermatocytes: 1.7;Spermatogonia: 2.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 5.3"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 5.3"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050492	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol		No	No			Centrosome	"Nucleoplasm, Cytosol"	"HPA050492: AB_2681145"	"prognostic unfavorable (1.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.23e-6)"	"unprognostic (8.63e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.68e-5)"	"unprognostic (4.61e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	0.4	0.5	0.2	3.1	0.2	6.0	3.0	0.9	0.8	1.5	2.2	0.2	0.2	1.5	0.9	0.8	4.6	0.6	1.0	0.2	0.2	0.3	0.5	0.5	0.8	4.7	0.7	0.2	1.2	0.5	0.0	0.6	0.9	0.9	0.7	2.5	0.2	1.1	0.2	2.6	1.3	2.1	0.5	1.3	4.0	1.5	2.0	0.2	13.1	0.5	2.8	5.6	0.7	1.6	0.5	0.3	0.5	0.2	5.3	1.1	0.4	11.0	9.7	8.9	5.6	0.6	1.1	4.9	11.9	5.5	10.4	11.0	7.9	6.9	17.9	4.5	4.2	14.1	9.2	16.8	8.8	18.6	10.2	12.2	6.2	3.4	4.6	0.0	12.0	8.7	0.1	0.5	14.5	2.7	1.7	5.8	9.1	8.1	4.4	10.6	8.7	11.4	7.0	16.2	10.8	15.0	9.6	16.0	3.2	2.6	6.9	7.4	5.3	8.8	5.9	2.2	7.6	4.5	2.7	3.5	7.1	11.4	13.3	7.7	3.5	5.3	15.5	5.0	8.3	7.0	0.0	0.2	0.5	0.1	0.1	0.6	0.2	0.5	0.1	0.1	0.5	0.4	1.1	0.3	5.3	0.2	0.3	1.1	0.4	0.2	0.2	0.9	0.8	0.2	0.3	0.7	0.2	0.9	0.2	0.0	0.0	0.8	0.2	0.2	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.0	0.1	0.3	0.0	0.1	0.1
ESYT2	"CHR2SYT, FAM62B, KIAA1228"	ENSG00000117868	"Extended synaptotagmin 2"	A0FGR8	7	158730995-158830253	"Plasma proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002132	Approved		Uncertain	Cytosol		NA	NA		130000	Cytosol		"HPA002132: AB_1078807"	"unprognostic (2.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.13e-1)"	"unprognostic (7.54e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (2.81e-5)"	33.3	25.6	15.3	16.2	23.5	19.6	27.3	21.7	26.3	26.7	27.9	17.8	21.6	15.8	31.2	31.0	32.5	28.3	31.1	28.4	16.1	17.5	20.6	16.7	26.1	18.0	15.6	16.7	41.6	23.2	29.7	22.0	35.2	20.6	21.1	22.6	23.4	26.7	31.4	34.5	24.5	22.5	37.8	14.9	13.2	19.4	13.3	12.1	29.0	30.5	24.3	23.2	30.5	27.6	1.4	3.6	2.0	2.3	6.6	8.5	2.9	29.6	17.8	5.7	6.0	19.2	22.3	19.0	14.0	14.3	11.2	12.6	9.9	39.0	9.1	16.2	25.1	23.1	14.8	8.2	14.7	10.8	9.4	8.4	7.5	14.2	10.5	19.6	26.9	17.2	16.1	18.3	12.6	16.9	22.5	13.2	24.8	16.1	30.8	18.2	24.9	27.9	19.5	9.1	20.0	17.2	23.8	11.0	11.2	19.0	12.7	16.7	9.2	44.6	36.1	20.3	13.9	13.1	29.5	20.4	12.4	6.5	54.7	17.8	21.1	5.4	8.9	30.7	28.0	36.5	2.0	1.9	1.5	8.5	2.3	4.7	1.4	7.1	6.0	3.6	1.0	6.7	7.9	1.2	6.6	1.5	2.4	5.8	2.9	15.3	23.5	21.7	26.3	16.1	17.5	15.6	16.7	20.6	12.1	35.7	32.5	9.0	10.9	41.0	15.1	25.8	22.9	36.1	33.0	45.4	15.7	24.1	3.3	13.5	11.2	41.4	27.1	23.3	17.1	22.4	41.1	18.3	11.6	17.4	18.3	12.7	20.3	25.2	23.8	3.0	32.5	22.6	49.0	10.8	29.5	15.2	24.1	5.8	51.2	8.2	10.6	32.3	52.8	10.9	10.0	45.2	34.1	25.9	22.5	21.4
ETAA1	ETAA16	ENSG00000143971	"ETAA1, ATR kinase activator"	Q9NY74	2	67397319-67412089	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035048, HPA035049"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035048: AB_10670300, HPA035049: AB_2674430"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.14e-2)"	9.3	23.4	6.4	11.0	11.3	6.6	14.7	14.0	10.6	15.4	11.7	6.3	9.4	7.2	14.6	13.9	12.0	13.9	15.7	9.4	8.7	5.5	17.5	11.1	11.3	14.8	9.7	10.4	15.6	16.2	14.2	13.9	8.8	10.7	11.6	9.2	6.1	12.4	13.7	11.4	12.4	11.1	10.6	8.5	11.8	10.5	11.3	10.3	19.2	15.9	9.7	9.8	11.6	12.7	7.5	4.4	3.4	5.2	4.2	7.4	3.1	9.1	7.0	12.0	10.8	9.4	13.0	9.8	9.8	13.0	10.4	10.1	5.6	11.1	17.1	5.4	8.0	14.7	11.2	10.1	11.8	15.0	10.0	8.1	9.5	17.0	8.2	8.9	9.4	9.0	10.2	16.9	7.7	12.1	16.6	16.5	14.0	7.7	7.4	14.3	4.1	13.9	10.4	12.2	14.7	7.7	10.1	19.1	7.9	12.7	6.0	10.1	20.1	9.9	9.1	9.3	12.3	7.9	4.6	11.4	14.2	10.9	6.7	11.4	8.3	7.4	13.8	13.2	10.0	10.7	3.4	2.5	2.0	5.5	4.1	6.0	7.5	5.1	3.2	3.1	7.0	7.0	6.2	0.2	4.2	5.2	4.4	7.4	3.1	6.4	11.3	14.0	10.6	8.7	5.5	9.7	10.4	10.7	10.3	20.8	16.0	0.0	6.9	2.2	4.8	8.5	17.8	22.7	10.3	12.2	0.0	5.7	10.0	15.6	0.3	3.1	4.2	0.0	15.9	5.0	7.6	6.2	5.8	8.2	4.1	4.8	10.3	7.4	5.1	1.5	11.2	6.7	1.7	9.0	6.1	5.2	16.4	3.5	12.4	10.0	4.3	0.0	3.1	11.4	7.8	2.3	1.7	5.0	6.0	4.7
ETS2		ENSG00000157557	"ETS proto-oncogene 2, transcription factor"	P15036	21	38805307-38824955	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 580.2;Suprabasal keratinocytes: 425.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 16.5;granulocytes: 18.5;monocytes: 14.9"	"Cell line enhanced"	"Detected in many"		"HEL: 60.5;hTCEpi: 55.4;hTERT-HME1: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003176			Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003176: AB_2666824"	"unprognostic (2.06e-1)"	"unprognostic (5.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.10e-2)"	33.6	10.4	25.8	29.6	12.8	44.7	28.5	5.5	36.5	28.4	38.1	7.3	13.7	39.7	27.0	20.3	30.1	21.8	42.6	42.9	16.2	10.8	21.2	75.5	58.3	56.9	13.8	18.2	23.6	11.7	20.0	19.7	23.2	14.2	31.4	50.6	12.9	17.6	17.4	64.2	72.4	59.0	43.3	13.6	68.7	25.8	8.3	11.0	7.2	21.5	28.4	13.7	40.8	35.5	0.2	16.5	18.5	14.9	0.1	2.5	3.6	23.4	5.0	3.5	1.1	4.0	13.6	9.4	5.5	32.0	7.3	9.7	4.4	6.7	5.1	2.7	4.9	10.7	7.0	5.9	14.7	14.0	4.7	2.3	60.5	30.4	11.0	41.2	3.7	5.9	8.0	55.4	10.3	45.2	4.7	5.8	3.4	6.2	0.0	3.2	3.4	11.2	4.0	11.3	7.8	3.3	36.8	2.2	4.7	10.3	15.2	2.7	3.6	15.6	6.4	1.2	1.3	0.3	6.9	6.2	17.6	2.5	11.2	12.0	0.1	0.0	5.1	4.2	12.5	14.6	10.1	9.2	3.3	1.7	12.3	2.0	0.2	1.6	2.5	16.5	0.2	1.6	1.6	18.5	0.1	14.9	4.0	0.1	3.6	25.8	12.8	5.5	36.5	16.2	10.8	13.8	18.2	14.2	11.0	47.6	133.7	24.2	580.2	379.6	2.1	25.0	45.9	141.8	183.1	48.8	0.0	42.0	10.0	60.7	3.0	196.3	148.0	23.3	94.2	94.1	55.2	133.5	49.7	211.1	50.3	0.0	88.0	256.6	144.5	1.7	16.7	174.6	64.1	29.7	182.6	1.0	94.1	98.2	23.3	27.9	1.1	51.8	93.5	0.6	2.9	425.2	148.5	18.1	194.6	292.4
EXOC4	"KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p"	ENSG00000131558	"Exocyst complex component 4"	Q96A65	7	133253073-134066589	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Rod photoreceptor cells: 229.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031443, HPA031444"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA031443: AB_10602496, HPA031444: AB_2673886"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (9.78e-3)"	"prognostic favorable (6.85e-5)"	"unprognostic (5.91e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.35e-2)"	21.2	23.7	18.5	17.7	22.3	10.5	19.4	25.7	24.4	20.8	17.0	19.7	22.2	11.2	25.8	20.6	21.5	24.2	16.8	16.5	14.7	15.4	15.6	15.2	16.5	12.6	14.2	19.3	27.7	26.5	28.5	31.2	16.4	22.0	16.9	18.8	19.3	20.5	18.8	50.7	24.4	13.7	20.8	18.7	17.9	16.3	17.2	17.3	34.7	22.9	18.3	22.1	26.3	20.6	8.3	16.3	8.1	12.7	18.4	12.4	10.4	17.8	14.7	20.4	20.1	23.9	25.0	7.1	13.1	21.9	11.9	15.7	8.5	25.2	13.4	9.5	24.6	17.5	11.4	10.9	17.9	19.8	20.4	13.1	10.8	15.5	8.9	26.3	14.2	11.8	24.3	22.4	17.0	31.5	26.4	20.3	17.8	15.5	13.4	22.1	11.7	25.8	15.7	15.3	21.5	13.8	11.5	18.1	24.1	19.2	16.0	15.9	25.1	19.7	18.2	21.1	24.0	12.0	13.4	22.0	13.3	7.0	14.0	14.3	21.3	13.0	13.0	39.3	16.7	20.2	8.1	12.0	6.9	11.8	12.7	10.5	8.3	12.3	12.4	16.3	8.0	10.1	10.4	4.0	18.4	10.5	7.3	12.4	10.4	18.5	22.3	25.7	24.4	14.7	15.4	14.2	19.3	22.0	17.3	20.8	21.1	11.9	14.2	16.8	35.3	24.9	7.6	18.7	15.9	14.0	88.4	13.6	3.3	12.9	23.1	21.5	15.8	0.0	15.7	13.8	11.9	17.0	8.1	14.4	15.6	47.7	16.7	24.5	30.4	20.6	16.1	18.0	13.5	12.6	21.4	20.6	13.9	17.5	17.7	13.3	229.7	12.9	10.8	18.1	12.6	14.9	9.4	20.8	18.4	16.9
FAAP100	"C17orf70, FLJ22175"	ENSG00000185504	"Fanconi anemia core complex associated protein 100"	Q0VG06	17	81539885-81553961	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023954, HPA024626, HPA026532"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023954: AB_1845601, HPA024626: AB_1845602, HPA026532: AB_1845603"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.87e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (1.00e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.24e-1)"	11.4	10.0	7.7	21.1	8.6	9.8	13.4	33.2	10.9	9.0	12.2	13.4	9.6	13.0	11.1	13.6	11.7	11.0	22.6	9.0	6.9	7.1	11.7	19.3	9.6	20.0	8.4	7.6	12.7	20.1	9.7	14.1	9.6	6.9	12.5	5.5	12.8	15.9	11.9	9.4	16.8	14.0	14.0	7.0	23.8	11.1	11.3	5.9	16.7	15.1	14.5	15.5	9.9	9.2	6.1	6.5	2.3	6.1	4.7	5.3	3.6	7.7	14.1	6.4	17.9	7.6	8.0	9.8	7.9	3.7	9.4	5.8	9.1	9.4	13.8	6.4	10.0	9.4	10.0	3.2	9.4	2.2	3.9	10.3	9.4	14.0	12.4	7.9	10.1	11.1	9.6	7.1	6.9	8.0	12.1	17.9	14.4	13.6	11.2	4.7	14.8	15.6	16.4	7.5	8.9	6.1	14.1	6.5	12.4	7.0	13.7	14.0	11.6	5.7	16.3	6.7	6.9	17.7	13.4	15.1	20.6	13.2	5.4	12.7	13.0	1.0	6.5	5.6	6.4	9.5	0.0	6.1	2.3	5.3	5.6	4.1	6.1	3.4	3.6	5.9	4.7	3.2	2.5	0.9	4.7	2.8	6.5	3.6	3.6	7.7	8.6	33.2	10.9	6.9	7.1	8.4	7.6	6.9	5.9	3.0	9.8	8.8	3.2	0.0	9.8	7.1	10.2	2.7	4.5	14.0	3.9	5.1	3.3	7.3	1.5	5.2	6.4	0.0	6.0	3.9	7.2	4.7	0.0	10.0	7.3	6.4	7.0	8.6	16.4	2.2	4.6	4.7	0.0	4.6	9.1	6.0	7.5	3.5	4.9	5.6	4.5	0.0	4.7	7.4	6.7	0.0	2.6	5.0	8.1	3.2
FAM169A	"KIAA0888, SLAP75"	ENSG00000198780	"Family with sequence similarity 169 member A"	Q9Y6X4	5	74777574-74866951	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.8;epididymis: 23.6"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 120.0;Collecting duct cells: 47.1;Cone photoreceptor cells: 133.5;Horizontal cells: 81.0;Muller glia cells: 163.2;Rod photoreceptor cells: 163.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.8;Hep G2: 15.5;SuSa: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041574	Enhanced		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"HPA041574: AB_10794382"	"unprognostic (3.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.75e-4)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.02e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	0.7	4.2	9.9	1.4	13.5	1.5	1.1	11.0	21.8	1.7	1.9	5.2	2.9	0.7	3.8	23.6	0.9	3.8	3.0	2.2	9.4	14.2	6.7	3.1	0.8	2.5	9.6	10.3	3.4	2.0	10.7	8.3	1.2	10.4	6.4	3.0	11.3	1.9	7.0	0.8	0.7	1.0	1.0	11.1	2.5	2.1	15.5	4.6	3.7	9.6	0.0	2.5	4.1	1.1	1.4	0.5	0.0	0.0	0.8	4.0	1.2	5.1	4.6	3.3	4.4	0.0	0.0	22.8	0.7	1.7	3.5	3.5	2.1	3.4	0.0	2.3	0.0	9.4	3.7	6.8	10.3	3.6	3.8	7.8	1.4	0.8	15.5	0.1	0.0	0.0	0.1	10.9	0.8	5.1	0.5	0.0	5.0	0.0	0.0	2.0	1.5	4.9	0.0	8.2	1.4	2.5	7.1	2.1	0.3	3.2	8.2	2.0	2.7	8.6	3.9	0.6	15.6	3.7	1.0	0.0	0.2	3.3	0.0	3.7	12.6	11.7	0.0	0.4	0.0	0.4	0.0	0.0	0.0	2.7	0.0	4.0	0.8	1.6	2.5	0.0	1.4	3.5	3.4	0.0	0.8	0.0	0.5	0.9	1.2	9.9	13.5	11.0	17.1	9.4	14.2	9.6	10.3	10.4	4.6	0.0	0.0	0.9	4.9	0.2	120.0	1.2	0.0	2.7	3.4	47.1	133.5	4.4	3.3	1.6	12.3	0.6	1.3	0.0	0.0	0.4	0.4	6.7	1.1	2.9	0.4	81.0	3.4	0.0	0.6	22.2	4.6	0.0	1.7	1.0	1.2	163.2	2.0	0.0	3.9	2.0	163.5	0.0	0.3	18.9	10.7	0.1	0.2	5.1	0.6	3.4
FAM47E-STBD1		ENSG00000272414	"FAM47E-STBD1 readthrough"		4	76251721-76311129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"liver: 38.2;skeletal muscle: 41.3"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 1.7;Ciliated cells: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.1;Karpas-707: 23.8"									HPA053331	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA053331: AB_2682115"	"unprognostic (3.52e-3)"		"unprognostic (3.44e-1)"		"unprognostic (1.53e-1)"		"unprognostic (8.98e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.92e-6)"	"unprognostic (5.59e-2)"		"unprognostic (1.52e-1)"	"unprognostic (3.77e-1)"	17.4	2.3	7.8	1.6	8.0	4.0	7.6	1.9	13.9	2.5	8.2	8.6	4.1	2.1	3.0	7.3	3.5	5.0	4.2	16.5	9.4	3.9	4.2	38.2	7.5	0.6	5.4	14.6	2.6	4.6	2.8	9.2	9.4	11.4	6.3	9.0	2.5	5.0	5.0	41.3	1.6	10.7	6.5	9.6	1.6	3.7	6.1	5.8	0.0	8.1	1.3	0.9	4.9	2.5	0.2	1.0	2.2	1.5	3.4	1.6	0.4	2.0	2.4	1.0	2.1	17.1	5.8	2.2	3.4	7.1	2.9	3.0	4.0	2.2	0.0	2.1	8.1	7.9	1.1	3.5	1.4	2.7	2.6	0.5	0.8	4.8	5.7	1.8	1.7	2.4	2.5	9.0	2.8	3.6	11.1	0.3	0.0	0.2	23.8	7.0	3.7	0.0	1.8	1.0	13.2	1.6	0.0	0.5	1.5	3.3	6.0	1.0	4.2	1.5	4.7	0.1	2.2	0.9	1.0	0.9	1.5	0.7	3.8	2.9	5.7	2.6	0.0	4.2	1.8	1.3	0.0	0.5	2.2	1.1	1.5	0.6	0.2	1.1	1.2	0.9	0.1	0.9	1.3	1.3	3.4	0.1	1.0	1.6	0.4	7.8	8.0	1.9	13.9	9.4	3.9	5.4	14.6	11.4	5.8	6.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	6.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM71F1	"FAM137A, NYD-SP18"	ENSG00000135248	"Family with sequence similarity 71 member F1"	Q96KD3	7	128709061-128731743	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	146	"testis: 64.8"	"Group enriched"	"Detected in some"	103	"Early spermatids: 1001.4;Late spermatids: 1429.0"	"Cancer enriched"	"Detected in single"	23	"testis cancer: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"NTERA-2: 19.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020636			Uncertain	Cytosol		No	NA			Cytosol		"HPA020636: AB_1854739"	"unprognostic (3.09e-2)"	"unprognostic (3.39e-3)"		"unprognostic (6.03e-2)"	"unprognostic (5.25e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-5)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-6)"	"unprognostic (6.97e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.99e-1)"	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	64.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.3	1.5	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1001.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1429.0	11.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.3	0.0	1.8	0.0	0.0	11.7	5.5	0.1	1.0	0.0	0.0	0.0
FAN1	"KIAA1018, MTMR15"	ENSG00000198690	"FANCD2 and FANCI associated nuclease 1"	Q9Y2M0	15	30903852-30943108	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048198			Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		NA	NA			Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA048198: AB_2680311"	"unprognostic (7.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.67e-2)"	"prognostic favorable (1.42e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.29e-1)"	5.9	8.9	11.6	6.9	17.4	6.3	12.7	19.6	18.4	15.0	11.4	17.7	11.9	4.6	11.6	22.9	6.5	8.5	8.5	13.0	12.6	11.0	14.7	14.4	6.9	5.5	18.5	11.8	12.5	18.2	7.2	17.0	10.6	15.4	16.4	9.7	8.6	17.3	8.3	16.8	9.3	6.7	11.5	13.0	7.3	8.5	9.4	15.0	5.1	14.3	6.3	5.8	9.0	9.1	4.0	3.6	0.6	1.7	4.5	5.4	1.6	6.3	10.9	3.6	2.0	12.9	11.5	2.4	4.5	1.9	4.8	5.0	7.5	3.3	1.4	8.0	4.8	10.0	12.9	6.1	9.4	4.7	5.1	2.9	1.1	11.2	1.3	5.6	0.9	6.1	3.4	7.0	2.9	7.6	10.4	2.3	6.6	5.4	10.0	7.8	1.4	9.9	4.4	2.8	10.2	2.5	8.4	11.8	2.7	7.0	5.0	8.3	5.8	9.9	6.8	3.5	13.6	6.1	7.6	8.2	15.0	3.6	4.1	5.7	13.8	9.6	1.7	6.5	4.8	1.3	0.1	0.8	0.6	3.7	1.3	4.7	2.8	3.5	1.7	2.7	4.0	5.4	2.8	0.3	4.5	1.7	3.6	3.2	1.6	11.6	17.4	19.6	18.4	12.6	11.0	18.5	11.8	15.4	15.0	14.9	9.6	0.8	4.9	3.7	20.0	15.7	0.0	16.0	13.6	8.7	19.6	5.5	8.3	3.3	8.7	6.7	3.8	0.0	2.5	1.8	3.5	4.6	8.1	11.0	3.2	25.4	7.5	8.0	4.1	5.8	9.8	4.1	5.0	2.8	9.7	14.7	3.3	2.9	6.3	5.1	24.3	6.5	4.2	19.5	12.9	2.0	3.4	6.9	8.3	3.1
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"Fanconi anemia complementation group D2"	Q9BXW9	3	10026414-10101930	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.4;testis: 23.3"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 46.7;Spermatocytes: 55.1;Spermatogonia: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 46.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		No	No			Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB016117: AB_2278211, HPA063742: AB_2685110"	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.08e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.23e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.41e-10)"	"unprognostic (9.11e-3)"	"unprognostic (3.99e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.89e-2)"	2.0	1.3	0.8	10.3	2.6	12.2	2.4	1.6	2.7	1.7	2.9	1.1	1.0	2.2	2.2	1.8	4.7	2.4	2.5	1.1	0.8	0.9	2.3	1.0	2.4	9.5	1.3	1.2	3.5	3.5	0.6	1.1	5.3	1.4	2.2	4.9	1.6	3.3	0.4	3.0	3.3	6.2	1.2	2.0	7.3	2.4	23.3	1.6	24.4	1.6	5.6	14.6	2.2	2.4	6.8	3.7	5.3	2.6	2.1	2.9	1.0	8.7	9.3	17.8	5.0	0.9	1.4	46.0	8.0	3.6	11.5	9.4	6.9	8.7	17.1	3.8	2.6	9.5	7.6	18.3	6.2	11.5	8.1	12.4	23.3	14.3	6.6	0.1	17.3	14.6	0.4	1.0	13.0	7.2	1.6	6.9	14.7	14.2	19.6	8.7	10.0	14.4	6.7	21.4	6.7	6.5	15.8	14.5	12.1	4.0	9.8	4.9	9.8	9.8	7.7	3.1	13.5	11.8	11.0	4.0	9.6	11.0	5.8	11.6	8.3	16.3	28.9	5.5	17.8	16.3	5.3	1.4	3.7	1.5	1.0	1.3	4.9	2.0	1.2	0.9	6.8	2.5	1.9	3.3	2.1	2.6	3.7	2.9	1.0	0.8	2.6	1.6	2.7	0.8	0.9	1.3	1.2	1.4	1.6	0.0	0.3	9.7	2.8	4.0	2.8	1.6	0.0	1.4	1.2	1.8	9.8	6.6	0.0	1.6	4.4	1.5	0.7	46.7	2.9	12.7	1.3	2.2	1.1	1.0	5.0	0.0	1.2	3.7	3.4	5.6	2.0	5.2	3.3	7.2	2.0	0.8	1.4	2.8	1.4	0.5	5.8	19.4	0.8	55.1	32.4	2.4	5.8	3.8	5.0	2.3
FBXL22	"Fbl22, FLJ39626"	ENSG00000197361	"F-box and leucine rich repeat protein 22"	Q6P050	15	63597353-63602428	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 65.9;smooth muscle: 68.0"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 10.5;Muller glia cells: 9.8;Peritubular cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 8.0;SCLC-21H: 9.1;U-937: 5.7"									"HPA047624, HPA054627"	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA047624: AB_2680107, HPA054627: AB_2682548"	"unprognostic (2.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	1.9	0.4	0.4	5.5	0.4	0.0	1.1	0.6	0.7	31.4	26.0	0.0	20.8	1.4	65.9	7.6	11.9	10.5	31.1	10.3	0.4	0.4	0.6	0.4	0.7	0.2	0.4	0.3	7.1	0.4	0.0	0.4	1.0	0.2	20.1	2.9	1.9	3.3	24.0	2.2	0.7	4.1	68.0	0.4	0.4	6.3	4.2	0.0	0.0	0.6	1.0	0.4	38.2	4.8	1.5	4.3	0.5	0.2	2.0	2.9	0.5	1.2	2.2	0.3	1.3	0.7	0.9	0.1	0.4	0.1	0.5	0.0	1.4	1.6	0.5	1.1	0.2	0.8	1.3	0.7	0.4	0.0	1.3	0.9	0.4	1.5	3.5	0.2	0.5	0.2	0.5	0.3	0.1	0.7	0.1	0.2	3.7	0.0	1.9	0.0	8.0	1.2	1.0	2.5	1.3	0.8	1.1	0.0	3.9	0.3	0.4	9.1	0.3	1.1	1.8	0.3	0.0	3.2	0.9	1.3	0.6	1.8	0.8	0.4	1.2	2.0	1.3	0.9	5.7	1.3	0.4	0.1	0.0	1.2	0.1	1.6	1.5	1.3	1.4	0.0	1.2	2.9	1.0	0.5	2.0	0.2	4.3	0.1	0.5	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.3	0.2	0.0	0.0	0.0	2.2	1.7	0.1	10.5	7.2	5.1	0.0	1.2	7.0	3.9	0.6	8.3	0.9	0.6	0.6	1.3	0.0	1.0	0.7	0.6	1.4	0.0	3.6	0.7	0.0	4.7	5.5	1.5	0.2	0.3	0.4	0.0	0.0	5.6	9.8	0.6	3.5	10.6	2.1	2.5	0.0	1.3	3.9	3.4	0.6	0.5	0.5	3.6	0.5
FDXACB1	"hCG_2033039, LOC91893"	ENSG00000255561	"Ferredoxin-fold anticodon binding domain containing 1"	Q9BRP7	11	111874056-111881243	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 35.1;Late spermatids: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039012, HPA061375"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA039012: AB_10670916, HPA061375: "	"unprognostic (2.91e-2)"	"unprognostic (3.32e-3)"	"unprognostic (1.32e-2)"	"unprognostic (6.81e-7)"	"unprognostic (1.32e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.95e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.42e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.79e-2)"	3.7	6.7	4.4	6.2	5.2	4.0	5.8	2.2	6.1	4.4	3.2	4.7	3.1	4.0	3.9	6.0	3.9	3.7	5.0	2.8	6.6	4.7	3.4	4.3	5.2	8.5	3.6	3.4	4.3	5.1	5.3	3.6	3.0	5.2	3.4	4.2	4.1	6.2	2.2	1.6	6.6	4.3	3.0	5.3	7.6	3.2	11.1	4.0	11.2	3.4	2.6	7.9	4.2	2.7	6.5	4.8	1.8	4.6	5.6	10.4	4.5	1.6	2.1	3.0	6.0	2.3	2.0	1.4	1.2	1.3	1.3	1.6	2.6	3.6	5.9	3.3	1.1	2.2	4.8	2.8	2.7	2.9	7.4	1.3	6.7	1.1	2.1	1.3	6.7	6.0	1.7	1.6	1.9	2.4	1.2	2.3	7.5	4.6	7.9	2.5	2.2	6.4	6.5	1.6	6.6	3.1	4.0	1.9	7.2	3.0	2.9	1.4	2.0	1.8	3.6	1.8	1.9	5.1	4.1	1.8	3.2	3.2	3.6	2.9	4.0	5.8	16.0	1.8	9.9	4.2	0.2	3.2	1.8	6.8	4.6	9.0	6.5	6.1	6.2	4.8	5.2	9.4	10.4	0.9	5.6	3.8	4.6	3.2	4.5	4.4	5.2	2.2	6.1	6.6	4.7	3.6	3.4	5.2	4.0	6.0	1.1	5.4	1.1	0.7	3.2	1.2	0.0	1.4	2.3	0.0	0.0	2.7	5.0	1.7	35.1	1.4	0.7	0.0	2.9	1.8	1.4	1.4	1.1	1.3	3.7	1.6	2.4	1.3	1.0	12.1	2.8	2.7	0.0	2.8	1.1	3.2	1.9	0.0	0.4	2.0	2.1	6.5	0.9	6.5	8.6	1.1	1.8	1.9	1.8	0.9
FOXC1	"ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1"	ENSG00000054598	"Forkhead box C1"	Q12948	6	1609972-1613897	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Deafness, Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"retina: 32.7;salivary gland: 86.6"	"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 40.9;Ito cells: 36.2;Urothelial cells: 55.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 39.8;HEK 293: 38.8;RPTEC TERT1: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040670			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040670: AB_10673412"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (3.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.83e-3)"	"unprognostic (3.74e-1)"	7.7	4.4	2.6	1.3	3.4	1.0	9.4	2.3	3.4	6.6	1.4	2.8	3.2	1.2	2.4	3.8	3.8	3.4	9.8	9.5	3.2	2.1	12.9	1.4	3.8	1.6	4.5	2.3	4.8	2.8	2.2	6.5	3.1	6.5	6.0	1.3	32.7	86.6	4.9	3.6	7.1	1.2	2.1	3.9	0.9	1.1	4.6	2.6	2.8	3.7	4.2	2.9	5.7	4.6	0.0	0.0	0.2	0.1	1.4	0.0	0.0	7.3	0.8	0.2	39.8	1.8	2.1	1.2	3.7	4.4	2.3	1.9	2.8	1.5	0.0	4.3	2.2	1.7	8.4	3.8	2.7	1.9	2.3	38.8	1.5	2.2	1.3	1.2	0.5	2.6	7.0	3.8	3.2	3.6	1.2	3.4	0.2	1.0	0.0	1.0	1.6	0.0	0.8	0.1	3.7	3.2	0.0	1.6	0.2	15.6	5.6	1.5	3.4	4.6	0.0	2.6	2.1	1.1	0.6	0.8	5.1	3.1	2.6	3.9	0.1	0.3	0.0	1.4	1.9	4.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.0	2.6	3.4	2.3	3.4	3.2	2.1	4.5	2.3	6.5	2.6	0.0	1.1	0.0	25.0	15.8	0.0	5.6	0.0	26.8	14.8	10.4	0.0	4.5	1.7	3.4	0.4	40.9	0.0	0.0	15.0	0.4	3.6	7.7	0.0	0.0	1.1	0.0	0.0	36.2	0.3	0.9	15.0	1.4	1.7	0.0	0.2	0.3	11.8	0.0	26.5	4.6	0.0	0.0	27.0	0.2	1.9	5.6	0.7	0.0	0.3	55.7
FOXM1	"FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident"	ENSG00000111206	"Forkhead box M1"	Q08050	12	2857681-2877155	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.5;testis: 40.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 16.5;Erythroid cells: 23.3;Extravillous trophoblasts: 15.0;Late spermatids: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			CAB017832	Uncertain		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	Yes			"Nucleoplasm, Nucleoli, Nucleoli rim"	Cytosol	"CAB017832: "	"unprognostic (3.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.95e-6)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (6.09e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.94e-1)"	1.7	1.7	1.0	9.3	0.9	13.8	2.4	0.4	1.2	2.0	6.5	0.4	1.1	6.0	1.2	2.1	13.5	0.4	4.1	1.2	0.8	0.6	1.3	1.6	2.8	6.6	0.8	0.3	0.8	0.6	0.0	0.5	3.9	0.9	0.9	8.2	0.6	2.6	1.1	0.7	3.7	7.1	4.4	1.2	5.0	3.2	40.1	0.4	47.5	0.6	11.4	11.6	2.0	3.7	0.7	0.6	1.0	0.6	0.4	1.9	0.1	28.5	29.0	22.5	20.7	3.4	4.5	28.7	18.7	18.4	37.9	34.4	36.6	25.6	18.5	4.0	26.7	43.1	22.2	33.7	17.1	37.2	34.5	18.0	20.8	27.8	15.6	0.5	16.7	17.1	2.3	1.9	35.2	24.8	9.0	26.7	21.2	11.6	41.5	29.8	26.8	22.7	7.9	49.7	29.7	21.7	16.5	34.2	9.6	8.9	18.3	12.7	20.1	23.9	20.1	10.9	44.4	19.6	18.7	10.7	30.8	46.8	35.9	64.8	5.5	9.1	26.8	14.3	16.1	32.6	0.4	0.6	0.1	0.4	0.2	0.4	0.7	0.5	0.4	0.2	0.7	0.9	0.3	1.0	0.4	0.1	0.6	1.9	0.1	1.0	0.9	0.4	1.2	0.8	0.6	0.8	0.3	0.9	0.4	0.0	2.2	0.8	0.7	2.6	1.6	0.5	2.5	0.0	1.2	1.8	3.9	1.4	1.7	0.2	16.5	0.3	1.7	23.3	0.0	15.0	1.3	0.8	0.0	0.9	7.3	4.8	0.0	3.1	1.9	20.0	0.9	1.7	0.0	1.8	3.7	0.6	0.2	0.0	0.7	0.0	4.4	0.0	0.0	7.6	5.9	1.3	1.6	2.5	3.7	1.3
FUT2	"SE, Se2, SEC2, sej"	ENSG00000176920	"Fucosyltransferase 2"	Q10981	19	48695971-48705950	"Blood group antigen proteins, Enzymes, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.3;salivary gland: 58.1"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 43.3;Enterocytes: 109.6;Exocrine glandular cells: 41.1;Mucus-secreting cells: 39.5;Paneth cells: 73.7;Undifferentiated cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"cerebellum: 8.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 34.7;OE19: 38.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014402	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA014402: AB_1849194"	"unprognostic (2.95e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.83e-4)"	"unprognostic (6.30e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.44e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.11e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	0.4	0.6	0.7	5.3	0.8	0.0	0.8	8.7	1.6	9.3	25.0	0.3	13.9	24.1	1.3	0.1	16.0	1.2	23.3	0.5	0.7	0.7	0.8	0.4	1.1	0.1	0.7	0.1	1.0	7.5	0.0	1.5	0.2	0.7	1.2	10.9	0.1	58.1	14.5	0.5	2.6	41.3	0.4	0.7	0.6	15.8	0.7	0.2	0.5	0.6	16.1	19.3	3.1	5.4	1.7	1.8	3.5	1.0	1.4	2.5	0.6	0.9	0.9	0.2	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.1	34.7	0.3	0.2	0.0	0.2	6.1	0.0	0.0	0.0	0.3	0.2	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.4	0.0	0.4	0.4	0.8	0.2	38.7	0.3	0.3	0.1	1.5	0.0	0.3	1.8	0.2	0.1	0.3	0.0	0.2	5.2	0.0	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.0	0.1	0.2	0.1	3.5	0.8	0.4	2.0	0.7	1.1	1.5	2.3	1.0	0.5	1.7	2.1	0.7	3.4	1.4	1.0	1.8	2.5	0.6	0.7	0.8	8.7	1.6	0.7	0.7	0.7	0.1	0.7	0.2	0.0	1.1	0.0	2.5	0.8	2.7	0.4	43.3	12.0	10.3	19.2	2.0	0.0	1.7	5.5	0.5	0.3	109.6	0.0	41.1	0.0	0.2	2.5	0.0	0.0	0.1	0.0	10.9	0.0	0.3	0.0	0.0	0.0	1.7	0.0	39.5	0.8	25.6	73.7	0.0	0.0	3.8	0.0	0.2	0.2	0.2	1.3	0.1	2.2	44.3	14.7
GABARAPL2	"ATG8, ATG8C, GATE-16, GATE16, GEF2"	ENSG00000034713	"GABA type A receptor associated protein like 2"	P60520	16	75566351-75577881	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036726	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA036726: AB_10672476"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.58e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.95e-8)"	"unprognostic (3.11e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.85e-1)"	29.6	47.4	69.0	18.0	70.5	24.7	33.8	52.3	61.4	29.4	23.9	54.2	26.0	18.7	25.7	47.1	21.7	30.9	23.7	76.6	59.6	69.5	42.0	31.4	25.4	23.4	73.4	52.5	28.9	25.8	46.2	33.6	31.8	52.4	33.4	23.6	30.8	27.3	31.0	52.7	24.3	19.4	28.2	72.0	25.7	21.8	20.2	45.4	17.5	35.7	22.4	26.8	22.6	19.3	38.2	47.0	87.8	25.4	18.9	35.1	35.9	23.9	20.4	34.9	16.4	54.2	47.8	17.7	28.2	40.9	38.7	43.6	18.7	31.1	34.6	34.8	32.1	23.4	20.7	25.9	26.4	47.9	14.9	49.4	20.4	18.8	27.7	29.6	19.5	36.9	33.0	37.5	32.5	24.3	35.3	31.4	31.4	29.8	14.2	38.6	33.9	28.8	37.4	20.9	27.0	22.9	32.5	16.8	41.7	40.4	15.7	41.1	43.0	44.1	10.6	40.5	29.1	34.0	30.8	28.6	16.8	25.7	24.4	15.1	40.5	38.3	72.4	40.5	19.0	24.7	47.8	25.3	61.1	23.9	23.4	30.6	38.2	25.6	27.3	30.4	32.1	23.3	21.8	87.8	18.9	25.4	47.0	35.1	35.9	69.0	70.5	52.3	61.4	59.6	69.5	73.4	52.5	52.4	45.4	80.4	128.3	143.1	246.6	244.3	234.3	274.6	119.8	196.7	104.6	165.7	43.2	221.0	581.9	172.6	40.2	247.2	151.5	210.2	153.9	100.3	212.4	297.8	105.3	119.0	199.3	290.8	266.6	200.1	176.9	47.4	225.5	212.5	244.6	505.9	147.5	338.5	185.4	241.8	245.4	443.3	155.9	155.2	146.3	296.3	235.3	239.5	326.2	159.2	111.7	275.4
GAGE10		ENSG00000215274	"G antigen 10"	A6NGK3	X	49303669-49319844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ovary: 3.9;pituitary gland: 3.1;testis: 2.9"	"Cell type enhanced"	"Detected in some"	28	"Leydig cells: 1.1;Peritubular cells: 1.1;Spermatocytes: 1.4;Spermatogonia: 4.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.0;BJ hTERT+: 1.5;SuSa: 2.2;WM-115: 2.9"									HPA043232	Supported		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"					"unprognostic (2.81e-2)"					"unprognostic (2.26e-1)"						"unprognostic (3.97e-1)"		0.0	0.0	0.6	0.0	1.8	0.1	0.8	0.5	0.3	0.0	0.2			0.0	0.5	2.0	0.0	1.7	0.1	0.5	0.5	0.5	0.0	0.0	0.0	0.6	0.4		3.9	0.0	0.0	3.1	0.0		0.4	0.3		0.2	1.1	0.2	0.0	0.0	1.4	0.2	0.3	0.0	2.9			0.8		0.2	0.0	0.1	0.0	0.7	0.0	0.5	0.1	0.5	0.3	0.0	0.0	0.6	7.0	0.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	1.0	0.0	0.0	0.2	0.0	0.2	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.2	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.3	0.0	0.1	0.5	0.7	0.3	0.3											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	4.9	0.1	0.0	0.0	0.0	0.1
GAGE12E		ENSG00000216649	"G antigen 12E"	A1L429	X	49551333-49558649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	18	"testis: 9.6"	"Cell type enriched"	"Detected in some"	12	"Spermatogonia: 11.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.4;HeLa: 4.1;Karpas-707: 2.0;T-47d: 1.7;U-266/84: 4.4;WM-115: 2.0"									HPA043232	Supported		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.6	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.7	0.0	0.0	0.5	0.3	0.0	0.0	0.7	4.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	11.5	0.0	0.0	0.0	0.0	0.0
GFRA3	GFRa-3	ENSG00000146013	"GDNF family receptor alpha 3"	O60609	5	138252379-138274671	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	23	"granulocytes: 27.5;Intestinal endocrine cells: 51.2;Late spermatids: 11.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"cerebellum: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SH-SY5Y: 27.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020731	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA020731: AB_1849635"	"unprognostic (1.22e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.90e-5)"	"unprognostic (2.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	2.4	2.4	0.3	7.1	1.0	0.0	1.8	7.0	0.6	7.9	13.0	0.1	11.0	3.8	3.0	6.1	9.3	1.2	9.4	6.2	0.3	0.3	0.9	0.4	2.9	0.1	0.6	0.1	4.7	7.0	0.0	2.3	0.1	1.3	4.4	5.8	10.0	7.5	10.9	1.3	3.6	4.7	8.6	1.4	0.1	6.9	8.4	0.5	0.4	1.0	2.8	0.8	4.4	8.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	1.5	0.9	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	27.0	0.4	0.0	0.3	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	7.0	0.6	0.3	0.3	0.6	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.3	0.0	0.0	0.0	0.2	0.2	0.0	0.1	27.5	0.0	0.1	0.0	51.2	0.0	0.0	11.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	8.1	0.0	0.2	0.0	0.0	0.0
GJC1	"CX45, GJA7"	ENSG00000182963	"Gap junction protein gamma 1"	P36383	17	44798448-44830816	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	23	"Sertoli cells: 155.2;Smooth muscle cells: 65.3;Spermatogonia: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA071788			Uncertain	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			Nucleoli	"Cell Junctions, Cytosol"	"HPA071788: "	"unprognostic (1.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.55e-8)"	"unprognostic (5.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (7.83e-4)"	7.3	0.8	2.2	4.1	3.4	1.0	4.7	8.2	4.2	14.8	23.0	2.8	7.0	1.6	24.2	3.1	3.2	5.0	5.4	10.0	3.3	1.8	1.5	0.9	6.5	2.3	2.5	4.0	2.2	1.3	2.6	0.7	28.5	3.4	8.2	2.8	3.7	1.7	17.0	5.4	1.9	4.8	27.5	2.2	0.9	7.8	8.0	2.9	1.4	5.3	2.9	1.7	12.6	10.4	1.2	1.0	4.7	1.0	1.9	1.0	0.4	17.4	9.0	22.7	7.8	3.0	4.7	8.9	19.4	15.3	20.9	22.5	5.2	9.7	0.1	1.0	18.1	28.6	4.5	11.8	6.0	29.4	0.1	8.8	0.1	4.8	0.5	1.8	0.1	0.7	3.2	0.6	15.9	5.3	7.8	7.1	3.9	0.8	0.2	12.1	0.1	2.8	1.7	10.2	0.0	7.7	16.5	28.8	0.1	5.0	7.3	4.3	9.9	2.2	0.1	6.5	15.3	4.7	2.7	5.9	18.5	17.9	8.4	16.5	0.1	4.5	12.9	6.4	0.1	17.3	4.7	1.0	1.1	0.9	0.6	0.8	0.9	0.7	0.6	0.3	1.2	0.9	1.0	3.9	1.9	0.7	1.0	0.6	0.4	2.2	3.4	8.2	4.2	3.3	1.8	2.5	4.0	3.4	2.9	0.0	0.0	0.0	1.6	1.8	1.0	18.1	0.0	0.0	0.0	1.8	2.0	0.3	0.0	1.3	1.3	11.7	0.0	0.0	0.0	2.1	5.7	1.2	0.0	0.0	1.2	12.7	0.0	6.2	0.8	0.0	1.4	0.0	3.3	1.0	0.0	0.4	0.6	0.0	2.1	0.3	1.0	155.2	65.3	10.2	32.0	2.6	0.5	0.0	0.0	1.4
GLYATL1	"FLJ34646, MGC15397"	ENSG00000166840	"Glycine-N-acyltransferase like 1"	Q969I3	11	58905398-59043527	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 113.8"	"Cell type enhanced"	"Detected in some"	31	"Distal tubular cells: 91.2;Hepatocytes: 198.3;Proximal tubular cells: 523.1"	"Group enriched"	"Detected in some"	8	"liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.9;Daudi: 9.7;RPTEC TERT1: 3.3;U-2197: 2.5"									HPA039501	Supported		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA039501: AB_2676545"	"unprognostic (9.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-5)"	"unprognostic (3.93e-3)"	"unprognostic (3.54e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (3.03e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.55e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.1	27.7	113.8	0.1	0.0	0.2	0.0	0.2	0.2	0.9	0.1	0.0	0.5	2.1	0.0	0.5	1.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.3	0.0	0.1	1.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	1.3	0.0	0.5	0.2	1.1	0.9	3.9	0.0	9.7	0.0	0.7	0.8	0.0	0.0	0.0	1.7	0.0	0.4	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.6	2.2	0.0	0.2	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	3.3	0.0	0.2	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	1.2	0.1	2.5	1.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.3	17.8	0.0	0.0	14.0	0.0	0.0	91.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	198.3	0.0	0.0	0.0	1.8	6.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	523.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1
GLYATL1B	GLYATL1P3	ENSG00000255151	"Glycine-N-acyltransferase like 1B"		11	59086307-59094786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	7	"blood: 4.9;breast: 12.5;lymphoid tissue: 4.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"					"Group enriched"	"Detected in some"	17	"memory B-cell: 1.9;naive B-cell: 4.9"	"Lineage enriched"	"Detected in single"	24	"B-cells: 4.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.9;JURKAT: 2.0;Karpas-707: 2.2;T-47d: 3.2;U-2197: 2.5;U-266/70: 5.0"									HPA039501	Uncertain		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA039501: AB_2676545"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"						"unprognostic (1.44e-1)"			"unprognostic (1.25e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.21e-4)"	"unprognostic (3.45e-1)"		0.0	0.0		1.0		0.0	12.5		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	4.1			0.0	0.0	0.0		0.0		0.9	0.0		0.0	0.0	0.0	0.1	0.0	0.0		0.6	0.0	0.0			0.0		0.0	0.0		4.9	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.1	2.2	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.5	2.5	0.2	5.0	1.6	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GM2A	SAP-3	ENSG00000196743	"GM2 ganglioside activator"	P17900	5	151212150-151270440	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease mutation, Gangliosidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 108.7"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 163.9;Hofbauer cells: 98.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 15.9;dendritic cells: 19.0;monocytes: 19.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.5;HBEC3-KT: 61.5;hTCEpi: 61.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008063	Enhanced		Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		23000000	"Vesicles, Cytosol"		"HPA008063: AB_1849842"	"unprognostic (4.33e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.77e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.33e-3)"	"unprognostic (9.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	55.8	16.1	17.8	15.5	18.8	9.6	15.2	8.1	15.2	20.5	10.3	31.7	6.4	8.4	9.5	17.3	39.5	8.8	12.6	13.8	18.0	12.6	7.5	13.2	24.8	30.2	22.4	13.0	12.2	9.3	11.7	5.6	108.7	18.9	11.9	14.5	14.1	13.3	10.4	3.9	42.8	11.2	10.9	35.9	28.5	8.2	8.9	15.3	21.9	7.1	25.9	39.7	21.0	32.0	15.9	19.0	4.2	19.4	1.9	3.3	8.0	4.6	3.0	3.2	15.3	21.3	10.6	44.5	7.3	15.8	4.0	5.5	6.3	5.4	15.0	7.7	5.6	11.0	12.7	3.5	61.5	5.8	8.4	2.2	2.4	3.8	7.7	5.2	3.9	25.2	14.2	61.3	5.2	3.5	5.6	5.8	19.1	2.3	6.5	6.3	1.9	8.2	3.7	2.2	2.3	6.9	3.7	1.5	9.4	3.9	9.1	0.8	2.9	6.0	28.4	12.0	11.7	6.5	4.6	5.1	10.0	3.9	8.2	2.2	16.2	19.3	41.1	11.4	6.2	4.1	3.5	19.4	1.1	1.9	6.5	1.4	14.9	2.3	2.0	19.0	15.9	3.3	2.5	4.2	1.9	1.4	13.7	2.4	8.0	17.8	18.8	8.1	13.9	18.0	12.6	22.4	13.0	18.9	15.3	14.9	23.1	14.7	13.3	13.3	4.5	26.2	0.0	13.4	12.5	17.4	2.0	45.1	1.7	5.8	0.4	6.3	4.6	0.0	6.9	163.9	8.0	7.4	66.0	16.3	98.1	6.4	3.5	7.4	38.4	1.1	7.5	34.4	8.5	55.1	5.0	8.0	5.4	3.5	13.1	4.5	3.1	0.0	5.7	1.4	4.9	20.8	43.8	3.8	5.6	32.5
GOLPH3L	GPP34R	ENSG00000143457	"Golgi phosphoprotein 3 like"	Q9H4A5	1	150646225-150697144	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"U-698: 100.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072016			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA072016: "	"unprognostic (1.21e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.24e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-2)"	16.5	19.4	16.0	10.2	14.6	4.9	18.6	20.7	16.7	21.6	26.5	10.5	26.2	15.7	19.3	30.0	36.6	24.6	14.8	11.7	10.6	15.5	21.3	13.0	14.5	10.5	12.2	11.0	22.7	30.4	16.8	30.8	14.1	15.9	19.2	32.6	16.5	25.4	22.4	16.1	17.3	20.2	14.9	11.0	15.0	19.5	14.9	12.1	21.1	30.7	11.7	20.8	21.6	22.2	10.6	11.7	7.1	3.1	16.2	13.1	4.9	7.1	7.0	3.9	2.2	9.9	7.2	6.4	6.6	10.1	7.3	10.4	3.1	12.8	9.0	9.6	4.7	4.7	6.2	6.4	5.6	8.8	6.1	7.1	10.0	3.8	4.1	8.7	8.2	8.0	4.8	9.6	7.6	16.4	8.5	10.6	6.2	8.1	5.8	4.2	7.3	6.9	3.5	7.4	13.3	6.8	4.8	4.5	10.2	8.4	4.8	6.0	5.7	3.4	9.6	4.8	10.0	7.3	9.1	8.4	2.4	3.9	3.1	5.5	7.3	6.4	100.5	7.0	8.5	3.2	7.1	1.5	2.7	9.7	1.3	13.1	10.6	9.8	9.5	8.1	8.8	12.9	9.6	1.3	16.2	3.1	11.7	10.3	4.9	16.0	14.6	20.7	16.7	10.6	15.5	12.2	11.0	15.9	12.1	8.9	6.4	8.2	8.5	11.4	8.0	9.7	22.9	37.5	15.9	12.2	5.9	18.7	21.6	17.4	12.4	12.1	29.9	0.0	32.0	12.8	8.8	22.2	11.5	9.7	10.3	0.0	20.2	16.0	9.1	9.7	15.3	8.2	15.1	19.0	40.8	13.4	21.9	31.9	18.7	20.3	12.7	0.0	8.2	11.2	3.2	15.6	25.7	10.0	31.6	23.8
GPAT3	"AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324"	ENSG00000138678	"Glycerol-3-phosphate acyltransferase 3"	Q53EU6	4	83535914-83605875	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.2;kidney: 43.7"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 41.3;Early spermatids: 68.5;Proximal tubular cells: 50.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 42.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 51.6;GAMG: 39.2;HMC-1: 19.0;U-87 MG: 22.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029414, CAB033749"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB033749: AB_2224941, HPA029414: AB_10601562"	"unprognostic (9.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.71e-9)"	"unprognostic (3.74e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (8.21e-4)"	7.9	0.7	0.7	5.2	1.4	5.2	17.5	4.2	2.9	3.7	18.0	1.2	1.3	20.2	3.0	2.1	5.1	2.1	6.0	24.8	1.2	2.2	43.7	9.0	3.2	4.5	1.9	0.8	12.9	1.7	11.8	5.8	1.2	9.5	2.6	5.7	1.3	3.6	1.9	35.9	1.9	47.2	3.7	3.0	4.3	7.4	4.6	1.4	0.9	26.6	14.6	3.4	4.5	7.2	0.0	23.2	42.0	9.7	0.5	1.8	2.9	9.8	9.7	0.0	0.1	0.5	1.2	0.2	0.7	1.4	0.2	0.2	0.7	51.6	0.0	1.1	1.8	39.2	2.2	4.6	0.9	0.1	0.6	2.2	0.0	3.1	9.5	1.4	2.8	19.0	0.6	0.0	0.3	1.1	3.8	4.8	2.7	7.9	7.8	0.2	1.0	0.7	0.7	0.2	14.5	4.2	0.1	2.2	3.7	9.8	0.6	0.2	0.0	1.9	2.0	5.4	0.5	0.4	0.5	0.2	2.3	4.2	2.3	9.3	0.4	0.6	0.0	22.6	5.6	17.2	42.0	9.7	1.0	0.2	7.7	1.8	0.0	1.0	0.6	23.2	0.0	0.7	0.3	26.4	0.5	6.1	0.1	0.6	2.9	0.7	1.4	4.2	2.9	1.2	2.2	1.9	0.8	9.5	1.4	6.0	5.0	0.0	41.3	0.0	0.0	0.0	7.6	2.7	9.1	10.4	0.0	0.2	13.3	1.6	68.5	0.6	21.6	0.0	5.9	1.0	0.1	25.8	7.0	11.9	15.3	4.8	1.2	5.5	16.7	17.2	1.1	28.3	0.0	5.4	4.8	0.0	6.6	8.0	0.7	50.3	0.2	6.5	0.0	8.8	1.7	0.0	0.8	0.0	2.1	25.4
GPR142	PGR2	ENSG00000257008	"G protein-coupled receptor 142"	Q7Z601	17	74367407-74372622	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.3;lymphoid tissue: 1.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-937: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA031392	Uncertain		Uncertain	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA031392: AB_10601935"	"unprognostic (6.81e-2)"		"unprognostic (1.75e-1)"			"unprognostic (1.98e-1)"		"unprognostic (1.34e-1)"		"unprognostic (1.36e-1)"	"unprognostic (6.54e-5)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-7)"	"unprognostic (3.95e-2)"	"unprognostic (7.72e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-3)"	0.2	0.0	0.0	1.3	0.1	0.0	0.1	1.3	0.2	0.3	0.1			0.8	0.6	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.2	0.0		0.1	0.8	0.0	0.0	0.1		0.2	0.1		0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.1			0.2		0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR34		ENSG00000171659	"G protein-coupled receptor 34"	Q9UPC5	X	41688973-41697277	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 60.8"	"Cell type enhanced"	"Detected in some"	23	"granulocytes: 35.9;Hofbauer cells: 198.9;Kupffer cells: 113.1;Macrophages: 46.2"	"Cancer enhanced"	"Detected in all"		"glioma: 26.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"basophil: 60.8;eosinophil: 25.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 60.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 5.0;JURKAT: 2.6;U-937: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010668, CAB025490"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB025490: , HPA010668: AB_1849294"	"unprognostic (1.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.81e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.18e-2)"	25.1	12.4	15.1	9.7	16.6	0.4	15.0	2.1	11.7	10.5	9.1	13.5	1.0	4.4	4.9	6.6	5.8	5.5	12.2	5.9	16.0	9.5	11.7	5.3	11.4	26.8	22.4	7.5	5.4	4.4	2.8	3.3	29.3	15.4	5.7	9.3	4.9	7.1	6.4	2.1	2.4	11.4	11.5	34.0	22.3	5.1	5.0	21.4	1.9	3.4	1.5	11.1	12.5	3.7	0.3	0.4	60.8	2.8	3.0	0.1	0.5	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	1.0	0.4	0.0	0.2	0.0	0.1	5.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	0.0	0.0	0.2	0.7	0.3	0.0	0.4	0.1	1.1	0.0	0.3	0.1	0.3	0.2	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.4	0.1	0.8	0.1	0.0	0.0	0.1	0.6	1.3	0.0	60.8	2.2	25.3	0.0	2.8	0.0	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.2	3.0	1.5	0.0	0.1	0.5	15.1	16.6	2.1	11.7	16.0	9.5	22.4	7.5	15.4	21.4	0.0	3.2	2.7	0.2	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.3	1.7	0.1	35.9	0.0	198.9	0.0	1.2	3.1	113.1	0.6	0.9	46.2	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	19.4	0.0	0.0	0.1	0.9	2.1	1.7	0.0	0.0
GPR63	"PSP24(beta), PSP24B"	ENSG00000112218	"G protein-coupled receptor 63"	Q9BZJ6	6	96794126-96837463	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Early spermatids: 21.8;Late spermatids: 26.5;Spermatocytes: 22.8;Spermatogonia: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 7.8;HHSteC: 12.8;Karpas-707: 19.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039103	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039103: AB_10672841"	"unprognostic (8.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.53e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-2)"	1.8	3.4	3.8	3.1	11.0	0.8	1.6	7.5	10.7	3.3	3.9	1.6	1.0	5.1	1.9	1.5	2.0	2.8	2.7	1.9	3.2	2.2	1.4	0.5	1.4	0.9	2.2	6.4	4.0	5.0	3.9	4.3	2.5	10.1	3.3	6.2	2.5	1.7	2.2	1.0	1.7	3.6	3.6	1.4	1.3	4.1	8.0	5.2	2.5	2.3	0.0	0.9	2.2	4.8	0.8	0.9	2.6	0.6	1.4	1.1	0.1	0.0	0.1	1.5	0.3	2.2	0.8	0.4	0.9	0.0	0.0	0.2	0.2	1.1	0.0	0.0	0.1	1.2	1.1	4.9	2.3	0.0	7.8	3.8	4.7	0.4	0.0	12.8	2.9	0.5	2.4	0.4	0.0	3.5	0.3	0.0	7.0	3.4	19.2	0.4	0.4	2.2	0.0	5.0	0.0	0.7	0.0	1.8	3.8	0.3	0.2	2.3	1.4	0.3	3.1	0.5	1.7	1.2	0.6	0.0	1.3	2.0	0.2	1.8	1.5	0.8	0.1	0.8	1.8	1.0	0.8	0.6	0.2	0.6	0.2	0.3	0.7	1.1	0.6	0.1	0.8	1.0	0.9	2.6	1.4	0.2	0.9	0.3	0.1	3.8	11.0	7.5	10.7	3.2	2.2	2.2	6.4	10.1	5.2	0.0	0.0	0.0	0.8	1.6	1.1	0.5	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.4	21.8	0.1	0.0	0.0	0.8	0.6	0.9	1.0	0.0	0.0	0.2	0.0	2.9	1.8	0.0	26.5	3.1	0.0	1.7	0.0	0.4	0.3	0.5	0.0	4.6	0.0	0.2	0.0	1.1	22.8	9.3	0.3	0.1	0.0	0.5	0.3
GPRC5C	RAIG-3	ENSG00000170412	"G protein-coupled receptor class C group 5 member C"	Q9NQ84	17	74424851-74451653	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 76.2"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 193.6;Hepatocytes: 148.3;Paneth cells: 149.7;Sertoli cells: 142.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 31.1"	"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 10.2"	"Group enriched"	"Detected in many"	9	"dendritic cells: 10.2;monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 24.0;HMC-1: 42.2;RPTEC TERT1: 56.9;RT4: 26.3;T-47d: 32.0"	"Region enriched"	"Detected in many"	9	"cerebellum: 47.7"	"Low region specificity"	"Detected in all"			HPA029776	Enhanced		Uncertain	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA029776: AB_10602324"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.58e-5)"	"unprognostic (7.58e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.54e-3)"	4.3	4.1	5.2	2.2	5.3	0.0	7.7	31.1	5.7	19.7	15.4	4.4	17.0	10.0	5.8	9.9	5.3	12.5	17.6	7.7	5.3	2.6	43.8	46.1	11.5	2.8	4.8	4.9	12.3	76.2	12.0	3.4	4.5	6.1	15.1	6.2	18.0	16.8	11.7	25.4	9.2	15.2	3.9	4.6	5.1	44.7	4.4	4.1	1.9	42.2	10.2	3.5	12.6	8.0	0.7	10.2	0.1	4.7	0.0	0.1	0.3	4.6	16.7	1.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	21.4	0.0	13.3	0.1	5.4	14.7	2.2	0.3	0.0	0.0	2.7	0.0	1.2	24.0	4.9	0.0	42.2	0.4	7.6	0.0	0.0	22.7	0.0	0.0	1.2	0.3	0.0	5.2	0.1	4.5	2.7	23.1	19.4	0.0	0.0	1.1	56.9	26.3	8.1	0.7	0.8	1.8	0.0	10.9	32.0	1.2	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	2.1	0.6	0.1	0.0	1.7	0.1	0.0	3.4	0.0	0.7	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	4.7	10.2	0.0	0.3	5.2	5.3	31.1	5.7	5.3	2.6	4.8	4.9	6.1	4.1	3.0	48.9	1.5	39.6	12.0	0.8	193.6	68.8	22.7	18.2	129.1	0.0	0.7	24.9	53.1	0.1	8.7	61.7	0.0	58.9	7.1	19.9	46.9	10.3	148.3	9.6	4.8	43.7	25.8	8.5	0.5	16.7	4.2	3.3	5.4	47.3	18.8	37.9	149.7	20.8	51.6	0.8	142.3	56.7	0.4	3.0	9.8	21.2	1.5	44.1	40.9
GRAMD1C	DKFZp434C0328	ENSG00000178075	"GRAM domain containing 1C"	Q8IYS0	3	113828182-113947174	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 74.3;Late spermatids: 57.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 5.1;naive B-cell: 4.1;neutrophil: 4.0"	"Group enriched"	"Detected in many"	11	"B-cells: 5.1;granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.4;HUVEC TERT2: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012316	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA012316: AB_1849949"	"unprognostic (2.73e-3)"	"unprognostic (6.16e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.50e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.49e-2)"	"prognostic favorable (4.22e-15)"	"unprognostic (8.48e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.09e-2)"	1.7	2.6	12.6	2.5	13.0	0.5	9.1	5.0	13.4	3.4	8.0	2.6	0.5	7.6	5.2	5.1	6.0	10.3	2.9	1.5	13.6	7.6	23.3	26.5	5.0	2.0	9.4	8.1	1.1	12.5	11.8	24.1	6.2	9.2	2.9	4.2	4.5	10.8	2.8	1.1	12.0	24.5	1.0	8.2	1.7	8.6	14.5	9.3	0.0	6.9	1.6	3.7	3.8	3.8	5.1	0.1	4.0	0.0	0.3	0.4	0.1	1.5	0.0	4.1	3.2	0.8	2.1	5.9	3.7	3.3	0.7	2.2	0.0	14.4	0.4	1.1	1.9	1.3	1.6	0.7	1.6	1.7	1.9	0.6	0.3	0.1	0.0	1.6	0.2	0.1	3.3	1.1	0.6	0.1	7.5	11.2	4.5	0.0	0.2	1.1	0.4	1.6	0.2	0.3	1.5	0.5	0.0	0.8	2.5	4.5	2.0	0.8	1.0	1.0	5.9	3.0	1.6	4.1	0.0	2.3	1.5	2.9	0.0	0.3	2.2	1.3	1.8	2.4	0.1	1.7	0.0	0.0	0.0	0.3	0.0	0.0	5.1	0.3	0.4	0.1	4.1	0.3	0.4	4.0	0.3	0.0	0.1	0.0	0.1	12.6	13.0	5.0	13.4	13.6	7.6	9.4	8.1	9.2	9.3	11.9	10.9	0.0	5.9	0.9	0.0	0.8	20.4	18.7	7.9	14.0	35.3	14.6	26.6	2.1	74.3	2.9	12.0	0.0	2.4	3.7	1.0	2.9	0.0	14.8	1.3	11.1	4.7	3.7	0.0	57.8	2.6	0.0	1.7	0.0	4.7	14.5	2.1	5.9	1.4	11.2	18.3	0.0	0.9	25.7	5.1	4.1	35.5	0.0	3.9	5.7
GRM7	"GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87"	ENSG00000196277	"Glutamate metabotropic receptor 7"	Q14831	3	6770001-7741533	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.8;parathyroid gland: 11.3"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 22.5;Early spermatids: 24.2;Late spermatids: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SH-SY5Y: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015964			Uncertain	Cytosol		NA	NA			Cytosol		"HPA015964: "	"unprognostic (2.04e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.37e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.84e-6)"	"unprognostic (1.45e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.59e-2)"	0.9	5.3	8.1	0.6	10.5	0.6	0.9	1.6	15.8	2.9	0.8	2.1	0.0	0.9	3.1	0.5	0.6	1.0	0.7	0.6	11.1	9.3	0.5	0.7	0.8	0.5	2.3	10.1	0.8	0.7	11.3	0.6	0.9	4.3	1.2	0.8	0.8	2.1	1.4	0.5	0.6	0.6	5.9	2.8	0.8	0.6	2.8	4.1	0.0	0.7	0.0	0.7	1.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	10.5	1.6	15.8	11.1	9.3	2.3	10.1	4.3	4.1	0.0	0.0	0.0	0.9	0.1	22.5	1.1	7.6	6.7	1.2	0.0	7.9	0.0	1.7	0.0	24.2	0.1	0.0	0.0	0.0	0.1	0.7	1.1	1.1	0.0	0.1	1.6	0.0	0.0	0.0	29.9	0.3	0.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	3.2	6.5	0.0	1.7	0.7	0.0	0.0	0.0	0.0	0.6
GSTM5		ENSG00000134201	"Glutathione S-transferase mu 5"	P46439	1	109712255-109775428	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"breast: 237.6;ovary: 66.1"	"Group enriched"	"Detected in many"	6	"Leydig cells: 132.9;Muller glia cells: 217.3;Peritubular cells: 119.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.7;T-cells: 1.9"	"Group enriched"	"Detected in some"	7	"fHDF/TERT166: 18.0;HHSteC: 7.7;HSkMC: 8.3"									"HPA048652, HPA055972, HPA055973"	Approved		Uncertain	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (1.46e-2)"	"unprognostic (8.64e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.34e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.40e-1)"	5.8	3.5	25.7	2.6	23.4	1.6	237.6	15.8	24.6	27.2	4.2	14.0	4.7	2.1	14.0	12.0	4.8	19.8	9.0	4.8	24.9	6.2	2.9	2.1	5.7	2.6	4.9	17.9	66.1	2.7	1.6	2.7	1.6	8.9	12.8	4.0	23.0	3.9	11.9	2.4	3.7	3.5	9.8	11.0	3.5	3.9	5.1	11.9	0.0	2.6	2.1	3.2	10.5	16.1	0.0	5.7	0.6	0.2	0.7	1.9	0.9	0.0	0.0	0.0	0.0	1.6	1.6	0.3	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.1	1.3	0.0	0.2	0.2	0.0	0.7	0.0	5.7	1.9	0.9	25.7	23.4	15.8	24.6	24.9	6.2	4.9	17.9	8.9	11.9	0.0	0.3	0.0	0.5	6.0	2.0	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	8.2	0.8	0.0	0.0	0.0	0.1	12.3	0.1	0.0	0.0	0.2	0.0	0.0	7.4	1.2	9.9	132.9	0.6	10.1	0.0	0.0	217.3	0.0	0.0	119.5	0.0	5.8	25.8	7.6	1.9	1.1	5.6	0.0	0.0	0.0	0.1
GTF2A1	TFIIA	ENSG00000165417	"General transcription factor IIA subunit 1"	P52655	14	81175452-81221377	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000869	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA000869: AB_1080253"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.87e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.88e-2)"	16.9	14.9	18.2	15.7	23.3	8.7	17.1	32.6	23.4	15.7	12.9	17.7	12.7	12.2	16.0	20.1	17.9	12.5	13.1	12.7	17.0	17.8	15.3	18.4	11.6	18.9	16.2	17.0	17.6	14.7	21.0	20.6	24.5	19.9	14.8	14.7	14.0	14.5	13.1	20.3	14.7	12.4	16.2	18.5	17.2	13.4	23.9	16.7	36.3	30.4	11.3	18.5	15.9	15.0	1.3	3.2	9.3	3.9	1.5	2.3	0.8	10.7	10.7	22.6	15.1	12.9	10.9	8.2	12.9	13.4	12.0	10.8	15.9	10.9	17.5	10.6	10.8	8.8	8.1	15.5	9.8	21.3	14.8	4.6	16.0	12.4	9.5	12.7	11.2	16.5	10.0	7.6	16.4	21.5	12.5	12.1	14.4	9.7	24.2	15.3	17.9	28.4	6.6	12.2	8.2	10.4	15.3	19.8	10.8	8.0	22.0	21.4	12.6	30.6	12.5	13.7	11.4	18.7	9.5	15.2	12.2	9.3	16.8	13.5	19.5	20.8	18.2	9.7	13.0	19.2	9.3	1.2	2.1	2.3	0.9	2.0	1.3	2.1	1.3	0.7	1.2	1.9	2.1	2.0	1.5	3.9	3.2	1.1	0.8	18.2	23.3	32.6	23.4	17.0	17.8	16.2	17.0	19.9	16.7	17.9	12.8	11.5	8.0	16.0	22.8	23.4	2.5	6.7	14.8	22.7	33.4	12.6	1.7	9.6	55.2	18.0	15.4	0.0	11.2	10.7	13.2	14.4	30.0	23.7	14.5	38.1	17.9	17.8	25.7	4.9	11.8	19.2	10.1	28.9	16.5	23.4	10.4	14.1	12.7	12.6	15.2	25.8	15.6	25.1	26.2	21.3	21.7	16.0	10.9	8.0
GUK1		ENSG00000143774	"Guanylate kinase 1"	Q16774	1	228139962-228148984	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028118, HPA048587, HPA068324"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA		240000	Nucleoplasm	Cytosol	"HPA028118: AB_2756308, HPA048587: AB_2680453, HPA068324: "	"unprognostic (9.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.60e-3)"	"unprognostic (7.91e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (8.85e-5)"	"unprognostic (2.91e-1)"	"unprognostic (5.41e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.12e-2)"	44.6	38.2	106.4	32.5	76.0	76.7	43.0	25.2	74.4	31.5	33.3	30.1	27.3	41.5	26.3	34.1	77.0	28.0	42.5	61.6	93.1	43.9	31.9	43.5	34.6	39.0	60.0	52.9	24.7	62.2	12.8	26.0	29.2	40.1	25.5	12.1	37.4	66.5	29.4	35.8	59.6	42.1	34.8	49.6	36.1	44.3	22.2	34.9	27.5	31.6	29.3	24.1	45.9	44.5	43.9	97.7	110.1	62.9	55.8	83.7	84.5	57.5	20.3	9.0	27.7	27.1	32.6	45.0	38.4	19.7	22.4	17.6	11.6	40.1	21.7	45.6	25.0	18.8	38.3	7.7	42.1	2.4	33.0	59.7	12.9	50.1	25.2	49.3	14.6	22.7	45.2	25.7	15.6	12.6	16.1	30.2	47.0	34.7	34.7	18.3	48.0	65.8	31.5	28.1	28.2	88.0	25.2	16.9	57.6	21.1	27.1	29.6	53.1	24.7	42.4	49.6	2.4	31.3	31.5	52.7	40.9	27.0	59.9	63.1	32.0	34.6	24.0	51.5	23.8	41.2	55.5	57.1	110.1	77.3	59.8	75.2	43.9	64.8	83.7	48.9	36.6	48.7	61.1	74.9	55.8	62.9	97.7	64.6	84.5	106.4	76.0	25.2	74.4	93.1	43.9	60.0	52.9	40.1	34.9	56.6	78.2	181.8	216.6	586.3	182.4	113.0	193.6	93.7	91.0	225.1	675.4	207.7	588.6	495.6	100.8	397.7	599.7	607.3	597.7	329.8	327.6	443.3	180.0	320.2	368.6	103.3	258.9	305.7	236.3	483.4	216.3	309.1	492.6	406.6	288.0	169.2	724.2	491.0	229.1	543.7	445.9	245.8	394.4	82.0	73.0	629.1	219.5	279.1	243.7	436.5
H6PD	GDH	ENSG00000049239	"Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase"	O95479	1	9234775-9271337	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 116.9"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 33.5;HSkMC: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004824, HPA005440"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		91000000	Cytosol		"HPA004824: AB_1079037, HPA005440: AB_1079036"	"unprognostic (4.83e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.35e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.95e-1)"	18.3	16.1	4.1	10.7	5.5	4.8	12.2	4.1	6.3	16.6	11.9	10.5	8.2	6.3	22.0	18.0	11.1	15.6	11.9	11.9	3.7	3.0	7.0	116.9	12.2	11.1	6.8	2.6	38.3	10.6	8.0	8.7	14.9	6.0	11.6	5.3	11.8	29.8	8.1	24.7	20.7	10.4	10.2	6.6	10.7	9.9	12.4	5.5	16.2	12.6	12.9	14.1	12.2	10.1	4.5	3.7	4.1	6.3	3.1	4.7	3.0	3.9	3.2	2.8	10.5	29.2	33.5	2.7	3.9	9.8	2.9	4.6	0.6	8.1	4.3	4.6	6.1	3.7	4.1	0.7	1.9	4.3	12.9	0.9	0.0	1.0	2.6	16.3	1.4	1.7	32.9	3.8	7.0	4.6	6.5	13.4	2.4	1.1	7.5	5.7	2.3	1.5	3.2	1.5	2.9	1.9	0.5	0.3	3.6	3.8	1.6	0.9	5.0	5.2	4.1	4.9	2.0	3.1	7.0	13.3	10.1	1.7	2.5	1.1	10.0	2.9	1.0	16.9	6.3	6.4	3.5	6.2	0.9	4.7	6.3	3.7	3.5	3.5	4.1	2.8	4.5	3.4	3.2	4.1	3.1	5.8	3.7	2.8	3.0	4.1	5.5	4.1	6.3	3.7	3.0	6.8	2.6	6.0	5.5	23.8	29.3	11.2	11.1	12.7	18.1	13.0	58.6	10.7	12.5	19.2	25.5	9.0	0.0	15.8	0.8	14.7	15.1	0.0	18.5	6.5	24.0	16.2	3.5	132.8	11.5	15.9	7.5	17.8	18.0	1.5	44.5	10.3	11.8	64.9	15.2	11.2	20.1	17.5	34.6	8.2	11.5	0.0	9.2	4.7	4.6	11.2	4.9	13.8	24.1	11.4
HAUS7	"UCHL5IP, UIP1"	ENSG00000213397	"HAUS augmin like complex subunit 7"	Q99871	X	153447666-153495516	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003614			Approved	"Nucleoli,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Centrosome, Cytosol"	Nucleoli	"HPA003614: AB_1080368"	"unprognostic (2.06e-1)"	"prognostic favorable (6.12e-4)"	"unprognostic (3.81e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.65e-3)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.09e-2)"	13.1	9.4	16.1	10.3	16.4	9.4	7.9	9.1	19.3	12.7	9.3	8.9	20.3	7.9	10.8	17.1	7.0	9.9	15.1	11.9	20.3	9.1	13.3	11.9	9.4	12.1	12.0	16.5	9.3	4.3	3.1	6.4	12.6	11.1	11.8	6.2	7.8	8.5	17.4	7.2	46.9	7.4	12.1	8.9	16.4	8.8	6.1	18.4	14.2	10.8	8.8	9.8	7.5	11.8	20.2	22.3	10.1	31.1	16.7	18.5	15.8	13.9	22.4	10.0	19.3	3.5	4.8	13.8	9.7	5.5	11.2	19.9	16.3	7.8	13.3	31.1	6.5	15.5	11.9	14.2	9.7	8.7	16.0	23.5	9.7	20.9	12.2	3.2	16.0	14.0	7.4	2.5	9.9	6.3	4.9	7.9	12.2	12.2	6.8	6.6	26.9	15.0	19.3	6.2	22.3	22.4	14.1	16.4	20.1	3.5	8.8	11.1	8.4	5.2	11.5	3.9	5.0	4.5	7.7	5.1	9.7	19.2	22.5	17.7	10.1	26.5	52.2	5.1	28.8	13.2	4.7	26.2	10.1	17.0	31.1	17.8	20.2	18.5	17.1	22.3	16.6	18.4	16.7	3.4	16.7	27.1	12.6	15.5	15.8	16.1	16.4	9.1	19.3	20.3	9.1	12.0	16.5	11.1	18.4	6.0	7.2	4.5	1.3	6.4	1.9	2.0	2.5	5.3	2.3	0.0	3.9	10.4	5.0	7.9	0.0	5.0	5.8	0.0	7.1	20.6	6.2	1.0	19.6	3.9	10.6	3.2	2.4	11.1	11.1	0.0	5.5	8.1	3.3	14.4	11.6	1.9	6.1	10.5	7.1	11.8	1.3	6.5	6.6	1.6	6.3	4.1	7.8	7.4	13.3	1.1
HERPUD1	"HERP, KIAA0025, Mif1, SUP"	ENSG00000051108	"Homocysteine inducible ER protein with ubiquitin like domain 1"	Q15011	16	56932048-56944863	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Melanocytes: 899.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 78.5;U-266/70: 89.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037041, CAB037104, HPA040754, HPA041219"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB037041: AB_1840910, CAB037104: AB_1840912, HPA040754: AB_10794068, HPA041219: AB_10794268"	"unprognostic (1.92e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.39e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.69e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.50e-1)"	"prognostic favorable (1.41e-9)"	"unprognostic (1.06e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.27e-3)"	22.7	38.8	16.2	35.6	20.7	21.6	39.4	17.7	20.0	30.1	32.1	20.0	48.8	21.4	21.6	51.6	15.0	20.2	32.5	28.8	15.8	15.5	42.9	57.7	30.4	40.0	25.6	12.5	44.8	148.6	37.6	26.7	26.2	25.6	49.5	32.3	35.3	108.6	76.1	34.6	18.3	24.7	17.6	24.2	38.3	37.2	10.6	20.8	9.6	64.2	20.4	53.8	24.4	25.9	50.8	121.9	29.0	39.5	22.4	33.4	46.5	4.5	5.0	4.9	10.2	11.4	15.0	17.6	10.8	17.2	14.0	11.0	6.9	10.4	18.5	13.9	10.5	14.3	7.9	8.3	3.8	13.9	10.7	5.0	1.6	8.3	25.0	62.5	3.3	8.3	18.1	36.5	6.3	20.2	16.9	10.6	20.7	2.5	26.5	39.0	3.8	6.2	6.8	3.1	26.5	11.4	4.3	12.5	78.5	30.0	5.1	5.4	6.3	9.4	46.4	47.9	7.3	5.2	12.5	6.5	5.8	5.8	5.1	4.3	89.5	29.1	28.9	8.3	4.6	7.6	23.9	39.5	18.0	16.1	31.0	17.4	50.8	17.5	21.1	30.6	37.8	11.4	17.4	29.0	22.4	21.5	121.9	33.4	46.5	16.2	20.7	17.7	20.0	15.8	15.5	25.6	12.5	25.6	20.8	65.5	113.2	400.7	628.3	323.4	125.0	136.3	71.4	44.2	47.8	68.0	265.1	118.1	144.2	165.3	52.0	119.9	168.3	70.0	173.1	150.4	186.1	478.3	152.0	140.9	178.2	44.5	416.3	118.4	182.3	185.2	96.4	276.3	899.3	227.2	208.8	76.2	141.3	182.4	89.8	157.6	103.7	97.0	210.0	43.1	8.9	223.2	580.2	183.3	123.2	295.1
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340919-72376476	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA018082, HPA054583"	Supported		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		20000000	Vesicles	Cytosol	"HPA018082: , HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	30.1	37.4	23.1	18.0	22.9	35.5	37.8	23.3	28.1	30.6	20.5	19.4	30.1	18.5	25.9	65.7	11.7	21.8	29.2	33.8	23.4	12.8	34.6	29.5	43.9	31.4	24.9	21.1	20.9	22.2	18.1	22.9	37.9	18.8	18.1	26.0	26.9	24.8	22.0	17.7	17.9	24.6	23.4	21.4	31.5	22.6	18.0	22.9	12.1	31.2	11.1	16.4	26.7	17.1	16.1	37.9	22.4	32.7	17.8	18.1	21.3	7.5	12.8	5.5	10.6	45.5	51.9	7.9	10.6	53.8	23.0	36.8	6.7	55.4	6.3	10.2	21.3	12.0	15.1	14.6	6.7	14.6	5.1	5.8	7.9	12.7	11.6	35.2	18.9	22.7	44.1	20.2	10.0	17.9	42.2	21.0	9.4	12.2	39.2	30.6	6.5	4.1	9.5	3.1	24.7	0.1	4.2	12.0	14.2	25.7	11.9	4.8	5.3	26.5	25.1	59.9	11.7	4.6	23.9	10.6	34.5	14.4	31.7	11.2	20.9	28.2	6.5	12.5	25.3	16.7	8.9	32.7	22.4	18.1	13.7	15.8	16.1	12.0	15.8	37.9	15.6	9.5	14.0	3.1	17.8	4.8	14.4	10.7	21.3	23.1	22.9	23.3	28.1	23.4	12.8	24.9	21.1	18.8	22.9	59.6	55.5	41.1	30.3	19.7	40.2	22.6	35.7	17.4	28.4	62.8	100.1	116.3	51.4	65.3	16.3	43.0	46.2	0.0	33.3	55.3	62.5	30.5	29.9	37.8	207.1	25.4	45.3	44.2	76.0	10.5	68.7	108.5	89.4	50.5	39.4	48.4	43.8	84.5	42.1	55.5	56.1	45.3	20.6	20.4	28.2	13.7	131.8	47.5	44.4	25.0
HHIPL2	"FLJ13840, KIAA1822L"	ENSG00000143512	"HHIP like 2"	Q6UWX4	1	222522258-222548103	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 9.4;testis: 10.4;thyroid gland: 4.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 14.1;Late spermatids: 21.2;Spermatocytes: 8.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 16.2;Hep G2: 4.9;RH-30: 18.4;SuSa: 7.1;U-87 MG: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA059673	Enhanced		Uncertain	Mitochondria,Cytosol	"Secreted in other tissues"	No	NA			Mitochondria	Cytosol	"HPA059673: AB_2684100"	"unprognostic (1.35e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.91e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.74e-3)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (8.07e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.14e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-2)"	"unprognostic (4.21e-4)"	"unprognostic (2.30e-3)"	"unprognostic (8.38e-2)"	0.3	0.7	0.0	0.1	0.6	0.1	0.2	0.1	1.4	0.7	0.0	0.6	0.0	0.0	0.1	0.5	0.5	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.9	9.4	0.2	0.3	1.9	3.9	0.0	0.1	0.1	0.0	0.0	0.1	0.1	10.4	0.0	0.0	4.6	0.0	0.3	0.2	0.7	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.5	0.1	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	16.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	4.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.3	0.0	18.4	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.1	0.0	9.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.1	1.4	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	1.7	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.5	0.0	0.0	0.0	0.0	0.0
HORMAD2	"CT46.2, MGC26710"	ENSG00000176635	"HORMA domain containing 2"	Q8N7B1	22	30080174-30177075	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 21.3"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 115.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.2;U-2197: 3.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA003074, HPA043880"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA003074: AB_1850916, HPA043880: "					"unprognostic (1.43e-1)"		"unprognostic (6.77e-3)"	"unprognostic (2.33e-1)"		"unprognostic (1.36e-2)"			"unprognostic (8.19e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.12e-1)"		0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.3	0.1	0.1	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.3	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	115.1	2.7	0.0	0.0	0.0	0.0	0.0
HOXB7	"HOX2, HOX2C"	ENSG00000260027	"Homeobox B7"	P09629	17	48607227-48633572	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 62.3"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 82.0;Distal tubular cells: 126.0;Enterocytes: 102.1;Mucus-secreting cells: 73.3;Paneth cells: 56.1;Undifferentiated cells: 65.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"pons and medulla: 4.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 30.4;OE19: 26.5;RPTEC TERT1: 24.2;SK-MEL-30: 28.8"	"Region enriched"	"Detected in single"	45	"pons and medulla: 6.0"	"Region enriched"	"Detected in single"	14	"pons and medulla: 1.5"	HPA049940	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049940: AB_2616461"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.05e-3)"	"unprognostic (9.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (7.01e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.39e-4)"	8.3	8.3	0.0	7.3	0.3	0.1	17.2	0.1	0.6	10.0	8.1	0.1	24.1	0.5	4.1	62.3	0.8	4.2	0.3	1.1	0.0	0.0	23.7	0.8	1.7	2.4	0.1	0.3	2.3	0.6	0.4	0.5	4.1	4.1	5.2	7.0	0.1	0.1	22.1	2.4	2.2	12.4	3.5	20.1	2.2	4.6	3.0	0.2	0.1	0.5	0.1	0.6	5.8	15.1	2.2	1.8	0.0	0.0	2.0	4.7	0.5	16.9	7.4	0.0	0.1	5.3	8.0	0.0	0.0	0.0	0.1	0.3	11.3	0.3	0.3	30.4	7.1	8.8	2.5	0.0	0.0	0.0	7.8	5.5	2.6	5.8	0.0	4.4	0.0	5.5	5.2	2.3	5.2	0.0	1.3	16.0	5.3	2.8	0.1	16.8	4.4	0.3	0.1	0.0	26.5	0.0	0.0	14.4	1.9	24.2	5.7	0.0	0.0	5.7	0.0	28.8	0.4	1.4	1.6	13.7	0.0	9.3	7.5	13.1	0.9	2.2	0.0	0.1	0.0	21.3	0.0	0.0	0.0	3.8	0.0	1.9	1.9	0.7	2.1	0.0	2.2	0.0	1.4	0.0	2.0	0.0	1.8	4.7	0.5	0.0	0.3	0.1	0.6	0.0	0.0	0.1	0.3	4.1	0.2	0.0	0.0	3.7	0.8	4.8	0.0	0.3	0.0	0.0	0.0	82.0	0.0	6.2	126.0	0.0	0.1	2.2	102.1	0.0	1.1	14.9	8.2	0.7	4.7	0.0	8.8	0.0	35.1	1.3	7.8	0.0	0.6	2.8	23.6	2.8	73.3	0.0	0.5	56.1	0.0	27.8	0.0	0.0	8.0	1.4	23.4	1.8	1.5	1.0	65.0	3.1
HOXC6	"HOX3, HOX3C"	ENSG00000197757	"Homeobox C6"	P09630	12	53990624-54030823	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 31.2"	"Cell type enhanced"	"Detected in many"	12	"Distal tubular cells: 14.9;Fibroblasts: 27.4;Leydig cells: 20.8;Peritubular cells: 14.2;Spermatocytes: 39.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	17	"pons and medulla: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.1;fHDF/TERT166: 19.0;HDLM-2: 31.8"	"Region enriched"	"Detected in single"	23	"pons and medulla: 1.5"	"Not detected"	"Not detected"			HPA054981			Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA054981: AB_2682662"	"unprognostic (3.54e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.01e-4)"	"unprognostic (5.52e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.81e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (8.63e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.71e-2)"	10.9	11.2	0.4	1.2	0.4	0.0	16.3	0.4	0.4	0.7	1.9	0.6	0.4	0.0	3.9	14.8	3.1	13.5	0.4	2.0	0.4	0.0	11.3	0.4	0.9	3.0	0.4	0.4	31.2	0.4	0.0	0.4	4.0	7.0	0.8	0.0	0.4	0.4	0.4	11.0	7.6	8.8	6.1	8.1	1.0	0.3	3.3	0.4	0.4	0.6	0.8	0.4	0.7	2.5	0.0	0.0	0.1	0.0	0.0	0.5	0.0	2.5	1.8	0.0	38.1	13.9	13.3	0.4	1.9	1.9	3.1	2.9	1.6	2.9	1.1	2.5	19.0	0.9	4.3	1.5	0.2	2.8	31.8	11.0	2.0	4.9	0.0	1.5	0.2	4.8	12.6	2.0	6.2	2.2	0.0	0.1	0.1	1.3	0.0	11.0	0.6	0.0	1.2	0.0	0.3	1.6	0.0	1.4	0.0	9.6	0.1	0.0	4.7	2.9	2.8	7.8	3.4	6.7	0.5	0.0	4.0	8.6	4.3	2.7	0.3	0.3	0.0	1.4	0.3	8.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	7.0	0.4	0.0	0.0	0.0	0.0	5.6	0.0	0.3	0.0	0.0	0.0	3.5	0.0	0.3	14.9	0.0	1.1	0.2	0.0	0.0	0.0	2.5	27.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	20.8	0.4	11.8	0.0	0.0	0.2	0.0	0.0	14.2	7.8	1.9	6.5	5.0	39.3	1.1	3.4	0.2	0.0	0.0	0.0
ICAM2	CD102	ENSG00000108622	"Intercellular adhesion molecule 2"	P13598	17	64002594-64020634	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 74.5;lymphoid tissue: 63.9"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 46.1;Endothelial cells: 80.1;Ito cells: 147.3;Kupffer cells: 54.5;T-cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"HUVEC TERT2: 167.1;TIME: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA071155			Approved	"Plasma membrane,Cytosol"		NA	NA		1200000000	"Plasma membrane"	Cytosol	"HPA071155: "	"unprognostic (9.43e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.93e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.29e-1)"	36.0	3.6	8.4	13.0	11.5	8.3	34.1	3.5	7.7	9.4	9.7	5.6	2.8	6.4	9.8	5.2	9.5	7.4	8.8	22.8	9.5	8.9	10.5	8.7	27.9	24.0	12.3	3.1	6.3	7.4	3.1	4.5	36.8	9.1	7.9	8.5	8.1	8.8	4.3	17.1	5.5	10.8	13.9	10.5	63.9	8.0	4.0	7.4	14.3	11.6	9.0	18.0	12.8	23.6	49.0	30.9	56.5	74.5	26.0	65.3	67.5	0.0	0.0	0.0	0.0	1.4	1.5	0.4	0.1	0.1	0.0	0.1	0.3	6.9	11.7	2.1	0.0	0.0	0.0	0.1	0.0	0.2	2.6	0.0	10.5	0.6	1.2	0.2	1.7	0.0	0.0	0.0	0.1	0.0	0.0	167.1	9.9	8.6	6.9	0.0	0.0	13.1	1.5	0.0	0.0	0.0	7.9	0.0	16.3	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	42.2	0.0	0.1	0.8	0.0	6.6	2.2	10.5	0.0	2.2	0.0	56.5	30.0	8.9	45.8	66.5	52.8	36.5	60.1	42.8	30.9	49.0	65.3	40.7	3.6	26.0	74.5	10.0	64.5	67.5	8.4	11.5	3.5	7.7	9.5	8.9	12.3	3.1	9.1	7.4	0.0	12.5	46.1	3.4	6.5	0.0	0.3	0.0	6.7	6.8	7.0	0.0	0.4	0.0	0.8	0.5	80.1	0.3	0.0	1.2	0.3	6.9	1.6	11.5	1.0	18.7	0.0	1.2	147.3	54.5	0.0	0.3	23.4	27.0	6.4	1.4	0.4	5.1	5.8	1.8	0.5	0.3	6.5	4.4	0.2	0.2	4.6	0.8	52.4	1.7	2.6
IFI30	"GILT, IFI-30, IP-30, IP30, MGC32056"	ENSG00000216490	"IFI30, lysosomal thiol reductase"	P13284	19	18173162-18178117	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 348.5"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 159.4;Kupffer cells: 201.6;Macrophages: 219.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 348.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 145.5;granulocytes: 95.4;monocytes: 348.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 76.0;RPMI-8226: 82.4;SK-BR-3: 55.7;U-266/84: 91.1"					"Low region specificity"	"Detected in many"			HPA026650	Enhanced		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		89000	"Vesicles, Cytosol"		"HPA026650: AB_10602237"	"unprognostic (4.66e-2)"	"unprognostic (1.25e-4)"	"unprognostic (2.35e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.40e-1)"	"unprognostic (4.01e-2)"	"unprognostic (9.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.29e-11)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.59e-3)"	104.2	31.0	5.8	85.5	10.8	28.3	13.9	1.2	5.2	5.3	17.4	6.5	3.2	23.3	5.0	13.7	9.3	15.9	13.1	16.2	5.0	4.0	37.5	60.4	109.7	139.5	12.0	0.8	15.0	14.6	2.0	7.6	123.2	11.0	8.6	18.2	9.2	18.7	4.3	7.2	10.1	28.5	18.9	13.3	140.6	19.4	5.7	7.9	20.6	15.6	9.6	41.2	24.5	8.2	24.3	145.5	95.4	348.5	1.7	1.0	213.4	12.8	6.8	0.0	4.5	1.3	1.8	12.2	1.4	1.9	3.9	10.2	15.3	23.0	76.0	11.7	4.4	20.2	10.1	8.1	3.0	0.4	20.2	5.8	0.9	12.6	21.7	13.0	2.2	5.9	7.9	6.9	6.4	2.3	0.5	0.2	2.3	10.7	47.8	1.9	25.2	1.0	0.2	2.5	44.2	6.8	7.4	0.5	82.4	11.7	0.4	0.6	0.8	23.6	55.7	1.3	0.9	3.8	0.9	0.3	6.8	4.1	13.9	1.4	1.6	91.1	43.3	18.8	15.0	1.0	2.0	228.9	95.4	1.0	348.5	1.0	24.3	0.7	0.8	145.5	16.8	0.5	0.6	52.5	1.7	230.0	4.3	1.0	213.4	5.8	10.8	1.2	5.2	5.0	4.0	12.0	0.8	11.0	7.9	8.9	51.2	68.0	1.9	3.2	0.1	0.6	7.6	13.4	31.8	12.2	0.0	4.4	1.7	1.2	0.2	2.2	3.8	0.0	1.0	12.3	1.9	3.5	12.8	1.5	159.4	0.0	0.0	4.9	201.6	0.0	0.3	219.1	5.0	58.7	4.6	0.6	1.7	2.5	0.0	4.8	0.4	0.0	0.9	0.0	0.7	2.9	10.1	3.8	5.1	1.3
IFITM1	"9-27, CD225, IFI17"	ENSG00000185885	"Interferon induced transmembrane protein 1"	P13164	11	313506-315272	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, Osteogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Club cells: 187.7;Leydig cells: 278.5;Sertoli cells: 271.7;T-cells: 358.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"eosinophil: 56.6;gdT-cell: 120.0;MAIT T-cell: 80.7;memory CD4 T-cell: 128.1;memory CD8 T-cell: 121.4;naive CD4 T-cell: 123.5;naive CD8 T-cell: 123.4;neutrophil: 106.8;NK-cell: 164.4;T-reg: 70.4"	"Group enriched"	"Detected in all"	7	"granulocytes: 106.8;NK-cells: 164.4;T-cells: 128.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 122.7;BJ hTERT+ SV40 Large T+ RasG12V: 219.9;HMC-1: 67.9"									"HPA004810, CAB017615"	Enhanced		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"CAB017615: AB_2264496, HPA004810: AB_1851419"	"unprognostic (1.03e-3)"	"unprognostic (6.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.06e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (5.77e-9)"	"unprognostic (7.29e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-2)"	81.1	14.2	17.4	36.7	24.5	41.2	57.0	11.9	23.1	71.0	28.2	12.9	20.6	17.2	48.3	152.4	44.4	67.2	31.2	62.6	19.8	13.9	59.8	34.5	44.1	159.7	34.8	14.7	100.2	16.3	22.3	23.3	36.3	27.3	38.7	22.1	49.5	27.4	41.6	38.7	23.6	33.0	46.0	37.9	112.9	20.5	29.4	20.1	42.7	48.3	28.0	50.3	39.3	52.8	13.0	4.3	106.8	18.6	164.4	128.1	147.7	6.4	0.1	53.3	4.3	3.9	13.7	0.3	11.3	53.0	122.7	219.9	0.1	44.5	0.1	8.5	11.9	1.2	15.1	1.7	1.1	2.4	13.5	2.8	6.5	4.1	0.4	35.3	9.5	67.9	25.6	0.0	1.3	0.1	1.3	0.2	2.1	23.2	53.9	0.0	0.9	4.7	18.3	15.2	0.0	1.6	1.2	0.1	1.2	32.8	0.0	0.0	0.0	5.9	0.6	10.9	7.6	2.2	0.8	0.3	0.1	0.1	0.0	0.0	3.8	2.0	0.3	0.1	14.3	0.1	15.6	2.3	56.6	120.0	10.9	80.7	13.0	128.1	121.4	4.3	11.3	123.5	123.4	106.8	164.4	18.6	1.2	70.4	147.7	17.4	24.5	11.9	23.1	19.8	13.9	34.8	14.7	27.3	20.1	32.8	96.7	12.5	9.5	24.7	0.0	4.8	0.0	36.1	187.7	31.4	0.0	1.2	5.0	0.9	1.2	146.9	12.4	0.0	1.2	25.0	131.5	1.8	17.4	17.9	9.3	0.0	1.2	130.1	11.0	0.0	278.5	21.9	74.2	0.0	14.4	0.0	0.9	10.1	117.0	0.3	0.0	271.7	95.7	0.3	1.0	12.5	3.3	358.0	24.3	4.4
IL21R	CD360	ENSG00000103522	"Interleukin 21 receptor"	Q9HBE5	16	27402162-27452042	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 17.9;lymphoid tissue: 47.8"	"Cell type enhanced"	"Detected in some"	10	"B-cells: 11.8;Early spermatids: 5.2;Hofbauer cells: 7.0;T-cells: 8.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 10.3;HDLM-2: 43.9;Karpas-707: 20.4;RH-30: 15.4;RPMI-8226: 24.5;U-266/70: 10.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042296	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA042296: AB_10806236"	"unprognostic (2.91e-2)"	"unprognostic (2.65e-3)"	"unprognostic (6.64e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.14e-1)"	"prognostic favorable (7.29e-4)"	"unprognostic (8.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.50e-6)"	"unprognostic (2.26e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-10)"	"unprognostic (8.79e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.58e-2)"	0.8	0.6	0.6	33.6	3.7	5.7	0.6	0.5	1.6	0.5	0.9	0.3	0.0	0.5	0.5	1.3	1.0	0.8	1.1	1.8	0.6	2.3	1.6	1.3	5.6	20.9	1.3	0.0	0.5	0.5	0.0	0.9	0.9	1.9	0.9	0.9	1.8	3.7	0.3	0.7	0.7	4.0	0.6	1.7	11.2	1.3	1.0	1.4	47.8	1.3	0.8	31.7	2.7	0.8	11.5	1.6	0.7	17.9	6.3	10.3	4.2	0.0	0.0	0.1	0.1	0.0	0.5	0.3	0.3	0.0	0.0	0.9	0.0	0.0	10.3	0.1	0.8	0.5	0.0	0.0	0.0	0.0	43.9	0.0	2.1	0.0	0.3	1.4	0.0	0.6	1.6	0.0	2.8	0.0	0.3	0.0	0.2	0.1	20.4	1.5	0.0	0.0	0.2	0.3	0.0	0.0	0.1	15.4	24.5	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.5	1.1	0.8	0.3	0.2	0.0	10.3	3.6	2.3	2.1	0.5	0.0	0.2	0.3	0.0	9.8	5.8	3.6	1.0	6.3	10.3	1.6	11.5	6.9	6.7	0.7	6.3	17.9	0.7	7.6	4.2	0.6	3.7	0.5	1.6	0.6	2.3	1.3	0.0	1.9	1.4	0.0	2.2	11.8	0.1	0.3	1.5	2.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	5.2	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	7.0	0.0	0.0	1.3	4.5	4.0	0.0	2.2	1.7	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.1	0.0	0.6	0.1	8.2	0.0	0.0
INTS12	"INT12, PHF22, SBBI22"	ENSG00000138785	"Integrator complex subunit 12"	Q96CB8	4	105682627-105895986	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035772, HPA041814"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nuclear bodies, Plasma membrane"	"HPA035772: AB_10671109, HPA041814: AB_2677687"	"unprognostic (5.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.06e-1)"	16.7	13.5	18.7	12.5	20.7	25.3	20.0	17.3	18.1	14.5	17.0	13.4	11.6	17.0	16.1	17.9	13.6	14.4	12.3	19.3	18.3	15.3	18.2	21.4	15.4	12.1	16.5	11.5	15.0	16.0	17.3	20.7	11.2	17.4	18.1	15.4	10.4	14.8	13.7	28.2	14.1	21.0	16.6	19.3	15.9	14.9	12.6	13.8	22.1	31.1	15.9	15.4	13.8	12.6	20.6	27.6	33.3	17.0	27.1	21.9	14.0	12.7	6.8	15.7	16.2	15.5	18.5	11.4	15.2	15.8	19.2	20.0	9.6	14.6	18.5	8.5	17.1	14.9	7.5	17.2	21.9	23.8	19.3	10.4	13.9	11.1	13.5	25.0	24.4	12.7	17.4	28.5	19.0	28.6	12.5	17.6	15.7	20.6	14.5	20.5	13.5	28.6	15.2	6.8	18.7	10.5	14.7	17.1	14.1	17.8	8.7	17.0	13.6	10.7	17.8	16.7	12.9	14.4	14.4	11.4	12.6	13.0	13.6	16.2	22.5	20.8	27.5	14.0	16.7	24.9	33.3	15.9	24.1	17.9	16.8	20.0	20.6	20.6	20.2	18.0	19.3	21.6	20.2	12.1	27.1	17.0	27.6	21.9	14.0	18.7	20.7	17.3	18.1	18.3	15.3	16.5	11.5	17.4	13.8	11.9	7.3	22.4	10.3	9.7	9.6	17.3	17.8	5.3	5.7	3.5	9.8	14.1	36.5	19.4	33.3	13.5	8.0	0.0	17.7	15.1	9.7	14.5	24.3	8.9	15.5	9.5	5.8	12.9	6.7	20.9	11.2	9.1	6.8	19.0	5.5	11.2	16.6	8.2	7.8	12.9	9.0	0.0	10.3	13.0	12.6	9.2	15.3	10.7	8.3	10.0
INTU	"KIAA1284, PDZD6, PDZK6"	ENSG00000164066	"Inturned planar cell polarity protein"	Q9ULD6	4	127623271-127726737	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 112.4;Cone photoreceptor cells: 129.6;Rod photoreceptor cells: 185.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036714, HPA036715, HPA061467"	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA036714: AB_10670238, HPA036715: AB_2675267, HPA061467: "	"unprognostic (1.09e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.33e-2)"	4.4	4.8	8.3	3.7	23.0	7.3	8.1	5.6	12.6	7.7	4.0	11.9	5.6	5.9	10.2	14.6	4.0	8.1	4.7	3.2	12.0	8.0	5.7	2.4	4.9	3.4	7.2	8.1	9.9	4.1	4.7	25.8	3.3	12.3	5.2	4.8	9.1	5.2	4.2	3.3	10.6	3.1	4.4	9.1	3.8	6.1	6.9	8.0	0.5	7.9	2.8	2.3	4.6	5.0	1.4	1.5	4.7	0.9	1.0	0.9	0.1	3.3	2.3	12.6	4.7	1.8	4.4	1.0	2.0	1.0	1.3	2.6	1.7	3.1	2.8	3.3	2.0	3.9	2.0	10.0	1.9	3.9	1.2	3.0	3.5	4.0	4.2	1.7	3.1	1.8	1.8	2.1	4.2	1.0	3.9	3.8	1.3	4.2	2.9	1.9	1.6	1.1	1.8	5.9	1.2	2.3	1.2	3.1	0.8	2.6	2.6	5.9	4.2	4.3	2.3	1.5	6.7	2.7	1.9	3.2	3.6	2.9	3.5	2.8	1.9	2.8	0.9	3.0	1.6	2.2	2.8	0.8	0.5	0.9	0.6	0.8	0.7	0.7	0.6	0.4	1.4	0.7	0.8	4.7	1.0	0.9	1.5	0.4	0.1	8.3	23.0	5.6	12.6	12.0	8.0	7.2	8.1	12.3	8.0	20.8	12.5	0.5	9.8	5.4	58.4	12.7	7.6	112.4	25.0	3.5	129.6	6.8	6.6	6.2	9.1	5.6	0.9	0.0	4.4	5.1	5.9	7.3	4.7	2.4	2.6	35.0	11.1	7.4	1.5	8.4	13.0	7.4	6.8	0.0	5.5	15.8	2.9	0.0	11.0	6.2	185.9	0.0	7.6	7.7	20.9	5.4	1.6	2.2	6.3	6.2
IRF4	"LSIRF, MUM1"	ENSG00000137265	"Interferon regulatory factor 4"	Q15306	6	391739-411447	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 48.7"	"Group enriched"	"Detected in some"	6	"Melanocytes: 42.2;monocytes: 92.8"	"Cancer enriched"	"Detected in many"	9	"melanoma: 27.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 9.5;myeloid DC: 9.0;naive B-cell: 9.7;plasmacytoid DC: 10.4;T-reg: 4.8"	"Group enriched"	"Detected in many"	5	"B-cells: 9.7;dendritic cells: 10.4;T-cells: 4.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 50.2;Karpas-707: 46.7;RPMI-8226: 45.1;U-266/70: 42.2;U-266/84: 31.4;WM-115: 25.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002038, HPA002698, CAB013508"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893"	"prognostic favorable (6.44e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.00e-3)"	"unprognostic (1.72e-4)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.18e-7)"	"unprognostic (2.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.65e-2)"	7.1	0.5	0.4	36.6	0.4	18.4	4.0	0.4	0.4	17.4	13.9	0.1	0.4	5.0	2.2	0.7	6.4	1.2	4.1	1.6	0.4	0.5	1.4	5.6	4.2	31.5	0.5	0.0	1.9	0.7	0.0	0.7	0.5	0.1	1.5	4.8	15.8	21.3	1.9	0.7	4.5	11.1	0.3	0.6	33.8	4.6	1.7	0.1	15.2	1.3	2.4	48.7	8.4	4.2	9.7	10.4	0.0	1.6	0.2	4.8	1.3	0.1	0.0	0.0	0.0	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.9	0.0	45.1	0.0	0.0	0.1	0.0	0.0	0.0	7.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.2	31.4	13.7	0.0	0.0	25.6	0.0	1.6	0.0	0.6	1.2	0.0	9.5	0.9	0.9	9.0	9.7	1.6	0.7	0.0	0.2	1.2	10.4	4.8	1.3	0.4	0.4	0.4	0.4	0.4	0.5	0.5	0.0	0.1	0.1	0.0	4.0	12.0	0.1	7.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.6	0.2	0.0	0.2	0.2	0.0	0.0	1.8	0.0	0.0	3.1	6.9	42.2	92.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.1	3.8	0.1	6.2	0.0	0.0
ITGAV	"CD51, MSK8, VNRA, VTNR"	ENSG00000138448	"Integrin subunit alpha V"	P06756	2	186590065-186680901	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 7.7;monocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"RT4: 71.7;SuSa: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002499, HPA004856"	Supported		Approved	"Focal adhesion sites,Cytosol"		NA	NA		750000	"Focal adhesion sites, Cytosol"		"CAB002499: AB_563594, HPA004856: AB_1846316"	"unprognostic (4.03e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.61e-1)"	"unprognostic (9.11e-2)"	"unprognostic (8.07e-2)"	23.2	22.1	17.9	18.3	21.8	3.1	25.8	16.7	23.1	22.9	13.6	23.4	11.6	8.4	26.0	11.4	14.2	14.5	25.2	40.7	16.8	12.3	51.5	9.5	20.6	7.6	24.2	11.6	35.4	18.7	65.0	11.0	29.6	22.1	16.5	11.9	83.4	17.9	15.9	13.1	21.5	10.1	29.6	33.0	12.1	17.3	11.2	17.0	7.8	33.1	10.9	11.1	17.6	17.9	0.3	0.9	7.7	2.3	0.4	1.1	0.5	9.3	11.1	7.4	23.7	27.3	18.5	28.3	18.3	14.8	6.5	6.5	9.7	32.2	0.0	36.1	20.6	22.7	11.7	3.8	17.2	9.4	1.8	3.4	2.2	14.6	13.3	10.8	1.5	1.4	13.4	8.2	14.4	12.3	39.0	15.4	1.1	2.1	4.7	17.2	3.7	0.9	1.3	5.6	5.6	5.6	0.0	15.2	1.2	16.8	71.7	1.5	4.6	21.1	6.5	7.7	62.1	5.1	4.3	46.8	40.2	12.6	8.2	15.4	1.1	1.9	1.0	16.2	0.6	19.8	7.7	1.1	1.6	1.0	2.3	0.7	0.3	0.5	0.8	0.9	0.1	0.5	0.5	0.5	0.4	1.2	0.4	1.1	0.5	17.9	21.8	16.7	17.3	16.8	12.3	24.2	11.6	22.1	17.0	26.8	18.5	2.4	54.8	114.0	118.2	124.7	73.9	12.0	20.5	73.3	72.6	46.9	1.7	78.4	0.5	50.4	13.2	0.0	89.0	21.8	61.3	83.9	49.5	15.8	26.1	14.3	7.0	34.4	33.9	1.6	17.8	18.2	43.9	20.8	18.9	82.5	120.4	18.2	24.4	16.5	54.8	32.3	47.2	0.7	1.4	90.7	33.2	6.9	11.4	48.6
JPH4	"JPHL1, KIAA1831"	ENSG00000092051	"Junctophilin 4"	Q96JJ6	14	23568035-23578800	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.7;seminal vesicle: 37.8"	"Group enriched"	"Detected in many"	19	"Bipolar cells: 144.6;Horizontal cells: 387.7"	"Cancer enhanced"	"Detected in some"		"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 5.4;myeloid DC: 5.9"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.9;monocytes: 5.4"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 10.1;SH-SY5Y: 25.2;U-2 OS: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013492			Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB013492: "	"unprognostic (3.30e-2)"	"unprognostic (1.91e-3)"	"unprognostic (5.05e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.77e-3)"	"unprognostic (5.98e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.96e-3)"	1.9	12.3	33.6	2.0	43.8	1.3	1.6	45.3	63.7	3.4	1.9	2.1	8.0	1.8	17.1	6.2	1.5	5.1	1.6	1.3	32.3	16.8	2.7	1.3	3.4	2.0	8.3	27.6	6.2	1.5	3.1	23.2	1.6	9.8	11.6	1.7	0.8	1.2	37.8	1.2	1.6	2.2	13.9	4.2	2.9	1.7	2.2	10.9	0.0	1.3	0.0	1.7	1.7	1.8	0.0	5.9	0.4	5.4	0.0	0.0	1.0	0.0	0.0	0.5	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.5	10.1	25.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	5.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	33.6	43.8	45.3	42.6	32.3	16.8	8.3	27.6	9.8	10.9	0.0	1.1	0.0	0.1	0.0	144.6	1.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	1.6	387.7	1.7	2.5	1.3	0.0	10.0	1.8	0.0	0.0	0.0	1.5	0.0	0.0	13.8	0.0	7.7	12.9	0.3	0.4	2.7	0.0	0.0	0.0	0.0	0.8
KANK4	"ANKRD38, KIAA0172"	ENSG00000132854	"KN motif and ankyrin repeat domains 4"	Q5T7N3	1	62236979-62319414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4"	"Cell type enhanced"	"Detected in some"	18	"Cytotrophoblasts: 22.8;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 23.5;Hep G2: 9.8;SuSa: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014030	Uncertain		Uncertain	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"HPA014030: AB_2128155"	"unprognostic (1.66e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.74e-6)"	10.6	0.7	0.9	1.0	3.1	0.1	3.1	0.5	2.2	0.6	1.2	8.9	1.0	0.4	0.3	1.0	0.4	0.7	0.6	0.6	1.9	2.7	1.7	3.6	2.9	0.1	11.1	0.1	0.4	18.4	20.4	0.4	14.4	23.2	1.8	1.2	2.6	10.4	0.8	0.5	0.8	0.6	0.2	13.4	0.8	2.4	1.0	4.9	0.1	0.7	0.8	0.2	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	23.5	0.1	0.0	0.1	0.0	3.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	9.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.7	0.4	0.0	21.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	3.1	0.5	2.2	1.9	2.7	11.1	0.1	23.2	4.9	0.0	0.0	0.0	2.3	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.2	0.0	0.0	0.0	7.3	14.9	0.8	0.0	0.0	0.5	2.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.3	0.0	3.5	0.2	0.3	0.0	1.7	0.0	0.1	0.0	4.6	0.0	0.6	0.0
KATNAL1	MGC2599	ENSG00000102781	"Katanin catalytic subunit A1 like 1"	Q9BW62	13	30202630-30307484	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 107.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 30.6"					"Low region specificity"	"Detected in all"			HPA046205			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA046205: AB_10965325"	"unprognostic (3.34e-1)"	"unprognostic (6.44e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.84e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.42e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.83e-3)"	11.0	5.7	12.2	6.4	12.5	7.6	12.0	11.0	14.4	14.1	11.4	10.4	4.6	2.2	12.7	4.2	8.1	6.6	5.4	22.6	8.5	9.8	5.9	5.4	6.7	8.2	10.3	14.9	6.3	2.9	3.2	11.9	4.2	11.9	6.7	5.9	4.1	3.5	8.5	7.1	3.8	4.2	19.7	10.8	4.5	4.7	25.1	7.8	12.0	4.4	3.3	9.1	7.7	7.9	5.2	6.9	3.4	1.0	9.5	7.1	1.4	5.5	4.6	8.1	4.3	6.2	13.2	0.2	23.0	7.4	12.3	9.7	0.9	5.6	8.9	2.7	30.6	15.5	1.5	5.7	5.9	18.8	7.7	2.1	6.4	5.7	2.1	3.3	3.1	4.3	5.1	3.0	13.8	3.4	11.6	12.9	5.0	3.4	3.9	15.0	1.1	7.0	2.9	3.5	0.1	3.0	7.9	9.6	0.9	4.4	0.4	3.4	7.1	6.1	1.2	4.3	7.1	2.0	1.9	11.7	10.9	16.6	5.9	9.2	2.1	3.8	12.3	4.3	3.1	15.6	1.9	0.9	3.4	5.8	0.5	2.9	2.6	4.6	5.8	2.3	5.2	1.1	2.6	0.3	9.5	1.0	6.9	7.1	1.4	12.2	12.5	11.0	14.4	8.5	9.8	10.3	14.9	11.9	7.8	8.9	2.6	1.9	3.5	5.3	9.0	35.3	2.5	16.0	2.3	5.2	25.5	0.2	3.3	5.4	107.1	6.4	0.0	0.0	1.3	0.7	9.4	1.6	9.3	9.0	2.8	20.6	9.8	6.7	2.1	42.6	8.3	3.4	16.9	35.1	0.5	8.5	4.5	0.0	4.9	5.7	17.6	6.5	11.2	41.6	21.5	5.0	0.2	7.5	0.6	1.3
KCNA10	Kv1.8	ENSG00000143105	"Potassium voltage-gated channel subfamily A member 10"	Q16322	1	110517217-110519175	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 1.4;U-87 MG: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.2"	"HPA015061, CAB022564"			Uncertain	Nucleoplasm,Cytosol		No	NA			"Nucleoplasm, Cytosol"		"CAB022564: , HPA015061: AB_1855573"														"unprognostic (2.96e-2)"				0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.2			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNE5	KCNE1L	ENSG00000176076	"Potassium voltage-gated channel subfamily E regulatory subunit 5"	Q9UJ90	X	109623700-109625172	"Disease related genes, Predicted membrane proteins"			"Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.5"	"Cell type enriched"	"Detected in some"	5	"monocytes: 16.2"	"Group enriched"	"Detected in some"	8	"glioma: 7.9;testis cancer: 2.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 5.6;monocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.2;hTEC/SVTERT24-B: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042316			Uncertain	Cytosol		NA	NA			Cytosol		"HPA042316: AB_10795397"	"unprognostic (5.33e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-3)"	"unprognostic (7.83e-2)"	"unprognostic (5.64e-6)"	"unprognostic (5.10e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.37e-3)"	4.8	1.1	6.4	1.3	11.3	6.8	1.2	6.0	6.6	1.0	0.6	8.2	0.0	0.7	0.8	1.3	1.2	0.5	2.4	2.2	8.9	8.1	0.7	0.7	0.8	0.8	14.3	1.6	1.7	0.4	0.4	0.2	2.5	29.5	1.9	0.5	0.1	0.6	2.3	3.2	1.1	0.8	0.9	7.3	1.4	0.6	1.2	0.3	8.5	0.6	2.6	0.8	0.8	0.2	0.0	5.6	0.0	1.7	0.1	0.8	0.3	1.0	0.0	0.2	0.4	0.1	0.1	0.1	1.9	0.5	0.7	0.7	0.1	0.4	0.4	0.0	0.4	0.8	0.8	0.0	2.2	0.9	0.2	0.4	2.7	2.6	1.8	0.1	0.0	4.2	0.6	1.5	5.5	1.3	0.5	0.4	0.4	0.0	0.1	0.5	0.0	0.8	3.4	0.0	0.0	0.1	0.2	0.1	0.1	0.8	0.1	0.2	0.4	1.3	0.0	1.1	1.5	0.0	2.5	1.2	1.8	1.0	1.0	2.4	0.5	0.6	0.3	1.2	1.2	0.5	0.0	0.7	0.0	0.8	1.7	0.0	0.0	0.1	0.1	5.6	0.0	0.0	0.1	0.0	0.1	0.1	1.2	0.0	0.3	6.4	11.3	6.0	6.5	8.9	8.1	14.3	1.6	29.5	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	1.1	0.0	0.6	0.0	0.0	1.3	3.0	0.0	1.1	0.2	0.0	16.2	0.0	2.9	0.2	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0
KCNJ12	"hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v"	ENSG00000184185	"Potassium voltage-gated channel subfamily J member 12"	Q14500	17	21376197-21419872	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 39.4;skeletal muscle: 47.8"	"Cell type enriched"	"Detected in some"	7	"Horizontal cells: 84.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 39.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.6;HeLa: 5.9;PC-3: 6.3;SCLC-21H: 7.3;SiHa: 3.7;SuSa: 8.0;U-2197: 6.3"	"Low region specificity"	"Detected in all"							HPA027021	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"	"unprognostic (3.81e-3)"	"unprognostic (2.69e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (7.84e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.91e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.90e-2)"	"unprognostic (9.70e-3)"	1.2	1.3	1.9	0.9	2.9	0.7	0.9	39.4	5.8	1.2	0.8	1.1	0.5	0.5	0.8	1.4	1.5	2.1	0.7	5.1	0.9	1.4	1.2	0.5	1.3	0.4	1.3	3.4	0.7	0.5	10.6	0.7	0.7	4.0	0.9	0.6	1.7	0.6	0.9	47.8	6.0	0.6	1.0	0.9	1.3	0.9	1.3	0.9	0.0	1.0	7.5	1.1	0.8	1.5	0.0	0.9	0.0	0.5	0.0	0.1	0.0	0.0	1.1	0.4	2.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	3.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	5.9	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.1	0.0	1.5	0.0	6.3	0.0	1.0	1.6	0.0	0.0	7.3	0.4	3.7	0.0	1.5	8.0	0.0	0.0	2.8	0.0	0.5	6.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.0	1.9	2.9	39.4	5.8	0.9	1.4	1.3	3.4	4.0	0.9	0.0	0.0	0.0	0.0	1.3	0.8	12.5	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	0.4	1.4	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.2	84.2	1.2	5.5	0.0	0.2	6.9	0.0	0.0	0.0	0.4	11.2	0.0	0.0	3.9	0.6	1.4	0.0	0.5	0.5	1.3	1.9	0.1	0.0	0.6	0.0
KCNJ18	"KIR2.6, TTPP2"	ENSG00000260458	"Potassium voltage-gated channel subfamily J member 18"	B7U540	17	21692523-21704612	"Disease related genes, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"lymphoid tissue: 3.5;skin 1: 8.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.0;HDLM-2: 2.1;HeLa: 1.7;RPMI-8226: 1.0;U-266/70: 3.3"					"Region enhanced"	"Detected in many"		"cerebellum: 75.1"	HPA027021	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"		"unprognostic (2.41e-1)"				"unprognostic (3.90e-5)"			"unprognostic (2.56e-1)"						"unprognostic (1.95e-1)"			0.0	0.0		0.0		0.0	0.4		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	8.1	0.0	0.0		0.0	0.0	0.3			0.0		3.5	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
KDM1A	"AOF2, BHC110, KDM1, KIAA0601, LSD1"	ENSG00000004487	"Lysine demethylase 1A"	O60341	1	23019443-23083689	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005884, HPA053660"	Supported		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"CAB005884: AB_443964, HPA053660: AB_2682220"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.31e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (4.47e-12)"	"unprognostic (1.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.39e-1)"	15.1	19.0	19.7	16.8	23.2	24.9	19.3	28.0	26.6	20.0	20.6	15.1	21.0	16.2	28.9	30.6	20.9	22.0	15.7	18.6	16.4	18.9	15.9	14.8	15.1	19.5	13.8	25.4	27.4	21.4	24.6	28.7	19.3	20.3	20.9	21.6	16.4	21.3	19.9	24.8	23.3	16.9	19.1	10.7	16.2	17.1	78.4	12.1	48.1	20.9	19.1	22.1	18.7	21.9	9.1	9.7	5.7	6.9	3.8	7.4	1.9	30.3	15.7	44.9	39.6	11.9	15.2	32.0	12.9	16.3	26.4	23.6	14.7	29.5	22.6	18.6	21.2	13.4	34.1	41.6	24.6	33.6	20.5	25.2	31.7	26.2	35.7	15.2	24.4	14.0	14.1	17.7	28.0	19.8	23.3	32.9	42.0	34.7	10.7	18.7	18.0	53.2	18.7	29.2	16.9	22.9	51.1	29.6	15.3	22.1	19.6	56.2	42.5	58.3	15.4	19.2	32.9	15.4	18.3	26.6	11.8	19.9	21.8	17.6	13.9	10.9	26.3	12.3	29.0	16.7	2.8	3.7	5.7	5.9	5.9	5.2	9.1	5.4	5.7	4.4	3.3	7.1	7.4	0.3	3.8	6.9	9.7	5.8	1.9	19.7	23.2	28.0	26.6	16.4	18.9	13.8	25.4	20.3	12.1	17.9	26.1	9.0	22.9	16.6	27.5	21.6	15.3	26.8	17.0	22.7	25.5	25.8	14.9	30.7	32.2	12.8	14.4	0.0	21.5	47.0	17.4	18.6	11.5	13.9	13.3	14.3	21.9	14.1	13.9	16.3	19.8	15.0	11.8	28.9	20.5	19.3	25.4	14.0	21.5	12.6	20.0	0.0	15.9	100.4	63.4	11.2	13.8	8.7	24.7	17.5
KDM4A	"JHDM3A, JMJD2, JMJD2A, KIAA0677, TDRD14A"	ENSG00000066135	"Lysine demethylase 4A"	O75164	1	43650158-43705515	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA007610	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA007610: AB_1852006"	"unprognostic (7.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.18e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (4.88e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.32e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-1)"	12.8	29.5	12.7	15.4	19.7	11.2	14.5	23.4	22.3	17.5	18.8	20.7	17.6	29.0	18.2	14.6	19.1	19.7	15.4	10.7	11.9	11.5	13.9	18.5	15.3	14.8	14.8	16.3	22.1	15.1	22.3	22.4	13.8	19.1	15.3	20.0	21.6	17.9	12.9	13.2	23.4	23.3	16.1	13.8	18.6	15.2	6.9	14.1	29.7	18.5	11.3	22.3	17.2	15.5	6.7	5.9	12.8	7.2	6.2	7.7	4.6	10.6	9.9	16.0	28.4	15.8	15.0	11.4	10.1	11.6	15.5	15.4	11.3	9.6	14.0	10.5	10.1	11.8	11.2	19.8	12.0	16.1	9.8	16.3	19.8	14.9	9.1	15.1	14.2	16.0	16.3	19.5	15.2	19.2	11.9	16.1	12.2	9.8	20.1	11.2	8.4	11.1	12.1	26.7	9.2	10.0	14.9	18.8	9.9	11.0	21.4	14.4	13.0	22.1	15.3	27.8	24.9	8.9	48.2	12.3	9.3	15.0	8.3	13.7	9.2	11.0	12.6	9.7	12.0	17.5	11.1	6.8	12.8	6.9	5.6	7.7	6.7	6.7	5.6	5.9	5.1	4.6	4.0	4.5	6.2	7.2	5.3	7.1	4.6	12.7	19.7	23.4	22.3	11.9	11.5	14.8	16.3	19.1	14.1	8.9	21.1	2.2	4.2	8.1	20.8	6.8	7.6	26.8	4.5	1.8	35.3	7.1	5.0	7.9	9.2	7.1	13.8	0.0	5.9	4.7	8.3	4.8	12.7	8.6	7.5	30.2	11.5	9.8	6.4	4.4	11.5	7.7	1.7	10.0	19.3	10.6	8.9	10.5	13.8	5.7	23.4	6.5	6.2	0.7	1.0	4.1	6.8	5.7	14.0	5.0
KDM5B	"CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A"	ENSG00000117139	"Lysine demethylase 5B"	Q9UGL1	1	202724491-202809470	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 74.0"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 181.0;Spermatocytes: 261.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027179, HPA053723, CAB068193"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241"	"unprognostic (1.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.23e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.79e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.56e-2)"	"unprognostic (4.13e-1)"	7.7	7.1	5.9	8.2	7.8	14.8	12.3	12.7	9.0	12.9	9.6	5.1	9.7	5.0	13.6	9.4	17.6	8.6	8.4	5.7	6.1	4.5	6.0	4.6	9.0	5.4	3.7	7.3	13.3	9.0	9.8	8.6	23.1	5.0	11.3	9.0	16.0	11.1	8.8	4.3	19.5	7.3	10.1	4.9	6.9	8.2	74.0	5.2	25.8	9.1	6.2	10.4	12.2	12.6	4.1	3.0	16.0	5.2	7.3	4.4	2.6	10.6	4.3	28.9	13.9	13.7	12.4	24.4	7.3	11.3	7.7	8.2	3.6	11.3	0.0	5.0	11.4	5.7	16.4	13.6	12.0	9.9	0.1	5.2	5.8	4.1	5.8	11.7	18.0	7.7	12.9	20.0	11.0	14.5	20.8	17.1	7.2	18.0	0.0	7.7	10.8	5.0	21.5	19.6	7.4	7.6	21.2	0.0	0.0	11.1	18.4	8.8	19.5	15.5	9.5	12.9	39.6	19.5	12.9	12.6	6.8	5.1	0.8	4.2	1.1	0.7	4.5	6.0	6.7	2.8	16.0	2.9	6.4	3.7	3.4	3.1	2.8	3.3	2.7	3.0	4.1	4.2	1.8	9.5	7.3	5.2	2.1	4.4	2.6	5.9	7.8	12.7	9.0	6.1	4.5	3.7	7.3	5.0	5.2	83.4	33.4	5.4	32.8	57.2	30.9	7.3	10.2	54.9	40.9	15.7	58.9	35.8	5.0	41.9	155.3	25.3	16.1	0.0	19.5	25.5	34.2	40.2	25.5	9.6	7.0	14.3	41.9	19.0	17.8	181.0	33.6	10.8	25.3	10.0	31.3	68.3	38.0	17.3	30.8	5.9	133.9	32.3	21.7	261.1	71.6	101.6	68.9	12.5	27.0	45.7
KIAA0513		ENSG00000135709	KIAA0513	O60268	16	85027751-85094230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.6"	"Cell type enhanced"	"Detected in many"	15	"Horizontal cells: 46.1;Late spermatids: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 15.9;monocytes: 13.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012866, HPA014431"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		8400	"Nucleoplasm, Cytosol"		"HPA012866: AB_1852321, HPA014431: AB_1852322"	"unprognostic (1.98e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.85e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.88e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.34e-1)"	5.2	11.0	20.8	8.8	30.8	14.3	2.8	57.6	57.6	6.9	8.1	4.6	1.8	4.7	3.3	3.1	7.6	2.3	4.9	4.5	19.7	14.9	3.0	1.9	6.7	5.2	11.3	27.6	2.9	13.0	4.1	14.8	4.0	17.6	6.2	6.1	2.9	8.3	5.2	5.6	9.9	6.0	5.6	6.9	7.4	10.1	5.7	4.6	0.5	2.8	1.0	6.2	8.3	3.5	0.0	3.6	15.9	13.6	0.7	0.9	3.1	5.7	6.2	4.2	6.1	7.9	5.9	1.0	5.8	9.3	8.4	4.9	2.8	2.7	2.0	2.6	7.0	5.1	5.1	3.9	9.2	5.2	4.3	3.2	3.7	1.9	1.5	3.8	0.4	5.3	10.9	4.9	9.6	1.2	3.6	4.4	4.1	16.2	4.8	7.4	9.0	0.7	1.5	4.1	6.7	5.0	0.7	5.4	1.2	7.8	4.2	12.4	1.9	6.8	11.4	2.8	4.4	9.2	1.2	8.9	5.2	3.9	7.8	2.0	7.6	1.3	4.1	6.8	2.9	5.6	11.0	7.2	10.6	0.9	8.3	0.3	0.0	0.6	0.6	2.6	0.0	0.6	0.6	15.9	0.7	13.6	3.6	0.2	3.1	20.8	30.8	57.6	45.9	19.7	14.9	11.3	27.6	17.6	4.6	6.0	7.2	3.0	6.5	3.5	13.4	5.8	2.5	1.4	2.3	1.8	5.9	0.4	0.0	2.0	38.3	3.2	5.9	0.0	4.1	0.6	3.9	11.1	2.3	2.4	6.7	46.1	10.9	5.5	18.3	149.1	15.0	8.8	3.3	5.4	8.4	2.5	6.6	7.0	25.1	1.3	5.9	0.0	3.1	3.6	4.9	3.9	2.9	4.4	3.5	26.5
KLC1	"hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A"	ENSG00000126214	"Kinesin light chain 1"	Q07866	14	103561896-103714249	"Predicted intracellular proteins"	"Host-virus interaction"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 117.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB009798, HPA044617, HPA052450"	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009798: AB_2280879, HPA044617: AB_2679024, HPA052450: AB_2681838"	"unprognostic (6.93e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.67e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.62e-2)"	"prognostic favorable (6.75e-4)"	"unprognostic (6.84e-3)"	"prognostic unfavorable (7.17e-4)"	"unprognostic (6.58e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.49e-1)"	19.5	20.4	61.3	15.7	45.6	17.6	16.6	103.0	117.9	15.2	14.8	22.4	11.5	10.5	21.1	18.7	19.7	16.0	15.7	27.1	61.0	65.1	8.6	8.9	20.0	15.9	66.2	47.9	19.8	14.8	25.2	17.0	17.9	50.7	16.3	14.1	14.1	16.9	19.7	28.2	22.4	12.8	23.1	56.0	18.3	13.8	14.3	23.2	7.9	13.8	13.0	18.1	15.7	14.9	7.3	10.4	12.4	8.6	4.1	10.9	3.1	16.4	22.1	42.7	23.3	28.9	31.6	19.7	38.8	31.9	36.5	24.9	18.9	18.0	21.8	20.2	41.8	16.2	27.5	26.0	20.5	34.6	26.3	13.1	12.2	26.1	19.1	32.9	23.9	24.3	22.9	33.3	27.5	33.5	38.9	31.3	15.5	18.2	25.1	31.7	27.7	16.0	21.1	13.7	26.3	40.9	15.4	18.0	10.7	22.7	36.5	50.4	28.2	31.5	16.0	25.6	27.6	14.1	11.8	45.5	27.1	13.4	37.1	21.5	20.1	14.0	24.2	31.0	13.8	29.0	7.6	5.8	12.4	10.3	6.0	9.5	6.4	9.3	10.9	6.8	7.3	7.9	7.2	7.0	4.1	8.6	10.4	8.4	3.1	61.3	45.6	103.0	90.3	61.0	65.1	66.2	47.9	50.7	23.2	41.7	27.5	24.9	39.0	23.1	133.1	34.0	22.9	16.0	14.8	19.2	49.1	19.5	8.3	42.1	4.2	42.8	13.0	0.0	26.7	27.4	32.1	34.5	32.4	15.6	26.3	130.3	43.0	31.9	18.1	11.4	35.6	24.1	37.1	46.9	20.2	42.5	49.1	14.4	45.3	3.4	89.3	25.8	40.6	36.8	78.0	15.4	35.2	28.9	14.7	31.8
KLF6	"BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9"	ENSG00000067082	"Kruppel like factor 6"	Q99612	10	3775996-3785281	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Basal glandular cells: 1442.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013529, HPA069585"	Supported		Supported	Nucleoplasm,Nucleoli,Vesicles,Cytosol		No	No			Nucleoplasm	"Nucleoli, Vesicles, Cytosol"	"CAB013529: AB_2533431, HPA069585: AB_2686157"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.35e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (8.07e-3)"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.37e-2)"	69.8	10.0	8.4	26.3	10.6	80.6	101.1	7.4	10.1	28.6	31.7	10.3	9.7	11.0	24.9	28.8	38.6	28.0	38.6	18.6	7.8	5.1	32.2	32.5	46.0	35.8	13.8	4.2	20.2	23.8	7.5	4.7	26.1	11.2	20.1	21.0	13.2	26.9	16.5	57.8	60.2	44.8	42.8	17.0	20.3	26.7	14.3	10.0	12.5	41.0	28.8	21.5	44.7	30.7	15.6	29.8	77.8	18.7	13.0	30.8	23.2	13.2	3.6	6.9	2.2	40.3	40.4	4.3	22.8	11.7	24.4	16.6	9.3	17.9	3.8	5.3	24.7	19.0	8.1	4.2	21.1	20.5	18.6	2.5	0.5	4.1	8.7	17.3	2.5	13.1	13.3	40.3	17.4	33.2	8.7	24.9	2.5	4.1	29.7	31.0	0.9	4.6	3.8	2.6	7.1	6.5	3.0	7.1	13.4	24.0	13.2	3.0	2.9	5.6	16.3	34.2	19.6	8.0	2.1	32.4	33.1	4.6	19.5	10.4	5.7	18.5	7.0	8.9	3.3	10.2	50.9	17.0	43.7	27.1	14.2	23.9	15.6	30.8	26.8	13.1	12.5	9.6	14.8	77.8	13.0	18.7	29.8	22.2	23.2	8.4	10.6	7.4	10.1	7.8	5.1	13.8	4.2	11.2	10.0	1158.3	540.6	237.0	1442.7	520.2	42.2	53.1	293.0	254.3	251.4	130.9	31.4	113.5	18.3	616.6	54.4	455.0	961.8	70.0	474.3	369.8	410.0	832.0	597.5	234.2	510.8	35.0	381.0	212.4	420.1	42.4	120.8	593.9	458.9	839.6	556.8	32.1	706.5	466.4	125.9	61.9	78.0	135.8	372.0	6.2	13.6	549.2	163.8	409.2	300.8	382.6
KLF7	UKLF	ENSG00000118263	"Kruppel like factor 7"	O75840	2	207074137-207167267	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003423, HPA030490"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA003423: , HPA030490: AB_10601922"	"unprognostic (5.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.85e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.26e-4)"	"unprognostic (3.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.47e-2)"	22.2	10.1	10.3	15.1	12.0	40.7	17.3	30.2	12.0	12.2	12.1	14.6	9.3	5.7	19.7	13.4	11.6	10.2	13.8	12.1	10.3	8.0	9.9	8.4	17.1	15.7	12.9	9.1	17.1	6.1	3.0	6.4	7.0	17.4	10.2	6.7	7.0	8.9	9.3	6.2	7.9	11.9	24.2	25.7	11.3	10.7	7.9	14.7	14.4	10.8	8.5	8.3	18.4	18.2	4.5	3.0	24.0	11.7	12.9	9.0	3.5	4.5	3.2	8.7	0.6	3.0	8.0	1.8	5.3	4.2	8.2	3.6	0.0	3.7	0.0	3.4	10.7	14.3	11.3	7.4	24.2	4.4	3.1	0.4	0.1	8.9	1.8	5.3	2.3	3.6	10.6	8.2	5.7	19.0	11.9	9.5	2.4	0.0	4.3	6.3	0.1	2.8	0.8	5.1	0.5	1.6	1.2	2.3	3.2	2.0	3.5	13.5	16.5	4.5	6.4	4.3	7.3	1.0	3.6	18.8	16.4	7.9	6.9	6.2	3.3	2.2	0.0	14.5	2.0	3.2	11.5	5.4	6.8	0.9	6.8	0.4	3.0	5.1	1.0	3.0	4.5	9.0	6.1	24.0	12.9	11.7	1.4	4.1	3.5	10.3	12.0	30.2	12.0	10.3	8.0	12.9	9.1	17.4	14.7	38.7	7.0	15.0	23.7	19.5	5.6	12.5	20.4	8.1	15.9	8.7	11.8	0.4	1.7	20.8	4.5	58.3	0.9	0.0	44.8	0.2	12.4	9.7	11.5	13.5	13.1	11.1	5.8	86.0	44.8	3.3	12.7	20.0	3.3	17.2	0.7	8.2	55.3	0.3	9.6	4.5	8.5	45.3	20.2	0.5	7.5	13.4	0.9	4.9	0.6	7.4
KLF9	BTEB1	ENSG00000119138	"Kruppel like factor 9"	Q13886	9	70384597-70414624	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Smooth muscle cells: 214.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 22.7;ASC TERT1: 31.6;HHSteC: 40.6;HSkMC: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029308			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA029308: AB_10601923"	"unprognostic (2.12e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.64e-3)"	"unprognostic (4.34e-1)"	"unprognostic (5.55e-1)"	"unprognostic (9.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.44e-1)"	"prognostic favorable (6.59e-6)"	"unprognostic (1.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	35.9	15.3	6.8	8.8	25.8	6.1	25.7	42.6	21.4	10.2	20.0	9.7	16.1	6.0	19.6	13.2	17.0	22.2	17.8	18.2	8.4	4.0	26.2	36.7	22.6	5.1	26.3	8.0	22.1	21.3	13.0	8.6	3.9	14.7	12.4	11.0	20.4	31.4	10.7	38.9	12.6	17.6	25.0	12.0	8.6	16.7	5.5	25.2	1.9	24.0	20.3	5.4	15.4	11.9	2.8	1.7	2.8	0.7	0.7	2.8	0.6	0.1	0.2	0.0	2.8	22.7	31.6	0.3	1.4	9.8	0.5	1.1	0.0	1.3	0.0	1.1	2.6	0.7	0.0	4.3	6.6	1.0	0.0	3.4	1.5	4.8	0.8	40.6	0.7	4.0	27.0	6.8	0.4	9.6	13.7	8.7	0.6	2.9	6.0	3.7	0.4	0.1	2.1	0.2	0.4	1.4	0.0	1.3	3.7	1.8	0.0	0.4	1.9	13.4	7.8	15.4	0.9	2.6	2.3	11.8	2.6	1.9	3.0	0.7	4.3	4.6	0.2	2.3	2.3	13.0	2.8	0.5	0.3	1.6	0.3	2.3	2.8	2.1	1.6	1.2	2.5	2.8	1.6	0.0	0.7	0.7	1.7	2.2	0.6	6.8	25.8	42.6	21.4	8.4	4.0	26.3	8.0	14.7	25.2	38.7	21.0	13.2	56.7	42.7	40.6	62.7	48.4	18.7	28.4	14.0	19.6	0.1	26.6	7.4	17.2	139.1	35.5	0.0	11.6	0.2	78.1	86.9	7.0	140.6	3.5	76.3	13.3	97.6	59.8	11.6	84.0	36.1	37.1	4.6	29.3	151.3	10.9	28.5	79.9	29.8	8.8	77.6	214.2	1.0	3.9	29.9	0.0	24.5	27.3	22.8
KLRB1	"CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A"	ENSG00000111796	"Killer cell lectin like receptor B1"	Q12918	12	9594551-9607886	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"blood: 178.9"	"Cell type enriched"	"Detected in many"	21	"T-cells: 765.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 178.9"	"Group enriched"	"Detected in many"	133	"NK-cells: 53.0;T-cells: 178.9"	"Cell line enhanced"	"Detected in some"		"HEL: 3.0;Karpas-707: 2.2"					"Low region specificity"	"Detected in all"			HPA039113	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039113: AB_10674979"	"prognostic favorable (3.51e-5)"	"unprognostic (1.23e-3)"	"unprognostic (7.03e-3)"	"prognostic favorable (1.42e-5)"	"unprognostic (1.69e-1)"	"prognostic favorable (6.99e-5)"	"unprognostic (1.54e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.12e-1)"	"unprognostic (8.23e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (1.17e-2)"	3.8	0.8	0.8	22.8	0.8	18.6	2.1	0.5	0.6	2.9	9.1	0.0	1.3	5.0	1.8	3.7	2.6	1.8	7.3	1.3	0.7	0.8	3.8	4.9	11.8	23.7	1.1	0.2	2.0	1.0	0.0	0.9	2.1	0.8	1.8	3.9	0.9	4.8	1.4	0.9	0.8	20.4	0.6	1.8	25.2	4.4	1.3	0.2	6.2	1.9	2.9	17.7	5.5	2.0	0.1	0.3	0.8	0.2	53.0	178.9	18.5	0.1	0.0	1.5	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.1	0.0	0.9	0.2	1.9	0.0	0.0	0.2	0.0	3.0	0.0	0.4	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.2	2.2	0.0	0.8	0.8	0.6	0.5	0.5	0.0	1.1	0.3	0.9	0.0	0.5	0.4	0.6	0.6	0.7	0.1	1.7	0.3	0.2	0.0	1.6	0.0	0.4	0.7	0.6	0.4	1.5	0.0	1.8	1.0	0.5	0.1	0.0	43.1	0.1	178.9	0.1	25.6	28.1	0.1	0.1	1.5	8.7	0.8	53.0	0.2	0.3	5.7	18.5	0.8	0.8	0.5	0.6	0.7	0.8	1.1	0.2	0.8	0.2	0.0	12.8	14.5	0.6	8.7	0.0	0.8	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	5.1	1.3	0.0	5.5	0.9	0.0	0.0	35.6	22.5	0.0	0.0	3.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.5	0.0	0.0	7.8	0.8	765.3	0.3	1.3
KMT5A	"PR-Set7, SET07, SET8, SETD8"	ENSG00000183955	"Lysine methyltransferase 5A"	Q9NQR1	12	123383773-123409358	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064495			Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA064495: AB_2685273"	"unprognostic (5.62e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.90e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (3.88e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.75e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.06e-1)"	7.6	5.4	8.9	14.0	7.5	20.2	7.9	9.8	14.1	13.9	9.1	9.9	21.4	7.3	15.7	9.5	22.3	12.3	8.3	10.9	8.1	5.5	6.7	7.4	8.7	8.4	7.8	10.6	7.2	13.1	6.8	7.4	9.9	12.8	18.6	9.1	7.9	19.3	12.5	13.6	15.6	9.1	11.0	10.3	13.3	9.0	5.2	8.6	42.2	17.2	8.9	19.7	12.3	14.2	3.5	3.8	7.8	3.8	4.1	5.4	0.6	12.4	7.9	9.5	14.6	6.1	10.9	13.0	18.6	8.9	10.8	9.5	9.0	7.3	28.7	10.8	12.3	4.0	11.6	13.6	6.8	11.6	12.1	14.1	24.1	8.3	4.5	9.1	18.7	6.1	4.6	8.6	11.7	10.9	10.4	8.8	12.3	43.6	13.4	8.8	9.0	18.9	27.9	4.4	11.3	9.0	22.5	8.1	7.8	7.5	15.2	13.0	10.2	18.5	9.4	8.5	8.8	13.1	23.9	11.2	12.2	8.9	14.5	13.3	7.5	7.8	26.3	8.4	9.8	10.2	4.1	2.5	7.8	2.8	3.8	5.4	3.5	3.3	4.3	2.0	2.3	1.8	2.3	3.4	4.1	3.6	3.8	2.7	0.6	8.9	7.5	9.8	14.1	8.1	5.5	7.8	10.6	12.8	8.6	11.9	12.6	0.0	14.2	0.0	19.6	0.0	5.1	21.4	12.5	26.2	5.9	10.7	6.6	8.0	7.4	11.3	8.5	0.0	8.1	13.9	8.7	20.1	2.3	13.4	15.1	3.2	4.7	28.8	17.1	2.1	15.0	10.3	0.0	1.0	28.5	22.4	11.3	10.5	40.3	8.3	16.8	6.5	0.0	8.9	11.7	0.0	11.9	8.2	12.4	19.3
LAMP5	"BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46"	ENSG00000125869	"Lysosomal associated membrane protein family member 5"	Q9UJQ1	20	9514358-9530524	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.1;brain: 105.2"	"Cell type enriched"	"Detected in some"	7	"Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"basal ganglia: 105.2"	"Cell type enriched"	"Detected in some"	15	"plasmacytoid DC: 42.1"	"Lineage enriched"	"Detected in many"	30	"dendritic cells: 42.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 95.0;SH-SY5Y: 17.4;THP-1: 33.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004802, HPA070765"	Enhanced		Uncertain	"Mitotic spindle,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Mitotic spindle, Centriolar satellite"	"HPA004802: AB_10603682, HPA070765: AB_2686309"	"unprognostic (2.78e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.73e-4)"	"unprognostic (5.47e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (6.46e-6)"	"unprognostic (5.12e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.49e-3)"	0.5	4.1	21.6	1.5	105.2	2.0	1.0	2.3	28.6	9.1	1.3	0.6	1.8	1.3	4.6	6.0	0.6	9.7	2.9	0.6	18.7	4.1	0.9	0.5	1.1	4.8	4.5	7.7	21.2	1.3	0.3	2.0	0.4	23.2	2.3	1.4	2.6	1.4	3.6	0.3	0.5	1.4	3.8	6.7	1.4	1.6	1.1	4.8	0.0	1.1	0.0	4.7	1.2	0.6	1.4	42.1	0.9	0.5	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.1	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.9	0.5	0.0	0.0	0.1	0.0	1.4	0.0	0.0	2.8	0.1	0.0	0.0	0.1	0.0	0.0	42.1	0.0	0.7	21.6	105.2	2.3	19.1	18.7	4.1	4.5	7.7	23.2	4.8	0.0	1.4	2.2	0.0	0.1	7.5	0.2	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.6	5.8	0.1	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	1.1	57.2	0.0	0.0	1.2	5.6	0.6	0.2	3.3	8.2	0.0	4.0	0.2	0.0	0.0	0.0	4.9	0.0	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0
LCA5L	"C21orf13, MGC33295"	ENSG00000157578	"LCA5L, lebercilin like"	O95447	21	39405844-39445805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 57.2"	"Cell type enhanced"	"Detected in many"	28	"Early spermatids: 967.3;Late spermatids: 347.9;Spermatocytes: 191.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MCF7: 6.9;T-47d: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA019790, HPA032010"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA019790: AB_1845690, HPA032010: AB_2674110"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.53e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.95e-1)"	0.4	1.3	1.4	0.3	3.7	0.3	1.2	1.1	1.6	1.2	0.6	2.3	2.7	0.4	0.9	4.6	0.4	4.4	1.0	0.5	1.9	1.2	1.6	1.3	1.0	0.3	0.7	1.2	0.8	1.1	1.7	9.1	0.3	3.1	0.7	0.4	2.2	0.8	1.8	1.7	0.7	0.4	0.5	0.7	0.4	0.6	57.2	1.1	0.3	2.9	0.4	0.3	0.5	0.5	0.3	0.7	0.2	0.5	0.0	1.1	0.0	1.7	1.8	1.0	3.2	1.6	1.4	0.2	0.5	0.8	1.0	0.1	1.0	1.9	1.2	1.5	1.7	0.4	0.5	0.1	1.0	0.6	0.6	1.5	0.9	1.9	0.2	1.3	2.0	0.0	1.2	4.2	3.0	3.4	2.2	0.6	1.9	3.1	1.2	1.1	6.9	0.6	0.7	6.2	1.3	1.9	0.4	0.4	1.2	3.3	0.6	2.1	0.9	3.8	1.6	2.5	0.6	7.4	0.3	0.1	0.6	0.4	1.8	0.5	3.7	1.9	0.4	2.8	0.7	1.2	0.0	0.3	0.0	0.6	0.0	0.4	0.0	0.5	0.6	0.2	0.3	0.0	1.1	0.2	0.0	0.5	0.7	0.0	0.0	1.4	3.7	1.1	1.6	1.9	1.2	0.7	1.2	3.1	1.1	3.0	0.3	0.0	0.8	0.5	2.0	1.7	2.5	84.3	27.3	7.0	5.9	0.8	16.6	2.7	967.3	1.0	0.0	0.0	2.0	0.1	1.5	0.5	0.0	1.5	0.5	1.6	4.1	1.8	0.6	347.9	6.1	1.0	1.7	1.0	1.3	3.1	1.7	0.0	7.4	9.1	15.3	19.4	0.9	191.0	27.7	0.5	0.2	0.0	0.8	0.5
LGALS9B		ENSG00000170298	"Galectin 9B"	Q3B8N2	17	20449395-20467539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 13.4;esophagus: 13.6;stomach 1: 23.2"	"Cell type enhanced"	"Detected in some"	26	"Enterocytes: 7.8;Mucus-secreting cells: 17.2;Paneth cells: 43.5"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	15	"NK-cell: 13.4"	"Lineage enriched"	"Detected in single"	15	"NK-cells: 13.4"	"Group enriched"	"Detected in some"	7	"CAPAN-2: 13.6;U-937: 4.5"									"HPA046876, HPA047218"	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (4.69e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.05e-1)"	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	1.2	5.7			2.3	0.0	0.0	13.6	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0		0.0	0.0	0.0	0.0	0.0		0.4	8.4		1.8	0.0	0.0	0.3	2.6	0.0	0.0	0.4	23.2	0.0			0.0		1.0	0.0	3.4	0.3	0.4	0.2	0.3	13.4	0.9	1.7	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.2	0.2	0.0	0.4	0.3	0.2	0.4	0.2	13.4	0.3	0.2	0.0	1.7											0.0	1.1	0.0	0.1	2.1	0.0	0.0	2.5	1.4	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.5	43.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	5.1	0.1
LIMS4	LIMS3L	ENSG00000256671	"LIM zinc finger domain containing 4"	P0CW20	2	110446640-110473075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"	26	"Exocrine glandular cells: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.7;HHSteC: 2.5;hTEC/SVTERT24-B: 4.9;HUVEC TERT2: 2.8;U-138 MG: 5.3"									HPA058455	Uncertain		Uncertain	"Focal adhesion sites,Cytosol"		NA	NA			Cytosol	"Focal adhesion sites"	"HPA058455: AB_2683723"										"unprognostic (2.12e-1)"								4.0	4.1	0.0	0.3	0.0	0.6	1.5	0.0	0.3	0.3	0.6			0.3	4.1	0.3	0.3	3.7	0.3	3.5	0.0	0.0	5.5	2.7	0.8	0.3	0.0		1.9	2.2	0.3	0.8	0.6		0.3	0.3		0.3	0.3	5.6	0.4	0.3	0.3	0.0	0.3	0.3	1.3			1.1		0.3	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	2.7	0.2	0.7	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	4.9	0.0	0.0	2.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.2	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LMAN1	"ERGIC-53, ERGIC53, F5F8D, FMFD1, gp58, MCFD1, MR60"	ENSG00000074695	"Lectin, mannose binding 1"	P49257	18	59327823-59359962	"Disease related genes, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 369.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002320, CAB037163"	Supported		Uncertain	Cytosol		NA	NA		13000000	Cytosol		"CAB037163: AB_532237, HPA002320: AB_1079256"	"unprognostic (5.64e-2)"	"unprognostic (8.96e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.71e-3)"	6.2	7.7	2.6	4.5	3.0	1.6	5.7	4.6	1.8	9.8	3.9			5.7	6.7	7.4	6.6	6.5	3.8	8.0	2.7	3.0	9.1	26.2	7.0	2.7	2.8		8.1	15.3	12.7	9.7	7.1		8.2	5.0		8.4	6.1	6.9	3.4	6.1	4.6	3.5	4.8	7.5	2.1			12.3		3.9	4.7	5.6	6.9	8.2	4.0	3.4	9.0	9.8	3.8	18.7	11.1	11.9	9.9	27.9	48.3	24.1	34.0	48.8	23.0	30.9	11.0	18.2	3.3	24.2	40.3	16.5	23.1	16.9	19.2	42.0	12.7	10.8	10.9	14.9	22.8	33.2	37.8	16.8	32.1	23.2	22.2	45.7	43.4	23.1	11.6	18.3	37.4	22.3	5.0	10.9	7.8	8.2	9.5	13.8	12.4	21.7	36.3	12.8	14.2	8.2	8.9	17.1	16.8	19.2	17.5	12.4	14.8	19.0	37.5	13.1	11.9	19.7	28.6	14.2	16.2	39.3	20.2	30.5	4.0	2.3	0.6	7.2	3.4	9.8	6.9	7.9	7.5	3.1	4.7	7.6	7.5	0.3	9.0	1.9	8.2	8.7	3.8											95.3	75.6	40.2	99.5	62.0	36.5	107.3	68.8	120.5	94.4	76.8	100.1	135.4	18.3	109.7	19.1	71.9	34.5	0.0	73.5	233.6	149.7	186.9	32.4	369.6	72.2	55.6	49.5	84.1	33.9	6.3	102.4	44.4	64.1	62.3	110.0	95.5	79.1	59.6	80.2	62.0	60.8	64.7	72.9	37.1	59.8	49.8	193.4	52.2	80.9	90.2
LMOD2		ENSG00000170807	"Leiomodin 2"	Q6P5Q4	7	123655807-123664290	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"heart muscle: 117.3;skeletal muscle: 297.2;tongue: 100.1"	"Cell type enriched"	"Detected in some"	1164	"Cardiomyocytes: 1233.0"	"Group enriched"	"Detected in some"	20	"head and neck cancer: 3.5;prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HSkMC: 5.7;SuSa: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046370, HPA051039"	Enhanced		Uncertain	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane"	"Actin filaments, Cytosol"	"HPA046370: , HPA051039: AB_2681321"	"unprognostic (2.55e-1)"			"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.50e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.98e-2)"		"unprognostic (2.13e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.82e-3)"	3.3	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.2	3.8	0.0	0.0	117.3	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.5	0.0	0.0	2.6	0.0	297.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.4	100.1	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.3	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1233.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRMP	JAW1	ENSG00000118308	"Lymphoid restricted membrane protein"	Q12912	12	25004342-25108334	"Predicted intracellular proteins, Predicted membrane proteins"	"Fertilization, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.8;lymphoid tissue: 69.5"	"Cell type enhanced"	"Detected in many"	9	"B-cells: 52.5;granulocytes: 24.4;Kupffer cells: 29.4;T-cells: 40.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 51.8"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Daudi: 96.3;REH: 33.5;U-698: 110.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA002967, HPA018505"	Enhanced		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA002967: AB_1079161, HPA018505: AB_1851988"	"unprognostic (3.78e-2)"	"unprognostic (2.59e-3)"	"unprognostic (7.54e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.97e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.72e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.59e-2)"	5.5	1.4	15.1	51.7	2.9	19.2	4.6	0.4	5.6	1.9	3.6	2.1	0.9	3.2	1.4	1.8	3.9	2.3	3.0	1.7	8.1	1.8	5.5	2.3	5.6	57.8	3.5	4.7	2.3	15.1	0.4	2.1	1.7	7.4	2.8	3.5	1.3	4.1	2.1	0.8	2.7	13.2	1.8	5.3	27.6	3.6	0.7	2.8	67.0	3.6	1.7	69.5	10.4	5.7	17.4	5.7	51.8	12.2	12.0	7.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.3	0.0	5.7	0.0	0.0	0.0	7.4	8.5	0.0	0.0	0.1	0.0	0.0	0.0	4.9	1.1	6.4	0.0	0.0	8.1	13.7	0.0	0.0	0.0	33.5	0.0	9.5	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.2	0.0	0.0	6.3	1.1	110.1	0.0	3.3	0.0	17.0	5.4	51.8	6.5	10.5	5.4	17.4	4.1	6.6	5.7	13.3	7.1	6.9	39.3	12.0	12.2	5.4	0.7	4.7	15.1	2.9	0.4	5.6	8.1	1.8	3.5	4.7	7.4	2.8	0.0	7.4	52.5	2.5	0.8	0.2	0.4	0.0	9.4	15.9	0.0	0.0	0.1	0.0	0.2	1.5	2.1	0.0	0.0	7.5	0.1	0.5	0.2	24.4	1.0	11.5	0.0	8.5	4.9	29.4	0.4	0.9	20.0	5.0	1.8	0.0	0.0	1.6	3.5	4.6	13.0	0.2	0.0	0.2	0.2	0.0	4.8	0.1	40.3	0.2	14.4
LYPLA2	APT-2	ENSG00000011009	"Lysophospholipase II"	O95372	1	23790970-23795539	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063151			Uncertain	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA063151: "	"unprognostic (8.84e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (5.84e-5)"	"unprognostic (3.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.99e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.24e-1)"	12.4	13.6	14.8	13.3	34.8	20.6	13.5	10.7	17.7	9.9	21.2	12.3	5.6	21.3	10.9	17.2	25.4	19.2	21.6	14.4	9.9	9.5	33.2	34.5	14.3	19.0	7.6	12.8	10.3	18.3	32.0	12.0	31.6	35.4	14.8	12.7	11.3	21.1	11.2	14.2	17.7	24.0	9.5	5.4	22.1	19.1	9.9	6.9	27.7	16.5	9.5	16.5	15.3	13.5	29.5	32.3	50.0	40.6	32.0	48.0	42.4	25.5	15.8	19.3	22.3	9.8	11.9	26.6	15.8	15.1	15.0	12.8	21.8	41.6	13.9	22.3	14.9	10.6	24.3	13.9	41.0	6.4	26.0	19.6	17.5	26.0	35.8	15.2	16.4	23.1	14.7	25.4	22.6	8.6	19.3	35.3	15.9	24.4	14.0	16.4	25.3	22.0	26.7	39.3	21.5	22.3	24.4	11.1	25.6	35.3	19.6	28.0	48.6	17.9	28.7	26.8	14.7	23.3	17.3	30.3	15.1	20.0	18.2	13.1	38.0	32.1	19.4	24.9	37.9	19.0	28.9	40.6	50.0	48.0	39.6	38.7	27.6	40.1	41.6	32.3	29.5	35.2	36.0	48.4	32.0	31.2	24.6	35.6	42.4	14.8	34.8	10.7	17.7	9.9	9.5	7.6	12.8	35.4	6.9	8.9	26.4	19.0	29.7	34.6	31.0	13.7	35.7	37.5	20.5	34.9	17.7	93.7	58.0	104.5	13.5	26.9	80.5	23.3	98.3	88.0	17.6	27.9	36.8	28.8	60.5	22.3	42.6	17.8	16.8	9.9	9.8	20.4	18.6	82.0	39.0	26.1	99.3	53.5	6.0	76.2	20.4	25.8	12.4	6.8	19.0	36.3	96.9	32.4	45.1	36.5
MAOA		ENSG00000189221	"Monoamine oxidase A"	P21397	X	43654907-43746824	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 358.2;Proximal tubular cells: 497.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.0;MAIT T-cell: 1.3"	"Group enriched"	"Detected in many"	10	"monocytes: 1.0;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 40.4;HHSteC: 75.9;HSkMC: 19.1;hTCEpi: 21.4;RT4: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009437, HPA054807, HPA059299"	Enhanced		Enhanced	Mitochondria,Cytosol		No	No			Mitochondria	Cytosol	"CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970"	"unprognostic (9.54e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.98e-3)"	72.3	11.0	8.2	10.2	7.8	0.3	35.2	3.3	6.1	12.4	85.7	2.8	10.7	53.6	12.5	6.2	36.6	12.0	14.7	37.8	6.7	8.3	77.8	45.9	34.4	5.2	11.1	6.1	14.2	24.4	9.6	1.5	79.8	8.7	26.2	39.9	6.2	49.1	12.9	12.5	11.2	90.1	23.6	3.4	2.1	19.3	5.5	4.7	0.0	68.6	9.7	3.9	35.3	35.1	0.0	0.0	0.1	1.0	0.0	1.3	0.1	0.0	0.8	0.1	2.4	40.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	4.1	1.5	5.4	0.0	0.0	0.6	1.6	0.1	4.3	75.9	0.0	4.1	19.1	21.4	0.0	11.2	0.0	4.8	0.0	0.0	0.1	1.4	0.6	0.0	0.1	0.4	4.9	1.2	0.0	0.0	0.1	5.5	31.3	0.7	1.9	0.0	0.0	0.0	0.1	0.1	0.0	2.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	8.2	7.8	3.3	6.1	6.7	8.3	11.1	6.1	8.7	4.7	65.5	115.2	10.9	141.7	9.7	4.4	90.1	91.7	34.8	50.0	57.6	21.6	9.7	102.8	29.5	19.6	35.3	358.2	0.0	12.0	17.7	14.2	55.4	5.7	169.3	6.2	3.2	36.6	36.8	14.9	22.5	5.2	4.0	10.1	29.7	119.4	23.2	31.4	140.8	0.0	497.3	21.7	6.5	15.1	1.1	0.4	12.5	173.1	3.1	215.1	89.9
MAP3K19	"FLJ23074, RCK, YSK4"	ENSG00000176601	"Mitogen-activated protein kinase kinase kinase 19"	Q56UN5	2	134964491-135047468	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 18.3;fallopian tube: 23.9"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 151.3;Early spermatids: 55.2;Late spermatids: 74.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.8"	"Region enhanced"	"Detected in many"		"pons and medulla: 18.3"	"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.5"	"Group enriched"	"Detected in some"	4	"RPMI-8226: 4.1;U-266/70: 2.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 20.2"	HPA011388			Uncertain	Cytosol		NA	NA			Cytosol		"HPA011388: AB_1848822"	"unprognostic (7.12e-3)"	"unprognostic (6.55e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.04e-6)"	"unprognostic (1.50e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.83e-4)"	0.1	0.2	1.7	0.2	6.2	0.1	0.1	0.0	0.5	1.1	0.2	7.3	0.0	0.2	1.0	6.7	0.2	23.9	0.1	0.1	2.9	3.8	0.2	0.2	5.6	0.2	0.5	1.5	7.3	0.1	0.1	1.0	0.1	18.3	0.3	0.2	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.2	7.6	3.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	4.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.7	6.2	0.0	0.5	2.9	3.8	0.5	1.5	18.3	3.1	0.0	0.6	0.0	0.0	0.0	0.2	0.4	0.0	151.3	17.0	0.0	9.8	0.0	0.0	0.0	55.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	74.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	1.1	0.0	0.0	0.0	0.0	0.1
MDM1		ENSG00000111554	"Mdm1 nuclear protein"	Q8TC05	12	68272443-68332381	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 49.5;Spermatocytes: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"							"HPA040411, HPA041594"	Uncertain		Supported	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"HPA040411: AB_10805711, HPA041594: AB_10793968"	"unprognostic (7.41e-2)"	"prognostic favorable (6.01e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.63e-2)"	"unprognostic (5.23e-3)"	7.0	6.7	11.5	11.9	11.4	15.4	10.0	8.2	12.7	11.9	28.7	9.6	12.4	5.1	15.2	12.7	5.4	20.3	6.5	6.7	12.3	10.0	8.8	4.9	6.8	12.8	11.4	10.5	10.9	11.3	8.8	22.8	6.0	14.9	12.3	11.1	9.0	6.8	15.9	3.8	4.2	9.0	18.8	11.4	9.5	9.8	20.7	12.4	14.6	11.0	5.3	13.4	17.0	8.9	7.1	4.0	13.3	17.2	6.0	8.1	5.4	5.0	4.2	8.1	7.8	4.0	5.5	6.2	6.7	3.7	10.7	9.9	5.0	2.3	11.6	4.4	3.0	5.3	5.2	5.5	3.6	12.2	15.1	5.3	25.4	5.4	3.4	6.2	14.0	10.1	2.5	4.7	7.2	7.0	5.8	6.0	13.4	4.8	13.0	6.2	3.6	19.8	9.9	4.3	5.0	5.1	19.5	7.2	3.4	5.1	4.4	7.4	3.9	6.5	3.9	6.6	6.7	9.3	10.1	3.2	8.6	3.8	5.4	6.1	6.8	19.8	7.8	4.5	9.2	5.5	6.0	4.7	13.3	5.0	11.1	8.1	6.8	6.4	5.2	4.0	7.1	7.7	6.2	3.1	6.0	17.2	2.3	5.9	5.4	11.5	11.4	8.2	12.7	12.3	10.0	11.4	10.5	14.9	12.4	3.0	5.8	13.3	3.9	4.2	12.7	8.1	0.0	49.5	7.9	7.0	0.0	3.7	8.3	4.3	22.5	6.3	1.6	23.3	3.1	3.8	5.8	2.3	6.9	4.2	5.4	7.9	2.4	3.7	2.4	9.0	8.3	7.6	15.1	3.6	2.6	24.9	2.7	3.6	12.7	8.4	32.9	6.5	7.2	38.1	17.8	3.6	0.2	13.6	4.1	1.3
MDN1	"KIAA0301, Rea1"	ENSG00000112159	"Midasin AAA ATPase 1"	Q9NU22	6	89642499-89819723	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 27.1;NTERA-2: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029666, HPA029667, HPA029668, HPA029669"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Nucleoli, Cytosol"	"Nucleoplasm, Intermediate filaments"	"HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429"	"unprognostic (2.00e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.28e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.09e-2)"	10.0	8.8	8.6	10.1	18.2	16.1	14.9	19.2	18.7	9.1	7.5	14.8	8.6	5.9	14.1	10.0	9.2	10.2	6.4	8.6	9.4	9.6	9.4	15.1	7.3	10.9	13.1	12.4	22.3	10.7	19.0	10.9	5.9	15.9	8.1	8.6	9.4	9.3	8.3	16.2	19.6	8.8	9.2	12.7	9.0	8.2	14.0	13.7	8.4	12.8	8.2	12.7	7.5	7.8	3.8	8.9	6.7	1.0	3.3	4.2	0.3	4.6	4.6	4.8	4.5	7.9	7.5	4.8	3.2	2.4	3.6	4.5	10.6	1.7	14.0	3.7	3.3	3.9	4.1	12.4	4.3	6.5	5.5	8.2	15.2	5.9	6.9	3.0	19.6	3.8	4.6	3.7	9.7	9.0	2.2	6.4	6.4	27.1	3.4	3.5	5.6	3.0	7.4	26.4	3.9	4.0	6.1	9.1	3.5	3.2	6.6	8.7	3.9	4.5	2.7	2.9	6.6	1.9	8.7	8.2	2.4	4.5	3.2	7.4	3.9	4.3	6.9	3.3	11.2	4.2	6.7	1.0	1.9	2.4	0.8	2.1	3.0	3.3	2.6	0.6	3.8	4.2	3.3	0.2	3.3	1.0	8.9	1.3	0.3	8.6	18.2	19.2	18.7	9.4	9.6	13.1	12.4	15.9	13.7	26.8	15.5	8.5	5.2	26.1	24.4	30.7	7.6	13.4	25.0	14.0	23.6	4.9	0.0	5.9	6.0	13.3	4.6	23.3	6.9	5.7	10.0	7.3	5.8	41.4	5.9	17.5	7.5	9.2	3.3	2.5	6.6	6.6	11.8	2.8	6.9	7.8	5.6	3.5	8.1	1.8	19.5	0.0	9.5	21.7	50.0	26.3	2.9	9.6	9.3	8.7
METTL25	"C12orf26, FLJ22789"	ENSG00000127720	"Methyltransferase like 25"	Q8N6Q8	12	82358497-82479236	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039534, HPA041207"	Uncertain		Uncertain	"Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Plasma membrane, Mitochondria, Cytosol"		"HPA039534: AB_10794749, HPA041207: AB_10794406"	"unprognostic (1.60e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.00e-3)"	"unprognostic (2.15e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.44e-2)"	8.3	9.2	8.7	8.5	8.1	5.0	11.1	23.6	8.3	8.2	7.7	8.1	9.0	7.5	8.2	9.1	10.0	8.0	5.8	8.7	9.1	3.1	8.8	6.3	6.5	8.1	7.6	5.7	10.8	6.5	7.8	25.9	6.8	7.6	8.0	9.2	5.8	10.5	6.0	10.7	9.7	8.2	7.5	5.8	8.6	6.7	11.0	13.0	9.9	10.2	8.7	7.4	8.8	8.5	7.9	13.2	14.4	7.6	9.8	7.6	3.8	1.4	3.3	4.5	0.9	5.1	6.0	4.6	7.0	4.0	3.7	2.7	4.3	3.9	8.6	1.5	5.1	0.9	1.5	8.9	1.1	2.4	8.2	7.5	4.1	1.8	4.1	3.1	7.2	5.0	4.4	4.2	1.2	0.0	7.3	7.6	3.1	3.1	3.9	3.8	4.9	3.1	6.3	6.8	3.9	1.0	1.7	2.7	4.4	11.5	5.2	3.4	2.6	2.5	4.2	4.4	3.9	3.7	6.8	2.8	1.7	1.6	2.8	3.9	4.9	3.0	3.2	2.8	4.4	3.9	14.4	7.6	4.4	4.9	6.4	7.3	6.4	5.3	4.0	6.0	7.9	7.6	5.4	13.6	9.8	5.7	13.2	4.5	3.8	8.7	8.1	23.6	8.3	9.1	3.1	7.6	5.7	7.6	13.0	8.9	8.1	3.7	6.4	4.0	6.1	10.1	7.6	16.0	3.4	3.5	5.9	10.0	6.6	4.2	2.8	6.2	4.5	0.0	2.7	4.4	6.1	4.2	3.5	3.9	5.0	3.2	7.0	6.7	3.1	1.1	4.4	5.4	5.0	15.4	4.2	3.5	4.1	5.5	9.9	6.8	9.7	0.0	5.1	11.8	6.4	5.4	6.5	4.9	5.5	3.1
MICAL2	KIAA0750	ENSG00000133816	"Microtubule associated monooxygenase, calponin and LIM domain containing 2"	"O94851, Q6ZW33"	11	12094008-12359144	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Actin-binding, Developmental protein, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 138.4"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 73.9;Late spermatids: 128.9;Peritubular cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebellum: 138.4;cerebral cortex: 39.8"	"Cell type enhanced"	"Detected in many"		"neutrophil: 12.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030437, HPA039895, HPA040438"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA030437: AB_10601873, HPA039895: AB_2676731, HPA040438: AB_10672896"	"unprognostic (2.68e-2)"	"unprognostic (1.77e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	4.1	3.3	15.4	7.3	15.1	6.8	2.9	138.4	39.8	6.6	14.7	2.7	2.9	7.2	14.7	7.7	11.5	5.4	11.1	24.8	22.0	6.9	2.9	3.9	12.8	2.3	5.6	17.9	3.9	4.4	0.7	2.4	5.0	5.5	3.3	15.1	2.8	2.9	8.4	14.6	9.3	10.8	22.7	7.6	2.6	5.9	24.6	0.6	0.0	4.5	1.9	2.2	7.8	3.2	0.2	5.5	12.2	6.7	3.7	3.5	2.1	11.8	6.3	0.3	1.4	1.6	3.0	7.5	18.9	21.4	7.4	11.6	13.2	8.5	0.3	4.1	13.2	21.2	8.4	2.3	30.4	18.4	13.7	1.5	11.2	1.2	0.9	14.2	2.1	1.4	5.3	5.4	32.6	31.9	13.8	16.9	0.8	19.5	0.5	11.9	0.7	0.1	1.0	0.4	8.4	5.9	0.1	7.5	7.9	1.5	14.9	6.1	0.5	6.2	17.3	1.2	4.7	1.7	0.6	30.1	40.3	15.2	6.6	16.4	0.4	0.9	0.4	24.5	3.0	0.8	0.1	6.7	0.5	2.8	1.7	3.5	0.2	1.7	1.7	5.5	0.2	0.2	0.9	12.2	3.7	0.5	1.0	2.1	2.1	15.4	15.1	138.4	39.8	22.0	6.9	5.6	17.9	5.5	0.6	38.7	29.6	4.2	6.7	9.0	2.8	28.1	7.6	5.3	11.4	3.5	0.0	2.1	0.0	9.6	73.9	7.1	31.5	23.3	12.4	9.5	4.5	7.0	1.1	17.8	3.0	0.0	21.7	11.1	11.1	128.9	19.5	8.9	5.0	8.2	10.0	0.2	29.0	14.1	106.1	0.6	1.6	12.9	27.6	0.9	0.9	8.3	1.9	9.2	9.9	9.7
MIS18BP1	"C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1"	ENSG00000129534	"MIS18 binding protein 1"	Q6P0N0	14	45203190-45253540	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA006504	Approved		Approved	Nucleoli,Cytosol		NA	Yes			Nucleoli	Cytosol	"HPA006504: AB_1078317"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (4.18e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.21e-1)"	10.3	5.2	5.1	22.5	5.7	26.3	14.1	1.8	5.7	9.0	11.8	2.3	7.6	6.0	9.8	9.5	10.2	8.6	5.7	5.3	5.1	2.8	5.0	4.3	14.3	23.9	4.5	4.1	12.5	7.1	1.8	5.2	9.5	6.7	7.9	7.6	1.9	12.5	10.2	3.0	8.4	10.7	7.3	10.2	22.5	6.9	9.5	3.1	38.4	7.1	8.2	15.5	8.2	7.7	13.1	14.7	23.6	22.6	4.5	4.8	4.0	21.0	7.9	16.5	7.2	5.1	7.3	12.2	14.6	7.7	12.2	15.2	4.2	20.4	29.1	6.4	7.2	5.2	14.8	9.7	7.4	23.0	15.3	6.1	17.4	9.8	5.4	3.4	40.1	16.3	5.2	3.0	7.2	6.8	7.9	14.8	5.6	7.6	6.9	11.8	7.7	16.7	17.7	12.5	10.4	9.9	20.0	6.7	11.2	6.2	8.8	11.6	5.1	5.9	10.0	5.3	10.3	11.9	23.0	8.1	6.5	19.8	7.9	6.4	6.2	8.2	13.6	3.6	16.8	9.1	23.6	14.2	16.2	3.9	13.2	4.1	13.1	3.6	3.2	9.6	12.9	2.4	2.5	8.5	4.5	22.6	14.7	4.8	4.0	5.1	5.7	1.8	5.7	5.1	2.8	4.5	4.1	6.7	3.1	23.8	23.8	43.1	9.7	17.9	7.9	11.8	10.2	20.1	35.2	8.7	15.7	30.2	5.0	11.5	2.9	28.7	11.1	23.3	9.7	38.0	14.2	17.4	41.7	6.7	32.5	0.0	26.5	30.1	69.4	3.6	51.2	58.2	5.0	70.3	23.5	4.8	11.1	34.8	57.0	3.6	8.2	0.0	14.2	67.2	107.7	23.1	16.2	47.3	24.4	11.0
MLLT3	"AF-9, AF9, YEATS3"	ENSG00000171843	"MLLT3, super elongation complex subunit"	P42568	9	20341665-20622543	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Mucus-secreting cells: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 14.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 3.8;T-cells: 14.4"	"Cell line enhanced"	"Detected in many"		"HEL: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001824	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA001824: AB_1079394"	"unprognostic (3.31e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-1)"	8.6	17.3	18.0	10.4	25.8	19.7	11.4	34.6	20.3	12.3	20.9	7.2	10.6	7.2	13.6	7.9	10.2	11.5	12.7	8.6	18.0	12.8	10.1	2.1	10.7	9.1	14.8	13.8	10.5	4.6	18.3	24.7	10.3	13.2	11.7	22.8	7.4	21.3	12.1	9.1	7.9	12.3	13.5	12.0	5.9	15.3	3.6	21.4	22.1	22.5	6.1	6.5	12.9	10.4	1.4	0.7	1.6	0.3	3.8	14.4	2.8	2.6	7.2	2.6	2.9	6.0	3.7	1.6	6.8	11.5	3.1	3.5	7.0	2.5	10.0	3.7	3.2	0.9	1.3	2.4	11.8	2.8	20.6	6.3	73.6	22.3	3.3	4.3	1.3	6.2	2.8	4.5	1.1	7.4	10.4	3.0	4.2	0.0	12.9	6.4	2.0	7.2	4.3	1.6	14.4	2.1	0.0	4.7	2.7	14.1	3.9	8.3	2.9	5.5	2.8	3.0	2.6	2.9	1.9	2.0	0.0	1.7	1.7	2.4	5.8	5.3	4.1	0.0	3.2	1.4	1.6	0.3	0.5	3.9	0.2	3.6	0.5	7.0	5.3	0.7	1.4	14.4	8.3	0.1	3.8	0.3	0.4	7.3	2.8	18.0	25.8	34.6	20.3	18.0	12.8	14.8	13.8	13.2	21.4	26.8	23.0	7.3	15.3	7.3	5.5	12.1	7.6	9.4	38.7	21.0	31.4	0.9	11.6	23.0	2.7	8.6	13.6	0.0	7.3	5.3	16.7	15.6	11.5	1.7	2.0	4.8	31.7	6.7	2.6	4.2	12.7	3.2	21.9	1.0	101.9	37.2	18.7	17.3	8.9	7.0	1.0	0.0	16.5	0.1	5.6	7.3	1.4	25.4	28.6	13.2
MOB3A	"MOB-LAK, MOB1C, MOBKL2A, moblak"	ENSG00000172081	"MOB kinase activator 3A"	Q96BX8	19	2071038-2096673	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 69.3"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 70.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057744			Uncertain	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA057744: "	"unprognostic (2.05e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.33e-6)"	"unprognostic (3.40e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.16e-2)"	"unprognostic (7.74e-3)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (5.90e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-1)"	19.6	9.5	9.8	31.9	10.0	27.4	11.9	11.1	9.2	15.5	19.2	12.7	7.7	7.7	19.9	9.2	14.3	16.7	14.1	10.6	10.0	6.9	10.7	5.7	14.9	39.6	9.4	6.4	15.6	8.2	6.7	7.0	15.9	8.8	15.3	9.2	13.4	11.6	13.1	7.9	12.0	18.2	17.0	7.6	37.3	12.5	8.3	10.0	39.3	11.7	6.7	42.2	17.1	13.1	11.6	14.5	69.3	22.0	13.0	16.5	17.1	14.1	5.8	6.9	6.6	16.5	18.2	5.4	8.9	5.6	6.1	4.9	2.3	5.1	36.3	3.2	15.3	4.9	6.0	3.8	19.7	4.9	12.7	1.9	7.9	4.1	3.1	16.3	12.3	40.9	10.7	13.1	16.6	7.1	7.0	11.3	7.0	4.0	36.5	8.8	5.6	6.4	12.5	2.1	1.7	4.2	3.9	2.0	28.2	7.5	3.5	4.4	5.9	4.5	4.8	4.9	5.4	5.1	20.1	19.2	7.4	4.1	13.7	5.2	7.2	25.6	28.7	19.9	8.3	8.8	18.0	20.6	23.9	16.5	20.8	14.2	11.6	12.3	13.6	14.5	10.7	9.4	11.8	69.3	13.0	22.0	8.3	14.7	17.1	9.8	10.0	11.1	9.2	10.0	6.9	9.4	6.4	8.8	10.0	3.0	5.0	50.6	9.8	13.4	3.1	3.2	2.5	8.1	7.9	10.4	19.6	7.9	3.3	9.5	1.2	10.7	14.2	0.0	8.2	48.6	12.6	10.3	27.6	4.0	28.8	1.6	14.3	14.7	70.3	4.0	17.0	36.1	15.1	49.5	10.5	6.2	9.2	8.6	15.9	6.8	6.6	6.5	12.0	6.6	6.4	13.9	23.0	40.6	7.6	10.1
MOB3B	"C9orf35, FLJ13204, MOB1D, MOBKL2B"	ENSG00000120162	"MOB kinase activator 3B"	Q86TA1	9	27325209-27529781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.2;ovary: 29.9"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 47.8;Muller glia cells: 68.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.8;myeloid DC: 4.6;naive B-cell: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.1;HAP1: 10.4;K-562: 29.7;SK-BR-3: 12.5"	"Low region specificity"	"Detected in many"							HPA057744			Uncertain	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA057744: "	"unprognostic (6.96e-3)"	"unprognostic (9.60e-2)"	"unprognostic (5.10e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.28e-1)"	"unprognostic (9.45e-2)"	"prognostic favorable (2.33e-10)"	"unprognostic (1.55e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (7.99e-2)"	6.0	2.3	6.2	4.2	18.0	1.0	7.0	5.0	13.9	7.8	13.2	32.6	2.8	19.0	10.9	6.1	4.3	9.4	5.8	2.0	9.8	6.4	8.6	1.9	7.5	4.2	19.7	6.2	29.9	4.5	0.9	1.8	5.3	17.2	2.8	14.9	5.7	3.9	3.8	8.5	7.1	16.6	7.5	33.2	8.6	6.2	3.7	17.5	0.6	7.0	2.9	6.2	4.0	5.2	5.9	4.6	0.0	1.4	0.0	0.1	0.5	2.0	1.5	4.8	0.0	1.2	0.1	10.1	0.0	0.1	0.1	0.1	1.1	0.0	0.0	2.1	0.0	0.0	6.8	10.4	8.2	0.0	4.6	1.6	3.0	6.3	0.0	0.0	0.0	0.6	2.2	8.7	0.0	1.6	0.0	0.0	0.0	29.7	0.1	0.0	0.0	0.0	0.0	6.1	3.8	0.5	2.0	0.5	0.0	2.9	3.9	0.0	1.5	1.7	12.5	2.9	6.6	0.8	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.9	0.0	0.0	1.4	0.0	4.8	0.0	0.0	4.6	5.9	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.5	6.2	18.0	5.0	12.0	9.8	6.4	19.7	6.2	17.2	17.5	3.0	5.5	18.6	6.8	20.1	1.2	1.2	30.6	1.4	4.5	10.4	0.0	18.9	8.3	13.5	0.7	4.3	47.8	0.0	18.5	45.9	11.2	4.0	1.1	2.6	4.6	1.6	2.4	6.2	11.6	1.7	14.7	22.9	15.1	8.2	27.2	68.7	10.1	17.5	15.2	9.1	1.3	0.0	12.2	1.4	1.7	8.3	9.8	1.0	31.1	6.2
MOB3C	"MOB1E, MOBKL2C"	ENSG00000142961	"MOB kinase activator 3C"	Q70IA8	1	46607715-46616891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA057744			Uncertain	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA057744: "	"unprognostic (1.76e-3)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.32e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (7.22e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.61e-3)"	16.9	9.0	8.8	8.0	14.7	4.1	12.1	19.7	7.5	10.7	11.2	9.3	11.8	8.8	8.4	12.9	12.6	9.6	10.8	12.3	10.1	5.6	9.1	8.8	13.3	7.8	13.2	6.8	12.6	29.8	10.4	10.9	12.8	12.5	12.2	9.3	9.5	16.8	12.5	20.2	6.0	12.5	9.8	5.5	14.7	10.9	4.2	9.4	3.1	11.1	19.1	11.4	10.8	16.0	9.3	7.1	15.1	9.0	16.1	21.5	11.4	7.4	3.0	1.5	4.5	14.9	11.7	0.6	4.2	10.7	7.7	7.5	0.9	5.3	0.6	4.6	7.2	11.1	10.8	1.6	5.4	4.1	11.1	0.2	17.5	4.0	1.1	7.8	1.5	6.6	9.5	8.4	7.3	2.0	10.2	5.0	1.9	2.6	4.4	3.2	3.1	0.7	2.3	0.5	4.7	9.0	1.9	5.0	3.2	4.3	13.5	0.6	1.8	6.5	4.6	5.2	1.8	2.8	5.9	3.7	3.9	2.7	6.4	3.7	4.1	0.9	0.5	5.8	2.6	3.2	2.1	8.4	15.1	12.2	9.0	21.5	6.9	12.0	12.3	5.8	9.3	10.7	10.8	6.0	16.1	5.7	7.1	8.1	11.4	8.8	14.7	19.7	7.5	10.1	5.6	13.2	6.8	12.5	9.4	6.0	5.8	3.7	9.1	9.8	2.1	3.9	2.5	5.3	4.5	7.0	0.0	1.6	5.0	2.4	7.1	5.1	6.0	0.0	5.5	0.8	8.0	8.1	5.7	2.6	10.5	4.8	8.1	7.4	8.5	0.4	5.8	10.4	3.3	4.6	7.9	1.5	4.0	2.9	6.3	2.6	0.6	6.5	9.8	0.0	0.2	5.6	1.1	7.9	5.2	13.3
MPHOSPH8	"HSMPP8, mpp8"	ENSG00000196199	"M-phase phosphoprotein 8"	Q99549	13	19633681-19673459	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039701, HPA040035"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039701: AB_10805484, HPA040035: AB_10794207"	"unprognostic (4.22e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.90e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.40e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.02e-1)"	20.6	27.1	37.7	33.4	37.1	19.2	21.4	48.9	45.0	32.0	26.6	13.2	31.7	17.8	29.4	26.7	19.1	22.3	18.8	27.9	31.0	27.2	18.9	16.5	22.9	28.4	28.8	32.8	43.6	22.0	20.9	44.3	20.0	28.4	26.1	20.1	11.9	24.5	38.8	25.7	26.6	23.9	31.3	37.1	30.0	22.5	16.6	33.5	16.5	26.8	11.7	20.4	31.3	37.9	21.7	13.8	39.4	9.9	11.5	17.6	3.6	12.9	8.3	12.5	20.2	16.2	20.6	22.1	19.5	14.2	12.3	10.6	12.7	22.9	20.5	15.6	11.8	19.2	21.7	22.9	13.6	15.9	25.5	11.7	33.0	13.7	15.4	14.4	23.7	26.9	12.1	17.7	9.7	13.7	18.8	16.2	16.7	15.9	13.2	11.4	12.6	18.1	19.9	12.2	24.1	9.3	14.6	28.8	16.2	21.4	10.1	17.1	10.5	18.2	16.8	17.7	21.8	10.2	19.7	19.0	9.6	8.6	18.1	9.8	9.0	9.3	20.4	7.3	22.0	14.8	39.4	9.5	15.4	13.0	6.9	11.5	21.5	14.6	12.5	4.3	21.7	17.6	14.4	27.5	11.5	9.9	13.8	11.3	3.6	37.7	37.1	48.9	45.0	31.0	27.2	28.8	32.8	28.4	33.5	86.4	100.8	102.7	102.3	61.2	189.0	78.6	81.5	60.2	84.2	97.7	78.5	107.7	41.4	45.8	58.1	101.2	89.2	23.3	47.7	70.1	98.0	73.8	137.8	68.9	64.6	198.6	56.6	106.2	53.3	25.9	166.0	79.7	64.1	91.0	71.4	105.7	42.2	94.7	147.8	48.2	208.1	174.6	116.5	181.6	204.0	64.6	49.1	124.6	63.9	55.3
MPHOSPH9	MPP9	ENSG00000051825	"M-phase phosphoprotein 9"	Q99550	12	123152320-123244014	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 48.9"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037485	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA037485: AB_10672792"	"unprognostic (2.98e-2)"	"unprognostic (5.00e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.53e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.17e-1)"	5.3	9.8	11.0	10.5	14.6	24.8	5.6	21.6	14.9	5.5	6.7	7.7	4.9	7.9	6.4	12.8	5.9	6.1	4.0	8.8	8.8	6.0	7.1	12.7	6.1	12.0	7.1	8.0	6.9	6.3	9.9	20.4	5.7	9.9	5.8	7.6	7.7	5.9	5.2	7.2	5.4	8.0	5.9	9.1	10.2	5.9	14.4	11.0	48.9	6.2	3.2	10.8	5.5	5.0	6.2	4.9	8.3	3.7	8.5	12.1	3.0	8.5	9.1	14.6	16.4	6.5	6.1	5.5	8.8	4.5	11.1	8.9	8.6	4.2	16.8	6.5	5.8	10.6	6.1	18.8	7.2	15.5	10.7	12.2	17.1	10.1	8.4	5.0	15.9	14.9	6.6	2.7	10.5	10.5	9.8	11.3	25.6	11.8	7.4	10.1	7.2	18.1	25.2	10.0	5.6	9.9	16.2	14.7	10.9	8.6	8.4	18.7	8.8	13.7	5.5	8.6	15.3	10.3	12.0	6.4	9.1	13.1	10.5	12.5	11.6	18.7	14.0	7.3	15.3	18.8	8.3	3.7	5.1	10.9	3.6	7.7	5.6	8.6	9.8	3.5	6.2	12.1	11.8	0.7	8.5	3.1	4.9	7.4	3.0	11.0	14.6	21.6	14.9	8.8	6.0	7.1	8.0	9.9	11.0	8.9	7.4	13.8	3.9	3.9	36.9	12.6	10.2	14.7	9.1	7.0	108.0	8.9	5.0	4.1	46.8	4.5	3.3	0.0	1.6	5.6	8.1	2.8	2.3	27.6	7.3	50.9	13.7	5.5	12.0	48.4	6.6	7.2	3.3	14.4	5.1	17.7	1.6	0.0	10.6	7.1	64.2	0.0	4.1	30.0	19.6	1.9	1.4	22.3	7.5	2.4
MPIG6B	"C6orf25, G6b, G6b-B, NG31"	ENSG00000204420	"Megakaryocyte and platelet inhibitory receptor G6b"	O95866	6	31718594-31726714	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Heparin-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.2"	"Cell type enriched"	"Detected in single"	30	"granulocytes: 9.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"NK-cell: 3.0;plasmacytoid DC: 1.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.8;NK-cells: 3.0"	"Cell line enriched"	"Detected in single"	17	"HEL: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA054404, HPA073017"			Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		7400000	"Golgi apparatus"	"Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol"	"HPA054404: , HPA073017: AB_2686566"	"unprognostic (1.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.71e-2)"	0.8	0.2	0.0	1.2	0.5	5.3	0.7	0.1	0.4	1.0	0.9	0.0	0.0	0.9	1.0	0.8	2.0	0.7	1.5	7.4	0.2	0.0	0.4	0.5	7.6	2.8	1.0	0.0	2.7	0.2	0.2	0.2	1.4	0.7	0.9	0.2	1.1	1.8	0.3	1.2	10.5	0.8	1.9	0.6	33.2	0.4	2.7	0.1	1.2	1.0	1.4	0.8	1.6	1.6	0.2	1.8	0.5	0.1	3.0	0.1	5.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.5	3.0	0.1	1.8	0.0	5.7	0.0	0.5	0.1	0.4	0.2	0.0	1.0	0.0	0.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MROH2A	HEATR7B1	ENSG00000185038	"Maestro heat like repeat family member 2A"	A6NES4	2	233775679-233833423	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 1.8;testis: 5.0;thyroid gland: 5.1"	"Cell type enhanced"	"Detected in single"	13	"Spermatocytes: 1.8"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RT4: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052107	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA052107: AB_2681729"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-3)"	"unprognostic (4.77e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.05e-2)"	"unprognostic (4.06e-9)"	"unprognostic (5.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	5.0			5.1		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	11.6	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.4	0.1	0.0	0.0	0.0	0.1
MSS51	"FLJ39565, ZMYND17"	ENSG00000166343	"MSS51 mitochondrial translational activator"	Q4VC12	10	73423579-73433561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	13	"parathyroid gland: 34.4;skeletal muscle: 66.9"	"Cell type enhanced"	"Detected in some"	7	"Cardiomyocytes: 3.9;granulocytes: 4.7;Leydig cells: 2.8;Paneth cells: 2.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"cerebellum: 2.7"	"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.7;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA038564			Uncertain	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA038564: AB_10674687"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.50e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-7)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.55e-2)"	2.8	0.3	0.4	0.4	0.4	0.3	0.4	2.7	0.4	0.5	0.5	0.4	0.4	0.2	0.6	0.4	0.9	0.6	0.4	3.9	0.4	0.1	0.4	0.4	0.6	0.4	0.4	0.4	1.1	0.5	34.4	0.7	0.4	0.4	0.8	0.3	0.4	2.3	0.4	66.9	0.8	0.8	0.4	0.4	1.4	0.4	0.4	0.4	0.6	0.4	1.2	0.4	0.5	0.6	0.1	0.0	0.0	0.5	0.0	1.7	0.4	1.2	1.3	3.0	4.7	4.2	6.0	2.6	1.5	1.1	0.6	1.3	0.7	1.5	3.8	0.5	1.5	0.2	2.3	1.9	0.4	1.7	1.8	1.5	3.3	2.0	1.1	1.5	2.2	3.1	4.7	1.5	1.3	3.5	4.3	0.6	1.5	1.1	2.0	2.5	0.5	1.9	3.0	0.9	1.0	1.6	1.1	7.8	0.2	1.8	1.9	0.6	1.2	1.0	2.2	1.7	3.2	1.9	1.8	2.7	2.3	1.4	0.9	3.0	1.2	3.4	2.0	1.0	3.8	0.6	0.0	0.4	0.0	1.7	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.3	1.2	0.0	0.0	0.5	0.0	0.0	0.4	0.4	0.4	2.7	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.0	2.2	2.2	0.0	0.5	1.4	3.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.7	0.4	0.0	0.3	0.1	0.5	0.3	4.7	0.0	0.2	0.0	0.0	1.3	0.6	0.0	2.8	0.1	0.0	0.0	0.6	0.9	0.1	2.9	1.4	0.0	1.2	0.0	0.4	0.5	0.2	0.0	0.1	0.7	0.6	0.1
MT-ND3	"MTND3, NAD3, ND3"	ENSG00000198840	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3"	P03897	MT	10059-10404	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 357.8"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 33020.6;Erythroid cells: 20674.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 644.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063296	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA063296: AB_2684978"	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (4.63e-5)"	"unprognostic (2.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-3)"	102.1	73.9	117.3	17.6	137.2	17.9	59.3	33.7	70.5	31.2	76.3			64.0	25.9	49.2	21.7	24.7	19.7	256.8	110.3	81.7	138.1	145.8	19.7	17.4	92.0		27.5	77.8	14.6	22.2	34.6		39.1	59.1		67.6	50.7	357.8	42.2	48.9	28.4	66.8	19.1	60.6	21.0			25.0		20.3	24.2	15.9	84.8	32.6	159.6	48.5	48.6	75.3	24.4	85.5	139.7	93.3	91.5	644.7	129.2	77.7	72.1	42.4	39.1	44.3	210.2	133.3	89.1	111.9	92.5	70.8	178.3	40.1	157.5	67.3	127.7	192.1	87.6	465.1	346.0	100.6	129.0	132.7	223.4	292.0	65.5	73.9	233.9	60.8	102.4	69.0	104.2	73.7	279.5	67.7	172.2	47.9	245.4	129.3	58.7	91.7	82.0	237.9	236.2	38.5	83.7	34.8	69.8	142.5	254.3	161.5	208.4	103.2	60.5	91.9	105.1	77.0	40.5	53.1	192.1	49.1	78.4	34.2	159.6	48.5	36.6	36.7	36.4	49.8	73.1	42.6	44.8	32.6	84.8	63.1	75.3	100.7	48.6	32.7	32.3	27.6	24.4											652.1	738.1	6543.7	1904.3	1765.5	0.0	33020.6	8848.3	2785.1	1856.3	4782.3	0.0	0.0	986.5	1173.3	880.9	872.1	11850.5	20674.5	2500.6	0.0	790.1	1401.0	1375.6	14769.6	0.0	0.0	2746.0	8921.3	11655.5	4356.4	8457.2	1642.1	1763.0	2463.5	12873.7	0.0	1918.1	9893.1	4573.5	7467.5	0.0	6887.9	1962.1	6063.0	3539.9	1651.0	0.0	4305.8	10869.3	1952.0
MTERF3	"CGI-12, FLJ10939, MTERFD1"	ENSG00000156469	"Mitochondrial transcription termination factor 3"	Q96E29	8	96239398-96261610	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007355			Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA007355: "	"unprognostic (4.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.75e-3)"	"unprognostic (3.11e-3)"	"unprognostic (6.43e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (5.88e-5)"	"unprognostic (8.67e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.74e-3)"	13.8	16.4	14.2	15.9	20.1	9.9	22.9	17.8	18.0	14.8	13.8	12.3	17.4	11.9	15.4	23.8	12.6	13.2	12.9	21.9	17.3	15.3	15.9	22.2	18.5	18.3	18.1	16.0	13.7	14.8	18.9	14.1	16.1	23.7	15.5	14.5	9.8	12.1	17.9	28.8	16.1	11.6	21.9	13.2	16.9	12.8	10.9	13.5	16.0	15.0	14.1	18.1	13.9	12.3	15.3	18.0	18.6	11.6	16.7	17.8	7.8	18.9	12.2	18.4	14.5	13.1	13.6	8.4	14.6	12.0	21.5	21.7	8.7	14.1	17.1	30.9	8.5	10.9	10.7	19.0	11.4	26.2	16.4	13.9	24.4	9.4	10.5	18.5	8.2	10.0	13.6	17.1	17.4	16.4	11.1	17.5	18.4	20.5	9.0	21.5	12.3	34.9	24.3	9.6	33.5	19.1	21.2	15.1	13.3	15.7	10.1	12.6	9.9	10.9	3.2	15.5	12.4	16.5	11.6	7.8	15.1	10.2	17.4	12.9	10.3	12.9	19.9	16.4	22.1	19.7	18.6	10.3	4.3	12.4	11.6	17.8	15.3	14.1	14.0	14.8	13.2	16.1	16.1	1.8	16.7	11.0	18.0	13.3	7.8	14.2	20.1	17.8	18.0	17.3	15.3	18.1	16.0	23.7	13.5	3.0	5.8	10.9	13.1	0.0	0.0	27.8	10.2	9.4	10.3	5.2	0.0	26.6	11.6	10.9	4.4	8.2	0.8	23.3	8.6	17.4	15.8	7.5	5.8	7.3	14.3	0.0	0.0	6.2	4.9	3.1	12.7	6.3	0.0	21.6	3.8	0.0	7.5	3.5	13.1	8.7	0.0	12.9	10.0	24.4	18.8	0.0	14.5	4.4	6.2	9.1
MTTP	"ABL, MTP"	ENSG00000138823	"Microsomal triglyceride transfer protein"	P55157	4	99563761-99623999	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	49	"intestine: 211.4;liver: 60.8"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 201.1"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 28.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Group enriched"	"Detected in some"	6	"AF22: 12.8;Hep G2: 14.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA051170, HPA054862"	Uncertain		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		450000	Cytosol		"HPA051170: , HPA054862: AB_2682628"	"unprognostic (1.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.49e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	0.1	0.1	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.0	53.2	0.2	0.1	53.4	0.0	0.0	0.2	0.2	0.4	0.4	0.3	0.4	2.7	60.8	0.1	0.0	0.4	0.1	1.1	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	211.4	0.7	0.4	0.1	0.2	1.8	0.2	0.1	0.1	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.8	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.3	0.5	0.0	0.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.2	0.3	0.1	14.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.7	0.6	0.0	0.3	0.3	0.2	1.3	0.0	0.0	0.8	1.0	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.3	0.4	0.4	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	7.6	0.0	0.0	1.8	0.0	0.1	0.0	0.0	25.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	201.1	0.1	0.0	0.0	5.5	3.3	7.9	0.9	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.4	18.6	0.0	6.5	0.0	21.9	1.5	0.0	0.0	0.0	0.0	0.0
MUM1	"EXPAND1, MUM-1"	ENSG00000160953	"Melanoma associated antigen (mutated) 1"	Q2TAK8	19	1354711-1378431	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 192.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048063	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA048063: AB_2680243"	"unprognostic (2.50e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (4.82e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.84e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.25e-6)"	"unprognostic (1.60e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-3)"	6.7	5.3	14.4	3.6	20.9	2.1	5.6	21.9	19.2	7.0	5.8	13.6	4.5	3.7	10.4	5.6	4.3	13.0	5.4	5.3	13.6	9.1	4.9	8.3	6.8	3.6	14.2	11.5	18.4	4.0	7.7	7.5	6.0	11.5	6.7	4.8	5.8	6.7	8.7	5.5	8.1	4.8	11.5	10.5	6.0	4.8	19.9	13.1	1.9	6.0	0.9	4.5	5.6	11.5	4.3	3.9	11.8	2.6	3.8	4.5	1.3	7.2	9.3	13.0	13.8	10.6	14.1	15.9	12.6	7.9	11.6	8.6	6.4	4.8	14.7	5.9	16.2	4.1	8.2	13.1	8.2	8.8	15.8	8.3	7.9	9.5	9.6	10.2	6.1	17.8	9.2	5.1	6.5	4.7	14.9	11.8	9.9	12.2	7.4	11.0	8.1	10.4	6.5	14.7	8.1	5.3	16.8	10.9	6.1	7.7	10.5	9.4	21.5	11.1	13.1	8.4	11.8	6.4	14.0	11.3	10.5	14.6	8.5	11.6	15.0	12.6	6.7	14.0	9.9	14.2	11.8	1.1	6.8	4.5	2.6	3.8	3.9	2.5	3.3	2.1	4.3	3.7	4.0	2.2	3.8	2.2	3.9	1.6	1.3	14.4	20.9	21.9	19.2	13.6	9.1	14.2	11.5	11.5	13.1	32.8	18.3	29.6	30.8	15.0	192.5	23.6	48.4	30.8	14.8	17.4	133.5	16.7	10.0	30.8	84.4	21.8	35.5	0.0	19.1	20.1	33.2	18.7	32.4	72.0	15.3	151.0	36.8	28.8	14.8	101.3	53.8	14.7	28.7	20.8	26.2	51.9	24.8	28.3	53.0	11.0	82.1	116.4	31.5	168.6	74.1	12.9	11.9	20.8	29.5	16.6
MXD1	"bHLHc58, MAD, MAD1"	ENSG00000059728	"MAX dimerization protein 1"	Q05195	2	69897688-69942945	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.1;bone marrow: 72.8;esophagus: 64.8"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 212.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 81.1"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 81.1"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001599	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA001599: AB_1079434"	"unprognostic (1.59e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (8.14e-6)"	"unprognostic (1.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (8.72e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.77e-2)"	6.9	2.2	2.7	18.7	3.8	72.8	3.7	5.7	4.1	15.8	19.6	4.7	0.9	13.6	2.9	2.6	64.8	3.8	4.9	10.8	3.0	2.9	3.0	5.5	17.0	14.3	5.9	2.4	3.3	2.5	3.6	4.0	15.8	3.1	3.3	14.0	5.1	8.8	1.4	3.1	5.9	50.2	4.6	4.3	15.8	8.2	3.6	3.7	9.4	4.0	20.8	34.0	6.3	21.6	0.2	0.8	81.1	1.6	0.4	0.4	0.6	3.5	1.5	2.2	1.6	5.0	2.5	8.4	3.9	2.2	1.9	1.3	4.9	2.8	2.0	2.0	1.5	1.9	12.6	4.2	7.8	2.0	1.1	5.1	4.2	4.5	4.9	16.8	5.0	4.2	2.8	13.3	4.4	20.4	2.4	2.4	2.1	7.3	8.1	1.2	2.8	2.4	10.1	0.6	5.2	2.5	1.1	2.3	5.0	2.5	4.2	7.3	3.1	5.2	7.0	2.7	2.7	1.0	3.0	9.6	2.8	0.8	3.0	3.7	5.5	9.3	0.8	2.9	8.9	1.0	17.0	1.6	16.8	0.3	1.0	0.4	0.1	0.2	0.2	0.8	0.2	0.2	0.3	81.1	0.4	0.8	0.2	0.2	0.6	2.7	3.8	5.7	4.1	3.0	2.9	5.9	2.4	3.1	3.7	35.7	30.8	18.2	23.9	22.9	27.8	4.8	7.6	10.7	11.4	1.8	51.1	7.9	6.6	10.8	12.4	9.0	212.1	0.0	14.8	5.1	13.6	61.3	26.5	6.7	26.9	9.5	93.4	6.2	48.3	15.3	4.4	71.5	15.1	20.8	115.5	40.4	44.4	91.2	2.5	5.1	17.8	0.0	28.7	8.1	2.0	49.3	88.6	20.8	26.6	110.0
N4BP2L1	CG018	ENSG00000139597	"NEDD4 binding protein 2 like 1"	Q5TBK1	13	32400723-32428311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"monocytes: 143.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 13.1;JURKAT: 12.5;NB-4: 33.0"	"Low region specificity"	"Detected in all"							HPA038971	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038971: AB_10673408"	"unprognostic (2.66e-3)"	"unprognostic (2.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (6.91e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.57e-3)"	12.1	9.4	19.6	10.5	22.2	29.5	22.1	24.5	21.8	12.3	11.0	9.4	4.2	11.6	14.6	12.8	8.3	14.0	9.6	6.3	15.0	16.6	7.4	57.8	17.3	17.6	12.1	18.8	30.1	11.0	7.3	21.2	10.0	11.0	11.3	11.3	7.3	7.6	9.5	11.0	17.5	13.4	11.3	10.6	19.2	7.2	3.6	15.5	14.2	10.4	5.1	12.9	13.5	16.5	15.9	28.0	24.2	25.5	15.2	13.5	17.4	0.5	0.1	0.7	0.2	2.9	2.3	0.2	0.3	1.2	0.7	1.2	2.1	2.9	5.6	0.8	0.6	2.1	0.0	2.1	0.2	0.9	8.5	1.3	13.1	0.6	6.2	4.6	4.9	0.8	1.6	0.5	0.5	0.6	5.2	0.4	12.5	0.0	10.5	0.5	0.4	10.0	33.0	1.1	0.0	0.3	9.6	0.3	4.7	2.8	1.0	2.0	2.4	2.1	0.0	0.9	1.5	0.3	9.3	0.2	0.2	0.1	0.1	0.1	5.9	3.5	0.3	0.3	1.8	0.4	24.2	25.5	6.6	9.8	23.1	8.5	14.0	9.5	11.9	21.9	15.9	13.1	11.3	6.2	15.2	15.8	28.0	13.5	17.4	19.6	22.2	24.5	21.8	15.0	16.6	12.1	18.8	11.0	15.5	41.7	25.1	28.7	27.2	26.8	7.4	3.4	10.2	5.3	22.7	5.2	0.0	17.0	8.3	8.8	17.8	35.7	4.5	0.0	7.4	0.9	15.9	22.7	8.1	57.2	20.1	0.0	36.5	11.6	41.3	15.5	25.3	44.8	28.7	143.3	11.5	10.0	6.2	10.7	20.8	8.4	1.6	77.6	56.7	0.7	0.2	30.9	8.7	43.1	13.3	12.8
NAA60	"FLJ14154, NAT15"	ENSG00000122390	"N(alpha)-acetyltransferase 60, NatF catalytic subunit"	Q9H7X0	16	3443611-3486963	"Enzymes, Predicted intracellular proteins"	"Chromosome partition"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040916	Approved		Uncertain	"Actin filaments,Cytosol"		NA	NA			"Actin filaments, Cytosol"		"HPA040916: AB_10794428"	"unprognostic (8.59e-2)"	"unprognostic (2.16e-3)"	"unprognostic (3.39e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.81e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.12e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.74e-3)"	18.5	28.7	24.2	17.9	30.8	26.6	16.2	38.1	40.2	17.1	29.4	29.1	34.0	36.8	24.3	18.6	21.3	21.7	23.7	26.2	25.6	21.3	35.8	40.3	23.6	19.4	21.6	17.7	21.2	41.8	46.4	29.0	27.0	24.4	23.7	21.4	29.1	20.7	31.6	38.9	16.9	42.2	19.9	25.7	28.1	34.8	25.3	19.0	22.8	21.8	21.8	24.1	21.7	22.1	8.5	11.2	34.8	13.2	11.6	13.4	10.0	8.2	32.5	23.0	24.2	18.4	12.6	20.6	15.8	16.9	16.4	14.8	22.2	17.8	17.2	16.1	18.0	11.7	19.3	22.7	18.4	16.0	25.8	15.3	20.9	20.5	26.0	19.9	26.7	27.7	15.4	14.3	11.2	21.7	20.2	26.2	15.4	22.0	24.5	11.5	37.8	16.8	19.7	28.0	21.9	9.5	21.1	17.4	26.0	16.9	17.4	12.2	26.4	23.5	26.2	12.5	23.0	23.4	18.9	19.3	21.1	18.1	6.8	14.6	20.5	19.0	16.7	6.7	16.6	16.1	19.8	10.5	34.8	11.8	12.3	12.5	8.0	10.8	11.5	11.2	8.5	9.3	10.8	13.2	11.6	13.2	7.8	13.4	10.0	24.2	30.8	38.1	40.2	25.6	21.3	21.6	17.7	24.4	19.0	8.9	16.5	13.7	11.2	0.1	21.2	12.6	35.7	6.7	10.3	12.2	5.9	22.8	36.5	27.5	41.1	18.6	61.4	0.0	36.4	33.1	15.4	16.7	30.0	42.3	27.8	11.1	25.9	27.6	28.5	44.0	10.6	14.5	0.0	26.2	34.4	20.8	29.9	45.6	14.9	32.7	14.2	25.8	11.2	14.9	20.2	0.3	27.6	21.0	31.9	22.0
NAALADL1		ENSG00000168060	"N-acetylated alpha-linked acidic dipeptidase like 1"	Q9UQQ1	11	65044818-65058549	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"blood: 49.5;intestine: 123.4"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 39.3;monocytes: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 49.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.4;fHDF/TERT166: 6.8;HHSteC: 19.0;HSkMC: 12.5;SCLC-21H: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047123	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA047123: AB_2679942"	"unprognostic (2.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.75e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.80e-2)"	4.1	0.9	1.4	3.3	1.6	7.0	4.1	1.9	1.4	6.0	54.3	1.2	2.6	7.8	7.2	1.8	2.7	4.4	3.4	3.5	1.3	0.6	2.3	1.2	3.4	5.2	1.5	1.5	6.2	1.0	0.9	2.0	1.5	1.6	4.6	2.6	3.1	2.3	4.8	2.0	1.6	123.4	4.3	1.4	5.0	2.8	1.8	1.2	1.8	1.8	2.3	2.9	3.1	5.4	8.8	4.9	49.5	6.3	22.2	12.9	7.0	0.0	0.0	0.1	0.2	0.5	5.4	0.9	2.0	0.0	2.5	1.1	0.0	0.0	0.1	0.0	6.8	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.1	3.1	19.0	0.0	0.0	12.5	0.0	2.5	0.0	0.0	3.2	0.1	0.0	0.2	0.0	0.2	0.2	0.6	0.0	0.0	0.1	0.1	0.0	0.8	0.2	0.0	9.8	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.7	0.0	0.1	0.1	49.5	6.3	10.3	9.5	4.3	4.9	8.0	7.6	4.8	4.9	8.8	8.8	4.9	1.1	22.2	2.5	0.2	12.9	7.0	1.4	1.6	1.9	1.4	1.3	0.6	1.5	1.5	1.6	1.2	0.0	0.0	8.2	3.2	3.2	1.1	1.1	2.5	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.6	9.0	39.3	0.0	0.7	0.2	5.7	0.5	19.6	0.0	2.8	9.5	1.2	16.5	7.6	1.7	10.9	6.4	15.1	22.6	0.7	10.8	0.3	14.4	17.0	0.0	0.9	0.0	13.7	1.6	2.6	2.9	0.3	11.7	0.4	0.3
NAPA		ENSG00000105402	"NSF attachment protein alpha"	P54920	19	47487637-47515240	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010100, HPA046149, HPA050196"	Approved		Uncertain	Cytosol		NA	NA		5400000	Cytosol		"CAB010100: AB_628263, HPA046149: AB_2679557, HPA050196: AB_2681048"	"unprognostic (9.83e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.76e-3)"	"unprognostic (9.72e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.09e-3)"	"prognostic favorable (4.26e-9)"	"unprognostic (4.04e-2)"	"unprognostic (4.17e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.90e-2)"	28.1	52.4	35.5	24.5	49.1	43.6	29.3	70.2	86.9	30.9	29.9	34.8	31.0	26.5	37.6	29.0	56.0	29.1	33.4	47.3	41.8	29.6	35.8	73.8	30.3	24.6	28.1	39.4	28.8	41.2	40.4	35.4	30.3	52.6	49.0	21.7	35.5	52.3	45.5	56.9	45.6	27.4	31.8	25.1	24.8	28.8	38.5	20.8	44.8	36.4	39.0	28.4	31.4	29.1	15.7	44.5	68.2	41.1	24.1	23.5	40.6	17.3	22.9	11.2	19.3	23.5	20.2	8.2	19.7	23.8	43.9	55.4	17.2	10.0	13.1	10.3	25.7	29.1	13.0	18.1	22.9	17.5	21.2	19.6	16.9	22.7	21.0	61.8	19.1	30.0	30.1	15.8	18.3	11.4	9.2	21.3	17.3	14.0	34.8	28.9	14.5	26.1	51.2	9.3	25.9	17.6	17.2	10.6	18.4	34.1	33.4	40.6	15.4	25.1	29.5	17.3	11.2	24.2	30.1	22.8	22.5	11.9	19.1	21.1	22.3	32.4	18.7	42.3	20.1	23.2	35.6	35.6	68.2	22.7	41.1	18.8	15.7	19.3	22.0	30.1	15.2	20.5	20.0	39.6	24.1	41.0	44.5	23.5	40.6	35.5	49.1	70.2	86.9	41.8	29.6	28.1	39.4	52.6	20.8	11.9	40.4	29.8	78.5	56.2	53.9	2.8	68.8	9.4	20.5	48.8	25.5	90.7	150.9	96.2	24.5	35.3	77.2	46.7	87.3	57.2	49.8	66.0	64.5	77.8	115.3	33.4	80.2	40.5	54.8	27.9	39.7	56.4	92.8	101.0	48.5	71.6	84.3	49.1	43.5	81.6	37.2	90.5	59.0	82.1	70.7	60.0	191.4	49.8	39.9	62.1
NAPB	"SNAP-BETA, SNAPB"	ENSG00000125814	"NSF attachment protein beta"	Q9H115	20	23374519-23421519	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 110.9"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 176.7;Cone photoreceptor cells: 62.8;Horizontal cells: 63.5;Rod photoreceptor cells: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 24.5;U-937: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037225, CAB037227, HPA046149, HPA050196"	Supported		Uncertain	Cytosol		NA	NA			Cytosol		"CAB037225: AB_477555, CAB037227: AB_477554, HPA046149: AB_2679557, HPA050196: AB_2681048"	"unprognostic (3.89e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.46e-3)"	"unprognostic (7.52e-3)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.60e-2)"	3.2	15.5	32.7	3.8	32.7	6.0	4.4	46.0	110.9	4.0	4.0	4.4	2.6	3.8	4.7	6.3	3.7	4.6	3.8	3.7	30.5	32.0	4.4	3.8	3.9	4.0	26.1	40.1	6.4	3.4	6.1	4.6	5.9	50.2	4.0	5.0	6.1	4.0	4.6	3.4	5.0	5.5	4.5	9.7	4.5	4.3	5.3	4.0	0.7	5.1	0.1	3.4	3.6	2.3	2.4	1.9	6.0	2.1	1.5	5.1	2.1	4.3	2.8	4.6	4.8	5.2	4.8	6.5	5.6	3.0	4.5	4.0	3.3	3.8	6.3	6.7	3.3	3.3	5.5	5.9	3.8	5.5	2.0	4.4	6.9	3.7	7.7	6.1	5.1	4.1	4.8	5.0	3.2	4.0	4.1	3.3	6.5	5.8	8.4	7.2	2.9	5.2	4.7	2.0	3.5	5.1	3.5	3.7	4.7	5.9	4.7	24.5	7.8	3.2	3.1	5.2	7.0	3.2	3.2	3.9	4.3	3.2	4.8	3.9	6.2	4.8	2.9	2.2	24.4	4.3	6.0	1.2	0.0	5.1	1.3	1.5	1.7	2.0	2.4	1.9	2.4	2.0	3.3	1.5	1.5	2.1	1.5	2.5	2.1	32.7	32.7	46.0	57.7	30.5	32.0	26.1	40.1	50.2	4.0	11.9	6.2	5.1	4.4	7.7	176.7	4.9	7.6	2.7	6.8	14.0	62.8	5.6	0.0	2.9	39.1	7.7	3.5	0.0	1.2	4.4	8.4	3.3	10.5	4.9	4.4	63.5	9.8	10.4	7.2	45.5	8.3	3.6	10.1	4.6	2.3	15.7	2.7	0.0	8.5	2.2	78.5	6.5	6.2	9.7	9.8	7.3	5.1	5.7	4.5	3.3
NARS2	"DFNB94, FLJ23441, SLM5"	ENSG00000137513	"Asparaginyl-tRNA synthetase 2, mitochondrial"	Q96I59	11	78435961-78574874	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026793	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Nucleoplasm, Mitochondria"	Cytosol	"HPA026793: AB_1848833"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.79e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.62e-3)"	"prognostic favorable (1.39e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.22e-6)"	"unprognostic (8.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.60e-1)"	10.9	16.0	11.8	9.3	11.2	6.4	13.4	19.4	11.8	11.6	13.0	13.1	13.5	12.0	17.6	13.9	10.8	12.0	9.9	12.7	11.3	12.2	22.3	26.8	9.0	10.2	13.4	8.4	15.9	20.0	14.0	17.3	9.4	13.8	13.3	13.3	23.2	12.7	13.2	24.4	9.1	11.1	10.6	10.8	12.6	11.3	11.8	10.3	17.3	16.0	7.7	14.1	9.7	10.7	14.6	13.5	6.7	9.4	16.2	16.6	8.7	7.3	10.3	10.8	7.1	7.6	6.4	9.0	6.1	6.0	9.5	7.9	17.7	7.9	18.2	15.9	3.9	9.2	9.7	18.2	11.9	13.3	11.9	9.8	12.8	8.0	15.0	6.3	13.7	4.8	4.5	7.7	8.4	15.0	8.6	8.1	15.4	19.3	5.0	10.6	8.6	14.2	22.2	11.8	30.0	12.5	14.9	17.7	24.6	12.7	10.4	12.9	8.1	9.1	11.7	15.7	12.2	11.0	5.5	4.9	13.0	15.3	14.8	10.3	8.4	14.1	40.1	2.5	12.4	8.8	6.7	7.9	3.5	9.8	8.3	12.0	14.6	11.3	10.8	13.5	12.6	16.6	14.8	1.7	16.2	9.4	10.3	8.2	8.7	11.8	11.2	19.4	11.8	11.3	12.2	13.4	8.4	13.8	10.3	17.9	17.1	9.0	12.7	11.9	5.3	8.3	2.5	10.7	7.9	5.2	2.0	17.3	24.9	8.2	11.0	6.3	5.0	0.0	6.5	20.2	10.4	14.0	8.1	16.3	10.6	0.0	11.5	2.5	6.5	3.9	7.2	6.1	16.9	1.0	7.7	5.7	6.1	13.3	4.6	22.1	8.7	6.5	8.3	7.4	18.1	12.0	12.8	5.1	13.7	7.5
NCKAP1L	HEM1	ENSG00000123338	"NCK associated protein 1 like"	P55160	12	54497711-54548238	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.1;lymphoid tissue: 56.7"	"Group enriched"	"Detected in many"	5	"B-cells: 52.5;granulocytes: 53.3;Hofbauer cells: 98.9;Kupffer cells: 144.7;Macrophages: 81.9;monocytes: 90.2;T-cells: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 33.5;HMC-1: 35.4;NB-4: 24.7;REH: 17.7;THP-1: 36.7;U-937: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039490, HPA040772"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA		52000	Cytosol	"Plasma membrane"	"HPA039490: AB_2676540, HPA040772: AB_2677129"	"unprognostic (4.54e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.63e-2)"	"unprognostic (4.74e-2)"	18.1	5.0	5.9	22.0	10.5	16.9	7.2	1.2	5.8	3.1	15.0	8.1	0.6	4.0	3.1	4.3	4.8	4.0	5.1	6.5	4.1	3.5	3.9	6.5	19.7	56.7	9.3	2.5	2.2	2.4	4.4	2.3	7.3	6.6	4.8	6.9	3.0	4.3	4.0	1.5	2.8	15.4	7.0	13.9	44.7	4.7	1.7	7.9	47.2	2.8	1.8	30.0	22.2	3.3	11.2	25.4	18.4	39.1	12.3	15.2	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.1	14.4	0.0	0.0	0.0	33.5	35.4	0.0	0.0	0.0	0.0	0.0	0.2	12.4	2.3	13.6	0.0	0.0	14.1	24.7	0.0	0.0	0.0	17.7	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.7	0.8	11.8	0.0	21.5	0.0	8.6	23.3	18.4	11.9	36.4	9.8	11.2	10.7	12.1	25.4	11.0	6.9	10.0	5.9	12.3	39.1	14.4	15.2	19.2	5.9	10.5	1.2	5.8	4.1	3.5	9.3	2.5	6.6	7.9	0.0	15.2	52.5	0.4	1.1	0.9	1.3	7.6	1.4	3.4	0.0	0.0	0.6	0.0	0.0	0.6	2.0	0.0	0.0	0.3	0.7	1.7	0.1	53.3	0.9	98.9	0.0	0.0	9.2	144.7	1.5	1.1	81.9	5.0	90.2	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.0	1.4	0.5	1.0	0.5	1.1	53.6	0.0	0.3
NDRG4	"KIAA1180, SMAP-8"	ENSG00000103034	"NDRG family member 4"	Q9ULP0	16	58462846-58513628	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 59.2;brain: 134.1;heart muscle: 112.6"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 389.7;Horizontal cells: 487.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 23.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 18.4;GAMG: 16.2;hTERT-RPE1: 15.2;SCLC-21H: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015313, HPA017587"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA015313: AB_1854343, HPA017587: AB_1854344"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.03e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.17e-2)"	3.6	59.2	28.7	2.9	49.4	1.6	2.3	65.4	134.1	3.8	3.5	11.0	15.6	3.4	10.2	5.1	10.0	3.9	3.4	112.6	30.5	32.0	2.3	1.9	6.5	3.4	33.7	35.4	2.1	2.6	10.8	11.6	2.6	81.2	2.1	3.2	8.7	2.9	18.2	5.3	3.9	3.2	8.7	11.7	11.7	2.6	19.9	7.4	0.0	2.6	0.3	3.5	2.7	8.0	1.5	0.1	0.2	0.0	0.1	0.9	0.2	0.1	9.3	8.9	1.7	0.2	1.7	0.7	2.9	4.5	1.4	0.9	3.5	2.4	0.2	18.4	2.2	16.2	0.8	0.7	0.5	1.2	0.0	1.8	0.4	1.5	2.5	2.5	0.1	0.1	2.1	0.2	0.9	0.0	15.2	11.7	0.0	0.1	0.1	1.3	2.3	0.9	0.1	0.8	0.3	6.8	0.2	2.5	0.2	0.4	5.8	27.8	10.4	0.3	0.8	0.1	1.1	0.3	0.1	4.2	1.2	3.5	0.3	0.4	0.5	0.2	3.0	6.4	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.2	28.7	49.4	65.4	63.4	30.5	32.0	33.7	35.4	81.2	7.4	0.0	3.4	0.0	4.0	1.8	38.9	389.7	0.0	0.0	0.0	0.0	3.9	0.0	0.0	3.6	4.6	13.5	0.0	0.0	0.2	0.1	1.5	1.4	0.0	0.2	0.0	487.8	1.7	23.9	1.0	6.2	4.0	0.7	6.8	0.0	0.0	74.2	3.2	0.0	2.5	0.0	22.6	6.5	5.7	3.9	3.6	5.1	0.0	0.0	0.0	7.5
NDUFA12	"B17.2, DAP13"	ENSG00000184752	"NADH:ubiquinone oxidoreductase subunit A12"	Q9UI09	12	94897055-95003770	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 129.0"	"Group enriched"	"Detected in all"	5	"Cardiomyocytes: 2083.1;Distal tubular cells: 525.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039903	Supported		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA039903: AB_10795516"	"unprognostic (2.76e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.27e-2)"	24.0	24.8	36.0	17.9	36.8	19.7	19.7	27.2	36.5	17.9	35.5	12.5	20.0	27.4	17.0	21.9	23.3	19.4	14.4	82.8	31.2	32.0	33.2	34.6	18.1	20.1	37.0	29.9	17.0	18.4	22.3	22.4	21.1	31.3	19.1	35.7	13.1	18.7	20.7	129.0	17.4	26.7	24.0	24.2	23.9	20.9	14.2	23.5	21.0	27.9	40.0	28.1	21.9	21.4	60.8	78.4	69.7	67.9	59.1	93.8	100.6	41.6	45.3	37.9	26.9	31.1	29.0	28.2	19.9	29.3	43.5	39.5	55.9	21.5	47.9	11.8	30.4	24.1	31.5	38.9	45.9	49.4	41.3	46.7	40.1	37.8	56.3	32.0	56.8	49.0	31.1	58.0	36.4	44.7	45.5	35.6	41.7	37.4	22.3	42.1	60.4	39.3	87.8	28.7	51.2	78.9	30.1	32.8	54.6	42.6	62.6	36.1	21.9	33.7	49.2	25.8	34.2	48.6	37.4	40.6	23.1	23.5	33.5	33.8	36.4	54.0	73.1	13.9	47.6	35.2	69.7	59.5	29.8	52.1	67.9	48.2	60.8	71.6	62.5	78.4	50.7	93.8	68.6	8.6	59.1	63.3	48.0	74.8	100.6	36.0	36.8	27.2	36.5	31.2	32.0	37.0	29.9	31.3	23.5	68.5	58.6	79.6	121.2	96.5	65.8	2083.1	160.5	77.6	45.5	102.9	60.9	215.5	525.6	141.2	192.8	157.8	177.2	46.7	143.2	214.5	94.4	120.9	56.6	123.1	168.7	35.0	81.9	98.8	95.5	70.6	90.3	125.9	151.8	218.2	146.8	79.4	169.8	188.7	125.5	242.6	113.4	103.5	149.9	130.8	119.2	111.7	175.3	96.5	189.4	182.6
NDUFAF1	"CGI-65, CIA30"	ENSG00000137806	"NADH:ubiquinone oxidoreductase complex assembly factor 1"	Q9Y375	15	41387349-41402519	"Predicted intracellular proteins"		Chaperone	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039933, HPA040064"	Supported		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA039933: AB_10795265, HPA040064: AB_10795687"	"unprognostic (2.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.88e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (3.34e-6)"	"unprognostic (1.68e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.05e-1)"	11.1	22.0	15.0	6.4	14.0	3.0	9.8	13.3	17.8	7.8	7.7	12.4	5.3	8.4	8.3	10.7	9.6	7.9	7.1	29.7	13.2	13.4	21.9	27.5	7.0	8.5	14.7	14.4	7.0	7.7	11.9	9.7	7.0	13.1	8.5	8.1	8.4	8.5	9.8	38.6	6.2	7.7	10.3	13.5	7.5	8.5	14.1	12.0	6.5	9.6	15.8	9.1	8.8	5.8	14.5	19.1	25.2	16.2	13.9	15.9	8.7	9.2	6.6	8.7	9.0	20.0	20.4	9.6	17.7	14.5	15.6	13.0	12.2	5.1	10.6	24.6	15.5	11.0	15.3	11.8	11.9	14.1	19.9	13.7	15.0	13.9	7.2	17.1	16.0	10.6	22.7	11.4	12.9	13.0	13.6	11.1	19.2	22.8	11.5	22.8	8.5	12.8	13.3	7.0	16.1	11.1	10.0	11.7	21.9	23.8	15.0	10.5	8.3	9.0	20.1	6.7	11.6	16.5	30.9	11.5	12.7	5.9	19.0	14.6	9.4	20.3	16.0	14.2	25.4	12.1	25.2	13.7	16.4	9.6	16.2	9.9	14.5	11.5	12.3	12.1	12.6	13.0	10.3	12.8	13.9	12.4	19.1	15.9	8.7	15.0	14.0	13.3	17.8	13.2	13.4	14.7	14.4	13.1	12.0	11.9	8.5	15.6	13.8	4.1	14.0	56.8	12.7	16.0	5.7	21.0	11.8	32.1	54.7	26.4	36.4	11.3	11.9	0.0	27.1	30.5	15.5	11.6	6.9	25.2	26.1	6.4	6.4	6.7	14.8	5.4	15.3	14.8	10.1	26.2	6.8	19.5	18.8	2.9	15.2	56.4	17.6	25.8	9.9	67.2	17.8	6.8	42.1	10.2	8.1	13.6
NDUFV1	CI-51K	ENSG00000167792	"NADH:ubiquinone oxidoreductase core subunit V1"	P49821	11	67606852-67612535	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 150.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045211, HPA075051"	Enhanced		Supported	Mitochondria,Cytosol		No	No			Mitochondria	Cytosol	"HPA045211: AB_10962830, HPA075051: AB_2686732"	"unprognostic (4.57e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.84e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.49e-10)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	23.3	28.9	27.3	20.7	33.9	20.3	18.9	32.9	48.8	18.5	33.0	23.1	19.2	40.6	19.4	21.5	25.5	22.5	23.4	93.0	26.5	24.1	39.0	41.5	15.9	20.6	31.5	40.5	24.6	38.3	49.2	18.8	15.7	34.8	16.1	25.1	17.6	27.3	27.0	150.8	28.4	30.3	22.7	23.1	21.5	28.2	30.2	24.3	18.3	23.4	67.9	20.3	18.7	18.6	23.8	41.2	13.5	30.7	36.2	28.2	24.3	25.9	27.9	14.2	28.5	17.8	17.9	26.6	16.2	15.6	25.4	17.0	52.8	31.5	48.0	34.2	13.9	20.7	35.0	30.0	25.3	8.0	24.4	23.7	19.6	37.9	26.0	25.2	26.7	22.0	26.5	24.6	20.6	18.5	16.1	22.5	35.2	35.7	39.3	15.4	39.0	31.2	52.9	13.9	59.1	35.2	36.3	27.6	77.9	20.6	19.5	22.7	21.4	20.5	71.8	54.1	9.9	36.4	27.2	17.8	24.7	18.4	35.1	17.0	38.4	21.8	23.9	28.7	28.3	23.7	12.6	26.7	13.5	25.9	30.7	28.2	23.2	21.7	24.5	41.2	23.8	20.2	25.1	4.8	36.2	17.4	26.5	27.8	24.3	27.3	33.9	32.9	48.8	26.5	24.1	31.5	40.5	34.8	24.3	56.6	80.9	64.0	70.8	71.3	67.0	408.9	66.2	72.3	67.1	82.0	47.1	180.6	336.5	96.7	57.0	53.7	205.0	23.3	97.8	127.6	79.5	47.7	59.0	122.2	121.6	60.4	94.7	53.4	67.1	159.3	60.7	67.5	108.0	83.8	141.7	63.1	68.4	126.7	55.5	398.9	60.4	45.3	98.9	77.2	78.1	70.4	158.1	71.2	225.4	78.9
NDUFV2	CI-24k	ENSG00000178127	"NADH:ubiquinone oxidoreductase core subunit V2"	P19404	18	9102630-9134345	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003404, HPA077896"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		No	No			Mitochondria	"Nucleoplasm, Cytosol"	"HPA003404: AB_1079466, HPA077896: AB_2686866"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.95e-3)"	20.0	34.5	25.2	18.0	23.7	31.1	25.6	20.6	37.3	15.6	26.1	13.1	20.3	23.1	14.7	21.5	27.5	13.9	17.6	82.6	22.7	23.8	40.7	89.1	17.2	29.9	26.7	19.4	11.2	36.3	14.9	14.9	21.6	26.2	20.8	27.8	17.8	20.1	20.2	122.6	17.4	24.4	23.5	20.8	19.3	25.2	19.0	12.7	20.5	20.5	59.5	22.7	20.4	14.1	55.6	74.7	49.3	45.1	27.0	53.5	48.1	18.6	19.6	22.7	21.1	16.8	24.0	19.2	23.5	37.4	31.1	29.6	36.6	15.4	28.8	21.6	22.0	28.7	9.5	22.0	24.4	29.8	14.5	19.4	18.4	20.2	49.3	19.4	51.2	22.9	20.1	20.5	19.2	20.8	22.5	33.5	26.0	29.3	91.0	28.5	23.4	35.7	44.9	18.9	103.3	24.4	17.0	16.8	109.2	49.6	30.3	23.8	17.7	23.2	26.5	29.5	16.9	24.8	39.0	20.5	39.7	28.2	28.4	30.5	26.3	39.0	32.2	28.3	22.7	25.6	49.3	39.9	44.1	30.2	45.1	37.6	55.6	45.5	35.7	56.6	43.6	40.0	36.9	18.0	27.0	41.6	74.7	53.5	48.1	25.2	23.7	20.6	37.3	22.7	23.8	26.7	19.4	26.2	12.7	74.5	120.4	122.8	254.8	131.4	96.8	61.3	175.8	207.5	127.4	143.1	82.5	309.8	742.8	337.2	214.8	108.5	232.3	46.7	461.4	265.4	107.6	372.3	115.7	324.6	267.7	89.0	102.4	92.7	98.1	135.7	113.1	187.8	219.4	393.1	177.0	104.6	465.3	175.4	95.8	576.3	143.4	103.5	138.2	182.6	170.4	129.0	242.0	118.9	207.0	348.6
NEXMIF	"KIAA2022, KIDLIA, MRX98, XPN"	ENSG00000050030	"Neurite extension and migration factor"	Q5QGS0	X	74732856-74925485	"Disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;parathyroid gland: 9.0"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 2.2;Ciliated cells: 5.3;Club cells: 4.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HAP1: 6.7;Karpas-707: 10.8;SiHa: 9.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000407	Uncertain		Supported	"Nucleoplasm,Midbody,Mitotic spindle,Cytosol"		Yes	NA			Nucleoplasm	"Midbody, Mitotic spindle, Cytosol"	"HPA000407: AB_2665984"	"unprognostic (1.04e-3)"	"unprognostic (6.07e-5)"	"unprognostic (1.81e-2)"	"unprognostic (2.07e-5)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.79e-4)"	"unprognostic (6.94e-4)"	0.6	3.0	5.4	0.7	6.2	0.4	1.3	10.2	9.4	1.7	1.9	0.7	1.0	0.6	1.7	0.9	1.8	1.3	0.5	0.3	5.0	6.2	2.4	0.2	0.9	0.5	1.8	5.0	1.7	4.4	9.0	7.5	0.5	1.9	3.2	1.1	1.1	2.5	2.5	0.4	1.8	1.1	2.6	1.2	0.6	1.6	0.9	1.5	0.0	1.5	0.0	0.5	0.7	2.8	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	10.8	0.0	0.2	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.0	9.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	6.2	10.2	6.8	5.0	6.2	1.8	5.0	1.9	1.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NFKBID	"IkappaBNS, TA-NFKBH"	ENSG00000167604	"NFKB inhibitor delta"	Q8NI38	19	35887653-35902303	"Predicted intracellular proteins, Transcription factors"	"Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 21.0"	"Cell type enhanced"	"Detected in many"	9	"granulocytes: 91.9;Macrophages: 54.1;monocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 10.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054778			Uncertain	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nuclear bodies, Plasma membrane"	"HPA054778: "	"prognostic favorable (6.01e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.51e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (4.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.64e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.71e-2)"	"prognostic favorable (8.34e-6)"	4.1	2.8	0.9	13.5	2.5	21.0	7.0	4.5	2.4	1.9	2.1	4.4	0.9	1.9	2.3	2.7	3.0	3.7	6.9	2.1	0.7	1.1	3.4	1.8	11.4	9.1	2.3	0.4	4.3	3.5	1.9	5.5	1.6	2.0	2.6	1.5	2.7	2.3	3.4	0.9	3.6	4.8	5.1	2.4	6.8	2.8	1.5	1.1	14.4	5.1	1.0	14.7	2.8	7.4	9.4	1.9	4.8	1.6	2.0	2.3	0.6	4.7	4.4	0.9	3.0	0.6	0.7	2.1	3.0	3.5	3.2	2.3	1.0	3.9	5.8	2.3	3.1	2.8	2.5	3.1	2.3	1.3	3.3	0.6	3.5	6.2	1.1	0.8	3.0	10.5	1.0	1.6	5.9	1.5	0.8	1.1	2.7	0.7	3.6	0.7	3.7	2.5	3.6	1.3	0.9	0.9	1.3	0.7	1.2	2.8	2.0	1.6	1.2	4.0	3.1	0.3	0.8	1.4	3.0	1.2	5.0	4.5	2.2	2.0	2.5	0.9	6.8	2.7	7.1	0.7	0.0	1.4	2.5	2.3	0.9	1.7	5.4	1.0	1.8	1.4	9.4	1.7	1.0	4.8	2.0	1.6	1.9	2.2	0.6	0.9	2.5	4.5	2.4	0.7	1.1	2.3	0.4	2.0	1.1	0.0	13.7	34.0	7.1	26.4	8.1	0.8	5.1	4.0	2.3	1.8	19.6	1.1	0.0	2.3	0.0	8.7	2.9	0.0	0.9	2.2	15.4	12.3	91.9	0.0	32.9	0.0	2.9	2.5	30.8	0.0	1.1	54.1	18.6	51.3	2.6	1.1	2.7	2.5	1.8	0.9	9.7	0.0	9.5	0.5	0.5	29.2	0.8	15.2	4.8	7.9
NKX1-1	"HSPX153, SAX2"	ENSG00000235608	"NK1 homeobox 1"	Q15270	4	1402932-1406331	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	19	"pituitary gland: 1.0;testis: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"pons and medulla: 0.2"	HPA029367	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA029367: AB_2673011"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NKX2-3	"CSX3, NKX2.3, NKX2C, NKX4-3"	ENSG00000119919	"NK2 homeobox 3"	Q8TAU0	10	99532933-99536524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.5;intestine: 21.6;lymphoid tissue: 36.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.1;NB-4: 4.8;REH: 6.2;THP-1: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047561	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA047561: AB_2680088"		"unprognostic (5.70e-2)"	"unprognostic (2.95e-1)"			"unprognostic (2.70e-4)"	"unprognostic (6.34e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	0.8	0.0	0.1	17.2	0.1	0.0	0.1	0.1	0.1	0.3	21.6	0.1	0.1	10.4	0.2	0.1	0.5	0.0	12.5	0.1	0.1	0.0	0.1	0.2	0.1	1.1	0.1	0.1	0.1	6.4	0.0	0.1	0.1	0.1	0.1	4.6	0.1	9.0	0.5	0.1	0.0	19.1	3.1	0.1	36.8	1.8	0.1	0.1	0.2	1.0	0.7	3.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	6.2	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.4	0.0	1.6	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
NLRP14	"CLR11.2, GC-LRR, Nalp-iota, NALP14, NOD5, PAN8"	ENSG00000158077	"NLR family pyrin domain containing 14"	Q86W24	11	7020446-7071308	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 2.5;testis: 3.4"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 1.7;Cone photoreceptor cells: 2.0;Distal tubular cells: 1.7;Early spermatids: 1.5;Rod photoreceptor cells: 2.9;Spermatocytes: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HEK 293: 1.7;HL-60: 1.2;HUVEC TERT2: 4.1;U-698: 2.2"	"Not detected"	"Not detected"							HPA039477	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA039477: AB_10794748"	"unprognostic (6.46e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.44e-4)"	"unprognostic (7.20e-4)"	"unprognostic (5.57e-2)"	"unprognostic (8.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.17e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.25e-1)"	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.8	0.1	0.2			0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.3	0.3	1.6	2.5	0.4	0.2	0.4		1.3	0.0	1.7	0.1	0.0		0.1	0.2		0.3	0.0	0.0	0.0	0.2	0.0	1.2	0.3	0.0	3.4			0.3		0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.2	0.2	0.9	0.5	0.7	0.0	0.4	1.6	0.0	0.1	0.4	0.0	0.0	0.1	0.7	0.0	1.7	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.1	0.0	0.1	0.0	4.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	2.2	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	2.0	0.0	1.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.3	2.9	0.0	0.0	2.5	0.9	0.0	0.0	0.0	0.0	0.0
NR2F6	"EAR-2, ERBAL2"	ENSG00000160113	"Nuclear receptor subfamily 2 group F member 6"	P10588	19	17231883-17245940	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 123.8;Hepatocytes: 131.0;Horizontal cells: 143.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 59.1;EFO-21: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB079917			Supported	"Nuclear speckles,Cytosol"		NA	Yes			"Nuclear speckles"	Cytosol	"CAB079917: AB_2635238"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.67e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.62e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.37e-3)"	10.0	8.0	5.4	9.3	5.6	1.1	15.2	6.9	7.4	9.0	23.4	4.7	10.9	26.0	7.9	26.3	16.8	7.7	11.3	14.8	4.6	5.9	17.7	49.3	10.0	2.8	4.8	4.7	9.8	23.5	7.0	8.6	26.5	4.0	10.5	8.2	8.0	13.4	10.3	20.2	9.4	36.2	6.6	2.4	5.0	26.8	9.7	4.5	1.7	13.8	9.3	6.7	10.7	11.5	2.7	1.8	1.6	1.1	7.4	6.5	1.3	19.4	11.7	6.4	11.6	2.5	2.8	59.1	11.0	4.0	4.8	4.1	7.9	17.2	4.6	34.6	4.9	2.8	9.7	4.8	6.3	2.1	6.1	28.0	4.2	7.5	14.2	5.6	2.0	5.9	3.7	7.3	2.2	3.6	5.0	2.9	2.1	9.9	1.1	2.0	10.4	1.7	7.4	17.6	14.6	18.2	3.5	4.0	3.9	6.6	12.7	5.1	14.8	6.1	21.5	12.4	6.5	11.9	6.4	4.8	3.4	8.3	6.5	8.7	6.6	2.3	3.3	4.2	3.0	4.1	0.0	1.1	1.6	2.7	0.0	2.4	0.5	3.9	2.5	1.8	2.7	6.5	2.2	0.2	7.4	0.1	0.8	3.5	1.3	5.4	5.6	6.9	7.4	4.6	5.9	4.8	4.7	4.0	4.5	8.9	18.5	4.7	14.9	9.4	63.1	33.0	33.1	10.7	11.4	24.4	72.6	54.8	24.9	20.6	7.8	12.6	123.8	0.0	41.6	54.2	11.1	17.2	1.1	131.0	13.7	143.0	44.1	17.8	2.9	4.1	16.4	3.3	10.1	1.8	71.7	40.3	40.0	73.0	17.7	29.4	53.0	6.5	15.5	1.0	7.7	9.3	66.7	2.9	56.2	14.1
NR5A1	"AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1"	ENSG00000136931	"Nuclear receptor subfamily 5 group A member 1"	Q13285	9	124481236-124507430	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 47.7;lymphoid tissue: 50.8"	"Group enriched"	"Detected in some"	10	"Leydig cells: 10.9;Peritubular cells: 7.1;Sertoli cells: 12.9"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.3"	"Cell line enhanced"	"Detected in some"		"HEL: 39.1;Hep G2: 25.3;K-562: 9.3"	"Region enriched"	"Detected in single"	20	"hypothalamus: 6.1"	"Not detected"	"Not detected"			HPA079181			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA079181: "	"unprognostic (1.66e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.13e-5)"	"unprognostic (2.32e-7)"	"unprognostic (3.95e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.14e-2)"			"unprognostic (4.75e-3)"	"unprognostic (1.14e-1)"		"unprognostic (1.49e-2)"	0.2	47.7	0.2	0.2	0.5	0.0	0.2	0.2	0.4	0.2	0.2	1.3	0.2	0.0	0.2	0.4	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	13.1	0.2	0.0	5.8	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	50.8	0.0	9.4	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.1	0.0	25.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.5	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	12.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
NRF1	"ALPHA-PAL, EWG"	ENSG00000106459	"Nuclear respiratory factor 1"	Q16656	7	129611714-129757082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029329	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029329: AB_10601240"	"unprognostic (2.80e-2)"	"unprognostic (2.20e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.20e-3)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.20e-1)"	"unprognostic (2.06e-3)"	14.8	7.3	10.9	18.9	13.0	20.3	18.2	22.2	11.1	15.4	10.3	12.6	16.0	9.0	15.7	10.4	10.1	18.7	10.0	12.3	11.5	11.1	10.0	7.8	11.2	18.7	12.1	7.7	24.4	15.2	13.5	10.9	12.5	11.5	11.5	9.9	11.7	13.8	13.9	19.3	12.2	10.7	14.0	9.6	14.2	8.7	17.2	15.2	29.2	13.8	11.4	16.1	12.8	19.2	8.8	7.0	13.1	7.0	5.8	13.3	6.2	11.8	9.7	14.1	12.4	8.5	6.8	11.2	8.3	8.6	12.7	9.9	11.7	7.9	13.6	6.1	9.3	8.0	9.1	15.1	8.4	13.0	13.0	10.8	11.3	8.2	7.9	6.2	13.8	11.3	5.8	7.9	12.5	12.1	7.3	9.3	13.3	13.6	10.5	7.7	10.8	27.0	13.0	13.1	10.9	8.7	17.2	11.4	12.1	7.2	8.7	12.2	13.3	12.5	13.0	8.4	12.0	8.1	13.2	7.2	7.2	10.0	8.4	15.2	11.5	11.4	24.2	7.6	12.8	13.9	6.1	5.5	13.1	11.4	6.9	13.3	7.7	8.7	10.5	7.0	8.8	9.6	8.2	11.4	5.8	7.0	4.7	9.1	6.2	10.9	13.0	22.2	11.1	11.5	11.1	12.1	7.7	11.5	15.2	3.0	6.2	3.7	2.8	6.0	10.2	5.1	5.1	13.4	5.7	3.5	9.8	2.1	0.0	2.1	0.3	6.7	3.2	0.0	3.1	3.5	3.7	4.4	4.7	4.7	2.6	9.5	6.4	8.0	5.6	1.4	4.9	5.8	5.0	2.8	5.0	5.6	2.4	5.8	4.2	2.2	10.4	6.5	3.6	6.7	6.0	6.8	2.9	9.2	3.9	2.6
NRL	"D14S46E, NRL-MAF, RP27"	ENSG00000129535	"Neural retina leucine zipper"	P54845	14	24080107-24115014	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	16	"retina: 124.5"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 2618.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026066, HPA064599"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB026066: , HPA064599: AB_2685295"	"unprognostic (2.71e-2)"	"unprognostic (8.17e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.88e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.38e-5)"	"unprognostic (2.56e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-3)"	1.5	2.7	4.4	2.3	4.1	1.0	1.8	2.1	2.8	1.9	1.3	1.7	1.7	3.2	1.4	7.9	1.3	1.4	1.2	2.7	3.8	3.1	3.5	3.9	1.7	1.9	3.9	1.4	1.8	3.4	5.4	2.8	1.8	2.1	1.8	1.0	124.5	1.6	2.4	4.1	0.9	1.9	1.0	4.4	2.6	1.3	4.3	1.2	3.3	4.3	1.8	1.6	1.5	2.2	3.8	1.4	4.1	1.3	2.0	2.7	1.2	0.8	1.7	0.5	1.8	0.5	0.5	1.6	0.4	0.4	2.2	1.0	1.1	0.8	2.5	0.8	1.0	1.6	1.0	1.0	1.2	0.3	1.8	1.5	0.7	0.5	3.7	1.2	1.9	3.3	0.7	1.0	0.6	1.2	0.4	1.1	3.1	1.6	3.0	0.8	2.6	2.2	1.8	0.6	3.4	1.8	2.2	2.1	0.7	1.2	1.7	2.0	2.0	1.3	1.5	1.6	0.7	1.1	2.6	0.4	1.4	0.8	0.6	1.2	7.6	3.2	2.7	0.2	1.6	1.5	0.0	1.1	4.1	1.1	1.2	0.7	3.8	1.1	1.6	1.3	2.4	2.7	2.3	0.2	2.0	1.3	1.4	1.0	1.2	4.4	4.1	2.1	2.8	3.8	3.1	3.9	1.4	2.1	1.2	0.0	0.3	4.4	1.7	0.7	340.0	1.6	0.0	0.0	1.2	7.0	406.4	1.0	11.6	0.5	1.7	0.6	2.1	23.3	1.0	0.8	0.5	2.4	0.0	2.6	1.7	236.8	1.7	0.0	0.6	2.8	1.1	0.2	1.7	1.0	1.8	381.3	0.4	0.9	1.8	6.8	2618.0	0.0	0.5	8.2	3.4	0.4	2.1	1.5	0.9	1.6
NUDCD2	"DKFZp686E10109, NudCL2"	ENSG00000170584	"NudC domain containing 2"	Q8WVJ2	5	163446526-163460140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037384, HPA037385"	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA037384: AB_2675447, HPA037385: AB_10673630"	"unprognostic (3.96e-1)"	"unprognostic (3.69e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.46e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (7.85e-2)"	18.3	17.3	19.1	17.4	20.2	14.0	16.6	10.4	21.8	8.5	15.1	23.2	12.7	20.2	12.5	9.7	15.0	14.3	9.9	10.1	19.9	15.1	16.2	20.1	11.8	18.9	27.0	14.5	13.4	24.4	9.6	13.2	14.5	19.3	12.7	9.1	9.3	19.4	10.6	25.7	11.7	18.0	14.1	30.5	16.6	15.9	12.5	20.9	16.9	14.6	11.0	13.4	12.8	11.5	34.3	30.3	14.1	21.6	28.5	36.5	24.4	23.5	12.2	9.3	14.6	5.7	4.2	12.3	9.5	2.8	3.4	5.5	10.9	18.1	13.4	23.0	1.5	15.9	11.9	4.9	5.4	4.1	26.7	13.7	12.4	15.5	9.9	6.2	13.9	14.1	1.5	3.2	3.3	4.8	4.9	3.8	15.3	13.0	16.8	3.5	9.6	20.6	30.7	10.2	7.0	13.5	17.4	15.5	23.8	3.1	5.5	23.7	13.4	15.0	9.7	24.7	5.8	18.6	14.4	8.5	11.8	17.7	13.0	21.8	13.9	23.2	22.6	13.7	24.2	12.3	14.1	18.9	11.8	23.8	21.6	30.3	34.3	34.0	28.4	25.4	24.4	36.5	31.9	2.4	28.5	17.9	30.3	30.0	24.4	19.1	20.2	10.4	18.1	19.9	15.1	27.0	14.5	19.3	20.9	26.8	18.4	48.4	46.7	52.8	29.3	36.7	30.6	41.5	31.8	36.6	21.6	97.0	126.0	54.7	60.9	45.6	19.3	23.3	55.7	43.8	50.3	51.1	30.1	51.3	61.4	9.5	42.1	31.9	41.1	11.4	47.8	38.8	47.2	40.5	42.0	35.3	54.2	28.1	48.1	89.3	36.4	38.8	41.9	69.5	42.8	59.1	47.5	42.4	61.0	48.8
NUDT19	RP2	ENSG00000213965	"Nudix hydrolase 19"	A8MXV4	19	32691961-32713796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042761			Uncertain	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli, Cytosol"		"HPA042761: "	"unprognostic (1.20e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.35e-3)"	"unprognostic (6.61e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.35e-4)"	9.9	18.7	7.2	11.1	7.0	10.8	10.7	7.4	7.6	5.6	12.8	6.1	8.4	10.2	6.6	8.8	16.9	6.3	7.6	19.3	6.1	6.5	10.5	16.4	15.9	9.2	6.2	5.5	8.5	18.9	9.5	9.3	6.6	6.1	11.2	10.7	9.4	14.7	11.8	29.5	13.2	12.9	6.9	5.6	8.9	11.3	6.8	6.6	6.8	5.9	13.1	13.0	9.9	8.4	8.4	11.9	9.0	23.6	18.7	14.8	6.5	13.7	16.0	1.8	15.9	5.5	7.2	0.3	7.8	2.9	5.8	5.5	9.0	7.6	0.2	9.4	9.0	4.5	9.0	11.0	9.1	7.7	15.8	6.6	17.8	6.4	3.3	7.6	13.3	5.5	5.8	12.1	4.9	12.0	6.8	8.5	2.8	13.7	10.2	10.4	9.1	0.1	12.3	1.9	3.8	7.6	0.1	3.5	7.7	9.6	10.3	7.2	10.3	13.9	11.9	9.8	3.3	6.5	16.3	6.8	8.1	5.2	8.0	13.9	12.0	10.1	4.5	9.7	12.8	7.4	6.6	17.3	9.0	11.9	21.7	12.8	8.4	12.5	14.8	11.9	5.9	10.0	13.8	3.3	18.7	23.6	9.5	13.8	6.5	7.2	7.0	7.4	7.6	6.1	6.5	6.2	5.5	6.1	6.6	11.9	12.6	8.2	6.5	19.5	12.8	18.7	5.1	4.0	4.5	7.0	11.8	9.8	23.2	2.6	7.7	4.5	9.7	0.0	9.9	9.4	9.4	8.5	1.1	9.3	12.6	3.2	11.6	12.3	12.1	3.1	3.7	10.8	11.8	7.2	13.0	5.5	9.5	14.0	8.9	14.8	26.4	0.0	6.6	1.4	1.9	27.6	6.5	13.3	15.8	7.9
NUF2	"CDCA1, CT106, NUF2R"	ENSG00000143228	"NUF2, NDC80 kinetochore complex component"	Q9BZD4	1	163266576-163355764	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 38.6;testis: 29.0"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 232.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059692, HPA076604"			Supported	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			Nucleoplasm	"Kinetochore, Cytosol"	"HPA059692: AB_2684103, HPA076604: "	"unprognostic (9.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.04e-5)"	"prognostic unfavorable (9.16e-4)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (3.70e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.96e-2)"	1.3	0.9	0.8	9.8	0.9	14.1	0.6	0.5	0.9	1.4	2.5	0.6	0.9	2.3	0.6	2.1	6.1	0.5	0.7	1.5	0.8	0.6	0.7	0.6	1.9	9.9	0.8	0.6	0.7	0.4	0.3	0.4	3.6	0.7	0.6	2.9	0.8	1.3	0.0	0.5	2.2	3.2	1.0	1.4	4.4	1.6	29.0	0.3	38.6	0.5	5.1	9.2	1.5	1.8	1.4	0.6	2.6	0.2	3.0	7.7	1.0	26.3	9.2	24.5	10.2	0.7	2.5	13.3	16.7	11.8	27.2	23.9	7.0	23.3	22.7	14.0	6.7	11.3	15.5	14.9	6.3	34.5	23.7	10.7	8.9	10.6	10.0	0.0	15.3	18.4	0.3	0.6	13.7	9.7	5.1	12.3	22.3	16.7	31.5	25.7	5.1	27.9	20.6	13.3	19.4	14.2	19.0	21.4	20.1	7.7	3.6	18.3	21.1	8.9	9.7	9.2	15.9	14.9	32.1	8.7	20.3	22.8	15.2	33.6	22.6	31.8	43.3	6.7	12.6	22.4	2.6	0.2	2.5	2.4	0.1	1.0	1.2	3.6	2.4	0.5	1.4	2.5	2.1	0.9	3.0	0.2	0.6	7.7	1.0	0.8	0.9	0.5	0.9	0.8	0.6	0.8	0.6	0.7	0.3	0.0	0.3	3.7	1.8	5.3	1.0	0.8	0.0	0.0	4.5	0.0	0.0	2.7	0.0	0.7	15.8	0.1	0.8	46.7	0.2	23.9	1.8	0.4	4.6	0.2	11.3	0.0	0.0	1.8	3.7	10.7	2.3	2.5	0.0	1.0	0.9	2.5	0.2	0.0	2.1	0.0	2.0	6.5	0.5	232.2	40.5	2.0	3.3	3.8	2.2	1.4
NUP188	KIAA0169	ENSG00000095319	"Nucleoporin 188"	Q5SRE5	9	128947699-129007096	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.3"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 43.2;Spermatocytes: 41.6;Spermatogonia: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061750, HPA063942"	Approved		Uncertain	Nucleoplasm,Nucleoli,Cytosol		No	No			Nucleoplasm	"Nucleoli, Cytosol"	"HPA061750: AB_2684602, HPA063942: AB_2685156"	"unprognostic (4.64e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.20e-5)"	"unprognostic (9.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-3)"	"unprognostic (3.53e-3)"	10.2	11.1	7.6	12.6	9.2	14.3	14.0	13.3	8.7	9.2	9.3	10.1	9.6	5.8	9.8	6.7	16.6	8.3	7.6	9.2	5.6	6.3	8.1	9.6	13.1	16.6	6.5	6.7	10.8	13.3	12.6	13.6	9.1	7.3	9.5	9.3	11.2	9.9	8.3	10.9	16.4	9.0	11.0	7.7	12.2	9.5	60.3	7.3	26.5	9.2	11.3	17.3	8.5	10.5	6.1	7.9	6.3	10.7	6.0	12.0	7.0	10.9	21.0	17.4	23.7	13.2	13.1	15.6	15.4	12.2	28.3	18.9	25.3	8.8	19.2	5.8	16.9	18.3	32.6	39.0	19.1	21.2	15.4	18.8	17.1	39.2	19.9	8.4	29.2	17.3	9.1	9.0	29.7	15.2	8.3	16.2	25.0	37.5	13.7	19.9	27.8	24.9	11.9	23.3	21.1	20.2	22.9	37.7	19.6	8.7	12.4	24.5	11.8	39.9	15.2	5.9	13.4	16.7	10.8	13.1	23.5	16.7	23.6	27.5	11.7	21.6	26.0	13.7	18.7	17.3	6.3	5.3	1.9	9.3	10.7	12.0	6.1	7.9	9.0	7.9	5.9	8.1	8.6	0.8	6.0	5.9	3.3	9.5	7.0	7.6	9.2	13.3	8.7	5.6	6.3	6.5	6.7	7.3	7.3	0.0	13.0	7.5	5.2	5.8	14.9	2.7	7.6	4.0	2.3	5.2	43.2	6.4	1.7	5.5	10.1	6.8	3.2	0.0	5.6	5.9	6.9	7.5	5.8	3.8	7.4	19.1	8.7	12.9	4.9	3.1	8.9	7.2	1.7	4.6	6.7	7.5	7.5	0.0	11.0	1.9	25.0	25.8	4.2	41.6	37.7	9.8	7.2	7.0	6.0	7.2
NUP43	"bA350J20.1, FLJ13287"	ENSG00000120253	"Nucleoporin 43"	Q8NFH3	6	149724315-149749665	"Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027126, HPA027291, HPA028500"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287"	"prognostic unfavorable (2.08e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (7.13e-7)"	"unprognostic (5.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	16.9	14.2	12.7	15.2	13.8	7.6	19.6	15.6	13.5	20.1	13.1	17.9	18.3	12.4	18.4	11.5	17.4	13.1	9.1	14.7	10.9	10.0	15.7	13.7	12.6	20.3	15.2	9.2	15.7	22.6	14.1	13.2	18.8	12.9	16.6	14.1	17.7	14.2	14.2	20.0	18.7	16.6	16.2	12.1	22.7	14.4	13.8	16.4	28.6	18.9	12.1	24.2	18.4	14.2	10.6	8.1	5.1	8.6	6.1	9.7	3.3	9.0	15.8	13.9	21.8	8.9	11.2	21.8	15.7	9.0	15.4	19.5	22.6	8.5	26.1	16.8	8.6	14.4	14.5	23.8	13.8	26.2	12.2	16.7	29.9	16.8	21.0	6.1	30.6	19.5	6.8	7.3	22.4	14.3	5.8	12.1	15.1	30.5	14.6	12.8	9.7	22.0	12.7	12.2	10.3	9.4	21.6	19.2	8.7	10.1	12.6	5.7	9.6	18.7	11.9	6.1	12.0	12.7	13.0	9.4	12.6	13.7	17.9	23.9	9.0	18.3	28.0	11.2	21.3	17.6	4.4	8.3	5.1	6.3	8.6	6.6	7.3	7.4	6.2	4.2	10.6	7.8	9.7	3.3	6.1	7.2	8.1	7.9	3.3	12.7	13.8	15.6	13.5	10.9	10.0	15.2	9.2	12.9	16.4	3.0	5.6	6.2	4.5	7.0	11.7	12.6	10.2	2.7	4.5	3.5	5.9	9.5	3.3	7.6	27.2	5.3	3.4	0.0	6.7	10.5	4.7	5.3	0.0	3.2	6.7	6.4	9.8	6.2	10.3	58.0	9.5	6.0	8.5	10.0	5.8	11.1	5.5	0.0	9.9	3.8	9.5	12.9	8.2	4.9	10.0	7.4	5.5	6.9	7.6	5.6
OPRK1	"KOR, OPRK"	ENSG00000082556	"Opioid receptor kappa 1"	P41145	8	53225716-53251697	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.0;prostate: 6.7"	"Group enriched"	"Detected in some"	8	"Extravillous trophoblasts: 7.3;Leydig cells: 4.4"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"U-937: 22.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067549	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA067549: AB_2732770"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-2)"		"unprognostic (8.70e-3)"	"unprognostic (3.73e-2)"	"unprognostic (6.74e-2)"		"unprognostic (2.22e-3)"		"unprognostic (8.09e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.28e-3)"		"unprognostic (3.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.54e-4)"	"unprognostic (1.61e-1)"	0.7	0.7	15.9	0.3	18.0	0.4	0.3	2.2	8.8	0.4	0.4	0.3	0.0	0.4	0.4	0.6	0.5	0.7	0.4	0.8	4.5	6.2	0.3	0.5	0.8	0.4	1.7	5.8	0.4	0.3	0.4	0.8	2.8	3.1	6.7	0.4	0.0	0.3	0.4	3.8	0.4	0.5	0.5	0.5	0.6	0.3	2.8	1.6	0.2	0.9	0.0	0.3	0.3	0.1	0.2	0.8	1.2	0.2	0.1	0.4	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	22.1	0.1	1.2	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.8	0.0	0.0	15.9	18.0	2.2	8.8	4.5	6.2	1.7	5.8	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.3	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0
OR6B2	OR6B2P	ENSG00000182083	"Olfactory receptor family 6 subfamily B member 2"	Q6IFH4	2	240028965-240030456	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	6	"testis: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.5"									HPA047529	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA047529: AB_2680077"																		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	2.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6B3	"OR6B3P, OR6B3Q"	ENSG00000178586	"Olfactory receptor family 6 subfamily B member 3"	Q8NGW1	2	240045077-240047027	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	6	"brain: 1.6;epididymis: 6.5;testis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HaCaT: 1.2"									HPA047529	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA047529: AB_2680077"																		0.1	0.0	0.8	0.0	0.5	0.0	0.3	0.0	0.1	0.0	0.0			0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	1.3		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.3			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTX1		ENSG00000115507	"Orthodenticle homeobox 1"	P32242	2	63050057-63057836	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.3;retina: 18.9;salivary gland: 19.6;skin 1: 14.3"	"Cell type enhanced"	"Detected in some"	21	"Basal keratinocytes: 1.4;Ciliated cells: 6.7;Club cells: 2.3;Suprabasal keratinocytes: 2.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	113	"neutrophil: 11.3"	"Lineage enriched"	"Detected in single"	113	"granulocytes: 11.3"	"Cell line enriched"	"Detected in many"	9	"THP-1: 34.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB012341, HPA052122"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"CAB012341: AB_2157155, HPA052122: AB_2681736"	"unprognostic (2.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.71e-1)"	"unprognostic (0.00e+0)"	"unprognostic (4.64e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.80e-4)"	"unprognostic (3.67e-3)"	0.5	0.4	8.2	0.4	4.3	0.4	1.1	0.2	7.2	0.4	0.4	5.8	0.0	0.6	0.4	0.4	1.4	0.5	0.5	0.4	9.0	1.4	0.4	0.5	0.8	0.4	2.0	3.4	0.6	0.6	0.4	0.1	0.4	0.1	2.3	0.4	18.9	19.6	0.4	0.4	14.3	0.4	0.4	0.1	0.6	1.0	0.9	4.4	0.0	0.4	4.4	5.6	0.6	0.2	0.0	0.0	11.3	0.0	0.0	0.0	0.0	1.5	0.8	2.8	1.7	0.0	0.1	3.9	0.0	0.2	0.2	0.2	2.8	1.5	0.1	0.5	0.0	0.7	2.0	1.8	1.2	0.3	0.7	1.6	1.8	1.4	3.2	0.0	1.2	1.3	0.0	0.5	0.0	0.5	0.5	0.0	1.7	1.5	0.0	0.1	1.3	1.6	2.9	0.0	1.4	1.0	1.5	2.4	0.4	0.7	0.5	0.3	0.4	1.1	0.1	0.9	0.0	0.6	34.7	0.1	0.6	1.1	0.0	0.6	1.0	0.7	2.6	0.2	1.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	8.2	4.3	0.2	7.2	9.0	1.4	2.0	3.4	0.1	4.4	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.0	6.7	2.3	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	2.3	0.1	0.0	0.0	0.0
OXSM	"CEM1, FASN2D, FLJ20604, KS"	ENSG00000151093	"3-oxoacyl-ACP synthase, mitochondrial"	Q9NWU1	3	25782917-25794534	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021293, HPA021300, HPA021337"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.35e-4)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.18e-9)"	"unprognostic (1.79e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.73e-2)"	6.2	13.7	6.7	9.8	10.5	3.7	10.3	8.3	11.9	6.0	11.8	6.2	13.7	10.1	6.4	16.2	10.3	7.7	7.9	13.5	6.6	6.4	14.9	26.1	10.0	7.7	6.6	6.5	6.4	18.7	8.3	13.0	7.3	7.0	8.0	13.8	10.4	15.5	15.6	19.4	8.3	8.9	5.8	6.7	9.6	8.9	19.9	8.0	8.1	11.7	12.3	11.3	7.9	6.4	8.4	9.0	3.7	6.5	10.3	11.8	6.6	7.7	12.9	2.7	7.6	8.0	8.8	8.0	6.2	9.0	11.7	8.3	9.8	9.3	14.3	8.4	5.7	6.8	8.2	11.4	11.9	11.0	8.6	11.5	15.8	10.9	11.8	9.8	12.7	10.1	8.2	14.8	9.3	9.8	7.6	10.0	13.6	16.2	11.6	9.9	11.5	9.3	9.8	0.5	6.2	14.9	12.4	7.2	23.4	17.1	4.8	3.9	7.2	9.9	17.0	12.6	4.6	18.6	11.9	6.1	7.3	8.8	9.6	8.9	11.1	12.8	4.5	10.3	11.2	7.5	2.1	5.4	3.7	9.4	6.0	10.8	8.4	9.7	11.6	8.6	8.2	11.4	11.8	0.9	10.3	6.5	9.0	6.0	6.6	6.7	10.5	8.3	11.9	6.6	6.4	6.6	6.5	7.0	8.0	0.0	10.3	2.9	5.0	2.7	6.2	9.8	7.6	5.3	4.5	10.4	3.9	17.5	10.0	11.3	38.3	4.9	6.3	0.0	5.9	13.9	6.5	5.4	9.3	13.9	7.7	4.8	2.4	6.7	2.7	11.5	6.6	3.7	5.0	6.4	9.8	8.3	7.4	7.6	3.9	16.1	6.5	0.0	3.1	26.1	12.0	3.9	11.8	5.0	9.6	2.4
P2RY2	P2U	ENSG00000175591	"Purinergic receptor P2Y2"	P41231	11	73218298-73236352	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.1;skeletal muscle: 29.5"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 14.0;Enterocytes: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 28.1"	"Group enriched"	"Detected in many"	12	"granulocytes: 28.1;monocytes: 10.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 16.4;HL-60: 15.5;MCF7: 12.4;NB-4: 12.6;PC-3: 12.9;SK-BR-3: 14.3;THP-1: 36.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB022642	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"CAB022642: "	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (6.50e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (9.69e-2)"	"unprognostic (4.92e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.57e-3)"	0.4	2.3	0.9	1.4	1.2	10.8	1.3	0.3	1.1	5.5	3.1	1.1	0.3	2.2	1.3	2.3	20.0	1.2	2.8	11.7	0.6	0.3	0.9	2.6	2.9	1.5	1.2	0.6	1.7	1.7	6.1	1.1	10.3	1.0	1.7	2.4	3.3	4.0	1.6	29.5	3.4	10.8	0.4	0.4	6.6	0.6	0.7	0.6	0.6	20.2	20.6	12.8	2.1	10.9	0.0	1.6	28.1	10.4	0.0	0.0	1.2	3.6	3.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	8.4	2.8	0.0	5.6	0.2	0.0	16.4	0.4	7.7	0.0	0.0	0.3	1.2	0.2	1.5	0.0	15.5	0.0	0.0	3.6	1.2	0.2	0.0	0.7	0.0	0.7	0.0	0.0	12.4	0.0	12.6	0.2	3.3	12.9	0.0	0.0	0.5	1.2	8.8	0.0	0.0	0.2	14.3	0.0	0.1	6.6	36.3	5.3	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	2.8	0.0	0.2	3.4	28.1	0.0	10.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	1.2	0.9	1.2	0.3	1.1	0.6	0.3	1.2	0.6	1.0	0.6	3.0	0.3	0.0	6.8	3.3	0.5	5.3	7.6	0.0	4.5	0.0	0.0	14.0	1.7	5.0	5.3	0.5	12.9	0.0	5.6	0.5	0.4	1.1	0.0	4.5	2.3	0.0	0.0	0.0	2.7	6.7	0.0	0.9	0.0	0.0	2.9	5.2	11.6	10.5	0.0	0.3	0.2	0.0	0.2	0.0	0.0	6.4	9.2	0.0	2.3	11.1
P4HTM	"EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4"	ENSG00000178467	"Prolyl 4-hydroxylase, transmembrane"	Q9NXG6	3	48989886-49007154	"Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007199	Supported		Uncertain	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA007199: AB_1855272"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.47e-2)"	"prognostic favorable (8.18e-4)"	"unprognostic (7.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-2)"	"prognostic favorable (3.28e-5)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.65e-3)"	7.4	25.5	22.1	6.4	28.5	4.7	8.9	17.6	32.9	13.5	10.8	15.9	13.8	10.4	9.7	18.9	5.4	34.7	13.0	18.6	23.0	26.5	14.1	5.4	10.6	5.6	18.7	20.3	11.4	29.9	20.8	35.7	9.6	15.7	15.5	6.7	14.1	16.0	16.5	10.0	4.3	7.8	7.0	14.3	6.3	15.7	11.7	16.4	3.4	21.5	3.3	6.7	7.5	6.1	9.8	7.8	6.7	7.6	4.9	14.4	4.8	3.7	10.3	1.9	0.0	5.8	6.9	0.1	6.7	8.9	5.1	5.5	2.3	20.2	3.2	7.1	8.2	4.1	2.0	4.4	2.2	1.5	12.1	7.6	0.0	15.3	0.0	15.3	3.1	0.1	4.0	2.2	5.1	0.4	19.2	5.7	0.0	0.0	14.0	2.4	16.1	0.4	0.4	2.8	18.8	12.1	0.0	0.0	18.8	9.0	5.8	8.0	0.1	7.6	8.1	0.0	0.5	7.1	5.2	4.0	3.0	2.6	7.6	5.3	19.9	11.0	0.0	22.5	0.3	3.1	6.7	7.6	4.8	6.4	2.7	8.7	7.0	11.6	10.3	7.8	9.8	12.0	8.3	0.8	4.9	3.6	1.4	14.4	4.8	22.1	28.5	17.6	32.9	23.0	26.5	18.7	20.3	15.7	16.4	20.8	12.9	13.4	30.2	8.1	71.6	10.6	22.9	76.3	21.6	43.6	82.5	24.6	16.6	32.6	102.4	11.9	34.1	0.0	34.1	8.5	27.3	29.0	23.0	7.6	14.9	111.2	77.7	12.3	8.1	112.9	28.1	11.2	11.8	12.6	33.5	60.4	23.6	40.3	24.4	25.5	55.3	19.4	27.4	37.5	7.9	9.2	21.9	22.4	42.1	30.2
PARM1	"Cipar1, DKFZP564O0823, WSC4"	ENSG00000169116	"Prostate androgen-regulated mucin-like protein 1"	Q6UWI2	4	74933095-75050115	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 143.3;Mucus-secreting cells: 90.2;Paneth cells: 120.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 10.1;myeloid DC: 4.6;naive B-cell: 6.4"	"Group enriched"	"Detected in many"	15	"B-cells: 10.1;dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.5;Karpas-707: 23.9;U-266/70: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038236	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles, Cytosol"		"HPA038236: AB_10675789"	"unprognostic (2.57e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.26e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.23e-1)"	23.1	21.5	5.7	25.0	15.2	0.3	16.4	1.3	29.4	18.7	36.0	1.2	28.5	2.8	20.3	18.0	5.8	12.2	11.5	39.8	6.9	13.0	27.5	1.1	15.1	10.2	3.3	10.3	11.9	29.2	23.2	32.1	16.1	4.8	35.0	45.8	70.2	25.6	27.6	7.4	6.2	8.3	29.3	2.4	9.7	5.5	11.2	1.2	6.3	79.8	3.7	8.0	24.9	19.7	10.1	4.6	0.1	0.5	0.0	0.0	0.7	0.5	1.0	0.9	0.0	24.5	0.1	0.1	0.0	0.1	0.0	0.0	2.0	0.2	0.0	0.1	0.0	0.0	0.0	8.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	4.1	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	23.9	0.4	0.2	2.6	0.1	2.3	0.0	1.4	0.0	2.2	6.0	0.1	4.9	1.5	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0	1.4	1.6	0.1	2.1	26.8	2.5	6.8	2.5	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.0	10.1	0.0	0.0	4.6	6.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.7	5.7	15.2	1.3	29.4	6.9	13.0	3.3	10.3	4.8	1.2	14.9	63.1	13.4	17.1	2.9	7.9	143.3	30.6	1.4	11.4	0.0	0.0	0.3	3.3	0.1	6.8	3.8	80.6	23.3	43.2	0.6	15.4	43.3	1.1	0.0	1.4	0.0	19.1	3.1	0.0	20.6	33.9	7.2	8.5	1.0	90.2	0.0	26.9	120.2	70.0	27.6	1.0	45.3	52.3	1.7	3.3	1.6	0.7	1.5	46.2	8.4
PATJ	"Cipp, INADL"	ENSG00000132849	"PATJ, crumbs cell polarity complex component"	Q8NI35	1	61742406-62178675	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.4"	"Group enriched"	"Detected in some"	9	"Alveolar cells type 1: 80.4;Alveolar cells type 2: 49.2;Ciliated cells: 49.5;Club cells: 71.7;Collecting duct cells: 54.1;Ductal cells: 30.3;Exocrine glandular cells: 23.0;Pancreatic endocrine cells: 38.8;Proximal tubular cells: 28.9;Syncytiotrophoblasts: 22.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 66.4"	"Cell type enhanced"	"Detected in many"		"eosinophil: 9.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 19.2;RPTEC TERT1: 16.9;RT4: 18.1"	"Low region specificity"	"Detected in many"							"HPA066352, HPA066960, HPA069079"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cell Junctions"	"Centriolar satellite, Cytosol"	"HPA066352: AB_2685663, HPA066960: AB_2685755, HPA069079: AB_2686079"	"unprognostic (1.81e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.90e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.99e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (3.05e-3)"	"unprognostic (6.72e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-1)"	2.6	4.6	3.4	6.3	4.4	1.9	11.6	66.4	3.2	5.7	9.6	2.0	17.9	5.5	4.4	17.7	11.6	5.3	10.3	27.8	2.3	5.1	19.8	7.7	12.5	6.1	4.6	2.0	4.7	17.9	15.2	21.4	2.8	14.2	8.4	7.0	4.4	24.8	24.3	25.4	13.9	15.7	5.2	15.8	2.2	6.3	2.7	3.0	1.3	17.0	11.1	9.6	7.4	7.5	1.8	0.3	9.9	0.2	3.2	4.1	0.8	19.2	3.9	1.3	1.7	0.7	1.9	16.3	1.1	1.5	1.2	1.6	6.7	7.3	0.1	5.2	2.4	10.5	11.6	2.8	10.2	2.1	1.9	4.8	0.1	5.6	5.9	1.6	0.0	0.1	0.7	10.9	2.0	4.6	3.0	0.6	0.0	0.0	0.0	1.0	6.7	0.0	0.0	6.7	8.7	1.0	0.0	1.4	2.7	16.9	18.1	3.3	1.1	4.9	16.0	4.2	13.8	12.7	0.2	0.1	1.0	2.4	0.1	2.2	0.8	1.4	2.5	0.9	0.0	0.2	0.4	0.1	9.9	1.9	0.1	3.5	1.8	3.1	2.6	0.1	1.5	4.1	2.6	0.9	3.2	0.2	0.3	2.7	0.8	3.4	4.4	66.4	3.2	2.3	5.1	4.6	2.0	14.2	3.0	80.4	49.2	0.0	0.0	0.0	0.0	0.0	0.0	49.5	71.7	54.1	0.0	2.5	5.0	30.3	0.0	0.0	0.0	0.0	23.0	0.6	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0
PCDH8	"ARCADLIN, PAPC"	ENSG00000136099	"Protocadherin 8"	O95206	13	52842889-52848641	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 20.6"	"Cell type enriched"	"Detected in some"	7	"Muller glia cells: 31.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AF22: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010509	Uncertain		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA010509: AB_10601384"	"unprognostic (3.50e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.11e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.97e-2)"		"unprognostic (7.01e-2)"		"unprognostic (1.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.59e-1)"		"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.32e-1)"		0.8	0.9	11.5	1.1	18.6	0.8	0.8	0.4	20.6	0.9	1.0	1.1	0.0	0.9	1.0	0.8	0.8	0.8	0.8	0.8	18.2	4.8	0.8	0.8	0.9	0.8	3.6	8.4	0.8	0.8	0.8	1.4	0.8	0.8	1.7	0.9	0.8	0.8	0.8	1.4	0.8	1.1	0.9	0.9	0.8	1.2	2.3	2.5	0.0	1.4	0.0	0.8	0.9	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	18.6	0.4	20.6	18.2	4.8	3.6	8.4	0.8	2.5	0.0	0.0	0.0	2.5	0.1	4.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.4	0.0	0.9	0.0	0.0	1.4	0.9	0.0	0.0	0.0	0.0	1.3
PCDHB4	PCDH-BETA4	ENSG00000081818	"Protocadherin beta 4"	Q9Y5E5	5	141121799-141125623	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 5.1;Horizontal cells: 7.9;Peritubular cells: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	17	"T-reg: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 13.0;SH-SY5Y: 8.8"									HPA014466	Approved		Uncertain	"Plasma membrane,Intermediate filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Intermediate filaments"	"HPA014466: AB_1855058"	"unprognostic (2.60e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.60e-3)"	"unprognostic (4.03e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.32e-4)"	"unprognostic (5.18e-3)"	7.1	5.3	13.0	2.0	12.0	0.6	5.9	11.3	11.4	8.0	3.4	12.9	0.1	1.9	12.3	9.1	4.0	5.8	5.7	4.3	10.9	6.3	4.1	1.3	5.1	1.4	13.1	11.3	9.9	18.2	7.3	5.1	0.9	11.0	6.1	2.7	3.7	5.0	5.1	3.8	3.1	2.6	7.9	21.1	2.0	2.6	1.6	12.3	0.0	2.8	1.5	1.1	5.6	5.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	2.1	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	13.0	8.8	0.0	0.0	0.0	0.4	0.4	0.1	0.0	0.6	0.2	0.3	0.0	0.0	0.0	0.0	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	13.0	12.0	11.3	11.4	10.9	6.3	13.1	11.3	11.0	12.3	0.0	0.3	0.0	0.4	1.0	5.1	0.6	0.0	4.0	4.5	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.0	0.0	1.4	0.0	3.8	0.9	0.0	0.0	0.1	7.9	0.0	4.3	0.0	0.0	1.4	0.0	1.7	0.0	0.0	3.5	0.4	0.0	6.0	0.0	0.6	0.0	3.1	1.1	0.2	1.8	0.0	0.0	0.0	0.2
PCDHGA1	PCDH-GAMMA-A1	ENSG00000204956	"Protocadherin gamma subfamily A, 1"	Q9Y5H4	5	141330571-141512981	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 3.0;Bipolar cells: 1.6;Cardiomyocytes: 1.7;Horizontal cells: 3.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 7.0;T-47d: 11.5;WM-115: 5.2"	"Low region specificity"	"Detected in many"							"HPA008755, HPA010580, HPA036547"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA036547: AB_10669798"	"unprognostic (9.50e-4)"	"unprognostic (2.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.45e-3)"	1.4	1.3	2.7	0.9	11.7	1.0	1.1	6.8	7.9	1.4	1.2	2.7	0.5	1.0	2.8	3.9	1.3	1.1	0.8	3.9	3.5	2.8	1.2	0.5	1.2	1.0	2.5	2.5	2.9	2.5	2.8	6.1	2.3	5.4	1.5	0.9	2.4	1.1	1.0	1.7	1.5	0.6	1.8	2.4	1.1	0.8	2.7	1.1	0.0	1.3	0.6	0.7	1.2	0.9	1.2	0.9	2.7	0.5	0.8	1.0	0.2	0.1	0.4	0.5	1.9	1.2	2.1	0.3	1.7	1.1	0.5	1.0	0.5	0.2	0.5	2.8	1.1	0.9	0.2	0.2	0.3	1.1	0.3	0.3	0.2	0.4	0.3	0.3	0.1	0.2	1.8	0.5	0.0	0.7	3.4	0.1	0.3	0.2	0.8	7.0	0.1	0.2	0.8	0.3	0.1	0.3	3.1	2.7	0.3	0.3	0.3	1.8	2.1	0.3	0.9	1.7	0.5	11.5	0.4	0.8	3.3	0.7	1.6	0.4	0.3	1.0	0.2	3.9	0.2	5.2	2.7	0.5	0.5	0.7	0.4	0.4	0.7	0.7	0.5	0.2	1.2	1.0	0.8	1.1	0.8	0.5	0.9	0.6	0.2	2.7	11.7	6.8	6.1	3.5	2.8	2.5	2.5	5.4	1.1	3.0	0.0	0.0	0.0	0.0	1.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PCDHGA10	PCDH-GAMMA-A10	ENSG00000253846	"Protocadherin gamma subfamily A, 10"	Q9Y5H3	5	141412987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 33.7"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 27.0;Cone photoreceptor cells: 15.7;Horizontal cells: 22.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 12.2;HSkMC: 13.8;T-47d: 16.3;U-2197: 9.6"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077276"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077276: "	"unprognostic (2.92e-1)"	"unprognostic (2.17e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.64e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.83e-3)"	5.2	4.2	7.9	1.6	11.4	1.2	2.7	2.4	33.7	3.6	2.9	9.8	1.2	2.4	3.0	2.4	4.3	3.6	3.7	2.3	9.1	4.4	2.0	6.5	3.5	1.7	5.1	7.2	3.6	1.9	1.4	2.4	7.4	5.3	3.6	2.6	4.9	4.1	4.6	2.0	4.7	2.9	3.1	6.7	2.5	4.7	2.0	6.5	0.0	4.9	1.5	3.3	2.5	3.5	0.9	1.1	1.5	0.7	0.8	1.0	0.2	0.0	0.0	12.2	6.2	5.4	2.3	5.8	2.1	0.1	3.0	4.8	0.3	0.7	0.7	8.1	3.0	0.2	0.3	2.9	1.9	2.4	0.8	0.0	0.0	0.3	0.0	2.2	1.2	0.2	13.8	0.3	2.0	0.8	0.3	1.1	0.3	0.0	0.1	7.4	0.0	0.1	0.3	1.2	0.0	0.1	0.1	1.0	0.0	2.1	0.1	1.6	0.6	0.3	0.0	0.3	3.0	16.3	1.5	2.7	5.6	0.3	9.6	0.1	0.2	0.9	0.1	2.9	0.0	0.3	1.5	0.3	0.3	1.0	0.4	1.0	0.6	0.4	0.6	0.1	0.9	0.4	0.9	0.9	0.8	0.7	1.1	0.3	0.2	7.9	11.4	2.4	8.5	9.1	4.4	5.1	7.2	5.3	6.5	0.0	1.3	0.0	1.8	0.1	27.0	2.3	2.5	0.0	2.3	1.8	15.7	1.7	0.0	0.9	0.0	2.1	0.4	0.0	1.2	1.1	1.2	3.2	1.1	1.1	0.8	22.3	1.2	3.1	0.0	0.0	3.1	0.3	1.7	0.0	1.1	8.7	2.1	0.0	2.1	0.0	5.2	6.5	1.1	0.3	0.7	0.4	0.3	0.0	0.8	0.9
PCDHGA11	PCDH-GAMMA-A11	ENSG00000253873	"Protocadherin gamma subfamily A, 11"	Q9Y5H2	5	141421047-141512979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.6"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 1.9;Horizontal cells: 1.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.0;ASC TERT1: 13.0;GAMG: 22.7;hTERT-RPE1: 33.8;WM-115: 20.8"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.13e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.89e-1)"	3.4	2.5	7.4	2.8	9.4	0.5	2.1	4.1	8.5	2.4	2.5	8.5	0.0	1.2	2.6	1.7	3.1	2.1	2.1	3.4	11.6	1.9	1.9	1.2	2.3	1.8	4.5	5.2	3.8	2.3	1.3	1.9	8.3	5.0	2.5	1.5	3.3	2.8	3.4	2.8	6.6	1.2	3.3	4.9	1.6	1.8	2.2	7.1	0.1	3.4	0.6	1.7	1.7	2.2	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	1.1	12.0	13.0	0.4	2.6	5.0	2.0	3.2	0.0	0.1	0.3	4.3	2.6	22.7	1.7	0.0	0.3	3.2	0.0	1.1	0.0	0.0	0.0	2.0	0.2	0.0	9.3	0.1	3.5	0.0	33.8	3.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	5.0	0.2	1.5	3.6	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	7.4	9.4	4.1	8.5	11.6	1.9	4.5	5.2	5.0	7.1	0.0	0.6	0.0	0.1	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PCDHGA12	"CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12"	ENSG00000253159	"Protocadherin gamma subfamily A, 12"	O60330	5	141430589-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 3.5;Cardiomyocytes: 1.8;Ito cells: 1.3"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 7.7;BJ hTERT+: 12.9;fHDF/TERT166: 19.1;HHSteC: 6.3;HSkMC: 14.3;TIME: 6.1"									"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.17e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.65e-4)"	"unprognostic (2.98e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-4)"	"unprognostic (8.30e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.85e-3)"	5.1	12.7	14.8	2.8	18.9	0.7	2.4	4.7	13.8	4.9	1.8	8.6	0.6	1.4	5.4	2.3	3.5	2.7	11.3	6.5	15.7	5.6	3.1	2.8	6.5	1.6	4.7	7.3	6.2	3.6	2.0	2.7	6.5	8.4	3.5	1.7	3.4	1.7	4.9	1.9	5.1	1.5	5.3	8.4	3.7	2.2	1.6	12.4	0.4	3.0	0.6	1.7	4.5	3.6	3.7	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.6	1.2	0.1	7.7	12.9	0.0	0.0	0.0	0.0	0.4	0.0	19.1	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	14.3	0.0	3.8	0.0	0.0	4.5	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	6.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	14.8	18.9	4.7	10.4	15.7	5.6	4.7	7.3	8.4	12.4	0.0	0.0	0.0	0.2	0.0	3.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.3	0.1	0.0	0.4	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 2.7;Cardiomyocytes: 1.6;Leydig cells: 1.1;Peritubular cells: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.8;BJ: 5.4;fHDF/TERT166: 6.3;HSkMC: 5.0;hTERT-RPE1: 5.8"					"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480"	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	5.1	4.3	6.7	2.1	8.0	0.6	4.2	5.2	12.6	6.6	2.6	4.6	1.0	0.9	6.5	5.7	2.4	5.5	5.5	11.1	6.5	4.6	3.3	2.4	4.6	1.1	6.0	2.3	15.3	8.4	9.2	10.6	2.2	7.8	5.3	1.4	13.8	3.3	5.8	2.6	2.9	1.4	5.2	5.6	1.9	2.1	10.4	3.5	0.0	4.3	1.2	1.1	3.2	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	3.9	9.8	0.1	5.4	2.1	0.5	0.9	0.1	0.1	0.1	0.7	6.3	0.8	0.2	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.0	0.2	0.1	0.3	5.8	2.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.3	0.2	0.8	0.0	0.3	0.7	0.0	3.6	0.1	0.5	0.7	0.0	3.3	0.9	0.5	0.3	0.1	0.0	0.4	0.0	2.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	8.0	5.2	7.2	6.5	4.6	6.0	2.3	7.8	3.5	0.0	0.0	0.0	0.1	0.0	2.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.5	0.3	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0
PCDHGA3	PCDH-GAMMA-A3	ENSG00000254245	"Protocadherin gamma subfamily A, 3"	Q9Y5H0	5	141343829-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	20	"Bipolar cells: 2.4;Cardiomyocytes: 1.1;Horizontal cells: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 11.2;BJ: 3.7;EFO-21: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (6.47e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.52e-4)"	4.0	4.5	11.7	1.4	10.5	0.7	2.5	6.9	13.7	4.7	1.3	7.9	0.0	0.7	4.5	3.5	1.5	2.9	3.5	12.2	8.5	5.8	2.5	2.5	2.6	1.0	6.6	7.7	8.6	3.6	1.8	6.3	5.7	8.7	3.0	1.3	4.6	2.9	3.2	1.5	1.9	1.1	3.6	6.0	1.5	1.2	5.2	3.8	0.0	3.3	1.3	1.0	1.7	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.1	0.2	1.5	0.0	3.7	0.3	0.0	0.1	0.0	0.0	0.1	9.2	0.8	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.4	0.1	0.5	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	10.5	6.9	13.7	8.5	5.8	6.6	7.7	8.7	3.8	0.0	0.0	0.0	0.1	0.0	2.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0
PCDHGA4	PCDH-GAMMA-A4	ENSG00000262576	"Protocadherin gamma subfamily A, 4"	Q9Y5G9	5	141355025-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 1.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.3;BJ: 5.7;HSkMC: 6.0;HUVEC TERT2: 5.7;U-87 MG: 8.2"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.27e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-4)"	5.4	4.7	6.5	1.8	8.3	0.5	3.0	8.5	11.2	4.8	2.0	10.4	1.5	1.2	5.0	3.0	1.9	3.4	3.1	4.8	6.3	5.9	2.0	2.7	3.6	0.9	5.6	8.1	5.8	6.7	8.5	3.4	2.8	6.1	4.1	1.4	3.5	4.3	4.2	1.5	1.8	1.2	5.0	5.9	1.3	1.4	2.7	4.0	0.0	2.6	2.7	0.9	2.3	2.5	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	1.0	0.6	4.5	10.3	0.0	5.7	4.6	0.3	1.1	0.0	0.1	1.0	2.0	4.8	1.8	0.1	0.2	0.2	0.6	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.4	6.0	0.2	0.1	0.0	3.5	5.7	0.0	0.2	0.3	2.4	0.8	0.3	0.2	0.2	0.0	0.3	0.3	1.6	0.1	0.3	0.0	0.8	1.7	0.3	0.3	1.1	0.5	2.2	0.0	3.7	2.4	0.7	3.2	0.5	0.2	0.3	0.2	8.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.3	8.5	9.3	6.3	5.9	5.6	8.1	6.1	4.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PCDHGA5	"CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5"	ENSG00000253485	"Protocadherin gamma subfamily A, 5"	Q9Y5G8	5	141364232-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 19.1"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 10.6;Horizontal cells: 9.5;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"ASC diff: 18.9;ASC TERT1: 7.5"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.61e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-1)"	"unprognostic (6.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.38e-4)"	4.0	2.7	6.1	1.8	9.1	0.9	3.9	19.1	9.6	9.0	2.7	7.7	4.1	1.0	7.6	3.2	3.3	4.7	4.5	4.9	6.9	4.0	1.5	1.2	3.3	1.3	3.2	3.8	6.6	1.7	3.3	3.7	2.7	4.6	5.6	1.6	4.1	2.5	4.0	1.5	3.0	1.5	4.3	6.3	1.4	1.7	1.7	3.7	0.0	1.8	0.9	1.0	2.5	4.2	0.9	0.8	1.6	0.6	1.9	0.7	0.2	0.0	0.5	0.3	0.1	18.9	7.5	0.0	0.8	0.2	0.1	0.4	0.0	0.0	0.9	0.4	0.3	1.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	1.8	0.2	0.0	0.0	0.4	0.6	0.0	0.1	0.6	0.8	0.3	0.5	0.7	0.1	0.0	0.3	0.9	0.7	0.1	0.0	0.0	0.2	0.3	0.1	0.3	0.3	0.3	1.6	0.0	1.0	0.7	0.2	1.0	0.7	0.1	1.0	0.1	0.3	0.2	0.8	1.5	0.6	0.6	0.7	0.3	0.3	0.6	0.6	0.4	0.1	0.9	0.7	0.7	1.6	1.9	0.2	0.8	0.4	0.2	6.1	9.1	19.1	9.6	6.9	4.0	3.2	3.8	4.6	3.7	0.0	0.6	0.0	0.6	0.1	10.6	1.6	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.4	0.3	1.1	0.0	0.1	9.5	0.0	1.8	0.3	0.0	3.4	0.0	0.0	0.0	0.0	3.3	0.2	0.0	1.8	0.0	1.1	6.5	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3
PCDHGA6	PCDH-GAMMA-A6	ENSG00000253731	"Protocadherin gamma subfamily A, 6"	Q9Y5G7	5	141373914-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.6"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 9.7;Cardiomyocytes: 4.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HSkMC: 5.8;SCLC-21H: 11.2;T-47d: 6.5;WM-115: 14.0"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (4.49e-2)"	"unprognostic (8.91e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-3)"	4.1	3.8	6.1	2.3	8.4	0.8	2.9	19.6	10.8	7.9	3.4	8.3	2.9	1.0	6.9	4.7	2.6	4.3	3.6	3.7	5.0	4.3	2.8	1.7	3.3	1.4	2.9	4.7	9.7	2.5	2.5	4.5	6.9	3.3	4.0	1.6	5.8	4.1	5.3	2.1	4.7	1.5	6.1	2.8	2.8	1.7	2.2	2.9	0.2	3.8	1.2	1.5	4.6	3.6	1.3	0.7	2.8	0.6	0.5	0.8	0.2	0.1	0.4	3.2	0.5	1.6	5.4	0.1	2.3	0.8	1.2	1.2	0.0	0.2	2.2	3.1	3.7	1.2	0.5	0.1	0.5	0.8	0.0	0.3	0.0	0.3	0.3	0.9	0.1	0.1	5.8	0.4	0.3	0.1	1.1	1.8	0.1	0.3	1.3	0.4	0.5	0.7	1.8	0.3	0.1	0.1	1.5	0.4	0.0	0.4	0.1	11.2	0.9	0.1	0.3	0.7	0.7	6.5	0.1	5.5	0.9	0.4	0.9	0.8	0.4	1.8	0.4	0.9	0.8	14.0	1.8	0.6	0.3	0.8	0.3	0.3	0.8	0.6	0.2	0.1	1.3	0.3	0.5	2.8	0.5	0.3	0.7	0.5	0.2	6.1	8.4	19.6	10.8	5.0	4.3	2.9	4.7	3.3	2.9	0.0	2.1	0.5	0.5	0.0	9.7	4.5	2.5	1.4	1.2	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.0	0.0	1.3	0.1	0.3	0.4	0.0	0.5	0.1	1.6	0.0	1.8	0.0	0.0	1.1	0.3	0.0	0.0	0.0	1.9	0.5	0.0	2.1	0.0	1.0	0.0	0.5	0.1	0.2	0.0	0.2	0.0	0.0	0.1
PCDHGA7	PCDH-GAMMA-A7	ENSG00000253537	"Protocadherin gamma subfamily A, 7"	Q9Y5G6	5	141382739-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.9"	"Cell type enhanced"	"Detected in some"	22	"Bipolar cells: 3.5;Cardiomyocytes: 1.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;BJ hTERT+: 17.3;hTERT-RPE1: 9.3;SH-SY5Y: 15.5;T-47d: 6.8"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.00e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.42e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.21e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-3)"	1.7	2.0	3.1	1.3	9.0	0.6	2.1	5.3	14.9	3.5	3.0	7.1	2.1	1.0	4.2	4.1	2.2	3.3	1.9	3.0	5.1	3.3	3.2	1.9	2.2	1.0	5.1	6.6	4.7	2.5	4.6	3.4	4.8	5.4	3.7	1.5	5.8	2.6	3.3	1.6	3.8	1.2	3.0	6.3	1.3	1.4	2.1	5.1	0.0	6.6	1.5	1.0	2.4	2.5	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	1.9	0.0	5.8	9.9	0.0	2.6	17.3	3.5	5.2	0.0	0.0	0.4	4.3	0.5	0.1	0.1	0.0	0.1	2.9	0.0	0.3	0.0	0.4	0.1	1.0	0.0	0.0	4.3	0.1	0.0	0.6	9.3	1.4	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	15.5	0.0	0.1	0.1	3.3	6.8	0.0	5.2	0.1	0.1	2.5	0.0	0.1	1.5	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	9.0	5.3	7.7	5.1	3.3	5.1	6.6	5.4	5.1	0.0	0.0	0.0	0.4	0.0	3.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3
PCDHGA8	"KIAA0327, PCDH-GAMMA-A8"	ENSG00000253767	"Protocadherin gamma subfamily A, 8"	Q9Y5G5	5	141390157-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 7.1"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 10.4;Cardiomyocytes: 2.5;Horizontal cells: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 2.9;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.9"	"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.28e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.99e-3)"	0.6	0.7	0.8	0.7	0.6	2.5	0.7	2.3	2.2	1.2	1.2	1.0	7.1	0.4	2.3	1.5	2.1	0.7	0.9	2.0	1.4	0.5	0.5	0.9	1.1	0.7	0.5	0.4	2.6	0.6	0.2	1.9	1.4	3.5	0.9	0.8	0.4	0.8	0.5	2.2	2.5	1.1	0.7	1.6	0.7	0.7	1.0	1.3	1.1	2.4	0.4	0.6	0.6	1.2	0.7	0.4	2.9	0.4	0.5	0.3	0.1	0.3	0.2	1.1	0.6	1.1	2.6	0.6	2.4	1.5	1.7	0.7	0.2	0.4	1.1	1.0	1.8	0.3	0.4	0.0	0.0	1.3	0.3	0.2	0.3	0.5	0.3	0.1	0.4	0.8	1.4	0.1	0.5	0.1	0.5	0.4	0.2	0.2	0.9	0.2	0.2	0.5	0.7	2.6	0.0	0.1	1.0	0.2	0.1	0.1	0.3	0.7	0.6	0.3	0.9	0.4	2.4	1.2	1.7	2.5	2.6	0.9	0.6	0.2	0.3	0.3	0.4	1.3	0.4	1.3	2.9	0.4	0.5	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.2	0.3	2.8	0.5	0.3	0.4	0.2	0.1	0.8	0.6	2.3	2.2	1.4	0.5	0.5	0.4	3.5	1.3	0.0	1.1	0.0	0.8	0.0	10.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.1	3.2	0.0	0.6	0.8	0.0	2.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	1.4	0.0	1.7	0.0	0.2	0.6	0.9	0.0	0.0	0.0	0.0	0.4
PCDHGA9	PCDH-GAMMA-A9	ENSG00000261934	"Protocadherin gamma subfamily A, 9"	Q9Y5G4	5	141402932-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 3.7;Club cells: 1.2;Horizontal cells: 3.2;Muller glia cells: 1.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.1;HSkMC: 4.6;hTERT-RPE1: 19.1;TIME: 5.0;U-87 MG: 5.8"					"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-3)"	"unprognostic (9.86e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-2)"	5.6	5.4	12.0	2.6	12.6	0.9	3.7	11.5	17.3	6.9	2.7	11.2	0.1	2.1	7.6	3.9	4.8	6.3	6.5	3.2	10.3	8.5	3.0	2.8	5.0	2.1	9.6	7.1	9.1	3.0	3.8	3.0	3.6	10.9	5.2	2.7	7.7	3.8	7.3	1.9	5.5	2.0	5.9	13.0	3.6	2.9	2.0	5.9	0.0	4.6	1.4	2.5	4.8	3.7	0.5	0.3	1.0	0.5	0.2	1.0	0.0	0.0	0.2	0.7	1.8	0.1	0.3	0.2	0.8	0.0	0.7	0.7	0.3	0.4	1.4	4.1	2.2	0.3	0.1	0.1	0.2	0.8	0.0	0.3	0.0	0.1	0.0	1.3	0.0	0.3	4.6	0.2	0.4	0.3	19.1	1.1	0.1	0.1	0.2	0.4	0.4	0.2	0.5	0.2	0.1	0.0	0.2	0.5	0.0	0.2	0.2	0.5	1.2	0.4	0.1	0.6	0.5	1.1	0.5	5.0	0.3	0.3	0.1	2.7	0.2	0.1	0.1	5.8	0.1	1.0	1.0	0.5	0.3	1.0	0.3	0.6	0.3	0.4	0.2	0.1	0.5	0.4	0.7	1.0	0.2	0.2	0.3	0.1	0.0	12.0	12.6	11.5	16.2	10.3	8.5	9.6	7.1	10.9	5.9	0.0	0.0	0.0	0.1	0.2	3.7	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1
PCDHGB3	PCDH-GAMMA-B3	ENSG00000262209	"Protocadherin gamma subfamily B, 3"	Q9Y5G1	5	141370264-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.5;ASC TERT1: 10.9;TIME: 6.8"									"HPA008755, HPA010580, HPA035822, HPA035823"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA035822: , HPA035823: AB_2674802"	"unprognostic (6.93e-3)"	"unprognostic (9.10e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	4.1	1.7	3.3	1.6	6.5	0.5	3.1	3.5	5.6	3.0	3.0	7.2	0.7	0.7	4.9	3.7	3.3	3.3	2.9	4.6	3.3	2.3	2.9	2.0	2.5	3.7	1.9	3.8	5.2	4.2	4.6	5.4	2.3	2.6	2.6	2.2	3.1	6.6	2.6	1.9	3.3	1.4	4.3	2.9	2.4	2.3	1.5	2.8	0.3	3.4	3.2	3.5	2.7	4.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.5	0.3	13.5	10.9	0.2	1.4	2.5	0.9	1.1	0.0	0.0	2.2	0.4	4.3	0.8	0.6	0.0	0.3	0.7	0.0	0.3	0.0	0.3	0.1	0.6	0.1	0.0	2.7	0.6	0.2	0.1	0.2	1.2	0.0	0.3	1.0	0.3	0.4	0.7	1.1	0.1	0.0	0.1	1.9	0.7	0.0	0.2	0.1	3.0	0.6	0.0	0.1	0.3	0.4	0.8	0.0	6.8	0.6	0.1	0.7	0.7	0.3	2.1	0.2	0.6	0.6	1.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	6.5	3.5	5.6	3.3	2.3	1.9	3.8	2.6	2.8	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGB4	"CDH20, FIB2, PCDH-GAMMA-B4"	ENSG00000253953	"Protocadherin gamma subfamily B, 4"	Q9UN71	5	141387698-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	24	"Alveolar cells type 2: 1.1;Horizontal cells: 1.6"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	7	"NK-cell: 1.6"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 28.6;SuSa: 10.9;TIME: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.33e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.27e-2)"	2.4	2.2	2.4	0.7	4.2	0.0	1.2	1.8	2.1	2.6	1.4			0.2	3.2	3.5	1.1	2.1	0.8	2.8	2.3	4.1	2.9	3.3	2.1	0.0	1.8		5.1	1.9	3.0	2.5	6.2		2.6	0.7		3.0	3.1	1.2	3.4	0.3	1.9	2.0	0.6	0.4	0.9			3.6		0.2	1.6	2.0	0.0	0.2	0.0	0.0	1.6	0.2	0.2	0.0	0.7	7.1	0.0	4.6	5.9	0.8	6.8	28.6	2.9	1.9	0.0	0.0	0.2	5.5	0.2	0.1	2.0	0.0	0.0	3.2	0.0	0.0	0.0	0.1	1.6	1.8	0.0	0.0	5.7	0.0	2.7	0.0	0.1	4.4	0.0	0.2	0.0	0.0	0.0	0.6	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	10.9	3.6	2.6	14.3	3.9	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2											0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGB5	PCDH-GAMMA-B5	ENSG00000276547	"Protocadherin gamma subfamily B, 5"	Q9Y5G0	5	141397987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 11.2"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 1.7;Ciliated cells: 1.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 32.8;ASC TERT1: 24.8;BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (2.71e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.69e-4)"	"unprognostic (9.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.25e-4)"	2.1	1.9	0.8	0.3	3.2	0.0	3.6	2.0	4.3	1.4	0.4	2.5	1.9	0.0	2.1	2.5	1.1	2.1	0.8	1.9	0.0		1.6	3.1	6.8	2.6	0.9	1.5	4.9	2.8	11.2	2.1	9.5	1.5	2.2	0.2	3.7	3.2	3.2	1.4	2.6	0.0	1.9	3.0	0.5	0.7	1.0	2.2	0.8	3.5	0.0	0.7	1.9	1.4	0.5	0.2	0.0	0.3	0.0	1.9	0.1	0.0	1.2	0.1	0.0	32.8	24.8	0.6	8.7	0.0	14.2	16.0	1.4	4.7	4.9	11.4	9.6	0.0	6.6	0.0	3.6	8.0	0.0	1.4	0.0	0.0	0.0	3.4	0.0	3.1	8.7	0.7	0.8	4.6	6.1	4.3	0.0	0.1	0.0	0.4	3.7	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.8	2.6	0.0	0.0	0.0	0.0	0.0	1.0	9.2	0.0	4.4	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.3	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1											0.0	0.0	0.0	0.2	0.0	1.7	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
PCDHGB6	PCDH-GAMMA-B6	ENSG00000253305	"Protocadherin gamma subfamily B, 6"	Q9Y5F9	5	141408021-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 26.6"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 6.4;Cone photoreceptor cells: 5.9;Horizontal cells: 9.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 18.6;EFO-21: 6.3;HSkMC: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.71e-4)"	6.7	7.2	8.8	2.6	9.9	1.6	4.4	6.1	26.6	5.8	4.1	10.1	0.3	1.8	7.2	5.7	3.0	5.1	4.4	4.6	8.9	5.7	3.2	9.4	4.4	2.2	6.9	4.4	13.3	5.2	16.1	4.7	6.8	5.9	4.0	2.3	9.0	5.3	5.9	5.7	4.7	2.2	4.8	4.1	4.0	2.5	2.1	6.7	0.3	6.1	1.9	2.1	4.2	5.1	0.8	0.5	3.2	0.4	0.5	0.9	0.2	0.0	0.1	18.6	0.2	0.6	0.7	0.9	1.7	0.0	0.4	1.0	0.2	0.3	1.5	6.3	1.0	0.3	0.3	0.0	0.4	1.2	0.0	0.3	0.0	0.2	0.1	1.5	0.1	0.1	4.3	2.1	0.9	0.1	0.2	0.6	0.4	0.1	0.3	0.1	0.3	0.1	1.2	0.8	0.0	0.0	0.2	0.1	0.1	3.0	0.2	0.2	0.3	0.0	0.1	0.1	0.4	1.5	0.4	3.0	0.1	0.3	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.9	1.1	0.4	0.2	0.9	0.3	0.2	0.6	0.4	0.2	0.1	0.8	0.4	0.3	3.2	0.5	0.3	0.5	0.2	0.2	8.8	9.9	6.1	7.9	8.9	5.7	6.9	4.4	5.9	6.7	3.0	0.3	0.0	1.3	0.0	6.4	2.5	0.0	1.4	2.3	0.0	5.9	0.1	0.0	0.4	0.0	0.9	0.0	0.0	1.1	0.1	0.4	0.6	0.0	0.8	0.2	9.5	0.0	1.3	0.0	0.0	1.7	0.0	0.0	0.0	0.0	3.3	1.6	0.0	1.1	0.0	2.4	0.0	1.0	0.2	0.3	0.1	0.1	0.0	0.0	0.6
PCDHGB7	"ME6, PCDH-GAMMA-B7"	ENSG00000254122	"Protocadherin gamma subfamily B, 7"	Q9Y5F8	5	141417645-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 3.0;Bipolar cells: 7.4;Horizontal cells: 3.2"	"Cancer enhanced"	"Detected in many"		"glioma: 7.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"AN3-CA: 38.8;HSkMC: 12.3;hTERT-RPE1: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.22e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-2)"	10.1	9.8	12.6	3.8	13.5	0.8	8.0	19.1	12.9	10.2	7.0	16.1	1.2	2.3	11.6	5.0	6.8	7.8	9.2	8.5	14.5	7.9	5.4	3.5	11.6	2.6	10.4	7.3	17.3	5.5	9.5	5.3	11.0	9.4	8.3	3.8	15.5	7.1	12.0	5.6	6.8	3.2	10.5	20.1	5.3	4.5	4.2	14.3	0.6	8.4	3.0	2.3	4.6	6.9	0.2	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	38.8	0.9	0.1	0.4	2.5	0.3	0.9	1.9	0.0	2.3	0.3	2.1	5.1	0.3	0.6	0.0	0.4	0.9	0.0	0.2	0.0	0.0	0.0	2.9	0.2	0.0	12.3	0.3	0.7	0.4	32.9	2.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.3	4.3	0.8	0.0	0.1	0.0	4.2	5.8	0.1	0.0	0.0	0.5	0.4	0.4	5.0	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	12.6	13.5	19.1	12.9	14.5	7.9	10.4	7.3	9.4	14.3	3.0	2.2	0.0	0.5	0.3	7.4	1.1	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.1	0.1	1.0	0.0	0.0	0.4	0.1	0.8	0.3	1.1	0.0	0.1	3.2	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.1	0.7	0.0	1.8	0.2	0.4	0.0	1.4	0.0	0.1	0.4	0.0	0.0	0.0	0.1
PCDHGC4	PCDH-GAMMA-C4	ENSG00000242419	"Protocadherin gamma subfamily C, 4"	Q9Y5F7	5	141484997-141512979	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 23.6"	"Cell type enhanced"	"Detected in single"	32	"Horizontal cells: 3.2"	"Cancer enriched"	"Detected in single"	10	"glioma: 4.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"REH: 9.3;SCLC-21H: 7.9;SH-SY5Y: 15.2;SuSa: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (6.05e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.20e-4)"	"unprognostic (8.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.75e-2)"	0.7	2.9	5.7	0.7	9.5	0.5	0.8	23.6	21.9	1.0	1.1	2.3	0.0	0.6	0.9	1.2	0.8	1.0	1.0	1.3	4.1	10.1	0.6	0.6	1.0	0.9	3.3	4.5	0.8	1.2	0.8	1.3	0.8	8.6	0.8	0.8	1.9	1.0	0.7	1.2	1.5	0.7	0.9	2.3	0.8	0.7	1.5	0.8	0.0	0.7	0.0	1.0	0.6	0.2	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.2	0.2	0.8	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.2	0.9	0.9	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.0	1.5	0.0	0.0	9.3	0.5	0.0	0.0	0.1	7.9	15.2	0.1	0.0	0.2	11.2	0.1	0.3	0.1	0.8	0.1	0.2	0.7	0.2	0.0	0.2	0.6	0.1	2.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	9.5	23.6	15.6	4.1	10.1	3.3	4.5	8.6	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGC5	PCDH-GAMMA-C5	ENSG00000240764	"Protocadherin gamma subfamily C, 5"	Q9Y5F6	5	141489121-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 43.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"glioma: 3.1;head and neck cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 5.0;SuSa: 8.4;U-138 MG: 16.0;U-251 MG: 6.8;U-87 MG: 9.8"	"Group enriched"	"Detected in many"	5	"amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4"					"HPA008755, HPA010580, HPA076140"	Supported		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: "	"unprognostic (2.86e-3)"	"unprognostic (7.63e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.52e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-9)"	"unprognostic (6.87e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.77e-3)"	1.0	1.1	7.4	1.1	34.5	0.9	1.1	3.0	43.7	1.1	1.0	2.8	0.0	0.9	1.4	1.3	1.0	1.2	1.2	2.8	11.8	2.8	0.9	0.9	1.1	0.9	2.2	10.0	1.1	1.0	1.0	1.1	1.0	2.3	1.3	1.0	0.0	0.9	1.6	1.6	1.5	0.9	2.0	0.8	1.0	1.0	1.3	1.1	0.0	1.0	0.0	1.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	1.7	0.2	0.8	0.6	0.5	0.6	0.0	0.0	0.5	1.6	2.4	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.5	0.0	5.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.9	0.8	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	8.4	0.1	0.2	0.1	16.0	0.2	0.2	6.8	0.0	0.0	0.0	9.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	34.5	3.0	39.2	11.8	2.8	2.2	10.0	2.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDCD1LG2	"B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2"	ENSG00000197646	"Programmed cell death 1 ligand 2"	Q9BQ51	9	5510570-5571254	"Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 15.1;monocytes: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 25.9;BJ hTERT+: 40.8;HDLM-2: 31.1;TIME: 18.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013411	Approved		Uncertain	Cytosol	"Secreted - unknown location"	NA	NA		34000000	Cytosol		"HPA013411: AB_1855102"	"unprognostic (3.93e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (6.68e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.37e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-3)"	15.2	1.8	1.2	7.7	1.4	0.2	9.5	0.7	1.2	7.0	1.9	2.3	0.0	0.8	2.9	7.2	3.9	3.8	4.0	5.8	1.2	1.3	2.5	6.4	13.3	10.8	1.6	0.5	4.1	1.8	0.5	1.1	12.9	1.9	5.0	2.5	2.4	2.9	1.7	5.5	3.6	2.5	4.6	3.7	19.5	1.9	4.2	1.2	8.1	3.5	3.5	8.1	6.0	5.4	0.5	0.9	4.1	3.6	0.0	3.0	0.7	2.1	0.0	0.0	0.0	1.8	2.1	0.0	25.9	40.8	12.5	15.2	0.0	0.1	0.0	0.1	10.5	1.8	0.2	0.0	3.5	12.5	31.1	0.0	0.0	0.0	0.0	10.1	0.0	0.0	1.9	0.0	5.8	6.9	3.6	8.2	0.0	0.0	3.1	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	18.0	9.0	0.5	4.3	7.1	0.4	0.0	0.0	5.1	0.0	1.1	4.1	0.9	0.0	1.4	3.6	1.9	0.5	2.2	0.9	0.9	0.3	0.0	1.0	2.0	0.0	0.5	0.0	3.0	0.7	1.2	1.4	0.7	1.2	1.2	1.3	1.6	0.5	1.9	1.2	6.0	0.3	0.8	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.0	0.0	0.2	15.1	2.1	0.1	3.5	0.0	2.8	0.0	0.0	6.7	4.3	0.0	5.5	2.2	1.7	45.9	0.0	0.0	2.1	0.0	2.1	0.0	0.0	0.0	1.4	0.0	0.0	0.9	0.7	0.0	0.0	0.0
PEAK3	"C19orf35, FLJ45778"	ENSG00000188305	"PEAK family member 3"	Q6ZS72	19	2274622-2282176	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.5;lymphoid tissue: 19.1"	"Group enriched"	"Detected in some"	11	"Ciliated cells: 1.4;Hofbauer cells: 1.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 24.5"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 16.9"					"Group enriched"	"Detected in many"	5	"basal ganglia: 6.4;cerebellum: 6.0"	HPA057806	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA057806: AB_2683534"	"unprognostic (9.42e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.40e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.90e-1)"	1.9	1.3	1.4	4.7	3.3	8.2	0.9	0.8	2.0	1.3	1.7	2.1	0.1	1.1	0.7	1.0	0.8	1.6	0.9	2.1	2.0	0.9	3.8	2.0	4.4	14.3	3.3	0.9	1.0	0.8	0.6	1.2	0.8	2.3	1.0	1.1	0.7	0.8	0.6	1.5	1.0	2.5	0.9	4.0	19.1	1.1	0.6	1.7	0.6	0.8	0.0	2.7	0.9	1.9	0.2	1.1	24.5	3.4	2.8	1.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.1	0.2	0.6	0.1	16.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	5.3	2.7	6.6	1.0	3.4	0.1	0.1	0.1	0.1	1.1	0.2	0.0	0.2	24.5	2.8	1.1	0.1	0.0	0.5	1.4	3.3	0.8	2.0	2.0	0.9	3.3	0.9	2.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PEMT	"PEMPT, PEMT2"	ENSG00000133027	"Phosphatidylethanolamine N-methyltransferase"	Q9UBM1	17	17505563-17591708	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 95.7;liver: 103.5"	"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 168.4;Peritubular cells: 326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042375, HPA073930"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria,Cytosol"		NA	NA			"Endoplasmic reticulum, Mitochondria"	"Vesicles, Cytosol"	"HPA042375: AB_10796905, HPA073930: "	"unprognostic (1.39e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.77e-6)"	"unprognostic (2.85e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.63e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.60e-2)"	21.8	7.5	5.6	2.8	6.2	4.2	26.5	2.9	8.1	16.1	6.1	6.4	13.2	7.4	8.7	95.7	5.6	10.5	4.7	5.3	5.3	6.1	8.5	103.5	5.5	6.7	6.3	4.8	7.7	11.4	4.4	5.7	7.1	6.2	7.3	2.2	7.3	12.7	12.9	7.4	7.3	5.8	4.0	6.4	2.8	4.6	19.1	3.2	3.8	9.9	6.3	5.4	3.9	5.2	12.8	17.0	1.6	23.4	15.1	14.4	11.6	14.2	27.3	7.2	18.8	15.4	10.8	10.8	9.1	8.2	12.5	9.9	15.9	9.7	12.5	16.6	9.3	9.4	17.0	10.6	5.5	3.2	9.2	37.0	6.2	14.9	22.8	17.0	5.5	9.3	11.0	11.5	8.3	12.7	4.2	6.7	17.6	5.9	5.3	5.5	27.2	9.8	9.9	10.1	27.3	22.4	9.2	11.6	11.4	10.3	5.3	7.2	17.2	6.5	4.4	16.3	14.5	6.7	2.1	5.8	12.3	12.4	20.5	7.9	7.3	4.9	2.2	11.4	7.7	10.1	1.0	23.4	1.1	10.1	20.8	14.4	12.6	13.2	12.7	17.0	12.8	10.6	11.9	1.6	15.1	14.2	15.5	12.0	11.6	5.6	6.2	2.9	8.1	5.3	6.1	6.3	4.8	6.2	3.2	14.9	13.7	17.0	16.7	16.3	4.4	12.5	12.7	16.0	26.1	26.2	0.0	16.2	14.9	26.3	2.2	18.3	14.6	0.0	33.6	18.8	27.5	23.7	12.7	168.4	21.4	4.8	66.0	9.2	11.1	6.8	87.8	10.8	20.3	1.0	24.8	26.7	26.0	10.5	326.0	21.4	4.8	6.5	30.9	11.1	18.5	15.8	12.2	7.0	22.8	16.6
PGM5	PGMRP	ENSG00000154330	"Phosphoglucomutase 5"	Q15124	9	68328308-68531061	"Predicted intracellular proteins"	"Carbohydrate metabolism, Cell adhesion, Glucose metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 123.0"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 88.7;Endothelial cells: 35.0;Ito cells: 31.9;Sertoli cells: 51.8;Smooth muscle cells: 36.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 16.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	89	"neutrophil: 8.9"	"Lineage enriched"	"Detected in single"	89	"granulocytes: 8.9"	"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 15.9;PC-3: 29.8;RH-30: 20.7;SK-BR-3: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB034397, HPA046329, HPA067102"	Enhanced		Uncertain	Cytosol		NA	NA		380000	Cytosol		"CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: AB_2732758"	"unprognostic (3.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.98e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-4)"	"unprognostic (1.22e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.28e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (1.83e-5)"	"unprognostic (3.04e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.73e-2)"	5.9	13.6	0.8	7.5	1.3	0.0	4.1	2.1	1.5	25.9	52.2	1.8	26.1	2.9	36.9	10.3	22.6	20.9	11.1	31.6	1.0	0.4	2.0	1.5	2.7	5.9	0.9	1.3	9.3	1.9	0.5	1.2	1.7	1.3	37.1	7.6	4.3	2.9	51.1	8.5	2.2	15.4	123.0	1.5	1.7	16.6	4.3	0.9	0.9	2.8	4.5	1.5	57.4	24.5	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	4.2	3.4	2.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.0	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	29.8	0.0	20.7	0.9	0.9	0.0	0.0	0.1	0.0	25.9	1.4	0.6	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.8	1.3	2.1	1.5	1.0	0.4	0.9	1.3	1.3	0.9	0.0	1.7	0.0	5.1	2.1	22.3	88.7	0.0	1.4	3.4	12.2	3.9	0.0	1.7	0.1	1.2	35.0	0.0	0.0	0.0	0.1	3.3	2.7	0.0	0.0	0.1	0.0	0.0	31.9	3.2	0.0	7.5	1.9	3.3	1.8	0.0	8.4	0.1	0.0	4.6	0.6	1.1	51.8	36.4	0.1	0.2	2.0	0.0	0.0	0.0	1.3
PHF20	"C20orf104, dJ1121G12.1, TDRD20A"	ENSG00000025293	"PHD finger protein 20"	Q9BVI0	20	35771974-35950381	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 349.5;Late spermatids: 510.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029619, HPA029620, HPA029621"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201"	"unprognostic (1.21e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.01e-2)"	19.1	11.6	14.0	16.8	19.0	14.1	17.2	25.1	19.2	15.9	15.9	16.1	8.1	8.1	19.1	11.6	16.5	14.2	14.8	15.2	14.1	13.8	11.2	11.1	16.5	17.3	14.9	13.0	18.9	9.4	17.9	20.0	15.6	15.0	14.7	11.7	14.7	15.3	15.7	46.6	12.9	12.3	17.2	18.9	20.8	12.7	17.4	15.2	19.4	14.2	14.5	20.8	18.7	21.8	12.0	8.2	23.6	11.9	13.0	12.4	6.5	9.7	7.8	13.7	20.3	10.0	11.5	12.8	11.2	10.7	11.3	9.9	22.8	7.4	16.4	10.2	14.9	13.9	6.1	12.6	15.6	13.8	7.4	5.4	30.5	15.0	8.4	10.0	14.6	11.9	9.0	22.0	11.9	18.4	13.4	12.3	11.7	12.5	10.6	12.9	5.8	14.7	8.5	6.8	6.5	9.8	10.8	20.3	9.7	9.0	6.8	12.5	10.2	20.0	23.2	10.2	13.0	18.3	10.9	17.2	25.1	5.7	13.0	11.4	9.8	11.6	12.0	18.5	10.7	12.8	11.9	8.6	23.6	10.6	9.0	11.3	12.0	10.5	11.9	8.2	9.8	12.0	12.4	20.5	13.0	11.9	7.7	5.5	6.5	14.0	19.0	25.1	19.0	14.1	13.8	14.9	13.0	15.0	15.2	35.7	39.9	77.0	65.2	30.9	75.5	47.0	30.6	57.6	40.9	36.6	92.3	85.9	31.5	25.8	349.5	40.9	11.8	0.0	17.4	39.0	36.8	47.3	136.5	15.3	46.9	108.1	34.5	39.3	53.1	510.4	33.1	60.9	37.1	31.5	24.9	44.2	20.8	25.7	50.2	19.5	75.2	19.4	39.6	55.4	46.4	24.7	18.7	82.0	29.0	53.3
PIGB		ENSG00000069943	"Phosphatidylinositol glycan anchor biosynthesis class B"	Q92521	15	55318960-55355648	"Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039929	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039929: AB_10673539"	"unprognostic (1.91e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.24e-2)"	9.5	11.9	5.7	13.0	11.9	11.2	10.4	3.9	9.3	7.1	8.5	8.2	6.6	9.1	10.5	13.2	11.1	9.5	10.0	6.3	5.9	5.9	12.4	10.3	8.8	20.1	6.9	6.8	8.7	8.1	19.2	12.5	8.7	8.6	9.7	9.4	13.0	9.6	8.4	3.2	8.1	11.6	7.0	8.9	14.2	9.3	17.4	6.0	11.5	16.3	6.2	16.2	10.7	9.3	8.4	8.1	20.1	11.5	5.6	8.9	6.4	7.5	8.7	4.0	3.1	4.4	9.0	5.7	6.3	12.7	7.1	11.4	3.8	7.9	7.3	8.4	8.8	11.0	12.7	2.5	6.6	6.0	7.3	5.7	7.2	10.9	4.7	7.9	20.5	6.3	9.4	8.2	5.6	7.2	9.1	8.8	6.6	8.5	6.2	9.4	6.6	2.5	8.0	2.5	5.8	4.4	3.2	3.9	16.7	11.0	8.3	2.3	4.5	5.8	9.4	11.0	3.8	10.1	14.9	6.7	9.6	3.2	2.5	12.7	6.2	11.1	6.5	8.5	23.1	6.9	10.5	8.9	4.1	8.3	10.4	8.9	8.4	8.3	8.6	8.1	5.4	7.0	7.8	20.1	5.6	11.5	6.3	8.6	6.4	5.7	11.9	3.9	9.3	5.9	5.9	6.9	6.8	8.6	6.0	8.9	7.4	8.6	8.7	4.0	2.7	2.6	2.5	8.1	12.5	0.0	11.8	10.0	1.7	6.2	16.8	4.5	5.2	0.0	9.7	9.3	4.1	4.1	8.1	3.8	7.5	1.6	6.3	7.4	6.5	2.4	1.4	6.3	3.3	8.2	3.7	3.1	5.9	4.2	1.4	8.2	9.1	6.5	4.7	2.6	3.0	3.4	5.5	8.6	3.7	3.3
PIH1D2		ENSG00000150773	"PIH1 domain containing 2"	Q8WWB5	11	112064010-112074274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 41.9"	"Group enriched"	"Detected in many"	10	"Ciliated cells: 123.1;Early spermatids: 307.7;Late spermatids: 93.6;Spermatocytes: 103.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 12.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039496			Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039496: AB_10959385"	"unprognostic (8.74e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.43e-3)"	"unprognostic (5.82e-2)"	"unprognostic (9.05e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.12e-1)"	0.7	1.0	1.5	0.3	3.3	0.2	1.6	0.9	2.0	1.6	0.8	3.2	2.3	0.4	1.5	8.1	1.0	14.4	1.2	0.9	2.6	2.0	4.9	0.5	2.8	0.3	1.1	1.8	2.5	1.2	4.4	10.5	0.5	9.7	1.4	0.7	2.7	1.1	1.5	0.9	0.9	0.5	0.9	0.8	0.4	0.8	41.9	1.2	0.1	5.8	0.6	0.3	0.9	0.8	1.2	1.0	0.7	1.2	0.3	0.3	0.2	2.9	1.5	4.6	2.0	2.3	2.6	3.2	1.1	3.8	3.8	3.7	5.7	9.4	1.3	4.0	2.2	4.5	3.7	1.0	2.4	3.7	1.4	3.8	2.1	2.5	2.5	2.1	2.2	1.4	1.6	2.8	7.0	4.0	3.4	2.0	2.7	2.7	0.8	2.3	1.1	0.9	2.8	1.3	1.6	2.5	1.8	3.0	3.2	9.8	1.5	5.9	1.5	3.7	1.4	1.9	1.9	12.6	0.6	1.1	2.1	2.4	1.3	1.0	1.1	0.4	1.6	3.1	0.3	1.7	0.0	0.3	0.7	0.0	1.2	0.3	1.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.2	1.5	3.3	0.9	2.0	2.6	2.0	1.1	1.8	9.7	1.2	6.0	0.3	0.0	1.6	0.6	2.0	2.0	7.6	123.1	10.3	3.5	2.0	0.8	13.3	3.1	307.7	0.9	0.2	0.0	2.0	0.6	0.9	0.7	1.1	0.0	0.6	1.6	2.9	0.6	0.3	93.6	2.6	0.8	3.3	1.0	0.3	3.4	1.5	0.0	1.4	6.8	15.4	0.0	1.0	103.7	7.7	0.9	0.2	0.0	0.4	0.8
PIRT		ENSG00000233670	"Phosphoinositide interacting regulator of transient receptor potential channels"	P0C851	17	10822475-10838445	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 7.3;brain: 24.8;intestine: 7.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	40	"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA042337			Uncertain	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA042337: AB_10794795"	"unprognostic (2.95e-1)"		"unprognostic (2.19e-2)"	"unprognostic (7.57e-2)"	"unprognostic (6.58e-3)"						"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"		"unprognostic (2.85e-3)"				0.4	7.3	9.9	3.2	14.0	0.3	0.3	5.6	5.2	0.4	6.3	10.8	0.0	2.9	0.4	0.4	0.8	0.9	0.7	0.3	13.1	11.6	0.3	0.3	0.4	0.3	12.5	2.3	0.4	0.3	0.3	0.1	0.3	24.8	0.4	7.5	0.0	0.4	0.4	0.4	0.4	5.2	2.5	19.9	0.3	4.9	0.5	12.8	0.0	0.3	0.0	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	14.0	5.6	5.2	13.1	11.6	12.5	2.3	24.8	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response"	"Exonuclease, Hydrolase, Nuclease"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 638.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 149.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 149.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		490000	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	45.7	57.5	44.6	23.1	79.0	12.8	21.9	35.5	126.1	31.2	23.5	25.4	17.1	22.6	26.3	35.0	18.3	30.0	30.8	33.0	46.4	73.4	22.1	25.6	49.7	25.2	44.7	53.9	44.8	42.5	32.9	122.1	38.9	62.2	29.6	16.1	31.6	35.3	37.2	27.4	24.2	23.5	25.6	28.6	48.9	23.0	17.0	19.3	11.9	20.6	11.2	12.9	27.3	20.7	3.6	23.0	149.2	24.6	9.7	7.8	16.8	14.1	43.7	28.3	44.5	78.9	37.6	21.6	35.1	35.8	25.5	29.2	8.3	16.0	6.1	36.9	30.5	8.3	6.6	6.8	13.8	11.2	22.9	24.9	6.6	15.0	10.4	53.9	2.7	75.9	71.5	28.9	19.4	13.4	42.8	21.4	10.1	23.3	24.9	18.3	18.5	4.8	13.1	18.5	23.2	9.0	6.1	21.6	25.2	13.1	10.6	20.3	33.8	16.8	10.4	18.8	30.9	14.3	47.6	37.6	21.5	10.3	18.2	7.8	26.0	27.7	6.3	34.6	11.0	13.3	149.2	24.6	35.3	7.8	12.8	6.4	3.6	6.2	6.9	23.0	3.1	6.5	6.5	2.5	9.7	5.7	3.3	6.1	16.8	44.6	79.0	35.5	126.1	46.4	73.4	44.7	53.9	62.2	19.3	29.8	62.9	34.4	70.6	31.5	98.5	18.5	25.5	12.0	28.4	54.1	31.4	137.8	18.3	50.7	5.8	46.8	52.7	0.0	51.3	94.8	142.4	49.1	59.9	35.8	638.2	114.4	69.9	90.9	219.8	8.6	140.4	84.2	87.7	44.1	36.8	99.5	49.7	41.2	135.1	30.0	39.3	19.4	53.1	13.9	57.5	29.2	163.8	35.4	34.5	52.0
PLEK2		ENSG00000100558	"Pleckstrin 2"	Q9NYT0	14	67386983-67412200	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 132.3;Pancreatic endocrine cells: 114.0;Suprabasal keratinocytes: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 4.0;naive CD4 T-cell: 6.5"	"Lineage enriched"	"Detected in single"	8	"T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"A-431: 26.7;CAPAN-2: 28.6;HBEC3-KT: 53.3;PC-3: 19.5;TIME: 20.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA001208	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA001208: AB_1079631"	"unprognostic (4.41e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (8.26e-5)"	"unprognostic (1.06e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.59e-2)"	1.7	28.8	0.5	7.6	1.1	4.1	1.5	0.5	0.8	2.4	14.9	1.4	1.6	12.4	1.1	14.9	9.7	0.4	7.4	0.5	0.5	0.2	6.0	29.1	1.9	0.5	0.5	0.5	1.0	16.5	2.5	0.9	2.6	0.7	5.1	12.7	0.9	6.9	2.3	1.4	12.1	28.1	1.2	0.7	0.6	8.5	2.4	0.5	13.9	28.6	6.5	6.5	4.8	4.4	0.0	0.8	0.0	0.1	0.0	6.5	1.2	26.7	4.0	0.0	0.0	0.0	0.3	2.7	5.4	0.8	1.3	1.6	14.6	28.6	0.0	5.3	0.7	0.0	12.8	0.0	53.3	3.0	0.0	0.2	0.0	6.2	0.1	1.1	0.0	0.0	0.6	3.8	1.4	17.1	0.0	4.4	0.0	0.1	0.1	0.9	8.5	0.0	0.0	0.1	17.3	19.5	0.0	0.0	4.1	9.1	0.7	0.2	0.0	5.1	2.4	1.5	0.2	3.5	0.2	20.7	0.0	16.7	0.1	0.1	0.0	0.0	0.1	3.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.7	0.8	0.0	6.5	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.5	1.1	0.5	0.8	0.5	0.2	0.5	0.5	0.7	0.5	0.0	0.6	0.0	20.4	132.3	0.0	0.3	5.1	1.4	3.4	5.2	0.0	0.9	3.3	40.6	0.1	0.7	36.5	0.0	41.0	5.1	9.3	10.8	0.0	9.4	7.0	0.0	8.1	0.0	1.0	0.0	0.3	15.0	20.3	9.0	44.7	0.0	114.0	21.0	0.0	1.6	0.0	0.0	5.1	0.3	0.9	79.3	1.3	0.0	46.5	23.8
PLEKHA2	TAPP2	ENSG00000169499	"Pleckstrin homology domain containing A2"		8	38901235-38973909	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 69.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004706	Approved		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA004706: AB_1079633"	"unprognostic (2.78e-1)"	"unprognostic (8.80e-3)"	"unprognostic (4.15e-3)"	"unprognostic (3.03e-1)"	"unprognostic (8.61e-2)"	"unprognostic (9.07e-3)"	"unprognostic (6.16e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.59e-2)"	"prognostic unfavorable (1.95e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.60e-3)"	7.7	9.7	8.8	19.1	6.6	14.2	6.4	3.4	6.9	8.6	8.2	4.8	11.8	3.7	9.0	11.5	6.7	6.9	8.9	17.7	7.0	4.7	7.3	4.0	9.7	29.9	6.6	6.9	10.5	4.5	15.3	6.9	6.9	4.8	9.0	5.0	16.7	5.9	10.3	5.4	5.4	8.8	9.9	8.0	16.3	6.4	5.0	5.7	5.2	7.8	3.2	26.2	12.8	8.6	14.2	5.3	7.5	2.0	3.8	2.7	0.9	9.5	2.2	1.4	3.4	3.6	7.2	1.5	11.6	9.2	8.9	7.6	1.2	6.6	53.5	13.9	10.7	8.0	6.0	3.7	7.4	13.5	13.5	0.3	27.3	19.0	1.3	13.2	8.7	11.2	16.4	5.1	4.6	8.3	21.0	1.5	8.9	2.7	15.5	8.3	1.2	17.8	4.1	1.3	7.7	3.4	4.6	7.4	11.3	10.9	8.3	0.1	2.1	13.6	2.5	9.3	2.2	5.7	4.3	2.1	6.5	5.1	1.1	9.2	4.9	4.5	24.9	10.3	9.5	1.4	5.2	1.5	7.5	2.0	2.0	2.1	8.9	2.3	2.3	1.8	14.2	1.5	2.7	3.4	3.8	2.0	5.3	1.9	0.9	8.8	6.6	3.4	6.9	7.0	4.7	6.6	6.9	4.8	5.7	3.0	22.7	61.4	10.3	7.8	1.4	36.3	12.7	16.0	7.9	38.4	0.0	6.5	1.7	7.0	0.6	10.3	9.7	0.0	4.7	13.6	10.8	9.2	35.8	10.2	42.5	55.6	12.6	26.4	69.1	0.9	21.0	38.7	15.1	13.6	10.4	15.1	16.5	3.5	23.7	11.5	1.4	12.9	14.1	0.5	6.1	5.8	3.8	36.2	12.1	26.6
PLOD2	LH2	ENSG00000152952	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2"	O00469	3	146069440-146163653	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.1"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 109.4;Pancreatic endocrine cells: 83.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 82.6;hTERT-RPE1: 93.9;U-87 MG: 73.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025898, HPA069126"	Approved		Uncertain	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoli, Cytosol"		"CAB025898: , HPA069126: "	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.29e-3)"	"prognostic unfavorable (7.64e-10)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.99e-11)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (6.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.41e-3)"	36.7	14.1	11.2	18.0	12.1	0.7	28.5	7.9	13.5	8.8	25.2	5.1	8.3	21.6	14.8	7.5	12.0	8.0	22.3	16.6	12.5	8.2	16.4	73.1	9.3	3.0	10.7	4.8	17.7	14.4	13.9	7.8	41.0	13.0	11.1	16.1	7.2	7.7	11.3	4.8	3.2	24.7	24.2	19.4	3.2	13.6	6.3	10.9	6.1	47.6	3.5	3.0	21.8	28.7	0.0	0.0	1.5	0.3	0.0	0.0	1.9	16.4	11.8	3.7	1.2	13.5	14.5	9.4	58.5	17.9	31.9	60.2	0.9	1.7	0.0	11.4	9.9	14.6	3.5	4.3	50.3	82.6	0.0	6.8	4.1	11.5	8.2	34.7	0.0	0.0	25.4	7.2	27.6	13.5	93.9	44.0	0.0	5.4	0.2	56.3	6.0	0.0	0.0	2.3	0.0	5.1	0.0	2.4	0.0	13.4	0.8	1.8	0.0	46.6	5.0	4.9	18.1	13.6	0.5	55.2	39.5	12.0	12.5	34.9	17.9	2.5	0.0	73.6	0.0	7.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	11.2	12.1	7.9	13.5	12.5	8.2	10.7	4.8	13.0	10.9	14.9	10.7	0.5	5.9	6.3	14.5	10.6	61.1	12.0	13.6	26.2	33.4	6.8	8.3	62.8	0.4	21.2	46.1	0.0	45.9	109.4	34.5	8.1	0.0	50.8	4.7	0.0	19.0	18.4	1.5	1.3	12.0	2.7	13.5	1.0	18.3	65.1	83.0	31.5	4.6	6.9	22.4	19.4	38.1	8.0	16.3	4.8	15.7	0.7	21.3	5.4
PNPLA7	"C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2"	ENSG00000130653	"Patatin like phospholipase domain containing 7"	Q6ZV29	9	137459953-137550534	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 16.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.6;T-reg: 3.5"	"Group enriched"	"Detected in many"	5	"B-cells: 3.6;T-cells: 3.5"	"Cell line enriched"	"Detected in some"	23	"HMC-1: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009130	Uncertain		Uncertain	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA009130: AB_2268411"	"unprognostic (1.49e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.72e-3)"	"unprognostic (5.14e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (2.24e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.45e-3)"	9.3	5.6	10.6	2.8	11.0	2.8	6.3	17.0	11.4	6.4	4.5	6.7	3.8	3.1	7.6	2.1	2.2	5.8	4.7	4.8	8.4	2.6	2.3	7.4	4.1	5.4	9.7	9.7	9.7	17.7	3.3	7.1	1.1	6.6	14.7	2.1	5.4	18.7	4.8	19.1	15.4	4.8	7.2	6.7	5.4	9.6	1.8	11.6	0.4	7.6	4.2	2.8	7.8	3.7	3.6	0.7	0.0	0.4	0.0	3.5	0.5	0.0	0.5	0.1	0.2	0.4	0.3	0.2	0.4	0.4	0.1	0.1	0.0	0.2	0.3	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.8	0.4	0.4	0.4	0.1	0.3	0.2	43.9	0.6	0.1	0.1	0.0	0.7	0.0	0.0	0.0	1.2	0.0	0.8	0.1	0.8	0.0	0.6	0.5	1.0	0.7	1.3	0.0	0.2	0.8	0.2	0.0	0.3	0.1	0.1	1.9	0.6	0.3	0.0	0.1	0.2	0.0	0.4	0.1	0.1	0.6	0.4	0.0	0.0	0.4	0.0	0.8	0.3	0.0	0.8	0.5	0.4	0.7	3.6	1.2	0.9	0.0	0.0	0.1	0.4	3.5	0.5	10.6	11.0	17.0	11.4	8.4	2.6	9.7	9.7	6.6	11.6	8.9	5.1	3.7	1.0	1.3	2.5	3.2	2.5	1.4	3.4	1.8	5.9	0.1	0.0	0.4	0.3	0.7	3.5	0.0	0.0	0.2	1.0	3.5	6.9	6.7	2.1	4.8	16.6	2.5	2.5	0.2	4.0	0.9	0.0	1.8	7.4	3.5	0.8	5.8	1.8	0.8	9.1	0.0	0.9	1.6	1.4	2.9	0.0	0.0	1.8	0.7
POLA2	FLJ21662	ENSG00000014138	"DNA polymerase alpha 2, accessory subunit"	Q14181	11	65261762-65305589	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037570	Supported		Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA037570: AB_10672280"	"unprognostic (2.28e-1)"	"prognostic favorable (4.61e-4)"	"unprognostic (1.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.09e-8)"	"unprognostic (1.60e-3)"	"unprognostic (8.26e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.25e-3)"	7.5	6.6	4.9	11.9	8.8	9.8	7.5	14.1	8.8	12.0	9.6	9.8	6.4	6.7	10.1	5.5	10.4	9.3	5.9	6.1	5.2	4.5	7.9	7.0	7.5	14.7	10.3	5.5	10.3	7.9	8.0	4.8	9.3	6.5	7.1	9.6	6.7	8.9	7.5	6.5	8.0	9.2	10.7	10.2	13.6	8.8	15.0	8.4	35.7	7.9	10.3	19.7	8.6	7.3	6.0	13.3	8.0	10.1	4.9	7.3	7.7	14.4	13.3	22.0	10.2	3.3	3.9	7.5	9.9	15.8	32.0	23.7	5.3	12.7	17.4	11.4	8.6	15.5	9.1	17.9	14.8	27.4	9.4	6.7	13.1	20.2	6.0	1.9	12.1	10.8	2.7	2.1	27.7	5.8	5.8	11.9	8.9	12.6	11.8	21.6	20.0	26.0	5.4	16.4	10.7	8.5	14.1	12.8	16.8	9.6	10.0	14.4	8.6	9.5	10.4	3.3	14.4	13.0	6.2	4.3	11.8	9.5	15.6	7.2	5.5	6.6	17.9	8.5	7.7	15.8	8.0	10.1	3.9	6.5	9.5	7.3	6.0	6.9	7.1	13.3	5.6	5.6	5.1	5.0	4.9	7.6	10.4	7.1	7.7	4.9	8.8	14.1	8.8	5.2	4.5	10.3	5.5	6.5	8.4	0.0	4.3	0.8	3.8	1.4	2.5	2.7	5.1	2.7	3.4	5.2	2.0	8.3	3.3	5.7	2.1	3.5	1.0	0.0	3.0	14.9	4.4	2.2	0.0	1.6	8.4	3.2	2.9	3.7	2.1	2.9	6.9	4.3	0.0	10.8	2.2	2.3	3.6	2.6	7.1	1.4	4.9	6.5	3.6	12.0	14.5	1.3	6.1	5.1	5.3	3.2
POLQ	POLH	ENSG00000051341	"DNA polymerase theta"	O75417	3	121431427-121546641	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.5;lymphoid tissue: 21.4"	"Cell type enhanced"	"Detected in some"	10	"Club cells: 3.4;Extravillous trophoblasts: 2.8;Spermatocytes: 7.0;Spermatogonia: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.2"	HPA053359			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA053359: "	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.09e-5)"	"unprognostic (8.55e-3)"	"unprognostic (1.09e-4)"	"unprognostic (2.86e-1)"	"unprognostic (5.59e-5)"	"unprognostic (2.06e-3)"	"unprognostic (0.00e+0)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.76e-2)"	0.5	0.8	0.2	8.2	0.7	9.5	0.6	0.6	0.4	0.9	3.5	0.2	0.8	2.0	0.9	0.6	6.0	0.3	0.4	0.8	0.3	0.2	0.4	0.6	0.9	4.7	0.3	0.0	0.4	0.4	0.0	0.2	2.8	0.3	0.4	3.7	0.1	1.1	0.8	1.2	2.4	3.9	0.5	0.4	2.6	1.1	5.8	0.6	21.4	0.3	5.6	7.5	0.6	1.7	0.5	1.1	1.6	0.4	0.0	0.4	0.0	13.5	9.2	7.9	5.6	0.7	0.9	7.2	6.4	2.5	7.6	10.2	7.3	5.0	16.1	2.9	3.5	9.2	10.7	9.3	4.1	12.9	4.7	5.1	10.3	5.7	4.5	0.0	11.1	9.5	0.1	0.3	6.9	4.3	1.3	3.7	6.0	6.8	12.3	7.9	5.2	10.0	6.5	7.5	4.1	4.5	8.5	9.5	5.7	2.4	7.8	4.3	3.9	7.4	4.0	2.6	7.2	3.7	11.1	2.9	6.7	8.8	2.6	8.3	6.2	5.0	16.7	3.2	8.3	4.9	1.6	0.2	0.0	0.3	0.2	0.0	0.3	0.4	0.3	0.4	0.5	0.0	0.2	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.7	0.6	0.4	0.3	0.2	0.3	0.0	0.3	0.6	0.0	0.3	0.0	0.4	0.8	0.3	1.4	0.0	1.4	3.4	0.0	0.0	0.9	0.0	0.1	0.3	0.0	0.4	0.0	0.0	2.8	0.7	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.2	0.3	1.5	0.0	1.0	0.4	0.5	0.3	0.3	0.0	0.1	0.1	0.0	0.5	7.0	3.3	0.1	0.2	0.9	0.9	0.9
POLR1B	"FLJ10816, FLJ21921, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112577150	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	8.8	11.0	6.4	10.6	6.8	4.9	15.7	8.0	8.2	7.6	7.0	7.7	8.6	5.8	9.3	7.4	12.8	9.2	9.2	6.1	5.7	6.1	11.3	20.5	8.0	11.3	6.8	3.7	11.3	25.2	20.7	11.5	7.2	5.2	7.7	8.5	7.3	10.0	8.3	14.7	9.2	8.0	7.9	4.8	11.4	8.1	15.7	5.0	9.6	15.7	11.5	14.6	8.9	11.8	9.4	11.0	2.5	6.3	10.2	17.1	7.3	9.5	10.0	6.3	13.1	6.9	6.6	11.9	7.2	5.5	12.2	10.6	22.4	5.7	22.9	10.7	4.7	9.5	13.5	26.7	14.6	14.1	10.3	13.5	13.2	9.9	16.9	7.3	21.1	9.2	6.3	10.6	12.6	19.5	5.1	9.4	4.8	23.9	8.3	6.3	8.4	9.5	13.7	30.9	14.1	19.8	14.3	10.5	24.3	8.4	9.1	16.1	14.9	6.6	16.6	9.0	7.1	7.7	7.5	8.5	7.5	11.0	6.8	10.5	11.2	18.4	19.8	5.7	13.6	6.2	0.2	6.0	2.5	8.3	6.3	17.1	9.4	8.4	8.9	11.0	9.3	10.3	10.4	0.4	10.2	4.8	2.6	11.3	7.3	6.4	6.8	8.0	8.2	5.7	6.1	6.8	3.7	5.2	5.0	14.9	5.1	8.2	2.2	13.4	3.4	5.7	10.2	2.7	7.9	8.7	2.0	2.9	5.0	4.0	133.9	5.6	1.2	0.0	3.9	2.3	2.8	2.2	4.7	8.5	3.3	1.6	3.5	1.8	2.5	29.4	2.8	2.9	1.7	1.8	4.4	3.8	2.9	6.0	2.8	4.1	2.9	0.0	2.8	9.5	7.5	15.1	0.5	6.4	4.5	3.4
POLR2C	RPB3	ENSG00000102978	"RNA polymerase II subunit C"	P19387	16	57462387-57472010	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040919, HPA041826"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040919: AB_10795483, HPA041826: AB_10793935"	"unprognostic (2.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (3.03e-6)"	"unprognostic (2.29e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.43e-3)"	26.2	30.1	24.2	18.4	26.9	23.9	25.8	34.1	37.6	27.2	22.9	28.8	23.1	21.5	26.0	45.0	26.2	30.3	29.9	32.6	24.5	25.9	38.3	44.8	29.9	30.2	25.0	30.1	37.2	39.4	33.7	35.0	29.2	25.5	29.2	26.0	29.6	30.4	31.4	47.5	23.7	27.9	26.1	24.1	22.4	25.2	26.4	21.9	30.5	35.8	27.3	27.1	27.5	22.2	21.8	16.2	41.7	19.8	26.2	28.6	21.9	17.7	29.4	24.6	22.3	22.3	20.1	21.9	23.5	25.6	37.7	24.9	37.6	22.6	20.1	27.6	25.8	22.9	18.7	32.5	24.7	42.0	9.2	24.2	15.4	17.6	42.8	25.3	27.9	29.7	18.0	20.4	28.7	26.6	20.6	22.7	27.5	26.7	11.4	24.6	24.5	30.9	29.6	36.9	21.4	44.8	45.1	29.2	35.6	30.5	17.6	31.3	36.5	38.0	21.3	24.6	24.2	16.2	25.8	17.5	23.8	24.3	18.1	26.7	26.3	22.5	40.9	24.0	24.1	31.4	24.8	17.3	29.0	20.7	16.4	22.6	21.8	23.6	19.1	16.2	20.9	28.6	26.8	41.7	26.2	19.8	13.2	22.5	21.9	24.2	26.9	34.1	37.6	24.5	25.9	25.0	30.1	25.5	21.9	23.8	34.7	45.5	39.7	27.5	84.3	9.7	33.1	28.1	14.8	26.2	53.0	65.7	77.9	47.3	3.0	36.0	36.6	0.0	57.8	72.3	37.6	40.0	61.0	18.5	36.7	49.3	36.7	22.1	18.6	6.6	47.8	21.9	38.8	64.9	27.6	87.9	46.7	36.8	48.8	96.7	87.2	45.3	39.2	40.2	65.5	26.2	77.7	42.4	33.6	35.9
PPARGC1B	"PERC, PGC1B"	ENSG00000155846	"PPARG coactivator 1 beta"	Q86YN6	5	149730298-149855022	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 105.6;Cone photoreceptor cells: 127.6;Rod photoreceptor cells: 72.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 6.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050543			Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA050543: AB_2681165"	"unprognostic (2.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.51e-3)"	"unprognostic (6.55e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.01e-6)"	"unprognostic (8.45e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.77e-3)"	4.5	2.4	3.9	9.5	7.1	4.3	3.5	16.3	8.7	3.9	15.6	1.6	16.3	13.1	5.4	2.6	9.0	5.5	6.2	10.0	3.3	4.1	2.3	3.7	7.4	3.0	3.3	4.8	3.2	3.4	17.7	2.0	3.2	7.2	6.4	11.6	7.6	4.0	19.7	10.3	6.6	16.6	18.6	2.7	4.2	7.9	2.0	1.3	2.2	1.7	8.4	5.8	11.5	5.6	1.9	2.4	2.2	6.2	0.8	0.7	0.5	0.5	1.9	0.8	4.6	1.8	0.6	7.4	0.3	0.0	0.5	0.7	8.3	1.9	9.0	1.3	0.0	2.1	5.6	6.8	3.4	0.6	0.5	5.9	8.4	3.2	1.7	0.5	11.5	3.4	0.9	4.6	1.8	3.1	0.3	1.0	4.0	5.7	3.0	0.4	2.2	4.2	5.4	3.0	2.5	4.9	8.0	5.0	5.0	1.4	11.0	2.5	0.6	1.3	9.8	1.5	1.4	2.6	3.8	1.3	1.1	1.7	3.7	1.8	3.7	2.7	5.3	2.3	7.3	0.9	1.0	2.0	0.7	0.4	3.8	0.7	1.9	0.4	0.3	2.4	0.9	0.6	0.6	2.2	0.8	6.2	0.3	0.3	0.5	3.9	7.1	16.3	8.7	3.3	4.1	3.3	4.8	7.2	1.3	0.0	0.6	1.5	3.2	4.5	105.6	18.8	2.5	0.0	1.2	1.8	127.6	1.5	1.7	0.2	0.2	3.5	17.2	0.0	0.7	1.2	1.8	1.7	1.1	3.4	6.9	7.9	5.2	5.5	9.5	0.0	1.4	8.3	3.3	1.0	8.5	3.6	0.5	3.5	0.4	1.9	72.0	6.5	6.1	0.2	3.2	9.4	4.1	0.0	19.0	3.4
PPIG	"CARS-Cyp, SCAF10, SRCyp"	ENSG00000138398	"Peptidylprolyl isomerase G"	Q13427	2	169584340-169641406	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021788, HPA057469"	Supported		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA021788: AB_1847408, HPA057469: AB_2683445"	"unprognostic (2.70e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.39e-2)"	26.2	25.3	28.5	23.8	45.3	39.2	26.7	45.0	40.7	33.1	27.1	14.6	26.0	25.3	27.1	28.1	29.4	24.3	21.2	24.2	30.0	20.3	26.0	41.1	25.5	30.4	27.7	35.9	29.5	22.8	39.4	56.7	26.0	38.0	29.3	23.9	13.8	28.6	28.8	27.8	24.5	30.8	31.9	39.7	29.7	24.1	19.8	33.7	24.1	28.4	22.6	29.9	37.4	27.6	36.4	23.7	41.7	24.7	18.7	29.6	13.3	19.5	9.3	26.3	14.4	14.6	17.9	24.8	22.4	16.8	16.5	17.1	25.4	22.6	33.7	20.6	16.1	20.7	18.8	20.6	18.3	24.5	23.4	16.6	50.7	13.9	30.9	14.1	47.7	22.6	15.0	20.7	22.4	25.2	15.7	18.1	20.6	48.9	28.2	18.8	15.8	35.2	29.3	37.7	15.9	9.5	32.4	26.3	32.9	20.4	29.4	23.0	15.2	24.0	17.9	24.3	21.1	16.7	27.6	20.8	21.6	16.5	14.4	18.3	16.4	23.6	47.1	15.9	25.6	19.7	20.7	20.0	29.9	20.3	20.1	23.2	27.6	27.0	23.8	14.9	36.4	29.6	23.7	41.7	18.7	24.7	23.7	22.9	13.3	28.5	45.3	45.0	40.7	30.0	20.3	27.7	35.9	38.0	33.7	205.4	160.5	152.0	169.4	134.5	178.8	130.1	61.1	132.5	155.8	89.0	51.1	146.0	68.0	90.9	6.8	121.2	97.1	70.0	90.5	147.9	117.4	133.0	172.3	157.2	134.3	208.2	100.6	106.2	118.2	8.4	131.5	135.1	104.6	124.4	115.6	123.1	82.2	108.7	137.9	99.6	103.2	161.7	154.6	225.0	148.0	150.9	171.9	152.4	132.6	136.1
PPP2R2B	"B55beta, PR52B, PR55-BETA, SCA12"	ENSG00000156475	"Protein phosphatase 2 regulatory subunit Bbeta"	Q00005	5	146581146-147084784	"Disease related genes, Predicted intracellular proteins"	Apoptosis		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 73.2"	"Cell type enhanced"	"Detected in many"	20	"Cone photoreceptor cells: 141.4;Early spermatids: 312.5;Late spermatids: 670.1;Rod photoreceptor cells: 261.9"	"Cancer enriched"	"Detected in some"	8	"glioma: 7.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 15.1;MAIT T-cell: 13.8;memory CD4 T-cell: 7.1;memory CD8 T-cell: 16.1;naive CD8 T-cell: 12.0;NK-cell: 9.5;T-reg: 8.0"	"Group enriched"	"Detected in many"	33	"NK-cells: 9.5;T-cells: 16.1"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038118, HPA042122, HPA042770"	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA038118: AB_10697238, HPA042122: AB_2677859, HPA042770: AB_2678155"	"unprognostic (4.54e-5)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.73e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.49e-8)"	"unprognostic (2.02e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.48e-5)"	"unprognostic (1.14e-4)"	2.0	9.7	30.8	2.5	35.2	2.9	1.8	10.2	73.2	1.6	2.7	26.0	0.0	3.0	1.7	1.8	2.9	14.5	2.9	2.9	26.4	20.9	4.7	2.4	2.5	4.3	25.5	22.4	1.6	2.9	16.0	6.4	2.6	27.5	2.7	2.8	4.6	2.0	2.9	1.5	4.9	2.3	3.5	18.6	2.9	2.2	15.7	29.3	0.0	4.2	0.0	2.4	6.8	1.1	0.0	0.0	0.3	0.0	9.5	16.1	4.1	0.4	0.4	2.4	1.0	0.1	0.1	0.2	0.5	0.2	1.1	1.6	1.3	4.8	0.2	0.1	0.0	0.0	10.2	0.8	1.0	1.1	47.5	0.2	0.6	2.8	0.5	0.2	0.0	0.2	0.1	0.7	0.0	0.2	0.7	0.1	0.4	0.6	0.5	0.7	0.3	0.0	0.0	6.3	0.0	1.1	0.7	0.1	0.1	4.2	10.9	1.9	0.2	0.3	0.0	0.2	1.7	0.4	0.1	0.3	0.2	0.7	2.5	0.4	0.4	0.2	0.0	1.7	4.3	1.4	0.2	0.0	0.0	15.1	0.0	13.8	0.0	7.1	16.1	0.0	0.0	1.3	12.0	0.3	9.5	0.0	0.0	8.0	4.1	30.8	35.2	10.2	34.1	26.4	20.9	25.5	22.4	27.5	29.3	3.0	2.6	0.0	1.1	1.8	83.2	1.2	12.7	0.0	1.2	8.7	141.4	14.1	18.3	1.3	312.5	2.1	0.0	0.0	0.0	0.2	1.1	0.2	0.0	0.0	0.8	44.5	12.5	0.0	1.2	670.1	3.1	1.7	5.0	0.0	0.0	31.8	0.8	0.0	2.1	4.0	261.9	0.0	8.6	3.7	1.6	1.3	4.5	16.7	0.0	0.7
PPP2R5C	"B56G, B56gamma, PR61G"	ENSG00000078304	"Protein phosphatase 2 regulatory subunit B'gamma"	Q13362	14	101761798-101927989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"T-cells: 251.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027553	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA027553: AB_10602081"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.72e-1)"	25.5	29.4	52.6	37.7	45.3	48.1	27.4	25.7	38.9	27.8	31.1	25.6	30.1	22.4	24.0	29.2	32.7	22.3	25.4	48.4	49.3	35.6	25.5	38.1	34.5	53.8	44.7	32.4	28.4	25.6	27.6	35.3	19.5	27.5	23.1	33.3	26.6	28.9	27.8	30.5	28.9	31.7	27.7	45.5	36.8	25.4	27.6	29.5	51.4	29.6	28.3	52.1	33.2	21.9	20.1	24.9	35.3	25.3	16.8	60.5	20.9	21.0	14.5	24.6	23.7	22.3	31.5	23.8	19.9	26.4	25.0	24.0	14.5	36.8	57.7	19.3	25.8	17.6	22.2	22.4	21.1	32.6	25.9	10.6	16.7	17.2	14.1	16.5	25.6	35.9	20.7	27.4	17.2	16.0	22.3	22.4	31.5	34.7	24.4	23.8	32.1	25.7	28.3	14.3	42.5	24.2	21.8	27.7	14.2	24.0	24.0	19.3	36.1	27.0	17.9	33.7	18.0	32.8	19.7	22.1	15.8	15.1	60.7	19.7	34.1	51.0	96.2	23.7	19.0	17.5	20.1	19.8	18.2	60.5	24.3	38.9	20.1	39.7	47.5	16.9	17.8	28.6	44.1	35.3	16.8	25.3	24.9	39.7	20.9	52.6	45.3	25.7	38.9	49.3	35.6	44.7	32.4	27.5	29.5	77.4	85.3	74.9	37.2	52.1	31.6	113.5	48.4	68.3	52.4	34.9	55.0	41.1	39.7	33.2	55.5	45.2	45.9	46.7	40.7	39.2	41.8	41.7	66.0	70.6	61.7	25.4	45.5	59.5	108.0	50.8	48.6	71.4	81.0	136.1	71.3	33.5	39.8	66.8	42.8	53.6	38.0	38.8	46.4	23.7	25.4	61.5	43.8	251.6	58.7	59.3
PPP5D1		ENSG00000230510	"PPP5 tetratricopeptide repeat domain containing 1"	E7EU14	19	46480796-46601200	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 19.6;Early spermatids: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 6.7"									HPA073186	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA073186: AB_2732220"	"unprognostic (2.84e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.00e-4)"	"unprognostic (3.90e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	1.9	4.5	8.9	0.9	6.8	1.5	2.2	3.6	7.5	3.5	1.5	5.8	6.6	0.9	3.9	7.4	1.1	6.8	2.6	2.8	6.5	8.7	1.6	1.2	2.2	1.4	6.9	5.9	5.8	2.3	2.8	6.9	2.3	4.1	4.4	0.9	3.7	7.2	4.3	2.4	2.2	0.9	1.9	5.4	1.9	1.8	5.3	4.7	1.0	5.8	0.6	1.4	1.9	2.4	2.0	2.2	6.2	1.4	2.6	1.8	0.5	1.7	1.0	1.4	1.0	0.9	3.0	0.3	1.0	0.9	2.6	0.6	0.1	1.2	1.8	1.7	3.4	2.6	1.0	2.3	0.4	1.4	2.1	5.8	3.0	1.5	1.7	1.4	1.0	2.4	2.3	3.6	0.4	1.2	2.1	0.8	3.1	1.2	1.4	2.3	6.7	1.0	3.0	0.7	0.3	1.4	3.3	0.6	0.5	1.3	1.0	4.4	1.6	1.0	0.6	0.7	0.3	0.8	1.6	1.9	0.2	0.6	0.4	0.8	0.9	0.8	1.5	0.9	3.1	0.7	6.2	1.4	0.7	0.9	1.0	0.5	1.7	0.4	0.7	2.2	2.0	0.8	1.8	2.0	2.6	0.4	0.9	0.4	0.5	8.9	6.8	3.6	7.5	6.5	8.7	6.9	5.9	4.1	4.7	3.0	1.3	2.7	2.4	1.4	8.1	1.6	10.2	1.4	0.0	1.8	19.6	1.7	1.7	1.2	14.6	3.0	1.6	0.0	1.6	1.4	2.8	2.4	0.0	0.8	2.5	9.5	0.0	5.5	2.9	2.7	3.7	2.1	3.3	4.6	0.6	8.6	0.7	0.0	2.8	0.4	9.1	0.0	1.7	4.9	3.6	1.1	1.4	2.9	1.7	1.7
PRKACG	PKACg	ENSG00000165059	"Protein kinase cAMP-activated catalytic subunit gamma"	P22612	9	69012529-69014113	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 27.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 55.1;Late spermatids: 73.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.3"									"CAB004530, HPA071185"	Supported		Uncertain	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"CAB004530: AB_628137, HPA071185: AB_2686356"					"unprognostic (2.74e-1)"									"unprognostic (3.61e-2)"	"unprognostic (7.22e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	1.5	0.0	0.0	0.0	0.0	0.0
PRM1	CT94.1	ENSG00000175646	"Protamine 1"	P04553	16	11280836-11281350	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	125	"testis: 747.3"	"Group enriched"	"Detected in some"	154	"Early spermatids: 123959.8;Late spermatids: 465852.4"	"Cancer enriched"	"Detected in single"	161	"testis cancer: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;Hep G2: 1.1;NB-4: 6.0;U-2197: 4.5;U-698: 2.0"									"HPA055150, HPA059371"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA055150: AB_2682718, HPA059371: "															"unprognostic (2.10e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	747.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	123959.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	465852.4	1718.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1588.2	0.0	0.0	1138.3	0.0	1916.0	855.6	0.0	0.0	0.0	0.0	0.0
PROSER2	"C10orf47, MGC35403"	ENSG00000148426	"Proline and serine rich 2"	Q86WR7	10	11823339-11872277	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 40.8"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 26.1;Urothelial cells: 72.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 32.9;CAPAN-2: 39.5;HBEC3-KT: 25.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 32.0"	HPA041337	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041337: AB_10794663"	"unprognostic (2.36e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.60e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.06e-2)"	"unprognostic (8.69e-2)"	2.7	1.1	0.7	1.8	1.4	9.5	9.8	1.0	1.3	3.7	2.5	0.4	2.4	1.2	2.5	1.7	6.2	3.0	2.2	1.4	1.5	0.7	8.6	40.8	10.2	0.2	1.4	0.3	1.7	21.7	0.0	1.5	9.2	1.2	7.3	2.0	9.9	4.5	2.7	1.7	3.2	1.1	1.3	1.0	8.2	7.1	7.5	0.5	4.3	12.0	3.6	5.6	6.5	9.9	0.0	1.9	0.0	1.0	0.0	0.7	0.9	32.9	4.7	0.3	0.1	1.0	1.3	1.9	1.5	0.7	1.2	0.6	10.9	39.5	0.0	6.1	0.1	0.5	8.7	3.3	25.2	0.6	0.0	8.1	3.8	2.0	7.0	5.9	0.0	2.4	1.4	5.5	7.1	8.1	0.1	3.6	0.6	5.6	0.0	1.7	4.5	0.0	1.2	2.1	4.4	2.7	5.3	4.3	0.0	2.6	1.6	0.0	0.4	2.4	10.0	4.2	1.7	5.2	2.0	2.5	0.0	8.0	13.2	0.1	0.0	0.0	0.0	0.0	1.3	1.8	0.0	1.0	0.0	0.0	0.3	0.7	0.0	0.1	0.2	0.1	0.0	0.4	0.2	0.0	0.0	0.0	1.9	0.0	0.9	0.7	1.4	1.0	1.3	1.5	0.7	1.4	0.3	1.2	0.5	8.9	5.1	0.0	22.8	5.0	0.0	0.9	20.4	6.7	5.7	5.2	0.0	4.7	5.0	9.6	2.5	2.8	0.8	0.0	3.3	16.0	3.1	21.4	0.0	26.1	0.7	0.0	1.7	1.8	0.8	2.3	1.7	0.3	3.3	0.0	1.3	0.0	13.3	0.0	4.2	0.3	0.0	0.0	1.0	1.7	2.8	4.1	0.6	0.0	3.3	72.6
PRR23B	FLJ46116	ENSG00000184814	"Proline rich 23B"	Q6ZRT6	3	139019031-139020926	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	36	"testis: 4.7"	"Group enriched"	"Detected in some"	13	"Spermatocytes: 6.6;Spermatogonia: 4.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047473	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (7.57e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	4.1	0.0	0.0	0.0	0.0	0.1
PTPRS		ENSG00000105426	"Protein tyrosine phosphatase, receptor type S"	Q13332	19	5158495-5340803	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 54.1;Melanocytes: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	82	"plasmacytoid DC: 13.4"	"Lineage enriched"	"Detected in single"	82	"dendritic cells: 13.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.4;HaCaT: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054747			Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA		92000000	"Plasma membrane, Cytosol"		"HPA054747: AB_2682591"	"unprognostic (8.14e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.46e-2)"	59.1	17.3	14.4	9.4	14.8	3.1	32.0	27.6	53.3	28.7	11.4	29.6	14.4	4.6	21.4	15.4	13.3	24.0	22.2	18.6	15.9	15.1	10.7	6.9	13.9	8.6	20.5	12.1	29.2	38.4	10.5	16.6	4.3	12.0	23.1	3.6	28.9	21.5	20.1	11.9	23.8	6.5	17.5	13.8	8.3	12.7	10.8	18.7	4.4	21.1	7.2	7.5	19.1	22.7	0.0	13.4	0.0	0.0	0.0	0.1	0.0	3.7	21.3	19.2	41.4	8.8	7.2	2.5	6.4	7.7	7.8	6.4	0.2	2.0	0.0	15.3	10.8	6.2	42.1	5.1	0.0	3.5	0.4	8.2	0.0	8.7	13.2	4.0	0.0	4.8	7.6	1.8	1.6	0.3	10.2	0.2	2.6	5.9	0.0	3.1	15.7	1.6	4.0	10.8	0.1	9.1	0.0	4.2	0.0	1.6	7.5	14.8	20.3	6.1	1.1	11.7	3.9	7.4	1.6	0.9	7.0	12.1	16.0	7.8	2.1	0.0	12.2	3.6	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	14.4	14.8	27.6	17.6	15.9	15.1	20.5	12.1	12.0	18.7	6.0	0.6	3.2	32.4	54.1	33.8	10.9	12.7	1.4	2.3	12.2	2.0	0.5	8.3	1.4	2.3	10.2	0.0	0.0	0.8	23.7	30.9	35.7	0.0	18.3	1.5	11.1	2.9	28.3	0.3	2.9	43.1	1.4	75.9	0.0	0.0	37.3	0.5	0.0	33.9	2.4	7.7	12.9	39.2	7.2	5.3	32.0	0.8	0.0	0.0	21.1
RAB25	CATX-8	ENSG00000132698	"RAB25, member RAS oncogene family"	P57735	1	156061160-156070514	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 98.3"	"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 238.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.3;naive CD4 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 3.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 24.3;CAPAN-2: 23.6;MCF7: 32.8;OE19: 75.9;RT4: 29.8;SK-BR-3: 48.5;T-47d: 45.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010872, CAB033645"	Enhanced		Uncertain	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"		"CAB033645: AB_1128883, HPA010872: AB_1079729"	"unprognostic (2.43e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.38e-6)"	"unprognostic (2.31e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.94e-2)"	0.4	0.3	0.3	10.9	0.3	0.0	10.8	0.5	0.4	23.6	28.4	0.3	28.1	14.8	4.0	15.9	98.3	9.7	33.3	0.3	0.3	0.3	18.2	1.0	19.1	0.6	0.3	0.2	2.3	27.4	8.6	9.5	19.1	0.3	13.3	16.2	0.4	44.1	26.8	0.4	48.0	43.0	2.1	0.4	0.3	16.2	1.1	0.2	3.7	36.1	74.6	60.9	13.0	31.8	0.1	0.0	0.0	0.0	0.0	3.4	0.8	17.8	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	17.5	23.6	0.0	0.0	0.0	0.0	21.5	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.9	75.9	0.0	0.0	0.0	0.0	0.0	29.8	2.6	0.0	0.0	48.5	0.0	4.4	45.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	2.8	0.8	0.0	0.0	3.4	2.9	0.0	0.0	0.0	0.0	0.9	0.8	0.3	0.3	0.5	0.4	0.3	0.3	0.3	0.2	0.3	0.2	26.8	27.6	0.0	90.6	48.9	0.0	0.1	79.0	53.5	27.3	82.0	0.0	84.0	140.9	146.8	0.0	0.1	182.7	0.0	132.5	23.0	3.7	95.3	5.7	0.0	6.1	0.0	82.1	0.0	0.0	0.0	0.3	2.5	20.3	6.4	160.3	0.0	154.4	238.4	0.0	16.8	0.0	0.0	2.1	0.2	0.7	135.3	67.2	1.5	195.0	192.0
RAB9A	RAB9	ENSG00000123595	"RAB9A, member RAS oncogene family"	P51151	X	13689125-13710506	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"monocytes: 563.5;Syncytiotrophoblasts: 309.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003094, CAB016411"	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB016411: AB_630176, HPA003094: AB_1079736"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.68e-2)"	17.1	36.0	17.7	20.3	17.1	30.6	48.4	16.2	24.1	14.8	17.6	20.2	19.7	9.3	18.8	14.3	19.7	11.9	14.5	23.1	16.9	14.3	19.6	15.6	17.3	21.0	24.7	13.8	18.9	23.6	19.1	11.3	17.8	18.1	13.5	16.2	8.0	22.8	17.6	12.0	21.2	12.3	15.3	25.5	15.1	14.2	6.4	23.4	9.8	16.8	13.2	19.3	16.1	19.7	13.1	19.1	17.7	25.7	19.8	27.3	13.9	12.5	6.7	8.6	20.4	29.0	23.2	7.7	7.0	24.7	10.8	15.7	7.2	14.0	11.4	17.4	11.0	25.8	12.9	12.8	14.9	10.6	25.1	19.9	3.6	14.8	8.2	17.4	6.3	9.8	24.9	26.4	13.5	14.6	17.4	9.9	6.4	6.9	16.8	11.5	8.6	5.9	10.3	9.3	8.7	12.7	8.2	9.1	33.9	29.5	11.6	7.1	5.0	14.9	21.2	24.2	22.5	11.7	6.7	7.7	8.2	4.3	29.0	4.2	13.4	23.2	4.5	8.2	5.5	8.0	17.7	25.7	11.1	27.3	16.6	21.1	13.1	15.0	22.4	17.6	10.0	11.3	19.4	15.3	19.8	14.5	19.1	11.7	13.9	17.7	17.1	16.2	24.1	16.9	14.3	24.7	13.8	18.1	23.4	44.7	26.4	18.5	59.6	57.6	9.0	13.8	43.3	33.5	26.1	31.4	0.0	70.1	68.0	112.1	0.4	21.5	28.9	0.0	55.4	48.9	36.8	75.0	44.9	17.8	51.1	14.3	23.5	13.5	35.6	1.1	34.8	34.0	54.0	563.5	26.2	40.0	73.2	70.2	37.8	51.9	8.8	12.9	28.8	5.9	19.0	72.9	309.7	49.6	23.6	72.2
RAI14	"DKFZp564G013, KIAA1334, NORPEG, RAI13"	ENSG00000039560	"Retinoic acid induced 14"	Q9P0K7	5	34656237-34832627	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 64.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 166.4;Early spermatids: 198.0;Late spermatids: 250.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 59.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036949, HPA036950"	Supported		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			Nucleoplasm	"Actin filaments, Cytosol"	"HPA036949: AB_10670568, HPA036950: AB_10669721"	"unprognostic (7.63e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.75e-2)"	"unprognostic (5.49e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.58e-2)"	"prognostic unfavorable (9.75e-4)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.81e-2)"	"unprognostic (4.34e-2)"	5.6	4.5	3.9	8.3	5.9	0.5	5.1	4.4	3.2	23.3	9.1	5.5	14.1	2.5	29.2	8.2	8.8	6.8	8.8	3.6	4.4	3.5	7.7	11.2	10.4	5.1	6.9	1.5	9.5	4.8	6.4	2.7	64.4	5.6	10.4	4.0	8.2	8.4	10.8	2.0	7.6	3.6	34.7	17.0	21.2	6.0	26.6	5.7	2.1	6.7	2.7	3.8	22.5	14.9	0.8	0.6	2.5	0.8	2.5	3.3	0.3	2.7	10.8	12.5	8.3	6.7	23.5	16.0	32.7	26.4	18.9	19.0	8.2	3.5	0.6	13.1	16.0	20.7	1.8	14.2	24.1	41.1	0.0	6.8	4.5	10.2	5.0	20.8	0.1	0.4	21.9	7.6	33.9	27.1	31.2	59.9	1.0	6.3	0.2	24.6	2.2	0.4	0.1	9.7	1.6	10.5	3.9	19.1	0.1	22.0	15.6	3.3	1.8	19.3	2.9	8.8	19.1	3.3	0.5	38.5	30.8	16.5	7.5	14.2	0.7	0.0	0.0	26.0	0.0	11.9	2.5	0.8	0.3	3.3	0.3	0.4	0.5	1.0	0.2	0.2	0.8	0.3	0.6	1.6	2.5	0.1	0.6	0.1	0.3	3.9	5.9	4.4	3.2	4.4	3.5	6.9	1.5	5.6	5.7	98.3	166.4	1.7	20.2	10.6	1.9	3.3	5.1	24.1	95.5	33.2	64.8	23.9	6.6	30.0	198.0	51.8	3.2	0.0	24.7	59.3	26.2	11.8	3.5	21.9	6.5	14.3	1.7	16.5	2.4	250.8	66.7	4.2	5.0	1.8	0.8	18.5	39.1	1.9	29.7	18.0	4.7	0.0	17.3	8.1	12.4	13.8	130.6	2.5	2.3	63.1
RALGPS2	"FLJ10244, FLJ25604, KIAA0351"	ENSG00000116191	"Ral GEF with PH domain and SH3 binding motif 2"	Q86X27	1	178725147-178921841	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Alzheimer disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 37.7"	"Cell type enhanced"	"Detected in all"	10	"Cone photoreceptor cells: 194.4;Rod photoreceptor cells: 376.7;Spermatocytes: 162.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"memory B-cell: 17.8;naive B-cell: 14.6"	"Lineage enriched"	"Detected in many"	12	"B-cells: 17.8"	"Cell line enhanced"	"Detected in many"		"U-266/84: 62.7;U-698: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027143, HPA028328"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA027143: AB_10602071, HPA028328: AB_10601889"	"unprognostic (8.13e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.45e-1)"	"unprognostic (6.35e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.97e-2)"	5.5	6.4	5.0	27.9	10.5	6.2	5.4	8.9	5.1	8.0	9.9	1.2	7.2	5.8	8.2	7.3	14.0	8.7	4.7	4.7	6.0	3.2	6.1	16.4	3.7	25.3	2.2	4.1	11.5	5.0	6.2	8.4	4.6	3.8	5.3	6.4	9.9	9.2	7.4	2.1	10.0	19.7	6.1	3.2	26.1	6.8	37.7	2.1	16.0	4.3	4.7	29.4	7.5	8.4	17.8	0.5	1.4	0.1	0.3	0.5	0.8	10.3	3.4	10.5	0.1	11.8	17.3	4.1	9.1	20.1	7.4	6.7	4.1	10.2	22.0	3.0	26.7	3.7	8.6	4.6	2.3	9.7	0.0	2.7	0.0	2.2	3.8	2.0	2.8	0.1	7.6	2.0	9.5	6.7	5.1	6.4	4.1	5.3	0.8	4.8	1.6	4.3	0.9	7.2	4.0	3.6	6.1	10.8	0.2	2.5	6.6	1.6	4.7	5.9	6.6	12.8	7.5	7.9	1.4	4.7	3.4	3.3	12.3	4.3	25.1	62.7	51.4	1.9	1.5	3.8	0.5	0.1	1.4	0.2	0.0	0.2	17.8	0.1	0.1	0.2	14.6	0.5	0.1	0.8	0.3	0.0	0.5	0.0	0.8	5.0	10.5	8.9	5.1	6.0	3.2	2.2	4.1	3.8	2.1	11.9	8.6	135.8	14.0	13.2	83.6	11.7	5.1	26.8	7.9	14.0	194.4	6.4	18.3	12.8	103.8	2.7	23.8	23.3	10.3	8.6	12.0	23.1	8.1	51.8	5.0	12.7	34.4	3.1	7.5	137.4	46.3	3.6	8.5	1.8	18.2	23.8	20.4	24.6	43.9	6.6	376.7	19.4	8.1	162.4	24.7	29.7	2.7	4.8	13.0	54.0
RBL2	"p130, Rb2"	ENSG00000103479	"RB transcriptional corepressor like 2"	Q08999	16	53433977-53491649	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 410.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016547, HPA019703"	Supported		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	No			"Nucleoplasm, Nucleoli rim, Mitotic chromosome"	Cytosol	"CAB016547: AB_785011, HPA019703: AB_1856106"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (3.57e-5)"	"unprognostic (9.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.51e-2)"	27.8	20.6	15.7	22.2	20.0	11.1	25.5	24.1	18.7	26.3	23.7	24.7	25.6	15.4	30.0	20.2	21.5	25.1	19.5	19.9	15.5	11.7	23.8	34.2	24.0	31.6	25.8	13.7	29.3	30.7	55.3	22.6	12.4	15.8	28.2	18.9	20.2	26.2	30.5	28.3	20.8	24.6	26.1	17.9	27.2	24.9	28.6	22.8	54.4	31.0	10.3	31.6	36.5	26.8	9.1	8.0	20.2	9.8	26.2	35.1	24.5	12.6	8.6	11.6	10.7	30.3	29.3	5.4	9.3	13.3	11.7	4.0	5.6	16.0	18.6	14.2	15.8	11.0	16.0	8.7	14.5	18.6	6.6	12.0	8.3	8.8	10.4	13.1	11.6	26.2	18.6	17.8	7.9	11.4	23.5	18.0	20.6	6.8	11.7	13.0	3.7	23.0	15.6	4.7	14.4	7.9	16.8	21.1	21.3	11.4	13.0	9.4	7.9	21.2	9.3	9.1	10.1	12.1	15.2	14.9	14.5	7.7	11.9	6.9	17.9	10.6	21.8	18.0	14.5	9.9	16.4	8.2	20.2	21.2	5.9	23.7	8.7	23.8	24.3	8.0	9.1	35.1	29.6	15.7	26.2	9.8	4.9	17.5	24.5	15.7	20.0	24.1	18.7	15.5	11.7	25.8	13.7	15.8	22.8	38.7	83.1	23.6	26.7	20.5	27.2	10.1	40.8	42.8	43.3	26.2	19.6	4.5	14.9	10.6	410.5	23.6	18.8	0.0	8.9	12.0	22.6	37.9	53.2	40.8	10.1	33.4	19.0	33.2	46.3	128.8	38.9	26.4	10.1	23.4	31.9	37.2	10.2	10.5	40.3	21.4	22.5	38.8	24.7	118.2	42.4	24.1	3.4	79.1	23.7	30.9
RBP7	CRBPIV	ENSG00000162444	"Retinol binding protein 7"	Q96R05	1	9997206-10016020	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 68.1;breast: 210.2"	"Group enriched"	"Detected in many"	5	"Endothelial cells: 121.4;Kupffer cells: 402.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 54.1;intermediate monocyte: 23.4;neutrophil: 60.6"	"Group enriched"	"Detected in many"	30	"granulocytes: 60.6;monocytes: 54.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.5;SK-MEL-30: 7.1;T-47d: 26.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA034749	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA034749: AB_10602084"	"unprognostic (1.93e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (9.59e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.90e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	68.1	3.7	3.8	3.0	11.4	7.5	210.2	2.1	5.5	4.3	10.9	8.7	2.7	0.5	6.4	4.5	7.2	2.4	14.7	29.7	5.3	2.8	7.6	2.5	2.5	4.5	7.6	3.0	2.6	3.7	14.7	3.5	4.4	6.2	4.7	1.2	3.5	4.8	2.7	5.9	6.6	2.0	4.4	8.9	21.5	3.0	2.6	5.2	1.2	11.3	1.8	1.4	4.5	17.5	0.0	1.8	60.6	54.1	0.0	0.1	15.0	0.0	0.6	0.2	0.0	0.0	0.4	0.0	0.0	0.0	2.0	0.8	1.8	2.4	0.0	10.5	1.0	0.0	0.0	0.0	0.8	3.4	0.0	2.5	0.0	0.1	0.9	1.2	0.0	0.0	0.0	1.6	1.6	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	4.4	0.0	0.0	0.0	0.5	0.0	0.1	0.4	1.9	0.1	7.1	2.9	26.8	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	54.1	0.4	0.0	23.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	60.6	0.0	11.1	0.3	0.1	15.0	3.8	11.4	2.1	5.5	5.3	2.8	7.6	3.0	6.2	5.2	0.0	2.2	11.2	7.8	18.3	0.0	17.6	10.2	1.4	1.2	1.8	0.0	4.5	19.9	1.3	2.6	121.4	0.0	0.0	2.3	2.2	8.2	19.2	3.5	1.3	54.6	0.0	0.0	49.7	402.1	4.7	5.8	23.1	20.3	0.0	0.0	1.3	3.7	0.0	0.7	0.7	1.1	0.0	5.3	1.2	1.5	15.4	5.1	1.3	0.4	4.3
RELB	REL-B	ENSG00000104856	"RELB proto-oncogene, NF-kB subunit"	Q01201	19	45001430-45038198	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 90.3;Glandular cells: 104.0;monocytes: 170.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 25.4;HDLM-2: 32.4;U-698: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB007753, HPA040506"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB007753: AB_562340, HPA040506: AB_2677011"	"prognostic favorable (1.55e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.02e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.48e-2)"	"prognostic unfavorable (2.99e-6)"	"unprognostic (2.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.20e-2)"	8.0	6.8	2.2	27.6	3.6	27.8	6.8	1.2	3.1	4.9	12.2	2.1	1.6	8.8	8.5	4.7	6.4	5.2	10.9	11.9	1.8	1.6	10.1	7.4	12.8	18.2	3.6	0.9	7.8	12.3	1.9	2.1	4.7	2.8	9.9	3.4	3.6	7.3	4.8	8.1	8.3	13.0	8.4	3.9	17.2	8.3	3.7	1.7	17.7	5.6	7.2	24.8	8.8	6.1	8.2	3.9	14.5	5.0	2.1	2.2	1.7	8.9	5.3	0.5	2.4	1.2	4.0	1.9	1.6	11.6	2.5	4.1	1.8	9.9	25.4	4.7	2.6	8.9	4.1	0.2	3.7	2.2	32.4	0.8	0.9	0.3	1.0	10.4	1.9	15.1	6.5	1.5	5.2	6.1	2.3	1.6	0.7	0.2	16.5	0.9	2.1	0.4	6.0	0.8	2.5	1.0	1.9	1.3	3.0	4.2	13.9	0.0	0.8	1.7	4.8	4.6	0.6	1.7	4.9	5.2	6.1	3.0	2.2	5.9	21.0	12.4	27.3	6.7	0.7	3.4	0.0	5.0	2.1	1.4	3.2	2.1	8.2	2.2	2.0	3.6	7.9	1.8	0.9	14.5	2.1	2.6	3.9	1.1	1.7	2.2	3.6	1.2	3.1	1.8	1.6	3.6	0.9	2.8	1.7	6.0	14.3	26.4	90.3	33.7	0.0	1.7	12.7	1.4	11.4	3.5	0.0	3.5	8.3	30.3	5.1	11.3	45.5	0.0	27.0	5.8	13.4	104.0	51.7	3.4	17.6	3.2	21.9	6.7	13.3	2.4	4.4	25.4	23.6	170.5	12.4	0.6	29.3	80.7	2.5	14.3	0.2	6.5	41.2	0.5	1.2	27.9	8.2	7.5	8.1	75.4
RGL3	FLJ32585	ENSG00000205517	"Ral guanine nucleotide dissociation stimulator like 3"	Q3MIN7	19	11384341-11419342	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 65.1;thyroid gland: 38.2"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 48.8;Muller glia cells: 28.8;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 14.8;CACO-2: 8.4;RT4: 17.4;SK-BR-3: 7.7;T-47d: 12.8"	"Region enriched"	"Detected in single"	6	"cerebellum: 10.1"					"HPA042763, HPA043615, HPA064578"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: "	"prognostic favorable (7.35e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.19e-3)"	"unprognostic (5.99e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (4.17e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.12e-3)"	4.3	6.2	5.3	1.2	7.9	0.7	4.3	1.9	6.8	7.6	1.9	3.4	23.3	1.8	4.9	14.5	1.1	5.3	6.5	5.2	8.2	1.3	20.7	6.0	7.5	1.2	6.7	3.0	1.6	12.1	65.1	9.1	5.8	7.9	4.1	1.8	7.3	3.5	23.9	5.0	1.1	1.2	1.4	9.5	5.1	6.8	1.1	7.3	0.0	38.2	0.4	0.9	4.5	4.5	0.3	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.9	0.1	14.8	0.9	1.1	0.5	1.6	8.4	6.0	0.0	5.4	1.0	2.1	3.7	0.0	0.0	0.0	0.0	0.0	0.1	3.1	2.6	2.3	0.0	0.0	0.0	0.1	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.3	1.1	0.0	0.6	1.6	5.1	17.4	0.8	4.4	0.2	7.7	2.6	3.1	12.8	0.0	0.0	2.7	0.0	2.0	0.7	0.0	0.4	0.7	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	5.3	7.9	1.9	6.8	8.2	1.3	6.7	3.0	7.9	7.3	17.9	15.2	0.0	2.0	0.1	0.1	2.5	5.1	2.7	22.7	48.8	0.0	12.2	10.0	8.3	0.0	3.9	0.0	0.0	3.6	9.6	4.6	1.0	1.1	4.3	2.6	0.0	9.9	25.8	4.3	0.0	3.4	0.6	5.0	0.0	7.1	28.8	5.8	5.3	0.4	3.0	0.4	38.8	12.4	0.5	1.2	0.0	10.1	0.0	2.7	1.4
RHOXF1	"OTEX, PEPP1"	ENSG00000101883	"Rhox homeobox family member 1"	Q8NHV9	X	120109053-120115937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 8.1;brain: 9.2;testis: 27.8"	"Cell type enriched"	"Detected in some"	39	"Spermatogonia: 154.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 9.2"	"Cell type enriched"	"Detected in some"	6	"T-reg: 8.1"	"Lineage enriched"	"Detected in single"	30	"T-cells: 8.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.2;HEK 293: 3.9;NB-4: 2.8"									"HPA052560, HPA056506"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA052560: , HPA056506: AB_2683157"	"unprognostic (5.03e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.50e-4)"	"unprognostic (1.97e-1)"	"unprognostic (5.85e-4)"	"unprognostic (3.00e-1)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.73e-3)"	2.8	0.5	0.9	0.5	1.1	0.3	0.9	9.2	1.7	0.5	0.7	0.5	0.5	0.2	0.5	0.5	0.5	1.5	0.5	0.5	0.8	2.4	0.8	0.5	0.5	0.6	0.8	0.5	2.2	0.5	0.8	0.9	1.1	0.5	0.5	0.1	0.5	0.8	0.6	0.5	2.4	0.5	0.5	0.5	0.5	0.2	27.8	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.1	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	3.2	3.9	0.4	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	8.1	0.0	0.9	1.1	9.2	1.7	0.8	2.4	0.8	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	2.7	0.0	0.0	3.9	0.1	1.7	0.1	1.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.1	0.8	0.0	0.0	1.4	0.0	1.3	0.0	0.0	2.9	154.2	0.3	0.0	0.0	0.1	0.0
RLIM	"MGC15161, NY-REN-43, RNF12"	ENSG00000131263	"Ring finger protein, LIM domain interacting"	Q9NVW2	X	74585217-74614617	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018895	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA018895: AB_1856323"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.20e-1)"	11.8	14.3	17.5	10.6	25.6	37.4	12.4	12.6	20.5	12.2	7.4	8.3	5.6	6.4	10.6	8.0	10.2	9.5	10.7	10.5	17.1	16.6	11.6	9.7	13.8	9.2	12.4	13.7	12.4	9.7	19.5	18.5	10.5	28.6	11.9	7.6	5.2	8.9	8.7	11.2	10.2	7.1	10.1	13.9	9.8	8.4	6.9	12.4	9.7	13.0	6.2	10.1	10.5	9.3	3.5	4.8	16.3	7.4	5.2	4.6	3.0	13.7	14.0	13.6	11.3	13.7	14.5	13.4	13.2	15.4	11.9	14.7	10.9	14.4	7.4	15.5	16.6	16.1	11.9	27.3	15.9	18.2	6.7	14.4	13.0	24.7	6.6	12.2	19.5	23.2	14.0	10.0	16.9	29.1	10.2	13.8	12.4	11.2	13.5	15.6	10.5	14.5	11.1	20.9	8.5	13.5	13.9	28.8	12.5	11.0	16.5	10.0	11.7	24.9	12.1	15.4	13.0	6.8	15.4	18.3	14.4	14.0	14.7	11.5	7.2	13.8	11.9	15.7	19.9	14.0	16.3	5.9	5.6	3.2	7.4	3.3	3.0	4.1	4.0	4.8	3.5	4.5	4.1	11.4	5.2	5.4	2.6	4.6	3.0	17.5	25.6	12.6	20.5	17.1	16.6	12.4	13.7	28.6	12.4	14.9	17.1	2.9	24.0	31.8	12.3	26.3	15.3	24.1	20.5	24.4	13.7	14.1	10.0	12.7	5.5	27.4	7.8	0.0	9.2	17.5	26.4	21.1	36.9	11.9	16.0	20.6	22.2	20.3	20.2	3.3	9.2	23.6	16.9	3.6	9.8	13.7	11.6	8.6	17.7	9.6	13.8	6.5	17.6	7.2	17.2	33.9	22.0	17.0	10.2	31.0
RMI2	"BLAP18, C16orf75, MGC24665"	ENSG00000175643	"RecQ mediated genome instability 2"	Q96E14	16	11249619-11351762	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.7;testis: 29.6"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 100.7;Peritubular cells: 40.0;Spermatogonia: 42.9;Syncytiotrophoblasts: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.5"	"Group enriched"	"Detected in many"	5	"B-cells: 6.5;T-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA040995	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	Yes			"Nuclear speckles"	Cytosol	"HPA040995: AB_10795531"	"unprognostic (2.76e-1)"	"prognostic favorable (5.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (3.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.03e-1)"	1.0	1.8	4.2	18.0	5.1	4.8	2.8	0.7	4.1	2.8	7.3	1.0	0.4	4.3	2.5	3.2	11.8	1.0	2.6	1.9	2.5	1.5	3.1	2.3	2.9	17.9	1.6	5.6	3.6	1.6	0.7	1.1	13.2	1.2	2.6	9.0	0.8	2.9	1.7	1.1	8.7	5.6	1.1	1.4	4.2	4.0	29.6	1.2	31.7	1.4	2.8	20.4	3.6	4.5	6.5	0.6	0.9	0.0	0.3	3.0	0.3	19.2	12.9	25.4	10.8	1.1	5.5	10.6	11.2	8.9	10.6	17.7	4.9	22.9	26.7	9.7	5.2	12.0	11.3	10.8	10.7	17.3	5.2	10.1	14.6	7.6	32.6	0.4	5.6	6.6	1.2	2.1	4.6	4.4	4.2	5.8	11.8	20.1	21.3	5.5	22.2	19.3	26.2	21.3	26.9	5.1	23.5	27.4	28.5	6.3	12.5	14.6	11.6	9.5	15.9	8.3	15.3	27.0	8.4	1.8	8.5	8.0	16.3	1.6	5.8	9.6	31.7	7.9	18.5	15.7	0.0	0.0	0.9	0.6	0.0	0.0	6.5	0.2	0.0	0.4	2.5	1.8	0.7	0.2	0.3	0.0	0.6	3.0	0.3	4.2	5.1	0.7	4.1	2.5	1.5	1.6	5.6	1.2	1.2	0.0	0.3	4.9	6.4	6.1	0.1	0.8	5.1	0.0	2.3	7.0	0.0	100.7	5.0	2.3	2.2	0.7	1.1	23.3	0.4	27.0	2.6	1.6	0.0	0.8	15.8	0.0	2.4	1.3	1.0	4.3	14.7	3.4	3.3	1.8	5.9	0.0	1.1	3.5	40.0	0.0	0.5	32.3	0.9	31.4	42.9	4.6	39.9	0.0	7.0	2.8
RNASEK-C17orf49		ENSG00000161939	"RNASEK-C17orf49 readthrough"		17	7012635-7017520	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.3"	"Group enriched"	"Detected in many"	8	"Alveolar cells type 1: 59.6;Alveolar cells type 2: 63.9;Ciliated cells: 103.1;Club cells: 56.9;granulocytes: 55.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 5.3;THP-1: 6.3;U-87 MG: 6.9"									"HPA022961, HPA024457"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA022961: AB_1845592, HPA024457: AB_1845593"	"unprognostic (4.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.37e-5)"	"unprognostic (4.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.77e-3)"	"unprognostic (8.26e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.78e-1)"	4.8	4.8	2.8	3.5	3.5	5.3	2.9	3.6	4.0	2.0	2.8	0.4	1.5	1.4	4.9	3.3	2.3	2.7	3.2	6.3	2.5	3.3	6.6	14.5	16.7	20.3	2.9	2.4	2.4	7.9	1.4	4.7	2.5	1.8	1.8	1.4	0.4	1.6	5.0	4.2	1.9	6.3	2.3	1.7	9.1	1.6	6.4	0.7	4.1	2.0	4.6	3.4	2.3	1.6	1.9	4.0	7.5	4.3	0.9	1.7	2.8	1.2	3.6	0.5	0.5	0.0	0.0	1.1	2.3	1.9	2.8	2.2	2.3	1.1	1.9	0.2	0.0	0.3	0.6	0.7	5.3	0.8	0.0	4.4	0.0	2.9	1.0	2.8	0.0	0.6	0.0	0.0	1.6	0.0	0.4	0.7	0.2	0.6	0.0	0.0	1.2	1.9	2.3	2.3	0.5	1.2	1.4	0.0	0.0	0.8	0.7	0.5	1.8	0.0	0.0	0.2	0.3	0.6	6.3	0.0	0.0	0.2	3.5	1.0	0.0	0.8	0.2	6.9	0.5	0.0	3.6	4.3	3.4	1.2	3.0	1.7	1.9	1.5	0.8	3.8	1.8	1.4	1.2	7.5	0.9	3.1	4.0	0.9	2.8	2.8	3.5	3.6	4.0	2.5	3.3	2.9	2.4	1.8	0.7	59.6	63.9	0.0	0.0	0.3	0.0	0.0	0.0	103.1	56.9	0.0	0.0	0.2	3.3	6.7	0.0	0.1	2.9	0.0	7.0	0.1	0.2	0.1	55.8	0.0	0.6	0.0	5.2	0.6	1.2	0.0	0.3	1.0	0.0	8.2	4.7	0.0	6.7	6.8	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.7	0.0	2.7	0.1
RPL36	"DKFZp566B023, L36"	ENSG00000130255	"Ribosomal protein L36"	Q9Y3U8	19	5674947-5691876	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047153	Supported		Uncertain	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA047153: AB_2679958"	"unprognostic (2.81e-2)"	"unprognostic (5.70e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.82e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	52.2	101.2	56.3	80.9	43.1	120.2	88.4	40.8	71.1	59.7	63.4	21.2	58.0	60.4	72.2	64.9	79.6	63.2	66.2	69.6	39.7	33.9	48.4	59.7	58.6	201.6	38.7	52.9	225.0	196.1	12.9	48.0	38.6	34.9	65.0	36.7	29.4	129.4	70.4	78.7	101.9	61.4	60.8	39.5	75.3	64.7	53.8	32.3	39.9	40.9	106.1	55.5	48.4	103.1	163.2	79.0	29.1	57.6	68.6	180.7	220.0	101.3	50.9	35.7	88.2	42.7	82.5	52.8	55.9	36.5	56.9	47.0	94.3	51.7	69.2	135.4	26.3	26.9	71.5	32.0	66.4	17.3	52.3	225.5	43.5	52.2	77.6	94.6	93.8	61.2	70.2	109.4	35.2	74.1	57.0	48.0	89.6	55.7	225.4	33.1	108.2	116.3	130.1	119.9	60.9	173.0	72.3	41.9	187.7	54.9	67.9	63.5	85.2	32.9	94.5	156.1	17.8	72.9	161.5	51.3	37.6	50.4	54.9	121.9	111.3	101.0	108.4	71.4	150.5	52.3	29.1	57.6	21.4	77.3	48.3	125.2	161.4	157.2	113.1	79.0	163.2	180.7	146.6	8.0	68.6	40.4	74.6	120.6	220.0	56.3	43.1	40.8	71.1	39.7	33.9	38.7	52.9	34.9	32.3	539.0	792.8	4383.3	2587.1	5914.7	210.4	280.4	1931.2	633.0	1136.3	1175.9	76.6	2530.1	2224.9	2450.7	422.3	2391.0	1994.6	934.5	7046.1	4296.7	2490.5	2459.5	1236.6	2515.3	2437.5	92.2	1971.2	2721.6	3281.5	1128.6	3011.7	2570.0	2884.9	4260.7	4637.6	399.1	5342.0	3492.9	1450.3	2290.2	228.2	911.9	2225.2	393.6	813.8	8042.2	2327.4	2040.6	4783.5	2658.3
RPS19BP1	"FLJ21770, MGC52010"	ENSG00000187051	"Ribosomal protein S19 binding protein 1"	Q86WX3	22	39529093-39532855	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042874	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			"Nucleoli, Cytosol"	Nucleoplasm	"HPA042874: AB_10793988"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.65e-1)"	"unprognostic (5.68e-2)"	"unprognostic (8.31e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.32e-2)"	32.8	38.8	38.9	29.5	30.6	36.9	47.5	24.2	34.7	26.4	28.0	19.2	40.6	31.4	18.8	25.2	24.1	18.0	25.0	30.5	38.9	28.4	30.8	40.7	22.5	29.4	40.3	27.0	23.4	45.0	15.4	18.8	21.9	31.9	31.6	14.4	19.2	65.2	35.4	55.0	19.8	30.9	28.5	31.1	27.1	32.6	28.8	24.6	16.3	40.8	28.0	23.7	24.3	54.5	64.2	73.5	67.3	57.7	42.8	60.3	50.5	20.9	25.9	12.5	17.6	14.1	9.2	26.3	24.1	19.6	21.1	16.8	28.7	13.9	26.2	25.2	14.2	17.2	17.0	19.6	24.7	7.3	37.7	62.7	25.2	22.0	25.3	20.6	36.8	32.9	13.8	18.7	18.1	22.2	11.4	14.3	19.9	28.1	19.0	13.3	23.2	17.6	36.7	21.7	46.7	49.7	28.1	16.3	39.4	22.1	20.8	27.9	15.6	19.5	31.1	43.3	8.0	22.4	29.8	16.9	17.6	40.2	19.6	31.4	33.1	30.4	40.7	23.9	25.6	41.1	42.1	57.7	67.3	53.4	52.1	49.2	62.0	54.4	55.2	46.3	64.2	53.2	54.1	63.4	42.8	42.0	73.5	60.3	50.5	38.9	30.6	24.2	34.7	38.9	28.4	40.3	27.0	31.9	24.6	41.7	44.3	107.2	91.0	121.8	95.6	68.3	109.5	34.8	36.4	92.5	49.1	134.1	184.1	166.7	17.8	129.5	196.8	46.7	167.0	202.1	94.9	166.3	69.2	175.1	185.7	33.4	136.9	111.1	105.7	22.2	126.8	125.3	102.9	172.3	137.0	80.8	187.2	164.9	118.5	232.2	81.9	77.6	104.0	59.0	146.0	129.4	110.1	136.4	130.8	112.7
RUNDC3B	"RPIB9, RPIP9"	ENSG00000105784	"RUN domain containing 3B"	Q96NL0	7	87627548-87832296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 13.2;brain: 16.4"	"Cell type enhanced"	"Detected in many"	6	"Endothelial cells: 13.7;Hepatocytes: 16.6;Spermatocytes: 20.2;Spermatogonia: 21.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.0;HEK 293: 2.5;SCLC-21H: 6.7;SH-SY5Y: 3.0;U-138 MG: 2.5;U-266/70: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056968, HPA057155, HPA075760"	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA056968: AB_2683292, HPA057155: AB_2683353, HPA075760: "	"unprognostic (2.49e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.42e-5)"	"unprognostic (4.44e-1)"	"prognostic favorable (2.62e-6)"	"unprognostic (1.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.55e-2)"	1.1	13.2	3.6	0.8	9.4	0.1	1.4	16.4	7.9	2.7	3.7	1.0	1.0	4.7	3.4	1.2	1.0	2.0	1.7	1.4	2.8	5.1	3.3	9.7	0.8	0.4	2.8	4.8	2.3	0.5	0.5	2.0	0.2	7.9	1.1	2.7	0.7	0.9	0.8	1.1	0.9	5.2	3.8	2.2	0.4	0.6	3.1	1.0	0.0	0.6	0.1	0.5	1.6	1.1	0.1	0.0	0.4	0.0	0.0	2.1	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	3.0	0.4	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	2.5	0.1	1.5	1.0	0.1	1.2	0.4	0.0	0.7	0.0	0.4	0.0	1.2	0.0	1.2	0.0	0.0	1.3	0.0	0.0	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.2	6.7	3.0	0.0	0.2	0.1	0.1	0.1	0.0	0.4	2.5	0.0	0.2	0.0	3.9	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.4	2.1	0.0	0.8	0.1	0.0	1.7	0.0	0.1	0.3	1.2	0.3	0.0	0.0	0.0	0.0	0.1	3.6	9.4	16.4	6.5	2.8	5.1	2.8	4.8	7.9	1.0	0.0	0.0	0.0	0.1	4.2	8.0	2.2	5.1	0.0	0.0	0.0	5.9	0.5	1.7	0.9	2.0	13.7	9.7	0.0	0.2	0.3	0.1	0.1	0.0	16.6	0.1	11.1	0.0	1.8	0.0	1.0	3.7	0.0	3.3	0.0	2.9	0.7	0.8	5.8	1.4	8.7	7.6	0.0	1.2	20.2	21.5	2.6	1.0	0.0	3.8	0.0
RYR2	"ARVC2, ARVD2, VTSIP"	ENSG00000198626	"Ryanodine receptor 2"	Q92736	1	237042205-237833988	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 106.6"	"Cell type enriched"	"Detected in many"	30	"Cardiomyocytes: 1960.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.8;HEK 293: 10.7;K-562: 3.3;NB-4: 2.7;NTERA-2: 4.0;U-937: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020028	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA020028: AB_1856528"	"unprognostic (5.23e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.02e-4)"	"unprognostic (6.26e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	1.1	0.9	6.2	0.9	18.7	0.5	1.1	14.8	10.5	1.3	1.2	0.0	1.2	0.7	1.1	0.7	1.8	1.0	1.8	106.6	5.7	1.1	0.9	0.9	1.4	0.6	1.0	7.3	2.2	4.2	0.5	2.0	1.1	1.6	2.0	0.8	0.2	0.9	1.4	0.9	1.0	1.0	4.6	1.0	1.0	1.2	1.1	3.0	0.0	2.7	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.3	0.0	0.0	0.3	0.6	0.0	0.0	7.8	10.7	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	2.7	4.0	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	18.7	14.8	10.5	5.7	1.1	1.0	7.3	1.6	3.0	0.0	0.3	0.0	0.0	0.3	65.2	1960.0	0.0	1.4	2.3	1.8	9.8	0.0	0.0	0.0	15.8	1.5	0.0	0.0	2.5	0.0	2.1	0.0	0.0	0.0	0.1	1.6	3.4	1.3	0.0	10.2	1.1	0.0	8.5	0.0	0.0	1.5	0.3	0.0	0.0	0.0	4.7	0.0	18.6	3.2	0.9	0.0	0.0	0.0	0.0	0.0
S100A7	"PSOR1, S100A7c"	ENSG00000143556	"S100 calcium binding protein A7"	P31151	1	153457744-153460701	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 116.2;lymphoid tissue: 156.7;tongue: 409.9"	"Group enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 78.3;Syncytiotrophoblasts: 22.1"	"Group enriched"	"Detected in many"	5	"cervical cancer: 458.9;head and neck cancer: 1201.5;melanoma: 638.4;urothelial cancer: 281.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 7.4;SK-BR-3: 17.3"									"CAB001453, HPA006997, CAB033766"	Enhanced		Uncertain	Cytosol	"Secreted in other tissues"	NA	NA		17000000	Cytosol		"CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860"	"unprognostic (3.28e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.94e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.27e-1)"			"unprognostic (2.99e-1)"	"unprognostic (5.41e-2)"		"unprognostic (1.21e-2)"	0.1	0.0	0.1	0.1	0.1	0.1	2.2	0.1	0.1	45.2	0.1	0.1	0.1	0.0	3.7	3.9	116.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	6.2	0.1	0.1	45.7	0.1	0.2	0.1	0.1	0.0	0.3	0.1	1.2	0.1	409.9	156.7	0.2	85.3	0.0	0.4	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	7.4	0.0	2.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.5	0.0	0.2	0.0	0.2	0.0	0.0	0.7	0.2	0.4	0.0	0.0	0.0	0.8	17.3	0.0	1.1	0.3	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	78.3	22.1	0.0	0.0	0.4
S100A7A	"S100A15, S100A7f, S100A7L1"	ENSG00000184330	"S100 calcium binding protein A7A"	Q86SG5	1	153416524-153423225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"tongue: 178.1"	"Group enriched"	"Detected in some"	6	"Early spermatids: 1.1;Late spermatids: 1.6;Suprabasal keratinocytes: 1.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 25.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"SK-BR-3: 3.4"									HPA006997	Supported		Uncertain	Cytosol		NA	NA			Cytosol		"HPA006997: AB_1079860"	"unprognostic (2.18e-1)"	"unprognostic (1.26e-1)"				"unprognostic (3.73e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"				"unprognostic (1.17e-1)"			"unprognostic (4.40e-3)"	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	11.5	0.0	0.0	0.0	0.0	1.9	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	178.1	12.5	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0
SCARF2	"HUMZD58C02, SREC-II, SREC2"	ENSG00000244486	"Scavenger receptor class F member 2"	Q96GP6	22	20424815-20437826	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 28.8;Fibroblasts: 17.0;Leydig cells: 12.4;Peritubular cells: 16.6;Sertoli cells: 12.9;Smooth muscle cells: 14.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"T-reg: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 14.2;SH-SY5Y: 15.8;SK-MEL-30: 15.7;U-138 MG: 21.8;U-2 OS: 22.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035079	Approved		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		360000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA035079: AB_10670287"	"unprognostic (2.12e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.92e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.38e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (4.28e-4)"	6.5	2.4	0.0	4.1	0.3	0.1	9.2	0.0	1.2	10.6	3.2	0.4	2.9	1.4	8.1	6.6	1.8	2.6	11.3	3.4	0.6		3.2	1.1	5.9	5.1	0.8	0.4	12.6	1.6	0.0	0.6	5.6	0.9	5.5	0.0	9.2	1.1	6.8	1.8	2.2	1.9	9.9	0.5	5.3	1.4	2.5	0.0	0.0	5.4	3.3	1.4	7.1	10.9	0.1	0.1	0.9	0.0	0.0	1.8	0.0	0.4	0.2	3.2	5.5	1.9	2.7	1.3	14.2	5.9	3.4	1.8	0.0	0.0	0.2	8.3	6.8	0.2	0.1	1.8	0.0	0.4	0.4	11.9	1.1	0.2	2.5	11.8	0.0	0.6	4.6	0.0	1.7	0.8	1.6	1.7	0.0	0.1	0.1	1.2	0.6	0.0	0.2	4.3	0.0	1.8	0.3	9.0	0.0	0.0	0.0	1.4	15.8	0.1	0.0	15.7	0.6	0.5	0.0	2.1	21.8	22.9	0.5	3.2	0.6	0.2	0.2	0.1	0.3	10.8	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	1.8	0.0											0.0	0.0	0.0	1.7	2.5	3.0	28.8	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.2	3.3	0.0	0.0	0.0	1.2	17.0	2.2	0.0	0.0	0.5	0.0	0.0	2.5	0.6	0.0	12.4	0.6	3.3	0.0	0.0	0.5	0.0	0.0	16.6	0.0	0.4	12.9	14.4	0.5	0.2	2.4	0.3	0.0	0.0	0.5
SDHAF2	"C11orf79, FLJ20487, PGL2, SDH5"	ENSG00000167985	"Succinate dehydrogenase complex assembly factor 2"	Q9NX18	11	61430042-61447529	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		Chaperone	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039464, HPA039732"	Supported		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	Nucleoli	"HPA039464: AB_10962146, HPA039732: AB_10962868"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-3)"	"unprognostic (4.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.48e-2)"	23.7	33.0	22.2	22.4	27.2	34.1	24.8	19.9	33.8	20.5	22.1	23.4	21.0	22.3	23.3	33.5	25.3	25.8	21.1	32.5	20.8	26.9	26.8	39.1	19.9	36.7	24.3	25.0	25.7	22.7	23.3	38.4	26.7	25.2	26.1	24.9	32.0	28.1	21.5	31.4	22.9	27.9	26.6	20.8	32.2	24.3	19.2	21.1	36.1	27.0	20.2	30.9	24.0	19.2	31.3	23.2	44.6	25.4	32.7	43.7	26.7	15.4	22.3	13.2	9.2	19.2	15.7	10.3	12.0	17.4	16.3	12.5	20.8	16.7	15.6	22.1	17.4	22.2	16.8	17.2	17.1	17.5	23.1	16.3	13.4	18.3	30.0	20.0	15.8	18.8	19.4	20.9	17.7	17.3	11.6	26.2	16.8	15.4	20.1	19.6	34.2	16.1	35.9	20.4	15.9	32.8	17.4	17.1	28.8	23.2	23.0	14.2	17.7	16.5	19.3	33.4	14.1	30.1	18.9	16.3	16.6	13.5	19.7	14.2	12.4	19.3	19.9	16.1	14.1	17.4	41.9	25.4	44.6	32.4	22.8	38.4	31.3	35.9	34.7	20.3	29.9	39.5	38.4	37.0	32.7	17.9	23.2	43.7	26.7	22.2	27.2	19.9	33.8	20.8	26.9	24.3	25.0	25.2	21.1	32.8	38.1	35.3	31.0	18.3	14.0	20.5	12.7	32.1	21.6	27.9	5.9	61.5	46.4	50.2	11.4	29.8	27.1	23.3	52.7	47.1	28.8	26.8	31.2	37.0	45.9	14.3	32.8	36.8	33.7	13.8	29.1	32.1	42.2	81.2	28.5	36.7	49.4	31.7	29.0	38.3	14.1	32.3	24.7	15.8	23.5	19.6	83.3	44.5	23.9	29.9
SEC14L5	"KIAA0420, PRELID4B"	ENSG00000103184	"SEC14 like lipid binding 5"	O43304	16	4958317-5019158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 29.4;heart muscle: 7.5;skeletal muscle: 11.0"	"Cell type enriched"	"Detected in some"	9	"Cone photoreceptor cells: 80.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.2;RPMI-8226: 4.2;SCLC-21H: 6.5;T-47d: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041492, HPA041825"			Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA041492: AB_10794519, HPA041825: AB_10794526"	"unprognostic (1.90e-3)"	"unprognostic (4.08e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.33e-3)"	"unprognostic (8.71e-4)"	"unprognostic (6.87e-2)"	"unprognostic (1.56e-4)"	"unprognostic (1.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	1.1	1.7	7.4	1.3	17.5	1.5	1.2	2.2	22.1	2.8	1.7	29.4	0.0	1.4	0.9	1.2	2.0	2.2	1.1	7.5	13.5	6.1	1.1	0.8	1.0	1.4	25.8	8.8	1.7	1.8	0.8	1.7	1.3	15.2	1.7	2.1	0.3	1.9	1.1	11.0	2.9	1.1	0.9	25.2	1.2	3.7	1.4	15.6	0.0	0.9	0.5	1.7	0.9	0.4	0.1	0.4	1.6	0.0	0.1	0.2	2.9	0.0	0.4	0.6	0.3	0.6	4.2	0.6	0.1	0.0	0.1	0.0	0.5	0.2	0.2	0.3	0.5	0.1	0.6	0.2	0.1	0.0	0.0	0.5	2.0	0.4	1.1	0.3	0.0	0.4	0.6	0.9	0.1	0.1	0.3	0.1	0.2	0.2	0.4	0.1	0.3	0.0	0.2	1.3	1.0	0.3	0.1	0.4	4.2	0.3	0.1	6.5	0.2	0.4	0.3	0.5	0.7	4.3	0.0	0.5	0.2	0.4	0.3	0.0	0.2	0.0	0.2	1.1	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	1.6	0.1	0.0	0.4	0.0	2.9	7.4	17.5	2.2	20.0	13.5	6.1	25.8	8.8	15.2	15.6	0.0	0.0	0.0	0.1	0.2	3.7	8.9	0.0	0.0	0.0	0.0	80.5	0.6	0.0	0.1	1.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	0.0
SELENON	"MDRS1, RSMD1, RSS, SELN, SEPN1"	ENSG00000162430	"Selenoprotein N"	Q9NZV5	1	25800176-25818224	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Desmin-related myopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 19.2;Ductal cells: 16.8;Exocrine glandular cells: 36.9;Hofbauer cells: 25.2;Pancreatic endocrine cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA058076	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA058076: AB_2683598"	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-1)"	"prognostic favorable (2.23e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (3.40e-5)"	"unprognostic (1.94e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.56e-3)"	"unprognostic (5.89e-2)"	41.4	27.2	26.3	26.4	24.8	12.4	53.6	22.0	29.7	32.2	21.9	26.5	26.3	14.3	30.7	20.4	25.4	34.3	27.4	29.3	26.3	16.3	33.0	15.1	35.2	47.8	19.2	18.2	35.3	39.9	23.0	23.7	31.6	22.0	37.5	17.8	30.0	29.1	35.0	30.0	18.0	16.5	45.8	21.0	29.1	24.4	11.6	19.1	10.7	31.4	17.6	16.8	26.1	28.0	1.7	2.1	5.9	3.3	0.7	2.6	1.0	12.2	11.7	39.1	33.4	25.5	44.9	13.2	14.8	22.5	16.5	13.2	3.0	13.0	0.0	9.9	22.4	18.3	11.9	10.2	15.7	12.6	12.9	7.8	12.0	4.5	3.7	18.4	2.5	28.5	47.8	10.6	17.3	8.7	19.6	51.5	4.2	4.2	1.7	15.5	6.2	0.5	3.6	14.7	9.6	8.1	10.5	17.1	1.5	6.8	3.5	8.2	13.9	9.3	8.5	12.4	11.0	8.6	8.4	42.8	16.8	11.5	30.7	8.6	1.4	0.0	0.3	23.3	3.7	20.2	5.9	3.3	3.8	1.8	2.6	1.1	1.7	1.7	1.3	2.1	1.1	2.6	1.6	0.5	0.7	2.5	0.3	1.7	1.0	26.3	24.8	22.0	29.7	26.3	16.3	19.2	18.2	22.0	19.1	8.9	9.3	0.0	0.0	0.0	0.0	0.0	0.0	6.7	6.8	19.2	0.0	12.7	0.0	16.8	0.0	0.0	0.0	0.0	36.9	9.5	0.0	0.0	2.3	0.0	25.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	5.4	0.0	0.0	23.6	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0
SELL	"CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR"	ENSG00000188404	"Selectin L"	P14151	1	169690667-169711698	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 227.5;lymphoid tissue: 77.8"	"Group enriched"	"Detected in many"	6	"B-cells: 178.5;Kupffer cells: 97.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.0;EFO-21: 6.8;JURKAT: 18.6;MOLT-4: 12.8;U-266/70: 24.1;U-698: 11.2;U-937: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002144, HPA051972"	Enhanced		Uncertain	Cytosol		NA	NA		8100000000	Cytosol		"CAB002144: AB_563862, HPA051972: AB_2797242"	"prognostic favorable (3.76e-4)"	"prognostic favorable (2.25e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.89e-2)"	"unprognostic (7.87e-3)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.39e-3)"	"unprognostic (3.43e-1)"	"unprognostic (2.70e-3)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (4.96e-5)"	"unprognostic (4.76e-2)"	"unprognostic (8.71e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.01e-1)"	6.9	0.9	2.0	25.1	4.6	30.3	1.5	1.1	2.5	0.9	1.4	1.1	0.0	0.4	1.0	1.1	4.2	3.2	5.4	4.1	2.5	2.2	2.3	2.5	11.4	77.8	5.2	0.2	0.8	1.0	10.7	7.9	3.4	2.7	1.2	1.3	3.8	12.1	0.1	0.9	0.8	8.8	2.9	5.2	67.7	1.7	1.0	2.3	43.8	1.9	1.3	64.0	8.1	6.1	40.4	40.7	227.5	49.7	130.8	69.5	90.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.2	7.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.8	0.8	0.3	0.0	0.0	0.0	0.0	1.2	18.6	0.0	0.9	0.0	0.8	12.8	0.1	0.0	0.2	0.2	4.9	0.1	0.3	3.9	0.2	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	24.1	0.0	11.2	1.3	7.0	0.1	170.8	49.7	88.6	16.5	11.2	4.5	33.8	30.7	17.0	40.7	40.4	69.5	39.6	227.5	130.8	4.5	32.8	52.7	90.1	2.0	4.6	1.1	2.5	2.5	2.2	5.2	0.2	2.7	2.3	8.9	20.2	178.5	0.3	0.3	0.0	0.3	2.5	2.7	3.4	10.4	0.0	9.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.6	0.8	0.0	9.3	0.4	5.6	0.0	0.0	1.8	97.5	0.0	0.6	7.5	1.7	0.0	0.0	2.3	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	23.8	20.3	0.0	0.5
SENP5	MGC27076	ENSG00000119231	"SUMO1/sentrin specific peptidase 5"	Q96HI0	3	196867856-196934714	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006575			Approved	Nucleoplasm,Nucleoli,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	"Centrosome, Cytosol"	"HPA006575: "	"unprognostic (4.07e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.63e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.89e-1)"	"unprognostic (9.57e-3)"	"prognostic unfavorable (2.14e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.71e-2)"	13.8	13.5	20.0	15.3	20.0	25.7	16.1	28.3	23.8	15.0	15.1	16.1	14.5	11.3	14.6	16.2	16.3	12.9	14.4	15.9	18.9	21.7	13.6	19.5	15.2	15.9	19.4	18.4	17.5	15.7	19.8	21.5	17.8	23.5	15.1	14.0	12.0	13.2	15.9	17.8	16.4	13.0	16.8	18.2	17.1	14.0	36.6	16.4	19.3	14.1	9.2	21.1	14.9	20.1	8.9	7.8	15.8	8.7	7.6	8.9	4.2	13.3	6.1	9.8	8.8	8.3	9.9	7.8	8.5	9.1	9.3	15.0	10.6	5.3	12.5	23.8	9.3	15.9	9.2	10.1	4.5	15.1	6.7	6.6	16.9	9.1	7.4	9.6	14.0	8.0	8.5	12.3	9.5	10.1	6.7	9.0	11.2	11.2	19.4	10.8	11.5	13.1	8.2	7.6	7.3	12.0	8.5	7.9	8.5	4.5	7.6	6.1	8.1	9.5	10.8	10.5	10.3	18.1	10.7	10.1	9.1	9.3	12.4	17.4	20.8	36.3	27.0	12.2	11.3	10.3	15.8	7.6	7.1	8.9	8.1	8.1	8.9	8.6	8.8	5.0	8.5	8.0	8.6	14.9	7.6	8.7	7.8	6.9	4.2	20.0	20.0	28.3	23.8	18.9	21.7	19.4	18.4	23.5	16.4	20.8	13.0	17.1	20.7	54.0	26.0	12.5	10.2	9.4	14.8	8.7	15.7	15.8	10.0	14.8	27.7	20.4	12.4	0.0	12.2	12.8	21.0	19.3	25.5	16.6	12.0	27.0	20.7	13.5	16.1	36.8	15.0	18.8	13.5	14.4	13.2	15.4	20.6	17.5	15.6	14.7	27.7	25.8	24.0	36.7	40.5	54.3	19.1	26.7	10.1	28.1
SERPINI1	"neuroserpin, PI12"	ENSG00000163536	"Serpin family I member 1"	Q99574	3	167735243-167825568	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 96.0"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 71.8;Muller glia cells: 71.6;Smooth muscle cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 15.9;HeLa: 16.5;Karpas-707: 18.5;U-266/84: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001565, HPA056092"	Enhanced		Uncertain	Cytosol	"Secreted in brain"	NA	NA		200000	Cytosol		"HPA001565: AB_1079924, HPA056092: AB_2683036"	"unprognostic (1.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.11e-1)"	5.9	8.2	31.9	2.4	27.9	1.3	6.1	3.6	96.0	4.2	2.8	7.1	0.4	1.5	4.3	4.3	3.2	3.9	3.4	6.4	35.9	35.3	14.5	2.5	3.4	2.3	36.9	35.7	4.0	16.3	3.7	10.3	3.5	22.9	5.8	2.5	2.4	9.9	3.6	1.7	2.1	2.5	3.1	51.6	4.1	3.6	7.0	15.9	0.0	5.2	0.3	3.8	3.1	1.6	15.4	4.4	1.0	0.4	6.0	16.0	3.4	0.4	2.0	3.2	0.2	6.0	1.6	0.2	1.2	1.8	0.8	1.3	0.7	3.9	15.9	6.1	0.8	2.7	0.9	2.1	2.2	0.9	5.0	4.5	5.4	16.5	6.7	0.4	0.8	0.6	2.3	0.8	0.4	0.8	1.8	0.2	6.1	10.1	18.5	0.7	1.5	0.4	1.1	2.0	2.5	2.5	1.8	0.1	2.0	6.9	0.5	1.3	8.4	2.3	4.3	5.1	7.8	6.6	2.4	0.5	3.5	0.3	0.3	5.7	13.9	17.1	11.6	2.9	4.1	2.0	1.0	0.2	0.5	6.2	0.4	4.5	12.7	6.5	6.6	0.3	15.4	4.7	5.7	0.6	6.0	0.3	4.4	16.0	3.4	31.9	27.9	3.6	78.9	35.9	35.3	36.9	35.7	22.9	15.9	6.0	1.0	8.0	12.2	3.3	71.8	7.3	0.0	13.4	7.9	5.2	13.7	5.0	6.6	1.5	0.3	9.2	0.0	0.0	15.6	4.7	5.2	9.8	2.3	0.6	2.3	4.8	4.6	3.1	0.8	1.8	3.7	1.9	6.8	1.8	0.1	71.6	4.6	0.0	2.5	31.2	31.4	25.8	68.9	1.8	13.2	1.5	4.2	5.3	0.0	1.6
SETBP1	"KIAA0437, SEB"	ENSG00000152217	"SET binding protein 1"	Q9Y6X0	18	44680173-45068510	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Leydig cells: 58.1;Peritubular cells: 37.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.9;naive B-cell: 7.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"AF22: 9.5;Karpas-707: 37.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049022, HPA057259"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA049022: AB_2680602, HPA057259: AB_2683384"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.52e-2)"	"prognostic favorable (6.34e-8)"	"unprognostic (2.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (7.81e-5)"	10.6	2.9	3.8	13.2	8.7	2.1	9.8	16.0	12.6	16.9	14.6	4.2	19.9	2.5	14.0	17.5	6.6	11.0	7.9	6.8	3.6	3.5	15.0	7.2	9.8	7.0	2.9	7.4	12.8	8.2	9.1	5.1	10.2	3.2	12.2	5.3	14.0	6.9	21.3	14.5	6.6	6.9	19.9	3.7	5.9	9.1	5.5	1.2	3.4	8.4	8.7	8.8	11.9	13.3	7.5	4.3	0.2	1.6	0.0	0.6	0.2	0.0	1.7	9.5	0.0	2.7	0.7	0.6	0.8	1.7	0.9	0.7	0.1	0.0	0.5	0.3	1.0	0.5	2.8	1.0	3.0	0.6	0.8	0.5	0.0	1.0	0.6	0.0	0.0	0.0	2.3	1.1	0.0	1.8	1.6	0.3	0.0	0.0	37.9	0.2	0.5	0.0	0.0	1.3	0.0	0.6	3.1	0.0	3.3	3.2	2.2	4.8	2.5	0.0	0.0	0.5	4.5	1.3	0.0	0.0	5.6	2.1	0.0	4.4	5.0	0.3	0.0	3.4	0.1	3.2	0.2	0.0	0.0	0.6	1.1	0.0	4.9	0.1	0.5	0.1	7.5	0.0	0.2	0.0	0.0	1.6	4.3	0.0	0.2	3.8	8.7	16.0	12.6	3.6	3.5	2.9	7.4	3.2	1.2	0.0	2.6	26.0	8.5	13.7	11.5	3.6	10.2	2.7	3.4	15.7	17.7	1.3	3.3	4.1	0.9	9.5	0.4	0.0	2.9	1.2	27.4	6.4	0.0	13.5	1.6	3.2	11.5	12.3	1.6	1.8	58.1	2.7	3.3	0.0	2.5	9.1	3.3	8.4	37.4	6.8	19.3	6.5	30.7	0.0	0.1	13.2	0.7	4.9	4.6	1.0
SETD6	FLJ21148	ENSG00000103037	"SET domain containing 6"	Q8TBK2	16	58515479-58521181	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041481, HPA053546"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041481: AB_10804004, HPA053546: AB_2682182"	"unprognostic (1.32e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (3.74e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.73e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.55e-1)"	7.8	11.3	7.7	7.4	8.8	4.3	12.6	18.6	11.8	8.4	7.1	6.6	17.0	7.0	10.2	14.0	11.5	10.3	9.6	8.6	8.8	7.0	11.7	12.1	7.9	7.9	8.9	9.0	9.0	20.0	22.1	17.1	7.0	8.3	12.2	8.2	7.2	15.5	19.7	14.7	14.4	7.8	9.2	7.7	9.2	9.6	10.2	9.7	5.5	13.6	9.5	8.8	7.4	10.3	3.2	3.9	3.8	3.0	8.6	4.9	2.7	1.8	3.8	0.8	7.3	2.8	2.0	13.7	3.1	3.4	4.4	2.6	6.5	3.8	13.6	5.0	3.1	0.6	5.7	5.7	4.1	3.2	1.7	20.6	0.6	6.3	11.6	2.9	9.9	6.2	2.5	8.3	3.7	5.7	3.2	3.2	0.1	10.8	1.7	0.9	6.6	0.2	11.9	15.5	5.9	8.4	0.2	1.7	18.5	4.6	0.2	13.6	9.6	13.6	10.4	5.1	4.1	6.7	1.2	2.7	1.7	4.9	2.1	5.2	9.4	5.7	10.1	3.5	4.8	3.3	3.8	2.4	0.2	4.6	3.0	3.3	3.2	3.9	4.9	3.9	3.1	4.8	4.8	0.1	8.6	2.9	3.8	3.2	2.7	7.7	8.8	18.6	11.8	8.8	7.0	8.9	9.0	8.3	9.7	6.0	5.8	7.9	8.7	12.4	13.5	7.6	10.2	13.4	7.9	8.7	13.7	14.4	1.7	7.0	6.6	6.7	4.9	0.0	10.5	7.4	5.2	8.3	1.1	6.2	3.2	11.1	4.6	3.7	3.5	14.2	8.3	4.5	5.0	7.2	4.0	12.1	5.3	2.9	9.6	8.4	11.9	12.9	6.3	9.8	20.4	10.7	10.5	5.3	6.8	5.4
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186292	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 40.1"	"Cell type enhanced"	"Detected in some"	27	"Cytotrophoblasts: 5.4;Extravillous trophoblasts: 33.5;Hofbauer cells: 8.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Enhanced	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			Nucleoplasm	"Kinetochore, Cytosol"	"HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214"	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.6	0.6	0.4	9.1	0.4	8.9	1.0	0.4	1.5	0.9	3.4	0.3	0.6	2.7	0.8	0.5	4.0	0.3	1.7	0.4	0.3	0.4	0.8	1.0	0.9	6.9	0.4	0.1	0.5	0.5	0.0	0.4	3.7	0.2	0.6	3.5	0.1	1.0	0.1	0.3	1.1	3.4	0.8	0.4	4.9	1.5	8.6	0.2	40.1	0.5	2.4	7.4	1.2	1.5	9.0	4.5	8.3	0.2	0.3	2.7	0.6	9.5	10.9	14.9	9.1	0.7	1.3	10.1	10.3	5.3	15.0	16.5	7.7	11.8	14.6	5.2	4.2	10.6	5.6	14.0	5.7	19.0	18.6	9.3	16.6	7.5	6.1	0.1	15.1	14.3	0.1	0.4	16.5	7.0	2.1	8.9	17.4	14.2	26.2	12.4	9.4	23.7	8.5	15.8	10.2	8.3	15.2	19.1	8.5	3.8	7.0	7.4	7.8	11.4	14.1	6.8	11.6	9.1	10.6	2.4	11.4	13.7	10.2	20.5	11.3	26.2	17.0	6.2	15.3	17.1	8.3	0.1	1.5	0.3	0.2	0.1	8.6	0.7	0.8	0.4	9.0	0.2	0.4	1.6	0.3	0.2	4.5	2.7	0.6	0.4	0.4	0.4	1.5	0.3	0.4	0.4	0.1	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	5.4	0.0	1.1	0.0	0.0	0.0	0.0	1.6	33.5	0.0	0.0	1.1	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
SHD		ENSG00000105251	"Src homology 2 domain containing transforming protein D"	Q96IW2	19	4278601-4290724	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"blood: 14.8;brain: 23.1;heart muscle: 17.3"	"Group enriched"	"Detected in some"	5	"Enterocytes: 82.3;Hepatocytes: 45.0;Mucus-secreting cells: 54.3;Paneth cells: 66.4;Undifferentiated cells: 41.3"	"Cancer enhanced"	"Detected in some"		"glioma: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	148	"plasmacytoid DC: 14.8"	"Lineage enriched"	"Detected in single"	148	"dendritic cells: 14.8"	"Group enriched"	"Detected in some"	46	"RH-30: 19.2;SH-SY5Y: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017955	Uncertain		Uncertain	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA017955: AB_1856828"	"unprognostic (2.41e-3)"	"unprognostic (7.68e-3)"	"unprognostic (4.77e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.93e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.69e-2)"	"unprognostic (8.16e-4)"	0.5	0.7	4.0	1.4	2.5	1.2	0.4	4.1	23.1	0.4	0.9	2.4	0.0	0.7	0.4	0.4	0.4	0.4	0.6	17.3	3.3	4.5	0.4	1.7	0.5	1.2	4.7	2.3	0.4	0.5	0.4	0.2	0.4	6.1	0.5	0.7	0.0	0.5	0.4	0.8	0.4	0.6	0.4	2.5	0.6	0.4	0.5	1.1	0.0	0.4	0.0	0.8	0.5	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.1	62.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	4.0	2.5	4.1	20.4	3.3	4.5	4.7	2.3	6.1	1.1	0.0	0.0	0.0	0.0	0.0	1.3	7.5	0.0	0.0	0.0	0.0	0.0	1.4	1.7	0.0	0.1	0.0	82.3	0.0	0.0	0.4	0.0	0.0	9.2	45.0	0.3	9.5	12.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	54.3	0.4	0.0	66.4	0.0	0.0	0.2	0.0	0.0	0.0	2.7	0.0	3.7	0.0	41.3	0.0
SIGLEC8	"MGC59785, SAF2, SIGLEC-8, SIGLEC8L"	ENSG00000105366	"Sialic acid binding Ig like lectin 8"	Q9NYZ4	19	51450847-51458456	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 63.0"	"Cell type enriched"	"Detected in some"	4	"granulocytes: 42.8"	"Cancer enhanced"	"Detected in many"		"glioma: 7.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	42	"eosinophil: 63.0"	"Lineage enriched"	"Detected in single"	623	"granulocytes: 63.0"	"Cell line enriched"	"Detected in some"	45	"HMC-1: 58.8"									HPA012556	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA012556: AB_1856869"	"unprognostic (1.27e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.19e-1)"	"unprognostic (8.62e-3)"	"unprognostic (7.18e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.29e-1)"	0.6	6.7	5.8	2.4	8.4	0.7	2.3	0.7	7.0	1.4	2.9	7.4	0.0	2.9	1.0	1.1	1.1	1.1	2.7	0.3	8.6	4.8	0.4	1.6	4.1	9.6	8.3	3.6	0.3	0.7	0.7	1.2	0.1	7.5	1.0	2.8	0.1	1.1	0.9	0.3	0.8	4.5	1.5	14.8	9.2	2.1	0.5	6.2	0.6	0.7	0.0	4.1	2.0	0.7	0.0	0.0	63.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	58.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.5	0.1	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.8	8.4	0.7	5.6	8.6	4.8	8.3	3.6	7.5	6.2	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	42.8	0.0	0.3	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SKIDA1	"C10orf140, FLJ45187"	ENSG00000180592	"SKI/DACH domain containing 1"		10	21513478-21526368	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"thyroid gland: 9.6"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 13.7;Early spermatids: 13.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 23.1;AN3-CA: 5.9;BEWO: 10.7;SH-SY5Y: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039208, HPA040439"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA039208: AB_10795034, HPA040439: AB_10796122"	"unprognostic (5.36e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.45e-4)"	"unprognostic (9.97e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.23e-1)"	"unprognostic (9.35e-3)"	"unprognostic (5.93e-2)"	"unprognostic (3.38e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.20e-2)"	"unprognostic (8.52e-3)"	0.9	1.9	1.9	0.4	3.3	1.7	2.2	3.1	5.9	1.3	1.7	0.0	0.0	0.3	1.0	1.0	0.9	1.7	0.6	5.5	2.5	1.8	4.1	4.3	1.0	0.3	1.4	3.4	4.2	1.5	7.3	1.8	2.5	3.0	1.1	0.6	4.1	2.6	2.0	0.5	2.9	0.5	1.0	1.2	0.4	0.6	4.6	0.3	0.9	9.6	0.7	0.3	1.1	1.1	0.6	0.5	1.5	0.6	0.5	0.3	0.1	0.4	1.0	23.1	5.9	0.5	0.2	10.7	0.5	0.3	0.0	0.0	2.1	0.1	0.2	0.9	0.3	0.1	1.4	2.1	0.4	0.0	0.0	2.6	0.1	1.0	0.2	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.7	0.2	0.4	0.1	0.2	0.1	0.9	0.7	0.1	1.4	0.0	0.0	0.3	0.7	0.0	0.4	0.6	2.5	5.3	0.8	4.0	0.1	2.0	0.4	4.6	0.3	0.2	0.7	0.2	0.5	0.1	0.0	0.3	1.4	0.0	0.2	1.5	0.3	0.5	0.2	0.3	0.3	0.3	0.2	0.2	0.3	0.6	0.3	0.3	1.3	0.5	0.6	0.5	0.2	0.1	1.9	3.3	3.1	5.9	2.5	1.8	1.4	3.4	3.0	0.3	0.0	1.0	0.0	0.8	1.3	13.7	5.2	5.1	0.0	2.3	1.8	0.0	4.6	6.6	0.1	13.5	3.5	0.0	0.0	0.6	3.1	1.7	0.6	1.1	8.9	2.4	1.6	0.0	3.1	1.5	6.6	1.4	0.0	0.0	0.0	0.0	6.8	0.5	0.0	2.1	5.1	4.0	6.5	0.6	4.8	3.2	1.6	2.9	0.0	0.0	0.2
SLC12A7	"DKFZP434F076, KCC4"	ENSG00000113504	"Solute carrier family 12 member 7"	Q9Y666	5	1050376-1112035	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Horizontal cells: 265.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 25.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041652	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA041652: AB_10793971"	"unprognostic (2.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.72e-2)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.93e-2)"	"prognostic favorable (3.16e-5)"	10.1	6.4	5.7	14.1	7.3	4.3	13.0	2.4	8.3	6.5	11.5	5.6	6.6	28.0	7.2	7.6	4.7	8.9	29.4	27.9	6.1	3.8	20.4	31.3	10.0	10.3	5.8	3.2	8.5	12.4	8.2	11.5	3.8	7.9	10.2	7.0	15.5	10.9	8.7	3.2	7.9	20.3	8.2	4.9	17.9	15.2	14.5	7.4	12.2	13.3	5.5	6.9	7.1	34.5	1.4	4.2	0.5	6.9	2.5	2.7	2.2	2.1	6.0	3.3	10.4	0.5	0.5	5.2	0.1	0.7	0.5	0.0	14.3	3.8	0.0	11.8	0.2	4.1	4.4	2.7	3.6	0.0	13.0	3.6	2.8	7.5	4.9	7.6	0.0	6.3	1.1	0.5	0.0	1.1	0.2	3.3	1.3	4.0	0.1	0.0	6.9	8.4	0.0	7.2	8.4	9.6	25.3	14.4	11.8	4.0	8.7	1.8	2.3	3.2	0.0	3.6	2.1	5.8	1.6	2.8	0.0	3.4	0.0	0.0	0.2	0.0	1.4	0.0	0.4	1.7	0.5	3.4	0.0	2.5	5.4	2.6	1.1	2.4	2.7	4.2	1.4	2.5	2.5	0.0	2.5	6.9	1.8	2.4	2.2	5.7	7.3	2.4	8.3	6.1	3.8	5.8	3.2	7.9	7.4	8.9	17.5	5.4	5.2	6.3	17.7	32.1	40.8	10.7	14.8	27.9	2.0	0.2	1.7	23.0	0.3	14.9	28.8	0.0	15.7	0.3	7.3	14.6	8.1	29.2	15.8	265.4	12.7	9.2	20.4	1.3	3.4	12.2	15.1	1.8	16.5	6.6	28.0	17.5	5.3	26.1	2.9	19.4	7.2	0.7	4.5	5.9	0.2	3.3	14.2	13.2
SLC25A12	Aralar	ENSG00000115840	"Solute carrier family 25 member 12"	O75746	2	171784370-171999859	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.7"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035333, HPA035334"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA035333: AB_10603028, HPA035334: AB_2674577"	"unprognostic (3.24e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (2.65e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.21e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.91e-8)"	"unprognostic (8.64e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	6.4	6.7	8.8	6.2	18.2	2.9	9.2	17.9	25.0	10.6	12.2	5.7	5.2	4.2	10.4	7.1	11.5	6.9	5.9	42.4	9.9	13.4	10.7	1.9	5.2	6.5	10.4	12.4	10.0	3.5	16.4	14.7	4.7	15.2	10.6	10.0	11.0	21.7	14.8	84.7	7.6	5.7	14.3	7.1	5.6	9.0	4.3	6.2	5.8	10.1	23.8	8.4	10.0	6.7	6.4	3.6	5.1	4.6	6.6	8.1	2.9	7.2	5.3	5.6	13.0	16.7	18.9	0.1	9.2	15.7	12.6	12.1	2.8	6.8	22.9	6.1	10.8	9.8	9.1	11.8	11.6	15.8	14.0	11.1	10.0	7.7	6.7	6.4	20.0	10.0	16.5	11.5	14.6	4.2	6.8	13.0	9.1	6.9	10.5	8.0	4.4	14.1	8.4	4.5	6.1	7.5	14.7	8.1	11.9	13.2	6.3	7.9	2.5	5.8	13.7	7.3	3.8	5.0	5.9	8.9	10.5	4.6	11.6	6.3	14.2	9.1	23.2	14.5	10.6	7.1	5.1	3.0	1.6	6.5	3.9	7.3	6.4	4.5	6.8	3.6	3.9	6.3	8.1	0.2	6.6	4.6	0.6	4.5	2.9	8.8	18.2	17.9	25.0	9.9	13.4	10.4	12.4	15.2	6.2	0.0	6.0	1.5	11.2	6.2	25.4	94.4	0.0	13.4	22.7	17.4	23.6	6.0	16.6	1.5	2.5	7.0	5.6	23.3	2.9	1.2	7.0	4.3	10.4	0.2	4.0	35.0	13.8	8.6	7.3	1.7	11.5	5.4	15.1	6.4	7.0	18.3	1.3	3.5	23.0	10.9	22.1	12.9	11.8	3.2	9.0	6.8	1.0	8.7	7.4	4.6
SLC25A20	"CAC, CACT"	ENSG00000178537	"Solute carrier family 25 member 20"	O43772	3	48856931-48898993	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 57.8;liver: 58.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 38.0;Hepatocytes: 55.2;monocytes: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 35.4;RPMI-8226: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016862, HPA029863"	Approved		Approved	Mitochondria,Cytosol		NA	NA		13000	"Mitochondria, Cytosol"		"HPA016862: AB_1857028, HPA029863: AB_10602893"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (3.49e-2)"	11.9	13.7	6.7	5.6	7.3	3.4	10.2	3.0	5.6	3.3	19.7	4.7	5.2	25.0	4.7	3.1	3.3	5.0	9.9	37.1	7.3	4.6	16.8	58.3	6.6	4.9	8.5	5.1	2.7	16.8	5.9	5.1	3.3	5.8	5.0	9.1	5.4	7.4	3.7	27.4	4.0	32.2	5.7	5.5	8.8	7.5	4.4	6.6	9.1	5.5	5.5	5.9	4.5	9.8	9.4	33.3	57.8	29.0	17.3	28.4	24.7	1.4	4.5	3.6	5.0	11.5	4.4	0.7	8.0	4.3	5.6	5.8	5.6	6.9	6.6	5.7	12.6	6.8	1.4	8.8	3.5	4.2	16.8	4.2	9.2	7.0	7.1	5.2	9.6	17.8	5.6	4.0	7.5	1.2	2.2	7.2	10.1	8.2	35.4	7.3	3.7	10.5	4.8	1.8	8.1	10.2	3.8	2.1	48.7	6.0	3.5	1.4	5.1	7.4	0.0	4.0	5.2	11.3	4.5	5.8	6.4	1.1	9.3	5.8	13.1	9.1	7.7	9.1	6.8	8.4	13.8	29.0	57.8	28.4	21.0	18.1	9.4	16.1	20.8	27.0	7.8	12.7	21.3	13.5	17.3	21.4	33.3	16.1	24.7	6.7	7.3	3.0	5.6	7.3	4.6	8.5	5.1	5.8	6.6	6.0	2.4	7.5	2.3	1.5	1.1	31.1	7.6	5.3	2.3	0.0	5.9	1.7	3.3	3.2	1.1	3.1	38.0	0.0	3.7	1.9	4.1	2.4	1.1	55.2	15.8	0.0	7.0	9.2	13.2	1.0	9.8	7.5	1.7	40.5	10.8	2.8	4.0	13.5	11.7	12.5	1.1	0.0	2.2	7.1	7.0	1.1	1.0	13.8	12.8	2.0
SLC26A6	DKFZp586E1422	ENSG00000225697	"Solute carrier family 26 member 6"	Q9BXS9	3	48625723-48635493	"Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 43.3;Mucus-secreting cells: 32.0;Paneth cells: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048363	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA048363: AB_2680371"	"unprognostic (1.54e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.09e-1)"	"unprognostic (9.66e-3)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.58e-2)"	5.3	5.7	6.4	12.3	9.8	18.8	5.7	6.8	6.9	6.3	24.8	6.0	7.3	9.7	6.8	7.4	6.5	4.7	6.3	6.7	4.9	3.1	13.6	6.2	7.8	7.4	9.4	3.1	6.7	14.9	6.8	5.8	6.5	9.3	10.2	25.4	7.7	9.6	7.4	8.8	6.7	19.5	6.8	4.8	10.6	19.7	7.7	9.9	7.7	5.5	5.4	6.3	5.1	6.6	0.9	8.8	5.2	10.7	0.5	3.3	4.5	4.5	5.1	7.3	8.2	23.1	11.6	6.2	7.5	9.9	14.6	15.7	9.7	4.2	6.5	2.6	6.4	16.2	6.1	6.8	6.9	4.2	4.8	6.8	5.9	14.5	18.7	16.8	2.8	9.2	15.8	24.8	9.9	7.2	12.6	4.5	6.7	4.5	7.4	3.5	5.4	5.4	14.8	10.4	12.5	9.9	2.8	2.7	7.9	10.7	4.5	1.8	3.5	9.8	12.1	14.1	10.6	6.3	10.5	3.6	6.3	5.3	8.5	17.1	8.8	9.2	2.9	5.3	11.1	15.9	5.2	10.7	2.1	3.1	10.0	2.8	0.9	1.9	2.0	8.8	0.2	1.1	1.6	1.5	0.5	8.9	5.0	3.3	4.5	6.4	9.8	6.8	6.9	4.9	3.1	9.4	3.1	9.3	9.9	3.0	5.1	0.8	2.4	2.9	1.5	6.4	2.5	2.7	1.2	1.8	13.7	7.5	0.0	2.5	1.2	2.9	43.3	0.0	5.6	13.1	4.3	1.9	0.0	4.2	6.2	4.8	19.5	5.5	5.2	0.7	3.4	7.0	5.0	4.6	32.0	2.0	5.2	36.6	8.9	5.1	6.4	0.0	5.7	2.5	5.7	3.0	8.8	3.8	23.5	0.8
SLC28A1	CNT1	ENSG00000156222	"Solute carrier family 28 member 1"	O00337	15	84884654-84945796	"Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"intestine: 32.7;kidney: 35.6;liver: 43.8"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 34.1;Hofbauer cells: 40.6;Proximal tubular cells: 88.5"	"Group enriched"	"Detected in some"	63	"liver cancer: 10.9;renal cancer: 33.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 2.0;Karpas-707: 1.1;RPMI-8226: 1.6;SK-BR-3: 1.8;SuSa: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019551, HPA056247"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nuclear speckles, Cytosol"	"HPA019551: AB_2670187, HPA056247: "	"unprognostic (3.81e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.42e-2)"	"unprognostic (7.72e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	5.0	0.1	0.1	17.3	0.1	1.5	0.1	0.1	0.1	0.5	0.1	0.1	35.6	43.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	32.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.5	0.3	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.1	0.4	0.1	1.8	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	7.6	1.4	0.0	7.0	0.0	0.4	10.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	34.1	40.6	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	88.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"kidney: 94.5"	"Cell type enriched"	"Detected in some"	16	"Proximal tubular cells: 128.7"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Group enriched"	"Detected in some"	12	"HEL: 6.7;U-937: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA			"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	7.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
SLC39A6	LIV-1	ENSG00000141424	"Solute carrier family 39 member 6"	Q13433	18	36108532-36129385	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 212.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 361.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042377	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA042377: AB_2677968"	"unprognostic (7.60e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.50e-2)"	"unprognostic (7.63e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	11.1	12.6	14.3	8.6	13.4	4.3	63.5	19.4	14.7	15.7	8.7	16.0	68.7	4.1	24.7	24.5	9.8	27.7	10.3	8.2	14.2	17.5	12.3	7.7	7.9	8.2	18.3	8.7	30.5	15.5	32.1	23.9	52.5	16.0	55.2	5.9	25.1	15.5	51.5	7.7	22.6	5.7	12.7	21.7	11.2	8.1	9.9	13.5	8.0	15.7	10.7	11.3	23.8	20.2	12.6	25.2	22.2	14.6	12.9	15.6	9.7	10.4	13.2	31.7	18.6	33.5	24.8	8.3	28.5	33.8	19.1	22.5	7.3	11.6	11.3	14.4	27.4	13.3	25.5	27.6	26.7	29.1	25.1	10.0	4.9	18.6	10.6	21.3	16.5	12.4	22.6	59.1	29.0	25.3	17.6	2.8	9.4	2.5	22.8	26.8	16.0	16.2	3.7	7.6	5.7	7.5	16.8	18.1	14.8	21.3	35.2	33.4	29.4	35.1	10.3	48.1	13.6	14.0	7.8	4.6	46.7	7.8	8.8	14.3	21.5	20.8	8.6	16.1	11.7	24.5	19.5	9.8	22.2	13.0	14.6	15.6	12.6	11.1	11.5	12.2	12.3	9.8	14.2	7.5	12.9	13.7	25.2	12.2	9.7	14.3	13.4	19.4	12.4	14.2	17.5	18.3	8.7	16.0	13.5	35.7	16.0	13.7	44.4	40.8	40.2	16.6	10.2	42.8	60.3	40.1	31.4	5.4	1.7	46.8	16.8	10.8	2.8	0.0	32.7	50.5	40.3	212.3	23.1	7.9	18.4	22.3	24.5	7.4	15.6	14.6	34.5	25.1	64.1	24.4	6.7	35.8	34.0	0.0	44.9	13.9	25.8	38.8	37.6	43.4	22.9	65.1	19.9	16.0	4.1	55.4
SLC40A1	"FPN1, HFE4, IREG1, MTP1, SLC11A3"	ENSG00000138449	"Solute carrier family 40 member 1"	Q9NP59	2	189560579-189583758	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 126.4;lymphoid tissue: 170.2"	"Group enriched"	"Detected in many"	5	"Kupffer cells: 1044.2;Syncytiotrophoblasts: 2060.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 64.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.2;CACO-2: 21.3;HEL: 75.5;HMC-1: 19.9;T-47d: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065634	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA065634: AB_2685524"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.44e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (4.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.11e-2)"	18.2	126.4	3.9	10.1	5.5	3.9	47.4	1.8	3.5	20.0	25.7	3.7	13.9	34.4	24.7	24.3	6.3	25.9	25.2	37.1	4.1	4.3	14.4	42.1	45.9	170.2	5.1	1.9	50.9	24.0	4.6	9.8	51.3	6.4	18.4	15.8	11.6	10.2	16.6	12.3	4.9	44.7	13.6	5.8	76.4	11.3	16.2	3.5	17.0	20.8	6.4	8.8	11.1	20.4	0.1	22.7	64.7	20.8	0.8	17.3	20.1	0.0	1.3	0.1	0.0	93.2	0.6	4.5	0.0	1.1	0.3	0.5	21.3	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.3	75.5	0.3	7.8	0.3	0.2	19.9	6.5	0.0	0.2	0.0	2.1	2.2	2.9	7.7	0.2	1.1	0.0	3.1	4.9	0.2	16.0	0.3	0.0	0.8	0.4	0.9	3.1	0.1	0.9	0.1	6.2	0.0	7.4	36.8	1.1	0.0	0.1	2.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.3	20.8	32.9	0.4	4.7	0.6	0.0	11.3	1.0	22.7	0.1	17.3	3.7	64.7	0.8	0.4	3.7	1.0	20.1	3.9	5.5	1.8	3.5	4.1	4.3	5.1	1.9	6.4	3.5	116.1	32.3	28.1	45.3	8.1	3.7	37.5	142.7	53.5	39.8	31.4	3.9	335.3	41.4	23.9	6.9	30.8	119.4	70.0	64.9	10.7	46.3	32.2	9.2	223.5	72.3	6.4	17.9	211.8	1044.2	4.7	112.2	26.2	8.5	1.8	50.3	9.6	51.2	77.2	55.2	100.1	43.2	64.7	18.1	5.0	0.9	7.0	2060.1	8.4	30.8	19.7
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043032-32113029	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 274.9"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 111.5;Cholangiocytes: 117.2;Early spermatids: 40.8;Late spermatids: 54.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"OE19: 27.0"	"Region enriched"	"Detected in single"	26	"cerebellum: 8.6"	"Not detected"	"Not detected"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Nuclear membrane, Cytosol"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favorable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.2	0.0	0.2	1.3	0.2	0.0	1.5	0.2	0.2	2.2	181.5	0.2	2.9	95.5	0.3	0.8	1.9	0.0	14.1	24.5	0.2	0.0	1.0	0.9	0.3	0.2	0.2	0.2	0.2	0.4	0.0	1.0	0.2	0.2	0.8	1.6	0.2	5.7	3.5	0.2	4.6	274.9	0.2	0.2	0.7	1.2	0.8	0.2	0.2	0.2	3.5	1.5	0.2	2.0	0.3	0.1	0.6	0.8	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	27.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.6	0.3	0.8	0.1	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	1.8	0.6	0.0	111.5	117.2	0.0	4.5	0.0	0.0	0.0	0.0	2.4	40.8	0.0	26.1	0.0	1.2	0.0	0.2	19.7	0.0	0.0	0.0	0.0	24.5	0.0	0.0	54.9	1.1	0.0	0.0	0.0	8.7	0.0	0.6	14.7	1.4	1.9	0.0	0.0	0.0	4.2	0.5	4.8	0.0	0.0	19.6	4.8
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 77.6;retina: 95.9"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 261.2"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 10.0;SuSa: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.6	0.5	3.0	0.4	5.8	0.5	0.5	2.1	5.8	0.5	0.5	2.5	0.0	1.8	0.5	0.9	0.4	4.2	0.5	1.0	3.1	2.4	77.6	13.2	0.9	0.5	3.4	4.1	0.5	0.4	0.4	1.0	0.5	4.8	0.5	0.5	95.9	0.5	0.5	0.6	0.6	0.8	0.4	5.7	0.5	0.5	1.1	2.1	0.0	4.9	0.0	0.5	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	1.3	0.2	0.1	0.0	0.0	0.3	0.0	0.5	0.4	0.4	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	10.0	0.1	0.1	0.0	0.1	0.0	0.9	3.7	0.0	0.0	0.3	0.2	1.0	0.0	0.4	1.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.3	3.0	5.8	2.1	5.8	3.1	2.4	3.4	4.1	4.8	2.1	0.0	1.1	0.5	0.0	0.0	0.2	1.3	0.0	1.4	0.0	17.4	2.0	0.0	41.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.7	0.0	0.0	0.0	0.6	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	261.2	0.8	0.0	0.0	0.5	0.5	0.0	0.2	0.0	0.0	0.0
SLC9A5	NHE5	ENSG00000135740	"Solute carrier family 9 member A5"	Q14940	16	67237683-67272190	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.5;lymphoid tissue: 14.5"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041004, HPA041329"	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA041004: AB_10794433, HPA041329: AB_10794373"	"unprognostic (8.90e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (9.85e-11)"	"unprognostic (9.21e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.07e-2)"	1.7	1.7	2.9	1.1	8.8	0.5	1.1	13.5	8.6	0.9	1.4	0.5	3.6	1.3	1.1	3.2	0.6	0.6	1.9	2.3	2.9	3.6	1.1	0.6	2.9	2.1	2.1	2.3	1.4	1.5	0.5	0.6	1.7	4.3	1.0	1.1	0.5	1.0	2.5	1.7	4.2	0.9	0.6	2.7	14.5	0.8	3.3	1.2	0.0	1.0	0.0	1.3	1.6	0.4	1.5	0.8	1.0	0.5	0.6	0.9	0.1	0.5	4.1	3.7	1.2	6.8	4.7	0.4	1.3	5.8	3.4	3.1	0.2	2.9	0.0	0.8	1.6	1.7	0.2	1.0	0.7	1.3	1.2	1.2	3.2	0.3	0.9	0.8	1.4	6.7	5.3	1.4	1.9	0.4	6.3	0.7	1.2	0.7	1.9	2.2	2.3	0.1	0.3	2.5	0.2	0.4	0.0	0.8	0.9	0.6	0.7	2.1	0.9	3.5	0.2	1.8	0.9	1.4	0.3	1.0	8.8	1.4	1.6	0.6	3.6	0.9	1.8	6.3	0.7	2.2	0.0	0.4	0.0	0.0	0.0	0.6	1.5	0.4	0.9	0.1	0.0	0.4	0.4	1.0	0.6	0.5	0.8	0.0	0.1	2.9	8.8	13.5	8.6	2.9	3.6	2.1	2.3	4.3	1.2	3.0	3.2	0.0	0.1	0.6	1.9	1.2	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.1	0.6	0.4	0.0	0.0	0.1	15.9	1.2	2.5	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.3	0.4	0.0	2.1	0.0	0.6	0.0	0.7	1.7	1.1	0.6	0.0	0.0	0.2	0.1
SLFN11	FLJ34922	ENSG00000172716	"Schlafen family member 11"	Q7Z7L1	17	35350305-35373701	"Predicted intracellular proteins"	"Antiviral defense, DNA damage, Immunity"	"Helicase, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Fibroblasts: 26.8;Hofbauer cells: 27.4;Kupffer cells: 33.5;Macrophages: 35.9;Smooth muscle cells: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 32.5"									"HPA023030, HPA062062"	Uncertain		Supported	Nucleoplasm,Cytosol		No	NA			Nucleoplasm	Cytosol	"HPA023030: AB_1856613, HPA062062: AB_2684673"	"unprognostic (1.93e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (9.93e-10)"	"unprognostic (1.65e-1)"	"unprognostic (5.71e-3)"	"unprognostic (6.33e-2)"	"unprognostic (8.81e-3)"	20.9	5.3	5.4	10.3	10.0	6.0	24.1	3.2	5.2	15.5	7.3	4.8	10.3	3.0	12.2	24.6	8.1	15.0	9.9	12.6	6.6	2.8	5.5	3.5	20.4	10.4	6.9	2.2	21.3	4.4	2.1	5.0	5.4	8.9	7.8	6.1	8.9	8.3	9.6	6.0	4.1	10.1	10.3	6.7	17.5	6.1	4.2	7.3	18.3	19.0	4.6	12.9	10.9	17.7	3.1	13.0	1.4	18.3	2.0	6.0	5.2	8.1	7.3	0.0	0.0	7.5	21.7	0.1	10.1	7.3	17.5	30.7	0.0	0.0	0.0	0.1	13.2	5.5	4.0	22.7	0.0	21.3	4.6	27.2	17.7	0.0	0.0	9.9	22.8	0.0	8.8	0.2	19.5	0.0	0.0	28.6	13.5	0.0	0.0	2.9	0.0	32.5	18.5	0.1	0.0	0.0	27.6	21.4	0.0	0.2	3.9	0.0	0.0	0.0	3.8	0.0	0.0	6.0	16.5	14.8	4.8	0.1	18.1	15.1	0.7	0.2	0.0	3.6	19.9	10.3	0.4	11.8	1.4	4.3	18.3	6.0	3.1	2.7	3.9	9.2	1.3	2.1	2.9	1.3	2.0	11.4	13.0	3.9	5.2	5.4	10.0	3.2	5.2	6.6	2.8	6.9	2.2	8.9	7.3	0.0	6.9	9.1	0.7	6.6	0.0	2.5	0.0	16.0	3.4	1.8	0.0	0.7	0.0	0.0	1.2	16.1	0.0	0.0	0.5	0.6	26.8	1.1	3.5	0.0	27.4	0.0	0.0	10.4	33.5	1.1	9.5	35.9	11.8	1.0	0.0	0.1	0.1	0.2	2.8	0.0	0.0	6.5	27.9	0.0	0.0	7.4	0.7	20.3	0.0	0.6
SLX4	"BTBD12, FANCP, KIAA1784, KIAA1987"	ENSG00000188827	"SLX4 structure-specific endonuclease subunit"	Q8IY92	16	3581181-3611598	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"		"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 19.9;testis: 25.0"	"Cell type enhanced"	"Detected in many"	8	"Rod photoreceptor cells: 10.9;Spermatocytes: 18.6;Spermatogonia: 10.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049421, HPA066238"	Approved		Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			Nucleoplasm	"Cell Junctions, Cytosol"	"HPA049421: AB_2680759, HPA066238: AB_2685642"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.28e-5)"	"unprognostic (6.52e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.74e-2)"	2.9	3.1	5.3	6.1	8.5	6.0	2.4	19.9	11.8	2.5	2.9	9.8	2.5	4.9	6.5	3.3	3.4	3.0	2.8	2.2	7.4	4.3	2.9	2.7	3.0	8.6	3.8	8.1	2.7	3.1	3.7	8.6	2.6	7.4	3.3	2.2	5.4	3.0	2.6	5.5	4.2	4.0	3.1	3.3	4.8	3.7	25.0	3.2	5.8	2.6	1.0	6.5	3.1	2.7	0.6	0.2	3.0	1.1	0.6	0.6	0.7	3.0	9.3	6.1	7.5	2.3	2.4	6.3	4.8	2.4	5.6	6.2	4.6	3.7	10.9	4.8	2.4	4.3	6.7	4.1	3.4	3.3	9.1	5.1	7.5	6.7	2.9	2.0	7.2	10.6	1.8	2.5	5.2	2.9	1.4	4.0	6.2	7.1	6.0	4.4	5.1	4.4	6.3	5.0	1.8	3.5	8.9	10.0	3.0	2.2	2.1	5.2	4.6	4.2	3.0	1.5	3.3	7.3	5.7	4.7	6.5	9.0	5.5	5.6	5.4	4.2	12.8	2.1	7.4	6.3	3.0	0.4	0.0	0.6	0.5	0.4	0.3	0.3	0.3	0.2	0.6	0.3	0.5	0.5	0.6	1.1	0.2	0.3	0.7	5.3	8.5	19.9	11.8	7.4	4.3	3.8	8.1	7.4	3.2	0.0	2.9	4.5	0.8	0.7	7.7	1.4	2.5	2.7	4.5	0.0	2.0	1.3	0.0	1.4	3.5	1.1	1.5	0.0	2.1	1.5	1.5	0.4	0.0	0.9	2.3	0.0	0.0	1.8	1.6	1.6	2.0	3.2	0.0	1.0	2.2	1.7	1.6	0.0	1.8	0.4	10.9	0.0	1.8	18.6	10.0	0.5	0.8	3.5	1.7	0.5
SMPD4	"FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3"	ENSG00000136699	"Sphingomyelin phosphodiesterase 4"	Q9NXE4	2	130151392-130182750	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046279, HPA049426"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane"	Cytosol	"HPA046279: AB_2679611, HPA049426: AB_2680762"	"unprognostic (5.02e-2)"	"unprognostic (9.61e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.69e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (3.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.73e-4)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.09e-1)"	13.2	16.1	12.4	17.1	20.7	39.1	14.8	22.1	25.1	19.9	15.8	31.4	15.3	15.5	22.5	14.1	19.3	19.5	12.7	13.4	13.2	16.0	14.3	18.5	14.7	20.5	21.3	12.2	22.2	22.2	24.1	31.2	24.3	19.5	16.3	16.7	17.7	17.1	15.2	17.0	17.5	15.2	18.3	16.0	16.4	14.5	23.6	21.6	27.9	22.8	19.6	27.1	16.9	16.6	10.5	9.8	14.5	11.4	11.7	15.2	9.7	32.0	15.8	20.0	14.8	10.3	7.6	26.1	17.1	12.7	25.2	21.1	45.8	16.5	20.9	15.2	17.1	14.4	18.2	25.5	22.6	17.5	27.7	24.7	23.5	17.0	36.3	8.8	26.2	15.0	8.8	15.2	28.3	11.3	9.3	14.5	20.9	29.2	17.0	14.1	17.3	27.4	13.2	30.7	13.7	21.1	29.1	15.2	22.7	10.7	15.2	27.8	15.6	16.8	20.6	7.5	11.6	14.0	11.5	11.2	21.6	21.0	14.1	20.0	14.8	16.6	28.1	19.5	15.0	15.3	1.8	9.3	14.5	13.9	11.4	15.2	9.5	10.4	12.4	9.8	10.5	10.2	11.4	4.5	11.7	8.0	6.4	9.4	9.7	12.4	20.7	22.1	25.1	13.2	16.0	21.3	12.2	19.5	21.6	3.0	9.9	10.2	9.1	13.4	20.0	3.2	5.1	6.7	6.8	7.0	11.8	19.8	8.3	8.1	17.4	7.4	7.1	0.0	10.5	21.1	10.3	8.6	5.8	13.5	12.1	14.3	12.6	9.8	9.4	32.6	13.6	6.5	15.1	5.4	12.5	7.8	11.0	9.1	17.3	5.6	15.1	0.0	8.0	24.0	22.0	18.1	13.0	12.8	12.1	7.9
SNAP91	"AP180, CALM, KIAA0656"	ENSG00000065609	"Synaptosome associated protein 91"	O60641	6	83552880-83709691	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 81.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 46.7;Cone photoreceptor cells: 58.9;Early spermatids: 16.0;Horizontal cells: 30.2;Rod photoreceptor cells: 59.2;Spermatocytes: 25.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 6.3"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 6.3"	"Group enriched"	"Detected in some"	11	"GAMG: 6.7;SCLC-21H: 21.5;SH-SY5Y: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009745, HPA029632, HPA029633"	Enhanced		Uncertain	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615"	"unprognostic (1.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.55e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.42e-1)"		"unprognostic (2.56e-2)"		"unprognostic (1.17e-1)"	"unprognostic (4.54e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	1.2	8.0	17.8	1.9	25.5	1.1	1.7	44.2	81.9	2.1	1.7	3.4	0.0	1.4	1.7	1.2	1.3	1.8	2.0	1.3	19.2	19.9	1.2	1.1	1.4	3.3	14.3	20.5	3.1	2.4	1.1	9.3	1.6	34.7	3.9	1.7	4.5	1.6	1.7	1.2	1.3	1.7	1.8	7.0	2.2	1.9	10.8	2.9	0.0	2.0	0.0	2.7	1.3	0.2	0.0	6.3	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	6.7	0.3	0.9	0.0	0.0	0.3	1.3	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.1	0.2	21.5	13.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	17.8	25.5	44.2	43.6	19.2	19.9	14.3	20.5	34.7	2.9	0.0	0.0	0.0	0.0	0.0	46.7	0.8	0.0	0.0	0.0	0.0	58.9	1.0	0.0	0.0	16.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	30.2	0.0	0.0	0.0	9.5	0.9	0.0	0.0	0.0	0.0	8.9	0.5	0.0	1.1	0.0	59.2	0.0	0.0	25.0	2.4	0.0	3.7	0.0	0.0	0.0
SNIP1	PML1	ENSG00000163877	"Smad nuclear interacting protein 1"	Q8TAD8	1	37534449-37554344	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, RNA-mediated gene silencing"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036896	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036896: AB_10670244"	"unprognostic (1.37e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.24e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.34e-3)"	"unprognostic (3.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	10.6	13.4	10.6	13.3	12.4	15.9	15.0	18.4	14.4	12.8	10.8	10.0	14.2	8.5	14.2	11.9	13.5	11.9	10.0	8.5	11.1	9.0	9.9	20.6	10.2	11.7	10.8	10.5	12.7	15.3	9.8	13.1	13.2	9.9	13.3	9.0	12.3	11.7	11.5	13.5	13.2	12.3	11.6	7.9	14.9	11.8	21.7	11.6	16.9	10.5	11.1	14.0	11.7	17.0	3.7	4.3	4.6	3.5	3.1	5.5	1.8	6.2	3.5	7.0	6.9	8.4	8.0	4.8	8.0	9.1	7.7	6.7	3.4	5.7	8.6	6.3	8.5	5.0	6.6	6.5	7.3	6.4	7.7	9.4	13.2	6.2	6.9	9.6	12.2	7.5	7.7	8.6	7.6	9.7	8.3	7.4	6.7	9.3	8.0	5.4	4.7	7.2	9.5	11.3	5.2	8.1	7.6	11.8	7.2	5.6	6.0	5.6	11.3	8.5	5.5	10.4	7.6	4.9	6.7	12.2	6.1	6.8	7.5	7.9	9.5	11.0	7.1	7.2	8.7	5.4	4.1	3.1	3.9	5.5	2.8	5.4	3.7	3.7	5.3	2.6	3.6	5.1	4.5	4.6	3.1	3.5	4.3	4.2	1.8	10.6	12.4	18.4	14.4	11.1	9.0	10.8	10.5	9.9	11.6	17.9	14.8	3.4	10.6	14.3	10.1	4.8	5.1	10.7	19.4	5.2	7.9	4.7	1.7	6.3	4.6	6.5	7.3	0.0	6.2	4.0	8.4	7.8	11.5	10.0	3.9	9.5	8.1	12.3	8.1	7.9	7.5	5.2	8.5	7.2	8.6	11.3	6.5	6.0	7.4	3.5	15.4	0.0	7.5	10.2	13.2	15.7	8.5	10.2	6.6	11.2
SNN		ENSG00000184602	Stannin	O75324	16	11668414-11679159	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.2"	"Cell type enhanced"	"Detected in many"	7	"monocytes: 71.3;Muller glia cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 31.5;REH: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011055	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA011055: AB_1857326"	"unprognostic (1.94e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (1.85e-6)"	"unprognostic (4.51e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.83e-5)"	"unprognostic (4.91e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.58e-1)"	"unprognostic (4.72e-2)"	29.2	16.6	34.7	10.0	51.5	11.0	13.7	27.2	52.2	6.9	4.4	11.2	1.8	4.9	6.8	11.5	10.5	5.9	12.0	13.2	33.0	15.5	7.0	5.1	9.2	15.0	29.8	25.2	9.8	4.7	4.5	4.6	4.5	15.6	8.1	3.3	6.9	9.9	12.9	29.1	4.5	4.4	6.6	15.2	17.4	4.6	2.2	11.4	6.1	9.5	4.8	14.2	9.3	6.1	7.0	9.0	24.1	20.3	0.3	3.0	7.4	3.0	2.9	31.5	8.5	20.9	6.0	3.0	1.3	2.8	3.8	3.8	4.7	2.1	3.1	12.9	4.3	6.7	6.0	9.4	3.7	2.9	0.8	2.1	10.4	3.2	6.2	5.6	0.7	6.3	5.2	17.2	2.0	4.2	5.4	7.0	9.3	1.6	5.0	3.5	5.1	8.3	2.3	16.3	3.8	2.1	29.4	4.2	21.7	3.5	9.0	18.8	7.6	7.1	9.4	4.6	12.9	3.8	6.2	6.2	4.4	9.2	25.7	1.3	2.0	1.3	7.4	2.6	8.9	5.5	0.0	9.5	6.9	0.3	16.3	0.3	7.0	1.6	0.7	9.0	6.8	3.0	2.1	24.1	0.3	20.3	3.6	0.9	7.4	34.7	51.5	27.2	39.3	33.0	15.5	29.8	25.2	15.6	11.4	0.0	6.7	34.4	17.9	16.4	6.5	14.3	10.2	4.0	3.4	5.2	0.0	1.0	21.6	15.0	0.6	14.3	0.0	0.0	16.3	19.9	8.2	15.5	13.8	2.4	17.7	6.4	5.1	20.3	27.0	0.0	4.6	26.4	20.3	71.3	0.2	90.5	13.6	0.0	14.5	4.4	5.9	6.5	26.7	0.3	2.1	16.7	1.1	5.7	0.4	9.1
SNRNP48	"C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234"	ENSG00000168566	"Small nuclear ribonucleoprotein U11/U12 subunit 48"	Q6IEG0	6	7590199-7611967	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029234	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029234: AB_10604097"	"prognostic unfavorable (8.30e-4)"	"unprognostic (3.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.03e-1)"	9.5	7.1	12.3	11.7	14.9	15.6	12.6	28.9	13.3	10.5	10.3	7.0	13.6	9.9	11.7	8.6	9.4	9.2	7.1	12.2	11.9	7.5	10.7	12.7	8.6	11.7	14.1	8.1	14.4	10.5	7.3	11.0	9.2	11.4	10.5	10.1	5.9	10.1	13.0	15.8	11.0	11.5	10.5	17.8	11.2	9.6	5.3	14.3	15.3	10.4	7.1	10.0	9.9	30.2	3.3	2.7	6.0	2.0	2.7	3.7	1.7	5.7	4.6	9.7	18.0	5.2	7.7	6.5	6.6	6.1	7.2	8.0	9.8	4.7	13.6	7.1	5.4	6.9	7.4	12.0	7.1	11.1	10.4	11.7	9.8	14.7	18.8	5.5	11.6	6.5	5.4	11.0	8.1	6.2	8.6	6.2	12.2	13.6	2.2	10.0	3.2	19.0	16.9	13.1	9.9	5.2	20.5	8.4	18.2	6.5	5.1	15.0	4.1	12.8	3.3	11.3	18.7	6.5	4.1	6.9	9.6	4.3	5.6	11.3	3.5	19.4	8.4	3.2	9.3	17.1	0.4	2.0	1.0	2.0	1.4	3.4	1.7	2.4	2.6	2.4	3.3	2.1	3.7	6.0	2.7	0.8	2.7	1.7	1.7	12.3	14.9	28.9	13.3	11.9	7.5	14.1	8.1	11.4	14.3	17.9	9.3	14.1	18.6	31.7	17.1	25.2	5.1	8.1	21.6	8.7	19.6	13.5	10.0	15.9	2.2	20.2	18.4	0.0	17.5	12.7	12.9	15.7	23.1	19.5	13.7	4.8	10.9	13.5	16.4	2.2	16.4	16.3	8.5	21.6	15.0	15.3	10.9	15.2	15.6	13.5	17.2	6.5	17.9	10.2	17.9	29.6	13.6	17.5	13.8	18.0
SPINT2	"HAI-2, Kop"	ENSG00000167642	"Serine peptidase inhibitor, Kunitz type 2"	O43291	19	38244035-38292614	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 1193.1;Syncytiotrophoblasts: 1181.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 77.2;CAPAN-2: 114.0;OE19: 138.0;RPTEC TERT1: 85.0;SK-BR-3: 74.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011101, CAB018969"	Approved		Uncertain	"Plasma membrane,Intermediate filaments,Cytosol"		No	NA			"Plasma membrane, Intermediate filaments, Cytosol"		"CAB018969: , HPA011101: AB_1079039"	"unprognostic (5.13e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.68e-2)"	1.5	7.2	11.9	15.1	14.0	10.7	29.2	14.3	20.8	24.0	46.3	4.7	63.2	38.3	7.1	44.9	60.6	30.4	51.8	3.3	10.4	22.9	47.5	2.8	25.6	10.3	9.3	14.6	15.3	78.7	30.2	82.7	77.3	11.0	29.6	40.3	15.3	143.1	61.6	0.7	41.7	82.3	13.1	5.6	9.4	34.1	87.0	2.8	15.0	95.6	32.0	37.5	27.1	25.0	23.1	73.9	70.7	17.9	2.6	13.2	17.6	77.2	56.1	0.2	0.3	0.0	0.0	36.8	1.5	0.1	0.1	0.2	39.7	114.0	0.6	6.2	0.4	0.1	25.6	4.0	55.0	0.1	0.7	4.6	14.5	1.4	0.0	0.0	0.1	0.0	0.0	63.5	0.0	26.9	6.8	0.1	13.4	0.3	0.0	0.1	59.9	2.2	0.2	5.6	138.0	15.8	7.9	0.0	34.7	85.0	65.9	21.2	0.3	23.0	74.8	0.2	23.2	33.4	9.6	0.0	0.1	0.4	0.3	0.3	5.3	6.7	4.3	0.1	1.0	0.1	57.2	17.9	70.7	0.5	12.5	1.1	20.0	6.5	3.2	41.7	23.1	13.2	11.9	7.8	2.6	8.4	73.9	2.5	17.6	11.9	14.0	14.3	20.8	10.4	22.9	9.3	14.6	11.0	2.8	342.4	185.3	64.0	449.2	334.9	13.5	2.4	313.4	305.1	279.8	530.4	5.9	1193.1	86.2	726.2	49.0	27.7	770.2	23.3	582.2	418.7	47.4	567.4	114.2	0.9	201.0	3.2	346.3	19.6	47.0	43.3	17.5	123.0	84.4	555.5	581.5	122.0	696.1	614.1	15.9	155.0	17.0	51.8	17.6	285.2	308.8	374.4	1181.8	32.3	502.6	795.6
SPNS1	"HSpin1, LAT, nrs, PP2030, SPIN1, SPINL"	ENSG00000169682	"Sphingolipid transporter 1 (putative)"	Q9H2V7	16	28974221-28984548	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041995, HPA042988"	Enhanced		Approved	"Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol"		NA	NA			Vesicles	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA041995: AB_10959609, HPA042988: AB_10964587"	"unprognostic (3.54e-2)"	"unprognostic (4.57e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.66e-1)"	"unprognostic (7.86e-5)"	"unprognostic (1.01e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.85e-7)"	"unprognostic (1.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.12e-2)"	23.4	23.9	14.5	22.0	15.9	38.3	24.2	21.0	22.8	18.2	22.1	24.1	20.1	26.9	25.1	21.3	20.9	17.1	26.8	16.1	14.9	12.1	24.1	28.3	33.4	22.6	15.4	17.0	18.3	20.8	29.5	17.2	40.7	15.4	20.1	12.6	19.8	20.8	22.8	21.3	30.9	22.3	26.3	14.5	27.3	20.7	22.3	17.2	31.0	22.0	24.5	17.2	21.2	19.5	3.1	15.6	7.2	23.5	4.2	7.9	10.1	10.3	24.5	9.3	21.6	17.9	9.9	26.5	11.6	12.0	19.4	17.4	22.3	24.9	6.6	28.6	10.4	16.1	22.0	15.0	12.8	7.0	7.6	25.5	9.6	23.9	27.7	30.4	10.6	20.7	16.5	17.2	20.9	8.9	11.4	17.8	12.4	21.5	12.0	9.7	27.7	11.6	30.4	21.9	8.4	16.2	14.7	11.2	29.6	10.5	10.1	16.7	21.6	8.2	24.7	18.0	8.1	24.6	12.9	15.0	15.8	12.0	22.0	8.9	18.2	14.3	6.2	20.2	16.3	12.7	6.4	18.2	7.2	6.0	23.5	5.0	3.1	6.0	7.9	15.6	2.8	6.2	4.1	3.3	4.2	15.7	6.5	6.8	10.1	14.5	15.9	21.0	22.8	14.9	12.1	15.4	17.0	15.4	17.2	6.0	7.4	9.0	18.6	18.9	27.1	0.4	10.2	12.0	3.4	19.2	27.5	55.8	11.6	51.1	1.5	21.6	16.8	0.0	39.5	59.8	27.5	13.4	20.9	12.1	87.9	25.4	11.7	19.6	37.6	1.9	21.0	27.5	32.1	26.2	18.9	29.6	34.8	14.0	15.6	13.5	33.9	6.5	15.3	17.2	28.3	19.8	73.0	22.5	23.8	17.0
SPRED3		ENSG00000188766	"Sprouty related EVH1 domain containing 3"	Q2MJR0	19	38388421-38399587	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 10.7"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 7.3;Intestinal endocrine cells: 10.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.3;TIME: 14.7;U-87 MG: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071521			Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA071521: "	"unprognostic (1.09e-1)"	"unprognostic (1.88e-3)"	"unprognostic (8.71e-3)"	"unprognostic (3.35e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.09e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.40e-11)"	"unprognostic (6.21e-4)"	"unprognostic (3.67e-1)"	"unprognostic (1.04e-3)"	"unprognostic (8.45e-3)"	2.0	1.2	4.3	2.7	10.1	0.9	1.2	2.8	10.7	0.9	0.6	1.7	0.0	4.7	1.2	1.2	0.9	0.7	2.0	1.1	5.0	4.7	1.2	0.4	0.9	0.5	2.8	4.6	0.5	2.9	4.5	5.8	0.8	4.7	1.2	0.8	0.9	0.8	1.1	0.9	2.3	3.7	2.3	1.7	0.5	1.3	1.7	0.9	0.0	1.8	0.0	0.6	0.9	0.8	0.8	0.7	2.2	0.6	0.9	0.5	0.3	0.2	1.1	3.8	3.1	0.6	1.8	2.1	7.5	5.0	2.5	2.3	0.4	0.8	0.2	2.7	2.5	2.0	0.1	0.6	0.9	2.3	0.7	1.4	0.0	0.2	0.4	1.3	2.0	0.1	1.3	0.9	5.9	1.7	12.3	7.8	0.6	0.6	1.4	7.6	0.4	0.0	0.1	1.7	0.5	3.8	0.9	1.3	0.1	5.4	0.6	0.2	2.9	0.1	0.2	0.3	1.7	0.6	0.1	14.7	2.8	8.6	2.3	4.1	0.6	0.2	0.5	9.4	0.3	4.7	1.6	0.6	0.4	0.4	0.2	0.3	0.3	0.5	0.3	0.1	0.8	0.4	0.3	2.2	0.9	0.5	0.7	0.2	0.3	4.3	10.1	2.8	9.8	5.0	4.7	2.8	4.6	4.7	0.9	0.0	0.0	0.0	1.1	0.0	7.3	1.0	0.0	0.0	0.0	1.8	2.0	0.4	0.0	0.8	0.3	0.1	0.7	0.0	0.5	0.2	0.0	1.1	0.0	0.0	0.1	1.6	10.4	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.3	2.5	2.2	0.0	0.0	0.0	0.2	0.0	1.0	0.9	0.6	0.1	0.7	0.0	0.6	0.6
SQLE		ENSG00000104549	"Squalene epoxidase"	Q14534	8	124998497-125022283	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018038, HPA020762"	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA018038: AB_2669753, HPA020762: AB_2670512"	"unprognostic (1.37e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.12e-2)"	"unprognostic (9.51e-3)"	"unprognostic (4.63e-1)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (4.76e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (3.45e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (9.71e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.74e-3)"	4.6	15.7	11.1	9.9	13.9	10.4	12.1	8.9	19.9	15.1	11.5	28.8	4.4	15.8	8.9	5.1	40.3	10.0	6.3	4.2	15.4	14.5	7.8	38.1	16.0	8.6	10.8	9.7	17.5	6.3	16.5	9.5	24.7	28.5	13.8	10.1	9.3	10.4	4.7	1.3	23.8	8.7	6.6	36.0	5.6	11.5	29.3	18.7	9.8	5.7	24.2	15.0	5.3	21.6	15.1	12.4	1.2	9.7	9.5	9.0	6.1	25.8	10.0	60.2	17.3	18.7	31.8	6.1	6.8	21.0	9.3	17.1	13.6	37.9	17.8	9.9	8.4	37.4	19.8	25.1	37.7	10.8	14.7	53.0	50.9	6.8	34.7	27.6	5.9	15.0	21.7	40.4	27.7	22.9	6.0	10.1	12.6	29.0	34.7	7.5	42.7	20.6	7.5	24.9	17.8	6.9	9.1	11.0	24.3	65.6	29.8	18.8	9.5	14.0	45.0	14.0	20.2	12.0	15.6	9.9	3.8	13.6	4.5	6.0	6.3	12.8	24.4	6.4	18.2	6.6	1.2	5.1	0.5	9.0	8.5	4.4	13.6	5.4	8.3	12.4	15.1	7.5	7.8	0.1	9.5	9.7	8.8	5.6	6.1	11.1	13.9	8.9	16.4	15.4	14.5	10.8	9.7	28.5	18.7	56.6	84.1	38.7	41.4	20.4	26.3	6.1	28.1	108.4	52.4	50.6	47.1	81.6	6.6	50.5	18.8	11.2	44.6	46.7	73.0	111.6	54.5	79.8	41.4	15.7	48.5	139.8	30.4	12.3	13.0	9.6	22.2	16.0	20.3	154.1	29.4	23.5	64.9	21.0	10.3	2.9	47.5	25.8	29.0	131.6	152.1	77.9	181.6	17.5	20.4	100.4
SSH1	KIAA1298	ENSG00000084112	"Slingshot protein phosphatase 1"	Q8WYL5	12	108778192-108857590	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019845	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA019845: AB_1857497"	"unprognostic (1.18e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.40e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (5.80e-5)"	"unprognostic (3.28e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.72e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.22e-2)"	7.3	7.8	8.5	7.4	8.1	10.6	9.3	20.3	8.8	7.4	8.5	6.8	13.1	4.4	9.8	7.9	7.6	8.2	8.3	10.1	8.0	6.9	5.8	7.4	10.1	8.7	7.7	5.2	7.9	8.0	9.7	6.8	7.8	8.4	6.5	6.5	15.0	5.9	8.0	21.4	7.1	6.5	10.4	8.1	8.6	7.1	5.2	6.6	2.0	7.0	7.9	6.6	10.0	13.3	1.8	2.0	5.7	4.0	2.1	2.9	1.2	5.1	6.8	4.5	3.5	8.5	7.3	4.0	6.6	14.2	6.1	5.4	3.4	2.5	2.4	4.7	15.5	10.4	5.1	2.7	11.2	5.0	5.0	2.6	5.7	3.1	2.1	4.6	2.9	15.2	10.0	3.8	5.5	12.3	15.1	5.6	3.0	1.3	2.0	15.9	2.9	3.3	4.2	3.1	2.0	5.5	2.4	5.3	3.2	2.4	9.2	3.3	4.5	5.8	1.6	12.8	6.5	2.1	2.6	4.4	10.9	4.7	6.5	3.8	3.9	3.5	3.0	5.7	2.4	34.4	4.2	2.4	4.8	2.9	4.0	2.7	1.6	1.5	2.5	1.6	1.8	1.4	1.6	5.7	2.1	3.2	2.0	1.7	1.2	8.5	8.1	20.3	8.8	8.0	6.9	7.7	5.2	8.4	6.6	8.9	17.3	4.7	15.4	8.4	10.6	21.2	12.7	8.1	14.8	14.0	15.7	4.7	5.0	7.7	1.6	37.5	3.5	0.0	7.0	3.7	10.3	7.2	19.7	13.4	11.2	11.1	5.2	25.8	24.7	2.6	6.1	17.8	11.8	43.3	6.6	8.8	10.1	0.0	12.0	4.9	20.7	6.5	17.6	1.1	6.6	7.9	1.9	15.4	5.7	12.2
STK17B	DRAK2	ENSG00000081320	"Serine/threonine kinase 17b"	O94768	2	196133566-196176503	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 158.6;granulocytes: 189.5;Kupffer cells: 142.8;Macrophages: 145.8;T-cells: 178.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 36.3;HMC-1: 36.8;Karpas-707: 34.1;U-698: 39.5"	"Region enriched"	"Detected in many"	6	"cerebellum: 71.1"	"Low region specificity"	"Detected in all"			HPA034858	Enhanced		Uncertain	"Plasma membrane,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"		"HPA034858: AB_10670981"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.72e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.80e-2)"	21.0	4.1	3.2	42.8	3.8	103.4	10.1	3.2	3.3	8.2	18.8	1.1	3.8	8.5	3.4	3.9	8.9	6.3	8.6	5.7	3.3	2.2	7.2	2.9	26.2	53.7	2.3	1.8	3.1	5.0	0.7	3.8	6.5	1.7	6.8	5.7	3.5	16.7	6.1	3.4	10.9	31.8	5.3	2.7	59.3	6.0	4.6	1.4	72.2	7.5	7.0	56.2	11.3	6.0	16.9	13.6	62.0	27.0	10.3	28.4	19.0	3.2	2.2	3.4	1.2	15.0	5.7	3.8	7.7	11.6	8.5	8.9	6.8	1.1	36.3	7.1	4.4	2.2	2.2	1.4	3.3	10.4	6.4	3.8	3.4	2.9	0.6	4.5	13.7	36.8	7.2	3.3	10.5	5.5	12.1	3.5	8.6	2.6	34.1	21.1	1.7	17.8	31.0	1.9	5.9	5.2	2.9	20.7	11.0	5.0	7.6	1.3	1.3	1.9	1.9	1.6	5.5	1.3	7.2	4.2	8.3	4.1	5.9	4.3	14.0	22.6	39.5	6.2	4.7	3.6	35.9	19.7	40.2	12.0	20.7	15.3	13.3	21.5	14.5	13.6	16.9	28.4	23.1	62.0	10.3	27.0	9.7	18.5	19.0	3.2	3.8	3.2	3.3	3.3	2.2	2.3	1.8	1.7	1.4	83.4	80.3	158.6	22.9	53.1	0.3	2.2	10.2	34.8	52.4	10.4	0.0	5.9	3.3	5.2	4.6	11.6	59.1	46.7	2.5	20.9	21.2	28.7	189.5	2.4	23.5	0.0	2.9	7.4	142.8	2.0	5.2	145.8	55.6	40.5	11.0	0.9	7.9	38.6	4.2	1.4	0.2	6.5	20.5	28.6	24.9	55.5	4.2	178.5	10.5	39.9
STRADB	"ALS2CR2, CALS-21, ILPIP, ILPIPA, PAPK"	ENSG00000082146	"STE20-related kinase adaptor beta"	Q9C0K7	2	201387858-201480846	"Enzymes, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Erythroid cells: 186.9;Proximal tubular cells: 173.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 60.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026549, HPA028520"	Approved		Uncertain	Aggresome,Cytosol		NA	NA			Cytosol	Aggresome	"HPA026549: AB_1844779, HPA028520: AB_10604100"	"unprognostic (6.34e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.65e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (7.83e-2)"	"prognostic favorable (4.45e-4)"	"unprognostic (4.93e-2)"	13.8	28.6	13.8	7.9	11.7	32.7	9.2	8.8	13.5	6.4	13.7	16.9	4.9	18.8	10.3	9.5	8.9	5.7	7.9	15.2	15.3	11.5	35.2	50.5	7.2	10.1	15.8	11.0	7.8	9.1	3.9	14.1	11.6	12.7	7.1	15.9	10.1	7.1	7.7	48.3	4.4	21.3	7.4	21.0	7.3	4.7	7.8	9.4	8.3	9.7	7.8	7.7	6.2	6.2	24.1	10.4	9.7	8.6	16.3	10.4	9.6	3.9	6.8	11.9	15.2	19.4	24.6	8.4	8.0	14.0	11.2	17.0	9.0	3.8	0.0	5.3	12.7	13.8	4.0	11.5	7.6	20.3	4.6	9.4	4.8	3.2	19.9	14.7	5.6	5.4	20.8	6.9	14.3	12.8	20.9	8.4	9.2	10.2	1.7	60.3	2.1	5.1	9.8	16.0	3.7	7.0	7.0	4.6	2.9	9.5	3.2	2.0	9.8	5.5	4.2	23.6	22.7	2.2	10.8	8.1	6.9	5.3	8.7	6.1	6.7	11.8	1.8	11.6	2.5	6.4	3.4	8.0	9.7	6.0	8.6	5.4	16.7	8.0	8.6	10.4	24.1	10.4	10.3	1.6	16.3	7.5	4.6	9.5	9.6	13.8	11.7	8.8	13.5	15.3	11.5	15.8	11.0	12.7	9.4	8.9	3.4	20.8	6.4	1.9	10.4	29.0	15.3	5.3	3.4	14.0	78.5	41.3	33.2	9.4	3.0	4.9	62.6	186.9	13.6	22.9	10.8	10.0	5.7	77.9	16.8	11.1	16.3	3.1	17.8	5.8	10.0	8.3	15.1	17.2	23.2	13.5	11.0	26.2	3.5	173.8	17.1	6.5	4.1	27.0	44.7	1.3	23.3	9.6	22.7	7.7
STT3A	"ITM1, MGC9042, STT3-A, TMC"	ENSG00000134910	"STT3A, catalytic subunit of the oligosaccharyltransferase complex"	P46977	11	125591712-125625215	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 202.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030735	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA030735: AB_10603342"	"unprognostic (8.25e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.82e-2)"	20.6	20.5	8.3	13.1	11.7	8.3	16.9	10.7	13.9	27.8	19.3	17.7	39.6	12.0	30.5	41.4	19.6	20.8	15.1	19.5	8.3	9.1	26.2	67.1	18.7	14.9	9.3	7.7	30.1	59.0	202.3	27.5	35.9	11.6	22.2	17.4	20.8	50.7	41.4	9.5	12.9	19.8	17.1	12.3	21.8	17.7	17.1	6.7	19.2	38.6	13.6	20.8	19.5	18.0	15.0	53.2	27.0	15.5	17.2	27.5	13.4	21.0	19.2	24.5	33.6	46.2	35.8	26.3	38.5	46.0	31.3	39.2	58.2	56.9	27.4	46.7	56.6	44.4	38.9	33.9	33.7	41.7	21.3	18.0	64.5	13.2	40.2	51.1	38.6	30.3	27.6	24.5	43.4	84.8	36.9	34.9	12.3	27.1	41.1	39.5	15.5	15.5	12.3	15.7	42.1	20.9	18.4	20.9	41.2	34.2	32.7	15.2	13.2	27.2	44.5	13.7	30.0	52.2	27.8	31.2	45.2	16.3	19.0	30.2	12.9	15.1	21.1	17.4	39.1	35.8	27.0	15.5	11.6	19.7	14.8	27.5	15.0	19.1	18.2	21.6	11.6	13.8	16.0	5.4	17.2	13.0	53.2	14.1	13.4	8.3	11.7	10.7	13.9	8.3	9.1	9.3	7.7	11.6	6.7	26.8	23.5	18.2	11.3	14.3	10.2	18.6	12.7	14.7	14.8	15.7	19.6	40.7	1.7	26.7	7.6	11.9	13.5	23.3	23.5	56.2	25.7	16.7	16.2	32.7	27.0	1.6	15.0	33.2	22.3	2.6	19.8	13.2	23.6	8.2	32.3	15.2	29.5	14.0	17.7	11.9	13.8	19.4	10.3	29.9	10.9	12.9	38.1	13.3	22.9	12.9
STX17	FLJ20651	ENSG00000136874	"Syntaxin 17"	P56962	9	99906633-99970341	"Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001204	Approved		Uncertain	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA001204: AB_1080118"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (1.62e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	15.1	15.8	13.5	16.4	16.3	13.6	16.1	10.8	17.8	19.4	18.5	14.2	29.3	13.4	21.7	25.2	19.9	12.0	14.9	14.5	13.8	13.2	14.3	26.0	13.2	11.9	15.4	14.2	18.2	17.8	25.5	37.1	17.6	14.1	18.2	14.6	16.3	20.6	28.7	28.5	20.6	18.9	20.4	19.1	13.3	15.0	12.0	10.4	17.0	21.8	18.3	15.9	18.8	17.8	7.4	4.9	15.5	8.1	14.3	10.4	4.5	10.7	9.8	10.0	12.0	11.4	11.6	19.9	8.2	12.2	9.3	8.0	12.2	14.4	21.0	8.2	8.7	15.0	12.3	8.3	11.5	7.5	18.3	6.8	13.5	12.9	7.4	13.3	19.8	4.9	11.4	13.4	10.0	15.2	9.8	10.8	18.2	18.7	11.7	7.0	13.1	11.8	5.4	8.8	14.0	7.9	10.1	17.7	9.6	12.3	12.5	5.8	10.3	16.6	12.7	8.1	6.7	12.6	5.5	8.5	6.2	8.8	10.0	6.6	16.6	20.2	4.2	8.7	8.3	6.7	15.5	4.2	7.3	7.4	4.5	10.3	7.4	9.1	8.2	4.9	5.9	10.4	9.8	4.3	14.3	8.1	3.1	4.9	4.5	13.5	16.3	10.8	17.8	13.8	13.2	15.4	14.2	14.1	10.4	14.9	21.7	14.5	18.1	9.4	14.0	16.9	10.2	24.1	22.7	22.7	19.6	20.4	24.9	15.8	40.4	13.7	9.7	0.0	17.1	15.8	11.1	23.3	25.4	23.1	9.2	9.5	24.2	20.9	8.3	24.8	23.9	15.1	8.5	27.1	15.7	20.3	14.1	15.9	17.0	15.7	12.9	38.8	13.9	25.9	16.6	10.7	22.9	16.6	13.1	12.9
SULT1E1	"EST, STE"	ENSG00000109193	"Sulfotransferase family 1E member 1"	P49888	4	69841212-69860152	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.8;liver: 26.2;vagina: 15.8"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 47.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"pons and medulla: 3.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"HHSteC: 38.0;HSkMC: 17.2;hTCEpi: 14.3;HUVEC TERT2: 10.4"									"HPA028213, HPA028728, CAB047344"	Enhanced		Uncertain	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894"	"unprognostic (5.60e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.48e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.11e-2)"		"unprognostic (5.55e-2)"	0.1	9.8	0.1	0.1	0.3	0.1	1.1	0.1	0.4	13.1	8.9	0.5	0.1	19.8	0.4	3.7	0.4	0.1	1.2	0.1	0.1	0.0	1.5	26.2	2.0	0.1	0.3	0.3	0.2	0.1	0.0	0.4	0.1	3.3	1.0	0.1	0.3	4.7	0.3	0.1	10.9	37.8	0.5	0.3	0.1	1.3	0.4	0.1	0.6	0.2	0.1	1.0	0.4	15.8	0.6	0.2	1.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	38.0	0.0	0.0	17.2	14.3	0.0	0.4	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.6	0.2	0.1	1.7	0.3	0.3	0.2	0.0	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.3	0.3	3.3	0.1	0.0	0.0	0.0	1.0	10.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.2	0.1	0.0	0.0	47.0	0.2	0.0	0.0	1.8	1.0	0.0	0.3	0.0	1.7	0.0	0.2	0.0	0.5	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	1.3	0.0	0.0	0.1
SVIL		ENSG00000197321	Supervillin	O95425	10	29457338-29736781	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 235.1;tongue: 93.5"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 411.9;Peritubular cells: 245.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 15.2;monocytes: 4.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010878, HPA020095, HPA020138"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane"	"Actin filaments, Cytosol"	"CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.26e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (5.70e-5)"	11.9	2.1	0.7	10.5	1.1	3.7	4.5	0.6	0.9	18.7	42.3	0.6	10.7	1.7	34.3	13.3	18.2	8.9	15.5	25.5	0.5	0.6	2.8	2.0	3.8	2.3	0.8	0.7	13.9	2.4	5.1	4.1	2.9	1.7	12.6	5.3	10.0	10.6	15.3	235.1	4.7	9.1	36.4	1.3	1.5	14.2	5.5	0.5	4.6	6.9	93.5	11.6	28.6	9.9	0.1	0.7	15.2	4.2	1.2	1.7	0.6	17.4	7.5	3.4	1.2	10.0	26.8	5.6	2.8	6.8	1.1	1.1	8.9	17.3	0.0	12.4	1.1	10.9	40.4	1.9	6.6	1.1	0.2	3.7	0.0	9.6	5.7	6.0	1.5	0.3	24.6	6.5	12.5	4.5	22.5	20.0	2.5	0.0	0.1	1.7	5.4	1.4	0.8	1.7	7.8	2.7	3.2	10.2	0.1	11.9	5.8	4.2	3.4	2.5	0.3	8.9	11.7	3.1	1.9	12.9	5.7	5.9	28.3	8.4	0.1	0.0	0.0	22.2	3.4	19.7	2.9	1.1	5.2	1.2	1.9	1.5	0.0	1.1	0.6	0.7	0.1	1.7	1.1	15.2	1.2	4.2	0.2	0.1	0.6	0.7	1.1	0.6	0.9	0.5	0.6	0.8	0.7	1.7	0.5	44.7	29.1	9.7	91.1	62.4	7.4	411.9	15.3	60.2	75.1	36.6	23.6	24.9	6.6	80.7	2.3	48.5	22.2	0.0	36.6	17.5	59.3	70.6	9.3	10.2	8.5	4.8	23.0	21.5	9.7	2.7	101.5	25.2	27.0	1.8	26.4	30.4	47.2	34.5	245.1	9.7	16.1	45.3	155.7	6.3	7.7	52.4	20.7	4.4	38.0	78.2
SYCE1	"bA108K14.6, C10orf94, CT76"	ENSG00000171772	"Synaptonemal complex central element protein 1"	Q8N0S2	10	133553901-133569835	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 75.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 103.1;Late spermatids: 85.3;Spermatocytes: 250.9;Spermatogonia: 112.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"K-562: 17.4;U-2 OS: 16.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA040208	Enhanced		Uncertain	Nucleoplasm,Vesicles,Cytosol		No	No			Nucleoplasm	"Vesicles, Cytosol"	"HPA040208: AB_10796450"	"unprognostic (5.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"		"unprognostic (1.85e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.75e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-1)"	1.8	1.8	4.9	0.7	5.4	0.3	1.3	8.1	8.2	0.4	0.7	0.9	0.0	0.4	0.8	0.5	0.6	1.4	1.6	0.7	4.0	3.3	0.9	3.9	0.5	1.1	1.5	6.7	1.1	1.5	0.2	0.3	8.6	3.5	1.8	0.6	0.2	0.4	0.6	0.9	0.3	0.5	0.7	1.7	0.8	0.5	75.4	0.0	0.1	1.4	0.1	0.7	0.4	0.0	1.3	2.0	0.3	2.6	0.2	3.2	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.7	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.4	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.1	16.1	0.2	0.3	0.2	0.3	0.4	0.0	0.1	0.0	0.0	1.7	0.3	3.2	1.8	3.0	0.9	2.4	0.8	1.2	1.3	1.4	2.7	0.0	0.2	2.6	2.0	2.2	1.8	4.9	5.4	8.1	8.2	4.0	3.3	1.5	6.7	3.5	0.0	0.0	1.0	0.0	1.5	0.9	1.8	0.2	2.5	2.7	2.3	0.0	0.0	0.3	0.0	0.0	103.1	0.1	0.0	0.0	0.9	0.1	0.8	0.4	0.0	5.1	0.6	9.5	0.0	0.0	0.0	85.3	4.9	0.6	0.0	0.0	0.0	0.3	0.7	0.0	3.5	0.3	1.6	25.8	0.4	250.9	112.4	0.9	0.2	0.0	0.0	0.3
SYCP2	SCP2	ENSG00000196074	"Synaptonemal complex protein 2"	Q9BX26	20	59863563-59933655	"Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 11.1;testis: 41.7"	"Cell type enriched"	"Detected in many"	6	"Spermatocytes: 330.2"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.7;cervical cancer: 11.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"JURKAT: 19.1;MOLT-4: 21.1;SiHa: 37.2;T-47d: 33.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA062401, HPA065613"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA062401: AB_2684752, HPA065613: AB_2685519"	"unprognostic (8.10e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.84e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	2.2	0.5	1.3	0.9	2.3	1.4	11.1	2.5	5.7	1.3	1.2	1.0	0.8	1.1	1.1	0.9	0.8	0.8	2.0	2.1	1.2	1.2	3.3	0.8	1.6	3.1	1.8	2.7	0.4	4.9	1.3	3.0	2.9	3.9	2.9	0.8	0.6	3.0	0.7	0.8	2.0	1.7	0.6	1.6	2.3	4.5	41.7	0.8	3.0	1.9	0.2	1.5	1.3	1.0	0.9	0.1	2.6	0.3	0.0	2.7	0.5	0.1	0.5	0.1	0.5	0.2	0.3	0.6	1.6	0.4	0.7	0.1	10.2	1.0	0.0	1.6	0.7	0.3	0.2	0.2	0.0	0.4	3.2	0.2	0.1	2.0	0.1	0.0	0.1	7.6	0.1	0.1	0.1	0.0	0.4	0.0	19.1	0.1	0.0	0.3	4.9	21.1	1.1	0.2	0.6	0.1	0.0	0.0	0.1	0.9	2.4	0.1	1.8	37.2	5.4	1.1	0.7	33.6	1.9	0.2	0.0	1.1	4.5	0.0	0.0	0.0	0.0	0.0	0.7	2.1	2.5	0.3	2.3	2.6	0.0	2.7	0.7	1.5	1.7	0.1	0.9	0.9	1.5	2.6	0.0	0.1	0.1	1.0	0.5	1.3	2.3	2.5	5.7	1.2	1.2	1.8	2.7	3.9	0.8	0.0	0.6	0.5	1.0	0.9	1.3	3.6	2.5	14.7	10.3	1.8	2.0	0.5	1.7	0.6	36.7	2.3	0.0	0.0	3.1	0.2	1.2	2.0	2.3	0.0	0.5	0.0	0.0	3.1	0.6	13.5	4.4	1.1	5.0	0.0	0.0	2.2	1.6	0.2	1.8	2.6	1.0	51.8	1.9	330.2	31.3	0.0	0.3	1.3	0.2	1.1
TBC1D22B	"C6orf197, dJ744I24.2, FLJ20337"	ENSG00000065491	"TBC1 domain family member 22B"	Q9NU19	6	37257772-37332970	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027908, HPA027909, HPA027910"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA027908: AB_10602073, HPA027909: AB_10601857, HPA027910: AB_10602203"	"unprognostic (9.83e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (8.15e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.48e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.53e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.73e-2)"	11.5	17.9	9.6	11.0	12.1	26.0	12.8	15.2	17.1	9.7	13.1	11.2	14.3	13.1	13.9	13.0	19.8	14.1	16.8	11.2	10.5	10.5	13.3	8.7	11.7	9.0	8.9	9.9	15.0	20.9	16.8	11.8	13.3	13.1	12.3	13.3	12.2	21.6	11.8	32.7	20.7	16.1	11.5	8.3	11.1	10.6	19.9	8.2	20.7	13.0	10.5	14.4	10.4	13.3	4.6	7.7	8.0	6.6	5.7	6.2	4.6	7.0	3.0	5.6	6.1	5.2	5.2	8.0	4.0	8.3	7.5	9.2	6.8	4.7	6.6	4.2	5.0	10.1	4.9	7.0	6.3	8.4	10.7	5.7	10.5	5.0	9.2	7.5	5.9	9.0	4.4	9.3	7.3	8.7	7.1	10.4	11.2	11.9	1.7	5.3	6.4	8.7	4.5	7.2	8.1	2.8	5.8	5.1	5.2	7.6	5.2	7.3	4.7	4.3	6.3	7.7	7.8	4.5	10.7	10.1	4.5	7.0	3.0	5.2	6.3	6.5	43.8	3.1	9.0	7.0	2.4	5.0	8.0	4.8	6.6	5.6	3.6	5.3	4.6	7.7	4.6	6.2	5.0	2.2	5.7	2.9	2.2	3.6	4.6	9.6	12.1	15.2	17.1	10.5	10.5	8.9	9.9	13.1	8.2	3.0	6.4	2.7	7.2	7.2	5.1	3.5	2.5	12.0	9.1	1.8	3.9	5.5	3.3	10.8	4.4	4.9	11.1	23.3	13.4	7.1	4.1	7.9	5.7	3.6	4.9	0.0	1.7	4.3	4.3	2.9	2.8	4.3	1.7	7.2	5.1	3.8	13.3	5.8	1.1	7.7	4.6	0.0	2.5	5.5	5.1	13.9	5.6	4.9	4.7	10.1
TBCEL	"LRRC35, MGC10233"	ENSG00000154114	"Tubulin folding cofactor E like"	Q5QJ74	11	121024072-121090775	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038593, HPA038594"	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA038593: AB_10669647, HPA038594: AB_2676103"	"unprognostic (9.06e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.02e-1)"	12.4	10.8	9.2	8.3	11.9	6.6	12.2	12.5	13.8	10.8	11.4	15.6	25.8	7.3	18.4	18.3	8.1	11.5	10.8	12.8	9.6	9.1	11.7	19.6	13.7	9.1	12.5	11.1	15.3	10.8	30.8	22.8	14.3	15.8	12.8	8.3	13.2	12.9	17.7	11.0	7.6	9.6	13.1	11.8	14.1	10.2	26.1	12.3	9.5	14.6	6.1	9.6	10.5	10.2	1.1	2.1	0.8	1.4	2.8	2.2	1.0	4.4	4.3	7.4	6.4	13.6	12.9	5.7	8.6	10.6	6.6	9.7	4.4	7.2	5.6	13.3	10.6	6.5	1.2	8.1	2.8	8.9	6.6	6.0	9.6	3.3	4.4	16.9	6.8	6.7	14.1	9.7	6.4	7.0	6.8	10.8	3.2	2.8	10.8	9.2	3.2	2.7	5.6	4.3	0.2	4.2	2.4	10.9	2.5	8.9	2.8	3.9	9.2	8.4	8.9	5.7	6.9	8.5	5.8	14.0	14.7	3.3	5.9	4.7	4.2	3.0	2.9	2.1	0.0	5.5	0.0	1.1	0.5	1.5	1.4	2.1	0.5	2.1	2.1	1.3	1.1	2.2	1.4	0.8	2.8	1.0	2.1	1.0	1.0	9.2	11.9	12.5	13.8	9.6	9.1	12.5	11.1	15.8	12.3	6.0	7.0	4.5	1.7	2.6	8.5	7.0	7.6	6.7	1.2	7.0	13.7	1.3	1.7	3.7	7.6	4.9	2.0	46.7	2.1	1.5	4.2	2.6	1.1	17.9	2.7	7.9	3.5	12.3	6.3	4.2	8.6	2.4	10.1	14.4	2.5	6.0	3.3	0.0	9.2	3.6	8.5	0.0	4.7	12.7	5.5	1.5	1.1	4.4	2.2	1.0
TCF7L2	"TCF-4, TCF4"	ENSG00000148737	"Transcription factor 7 like 2"	Q9NQB0	10	112950250-113167678	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 184.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 12.1;non-classical monocyte: 33.1"	"Lineage enriched"	"Detected in many"	13	"monocytes: 33.1"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"midbrain: 84.5;thalamus: 98.3"	"Group enriched"	"Detected in all"	5	"midbrain: 190.1;pons and medulla: 104.8;thalamus: 169.1"	"CAB013535, HPA038800"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB013535: AB_2533167, HPA038800: "	"unprognostic (1.79e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.36e-3)"	27.4	10.3	8.7	18.7	10.0	7.3	46.4	5.4	10.3	27.4	34.2	15.4	28.1	21.0	26.6	14.9	12.6	18.2	15.3	13.5	8.1	17.9	10.2	22.9	26.9	13.9	8.5	9.0	25.6	13.9	16.5	17.9	24.0	10.2	14.4	23.7	13.9	14.9	52.8	13.7	17.6	40.4	18.0	13.9	27.3	24.0	10.6	10.1	6.6	14.3	9.3	7.0	21.5	16.3	0.0	1.7	2.5	33.1	0.0	0.6	1.1	7.1	18.6	20.4	19.7	10.7	7.1	24.4	5.1	9.9	3.5	4.3	12.3	21.6	0.0	5.7	9.5	4.8	5.1	6.9	8.8	4.5	0.8	6.4	5.0	12.4	11.3	11.4	1.9	1.8	12.6	3.2	5.5	9.4	15.1	5.9	4.2	5.2	0.3	4.1	13.9	3.2	1.2	14.6	8.0	10.7	9.0	15.0	3.2	7.7	9.9	0.4	6.3	7.7	7.6	8.1	16.5	4.9	1.1	13.7	3.3	9.6	8.5	10.4	1.3	0.1	0.1	3.3	4.2	7.4	0.1	1.8	0.1	0.6	12.1	0.4	0.0	0.1	0.5	1.7	0.0	0.1	0.3	2.5	0.0	33.1	0.0	0.0	1.1	8.7	10.0	5.4	10.3	8.1	17.9	8.5	9.0	10.2	10.1	20.8	21.6	4.7	23.8	37.8	2.4	10.6	35.7	20.1	34.2	38.4	5.9	36.9	10.0	28.5	5.5	37.0	121.0	0.0	38.6	184.2	40.4	33.1	0.0	57.7	15.1	4.8	19.0	55.3	68.7	2.7	54.7	21.0	30.4	1.0	68.2	36.6	41.7	91.2	45.6	13.4	5.7	90.5	44.3	3.0	23.4	34.8	23.8	4.3	42.7	42.0
TDGF1	"CR, CRIPTO, Cripto-1"	ENSG00000241186	"Teratocarcinoma-derived growth factor 1"	P13385	3	46574534-46582463	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7"	"Cell type enriched"	"Detected in some"	18	"Distal tubular cells: 102.8"	"Group enriched"	"Detected in many"	9	"colorectal cancer: 6.4;testis cancer: 27.1"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 9.5;NTERA-2: 43.2;SuSa: 27.0"	"Group enriched"	"Detected in many"	5	"cerebellum: 12.5;pons and medulla: 9.1"	"Low region specificity"	"Detected in single"			HPA051928			Uncertain	Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			Vesicles	Cytosol	"HPA051928: "	"unprognostic (7.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	0.6	3.9	0.6	0.6	0.8	0.0	0.6	0.6	0.6	0.6	2.1	0.6	0.6	0.2	0.7	1.3	0.6	0.0	0.6	0.6	1.0	0.6	9.9	0.8	0.6	0.6	0.9	0.6	9.7	0.6	0.0	0.6	0.6	0.6	0.6	4.3	1.1	0.6	0.6	1.0	0.0	0.6	0.8	1.0	16.7	2.4	0.6	0.6	5.2	2.1	0.6	0.6	0.6	0.6	1.0	0.7	3.7	0.6	1.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	9.5	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	43.2	1.7	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.6	0.5	0.5	0.3	0.3	0.6	0.4	0.3	0.1	1.0	0.6	0.4	3.7	1.5	0.4	0.7	0.2	0.1	0.6	0.8	0.6	0.6	1.0	0.6	0.9	0.6	0.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	5.2	0.0	0.0	102.8	0.1	4.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	2.4	0.0	0.0	0.7	0.3	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.7	0.0
TDO2	"TDO, TPH2"	ENSG00000151790	"Tryptophan 2,3-dioxygenase"	P48775	4	155854738-155920406	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"liver: 187.9"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 1048.1"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 35.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.6;HDLM-2: 16.7;U-87 MG: 9.8"	"Group enriched"	"Detected in some"	9	"cerebellum: 7.0;hippocampal formation: 5.9"	"Not detected"	"Not detected"			HPA039611	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039611: "	"unprognostic (1.10e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-8)"	"unprognostic (7.99e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-2)"	0.2	0.5	0.2	2.5	0.5	0.0	0.1	0.1	2.0	0.1	0.2	0.0	0.1	0.6	0.1	0.2	0.2	0.1	0.3	0.1	1.5	0.2	0.2	187.9	0.8	2.9	0.2	0.7	0.1	0.1	0.0	5.8	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	1.1	0.4	0.2	1.5	0.3	0.1	0.0	0.0	0.1	0.0	0.4	1.2	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.2	0.0	0.1	0.0	0.0	16.7	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.1	2.9	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	1.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.1	0.4	0.4	0.0	2.7	0.0	0.0	9.8	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	2.0	1.5	0.2	0.2	0.7	0.1	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.4	132.5	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	23.3	0.0	0.0	0.1	0.3	0.0	1048.1	0.9	0.0	0.0	25.2	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0
TFCP2	"CP2, LBP-1C, LSF, TFCP2C"	ENSG00000135457	"Transcription factor CP2"	Q12800	12	51093663-51173134	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070247			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA070247: AB_2686239"	"unprognostic (6.27e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.31e-2)"	17.4	16.7	21.1	29.3	21.6	9.6	17.7	22.7	21.6	20.2	19.0	20.5	20.8	15.7	19.3	18.9	16.7	21.1	20.7	17.7	20.0	18.7	17.2	12.5	14.1	20.4	19.4	24.9	20.8	14.6	29.2	23.2	22.4	15.4	20.3	21.7	16.4	17.8	19.0	26.6	15.4	15.9	23.8	21.3	18.4	16.1	11.2	18.6	32.1	17.9	12.9	25.9	19.0	18.1	4.5	8.2	9.1	9.4	9.4	6.1	5.0	7.5	13.0	19.5	17.5	11.2	14.1	28.6	14.7	8.0	12.9	7.7	24.8	16.3	0.7	12.9	12.8	10.3	14.5	24.9	15.8	12.9	16.2	14.4	22.9	12.5	10.3	9.4	25.9	22.2	9.6	14.3	13.3	21.2	15.3	12.0	7.5	23.1	0.0	13.6	0.0	23.3	17.2	28.2	17.8	23.6	18.0	10.8	0.1	16.8	18.2	18.6	16.2	18.2	14.9	11.9	19.0	5.6	21.6	12.1	11.9	12.9	12.3	12.7	14.1	23.8	0.0	11.3	16.1	8.5	9.1	9.2	9.0	3.9	7.7	6.1	4.5	4.1	4.2	8.2	3.4	4.9	4.0	3.5	9.4	9.4	3.5	5.4	5.0	21.1	21.6	22.7	19.4	20.0	18.7	19.4	24.9	15.4	18.6	8.9	16.0	9.8	6.7	6.0	19.0	21.8	7.6	2.7	5.7	12.2	19.6	10.4	5.0	8.7	0.4	9.2	9.2	0.0	6.7	8.9	8.4	9.3	10.4	8.9	11.7	9.5	10.4	9.8	24.1	0.4	11.2	12.1	10.1	16.2	11.9	8.7	9.6	8.6	10.3	7.2	25.6	0.0	7.5	6.1	11.1	4.5	14.0	8.7	14.0	5.4
TFE3	"bHLHe33, TFEA"	ENSG00000068323	"Transcription factor binding to IGHM enhancer 3"	P19532	X	49028726-49043486	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023881	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA023881: AB_1857931"	"unprognostic (2.68e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (2.19e-8)"	"unprognostic (1.93e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.19e-2)"	"unprognostic (6.25e-1)"	31.3	20.9	12.6	18.2	14.4	22.6	53.1	16.5	18.1	22.6	17.7	16.6	30.0	9.9	22.8	21.9	20.5	18.8	16.4	15.1	11.3	11.8	21.6	14.1	22.8	10.3	13.2	9.4	24.4	15.9	16.5	16.3	22.0	15.9	21.2	10.4	15.7	12.6	30.6	13.6	14.1	13.5	21.2	14.8	23.0	14.7	10.4	15.2	4.2	21.7	10.8	10.5	28.6	20.5	1.2	1.9	10.5	4.4	0.4	1.4	1.6	11.8	15.3	5.1	14.7	16.6	15.1	5.1	15.7	18.2	16.0	13.7	9.3	9.5	4.5	6.7	23.0	17.7	9.8	9.6	14.1	13.0	9.8	5.2	4.1	11.3	8.7	22.4	4.3	10.2	13.0	9.1	26.3	18.8	14.9	7.7	3.1	7.9	19.6	13.6	7.0	2.8	4.0	13.9	3.5	13.8	4.3	8.8	10.1	10.2	5.5	4.9	4.8	16.7	7.2	5.5	18.0	10.2	3.9	16.2	17.6	18.8	17.5	8.6	12.1	11.3	3.7	21.0	5.3	12.0	0.0	3.5	1.6	0.5	4.3	0.9	0.6	0.9	0.5	1.9	1.2	0.6	0.4	10.5	0.4	4.4	0.4	1.4	1.6	12.6	14.4	16.5	14.9	11.3	11.8	13.2	9.4	15.9	15.2	14.9	9.1	5.2	18.6	17.5	6.5	6.2	17.8	4.0	11.4	19.2	3.9	13.6	8.3	16.6	0.6	14.6	11.8	0.0	13.7	7.4	16.4	16.4	5.7	13.9	19.2	17.5	12.0	9.8	23.8	1.3	25.3	13.0	8.5	10.0	8.5	9.6	17.6	14.0	23.0	8.6	5.3	12.9	13.3	2.6	0.9	19.3	31.0	8.6	6.5	15.8
TGFB1	"CED, DPD1, TGFB, TGFbeta"	ENSG00000105329	"Transforming growth factor beta 1"	P01137	19	41301587-41353911	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Mitogen"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 377.2;Hofbauer cells: 124.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000361, HPA073356"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	1290000	38000000	"Golgi apparatus"	Cytosol	"CAB000361: AB_2201910, HPA073356: "	"unprognostic (1.49e-2)"	"unprognostic (5.43e-3)"	"unprognostic (3.29e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.75e-3)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (8.51e-3)"	"unprognostic (5.63e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (1.65e-3)"	"unprognostic (2.79e-2)"	"unprognostic (6.39e-2)"	"unprognostic (4.86e-3)"	24.3	14.4	7.7	29.8	11.9	53.1	19.0	2.2	8.2	27.8	15.3	14.3	11.5	11.4	24.1	12.8	24.5	13.0	15.6	17.6	8.8	6.5	19.2	10.4	32.4	33.3	12.0	4.1	15.3	8.2	6.9	9.7	54.7	11.7	17.2	5.8	10.3	10.9	15.9	8.7	14.0	17.6	14.6	12.8	55.8	12.8	9.5	12.3	30.6	10.3	9.1	30.6	28.7	24.6	0.7	1.4	7.5	2.2	0.5	1.7	1.3	14.5	22.9	1.2	0.2	10.6	9.4	2.9	21.1	19.0	6.8	4.6	9.7	9.1	14.4	22.8	28.6	6.7	7.9	4.2	13.5	2.4	19.2	4.5	48.6	5.5	12.3	13.8	13.4	33.2	12.2	4.3	13.2	8.4	33.9	34.2	6.0	26.0	36.4	6.3	10.7	11.4	19.5	2.5	2.9	13.7	12.3	3.2	21.7	12.1	6.3	0.2	1.6	5.8	0.3	4.1	7.4	0.5	12.0	43.2	26.8	20.9	5.6	23.0	20.1	7.8	9.5	26.2	26.8	4.7	1.5	1.9	7.5	1.7	2.2	1.3	0.4	0.9	0.9	1.4	0.7	0.7	0.9	4.7	0.5	2.0	1.4	0.5	1.3	7.7	11.9	2.2	7.6	8.8	6.5	12.0	4.1	11.7	12.3	0.0	0.0	38.4	25.0	39.4	0.1	1.6	5.1	2.7	0.0	15.7	0.0	2.6	0.0	11.9	0.4	42.2	0.0	0.0	14.4	377.2	50.3	9.8	66.6	2.1	124.5	0.0	0.0	65.1	113.9	1.1	11.2	100.1	21.9	10.8	0.3	0.3	34.0	11.6	17.0	7.9	0.5	38.8	45.3	1.7	7.8	16.6	46.6	119.6	0.1	27.1
TMEM35A	"FLJ14084, TMEM35"	ENSG00000126950	"Transmembrane protein 35A"	Q53FP2	X	101078720-101096364	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;seminal vesicle: 46.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.5;HUVEC TERT2: 32.3;SH-SY5Y: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048583	Enhanced	Supported	Supported	"Vesicles,Focal adhesion sites,Cytosol"		NA	NA			Vesicles	"Focal adhesion sites, Cytosol"	"HPA048583: AB_2680451"	"unprognostic (7.98e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.49e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.37e-3)"	3.6	6.7	12.8	1.7	28.2	0.7	1.3	21.2	28.6	3.3	17.3	2.5	6.8	3.5	7.4	3.9	10.4	4.3	3.6	1.1	14.4	33.8	1.1	0.7	2.6	0.8	12.2	10.0	7.7	0.9	6.1	1.5	0.8	30.0	20.5	9.1	2.9	1.0	46.4	1.3	0.9	4.1	11.8	3.9	1.3	3.4	1.8	2.3	0.0	1.3	0.0	0.9	13.3	2.7	0.2	0.0	0.2	0.1	0.6	0.8	0.4	0.0	0.0	3.4	0.0	2.5	6.5	0.0	0.6	0.4	0.3	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	2.2	0.0	1.1	0.0	4.7	32.3	0.0	0.0	0.0	4.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	8.3	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.5	0.2	0.5	0.2	0.0	0.0	0.6	0.4	0.2	0.6	0.1	0.0	0.8	0.4	12.8	28.2	21.2	28.6	14.4	33.8	12.2	10.0	30.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM82		ENSG00000162460	"Transmembrane protein 82"	A0PJX8	1	15742422-15747982	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 35.6;liver: 30.1"	"Group enriched"	"Detected in some"	9	"Enterocytes: 86.8;Hepatocytes: 38.2;Paneth cells: 57.5;Proximal tubular cells: 47.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"CACO-2: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060282	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA060282: AB_2684241"	"unprognostic (2.46e-2)"		"unprognostic (7.96e-2)"	"unprognostic (4.88e-2)"			"unprognostic (1.40e-2)"	"unprognostic (6.45e-2)"		"unprognostic (6.90e-2)"	"unprognostic (4.80e-2)"		"prognostic favorable (3.80e-7)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	18.9	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	7.5	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.1	6.6	0.0	0.0	0.0	86.8	0.0	0.2	1.9	0.0	0.0	0.0	38.2	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.5	57.5	0.0	47.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	6.3	0.0
TMIE	DFNB6	ENSG00000181585	"Transmembrane inner ear"	Q8NEW7	3	46694528-46710886	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 11.7;brain: 11.4"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 3.5;Distal tubular cells: 1.7;Spermatogonia: 3.1"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 6.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.3;EFO-21: 3.8;JURKAT: 15.0;SH-SY5Y: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038298	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA038298: AB_10675792"	"unprognostic (6.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.78e-2)"	1.2	11.7	6.7	0.7	2.9	0.0	0.5	2.7	7.0	0.8	0.9	2.3	0.4	0.6	0.8	1.2	2.2	1.0	0.4	1.0	5.9	11.4	1.4	0.9	1.8	1.2	5.8	4.8	2.8	0.4	0.0	8.1	0.7	3.8	0.9	0.6	1.1	0.8	1.8	5.8	1.3	0.6	0.7	5.2	1.2	0.3	1.6	1.0	0.4	0.8	1.7	1.3	0.8	0.4	0.0	0.3	0.0	0.1	0.0	6.1	1.2	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	4.3	0.0	3.8	0.0	0.7	0.2	0.2	0.3	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.0	2.6	0.0	1.7	0.0	0.7	15.0	0.0	0.4	0.0	0.2	0.1	0.0	0.3	1.0	0.2	1.6	0.0	0.3	0.1	0.1	0.4	3.3	0.4	0.5	0.0	0.2	0.1	0.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.2	0.0	1.8	1.0	0.3	0.0	6.1	0.9	0.0	0.0	0.0	0.0	1.0	1.2	6.7	2.9	2.7	7.0	5.9	11.4	5.8	4.8	3.8	1.0	0.0	0.0	0.0	0.1	0.7	3.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.2	0.2	0.0	0.0	0.4	0.1	0.5	0.2	0.0	0.0	0.5	0.0	0.0	0.6	0.0	1.0	0.6	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.4	0.0	0.4	0.0	1.4	1.4	3.1	0.6	0.1	0.0	0.0	0.1
TNFRSF11A	"CD265, FEO, LOH18CR1, PDB2, RANK"	ENSG00000141655	"TNF receptor superfamily member 11a"	Q9Y6Q6	18	62325287-62391292	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 28.7;intestine: 23.9;salivary gland: 34.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 21.1;monocytes: 34.3;Mucus-secreting cells: 23.6;Paneth cells: 28.1;Undifferentiated cells: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"NK-cell: 8.9"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 8.9"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 52.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010391, HPA047976"	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	Cytosol	"CAB010391: AB_2205352, HPA047976: AB_2680227"	"unprognostic (4.08e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.96e-4)"	"unprognostic (4.24e-3)"	"unprognostic (7.79e-4)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.69e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.07e-2)"	6.5	1.7	1.7	4.8	1.2	0.2	4.3	0.4	2.3	1.5	18.4	0.8	7.6	23.1	0.9	1.9	3.8	1.3	28.7	1.1	1.3	0.7	0.9	0.8	2.3	7.4	1.0	1.0	0.7	2.9	0.1	10.1	2.8	0.7	2.1	13.9	1.3	34.3	12.9	0.6	3.3	23.9	1.3	2.9	1.2	4.3	1.2	0.8	0.7	2.0	1.8	2.3	2.3	2.3	0.0	0.6	0.2	0.0	8.9	1.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.0	1.5	0.1	0.6	0.9	3.5	0.3	0.1	52.5	2.3	0.0	0.5	0.7	0.0	0.2	0.5	0.1	0.1	0.3	1.3	1.8	1.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.5	2.9	8.3	0.1	0.0	0.2	0.6	0.6	8.9	0.3	0.2	1.3	0.0	0.3	0.5	0.1	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	8.9	0.0	0.6	1.0	0.0	1.7	1.2	0.4	2.3	1.3	0.7	1.0	1.0	0.7	0.8	0.0	2.1	0.0	2.9	1.1	0.4	1.1	10.2	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.2	2.2	21.1	0.0	6.5	0.6	0.3	2.6	0.0	0.0	12.8	3.2	10.4	3.7	15.0	0.0	0.6	2.5	1.7	34.3	23.6	0.0	9.6	28.1	0.0	0.0	0.0	0.0	0.3	0.7	1.4	1.9	0.1	0.0	33.6	3.8
TOR1B	"DQ1, MGC4386"	ENSG00000136816	"Torsin family 1 member B"	O14657	9	129803153-129811281	"Predicted intracellular proteins"		"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013403, HPA013697, CAB022709"	Approved		Uncertain	"Nuclear speckles,Cytosol"	"Intracellular and membrane"	NA	NA			"Nuclear speckles"	Cytosol	"CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196"	"unprognostic (2.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.69e-3)"	14.2	14.4	9.7	13.8	12.2	14.0	18.4	23.6	11.9	11.3	22.5	10.5	11.6	12.3	14.0	8.2	13.5	10.5	15.0	13.3	11.7	11.5	11.8	35.3	13.0	10.8	9.4	9.0	10.8	21.1	13.3	13.6	20.0	10.6	12.9	25.8	10.8	12.8	13.7	13.5	13.0	18.1	14.2	8.9	12.4	14.9	19.5	8.3	16.8	16.4	10.0	11.9	14.9	18.0	4.6	6.2	17.2	14.6	7.3	12.3	8.4	5.3	12.3	5.1	13.7	25.9	19.4	12.0	19.2	12.5	13.2	13.1	10.1	12.2	3.8	12.2	18.8	20.6	21.8	5.6	7.9	13.6	13.9	5.9	3.3	10.4	7.1	11.1	6.3	14.9	11.0	13.9	18.8	9.3	9.8	11.7	10.1	11.5	8.9	12.3	14.9	8.6	9.9	10.8	25.1	9.7	3.5	9.0	11.5	10.1	5.6	7.1	8.3	12.4	14.3	7.6	9.7	20.6	6.2	10.7	25.0	11.9	29.7	16.4	6.5	24.2	3.2	13.7	8.2	16.9	6.3	11.5	17.2	12.2	14.6	12.3	3.9	9.5	10.5	6.2	4.6	7.1	7.1	14.2	7.3	8.5	3.8	9.1	8.4	9.7	12.2	23.6	11.9	11.7	11.5	9.4	9.0	10.6	8.3	8.9	3.7	4.5	5.2	5.8	2.5	5.1	5.1	5.3	1.2	5.2	3.9	9.7	0.0	8.8	9.2	6.7	8.0	0.0	12.2	15.2	8.5	9.2	4.6	13.5	10.8	6.4	18.4	11.6	4.3	10.9	4.0	7.6	3.3	12.6	15.5	4.8	10.0	3.5	5.3	3.0	2.5	19.4	9.5	10.3	7.0	4.6	12.7	10.0	10.7	10.1
TPH1	"TPH, TPRH"	ENSG00000129167	"Tryptophan hydroxylase 1"	P17752	11	18017564-18042426	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 4.2;intestine: 16.2;pituitary gland: 5.4;stomach 1: 13.3"	"Cell type enriched"	"Detected in many"	164	"Intestinal endocrine cells: 1412.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"cerebral cortex: 4.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 4.5"	"Low region specificity"	"Detected in some"							"CAB010767, HPA022483"	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"CAB010767: AB_261587, HPA022483: AB_1858378"	"unprognostic (2.14e-4)"	"unprognostic (9.97e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.26e-5)"	"unprognostic (1.73e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.19e-4)"	"unprognostic (6.72e-2)"	"unprognostic (5.40e-8)"	"unprognostic (3.76e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.46e-5)"	0.7	0.0	0.7	0.7	0.7	0.6	0.9	0.7	4.2	0.7	7.1	0.7	0.7	8.2	0.7	0.7	0.7	1.5	0.7	0.7	0.7	0.3	0.7	0.7	0.7	0.7	0.7	0.7	1.0	0.7	0.0	5.4	0.7	0.7	1.3	16.2	0.7	0.7	0.7	0.7	1.0	9.1	0.7	0.7	1.0	13.3	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	1.4	0.8	1.5	0.5	0.9	1.6	0.2	0.4	0.1	1.7	1.5	0.1	0.0	0.6	0.6	0.5	0.2	1.1	1.8	0.3	1.4	0.3	0.0	0.1	0.6	0.4	1.5	0.7	1.3	3.1	2.2	0.8	3.5	0.0	4.5	1.2	0.0	1.8	0.2	0.6	0.3	0.7	2.7	0.9	0.8	0.1	0.5	1.0	0.7	0.5	0.1	0.3	1.7	0.3	0.0	0.0	1.0	1.3	0.9	0.2	0.4	0.9	0.2	0.3	2.9	0.2	0.4	1.3	0.5	1.7	0.2	0.3	1.1	0.2	1.0	1.4	1.5	0.4	0.4	1.6	0.2	0.8	0.5	0.5	0.4	0.1	1.4	0.6	0.6	1.5	0.9	0.5	0.8	0.6	0.2	0.7	0.7	0.7	4.2	0.7	0.3	0.7	0.7	0.7	0.7	0.0	0.0	0.0	0.4	0.3	4.7	0.4	0.0	1.4	0.0	5.2	2.0	0.2	0.0	0.2	0.7	0.3	1.0	0.0	0.5	0.0	0.7	2.0	0.0	0.0	0.2	1.6	1412.4	0.0	0.0	0.4	0.9	0.9	0.0	0.0	2.8	1.5	0.4	8.6	1.1	0.2	6.0	6.5	1.0	2.7	3.4	1.3	0.0	0.5	1.7	0.0
TRIM60	"FLJ35882, RNF129, RNF33"	ENSG00000176979	"Tripartite motif containing 60"	Q495X7	4	165031953-165041744	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"placenta: 5.0;testis: 6.6"	"Cell type enhanced"	"Detected in some"	11	"Cytotrophoblasts: 4.8;Extravillous trophoblasts: 8.2;Spermatocytes: 3.8;Spermatogonia: 6.4;Syncytiotrophoblasts: 4.7"	"Cancer enriched"	"Detected in single"	103	"testis cancer: 5.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"BEWO: 18.0"	"Not detected"	"Not detected"							"HPA035809, HPA035810, HPA061496"	Uncertain		Uncertain	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540"															"unprognostic (1.10e-1)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.7	1.1	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.4	0.1	0.2	1.1	0.2	0.3	0.0	0.5	0.3	0.2	1.1	0.1	0.1	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.5	0.0	1.4	0.0	0.0	0.0	4.8	0.0	0.0	1.6	0.0	0.0	0.0	0.0	8.2	0.2	0.2	0.0	0.8	0.4	0.0	0.0	0.0	2.2	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.3	0.0	0.0	3.8	6.4	0.3	4.7	0.5	0.0	0.0
TRIM73	TRIM50B	ENSG00000178809	"Tripartite motif containing 73"	Q86UV7	7	75395063-75410996	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"stomach 1: 11.5"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 20.3;Cone photoreceptor cells: 17.7;Horizontal cells: 30.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 7.9;Hep G2: 13.3"									"HPA047843, HPA051845"	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA047843: AB_2680176, HPA051845: AB_2681635"	"unprognostic (1.01e-2)"	"unprognostic (9.85e-5)"	"unprognostic (4.72e-3)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.46e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-3)"	1.9	1.6	0.3	1.2	0.9	2.4	1.6	4.0	0.6	2.4	0.6			4.2	1.7	0.3	0.3	3.8	1.0	0.9	0.4	0.5	1.7	2.3	1.1	2.3	0.2		2.3	7.2	1.3	1.7	0.1		2.1	0.0		1.9	1.9	2.6	2.4	2.2	0.0	0.5	1.8	11.5	5.4			2.4		0.2	0.7	1.3	1.3	1.4	2.0	0.8	1.7	2.2	1.3	1.3	4.1	1.7	2.5	0.0	0.9	0.6	0.5	0.1	0.1	1.0	0.0	2.0	2.3	0.4	0.2	0.3	1.4	0.3	0.0	0.2	5.1	7.9	1.5	3.1	13.3	0.9	0.8	5.6	2.3	0.0	0.3	0.4	1.2	0.1	3.3	0.7	6.5	0.0	0.9	2.1	2.7	0.2	0.3	1.4	3.6	0.2	1.2	0.4	0.0	2.1	1.6	2.6	0.9	2.1	0.7	0.6	2.4	1.6	1.1	1.9	1.7	1.1	3.1	1.8	2.4	1.7	3.3	1.5	1.1	0.8	0.7	2.2	0.6	1.2	1.1	1.3	0.4	0.4	1.3	2.1	1.6	2.0	1.7	0.2	1.4	2.0	1.3											0.0	0.3	1.9	2.2	0.8	20.3	2.0	2.5	5.3	3.4	5.2	17.7	1.9	5.0	1.6	5.0	2.2	2.0	0.0	4.0	0.6	1.3	2.7	0.0	1.8	2.5	30.2	4.7	3.1	1.0	8.5	6.1	1.7	1.7	1.0	4.0	9.5	3.1	4.0	3.5	2.9	12.6	0.0	1.1	9.4	2.7	1.8	0.9	4.5	3.3	2.4
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564032	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 76.6;Spermatogonia: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli, Actin filaments"	Cytosol	"HPA047601: AB_2680099, HPA058241: AB_2683651"	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (1.68e-2)"	7.0	8.9	6.5	7.5	8.9	3.3	13.1	6.1	8.7	4.6	6.0	9.3	7.5	7.3	5.5	7.2	9.2	10.1	6.1	5.0	7.9	6.7	9.1	16.8	4.9	7.4	9.2	6.1	6.6	12.4	6.7	12.2	10.0	9.7	7.4	6.9	2.5	7.3	4.7	9.3	6.5	10.4	5.1	10.5	7.0	7.6	16.7	10.1	10.7	10.8	5.1	8.0	7.2	10.8	8.8	10.0	9.2	7.6	5.8	7.1	4.0	6.7	4.8	9.3	4.8	5.5	7.8	6.7	8.2	3.2	5.8	4.3	3.9	8.4	9.3	3.2	4.8	5.2	3.9	10.8	5.2	8.9	11.8	4.8	6.4	4.1	6.4	5.3	16.2	6.9	4.9	13.4	5.8	12.7	3.4	5.8	8.5	14.7	8.4	4.9	7.8	13.6	3.3	5.5	12.1	4.6	7.9	8.9	5.9	7.8	5.5	5.8	5.1	4.5	24.9	8.2	8.1	8.1	7.0	4.2	5.9	6.1	4.8	9.3	5.8	9.8	8.5	4.5	9.5	4.1	4.0	7.6	3.7	3.8	7.1	3.1	6.3	6.5	6.4	10.0	8.8	6.7	6.2	9.2	5.8	6.2	5.6	7.1	4.0	6.5	8.9	6.1	8.7	7.9	6.7	9.2	6.1	9.7	10.1	3.0	9.3	6.0	5.1	7.2	4.6	5.9	12.7	20.1	4.5	10.4	3.9	14.6	36.5	11.9	34.0	6.7	10.7	0.0	16.6	14.7	5.4	5.0	8.1	24.2	7.1	4.8	6.9	9.2	7.9	11.7	6.1	4.7	5.0	5.4	9.8	7.8	14.8	11.0	7.1	17.0	5.9	12.9	7.1	76.6	51.2	8.3	14.6	4.8	9.6	5.9
TRMT61B	FLJ20628	ENSG00000171103	"TRNA methyltransferase 61B"	Q9BVS5	2	28849821-28870301	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA026747, HPA026751"	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA026747: AB_1848782, HPA026751: AB_1848784"	"unprognostic (1.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.36e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (9.61e-5)"	"unprognostic (2.19e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.34e-1)"	11.6	19.5	20.4	12.8	22.5	10.9	18.5	33.7	21.0	13.8	11.7	17.4	10.9	19.2	15.6	20.4	12.6	11.8	10.1	16.3	17.2	18.4	19.8	16.9	9.0	13.8	17.0	15.6	13.7	10.0	21.1	25.4	12.2	17.8	15.2	13.2	14.2	12.6	11.8	17.9	11.9	18.6	14.4	14.7	13.2	12.4	14.6	18.7	12.6	12.8	10.4	14.5	14.8	10.8	11.9	6.8	2.7	7.0	13.9	12.4	6.3	17.9	10.8	11.0	19.4	15.0	12.9	13.3	10.7	13.3	13.7	12.8	12.3	9.7	19.0	9.9	9.3	16.4	14.1	15.3	13.0	14.2	14.2	10.3	5.8	8.9	16.1	17.1	12.2	6.6	13.1	14.5	10.8	14.8	10.1	13.0	12.5	11.7	7.3	11.2	7.1	10.8	18.6	20.3	21.4	17.4	8.1	17.7	16.4	11.9	11.7	18.6	19.8	11.5	18.2	17.5	9.6	9.3	4.3	10.2	9.2	15.4	9.0	13.4	9.1	14.9	29.5	12.1	18.4	12.2	0.0	6.6	2.7	9.8	7.0	12.1	11.9	11.1	10.5	6.4	11.6	12.4	8.9	0.9	13.9	5.7	6.8	11.6	6.3	20.4	22.5	33.7	21.0	17.2	18.4	17.0	15.6	17.8	18.7	14.9	5.4	12.0	9.6	16.1	9.9	2.0	10.2	12.0	9.1	8.7	5.9	17.9	13.3	12.4	6.3	6.8	7.1	0.0	8.9	13.0	9.9	6.1	9.2	8.3	8.0	6.4	4.6	1.3	6.9	2.7	8.1	7.1	6.8	10.0	9.5	9.1	9.0	9.9	9.9	23.8	20.7	6.5	9.5	21.8	9.6	13.8	7.3	7.9	13.3	6.5
TSPAN15	"NET-7, TM4SF15"	ENSG00000099282	"Tetraspanin 15"	O95858	10	69451473-69507669	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 106.8;Exocrine glandular cells: 167.5;Mucus-secreting cells: 103.1;Pancreatic endocrine cells: 141.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 17.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 34.9;EFO-21: 48.7;MCF7: 36.8;OE19: 33.8;PC-3: 60.5;SK-BR-3: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044657, HPA071160"	Approved		Approved	"Nuclear bodies,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nuclear bodies, Plasma membrane"	"Vesicles, Cytosol"	"HPA044657: AB_10967927, HPA071160: "	"unprognostic (2.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.81e-3)"	"prognostic unfavorable (8.00e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.22e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.78e-3)"	34.2	3.1	11.5	9.7	22.7	0.9	24.9	40.4	17.0	8.9	30.4	49.2	12.5	24.0	15.1	8.4	7.1	16.2	17.1	8.3	18.0	9.2	10.2	3.0	20.4	4.9	33.1	11.2	3.0	10.8	1.4	3.3	17.7	16.8	17.6	24.9	5.4	16.8	17.0	9.9	4.6	21.5	23.0	43.0	13.5	46.4	4.0	28.3	0.8	6.7	2.7	4.8	22.6	6.8	0.0	2.7	0.0	0.0	0.1	17.4	0.5	11.1	23.2	0.4	0.0	0.5	0.0	2.7	0.0	0.4	0.6	1.5	10.0	34.9	0.0	48.7	0.5	2.1	22.8	1.6	2.5	0.7	9.2	4.6	0.6	0.7	2.2	0.2	0.0	0.4	0.5	0.7	0.3	0.3	1.7	8.9	4.6	0.2	0.0	0.2	36.8	0.1	0.2	0.6	33.8	60.5	0.8	0.4	0.4	6.8	20.7	7.9	3.0	0.1	30.7	3.8	4.1	13.4	0.5	7.7	0.0	0.1	0.0	3.8	0.2	1.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	17.4	0.0	2.7	2.5	2.7	0.0	0.9	0.2	0.0	0.1	0.0	0.2	0.9	0.5	11.5	22.7	40.4	17.0	18.0	9.2	33.1	11.2	16.8	28.3	29.8	5.8	2.7	9.7	3.2	3.0	0.8	25.5	14.7	6.8	27.9	5.9	1.5	3.3	106.8	26.3	18.7	73.5	0.0	167.5	9.1	4.7	50.7	1.1	0.0	20.5	1.6	38.6	11.1	5.6	4.9	0.6	10.5	27.0	27.1	103.1	36.7	141.3	88.3	0.0	1.3	1.4	12.9	7.6	0.9	17.7	2.8	2.5	2.5	61.6	27.1
TSPO	"BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS"	ENSG00000100300	"Translocator protein"	"B1AH88, P30536"	22	43151514-43163242	"Cancer-related genes, FDA approved drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 139.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 81.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB011232, HPA046260, HPA072304"	Uncertain		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			Mitochondria	"Vesicles, Cytosol"	"CAB011232: , HPA046260: , HPA072304: "	"unprognostic (5.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.02e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-3)"	33.9	21.2	9.8	17.8	11.0	117.3	48.7	2.7	8.1	24.9	23.9	12.3	10.3	20.5	12.3	13.6	83.2	14.3	36.8	32.1	8.0	5.4	18.0	22.0	39.8	40.0	15.4	5.2	13.3	13.2	4.0	6.7	15.5	9.7	23.1	9.7	16.4	34.6	9.2	13.2	46.6	23.0	12.7	11.4	27.2	39.0	10.5	10.0	9.4	17.9	44.3	50.0	19.1	41.3	22.9	99.9	91.4	139.5	28.5	43.8	104.8	47.6	23.6	1.6	22.4	9.0	29.9	1.8	35.6	17.4	17.9	19.1	4.6	36.5	0.0	24.7	27.6	8.8	39.5	4.5	27.6	2.3	7.9	18.6	4.8	25.9	1.6	32.7	10.8	24.4	23.2	45.5	10.6	9.5	21.1	42.4	0.0	3.9	9.0	18.3	39.9	0.1	30.2	1.9	24.6	59.0	10.7	0.0	81.4	22.9	28.8	2.3	11.0	16.9	33.8	41.5	0.0	12.7	42.0	43.7	22.3	16.7	22.7	14.9	3.6	0.6	0.4	28.9	35.1	28.5	43.8	139.5	75.3	28.4	86.3	22.2	16.3	39.5	27.8	99.9	22.9	30.4	24.5	91.4	28.5	57.1	17.7	43.8	104.8	9.8	11.0	2.7	8.1	8.0	5.4	15.4	5.2	9.7	10.0	148.9	135.1	105.0	344.2	325.8	2.2	79.7	336.3	127.2	167.2	195.4	2.0	9.0	313.4	570.0	2.1	215.5	499.4	46.7	512.5	126.3	307.4	297.1	261.1	99.0	745.0	3.2	187.3	163.2	688.0	6.1	76.5	573.3	686.7	477.9	485.1	116.9	963.2	644.9	148.2	97.5	17.1	103.5	217.3	1.1	4.9	468.6	16.7	155.6	529.3	666.0
TTC3	"DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII"	ENSG00000182670	"Tetratricopeptide repeat domain 3"	P53804	21	37073226-37203112	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016810, HPA023964, HPA036304"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli"	Cytosol	"HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: AB_2675049"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.52e-2)"	"unprognostic (9.29e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-2)"	22.9	22.1	34.0	18.7	36.5	12.0	23.4	39.2	40.0	34.9	20.6	15.9	26.7	13.0	21.6	33.3	15.3	19.5	19.0	21.5	29.1	16.5	21.4	17.0	15.4	14.3	17.7	27.5	34.5	25.8	27.4	50.4	15.2	34.7	28.9	19.9	16.1	24.5	25.4	21.6	16.1	16.8	21.6	21.7	13.6	21.3	19.5	19.9	19.7	35.4	11.1	15.1	23.3	18.9	10.6	12.8	4.8	5.7	9.1	18.6	3.8	21.7	7.8	36.3	6.8	35.0	51.1	12.6	24.0	29.9	10.8	14.7	10.2	11.0	18.8	8.4	40.2	10.1	7.2	10.9	14.8	15.3	19.9	7.8	38.0	11.6	13.4	12.8	21.2	12.3	26.4	9.1	11.0	9.8	21.8	16.0	16.7	22.8	22.1	20.3	16.8	20.6	5.5	10.3	14.5	13.2	27.6	17.4	9.9	12.6	16.9	27.7	21.1	29.8	17.1	15.4	8.7	19.4	8.3	20.9	15.5	6.2	19.0	9.0	22.2	15.9	18.8	25.6	21.2	11.7	2.9	4.4	4.8	9.1	4.8	13.6	9.5	10.6	12.3	7.9	10.6	18.6	11.3	0.7	9.1	5.7	12.8	7.2	3.8	34.0	36.5	39.2	40.0	29.1	16.5	17.7	27.5	34.7	19.9	116.1	118.5	109.7	81.2	58.5	344.6	127.3	56.0	75.0	101.2	71.5	214.0	39.6	140.9	74.9	160.4	67.6	60.1	0.0	65.5	79.7	132.8	164.9	62.4	80.5	56.3	311.4	182.6	102.5	80.0	149.3	194.5	74.4	200.8	61.3	133.8	187.6	72.0	84.2	245.4	81.7	228.9	51.8	103.8	264.1	280.4	54.8	44.1	76.7	118.3	90.4
TXNRD2	"TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941992	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Approved	Vesicles,Mitochondria,Cytosol		NA	NA		410000	"Vesicles, Mitochondria, Cytosol"		"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	9.8	30.2	8.5	8.3	10.1	11.6	7.4	19.0	15.0	8.3	10.3	9.0	7.6	9.2	11.9	12.3	8.8	8.4	13.0	22.6	8.3	7.5	13.9	40.9	10.8	8.4	7.8	9.7	11.9	13.0	9.9	9.9	14.0	7.1	17.9	4.5	10.0	15.2	8.8	16.5	6.0	10.2	5.4	5.6	11.2	14.6	10.5	6.8	4.9	12.6	9.2	10.5	7.5	7.9	4.8	9.1	5.8	12.1	4.8	4.9	4.9	6.4	13.3	1.2	5.2	2.4	3.4	3.0	6.2	7.3	11.2	8.3	12.4	6.7	3.6	15.1	6.5	11.6	11.4	6.2	8.5	4.3	6.8	15.3	6.0	10.6	7.3	4.6	6.7	2.9	3.3	6.5	5.7	4.9	4.6	31.8	0.7	33.2	6.1	8.7	15.6	2.3	10.0	6.1	15.9	9.5	3.4	29.6	3.3	6.8	7.0	6.6	5.8	10.7	13.9	7.1	2.1	11.4	9.1	17.7	8.2	49.4	6.8	13.0	6.1	4.4	2.2	7.9	5.1	10.3	3.2	12.1	5.8	4.3	9.2	3.3	4.8	3.8	3.9	9.1	3.6	4.9	4.0	1.3	4.8	8.7	3.4	2.4	4.9	8.5	10.1	19.0	15.0	8.3	7.5	7.8	9.7	7.1	6.8	14.9	27.1	5.2	19.2	3.8	20.0	13.6	17.8	13.4	10.3	19.2	9.8	51.6	49.7	18.7	21.0	11.3	13.5	0.0	27.8	19.6	12.5	19.5	1.1	47.4	23.3	9.5	1.2	10.4	20.5	14.1	14.4	12.1	5.0	25.2	12.1	19.0	19.9	14.0	8.5	44.0	9.5	6.5	9.1	8.6	12.8	4.5	35.1	11.7	14.7	12.7
TYSND1	"MGC34695, NET41"	ENSG00000156521	"Trypsin domain containing 1"	Q2T9J0	10	70137981-70146676	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.7"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 90.7;Late spermatids: 154.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 18.0;PC-3: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030304	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Centrosome"	Cytosol	"HPA030304: AB_10670560"	"unprognostic (4.75e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	15.2	8.2	4.7	7.0	6.8	3.0	8.0	6.7	7.3	6.0	6.7	5.9	6.9	10.1	5.3	8.4	13.9	5.4	5.2	3.5	3.7	2.8	7.4	7.4	3.5	7.2	3.7	3.6	5.6	9.0	3.3	4.5	4.7	3.5	6.9	2.7	6.9	8.0	5.7	5.3	12.5	8.5	4.8	4.7	9.0	8.2	40.7	3.4	6.2	8.5	6.6	10.1	6.5	7.6	6.1	1.4	1.2	1.6	2.9	6.3	2.3	9.5	6.9	0.5	4.1	0.8	0.6	2.5	1.2	0.9	1.4	1.3	4.3	6.1	8.6	4.0	0.3	0.3	18.0	0.7	2.7	0.3	5.4	6.2	0.5	1.9	2.1	1.7	0.7	0.0	1.3	5.2	1.2	2.2	0.8	1.0	3.1	0.0	2.6	0.6	4.2	3.2	3.5	2.2	2.3	27.7	5.7	1.6	3.8	0.6	1.6	5.0	2.6	4.2	9.4	3.6	0.2	6.1	0.7	1.7	1.6	1.1	3.0	5.4	9.8	5.9	4.2	1.9	3.6	1.2	0.0	1.3	1.2	6.3	1.6	4.1	5.1	3.7	4.9	1.4	6.1	5.3	4.4	0.4	2.9	1.1	1.0	4.0	2.3	4.7	6.8	6.7	7.3	3.7	2.8	3.7	3.6	3.5	3.4	8.9	4.0	13.7	13.8	12.7	6.8	4.3	25.5	1.4	5.7	10.4	0.0	30.0	14.9	6.8	90.7	6.7	14.8	0.0	8.3	6.8	6.3	10.9	13.8	14.3	10.7	0.0	13.7	6.7	9.5	154.7	8.6	8.0	11.8	2.8	10.6	6.2	5.1	10.5	7.4	12.4	4.5	6.5	4.7	41.1	11.1	16.2	14.0	11.8	20.3	5.2
UBE2D3	UbcH5C	ENSG00000109332	"Ubiquitin conjugating enzyme E2 D3"	P61077	4	102794383-102868896	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003920	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (7.43e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.31e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.34e-2)"	67.2	70.6	39.1	52.7	44.6	132.7	70.4	36.9	50.9	45.5	51.8	37.5	38.4	49.3	46.3	39.1	63.2	45.7	47.5	72.5	37.3	39.5	63.0	91.9	67.5	68.1	43.4	36.9	60.6	53.4	42.8	49.1	66.5	45.2	49.6	48.5	38.4	46.7	43.3	91.1	53.2	58.9	48.4	44.4	68.2	49.5	40.0	42.2	88.8	66.3	55.4	61.4	74.6	81.4	24.7	31.2	118.0	36.2	29.7	33.2	50.9	53.5	30.7	51.2	41.3	54.7	79.0	44.0	54.5	72.7	48.7	46.0	46.0	76.5	57.4	35.7	55.3	63.2	30.7	54.6	73.2	67.1	53.2	27.5	52.2	31.6	37.5	57.4	73.4	45.0	59.9	46.4	53.7	75.3	63.0	63.1	47.3	65.6	58.7	64.8	43.2	107.7	41.8	37.1	61.3	30.7	56.8	50.3	41.4	49.1	51.2	51.8	43.6	33.5	86.1	61.5	63.1	35.7	43.4	57.9	51.0	43.6	33.3	49.5	52.0	67.0	87.8	54.3	40.9	54.7	71.1	35.9	54.6	25.1	36.1	33.2	24.7	31.8	29.6	31.2	20.1	32.6	29.7	118.0	29.7	36.2	21.5	32.6	50.9	39.1	44.6	36.9	50.9	37.3	39.5	43.4	36.9	45.2	42.2	154.9	181.2	227.9	605.7	749.7	127.0	210.7	150.3	190.1	129.7	132.6	117.8	279.1	464.2	286.3	668.3	228.0	265.9	93.5	333.2	474.9	260.0	477.5	219.4	203.4	354.6	116.0	231.0	159.0	357.1	423.2	152.5	359.3	339.1	356.1	198.5	111.8	351.4	245.4	140.0	328.0	157.1	103.5	376.3	128.5	151.0	711.0	533.9	297.5	192.3	680.6
UBE2L5	UBE2L5P	ENSG00000236444	"Ubiquitin conjugating enzyme E2 L5"		13	30422488-30428616	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	9	"testis: 31.5"	"Cell type enriched"	"Detected in single"	4	"Ciliated cells: 1.4"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in single"			"HPA045609, HPA062415"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: AB_2684756"	"unprognostic (2.09e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.01e-3)"	"unprognostic (6.41e-4)"	"unprognostic (1.78e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.50e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.44e-2)"	"unprognostic (8.75e-2)"	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.3	0.3	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.7		0.3	0.2	0.2	0.1	0.2	0.5	0.3	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	31.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.2	1.9	2.7	3.6	1.9	2.0	2.8	0.7	0.3	1.3	1.6	0.6	0.7	0.7	1.2	0.6	0.4	0.2	0.0	3.1	1.4	0.6	1.3	1.3	0.6	0.8	0.4	1.1	2.5	0.6	0.4	0.8	0.2	0.2	0.7	1.5	0.2	0.3	0.6	0.2	1.4	0.9	0.9	0.8	1.3	0.3	0.0	1.6	2.6	1.4	0.2	0.2	0.4	0.6	0.4	0.9	1.5	1.2	0.3	0.4	0.1	1.8	0.9	0.6	2.4	0.0	0.7	0.5	0.7	1.1	1.5	0.3	1.6	1.0	0.9	0.4	1.8	1.1	1.9	1.4	3.6	1.2	3.2	1.5	1.6	1.5	1.7	1.4	2.0	2.7	1.9	1.6	1.9	2.0	2.8											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UBE2R2	"CDC34B, FLJ20419, MGC10481, UBC3B"	ENSG00000107341	"Ubiquitin conjugating enzyme E2 R2"	Q712K3	9	33817567-33920404	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 295.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 21.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061000, HPA074334"			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA061000: AB_2684408, HPA074334: "	"unprognostic (1.51e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.82e-3)"	"unprognostic (4.61e-3)"	"unprognostic (3.05e-3)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.43e-1)"	26.1	19.7	29.4	19.7	26.8	13.9	39.3	23.7	32.3	25.6	24.1	27.9	16.3	28.0	26.1	18.4	25.3	22.3	21.8	29.2	25.5	20.3	22.1	34.5	23.0	27.1	30.5	23.2	29.8	44.5	15.7	13.9	24.6	21.6	21.0	21.4	19.3	18.7	20.8	56.1	28.1	25.7	28.5	24.2	21.6	20.8	34.5	29.6	36.7	19.5	22.5	25.7	35.8	30.5	3.3	4.2	21.9	11.6	5.0	2.1	2.4	16.5	18.1	35.0	15.2	19.3	31.5	10.8	14.7	20.5	17.3	17.3	14.5	12.4	14.1	6.0	20.5	12.6	7.4	18.3	16.8	19.0	23.2	9.7	12.2	20.0	18.4	27.5	14.4	13.3	26.7	25.0	14.1	26.8	27.7	29.0	17.0	11.4	15.2	17.1	9.6	27.1	38.0	19.9	14.2	15.1	25.3	10.6	7.3	18.3	12.5	16.4	19.7	17.2	15.4	11.0	23.2	13.5	17.6	21.7	16.7	15.2	11.5	13.6	9.7	9.1	19.8	15.9	8.4	35.9	12.4	7.5	4.1	2.0	7.5	1.3	3.1	1.9	1.6	4.2	3.3	1.9	1.7	21.9	5.0	11.6	2.6	2.1	2.4	29.4	26.8	23.7	32.3	25.5	20.3	30.5	23.2	21.6	29.6	20.8	30.7	29.5	39.6	93.8	61.0	106.8	56.0	22.7	25.0	21.0	13.7	52.6	13.3	43.8	295.7	77.1	60.6	23.3	59.7	65.2	54.0	68.4	12.7	72.1	68.5	57.2	69.2	77.3	105.2	195.4	62.2	81.9	33.7	49.5	57.3	87.1	69.4	38.6	71.5	49.6	30.1	58.2	41.9	90.2	66.2	105.3	69.2	30.5	49.0	79.7
UGGT1	"HUGT1, UGCGL1"	ENSG00000136731	"UDP-glucose glycoprotein glucosyltransferase 1"	Q9NYU2	2	128091200-128195677	"Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012761, HPA015127"	Enhanced		Uncertain	Cytosol		NA	NA		3800000	Cytosol		"HPA012761: AB_1858597, HPA015127: AB_1858596"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.45e-2)"	"unprognostic (7.03e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-3)"	13.7	14.7	7.6	16.4	10.2	23.8	11.3	10.7	10.8	12.7	15.2	10.0	21.1	11.4	12.3	26.3	13.1	10.6	11.3	13.0	7.7	7.9	13.7	33.4	13.9	14.6	11.0	5.7	10.4	44.1	13.4	11.2	22.1	9.1	11.7	13.5	9.7	15.5	20.5	19.3	11.1	17.4	8.9	9.0	16.1	13.0	9.9	9.5	24.3	13.8	6.4	15.7	11.4	11.0	6.3	7.4	8.8	6.2	4.7	5.9	2.8	16.5	5.8	11.1	23.8	14.6	11.7	16.9	19.1	8.4	6.4	5.8	12.8	12.3	23.5	7.7	14.0	5.8	12.3	8.4	8.3	13.1	14.9	4.0	20.6	7.6	39.1	14.5	27.5	13.0	8.5	6.6	12.9	11.8	12.8	14.9	9.8	13.2	12.8	13.5	11.6	11.1	15.8	19.6	11.7	6.0	9.1	10.6	10.0	11.8	12.3	5.8	8.8	13.2	18.1	11.2	11.9	7.1	19.5	20.5	17.7	12.1	10.1	13.6	13.4	18.6	10.8	15.0	15.1	16.3	7.1	6.2	5.4	5.9	6.0	5.8	4.0	4.8	5.3	4.5	6.3	4.1	5.9	8.8	4.7	5.7	7.4	3.8	2.8	7.6	10.2	10.7	10.8	7.7	7.9	11.0	5.7	9.1	9.5	32.8	24.8	6.7	4.9	7.2	20.0	14.1	17.8	6.7	25.0	3.5	21.6	9.5	1.7	12.2	7.0	11.3	19.4	0.0	16.8	15.8	10.8	11.7	10.5	33.0	14.7	19.1	21.9	19.6	23.0	1.8	13.8	15.5	13.5	12.6	20.8	9.7	18.4	10.5	12.7	8.7	18.9	6.5	11.1	8.9	8.1	9.4	9.0	13.8	17.5	9.8
UQCC3	"C11orf83, UNQ655"	ENSG00000204922	"Ubiquinol-cytochrome c reductase complex assembly factor 3"	Q6UW78	11	62670273-62673687	"Disease related genes, Predicted membrane proteins"	"ATP synthesis"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046851	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA046851: AB_2679839"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.91e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.70e-3)"	"unprognostic (7.84e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.36e-1)"	10.0	13.4	8.9	11.4	8.5	10.6	14.7	8.7	9.9	7.3	15.4	4.7	19.7	16.5	7.3	8.5	14.5	6.5	12.4	13.2	8.0	8.7	10.7	13.4	5.6	8.3	8.5	8.7	9.5	15.4	5.3	7.6	6.2	7.7	12.3	4.9	7.1	22.9	14.1	27.8	8.6	14.8	6.0	6.2	9.6	12.2	5.7	5.4	6.4	13.5	12.3	9.1	8.0	18.1	23.7	21.2	15.2	20.8	14.0	19.4	15.5	12.0	24.5	3.6	5.6	2.2	2.2	3.0	4.8	1.6	3.6	3.6	14.3	10.5	7.8	10.0	1.6	4.9	12.0	3.4	5.6	1.1	3.9	12.7	4.4	12.8	9.1	3.0	7.1	3.6	2.1	4.8	3.2	3.6	2.3	2.8	3.8	9.4	5.7	2.0	36.8	6.9	17.5	4.0	4.8	13.9	8.1	5.5	13.9	2.7	6.0	7.3	7.4	5.3	19.4	7.1	1.1	18.4	6.7	3.6	7.9	9.3	8.2	10.6	8.8	4.8	8.1	6.5	6.2	5.7	9.1	20.8	15.2	18.1	14.4	17.1	23.5	18.0	15.9	15.8	23.7	16.6	13.3	8.9	14.0	12.7	21.2	19.4	15.5	8.9	8.5	8.7	9.9	8.0	8.7	8.5	8.7	7.7	5.4	41.7	23.5	61.4	42.6	0.0	20.8	31.7	66.2	22.7	29.6	61.1	15.7	44.7	119.3	51.7	1.4	26.8	115.3	46.7	67.1	41.2	21.0	70.4	4.7	99.1	47.7	17.5	33.9	39.9	38.4	2.3	44.8	22.9	0.0	43.3	98.1	39.6	57.0	91.2	33.9	137.3	26.2	38.8	31.1	2.7	33.7	0.0	24.3	25.9	101.8	45.4
UTP14A	"NY-CO-16, SDCCAG16, Utp14"	ENSG00000156697	"UTP14A, small subunit processome component"	Q9BVJ6	X	129906121-129929761	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047217, HPA054023"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA047217: AB_2679987, HPA054023: AB_2682346"	"unprognostic (6.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (7.67e-4)"	"unprognostic (3.00e-3)"	"unprognostic (8.24e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.99e-3)"	"prognostic unfavorable (8.12e-8)"	"unprognostic (4.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"unprognostic (9.99e-2)"	15.1	11.4	8.2	13.3	11.2	10.2	15.8	12.7	13.8	13.3	13.4	8.4	8.5	8.5	17.6	13.9	16.9	13.9	9.0	10.0	7.1	7.2	13.2	14.9	10.7	14.8	7.6	9.8	17.4	22.7	13.1	13.8	12.5	10.6	13.5	14.7	8.6	13.2	10.6	19.6	11.8	11.0	15.3	7.7	16.1	13.3	4.3	7.7	20.7	12.4	16.3	19.5	16.0	13.5	11.1	11.8	16.2	14.3	15.5	14.6	7.7	14.3	16.0	8.6	22.6	14.5	14.8	14.5	15.9	12.2	16.0	12.8	16.3	14.2	34.0	32.1	11.5	17.5	18.4	34.4	17.3	19.7	11.3	17.1	19.4	13.7	12.3	16.4	27.4	14.9	18.1	15.3	21.7	23.0	10.4	12.6	12.7	19.3	10.7	13.8	23.6	19.7	20.9	17.9	27.4	18.0	15.5	13.0	23.3	11.1	11.0	9.0	23.8	9.0	16.7	18.8	11.9	9.0	16.0	10.9	7.1	9.2	19.7	30.5	13.4	15.5	30.3	10.7	34.1	15.9	16.2	8.0	4.0	12.7	14.3	14.6	11.1	10.7	11.8	11.8	10.9	13.5	12.4	1.0	15.5	12.0	9.4	14.4	7.7	8.2	11.2	12.7	13.8	7.1	7.2	7.6	9.8	10.6	7.7	11.9	10.4	11.5	13.1	7.4	5.4	8.1	15.3	12.0	29.6	0.0	3.9	19.7	11.6	16.5	0.3	7.4	2.9	0.0	10.9	16.6	8.7	7.6	13.9	4.0	12.0	1.6	7.5	6.2	7.8	0.2	5.8	9.4	5.0	17.2	7.3	6.0	12.1	10.2	6.7	6.7	4.4	12.9	10.8	1.4	2.4	6.9	34.0	10.2	10.1	9.5
UTP14C	"2700066J21Rik, KIAA0266"	ENSG00000253797	"UTP14C, small subunit processome component"	Q5TAP6	13	52024691-52033600	"Predicted intracellular proteins"	"Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047217, HPA054023"	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA047217: AB_2679987, HPA054023: AB_2682346"	"unprognostic (7.89e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.47e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (7.35e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.46e-5)"	"unprognostic (2.44e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.04e-2)"	4.8	4.8	5.3	3.4	5.9	0.5	6.2	6.6	5.9	6.8	5.3			4.6	6.7	4.6	3.6	5.2	3.9	5.5	5.1	5.2	8.0	7.9	4.5	3.5	5.5		6.1	5.8	8.9	4.8	6.6		7.1	5.9		5.7	5.5	5.3	2.9	4.5	5.3	6.2	4.4	5.7	2.3			9.1		3.8	4.6	4.2	4.1	5.8	6.7	4.8	3.5	6.8	3.1	4.2	6.8	14.1	11.1	14.5	10.5	10.9	12.3	9.6	8.3	7.7	6.7	9.0	10.5	3.3	11.6	10.5	10.0	12.4	6.8	11.0	10.7	8.8	20.2	4.8	6.5	9.9	17.9	14.0	9.2	13.0	6.4	12.4	10.9	6.8	12.5	11.6	5.3	12.4	3.1	10.9	10.0	12.8	19.5	4.9	10.7	9.9	4.5	14.1	6.9	4.6	9.5	7.3	11.0	8.4	13.5	9.8	14.2	10.3	7.7	8.0	8.6	8.4	5.4	7.8	12.7	4.1	6.7	14.4	6.7	3.7	5.4	4.6	4.8	3.9	3.0	4.9	3.7	4.4	4.1	6.8	6.7	2.4	3.5	3.9	5.8	5.2	3.1											6.0	17.4	11.2	5.0	5.3	13.0	18.5	20.4	12.0	13.6	15.7	3.9	8.5	0.0	6.0	0.3	10.6	10.8	0.0	6.6	8.1	10.8	11.1	11.5	28.1	7.9	23.8	17.9	12.3	14.8	0.0	9.8	6.7	8.5	2.8	15.1	13.6	6.8	14.0	13.4	5.0	10.6	6.5	7.6	6.6	12.2	7.3	5.8	6.9	12.7	5.4
VENTX	"HPX42B, VENTX2"	ENSG00000151650	"VENT homeobox"	O95231	10	133237404-133241929	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 2: 1.4;Collecting duct cells: 1.8;Kupffer cells: 6.5;Macrophages: 5.6"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 30.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 2.4;classical monocyte: 4.6;intermediate monocyte: 5.1;myeloid DC: 3.1;neutrophil: 1.8;non-classical monocyte: 3.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.1;granulocytes: 2.4;monocytes: 5.1"	"Group enriched"	"Detected in some"	10	"NB-4: 18.0;NTERA-2: 10.3"									HPA050955	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	Cytosol	"HPA050955: AB_2681288"	"unprognostic (9.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.70e-4)"	"unprognostic (4.22e-1)"	"unprognostic (2.51e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.48e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.14e-1)"	5.6	2.4	1.2	6.6	1.2	4.4	2.0	1.2	1.2	1.7	1.7	1.2	1.2	0.4	1.7	1.2	1.2	2.0	2.5	1.2	1.2	1.5	1.9	1.2	4.4	1.2	1.2	1.2	1.7	2.1	1.0	1.5	1.2	1.2	1.2	0.4	1.2	1.5	1.2	1.2	2.0	1.2	2.1	2.2	7.3	0.9	6.3	1.2	2.9	1.2	1.2	1.2	1.5	1.2	0.5	3.1	2.4	5.1	0.6	0.3	1.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	18.0	10.3	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	1.4	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	2.4	4.6	0.6	0.3	5.1	0.1	0.5	0.2	0.2	3.1	0.5	0.2	0.3	1.8	0.6	3.9	0.2	0.1	1.0	1.2	1.2	1.2	1.2	1.2	1.5	1.2	1.2	1.2	1.2	0.0	1.4	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	6.5	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VPS50	"CCDC132, DKFZp313I2429, FLJ20097, KIAA1861, VPS54L"	ENSG00000004766	"VPS50, EARP/GARPII complex subunit"	Q96JG6	7	93232340-93361121	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026679	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA026679: AB_1846135"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.43e-2)"	"unprognostic (4.97e-2)"	"prognostic unfavorable (7.21e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.69e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (1.35e-6)"	"unprognostic (2.08e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	15.9	16.3	16.4	15.3	24.2	6.9	21.6	26.1	28.3	13.0	16.0	9.9	13.3	11.5	17.7	17.5	15.7	11.9	10.4	12.6	19.8	16.0	20.0	12.1	13.2	15.3	16.4	22.2	15.4	13.5	23.9	30.8	12.8	26.7	14.3	18.5	7.5	15.0	14.2	18.7	16.8	12.8	14.8	15.9	15.5	14.1	13.8	19.2	15.8	15.8	14.0	15.3	14.2	12.9	5.5	10.4	4.2	8.1	5.2	11.2	4.3	11.1	6.7	8.7	13.4	16.2	11.6	8.7	10.5	9.0	10.9	12.0	9.4	13.0	9.9	11.9	9.1	20.1	9.6	12.9	10.0	15.2	11.5	9.0	18.4	13.0	5.9	9.9	9.4	10.1	9.8	11.6	13.2	13.3	10.7	14.1	9.7	14.5	12.8	14.5	11.1	8.8	8.4	6.0	15.2	9.5	7.0	11.5	13.4	10.2	8.9	6.3	13.4	12.2	26.8	10.8	13.7	9.2	7.1	12.7	15.9	9.4	29.0	10.7	7.0	15.5	11.9	11.7	9.3	12.6	4.2	7.0	3.4	6.2	8.1	11.2	5.5	6.9	7.6	10.4	5.5	5.5	7.4	1.7	5.2	4.8	5.1	8.1	4.3	16.4	24.2	26.1	28.3	19.8	16.0	16.4	22.2	26.7	19.2	11.9	9.9	3.4	3.8	0.0	11.8	0.0	2.5	10.7	9.1	5.2	15.7	5.9	3.3	6.3	12.3	5.3	1.1	23.3	4.7	9.2	1.9	2.7	7.0	6.4	9.4	9.5	2.4	9.8	10.4	11.0	8.3	6.4	0.0	6.4	9.9	8.5	6.3	7.0	6.7	6.9	13.7	6.5	0.0	17.2	12.5	0.0	7.9	6.9	5.9	2.0
VSIG4	Z39IG	ENSG00000155659	"V-set and immunoglobulin domain containing 4"	Q9Y279	X	66021738-66040125	"Plasma proteins, Predicted membrane proteins"	"Complement alternate pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	31	"Hofbauer cells: 772.9;Kupffer cells: 436.3;Macrophages: 389.0"	"Cancer enhanced"	"Detected in all"		"glioma: 88.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	26	"classical monocyte: 13.9;intermediate monocyte: 8.1;myeloid DC: 13.1"	"Group enriched"	"Detected in many"	30	"dendritic cells: 13.1;monocytes: 13.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;HMC-1: 1.1;NB-4: 3.1;SH-SY5Y: 1.1;U-937: 2.7"					"Low region specificity"	"Detected in many"			"HPA003903, CAB026000"	Enhanced		Uncertain	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		41000000	"Plasma membrane, Cytosol"	Nucleoli	"CAB026000: , HPA003903: AB_1858776"	"unprognostic (6.87e-3)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.95e-6)"	"unprognostic (3.70e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.47e-2)"	67.1	28.1	15.9	17.6	16.6	2.6	19.0	1.8	10.4	6.3	18.0	5.6	1.0	9.2	6.1	14.2	9.3	28.7	15.5	15.9	11.5	3.5	18.5	22.9	61.4	37.0	17.9	3.4	8.2	8.2	3.7	7.9	52.4	12.0	10.9	12.6	8.1	11.3	4.0	10.5	4.0	14.6	39.9	16.7	28.5	9.4	13.5	17.8	0.0	10.7	1.7	1.8	14.4	9.0	0.1	13.1	0.4	13.9	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.5	0.0	0.0	0.1	3.1	0.2	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.8	2.7	0.0	0.0	13.9	0.0	0.0	8.1	0.0	0.0	0.0	0.2	13.1	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	3.3	15.9	16.6	1.8	10.1	11.5	3.5	17.9	3.4	12.0	17.8	3.0	17.3	3.0	0.1	2.1	0.0	0.8	7.6	8.1	5.7	0.0	0.0	4.4	0.0	0.0	5.8	1.9	0.0	0.0	0.0	3.7	3.8	0.2	3.5	2.4	772.9	0.0	0.0	5.5	436.3	13.2	1.4	389.0	3.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	6.5	0.2	0.2	0.9	1.5	10.3	0.0	0.0	0.2
WASHC2A	"bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824"	ENSG00000099290	"WASH complex subunit 2A"	Q641Q2	10	50067888-50133506	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 35.7;Ciliated cells: 76.3;Club cells: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoli, Cytosol"	"HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656"	"unprognostic (2.46e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (4.60e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.40e-2)"	24.0	21.0	15.8	31.4	19.3	24.7	27.1	22.5	18.3	19.1	21.2	16.2	12.6	19.4	22.8	15.3	15.7	15.5	14.4	42.9	17.6	13.9	26.1	12.1	20.7	20.2	15.3	15.8	22.5	14.0	21.2	27.0	17.7	22.0	16.7	23.0	13.1	17.5	16.5	15.5	19.2	21.3	16.8	14.6	27.4	16.2	9.4	14.8	27.0	21.4	9.8	20.2	18.4	27.4	6.6	9.0	11.7	13.9	9.0	12.5	8.8	11.1	5.4	9.2	10.8	37.6	21.0	7.5	13.1	27.8	19.5	20.8	12.5	16.7	9.8	8.2	19.5	18.3	12.2	13.3	11.0	19.3	9.4	9.7	7.0	10.8	12.5	26.2	11.9	12.2	21.6	13.9	21.3	13.5	20.5	14.7	8.4	11.3	9.9	23.4	7.9	6.5	19.5	7.5	7.1	25.5	10.0	13.4	5.8	13.4	12.8	3.2	9.9	12.2	11.3	17.4	14.2	14.0	8.2	21.5	10.0	8.4	28.1	10.7	10.3	20.3	8.4	21.9	21.9	4.0	1.2	10.7	11.7	12.0	13.9	12.5	6.6	10.2	11.0	9.0	6.5	10.2	7.4	5.1	9.0	8.2	5.3	10.4	8.8	15.8	19.3	22.5	18.3	17.6	13.9	15.3	15.8	22.0	14.8	35.7	22.0	0.0	0.0	0.0	0.0	0.0	0.0	76.3	42.1	14.0	0.0	6.6	0.0	14.2	0.0	0.0	0.0	0.0	13.5	5.7	0.0	0.0	14.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	10.0	0.0	0.0	12.2	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0
WASHC2C	"Em:AC012044.3, FAM21C, KIAA0592"	ENSG00000172661	"WASH complex subunit 2C"	Q9Y4E1	10	45727200-45792961	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 32.8;Alveolar cells type 2: 26.2;Ciliated cells: 45.5;Collecting duct cells: 22.7;granulocytes: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoli, Cytosol"	"HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656"	"unprognostic (7.50e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.98e-3)"	"prognostic unfavorable (1.35e-5)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-2)"	17.2	15.8	10.0	33.6	15.7	30.1	27.2	24.9	17.1	16.7	15.8	10.7	15.9	12.2	18.3	17.0	12.3	13.2	13.6	23.2	14.2	10.2	20.6	12.8	17.3	14.8	16.0	8.4	20.2	10.1	22.7	16.5	13.4	16.2	13.4	18.5	13.0	15.3	24.0	17.1	14.8	17.0	15.8	14.0	15.5	12.5	10.1	15.3	19.4	14.9	13.2	14.6	19.3	14.8	10.7	11.4	17.2	20.3	12.2	13.4	11.6	11.2	12.2	9.9	11.3	25.9	23.0	6.0	13.3	21.9	15.7	15.2	7.4	11.1	9.3	9.1	19.6	15.0	10.3	11.1	6.1	15.9	8.7	9.2	9.6	15.2	5.7	27.5	9.6	12.0	21.7	14.8	17.0	12.8	15.5	16.2	7.9	15.3	7.4	19.3	5.9	6.4	16.7	7.2	6.8	1.9	8.1	14.6	4.8	11.7	17.8	4.8	10.9	15.4	7.8	18.6	10.6	10.5	9.7	27.2	8.2	8.8	21.7	8.9	10.5	16.2	9.3	11.6	23.2	4.3	12.5	16.9	11.0	13.0	18.2	12.5	10.7	10.8	13.4	11.4	9.6	10.8	9.7	17.2	12.2	20.3	8.4	10.1	11.6	10.0	15.7	24.9	17.1	14.2	10.2	16.0	8.4	16.2	15.3	32.8	26.2	0.0	0.0	0.0	0.0	0.0	0.0	45.5	21.6	22.7	0.0	6.2	3.3	10.9	0.0	0.0	0.0	0.0	12.1	5.4	0.0	0.0	27.9	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	18.0	0.0	0.0	10.6	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0
WDR66	"CaM-IP4, MGC33630"	ENSG00000158023	"WD repeat domain 66"	Q8TBY9	12	121917862-122003927	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.6;pituitary gland: 28.4;testis: 35.0"	"Cell type enriched"	"Detected in many"	5	"Ciliated cells: 228.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 21.9;hTCEpi: 20.7;hTERT-HME1: 14.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039902, HPA040005"	Supported		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039902: AB_10795236, HPA040005: AB_10795160"	"unprognostic (4.92e-3)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (5.58e-3)"	"unprognostic (6.89e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	1.3	1.2	6.3	1.0	13.2	0.4	1.7	0.4	4.0	4.4	0.5	4.5	1.5	0.4	2.5	11.3	0.5	24.6	2.0	1.5	6.4	3.7	3.2	1.8	6.4	0.9	0.7	3.2	3.9	2.1	4.7	28.4	1.3	18.0	0.8	0.4	1.3	1.3	2.2	0.5	1.8	0.5	1.0	0.9	2.0	0.8	35.0	2.4	0.0	6.7	0.0	1.2	0.8	1.7	0.2	4.9	0.4	0.0	0.1	0.3	0.0	1.8	0.2	0.3	0.1	0.3	0.3	0.3	0.2	1.7	0.8	2.1	0.2	0.9	0.1	2.5	0.1	0.5	0.6	0.2	21.9	3.1	0.1	0.3	0.1	0.4	0.2	2.6	0.0	6.0	1.2	20.7	1.7	14.0	0.4	0.9	0.3	5.0	0.0	1.3	0.6	0.2	0.4	0.3	0.3	0.1	0.3	0.5	0.0	3.8	0.3	1.7	0.1	0.2	0.0	0.1	0.6	0.5	0.1	0.7	1.8	2.7	0.3	0.3	0.3	0.1	2.6	2.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.4	0.1	0.0	4.9	0.3	0.0	6.3	13.2	0.4	4.0	6.4	3.7	0.7	3.2	18.0	2.4	6.0	10.0	1.5	5.9	5.5	5.0	2.2	5.1	228.8	36.4	10.4	29.5	0.2	3.3	3.1	38.6	1.3	0.0	0.0	0.4	0.1	1.9	1.9	8.1	0.8	0.5	7.9	1.7	28.3	2.2	49.3	6.9	1.8	1.7	1.0	0.0	1.8	0.7	0.0	7.1	1.1	16.8	6.5	1.0	34.9	14.4	3.1	0.5	0.8	0.0	2.2
WEE2	FLJ16107	ENSG00000214102	"WEE1 homolog 2"	P0C1S8	7	141708353-141731271	"Enzymes, Predicted intracellular proteins"	Meiosis	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	21	"Distal tubular cells: 1.7;Proximal tubular cells: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"CACO-2: 8.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA027418, HPA054280"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027418: AB_10603144, HPA054280: "	"unprognostic (6.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.88e-3)"	0.6	0.1	0.5	0.3	1.0	0.0	0.4	0.8	0.6	0.6	0.1			0.0	0.7	0.0	1.3	0.7	1.6	1.3	0.5	0.6	1.3	0.1	0.3	1.6	0.6		1.2	1.1	0.0	1.0	0.0		0.3	0.0		0.9	0.0	0.7	2.8	0.4	0.0	0.8	0.4	0.8	1.3			2.0		0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.2	0.4	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.4	0.1	0.1	0.0	0.3	1.0	0.3	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.3	0.5	1.6	1.2	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.0	0.2	0.1	1.7	1.1	0.5	0.0	0.4	0.7	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.4	0.6	0.0	0.1	0.1	0.6	0.0	0.5	0.0	0.0	0.2	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZBTB4	"KAISO-L1, KIAA1538, ZNF903"	ENSG00000174282	"Zinc finger and BTB domain containing 4"	Q9P1Z0	17	7459366-7484263	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008980, HPA064763"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB008980: , HPA064763: AB_2685347"	"unprognostic (2.23e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-3)"	"prognostic favorable (2.53e-4)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.65e-9)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.04e-3)"	20.1	23.5	20.1	10.9	22.7	4.7	20.6	27.9	38.3	26.3	21.8	19.8	13.7	9.2	22.8	22.7	16.6	22.5	15.1	22.3	19.6	18.3	15.6	6.3	21.4	10.7	21.0	19.4	35.1	16.3	70.1	15.4	14.6	25.8	22.3	9.9	26.2	19.9	30.0	21.4	14.8	11.3	22.3	20.2	18.7	14.2	10.6	14.7	8.2	23.9	9.5	12.7	23.4	24.7	1.8	1.3	1.4	4.6	2.0	3.5	1.5	6.3	8.7	2.2	4.2	23.5	12.2	4.0	8.9	12.9	8.1	8.1	2.9	3.1	0.6	7.1	16.9	5.9	10.1	2.2	12.5	5.9	10.1	3.8	3.2	7.1	2.0	6.6	0.6	7.6	8.5	13.1	7.8	10.0	19.1	7.0	2.4	1.0	2.1	8.9	4.2	2.2	1.3	0.9	2.6	4.2	4.0	3.8	0.9	9.9	5.4	1.3	3.3	3.9	2.8	4.1	4.1	5.2	1.4	9.7	9.1	3.6	8.6	7.3	3.8	2.6	0.4	9.8	2.0	4.7	1.1	0.9	1.4	3.2	1.4	3.5	1.6	2.6	2.6	0.7	1.8	3.4	3.1	0.6	2.0	4.6	1.3	1.3	1.5	20.1	22.7	27.9	38.3	19.6	18.3	21.0	19.4	25.8	14.7	47.6	49.8	8.2	16.6	27.2	75.9	76.7	22.9	17.4	19.4	19.2	64.8	8.5	3.3	13.6	34.6	26.1	5.4	0.0	12.4	1.9	17.3	18.9	12.8	7.8	11.9	69.9	16.7	22.1	26.3	41.2	48.1	17.7	16.9	5.4	10.3	24.7	16.4	7.0	65.7	8.9	38.5	32.3	30.9	5.4	4.1	20.6	4.3	20.1	7.6	11.1
ZBTB48	"HKR3, TZAP, ZNF855"	ENSG00000204859	"Zinc finger and BTB domain containing 48"	P10074	1	6580001-6589280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030417	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030417: AB_10603145"	"unprognostic (6.66e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.15e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.15e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.70e-1)"	"prognostic favorable (5.19e-6)"	"unprognostic (7.73e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.91e-3)"	10.8	12.0	9.6	15.1	12.6	13.3	12.3	11.1	16.3	13.5	12.2	12.7	21.4	11.7	13.2	15.1	12.7	14.2	17.6	9.6	8.9	7.5	12.9	21.6	14.3	17.1	7.0	11.3	19.9	15.8	17.1	14.0	10.7	11.4	17.2	13.2	16.9	12.6	11.7	10.9	14.4	17.2	11.3	8.8	17.1	12.9	28.2	10.3	19.9	18.4	7.4	15.9	13.0	14.4	7.5	7.8	26.7	6.8	6.6	6.4	5.3	3.9	4.8	7.6	11.1	8.5	6.6	3.9	4.0	4.8	7.7	8.4	4.9	9.1	13.1	7.2	3.5	5.3	7.4	11.5	8.0	6.2	13.3	10.9	10.6	13.9	4.8	10.1	17.0	28.8	6.6	6.2	7.5	12.1	10.4	5.6	10.0	10.4	8.6	5.7	7.6	8.3	12.2	5.7	7.7	8.3	9.5	7.1	14.4	6.9	3.7	14.9	6.9	6.0	13.8	9.2	8.3	7.9	13.7	6.3	5.3	3.5	5.7	5.0	9.4	8.1	20.3	4.9	13.7	3.0	10.9	6.8	26.7	6.0	4.2	6.0	6.5	4.7	5.7	7.8	7.5	6.4	5.5	10.0	6.6	6.6	5.0	3.8	5.3	9.6	12.6	11.1	16.3	8.9	7.5	7.0	11.3	11.4	10.3	3.0	10.5	6.7	8.5	4.1	7.1	4.5	12.7	13.4	7.9	10.4	5.9	5.1	10.0	4.1	36.3	4.7	15.8	0.0	3.2	4.1	5.8	5.2	26.5	11.6	9.6	9.5	14.9	4.3	6.2	14.2	8.1	9.8	5.0	10.0	12.7	10.4	2.7	14.0	5.3	10.5	7.4	19.4	5.2	17.7	10.4	4.8	4.2	10.1	9.5	5.8
ZC3H7B	"DKFZp434K0920, FLJ13787, KIAA1031, RoXaN"	ENSG00000100403	"Zinc finger CCCH-type containing 7B"	Q9UGR2	22	41301522-41360147	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001784, HPA076092"	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA001784: AB_1080637, HPA076092: "	"unprognostic (1.71e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.73e-2)"	"unprognostic (7.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.19e-1)"	"prognostic favorable (5.43e-7)"	"unprognostic (1.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-1)"	21.7	31.9	31.0	14.7	24.9	10.9	13.4	30.0	45.6	17.8	13.3	24.2	13.7	18.8	19.0	11.3	15.1	21.3	14.4	17.1	30.5	20.2	21.3	29.0	18.4	14.9	24.5	27.8	34.3	23.9	41.7	21.9	14.4	29.4	18.8	10.7	20.4	32.8	22.7	17.2	15.4	19.6	16.6	21.7	19.4	16.1	9.8	28.0	13.1	37.2	9.2	11.7	14.4	11.8	1.9	1.5	0.5	0.6	1.4	1.4	0.3	22.2	12.5	16.6	10.0	15.3	13.9	19.5	25.6	27.4	21.4	16.9	13.5	9.3	12.6	31.6	35.5	12.0	15.2	14.0	24.0	11.0	28.8	23.1	11.3	15.4	17.2	20.5	21.6	9.9	17.4	13.8	18.4	22.6	18.3	23.1	10.0	22.6	7.0	18.0	22.5	16.9	11.2	11.9	16.9	9.5	26.1	10.5	14.4	18.2	16.0	10.8	8.1	23.5	14.4	12.1	12.1	9.5	14.6	46.1	21.0	22.0	6.4	15.6	12.3	6.8	12.7	17.6	10.7	18.1	0.0	0.6	0.5	1.0	0.4	1.0	1.9	1.2	1.1	0.5	1.8	1.4	0.9	0.0	1.4	0.2	1.5	0.9	0.3	31.0	24.9	30.0	45.6	30.5	20.2	24.5	27.8	29.4	28.0	11.9	20.3	13.7	10.3	6.4	20.6	8.3	22.9	12.0	18.2	21.0	17.7	7.7	6.6	13.0	0.7	16.5	13.8	0.0	11.2	7.7	10.8	15.7	8.1	35.4	10.0	39.7	32.2	20.3	10.8	2.4	30.8	7.4	11.8	16.2	13.6	7.8	16.5	5.8	27.3	16.7	22.5	19.4	12.5	1.9	5.1	5.1	5.1	8.3	16.9	13.7
ZEB2	"KIAA0569, SIP-1, SIP1, ZFHX1B"	ENSG00000169554	"Zinc finger E-box binding homeobox 2"	O60315	2	144364364-144524583	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 76.6"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 626.1;Kupffer cells: 357.2;Macrophages: 271.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 39.1;THP-1: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003456	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA003456: AB_10603840"	"unprognostic (1.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.77e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.04e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.32e-2)"	30.2	23.7	48.0	27.8	42.4	55.5	16.6	6.7	36.6	29.4	12.3	72.9	3.4	11.3	15.6	11.1	14.4	11.1	22.6	22.5	52.5	28.8	9.9	11.6	20.7	19.6	54.4	26.4	37.5	3.6	5.0	3.1	31.5	37.6	10.9	16.3	15.7	5.7	12.5	9.6	7.7	12.8	17.2	76.6	32.6	9.3	8.2	38.7	1.9	8.3	7.5	12.4	21.5	14.8	5.0	12.7	9.7	21.6	3.6	10.7	7.4	0.4	0.5	22.5	0.0	26.9	13.7	0.0	9.2	9.4	10.4	10.1	0.0	0.2	1.7	0.0	10.0	2.8	0.1	3.8	0.0	13.0	9.6	2.6	39.1	1.6	0.0	6.1	6.7	31.1	11.2	0.2	12.9	6.2	8.8	7.8	0.0	10.9	1.1	12.2	0.0	0.0	20.5	3.2	0.0	0.5	11.5	15.5	0.0	0.1	0.2	0.2	5.9	1.1	0.0	24.3	7.5	0.0	46.5	12.1	12.0	0.2	23.3	2.9	12.7	0.0	1.9	17.9	20.2	32.2	9.7	21.6	5.7	10.7	20.8	1.0	4.4	1.4	5.3	12.7	5.0	1.1	4.0	7.5	3.6	19.5	10.2	0.3	7.4	48.0	42.4	6.7	35.6	52.5	28.8	54.4	26.4	37.6	38.7	6.0	25.8	45.8	1.2	22.0	178.1	50.1	2.5	6.7	18.2	5.2	3.9	1.3	1.7	0.6	2.0	23.8	0.0	23.3	0.7	1.6	146.0	1.5	150.5	2.1	126.8	626.1	0.0	81.0	357.2	4.0	111.7	271.2	97.8	46.9	0.0	84.2	0.2	0.0	62.6	7.3	8.6	181.1	167.0	2.3	7.0	17.1	3.9	99.2	0.0	2.0
ZHX1-C8orf76		ENSG00000259305	"ZHX1-C8orf76 readthrough"	Q96EF9	8	123226189-123274284	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 9.5;Urothelial cells: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 24.3"									HPA023708	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023708: AB_1845785"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.49e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.34e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.64e-11)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-2)"	8.6	7.4	11.4	5.0	11.0	25.9	8.7	10.3	10.7	8.5	6.2	5.9	8.9	8.1	7.3	8.1	10.4	5.9	5.4	8.7	11.2	5.0	7.1	9.7	9.7	8.7	9.6	7.4	8.7	6.8	7.1	12.7	7.1	8.8	8.7	9.9	4.5	9.0	8.7	11.9	9.9	9.3	7.7	11.4	10.5	6.6	5.1	11.7	5.8	10.5	4.6	10.2	7.5	11.6	5.5	4.6	8.0	8.3	4.8	8.5	3.3	3.0	3.9	2.9	2.0	1.8	2.0	2.1	1.3	1.4	3.4	2.6	3.2	2.4	1.8	1.2	2.3	2.0	2.1	3.3	1.8	5.1	2.9	6.7	5.3	2.7	3.8	1.9	1.1	3.0	2.7	2.7	2.8	1.7	1.5	3.9	5.6	4.4	2.6	3.0	9.5	4.4	3.5	0.7	6.2	4.4	3.5	1.9	2.5	2.4	3.1	4.5	3.3	2.8	24.3	1.4	1.7	3.6	1.0	0.3	1.5	2.7	2.3	3.2	3.7	4.5	3.9	2.0	2.9	1.0	3.1	5.7	8.0	4.1	8.3	3.7	5.5	5.3	3.5	4.6	4.6	4.4	3.6	1.8	4.8	5.9	4.0	8.5	3.3	11.4	11.0	10.3	10.7	11.2	5.0	9.6	7.4	8.8	11.7	0.0	1.4	0.5	3.5	0.0	0.4	0.8	2.5	2.7	1.2	3.5	0.0	1.6	1.7	1.6	0.7	1.5	1.1	0.0	1.6	2.0	0.1	2.4	0.0	0.9	2.5	9.5	2.9	1.3	0.6	0.9	0.9	1.2	0.0	1.8	1.3	0.8	1.7	0.0	1.1	1.2	1.1	0.0	0.9	2.5	2.2	0.0	0.8	0.7	1.0	6.0
ZMYND15	DKFZp434N127	ENSG00000141497	"Zinc finger MYND-type containing 15"	Q9H091	17	4740015-4746119	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.6"	"Group enriched"	"Detected in many"	6	"Early spermatids: 141.0;monocytes: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.1;non-classical monocyte: 1.5"	"Group enriched"	"Detected in many"	11	"granulocytes: 1.1;monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"A-431: 5.1;CAPAN-2: 4.8;HaCaT: 3.9;T-47d: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023286			Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA023286: AB_1859076"	"unprognostic (2.30e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.62e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.49e-1)"	"unprognostic (6.72e-3)"	"unprognostic (4.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	3.6	1.6	2.3	2.9	2.0	0.9	2.0	0.7	2.7	1.3	1.0	5.1	1.4	5.2	1.8	4.5	1.2	1.5	3.8	3.8	3.6	1.8	2.4	3.5	6.1	4.9	3.7	1.7	0.9	4.7	12.5	1.8	1.5	3.4	1.9	1.0	4.2	3.8	2.7	0.4	1.8	3.9	1.2	4.8	6.2	2.4	25.6	2.9	0.7	1.4	0.7	0.8	1.6	0.9	0.0	0.1	1.1	1.5	0.0	0.0	0.2	5.1	0.9	0.0	2.5	0.1	0.2	0.4	0.1	1.4	1.3	3.1	2.3	4.8	0.0	0.2	0.0	0.6	3.9	0.9	0.4	0.1	0.5	1.7	0.0	0.5	1.3	0.8	0.1	1.4	0.2	0.6	0.2	0.2	0.7	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.7	0.6	0.6	0.0	0.1	1.4	1.6	2.3	0.0	3.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	1.5	0.0	0.0	0.2	2.3	2.0	0.7	2.7	3.6	1.8	3.7	1.7	3.4	2.9	0.0	1.3	0.0	5.2	0.8	0.1	0.6	0.0	0.0	1.2	1.8	0.0	0.0	0.0	1.4	141.0	0.3	4.0	0.0	3.5	0.0	0.3	5.3	0.0	0.2	5.0	0.0	1.2	3.7	7.6	15.1	0.6	10.7	1.7	36.9	2.6	1.4	2.6	0.6	2.1	0.7	0.2	0.0	0.5	0.7	1.2	0.6	0.0	0.0	0.6	7.4
ZNF232	ZSCAN11	ENSG00000167840	"Zinc finger protein 232"	Q9UNY5	17	5105541-5123116	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA027309, HPA028611"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA027309: AB_10603464, HPA028611: AB_2672700"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.69e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.12e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (6.55e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.49e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.61e-3)"	6.7	5.2	6.5	6.7	9.5	2.0	7.4	14.3	11.1	6.6	8.2	11.1	7.8	4.5	8.9	10.1	5.5	9.9	5.5	5.9	7.3	5.4	6.6	6.3	6.3	7.0	9.8	5.7	14.3	10.0	3.8	8.7	6.2	8.7	7.6	5.9	6.5	8.8	6.4	7.7	5.5	6.3	8.5	6.2	6.9	7.2	7.5	10.7	6.4	8.0	5.4	6.1	6.3	6.2	11.8	7.4	1.9	2.1	5.4	7.8	3.9	5.4	4.1	6.8	6.9	2.4	1.0	3.7	2.7	1.4	2.7	3.7	6.4	1.3	11.0	3.3	0.9	3.9	3.8	4.7	2.7	1.6	4.3	7.2	1.9	9.5	5.7	3.5	0.0	3.4	2.0	3.0	2.8	2.5	1.9	1.9	13.3	9.2	4.1	3.2	2.6	9.3	3.8	13.3	4.7	4.5	8.0	4.3	7.4	2.2	0.8	7.1	4.6	5.3	2.1	4.3	5.4	1.1	2.7	3.1	2.7	4.6	2.1	5.2	5.5	8.6	2.8	6.9	0.3	4.4	1.4	2.1	1.9	4.7	1.9	5.5	11.8	5.2	6.2	4.0	11.0	7.8	7.2	0.1	5.4	1.2	7.4	4.2	3.9	6.5	9.5	14.3	11.1	7.3	5.4	9.8	5.7	8.7	10.7	0.0	1.6	2.2	3.1	3.8	5.0	5.0	0.0	5.3	4.5	5.2	0.0	3.2	3.3	5.3	6.0	4.0	2.1	0.0	3.5	4.0	2.4	2.0	0.0	3.2	5.1	0.0	1.2	3.1	2.7	4.8	3.4	1.8	0.0	1.0	2.7	3.8	3.5	5.8	4.9	2.6	2.8	0.0	4.1	12.1	10.9	4.1	1.7	1.5	3.3	1.6
ZNF260	"ozrf1, Zfp260"	ENSG00000254004	"Zinc finger protein 260"	Q3ZCT1	19	36510695-36528660	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028806	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028806: AB_10795285"	"unprognostic (1.34e-1)"	"unprognostic (6.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.11e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (7.73e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.89e-3)"	8.4	9.4	10.3	7.6	16.8	2.3	12.0	18.4	14.1	10.8	7.0	6.2	9.4	6.2	11.2	7.9	8.0	8.4	8.2	7.5	11.2	9.5	11.6	8.5	7.3	12.4	17.1	9.1	13.4	6.6	20.4	19.5	10.9	11.9	10.3	7.1	5.9	8.8	7.6	4.8	10.0	7.7	8.1	20.6	8.3	8.1	4.5	15.4	17.3	14.7	5.5	9.7	10.7	8.4	5.9	3.2	6.8	3.5	4.1	7.2	3.0	7.9	8.1	18.8	14.1	5.8	8.9	8.2	7.0	7.5	6.5	8.3	3.6	4.5	5.2	11.5	5.6	4.9	3.0	9.4	4.3	10.0	6.9	4.1	7.8	6.2	4.1	8.1	3.9	6.5	8.0	7.2	6.7	10.3	9.3	8.6	7.9	6.1	5.8	12.8	4.3	14.4	2.5	11.9	4.9	3.5	9.6	11.6	3.9	7.2	14.3	13.6	14.9	15.5	8.3	5.7	12.1	7.0	7.4	7.4	11.3	11.8	6.6	6.2	7.5	14.3	12.3	0.3	4.1	15.2	6.8	2.8	3.0	4.0	2.5	4.2	5.1	5.3	3.2	3.2	5.9	7.2	5.5	1.6	4.1	3.5	2.2	4.6	3.0	10.3	16.8	18.4	14.1	11.2	9.5	17.1	9.1	11.9	15.4	8.9	3.8	4.4	7.3	9.2	7.6	7.5	0.0	5.3	12.5	0.0	7.9	5.5	5.0	7.1	7.4	6.7	2.5	0.0	3.9	5.7	6.1	7.0	8.1	3.0	4.1	20.6	11.5	9.8	3.3	3.1	5.5	4.9	1.7	7.2	6.6	7.5	5.2	2.9	7.8	6.7	7.4	6.5	4.8	5.6	3.7	11.4	3.4	6.9	5.0	10.8
ZNF318	"HRIHFB2436, ZFP318"	ENSG00000171467	"Zinc finger protein 318"	Q5VUA4	6	43307134-43369478	"Predicted intracellular proteins"	"Meiosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 78.2;Spermatogonia: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"naive B-cell: 6.3"	"Lineage enriched"	"Detected in many"	4	"B-cells: 6.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027022, HPA027031"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027022: AB_1859189, HPA027031: AB_1859190"	"unprognostic (1.64e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.61e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-2)"	8.3	7.1	14.2	15.3	13.7	9.9	12.2	24.7	17.7	12.5	8.9	10.4	9.2	7.1	12.7	11.1	7.0	9.0	7.1	7.6	12.8	6.3	7.3	8.3	9.2	23.6	15.4	9.4	13.2	8.6	14.6	8.0	7.9	11.4	10.2	8.2	7.9	7.9	8.6	8.6	11.7	10.0	9.2	9.0	14.6	6.8	39.2	16.8	10.0	13.7	4.7	23.6	9.8	10.9	6.3	0.9	0.4	0.7	0.7	1.4	0.5	15.4	3.9	11.3	18.8	10.0	9.0	5.6	6.7	8.9	8.2	7.1	4.1	2.0	24.6	3.8	8.9	9.6	7.0	12.6	5.9	10.7	6.4	6.4	6.8	5.0	6.5	5.0	12.1	5.5	5.7	6.3	6.9	6.1	6.9	6.3	7.0	9.1	12.3	8.6	5.5	3.6	7.7	5.1	26.2	3.7	4.5	11.0	3.9	4.5	3.7	10.4	6.4	5.2	4.6	5.5	9.2	5.7	16.9	6.3	11.5	5.7	7.7	6.6	7.3	5.9	17.6	3.6	9.3	6.4	0.0	0.7	0.0	1.4	0.5	0.4	1.4	1.2	0.9	0.9	6.3	0.9	1.0	0.4	0.7	0.4	0.7	1.2	0.5	14.2	13.7	24.7	17.7	12.8	6.3	15.4	9.4	11.4	16.8	8.9	12.6	7.3	4.2	8.7	15.4	7.7	12.7	6.7	7.9	8.7	7.9	4.9	3.3	4.1	21.1	4.7	5.7	0.0	4.0	3.8	6.4	3.2	5.8	16.8	5.5	23.8	5.2	14.1	10.8	12.9	5.8	6.6	3.3	4.6	4.9	10.2	4.2	9.1	9.2	3.4	12.1	25.8	3.9	78.2	41.7	4.4	1.5	5.0	8.5	1.3
ZNF354A	"EZNF, HKL1, KID-1, KID1, TCF17"	ENSG00000169131	"Zinc finger protein 354A"	O60765	5	178694605-178730702	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052043	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA052043: AB_2681706"	"unprognostic (2.79e-1)"	"unprognostic (3.44e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.66e-3)"	"prognostic favorable (8.28e-4)"	"unprognostic (4.06e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (8.71e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	14.0	7.0	13.0	12.1	13.6	14.2	14.2	13.3	14.4	12.6	15.0	6.7	11.4	7.1	13.7	13.3	10.4	11.7	9.8	14.5	13.2	9.3	18.0	6.2	10.8	12.7	16.7	16.1	10.9	15.0	11.7	14.1	14.0	13.4	13.3	10.0	7.1	8.8	15.1	11.9	12.3	10.6	13.6	12.9	17.1	10.4	14.0	14.4	13.1	15.1	8.6	14.2	17.0	25.1	5.7	5.3	15.0	5.8	6.0	6.4	3.6	4.3	3.4	7.1	18.8	12.4	10.1	29.4	5.0	6.7	7.0	7.5	5.0	7.3	5.8	6.6	4.5	12.9	8.6	2.6	21.3	10.8	7.7	8.1	1.7	4.2	0.6	9.4	0.0	4.9	7.9	13.7	6.1	12.5	9.0	6.6	7.9	1.4	0.0	10.1	8.7	8.7	5.8	6.2	4.0	8.8	6.5	1.2	3.6	6.5	4.4	7.8	8.5	6.3	7.2	9.7	9.8	5.9	8.5	5.1	7.9	5.2	4.5	4.2	1.9	4.0	3.6	0.2	1.3	9.9	4.4	5.8	14.5	5.1	3.8	6.4	5.7	4.6	5.7	5.3	3.6	5.3	3.8	15.0	6.0	3.9	1.9	4.1	3.6	13.0	13.6	13.3	14.4	13.2	9.3	16.7	16.1	13.4	14.4	11.9	6.1	3.2	10.0	4.4	8.9	5.5	0.0	12.0	10.3	7.0	13.7	10.6	11.6	9.8	9.2	8.0	2.1	0.0	6.6	10.6	6.1	5.3	5.8	0.8	8.0	6.4	4.6	6.2	8.2	3.2	6.4	7.8	10.1	3.6	2.2	7.4	6.7	0.0	9.9	13.5	9.7	6.5	9.2	22.3	9.8	4.8	10.2	10.9	4.3	6.9
ZNF480	MGC32104	ENSG00000198464	"Zinc finger protein 480"	Q8WV37	19	52297177-52325922	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA042218	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042218: AB_10794791"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (4.22e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.97e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.82e-3)"	9.8	8.4	8.2	7.9	15.4	7.0	7.1	13.6	12.5	6.5	8.3	4.8	3.4	7.9	6.2	2.4	8.5	4.5	4.7	17.9	8.7	3.2	10.9	7.5	8.4	9.8	13.1	4.1	6.0	3.8	5.6	10.7	6.2	12.5	5.9	8.6	4.9	8.4	5.5	12.9	8.0	9.3	5.1	8.7	15.0	8.0	3.3	12.6	10.8	8.4	7.9	12.3	8.7	8.2	16.6	17.0	9.4	9.1	14.6	15.0	5.9	3.2	13.4	8.8	10.2	10.4	9.8	7.0	8.6	12.7	6.2	7.3	6.0	4.8	16.7	5.4	7.1	11.4	7.2	9.4	8.7	9.0	0.1	15.8	17.0	6.7	5.7	10.0	24.0	13.9	8.9	11.2	8.5	10.1	13.0	8.9	14.6	12.2	6.0	13.8	5.4	21.9	4.9	6.8	10.9	11.0	11.3	9.3	13.8	8.9	23.9	8.6	7.2	12.5	9.1	3.5	18.9	7.5	17.7	15.2	6.2	7.8	3.5	13.3	13.7	25.3	34.6	2.7	13.2	10.9	7.7	8.5	9.4	12.0	8.2	13.7	16.6	12.0	13.9	10.4	16.5	11.5	15.0	3.6	14.6	9.1	17.0	13.4	5.9	8.2	15.4	13.6	12.5	8.7	3.2	13.1	4.1	12.5	12.6	32.8	10.2	16.1	11.4	4.8	4.0	37.0	10.2	20.1	14.8	3.5	2.0	7.5	14.9	15.0	1.5	18.5	10.3	23.3	24.0	12.9	7.1	10.7	11.6	13.5	15.1	6.4	12.1	14.7	14.0	2.1	8.3	16.7	6.8	19.8	17.3	4.1	29.6	8.6	7.8	20.7	6.6	0.0	9.2	1.8	5.6	7.3	12.4	23.5	16.1	18.3
ZNF660	FLJ36870	ENSG00000144792	"Zinc finger protein 660"	Q6AZW8	3	44578223-44599694	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 23.8;Muller glia cells: 30.4;Rod photoreceptor cells: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"myeloid DC: 1.1;naive B-cell: 1.3;NK-cell: 1.6;plasmacytoid DC: 3.7"	"Group enriched"	"Detected in many"	5	"B-cells: 1.3;dendritic cells: 3.7;NK-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"AF22: 5.6;HEL: 5.5;NTERA-2: 8.6;RH-30: 5.7;SuSa: 4.9"					"Low region specificity"	"Detected in all"			HPA029705	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center, Cytosol"		"HPA029705: AB_10602592"	"unprognostic (5.43e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.87e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.94e-2)"	3.1	3.1	3.5	3.0	5.9	3.5	3.0	10.3	7.2	7.6	3.8	3.8	4.4	1.3	7.9	5.2	2.2	5.2	3.6	2.9	4.4	3.8	2.5	1.3	2.9	4.2	5.7	6.2	11.3	2.6	6.3	11.5	3.7	6.0	5.7	2.2	5.5	2.1	4.7	2.3	2.1	2.7	5.9	6.4	3.4	2.7	4.4	4.7	1.8	4.7	0.8	3.1	4.1	4.1	1.3	3.7	0.4	0.4	1.6	0.3	0.2	0.0	0.0	5.6	1.3	0.1	0.0	0.8	0.6	1.4	0.8	0.8	0.0	0.0	0.1	1.2	0.5	0.0	0.0	1.8	0.0	1.0	0.0	0.0	5.5	0.4	0.8	1.3	0.1	0.0	2.3	0.1	2.0	0.0	0.1	1.3	0.0	0.0	0.3	2.9	0.0	0.0	3.2	8.6	0.0	0.0	0.1	5.7	0.0	0.1	0.3	1.4	3.8	0.0	0.0	0.1	4.9	0.1	2.1	0.4	1.6	1.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.2	0.1	0.1	0.2	0.2	0.3	1.1	1.3	0.2	0.2	0.2	1.6	0.0	3.7	0.0	0.2	3.5	5.9	10.3	7.2	4.4	3.8	5.7	6.2	6.0	4.7	0.0	5.9	0.0	0.8	0.1	23.8	1.9	5.1	1.4	5.7	0.0	5.9	0.0	0.0	0.9	8.0	3.6	0.0	0.0	0.5	0.0	2.4	0.6	5.8	0.0	1.6	11.1	4.1	1.8	0.6	1.3	4.6	1.1	0.0	3.6	0.1	30.4	0.8	0.0	3.2	0.1	22.7	0.0	2.5	3.9	3.1	0.0	0.0	0.8	0.2	0.3
ZSCAN22	"HKR2, ZNF50"	ENSG00000182318	"Zinc finger and SCAN domain containing 22"	P10073	19	58327019-58342332	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 5.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 18.2"	"Low region specificity"	"Detected in all"							HPA006471	Uncertain		Uncertain	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Actin filaments"	"HPA006471: AB_2221026"	"unprognostic (5.55e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.15e-3)"	"unprognostic (5.00e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.07e-1)"	4.8	5.6	4.1	8.5	6.1	3.0	10.8	9.3	6.2	6.7	4.8	4.7	9.3	5.1	5.7	4.2	6.1	4.6	3.5	4.9	4.3	4.1	4.2	7.7	4.8	4.8	9.7	3.7	7.8	7.3	9.4	9.1	5.3	6.8	5.1	4.3	2.7	7.0	9.2	6.1	8.1	5.2	5.6	3.9	5.2	5.5	5.7	6.2	8.0	6.5	4.3	6.4	4.6	5.3	3.2	3.0	2.7	2.3	3.2	5.6	2.3	2.8	5.3	2.9	4.4	3.4	2.1	3.1	2.4	1.2	1.5	1.4	2.8	2.0	2.4	1.6	2.1	1.9	2.3	4.1	2.8	1.6	3.6	18.2	4.9	4.9	2.6	2.7	3.9	5.1	2.4	2.8	3.4	3.6	2.8	2.2	2.4	4.9	4.5	2.6	2.4	1.9	1.8	2.5	3.6	5.9	2.7	4.5	3.9	1.6	3.8	4.6	3.3	3.6	5.0	2.2	2.5	2.4	2.6	2.1	8.3	2.4	2.1	4.2	4.5	6.1	1.8	3.3	2.7	2.9	0.3	2.1	2.7	5.6	1.8	3.9	2.6	3.3	4.6	3.0	3.2	2.9	2.9	0.7	3.2	2.3	1.4	2.6	2.3	4.1	6.1	9.3	6.2	4.3	4.1	9.7	3.7	6.8	6.2	0.0	5.5	0.0	0.4	1.5	0.7	0.4	2.5	1.4	2.3	1.8	0.0	0.7	1.7	0.8	0.1	0.9	0.5	0.0	0.6	0.7	0.9	0.9	0.0	0.8	0.4	1.6	0.0	0.0	0.8	0.0	2.0	1.1	1.7	1.8	0.7	0.3	1.2	0.9	0.4	0.5	0.7	0.0	0.8	2.2	1.3	3.1	0.6	1.3	0.9	0.4
ZSWIM7	SWS1	ENSG00000214941	"Zinc finger SWIM-type containing 7"	Q19AV6	17	15976560-15999717	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054681	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA054681: AB_2682572"	"unprognostic (3.07e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.54e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (4.23e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (1.70e-1)"	10.0	16.2	14.3	11.5	21.7	7.0	21.5	9.8	28.7	9.4	10.3	9.8	13.8	13.2	11.5	14.2	11.6	11.2	8.8	18.7	17.4	13.8	15.2	14.4	13.6	13.8	16.9	12.2	14.3	13.9	8.6	15.5	10.2	16.5	9.6	9.1	9.9	14.0	13.1	49.2	13.8	9.3	11.2	22.1	12.2	10.5	10.8	12.1	6.2	12.1	8.4	7.3	11.4	11.2	17.2	26.0	15.2	17.2	10.0	12.6	12.2	10.1	14.9	8.1	18.6	3.3	3.1	9.4	6.9	2.6	7.3	5.4	2.8	3.0	4.9	6.1	7.5	2.2	3.3	2.5	5.5	3.5	5.0	9.1	5.5	6.9	5.7	7.7	4.4	9.3	7.5	9.9	4.0	6.9	1.1	9.3	12.8	3.5	2.7	3.7	13.8	15.2	10.5	4.9	14.9	8.9	9.7	19.8	7.6	6.6	5.6	2.7	11.8	10.6	10.7	6.9	21.8	7.7	1.1	13.1	11.9	4.1	3.1	5.9	1.3	3.6	5.6	10.2	5.6	10.1	15.2	17.2	7.0	8.9	16.1	9.3	17.2	10.4	8.5	26.0	14.3	12.6	12.0	1.0	10.0	11.3	16.1	7.5	12.2	14.3	21.7	9.8	28.7	17.4	13.8	16.9	12.2	16.5	12.1	32.8	55.7	24.4	28.2	22.8	38.5	59.6	68.8	41.5	26.1	38.4	58.9	74.3	72.9	53.3	8.3	29.2	35.8	0.0	45.1	51.4	24.4	30.3	54.3	39.8	44.0	17.5	48.8	32.5	52.9	9.8	42.0	43.4	52.3	18.0	36.4	46.9	43.1	35.1	37.4	102.1	54.4	25.8	26.9	89.2	59.4	24.1	60.9	27.9	31.8	20.3